{"version":3,"sources":["logo.svg","App.js","reportWebVitals.js","index.js"],"names":["App","useState","responsive","setResponsive","tableBodyHeight","setTableBodyHeight","get_cell_style","val","style","position","height","top","right","bottom","left","boxSizing","display","width","overflow","textOverflow","whiteSpace","columns","name","options","customBodyRender","href","Fragment","FormControl","marginLeft","InputLabel","id","Select","labelId","value","marginBottom","marginRight","onChange","e","target","MenuItem","title","data","filter","filterType","resizableColumns","fixedHeader","draggableColumns","enabled","reportWebVitals","onPerfEntry","Function","then","getCLS","getFID","getFCP","getLCP","getTTFB","ReactDOM","render","StrictMode","document","getElementById"],"mappings":"6NAAe,I,oEC+0BAA,MAn0Bf,WACE,MAAoCC,mBAAS,YAA7C,mBAAOC,EAAP,KAAmBC,EAAnB,KACA,EAA8CF,mBAAS,QAAvD,mBAAOG,EAAP,KAAwBC,EAAxB,KACA,EAAoDJ,mBAAS,IAA7D,mBAIA,SAASK,EAAeC,GAiBtB,OACE,qBAAKC,MAAO,CAAEC,SAAU,WAAYC,OAAQ,QAA5C,SACE,qBAAKF,MAlBS,CAChBC,SAAU,WACVE,IAAK,EACLC,MAAO,EACPC,OAAQ,EACRC,KAAM,EACNC,UAAW,aACXC,QAAS,QACTC,MAAO,QAUL,SACE,qBAAKT,MATK,CACdO,UAAW,aACXG,SAAU,SACVC,aAAc,WACdC,WAAY,UAKR,SAAwBb,QAxBhC,UAyDA,IAAMc,EAAU,CACd,CAAEC,KAAM,oBAAqBC,QAAS,CAAEC,iBAAkBlB,IAC1D,CAAEgB,KAAM,wBAAyBC,QAAS,CAAEC,iBA7B9C,SAA4BjB,GAiB1B,OACE,qBAAKC,MAAO,CAAEC,SAAU,WAAYC,OAAQ,QAA5C,SACE,qBAAKF,MAlBS,CAChBC,SAAU,WACVE,IAAK,EACLC,MAAO,EACPC,OAAQ,EACRC,KAAM,EACNC,UAAW,aACXC,QAAS,QACTC,MAAO,QAUL,SACE,qBAAKT,MATK,CACdO,UAAW,aACXG,SAAU,SACVC,aAAc,WACdC,WAAY,UAKR,SAAuB,mBAAGK,KAAMlB,EAAT,SAAeA,aAU5C,CAAEe,KAAM,aAAcC,QAAS,CAAEC,iBAAkBlB,IACnD,CAAEgB,KAAM,wBAAyBC,QAAS,CAAEC,iBAAkBlB,IAC9D,CAAEgB,KAAM,cAAeC,QAAS,CAAEC,iBAAkBlB,IACpD,CAAEgB,KAAM,oBAAqBC,QAAS,CAAEC,iBAAkBlB,IAC1D,CAAEgB,KAAM,oBAAqBC,QAAS,CAAEC,iBAAkBlB,IAC1D,CAAEgB,KAAM,sBAAuBC,QAAS,CAAEC,iBAAkBlB,IAC5D,CAAEgB,KAAM,+BAAgCC,QAAS,CAAEC,iBAAkBlB,IACrE,CAAEgB,KAAM,wCAAyCC,QAAS,CAAEC,iBAAkBlB,IAC9E,CAAEgB,KAAM,oBAAqBC,QAAS,CAAEC,iBAAkBlB,IAC1D,CAAEgB,KAAM,uBAAwBC,QAAS,CAAEC,iBAAkBlB,IAC7D,CAAEgB,KAAM,gCAAiCC,QAAS,CAAEC,iBAAkBlB,IACtE,CAAEgB,KAAM,yCAA0CC,QAAS,CAAEC,iBAAkBlB,IAC/E,CAAEgB,KAAM,sBAAuBC,QAAS,CAAEC,iBAAkBlB,IAC5D,CAAEgB,KAAM,aAAcC,QAAS,CAAEC,iBAAkBlB,IACnD,CAAEgB,KAAM,mBAAoBC,QAAS,CAAEC,iBAAkBlB,IACzD,CAAEgB,KAAM,4BAA6BC,QAAS,CAAEC,iBAAkBlB,IAClE,CAAEgB,KAAM,qCAAsCC,QAAS,CAAEC,iBAAkBlB,IAC3E,CAAEgB,KAAM,UAAWC,QAAS,CAAEC,iBAAkBlB,IAChD,CAAEgB,KAAM,WAAYC,QAAS,CAAEC,iBAAkBlB,IACjD,CAAEgB,KAAM,gBAAiBC,QAAS,CAAEC,iBAAkBlB,IACtD,CAAEgB,KAAM,mBAAoBC,QAAS,CAAEC,iBAAkBlB,IACzD,CAAEgB,KAAM,kBAAmBC,QAAS,CAAEC,iBAAkBlB,IACxD,CAAEgB,KAAM,kBAAmBC,QAAS,CAAEC,iBAAkBlB,IACxD,CAAEgB,KAAM,sCAAuCC,QAAS,CAAEC,iBAAkBlB,IAC5E,CAAEgB,KAAM,mBAAoBC,QAAS,CAAEC,iBAAkBlB,IACzD,CAAEgB,KAAM,0BAA2BC,QAAS,CAAEC,iBAAkBlB,IAChE,CAAEgB,KAAM,eAAgBC,QAAS,CAAEC,iBAAkBlB,IACrD,CAAEgB,KAAM,yBAA0BC,QAAS,CAAEC,iBAAkBlB,IAC/D,CAAEgB,KAAM,wBAAyBC,QAAS,CAAEC,iBAAkBlB,IAC9D,CAAEgB,KAAM,iBAAkBC,QAAS,CAAEC,iBAAkBlB,IACvD,CAAEgB,KAAM,WAAYC,QAAS,CAAEC,iBAAkBlB,IACjD,CAAEgB,KAAM,mBAAoBC,QAAS,CAAEC,iBAAkBlB,IACzD,CAAEgB,KAAM,eAAgBC,QAAS,CAAEC,iBAAkBlB,IACrD,CAAEgB,KAAM,qBAAsBC,QAAS,CAAEC,iBAAkBlB,IAC3D,CAAEgB,KAAM,yBAA0BC,QAAS,CAAEC,iBAAkBlB,IAC/D,CAAEgB,KAAM,qBAAsBC,QAAS,CAAEC,iBAAkBlB,IAC3D,CAAEgB,KAAM,WAAYC,QAAS,CAAEC,iBAAkBlB,IACjD,CAAEgB,KAAM,2BAA4BC,QAAS,CAAEC,iBAAkBlB,IACjE,CAAEgB,KAAM,qCAAsCC,QAAS,CAAEC,iBAAkBlB,KA2qB7E,OACE,eAAC,IAAMoB,SAAP,WACE,eAACC,EAAA,EAAD,CACEnB,MAAO,CAAEoB,WAAY,IADvB,UAGE,cAACC,EAAA,EAAD,CAAYC,GAAG,2BAAf,+BACA,eAACC,EAAA,EAAD,CACEC,QAAQ,2BACRF,GAAG,qBACHG,MAAO/B,EACPM,MAAO,CAAES,MAAO,QAASiB,aAAc,OAAQC,YAAa,IAC5DC,SAAU,SAACC,GAAD,OAAOlC,EAAckC,EAAEC,OAAOL,QAL1C,UAOE,cAACM,EAAA,EAAD,CAAUN,MAAO,WAAjB,sBACA,cAACM,EAAA,EAAD,CAAUN,MAAO,WAAjB,sBACA,cAACM,EAAA,EAAD,CAAUN,MAAO,SAAjB,oBAEA,cAACM,EAAA,EAAD,CAAUN,MAAO,SAAjB,iCACA,cAACM,EAAA,EAAD,CAAUN,MAAO,kBAAjB,0CAGA,cAACM,EAAA,EAAD,CAAUN,MAAO,UAAjB,wCAGJ,eAACN,EAAA,EAAD,CACEnB,MAAO,CAAEoB,WAAY,IADvB,UAGE,cAACC,EAAA,EAAD,CAAYC,GAAG,2BAAf,+BACA,eAACC,EAAA,EAAD,CACEC,QAAQ,2BACRF,GAAG,qBACHG,MAAO7B,EACPI,MAAO,CAAES,MAAO,QAASiB,aAAc,OAAQC,YAAa,IAC5DC,SAAU,SAACC,GAAD,OAAOhC,EAAmBgC,EAAEC,OAAOL,QAL/C,UAOE,cAACM,EAAA,EAAD,CAAUN,MAAO,GAAjB,qBACA,cAACM,EAAA,EAAD,CAAUN,MAAO,QAAjB,mBACA,cAACM,EAAA,EAAD,CAAUN,MAAO,QAAjB,mBACA,cAACM,EAAA,EAAD,CAAUN,MAAO,OAAjB,wBAGJ,cAAC,IAAD,CACEO,MAAO,KACPC,KAhsBO,CACb,CAAC,oBAAqB,4DAA6D,sDAAuD,0CAA2C,mGAAoG,MAAO,aAAc,YAAa,MAAO,YAAa,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,2CAA4C,kBAAmB,wWAAyW,8DAA+D,6GAA8G,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,mFAAoF,GAAI,KAC1sC,CAAC,yBAA0B,iEAAkE,uCAAwC,qCAAsC,0GAA2G,QAAS,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,0DAA2D,yBAA0B,qkBAAskB,+GAAgH,sDAAuD,wGAAyG,GAAI,cAAe,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,aAAc,GAAI,KACl+C,CAAC,eAAgB,uDAAwD,wCAAyC,wCAAyC,uHAAwH,QAAS,aAAc,YAAa,MAAO,YAAa,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,gDAAiD,wBAAyB,kdAAmd,sHAAuH,sFAAuF,oBAAqB,GAAI,eAAgB,aAAc,MAAO,GAAI,qBAAsB,GAAI,SAAU,aAAc,KAAM,IAAK,oBAAqB,8CAA+C,GAAI,KACz2C,CAAC,UAAW,kDAAmD,uDAAwD,0CAA2C,8GAA+G,QAAS,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,mDAAoD,oBAAqB,ogBAAsf,kHAAmH,sDAAuD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,4DAA6D,GAAI,KACz0C,CAAC,wBAAyB,gEAAiE,2DAA4D,2CAA4C,+GAAgH,QAAS,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,+CAAgD,GAAI,kuBAAmuB,iFAAkF,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,MAAO,GAAI,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,mDAAoD,GAAI,KAClkD,CAAC,sBAAuB,6DAA8D,qDAAsD,kCAAmC,6IAA8I,QAAS,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,sDAAuD,sBAAuB,uhBAAwhB,2FAA4F,2EAA4E,GAAI,GAAI,GAAI,aAAc,MAAO,GAAI,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,4CAA6C,GAAI,KAC53C,CAAC,yBAA0B,kDAAmD,2CAA4C,uCAAwC,mGAAoG,QAAS,aAAc,YAAa,MAAO,YAAa,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,2CAA4C,mBAAoB,qeAAie,2GAAuG,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,cAAe,GAAI,KACjxC,CAAC,WAAY,mDAAoD,kFAAmF,2CAA4C,mIAAoI,QAAS,aAAc,UAAW,MAAO,UAAW,QAAS,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,6CAA8C,qBAAsB,shBAAkhB,oFAAqF,8FAA+F,yBAA0B,GAAI,eAAgB,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,qDAAsD,GAAI,KAC56C,CAAC,UAAW,kDAAmD,yEAA0E,oCAAqC,+IAAgJ,QAAS,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,4CAA6C,oBAAqB,8qBAA+qB,wGAAyG,6GAA8G,GAAI,GAAI,GAAI,aAAc,QAAS,GAAI,sBAAuB,GAAI,SAAU,aAAc,KAAM,IAAK,oBAAqB,2EAA4E,GAAI,KAC9mD,CAAC,oBAAqB,4DAA6D,oDAAqD,iDAAkD,4FAA6F,QAAS,aAAc,YAAa,MAAO,YAAa,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,sDAAuD,uBAAwB,kTAAmT,oEAAqE,sDAAuD,wGAAyG,GAAI,gBAAiB,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,oEAAqE,GAAI,KAC1tC,CAAC,oBAAqB,6DAA8D,oDAAqD,0CAA2C,+HAAgI,QAAS,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,sBAAuB,sDAAuD,oBAAqB,ulCAAikC,4FAA6F,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,6BAA8B,GAAI,KACj9D,CAAC,WAAY,mDAAoD,2CAA4C,0CAA2C,iIAAkI,QAAS,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,yBAA0B,0DAA2D,sBAAuB,ibAAkb,4GAA6G,sDAAuD,wGAAyG,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,4EAA6E,GAAI,KACt5C,CAAC,iBAAkB,yDAA0D,yDAA0D,oCAAqC,6EAA8E,QAAS,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,gCAAiC,wDAAyD,0BAA2B,iWAAmV,+GAAgH,cAAe,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,mCAAoC,GAAI,KAC7lC,CAAC,qBAAsB,qDAAsD,6BAA8B,0CAA2C,2EAA4E,QAAS,aAAc,YAAa,MAAO,YAAa,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,qCAAsC,uDAAwD,GAAI,8MAA+M,2FAA4F,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,oBAAqB,GAAI,KAC16B,CAAC,sBAAuB,kEAAmE,oCAAqC,uCAAwC,gHAAiH,QAAS,aAAc,YAAa,MAAO,YAAa,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,oBAAqB,4CAA6C,kBAAmB,oHAAqH,GAAI,sDAAuD,oBAAqB,GAAI,gBAAiB,aAAc,MAAO,IAAK,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,GAAI,GAAI,KACn0B,CAAC,kBAAmB,0DAA2D,iDAAkD,0CAA2C,sIAAuI,QAAS,aAAc,GAAI,GAAI,GAAI,2BAA4B,YAAa,MAAO,YAAa,SAAU,SAAU,aAAc,MAAO,aAAc,4BAA6B,kDAAmD,2BAA4B,2fAA4f,2FAA4F,sDAAuD,GAAI,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,MAAO,IAAK,oBAAqB,kCAAmC,GAAI,KAC72C,CAAC,cAAe,sDAAuD,2EAA4E,wCAAyC,6HAA8H,QAAS,aAAc,YAAa,MAAO,YAAa,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,gDAAiD,uBAAwB,yhBAA0hB,iGAAkG,0EAA2E,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,mDAAoD,GAAI,KAC74C,CAAC,cAAe,sDAAuD,uDAAwD,mCAAoC,+GAAgH,QAAS,aAAc,YAAa,MAAO,YAAa,iBAAkB,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,oDAAqD,kCAAmC,qdAAid,2GAA4G,cAAe,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,iBAAkB,GAAI,SAAU,aAAc,KAAM,IAAK,oBAAqB,gCAAiC,GAAI,KAC3yC,CAAC,oBAAqB,4DAA6D,iDAAkD,0CAA2C,kIAAmI,QAAS,aAAc,YAAa,MAAO,YAAa,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,sBAAuB,2CAA4C,kBAAmB,ykBAA0kB,kFAAmF,sDAAuD,wGAAyG,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,2CAA4C,GAAI,KACnhD,CAAC,YAAa,oDAAqD,uFAAwF,wCAAyC,uHAAwH,QAAS,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,6CAA8C,qBAAsB,gvBAA4uB,+CAAgD,0GAA2G,6EAA8E,GAAI,cAAe,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,2BAA4B,GAAI,KAChoD,CAAC,cAAe,sDAAuD,uDAAwD,2CAA4C,+IAAgJ,QAAS,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,gDAAiD,sBAAuB,yaAAqa,yGAA0G,0EAA2E,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,4DAA6D,GAAI,KACjzC,CAAC,UAAW,kDAAmD,yCAA0C,wCAAyC,qGAAsG,QAAS,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,2BAA4B,0CAA2C,yBAA0B,mhBAAohB,8FAA+F,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,GAAI,GAAI,MACz0C,CAAC,wBAAyB,gEAAiE,yBAA0B,oCAAqC,uHAAwH,QAAS,aAAc,WAAY,MAAO,WAAY,OAAQ,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,GAAI,GAAI,iLAAkL,oGAAqG,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,OAAQ,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,kDAAmD,GAAI,KAC/4B,CAAC,sBAAuB,8DAA+D,2CAA4C,0CAA2C,6HAA8H,QAAS,aAAc,WAAY,MAAO,WAAY,gBAAiB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,4BAA6B,+CAAgD,sBAAuB,saAAua,qGAAsG,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,iBAAkB,GAAI,MAC3xC,CAAC,UAAW,kDAAmD,oDAAqD,uCAAwC,gIAAiI,QAAS,aAAc,WAAY,MAAO,WAAY,iBAAkB,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,iDAAkD,8BAA+B,00CAAmzC,mGAAoG,sDAAuD,wGAAyG,GAAI,cAAe,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,sDAAuD,GAAI,KAChvE,CAAC,SAAU,iDAAkD,iDAAkD,yCAA0C,+IAAgJ,QAAS,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,+CAAgD,kBAAmB,0ZAAsZ,+DAAgE,qEAAsE,oBAAqB,GAAI,cAAe,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,qCAAsC,GAAI,KACptC,CAAC,qBAAsB,6DAA8D,iDAAkD,4CAA6C,oEAAqE,QAAS,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,qBAAsB,2DAA4D,mBAAoB,uvCAAouC,+FAAgG,sDAAuD,wGAAyG,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,MAAO,IAAK,kCAAmC,6EAA8E,GAAI,KACtrE,CAAC,UAAW,kDAAmD,8DAA+D,uCAAwC,6GAA8G,QAAS,aAAc,WAAY,MAAO,WAAY,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,8DAA+D,mBAAoB,wqBAAyqB,4IAA6I,sDAAuD,wGAAyG,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,eAAgB,GAAI,MAC3lD,CAAC,SAAU,iDAAkD,yDAA0D,0CAA2C,sIAAuI,QAAS,aAAc,YAAa,MAAO,YAAa,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,2CAA4C,qBAAsB,yXAA0X,2EAA4E,6GAA8G,GAAI,GAAI,cAAe,aAAc,QAAS,IAAK,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,kCAAmC,GAAI,KACxtC,CAAC,eAAgB,uDAAwD,6CAA8C,2CAA4C,uIAAwI,QAAS,aAAc,YAAa,MAAO,YAAa,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,8BAA+B,+CAAgD,wBAAyB,yYAA0Y,sFAAuF,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,GAAI,GAAI,KACjtC,CAAC,SAAU,iDAAkD,gEAAiE,0CAA2C,yHAA0H,QAAS,aAAc,YAAa,MAAO,YAAa,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,2CAA4C,oBAAqB,8eAA0e,qGAAsG,8EAA+E,wGAAyG,GAAI,eAAgB,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,6CAA8C,GAAI,KAC96C,CAAC,sBAAuB,8DAA+D,sCAAuC,sCAAuC,sGAAuG,QAAS,aAAc,GAAI,GAAI,GAAI,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,iCAAkC,wDAAyD,8BAA+B,uUAAwU,uGAAwG,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,qDAAsD,GAAI,KACtsC,CAAC,sBAAuB,8DAA+D,yBAA0B,0CAA2C,wHAAyH,QAAS,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,yBAA0B,sDAAuD,8BAA+B,woBAAyoB,0GAA2G,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,uFAAwF,GAAI,MAC9jD,CAAC,OAAQ,oDAAqD,oDAAqD,0CAA2C,sGAAuG,QAAS,aAAc,GAAI,GAAI,GAAI,2BAA4B,YAAa,MAAO,YAAa,SAAU,SAAU,aAAc,MAAO,aAAc,oBAAqB,4CAA6C,gBAAiB,0ZAA2Z,uHAAwH,sDAAuD,wGAAyG,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,GAAI,GAAI,GAAI,4BAA6B,GAAI,KAC3yC,CAAC,qBAAsB,6DAA8D,2DAA4D,wCAAyC,uHAAwH,QAAS,aAAc,YAAa,MAAO,YAAa,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,uDAAwD,iBAAkB,4pBAA6pB,iFAAkF,sDAAuD,GAAI,GAAI,gBAAiB,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,6BAA8B,GAAI,KACv9C,CAAC,aAAc,2DAA4D,6CAA8C,yCAA0C,mGAAoG,QAAS,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,mDAAoD,sBAAuB,ycAA0c,0FAA2F,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,MAAO,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,qDAAsD,GAAI,MACvxC,CAAC,mBAAoB,2DAA4D,+EAAgF,uCAAwC,+HAAgI,QAAS,aAAc,YAAa,MAAO,YAAa,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,gCAAiC,oDAAqD,yBAA0B,i/BAAk/B,8FAA+F,sDAAuD,UAAW,GAAI,eAAgB,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,8DAA+D,GAAI,KACl4D,CAAC,SAAU,mDAAoD,2DAA4D,2CAA4C,sIAAuI,QAAS,aAAc,YAAa,MAAO,YAAa,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,2CAA4C,gBAAiB,i0BAAk0B,gFAAiF,gEAAiE,GAAI,GAAI,gBAAiB,aAAc,OAAQ,IAAK,sBAAuB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,wBAAyB,GAAI,KAC/mD,CAAC,cAAe,sDAAuD,sCAAuC,yCAA0C,yIAA0I,QAAS,aAAc,WAAY,MAAO,WAAY,iBAAkB,WAAY,MAAO,WAAY,SAAU,WAAY,YAAa,MAAO,YAAa,4BAA6B,oDAAqD,sBAAuB,kcAAmc,0EAA2E,sDAAuD,GAAI,GAAI,QAAS,aAAc,OAAQ,IAAK,MAAO,aAAc,SAAU,aAAc,MAAO,GAAI,eAAgB,gCAAiC,GAAI,KACvwC,CAAC,SAAU,iDAAkD,+DAAgE,uCAAwC,+IAAgJ,QAAS,aAAc,GAAI,GAAI,GAAI,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,4CAA6C,qBAAsB,2bAAub,0DAA2D,sDAAuD,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,6BAA8B,GAAI,KAC/rC,CAAC,mBAAoB,2DAA4D,8BAA+B,uCAAwC,uHAAwH,QAAS,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,oDAAqD,2BAA4B,oiBAAqiB,SAAU,yCAA0C,oBAAqB,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,IAAK,oBAAqB,kCAAmC,GAAI,KACnxC,CAAC,2BAA4B,mEAAoE,+EAAgF,oCAAqC,yIAA0I,QAAS,aAAc,YAAa,MAAO,YAAa,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,wCAAyC,6DAA8D,gCAAiC,kqDAA8pD,8BAA+B,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,kEAAmE,GAAI,KACjkF,CAAC,WAAY,mDAAoD,+EAAgF,0CAA2C,oIAAqI,QAAS,aAAc,WAAY,MAAO,WAAY,iBAAkB,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,sBAAuB,6CAA8C,oBAAqB,kjBAAmjB,oFAAqF,8EAA+E,wGAAyG,GAAI,cAAe,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,uBAAwB,GAAI,KAC7+C,CAAC,uBAAwB,+DAAgE,oEAAqE,0CAA2C,6GAA8G,QAAS,aAAc,WAAY,MAAO,WAAY,2BAA4B,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,wBAAyB,yDAA0D,qBAAsB,uxBAA+vB,+DAAgE,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,gBAAiB,GAAI,KACtmD,CAAC,mBAAoB,2DAA4D,sCAAuC,qCAAsC,+IAAgJ,QAAS,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,iCAAkC,oDAAqD,sCAAuC,sbAAub,uGAAwG,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,0BAA2B,GAAI,KACn1C,CAAC,sBAAuB,gEAAiE,gBAAiB,wCAAyC,uHAAwH,QAAS,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,yBAA0B,4DAA6D,mBAAoB,ysBAAgsB,6HAA8H,yCAA0C,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,uCAAwC,GAAI,KAC5jD,CAAC,YAAa,oDAAqD,mEAAoE,wCAAyC,wIAAyI,QAAS,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,8CAA+C,qBAAsB,8eAA+e,sGAAuG,8EAA+E,wGAAyG,GAAI,cAAe,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,mDAAoD,GAAI,KACh9C,CAAC,gBAAiB,4DAA6D,iDAAkD,0CAA2C,mHAAoH,QAAS,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,wBAAyB,kDAAmD,gBAAiB,+UAAgV,yGAA0G,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,yCAA0C,GAAI,KAC9sC,CAAC,oBAAqB,4DAA6D,+DAAgE,uCAAwC,iHAAkH,QAAS,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,2BAA4B,wDAAyD,GAAI,4iBAA6iB,sHAAuH,sDAAuD,oBAAqB,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,GAAI,gCAAiC,GAAI,KAC55C,CAAC,aAAc,qDAAsD,yEAA0E,sCAAuC,+IAAgJ,QAAS,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,wBAAyB,iDAAkD,uBAAwB,qeAAse,mGAAoG,sFAAuF,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,mBAAoB,GAAI,MAC93C,CAAC,UAAW,kDAAmD,sCAAuC,uCAAwC,yIAA0I,QAAS,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,qBAAsB,2CAA4C,mBAAoB,g4BAAi4B,mIAAoI,sDAAuD,oBAAqB,GAAI,eAAgB,aAAc,OAAQ,IAAK,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,yCAA0C,GAAI,KAC/uD,CAAC,8BAA+B,sEAAuE,gFAAiF,6CAA8C,uIAAwI,QAAS,aAAc,UAAW,MAAO,UAAW,QAAS,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,2CAA4C,GAAI,w4BAAo4B,uFAAwF,qEAAsE,wGAAyG,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,IAAK,kCAAmC,iDAAkD,GAAI,KACt3D,CAAC,4BAA6B,6DAA8D,gDAAiD,sCAAuC,4IAA6I,QAAS,aAAc,YAAa,MAAO,YAAa,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,8BAA+B,gDAAiD,oBAAqB,icAAkc,gFAAiF,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,IAAK,MAAO,aAAc,SAAU,aAAc,MAAO,GAAI,GAAI,mBAAoB,GAAI,KACzyC,CAAC,qBAAsB,6DAA8D,4EAA6E,0CAA2C,yIAA0I,QAAS,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,2BAA4B,uDAAwD,oBAAqB,4oBAA6oB,mGAAoG,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,+DAAgE,GAAI,KAC1kD,CAAC,WAAY,+DAAgE,qDAAsD,sCAAuC,uHAAwH,QAAS,aAAc,YAAa,MAAO,YAAa,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,wBAAyB,6CAA8C,uBAAwB,+oBAAgpB,yDAA0D,sDAAuD,wGAAyG,GAAI,eAAgB,aAAc,OAAQ,IAAK,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,iBAAkB,GAAI,MACzgD,CAAC,WAAY,mDAAoD,iDAAkD,iDAAkD,iHAAkH,QAAS,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,sBAAuB,GAAI,oBAAqB,41BAA80B,wBAAyB,sDAAuD,GAAI,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,gBAAiB,GAAI,KACl/C,CAAC,oBAAqB,4DAA6D,8CAA+C,sCAAuC,wGAAyG,QAAS,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,kCAAmC,0DAA2D,4BAA6B,oOAAqO,+DAAgE,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,YAAa,GAAI,KACrhC,CAAC,uBAAwB,+DAAgE,8CAA+C,0CAA2C,wIAAyI,QAAS,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,wBAAyB,wDAAyD,qBAAsB,4hBAA6hB,+DAAgE,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,sCAAuC,GAAI,KAC94C,CAAC,YAAa,oDAAqD,sDAAuD,0CAA2C,oIAAqI,QAAS,aAAc,WAAY,MAAO,WAAY,QAAS,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,mDAAoD,wBAAyB,qgCAAu/B,4GAA6G,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,QAAS,GAAI,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,sDAAuD,GAAI,KACn4D,CAAC,sBAAuB,8DAA+D,6CAA8C,0CAA2C,iHAAkH,QAAS,aAAc,YAAa,MAAO,YAAa,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,wDAAyD,qBAAsB,uiCAAohC,oEAAqE,sDAAuD,oBAAqB,GAAI,cAAe,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,6BAA8B,GAAI,KACt0D,CAAC,gBAAiB,wDAAyD,6CAA8C,0CAA2C,2FAA4F,QAAS,aAAc,YAAa,MAAO,YAAa,WAAY,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,+BAAgC,kDAAmD,wBAAyB,8yBAA+yB,6KAAyK,sDAAuD,wGAAyG,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,uBAAwB,GAAI,KACpwD,CAAC,WAAY,mDAAoD,6CAA8C,wCAAyC,sFAAuF,QAAS,aAAc,YAAa,MAAO,YAAa,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,0BAA2B,gDAAiD,wBAAyB,yhFAA6gF,kIAAmI,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,iBAAkB,GAAI,MACt3G,CAAC,kBAAmB,0DAA2D,iDAAkD,iDAAkD,4FAA6F,QAAS,aAAc,YAAa,MAAO,YAAa,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,0BAA2B,0CAA2C,uBAAwB,0gBAA2gB,mEAAoE,8EAA+E,oBAAqB,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,kBAAmB,GAAI,KACl0C,CAAC,uBAAwB,+DAAgE,oEAAqE,4CAA6C,sGAAuG,QAAS,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,sEAAuE,GAAI,2iCAAuiC,yGAA0G,qEAAsE,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,+EAAgF,GAAI,KAC/9D,CAAC,uBAAwB,+DAAgE,yCAA0C,uCAAwC,0HAA2H,QAAS,aAAc,WAAY,MAAO,WAAY,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,sCAAuC,6DAA8D,gCAAiC,i5BAAw4B,8EAA+E,sDAAuD,oBAAqB,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,iCAAkC,GAAI,KACpuD,CAAC,aAAc,qDAAsD,iDAAkD,wCAAyC,4HAA6H,QAAS,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,mDAAoD,GAAI,ieAAwd,+EAAgF,sDAAuD,oBAAqB,GAAI,cAAe,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,IAAK,IAAK,oBAAqB,iBAAkB,GAAI,KAC9vC,CAAC,yBAA0B,gEAAiE,iDAAkD,wCAAyC,4GAA6G,QAAS,aAAc,WAAY,MAAO,WAAY,gBAAiB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,wBAAyB,0DAA2D,kBAAmB,kpBAA8oB,qHAAsH,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,mBAAoB,GAAI,KAC1/C,CAAC,yBAA0B,iEAAkE,mCAAoC,uCAAwC,iIAAkI,QAAS,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,uCAAwC,0DAA2D,4BAA6B,wVAAyV,sIAAuI,sDAAuD,wGAAyG,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,2EAAuE,GAAI,KAC73C,CAAC,2BAA4B,mEAAoE,yCAA0C,uCAAwC,6IAA8I,QAAS,aAAc,YAAa,MAAO,YAAa,WAAY,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,iCAAkC,6DAA8D,yBAA0B,mXAAoX,kFAAmF,sDAAuD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,GAAI,mBAAoB,GAAI,KACvtC,CAAC,WAAY,mDAAoD,sDAAuD,oCAAqC,uEAAwE,QAAS,aAAc,YAAa,MAAO,YAAa,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,4CAA6C,oBAAqB,0hBAAihB,gFAAiF,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,4CAA6C,GAAI,KACzyC,CAAC,uBAAwB,+DAAgE,qDAAsD,0CAA2C,gHAAiH,QAAS,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,4BAA6B,yDAA0D,qBAAsB,mlBAAolB,yFAA0F,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,iBAAkB,GAAI,KACp8C,CAAC,kBAAmB,0DAA2D,2DAA4D,wCAAyC,kIAAmI,QAAS,aAAc,YAAa,MAAO,YAAa,gBAAiB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,gCAAiC,wDAAyD,0BAA2B,2lBAAulB,4GAA6G,gEAAiE,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,kCAAmC,GAAI,KACzgD,CAAC,mBAAoB,2DAA4D,2CAA4C,0CAA2C,4HAA6H,QAAS,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,kCAAmC,yDAA0D,sBAAuB,uaAAwa,iGAAkG,sDAAuD,oBAAqB,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,oBAAqB,GAAI,KAC1vC,CAAC,2BAA4B,mEAAoE,2CAA4C,oCAAqC,6IAA8I,QAAS,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,4BAA6B,6DAA8D,oBAAqB,mNAAoN,yFAA0F,sDAAuD,GAAI,GAAI,eAAgB,aAAc,QAAS,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,GAAI,eAAgB,GAAI,KACrjC,CAAC,2BAA4B,6DAA8D,2CAA4C,oCAAqC,0IAA2I,QAAS,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,2DAA4D,gBAAiB,88BAA+8B,iEAAkE,sDAAuD,sEAAuE,GAAI,eAAgB,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,0CAA2C,GAAI,KAC10D,CAAC,WAAY,mDAAoD,iDAAkD,iDAAkD,uGAAwG,SAAU,aAAc,YAAa,MAAO,YAAa,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,0BAA2B,gDAAiD,oBAAqB,mxBAAqwB,iFAAkF,sDAAuD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,kBAAmB,GAAI,KAC/hD,CAAC,wBAAyB,gEAAiE,8DAA+D,uCAAwC,oIAAqI,SAAU,aAAc,UAAW,MAAO,UAAW,WAAY,UAAW,MAAO,UAAW,SAAU,SAAU,GAAI,GAAI,GAAI,wBAAyB,yDAA0D,sBAAuB,kXAAmX,GAAI,sDAAuD,wGAAyG,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,0CAA2C,GAAI,KAC/uC,CAAC,UAAW,kDAAmD,iFAAkF,2CAA4C,6HAA8H,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,2CAA4C,uBAAwB,wXAAyX,mHAAoH,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,oDAAqD,GAAI,KAC7wC,CAAC,sBAAuB,8DAA+D,2DAA4D,iDAAkD,kHAAmH,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,wBAAyB,wDAAyD,GAAI,ySAA0S,uFAAwF,sDAAuD,oBAAqB,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,gCAAiC,GAAI,KACvoC,CAAC,cAAe,sDAAuD,gBAAiB,0CAA2C,6EAA8E,SAAU,aAAc,GAAI,GAAI,GAAI,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,+CAAgD,sBAAuB,ueAAwe,6BAA8B,yCAA0C,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,IAAK,IAAK,oBAAqB,gBAAiB,GAAI,KAC3mC,CAAC,SAAU,iDAAkD,oDAAqD,uCAAwC,kFAAmF,SAAU,aAAc,YAAa,MAAO,YAAa,WAAY,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,0BAA2B,2CAA4C,kBAAmB,wbAAyb,2IAA4I,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,gCAAiC,GAAI,KACrxC,CAAC,YAAa,oDAAqD,4CAA6C,yCAA0C,+IAAgJ,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,6CAA8C,qBAAsB,gTAAiT,mBAAoB,gEAAiE,yCAA0C,GAAI,iBAAkB,aAAc,OAAQ,IAAK,GAAI,GAAI,SAAU,aAAc,MAAO,IAAK,oBAAqB,sBAAuB,GAAI,KAC7lC,CAAC,MAAO,8CAA+C,wCAAyC,oCAAqC,2IAA4I,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,WAAY,GAAI,GAAI,GAAI,wBAAyB,4CAA6C,gCAAiC,iJAAkJ,2EAA4E,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,gBAAiB,GAAI,KAC/8B,CAAC,UAAW,sDAAuD,oDAAqD,uCAAwC,+IAAgJ,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,yBAA0B,gDAAiD,oBAAqB,00BAA20B,sGAAuG,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,MAAO,GAAI,GAAI,kBAAmB,GAAI,MAChrD,CAAC,UAAW,kDAAmD,wCAAyC,uCAAwC,6HAA8H,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,yBAA0B,GAAI,mBAAoB,+jCAAqjC,sFAAuF,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,8BAA+B,GAAI,KACr0D,CAAC,uBAAwB,kDAAmD,gBAAiB,0CAA2C,kHAAmH,SAAU,aAAc,YAAa,MAAO,YAAa,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,sBAAuB,kDAAmD,mBAAoB,uQAAwQ,yGAA0G,yCAA0C,yCAA0C,GAAI,eAAgB,aAAc,MAAO,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,GAAI,cAAe,GAAI,KAC3jC,CAAC,UAAW,kDAAmD,mEAAoE,wCAAyC,+IAAgJ,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,iDAAkD,uBAAwB,ojBAAqjB,oBAAqB,wDAAyD,wGAAyG,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,YAAa,GAAI,KACl4C,CAAC,4BAA6B,oEAAqE,iDAAkD,2CAA4C,4IAA6I,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,SAAU,YAAa,MAAO,YAAa,sBAAuB,6DAA8D,eAAgB,2WAA4W,8FAA+F,sDAAuD,oBAAqB,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,yFAA0F,GAAI,KACvyC,CAAC,sCAAuC,8EAA+E,0CAA2C,2CAA4C,iIAAkI,SAAU,aAAc,UAAW,MAAO,UAAW,QAAS,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,uEAAwE,qBAAsB,6SAA8S,SAAU,gDAAiD,GAAI,GAAI,eAAgB,aAAc,OAAQ,KAAM,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,aAAc,GAAI,KACpiC,CAAC,qBAAsB,6DAA8D,6CAA8C,wCAAyC,+GAAgH,SAAU,aAAc,WAAY,MAAO,WAAY,gBAAiB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,uBAAwB,2DAA4D,iBAAkB,ioBAAkoB,8FAA+F,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,mCAAoC,GAAI,KAC79C,CAAC,YAAa,oDAAqD,0DAA2D,oCAAqC,8EAA+E,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,6CAA8C,qBAAsB,0tBAAusB,2GAA4G,sDAAuD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,KAAM,IAAK,oBAAqB,mBAAoB,GAAI,KAC79C,CAAC,WAAY,mDAAoD,oCAAqC,mCAAoC,2HAA4H,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,6CAA8C,uBAAwB,uZAAwZ,0CAA2C,wBAAyB,yBAA0B,GAAI,cAAe,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,8CAA+C,GAAI,KAC9nC,CAAC,0BAA2B,kEAAmE,sCAAuC,0CAA2C,8GAA+G,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,+BAAgC,0DAA2D,yBAA0B,mlBAAolB,mGAAoG,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,8BAA+B,GAAI,KACz7C,CAAC,uBAAwB,+DAAgE,uCAAwC,0CAA2C,0HAA2H,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,4BAA6B,4CAA6C,yBAA0B,wlBAAylB,wEAAyE,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,+BAAgC,GAAI,KACp7C,CAAC,wBAAyB,gEAAiE,4CAA6C,0CAA2C,+GAAgH,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,6CAA8C,GAAI,6PAA8P,wEAAyE,sDAAuD,wGAAyG,GAAI,gBAAiB,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,4CAA6C,GAAI,KAC9nC,CAAC,oBAAqB,4DAA6D,6CAA8C,oCAAqC,8IAA+I,SAAU,aAAc,YAAa,MAAO,YAAa,WAAY,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,mCAAoC,oDAAqD,GAAI,wqBAAyqB,iIAAkI,sDAAuD,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,GAAI,GAAI,KAC9+C,CAAC,aAAc,qDAAsD,2CAA4C,uCAAwC,4GAA6G,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,SAAU,YAAa,MAAO,YAAa,4BAA6B,8CAA+C,yBAA0B,y9BAA09B,yHAA0H,sDAAuD,oBAAqB,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,mBAAoB,GAAI,KACnyD,CAAC,aAAc,qDAAsD,6CAA8C,uCAAwC,6GAA8G,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,yBAA0B,8CAA+C,GAAI,+fAAggB,4GAA6G,sDAAuD,GAAI,GAAI,iBAAkB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,cAAe,GAAI,KACvwC,CAAC,UAAW,kDAAmD,iDAAkD,oCAAqC,+CAAgD,SAAU,aAAc,WAAY,MAAO,WAAY,qBAAsB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,0BAA2B,gDAAiD,wBAAyB,2iBAA4iB,6HAA8H,sDAAuD,oBAAqB,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,gBAAiB,GAAI,KACn0C,CAAC,sBAAuB,8DAA+D,+CAAgD,2CAA4C,iFAAkF,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,qCAAsC,GAAI,8BAA+B,qaAAia,yGAA0G,sDAAuD,GAAI,GAAI,cAAe,aAAc,QAAS,GAAI,sBAAuB,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,kCAAmC,GAAI,KAC7qC,CAAC,sBAAuB,8DAA+D,2DAA4D,sCAAuC,yHAA0H,SAAU,aAAc,WAAY,MAAO,WAAY,gBAAiB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,0BAA2B,sDAAuD,oBAAqB,guBAA4tB,gHAAiH,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,MAAO,IAAK,oBAAqB,eAAgB,GAAI,KACxnD,CAAC,wBAAyB,gEAAiE,2CAA4C,+BAAgC,qIAAsI,SAAU,aAAc,YAAa,MAAO,YAAa,kBAAmB,aAAc,MAAO,aAAc,SAAU,SAAU,GAAI,GAAI,GAAI,6BAA8B,gDAAiD,uBAAwB,ugBAAwgB,sHAAuH,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,cAAe,GAAI,MAC93C,CAAC,YAAa,oDAAqD,uDAAwD,yCAA0C,gIAAiI,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,SAAU,WAAY,MAAO,WAAY,2BAA4B,6CAA8C,yBAA0B,4+BAA6+B,gGAAiG,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,qBAAsB,GAAI,KAC91D,CAAC,UAAW,0DAA2D,2CAA4C,uCAAwC,yIAAqI,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,qBAAsB,sDAAuD,wBAAyB,uoCAAonC,gDAAiD,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,gBAAiB,GAAI,KACr5D,CAAC,2BAA4B,mEAAoE,2CAA4C,0CAA2C,qIAAsI,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,sBAAuB,sCAAuC,gBAAiB,2gCAAu/B,qGAAsG,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,MAAO,GAAI,GAAI,yCAA0C,GAAI,KAC72D,CAAC,uBAAwB,+DAAgE,2DAA4D,wCAAyC,8HAA+H,SAAU,aAAc,GAAI,GAAI,GAAI,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,yDAA0D,qBAAsB,8dAA+d,mGAAoG,sEAAuE,oBAAqB,GAAI,gBAAiB,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,gCAAiC,GAAI,KAC/0C,CAAC,cAAe,sDAAuD,8CAA+C,uCAAwC,iIAAkI,SAAU,aAAc,UAAW,MAAO,UAAW,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,+BAAgC,qDAAsD,yBAA0B,4hBAA8hB,4GAA6G,sDAAuD,oBAAqB,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,iEAAkE,GAAI,KACh8C,CAAC,sBAAuB,mEAAoE,oDAAqD,wCAAyC,yGAA0G,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,wBAAyB,wDAAyD,qBAAsB,sUAAoU,sEAAoE,sDAAuD,oBAAqB,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,GAAI,sBAAuB,GAAI,KAC3nC,CAAC,uBAAwB,+DAAgE,2CAA4C,iDAAkD,yIAA0I,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,4BAA6B,yDAA0D,mBAAoB,svBAA6uB,wFAAyF,sDAAuD,oBAAqB,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,+BAAgC,GAAI,KACnmD,CAAC,gBAAiB,wDAAyD,6CAA8C,uCAAwC,6GAA8G,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,iDAAkD,wBAAyB,6WAA8W,qFAAsF,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,gBAAiB,GAAI,KACnqC,CAAC,yBAA0B,iEAAkE,uCAAwC,sCAAuC,mIAAoI,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,uCAAwC,8DAA+D,GAAI,uYAAwY,kIAA8H,sDAAuD,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,aAAc,GAAI,KAC9tC,CAAC,sBAAuB,8DAA+D,qEAAsE,wCAAyC,0GAA2G,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,0DAA2D,sBAAuB,0bAA2b,sFAAuF,sDAAuD,oBAAqB,GAAI,eAAgB,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,YAAa,GAAI,KAC7vC,CAAC,uBAAwB,+DAAgE,2EAA4E,+BAAgC,wIAAyI,SAAU,aAAc,YAAa,MAAO,YAAa,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,qCAAsC,wDAAyD,mBAAoB,q3BAAs3B,iFAAkF,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,oCAAqC,GAAI,KACrwD,CAAC,sBAAuB,8DAA+D,uDAAwD,oCAAqC,yGAA0G,SAAU,aAAc,YAAa,MAAO,YAAa,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,gCAAiC,0CAA2C,iCAAkC,spBAAkpB,+EAAgF,sDAAuD,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,6BAA8B,GAAI,KACl9C,CAAC,eAAgB,+CAAgD,sGAAuG,kCAAmC,6IAA8I,SAAU,aAAc,WAAY,MAAO,WAAY,iBAAkB,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,gCAAiC,iDAAkD,wBAAyB,wwBAAowB,wBAAyB,6DAA8D,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,aAAc,GAAI,KACnkD,CAAC,YAAa,oDAAqD,6CAA8C,uCAAwC,gHAAiH,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,aAAc,MAAO,aAAc,wBAAyB,8CAA+C,uBAAwB,4mBAAwmB,sBAAuB,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,IAAK,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,sBAAuB,GAAI,KACl3C,CAAC,cAAe,sDAAuD,8CAA+C,uCAAwC,iHAAkH,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,4BAA6B,+CAAgD,uBAAwB,y2BAAq2B,+FAAgG,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,gBAAiB,GAAI,KACpqD,CAAC,OAAQ,2DAA4D,mGAAoG,kCAAmC,qEAAsE,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,sBAAuB,4CAA6C,mBAAoB,yqBAAqqB,4GAA6G,6GAA8G,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,uCAAwC,GAAI,KAC/iD,CAAC,QAAS,qDAAsD,+DAAgE,wCAAyC,yIAA0I,SAAU,aAAc,GAAI,GAAI,GAAI,kBAAmB,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,uBAAwB,yCAA0C,iBAAkB,8NAA+N,qCAAsC,sDAAuD,wGAAyG,GAAI,gBAAiB,aAAc,MAAO,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,iBAAkB,GAAI,KACjiC,CAAC,eAAgB,uDAAwD,uCAAwC,0CAA2C,gFAAiF,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,yBAA0B,gDAAiD,uBAAwB,y1CAA01C,uHAAwH,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,mCAAoC,GAAI,KACvpE,CAAC,UAAW,kDAAmD,sCAAuC,qCAAsC,0HAA2H,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,qBAAsB,2CAA4C,mBAAoB,6gBAAygB,mFAAoF,sDAAuD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,GAAI,0CAA2C,GAAI,KACryC,CAAC,WAAY,mDAAoD,2EAA4E,0CAA2C,0HAA2H,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,4CAA6C,oBAAqB,+SAAgT,yEAA0E,sDAAuD,wGAAyG,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,gBAAiB,GAAI,MAC/qC,CAAC,kBAAmB,0DAA2D,2EAA4E,qCAAsC,yFAA0F,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,iCAAkC,mDAAoD,6BAA8B,sbAAub,oHAAqH,sDAAuD,UAAW,GAAI,cAAe,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,4CAA6C,GAAI,KAC/xC,CAAC,SAAU,iDAAkD,8DAA+D,oCAAqC,6EAA8E,SAAU,aAAc,UAAW,MAAO,UAAW,cAAe,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,6CAA8C,qBAAsB,6NAA8N,kGAAmG,uCAAwC,GAAI,GAAI,gBAAiB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,wDAAyD,GAAI,KACz9B,CAAC,uBAAwB,+DAAgE,6CAA8C,uCAAwC,6FAA8F,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,yDAA0D,GAAI,2cAA4c,GAAI,sDAAuD,GAAI,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,uBAAwB,GAAI,KACzoC,CAAC,cAAe,sDAAuD,6DAA8D,4CAA6C,uHAAwH,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,+CAAgD,8BAA+B,qjBAAsjB,+FAAgG,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,kBAAmB,GAAI,MACt5C,CAAC,aAAc,qDAAsD,6CAA8C,uCAAwC,0HAA2H,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,8CAA+C,sBAAuB,ubAAwb,0BAA2B,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,mBAAoB,GAAI,KACtrC,CAAC,sBAAuB,8DAA+D,0CAA2C,uCAAwC,sHAAuH,SAAU,aAAc,GAAI,GAAI,GAAI,QAAS,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,gCAAiC,2DAA4D,8BAA+B,gkBAAikB,qIAAsI,sFAAuF,wGAAyG,GAAI,gBAAiB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,eAAgB,GAAI,KAClgD,CAAC,4BAA6B,oEAAqE,qEAAsE,iCAAkC,8FAA+F,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,8BAA+B,4DAA6D,wBAAyB,6aAA8a,mFAAoF,sDAAuD,wGAAyG,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,qBAAsB,GAAI,MAC50C,CAAC,kBAAmB,0DAA2D,wCAAyC,sCAAuC,wHAAsH,SAAU,aAAc,SAAU,MAAO,SAAU,QAAS,UAAW,MAAO,UAAW,SAAU,SAAU,GAAI,GAAI,GAAI,yCAA0C,oDAAqD,iCAAkC,6JAAsJ,+HAAgI,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,GAAI,GAAI,KAC7/B,CAAC,mBAAoB,2DAA4D,sDAAuD,qCAAsC,gHAAiH,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,WAAY,GAAI,GAAI,GAAI,iCAAkC,oDAAqD,2BAA4B,+vCAAqvC,2HAA4H,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,MAAO,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,kCAAmC,gCAAiC,GAAI,KAC/pE,CAAC,mBAAoB,+DAAgE,yCAA0C,qCAAsC,iIAAkI,SAAU,aAAc,WAAY,MAAO,WAAY,QAAS,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,mBAAoB,6CAA8C,GAAI,kKAAmK,kGAAmG,sDAAuD,wGAAyG,GAAI,gBAAiB,aAAc,MAAO,GAAI,sBAAuB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,4BAA6B,GAAI,KACliC,CAAC,yBAA0B,iEAAkE,4CAA6C,0CAA2C,oJAAgJ,SAAU,aAAc,GAAI,GAAI,GAAI,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,0DAA2D,iBAAkB,usBAAwsB,4FAA6F,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,qCAAsC,GAAI,MAC5jD,CAAC,UAAW,kDAAmD,iDAAkD,uCAAwC,sIAAuI,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,SAAU,WAAY,MAAO,WAAY,yBAA0B,0CAA2C,mBAAoB,yqBAA+pB,mEAAoE,sDAAuD,UAAW,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,gBAAiB,GAAI,KACv7C,CAAC,yBAA0B,uDAAwD,iDAAkD,wCAAyC,4HAA6H,SAAU,aAAc,WAAY,MAAO,WAAY,QAAS,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,0BAA2B,yDAA0D,wBAAyB,wlCAAylC,oEAAqE,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,iCAAkC,GAAI,KACr6D,CAAC,WAAY,mDAAoD,mEAAoE,0CAA2C,oHAAqH,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,kDAAmD,uBAAwB,qcAAsc,wFAAyF,sDAAuD,oBAAqB,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,oCAAqC,GAAI,KACjxC,CAAC,sBAAuB,8DAA+D,sDAAuD,8CAA+C,uIAAwI,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,sDAAuD,oBAAqB,2zBAA4zB,uGAAwG,yEAA0E,qEAAsE,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,aAAc,GAAI,KAC/tD,CAAC,iBAAkB,yDAA0D,sCAAuC,oCAAqC,kHAAmH,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,iCAAkC,GAAI,mBAAoB,wmBAA+lB,0CAA2C,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,qCAAsC,GAAI,KAC91C,CAAC,sBAAuB,8DAA+D,2CAA4C,uCAAwC,gHAAiH,SAAU,aAAc,GAAI,GAAI,GAAI,QAAS,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,oBAAqB,uDAAwD,kBAAmB,wVAAyV,mGAAoG,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,8BAA+B,GAAI,KACzqC,CAAC,oBAAqB,4DAA6D,uCAAwC,wCAAyC,wHAAyH,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,GAAI,oBAAqB,0lBAA2lB,6EAA8E,sDAAuD,oBAAqB,GAAI,eAAgB,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,gBAAiB,GAAI,KAC10C,CAAC,wBAAyB,2DAA4D,iDAAkD,mCAAoC,mIAAoI,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,yDAA0D,uBAAwB,qdAAsd,6EAA8E,sDAAuD,UAAW,GAAI,cAAe,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,KAAM,IAAK,oBAAqB,uBAAwB,GAAI,KACjyC,CAAC,wBAAyB,+DAAgE,qDAAsD,mCAAoC,gHAAiH,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,wCAAyC,yDAA0D,+BAAgC,6WAAyW,8GAA+G,sDAAuD,wGAAyG,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,sCAAuC,GAAI,KACv2C,CAAC,iBAAkB,yDAA0D,sDAAuD,yCAA0C,8IAA+I,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,sDAAuD,gCAAiC,sfAAuf,4GAA6G,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,6BAA8B,GAAI,MACt4C,CAAC,iBAAkB,8DAA+D,oEAAqE,uCAAwC,4HAA6H,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,4CAA6C,oBAAqB,4HAA6H,6FAA8F,sDAAuD,wGAAyG,GAAI,eAAgB,aAAc,QAAS,GAAI,sBAAuB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,yCAA0C,GAAI,KACrjC,CAAC,yBAA0B,iEAAkE,2CAA4C,wCAAyC,wEAAyE,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,+BAAgC,GAAI,GAAI,oUAAqU,4GAA6G,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,mCAAoC,GAAI,KACjlC,CAAC,SAAU,iDAAkD,6CAA8C,qCAAsC,yIAA0I,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,WAAY,MAAO,WAAY,wBAAyB,qDAAsD,GAAI,0TAA2T,qGAAsG,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,6CAA8C,GAAI,KAC5rC,CAAC,mBAAoB,2DAA4D,2DAA4D,oCAAqC,iIAAkI,SAAU,aAAc,WAAY,MAAO,WAAY,gBAAiB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,kCAAmC,qDAAsD,yBAA0B,sgBAAugB,sFAAuF,sDAAuD,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,oBAAqB,GAAI,KAC10C,CAAC,WAAY,mDAAoD,qDAAsD,+CAAgD,sGAAuG,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,sBAAuB,4CAA6C,yBAA0B,udAAwd,yFAA0F,iEAAkE,6EAA8E,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,mBAAoB,GAAI,KACvzC,CAAC,qBAAsB,6DAA8D,6CAA8C,+BAAgC,4GAA6G,SAAU,aAAc,WAAY,MAAO,WAAY,gBAAiB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,4BAA6B,qDAAsD,GAAI,upBAAwpB,sFAAuF,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,uBAAwB,GAAI,MACv9C,CAAC,UAAW,kDAAmD,uCAAwC,wCAAyC,oFAAqF,SAAU,aAAc,YAAa,MAAO,YAAa,iBAAkB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,qBAAsB,gDAAiD,mBAAoB,2fAA4f,gFAAiF,cAAe,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,kBAAmB,GAAI,KACvuC,CAAC,mBAAoB,2DAA4D,gBAAiB,wCAAyC,2IAA4I,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,wDAAyD,uBAAwB,kdAA8c,qCAAsC,yCAA0C,UAAW,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,IAAK,kCAAmC,gBAAiB,GAAI,KACrtC,CAAC,yBAA0B,iEAAkE,mDAAoD,oCAAqC,gIAAiI,SAAU,aAAc,WAAY,MAAO,WAAY,gBAAiB,WAAY,MAAO,WAAY,SAAU,WAAY,GAAI,GAAI,GAAI,8BAA+B,GAAI,wBAAyB,wiDAAyiD,qIAAsI,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,kCAAmC,uBAAwB,GAAI,KACh7E,CAAC,SAAU,iDAAkD,yCAA0C,kCAAmC,qIAAsI,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,yCAA0C,kBAAmB,qeAAse,qDAAsD,yEAA0E,wGAAyG,GAAI,eAAgB,aAAc,OAAQ,IAAK,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,aAAc,GAAI,KACzzC,CAAC,gBAAiB,mEAAoE,sCAAuC,sCAAuC,sGAAuG,SAAU,aAAc,WAAY,MAAO,WAAY,gBAAiB,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,6BAA8B,gEAAiE,0BAA2B,moBAA+nB,iDAAkD,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,YAAa,GAAI,KACx5C,CAAC,kBAAmB,0DAA2D,sCAAuC,qCAAsC,4HAA6H,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,sBAAuB,wDAAyD,mBAAoB,yVAA0V,GAAI,sDAAuD,UAAW,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,eAAgB,GAAI,KACpjC,CAAC,SAAU,iDAAkD,2CAA4C,sCAAuC,iIAAkI,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,oBAAqB,yCAA0C,kBAAmB,ysBAAgsB,sHAAuH,sDAAuD,oBAAqB,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,iBAAkB,GAAI,KAC7gD,CAAC,WAAY,mDAAoD,0EAA2E,oCAAqC,oGAAqG,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,4CAA6C,oBAAqB,wLAAyL,GAAI,sDAAuD,yDAA0D,GAAI,gBAAiB,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,0BAA2B,GAAI,KACj7B,CAAC,aAAc,qDAAsD,2CAA4C,uCAAwC,mIAAoI,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,wBAAyB,6CAA8C,sBAAuB,o7BAAq7B,+EAAgF,sDAAuD,wGAAyG,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,MAAO,GAAI,eAAgB,qEAAsE,GAAI,KAC52D,CAAC,2BAA4B,mEAAoE,qDAAsD,0CAA2C,2IAA4I,SAAU,aAAc,WAAY,MAAO,WAAY,iBAAkB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,iCAAkC,GAAI,2BAA4B,4iBAA6iB,0GAA2G,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,iDAAkD,GAAI,KACx8C,CAAC,UAAW,wDAAyD,0EAA2E,uCAAwC,8IAA+I,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,gDAAiD,wBAAyB,kZAAmZ,iGAAkG,sDAAuD,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,mCAAoC,GAAI,KACxvC,CAAC,uBAAwB,+DAAgE,qDAAsD,sCAAuC,+IAAgJ,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,2BAA4B,uDAAwD,qBAAsB,0cAA2c,gEAAiE,sDAAuD,wGAAyG,GAAI,gBAAiB,aAAc,MAAO,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,GAAI,GAAI,KAC72C,CAAC,cAAe,sDAAuD,gCAAiC,oCAAqC,8DAA+D,SAAU,aAAc,WAAY,MAAO,WAAY,gBAAiB,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,6BAA8B,GAAI,sBAAuB,yTAA0T,6BAA8B,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,KACr7B,CAAC,YAAa,oDAAqD,4DAA6D,sCAAuC,iIAAkI,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,kDAAmD,0BAA2B,wqBAAyqB,oCAAqC,sDAAuD,GAAI,GAAI,gBAAiB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,gDAAiD,GAAI,KACj8C,CAAC,yBAA0B,iEAAkE,oCAAqC,oCAAqC,uGAAwG,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,0DAA2D,wBAAyB,kUAAmU,iBAAkB,sDAAuD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,MAAO,GAAI,GAAI,iBAAkB,GAAI,KACxhC,CAAC,SAAU,iDAAkD,oDAAqD,0CAA2C,uIAAwI,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,yCAA0C,kBAAmB,uWAAwW,eAAgB,gEAAiE,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,sCAAoC,GAAI,KACzlC,CAAC,UAAW,kDAAmD,8BAA+B,sCAAuC,qIAAsI,SAAU,aAAc,WAAY,MAAO,WAAY,mBAAoB,WAAY,MAAO,WAAY,SAAU,SAAU,YAAa,MAAO,YAAa,sBAAuB,GAAI,GAAI,0hBAA2hB,0GAA2G,sDAAuD,oBAAqB,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,+CAAgD,GAAI,KACvzC,CAAC,wBAAyB,gEAAiE,6CAA8C,0CAA2C,0HAA2H,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,6BAA8B,wDAAyD,uBAAwB,+1DAAg2D,QAAS,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,GAAI,GAAI,KACnmF,CAAC,oBAAqB,4DAA6D,uCAAwC,uCAAwC,4GAA6G,SAAU,aAAc,GAAI,GAAI,GAAI,kBAAmB,WAAY,MAAO,WAAY,SAAU,SAAU,YAAa,MAAO,YAAa,2BAA4B,iDAAkD,oBAAqB,8UAA+U,iEAAkE,sDAAuD,wGAAyG,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,gCAAiC,GAAI,KAC5rC,CAAC,kBAAmB,0DAA2D,6CAA8C,uCAAwC,wIAAyI,SAAU,aAAc,WAAY,MAAO,WAAY,iBAAkB,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,mDAAoD,0BAA2B,u1BAAo0B,qGAAsG,oFAAqF,wGAAyG,GAAI,eAAgB,aAAc,OAAQ,GAAI,iBAAkB,GAAI,SAAU,aAAc,MAAO,GAAI,GAAI,6FAA8F,GAAI,KAC11D,CAAC,SAAU,iDAAkD,6CAA8C,sCAAuC,uIAAwI,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,GAAI,wBAAyB,8SAA+S,2GAA4G,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,mEAAoE,GAAI,KAC1oC,CAAC,WAAY,mEAAoE,6DAA8D,gDAAiD,qIAAsI,SAAU,aAAc,YAAa,MAAO,YAAa,iBAAkB,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,6CAA8C,sBAAuB,0XAA2X,uHAAwH,sDAAuD,sBAAuB,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,GAAI,GAAI,KACvtC,CAAC,yBAA0B,iEAAkE,2CAA4C,+BAAgC,+HAAgI,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,oBAAqB,0DAA2D,kBAAmB,6zBAA8zB,mFAAoF,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,aAAc,GAAI,KAC3nD,CAAC,WAAY,mDAAoD,wCAAyC,uCAAwC,qHAAsH,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,WAAY,YAAa,MAAO,YAAa,0BAA2B,gDAAiD,oBAAqB,yOAA0O,iFAAkF,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,kHAAmH,GAAI,KAC5oC,CAAC,eAAgB,uDAAwD,uCAAwC,yCAA0C,uFAAwF,SAAU,aAAc,GAAI,GAAI,GAAI,kBAAmB,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,GAAI,kCAAmC,wSAAyS,2BAA4B,cAAe,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,4BAA6B,GAAI,KAC54B,CAAC,UAAW,kDAAmD,wDAAyD,+CAAgD,sIAAuI,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,4BAA6B,8CAA+C,uBAAwB,4wCAA6wC,uGAAwG,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,iDAAkD,GAAI,KACvqE,CAAC,uBAAwB,+DAAgE,2CAA4C,qCAAsC,qIAAsI,SAAU,aAAc,SAAU,MAAO,SAAU,gBAAiB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,yBAA0B,wDAAyD,mBAAoB,i1CAA60C,uEAAwE,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,GAAI,GAAI,MACpoE,CAAC,UAAW,kDAAmD,6CAA8C,2CAA4C,+GAAgH,SAAU,aAAc,WAAY,MAAO,WAAY,iBAAkB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,yBAA0B,GAAI,mBAAoB,8eAA+e,2GAA4G,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,+BAAgC,GAAI,KAC/yC,CAAC,cAAe,sDAAuD,0DAA2D,qCAAsC,6EAA8E,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,2DAA4D,2BAA4B,i6CAA03C,sGAAuG,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,gCAAiC,GAAI,KACnsE,CAAC,+BAAgC,iEAAkE,sDAAuD,yCAA0C,2HAA4H,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,qCAAsC,gEAAiE,GAAI,sPAAkP,GAAI,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,iCAAkC,GAAI,KACviC,CAAC,wBAAyB,gEAAiE,wCAAyC,kDAAmD,wHAAyH,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,6BAA8B,wDAAyD,6BAA8B,wXAAyX,+CAAgD,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,wBAAyB,GAAI,KAC/rC,CAAC,cAAe,sDAAuD,sCAAuC,wCAAyC,iHAAkH,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,6BAA8B,GAAI,oCAAqC,4kBAA0kB,2FAA4F,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,MAAO,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,IAAK,kCAAmC,0CAA2C,GAAI,KAC56C,CAAC,gBAAiB,wDAAyD,oCAAqC,qCAAsC,gHAAiH,SAAU,aAAc,UAAW,MAAO,UAAW,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,0BAA2B,iDAAkD,sBAAuB,2UAA4U,0HAA2H,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,MAAO,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,gBAAiB,GAAI,MAC1pC,CAAC,eAAgB,kDAAmD,6BAA8B,2CAA4C,oHAAqH,SAAU,aAAc,UAAW,MAAO,UAAW,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,+CAAgD,uBAAwB,wbAAob,8BAA+B,sDAAuD,GAAI,GAAI,gBAAiB,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,+BAAgC,GAAI,KACxoC,CAAC,oBAAqB,4DAA6D,4CAA6C,yCAA0C,8FAA+F,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,qDAAsD,iCAAkC,gdAAid,GAAI,6DAA8D,UAAW,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,wEAAyE,GAAI,KACptC,CAAC,kBAAmB,0DAA2D,sCAAuC,uCAAwC,kIAAmI,SAAU,aAAc,WAAY,MAAO,WAAY,iBAAkB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,gCAAiC,GAAI,0BAA2B,woDAAooD,iGAAkG,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,GAAI,GAAI,MAC/6E,CAAC,kCAAmC,0EAA2E,6EAA8E,oCAAqC,2GAA4G,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,uEAAwE,GAAI,qkBAAskB,uFAAwF,kCAAmC,uCAAwC,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,gCAAiC,GAAI,KACr7C,CAAC,eAAgB,uDAAwD,mCAAoC,0CAA2C,oGAAqG,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,GAAI,4BAA6B,gbAAib,oDAAqD,yDAA0D,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,yFAA0F,GAAI,KACjtC,CAAC,yBAA0B,iEAAkE,6CAA8C,0CAA2C,0IAA2I,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,WAAY,MAAO,WAAY,wBAAyB,8DAA+D,kBAAmB,uzBAAwzB,yBAA0B,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,IAAK,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,uBAAwB,GAAI,KACtpD,CAAC,wBAAyB,gEAAiE,sDAAuD,0CAA2C,6IAA8I,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,WAAY,YAAa,MAAO,YAAa,6BAA8B,wDAAyD,qBAAsB,iiCAAkiC,gGAAiG,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,eAAgB,GAAI,KAC78D,CAAC,kBAAmB,0DAA2D,6CAA8C,8CAA+C,iHAAkH,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,iCAAkC,mDAAoD,8BAA+B,6eAAye,sHAAuH,gEAAiE,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,cAAe,GAAI,KACt0C,CAAC,cAAe,sDAAuD,6CAA8C,gDAAiD,sFAAuF,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,oDAAqD,GAAI,gbAAib,oHAAqH,sDAAuD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,qCAAsC,GAAI,KAC/sC,CAAC,eAAgB,8DAA+D,4CAA6C,qCAAsC,iGAAkG,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,mBAAoB,wDAAyD,gBAAiB,4mBAAwmB,kBAAmB,sDAAuD,wGAAyG,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,GAAI,mBAAoB,GAAI,KACz4C,CAAC,4BAA6B,oEAAqE,uCAAwC,0CAA2C,2IAA4I,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,8BAA+B,iEAAkE,wBAAyB,2hBAA4hB,gHAAiH,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,wDAAyD,GAAI,KACn9C,CAAC,cAAe,sDAAuD,yDAA0D,oCAAqC,0IAA2I,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,6BAA8B,8CAA+C,sBAAuB,sxBAA0wB,oGAAqG,8EAA+E,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,gBAAiB,GAAI,KACnoD,CAAC,QAAS,4DAA6D,mFAAoF,qCAAsC,+EAAgF,SAAU,aAAc,WAAY,MAAO,WAAY,QAAS,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,wBAAyB,mDAAoD,GAAI,seAAue,qBAAsB,kFAAmF,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,iCAAkC,GAAI,KAC1uC,CAAC,uBAAwB,+DAAgE,6CAA8C,iCAAkC,qFAAsF,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,WAAY,YAAa,MAAO,YAAa,0BAA2B,2DAA4D,GAAI,oaAAqa,2FAA4F,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,kCAAmC,eAAgB,GAAI,KAC3vC,CAAC,YAAa,oDAAqD,sDAAuD,gCAAiC,0IAA2I,SAAU,aAAc,WAAY,MAAO,WAAY,gBAAiB,YAAa,MAAO,YAAa,SAAU,WAAY,YAAa,MAAO,YAAa,sBAAuB,kDAAmD,oBAAqB,2lBAA4lB,mGAAoG,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,oCAAqC,GAAI,KACp+C,CAAC,0BAA2B,kEAAmE,6CAA8C,iDAAkD,6HAA8H,SAAU,aAAc,WAAY,MAAO,WAAY,gBAAiB,YAAa,MAAO,YAAa,SAAU,WAAY,GAAI,GAAI,GAAI,yBAA0B,0DAA2D,mBAAoB,0WAA2W,gFAAiF,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,YAAa,GAAI,KACrtC,CAAC,YAAa,oDAAqD,oDAAqD,oCAAqC,4IAA6I,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,uBAAwB,6CAA8C,qBAAsB,4KAA6K,uIAAwI,sDAAuD,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,GAAI,GAAI,KACjgC,CAAC,uBAAwB,+DAAgE,6CAA8C,wCAAyC,kFAAmF,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,0CAA2C,mBAAoB,uvBAAwvB,yFAA0F,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,iBAAkB,GAAI,KACriD,CAAC,0BAA2B,kEAAmE,yCAA0C,iDAAkD,gIAAiI,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,yBAA0B,4DAA6D,mBAAoB,woCAAyoC,8FAA+F,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,gCAAiC,GAAI,KACniE,CAAC,WAAY,mDAAoD,qCAAsC,qCAAsC,+IAAgJ,SAAU,aAAc,WAAY,MAAO,UAAW,gBAAiB,YAAa,MAAO,YAAa,SAAU,WAAY,GAAI,GAAI,GAAI,2BAA4B,0CAA2C,qBAAsB,sUAAuU,iGAAkG,yDAA0D,wGAAyG,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,oCAAqC,GAAI,KACluC,CAAC,yBAA0B,iEAAkE,6CAA8C,2CAA4C,uIAAwI,SAAU,aAAc,UAAW,MAAO,UAAW,kBAAmB,YAAa,MAAO,YAAa,SAAU,WAAY,YAAa,MAAO,YAAa,wBAAyB,yDAA0D,oBAAqB,wRAAyR,kHAAmH,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,kCAAmC,uCAAwC,GAAI,KACzuC,CAAC,WAAY,mDAAoD,yCAA0C,kCAAmC,qIAAsI,SAAU,aAAc,WAAY,MAAO,WAAY,cAAe,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,sBAAuB,4CAA6C,sBAAuB,+TAAgU,GAAI,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,iBAAkB,GAAI,KACzhC,CAAC,wBAAyB,gEAAiE,6CAA8C,uCAAwC,iIAAkI,SAAU,aAAc,WAAY,MAAO,WAAY,gBAAiB,YAAa,MAAO,YAAa,SAAU,WAAY,GAAI,GAAI,GAAI,wBAAyB,yDAA0D,kBAAmB,wuBAA4tB,wEAAyE,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,eAAgB,iCAAkC,GAAI,KACrkD,CAAC,uBAAwB,0DAA2D,6CAA8C,0CAA2C,oHAAqH,SAAU,aAAc,UAAW,MAAO,UAAW,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,uCAAwC,6DAA8D,0BAA2B,kJAAmJ,wGAAyG,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,kCAAmC,kBAAmB,GAAI,MACxiC,CAAC,kBAAmB,0DAA2D,6CAA8C,uCAAwC,wDAAyD,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,oDAAqD,+BAAgC,8IAA+I,iGAAkG,sDAAuD,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,wDAAyD,GAAI,KAC16B,CAAC,WAAY,mDAAoD,4DAA6D,wCAAyC,+FAAgG,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,SAAU,WAAY,MAAO,WAAY,sBAAuB,2CAA4C,oCAAqC,0iCAA2iC,GAAI,qEAAsE,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,GAAI,GAAI,KAC5xD,CAAC,cAAe,sDAAuD,2DAA4D,0CAA2C,oIAAqI,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,4BAA6B,GAAI,sBAAuB,0UAA2U,yGAA0G,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,MAAO,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,cAAe,GAAI,MACxoC,CAAC,oBAAqB,4DAA6D,sCAAuC,mCAAoC,qIAAsI,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,WAAY,MAAO,WAAY,0BAA2B,oDAAqD,GAAI,ghBAAihB,6DAA8D,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,IAAK,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,GAAI,GAAI,MAC30C,CAAC,aAAc,qDAAsD,8CAA+C,0CAA2C,oFAAqF,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,oEAAqE,yBAA0B,mMAAoM,2HAA4H,sDAAuD,yCAA0C,GAAI,iBAAkB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,cAAe,GAAI,KACriC,CAAC,SAAU,iDAAkD,gBAAiB,+BAAgC,qHAAsH,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,sBAAuB,gDAAiD,kBAAmB,kpBAAmpB,4CAA6C,yCAA0C,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,IAAK,IAAK,oBAAqB,GAAI,GAAI,KACxzC,CAAC,eAAgB,sDAAuD,oDAAqD,uCAAwC,sIAAuI,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,wBAAyB,GAAI,GAAI,6eAA2d,qBAAsB,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,IAAK,oBAAqB,GAAI,GAAI,KAC1qC,CAAC,aAAc,qDAAsD,wFAAyF,sCAAuC,8IAA+I,SAAU,aAAc,UAAW,MAAO,UAAW,OAAQ,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,8CAA+C,wBAAyB,05BAAu4B,GAAI,6GAA8G,GAAI,GAAI,gBAAiB,aAAc,OAAQ,GAAI,OAAQ,GAAI,SAAU,aAAc,IAAK,IAAK,oBAAqB,mCAAoC,GAAI,KACvsD,CAAC,UAAW,kDAAmD,+EAAgF,kCAAmC,oFAAqF,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,qBAAsB,2CAA4C,8BAA+B,orBAAsqB,8DAA+D,kHAAmH,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,oBAAqB,GAAI,MAC9+C,CAAC,yBAA0B,iEAAkE,uCAAwC,2CAA4C,sHAAuH,SAAU,aAAc,WAAY,MAAO,WAAY,iBAAkB,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,gCAAiC,GAAI,GAAI,4HAA6H,+FAAgG,cAAe,GAAI,GAAI,eAAgB,aAAc,MAAO,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,IAAK,kCAAmC,mBAAoB,GAAI,KACj2B,CAAC,uBAAwB,+DAAgE,sCAAuC,iDAAkD,2IAA4I,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,oDAAqD,qBAAsB,kcAAmc,iGAAkG,sDAAuD,UAAW,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,qCAAsC,GAAI,KACzyC,CAAC,qBAAsB,6DAA8D,sCAAuC,wCAAyC,uIAAwI,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,mCAAoC,uDAAwD,6BAA8B,4oBAA6oB,wGAAyG,sDAAuD,GAAI,GAAI,iBAAkB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,mBAAoB,GAAI,KACl/C,CAAC,SAAU,iDAAkD,wCAAyC,qCAAsC,uFAAwF,SAAU,aAAc,WAAY,MAAO,WAAY,gBAAiB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,wBAAyB,qEAAsE,kBAAmB,gdAA4c,0FAA2F,sDAAuD,GAAI,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,iBAAkB,GAAI,KACjsC,CAAC,kBAAmB,wEAAyE,6CAA8C,uCAAwC,mHAAoH,SAAU,aAAc,WAAY,MAAO,WAAY,iBAAkB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,qBAAsB,gEAAiE,mBAAoB,kiBAAmiB,GAAI,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,oBAAqB,GAAI,KACvxC,CAAC,YAAa,oDAAqD,4CAA6C,sCAAuC,yIAA0I,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,6CAA8C,qBAAsB,oaAAqa,qEAAsE,iEAAkE,wGAAyG,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,6DAA8D,GAAI,MAC5zC,CAAC,iBAAkB,yDAA0D,0DAA2D,uCAAwC,qIAAsI,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,GAAI,yBAA0B,65BAA85B,4FAA6F,sDAAuD,UAAW,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,gCAAiC,GAAI,KACttD,CAAC,UAAW,kDAAmD,oFAAqF,kCAAmC,wHAAyH,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,yCAA0C,mBAAoB,4iBAA6iB,oGAAqG,4EAA6E,yDAA0D,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,oBAAqB,GAAI,KACv6C,CAAC,0BAA2B,kEAAmE,4DAA6D,gCAAiC,6FAA8F,SAAU,aAAc,WAAY,MAAO,WAAY,iBAAkB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,iCAAkC,+DAAgE,sBAAuB,2rBAAkrB,+FAAgG,+EAAgF,yCAA0C,GAAI,cAAe,aAAc,MAAO,GAAI,qBAAsB,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,YAAa,GAAI,MACtiD,CAAC,kBAAgB,sDAAuD,gBAAiB,2CAA4C,+CAA6C,SAAU,aAAc,UAAW,MAAO,UAAW,OAAQ,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,+CAAgD,mBAAoB,0JAAwJ,0CAA2C,yCAA0C,GAAI,GAAI,GAAI,aAAc,MAAO,GAAI,OAAQ,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,kCAAmC,GAAI,KACtvB,CAAC,kBAAmB,0DAA2D,oEAAqE,mCAAoC,oIAAqI,SAAU,aAAc,UAAW,MAAO,UAAW,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,4BAA6B,oDAAqD,0BAA2B,0nBAA2nB,sCAAuC,sDAAuD,oBAAqB,GAAI,iBAAkB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,4BAA6B,GAAI,KACz7C,CAAC,yBAA0B,iEAAkE,iDAAkD,sCAAuC,2IAA4I,SAAU,aAAc,WAAY,MAAO,WAAY,gBAAiB,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,4BAA6B,GAAI,wBAAyB,60BAA80B,GAAI,sDAAuD,yCAA0C,GAAI,cAAe,GAAI,GAAI,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,KACniD,CAAC,yBAA0B,iEAAkE,6CAA8C,0CAA2C,0IAA2I,SAAU,aAAc,UAAW,MAAO,UAAW,kBAAmB,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,wBAAyB,yDAA0D,kBAAmB,yhCAA0hC,sHAAuH,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,GAAI,GAAI,KACl5D,CAAC,mBAAoB,2DAA4D,0DAA2D,qCAAsC,qIAAsI,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,iCAAkC,qDAAsD,+BAAgC,qMAAsM,oCAAqC,8DAA+D,wGAAyG,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,8BAA+B,GAAI,KACnlC,CAAC,mBAAoB,sDAAuD,4DAA6D,2CAA4C,sDAAuD,SAAU,aAAc,UAAW,MAAO,UAAW,OAAQ,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,6CAA8C,uBAAwB,mSAAoS,oBAAqB,8EAA+E,GAAI,GAAI,GAAI,aAAc,MAAO,GAAI,OAAQ,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,uBAAwB,GAAI,KACn8B,CAAC,iBAAkB,yDAA0D,uCAAwC,wCAAyC,0FAA2F,SAAU,aAAc,WAAY,MAAO,WAAY,gBAAiB,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,gCAAiC,sDAAuD,6BAA8B,knBAA2mB,oFAAqF,cAAe,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,GAAI,GAAI,KAC9yC,CAAC,SAAU,iDAAkD,2CAA4C,qCAAsC,+HAAgI,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,0CAA2C,kBAAmB,grBAAirB,2EAA4E,sDAAuD,oBAAqB,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,8BAA+B,GAAI,KAC/7C,CAAC,mBAAoB,2DAA4D,yCAA0C,mCAAoC,qIAAsI,SAAU,aAAc,UAAW,MAAO,UAAW,kBAAmB,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,iCAAkC,mDAAoD,yBAA0B,sZAAuZ,qBAAsB,kEAAmE,UAAW,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,GAAI,GAAI,KAC1pC,CAAC,WAAY,mDAAoD,iEAAkE,oCAAqC,0IAA2I,SAAU,aAAc,UAAW,MAAO,UAAW,iBAAkB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,GAAI,yBAA0B,oLAAqL,6FAA8F,gEAAiE,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,eAAgB,GAAI,KACl/B,CAAC,wBAAyB,gEAAiE,4DAA6D,qCAAsC,iJAA+I,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,4BAA6B,GAAI,0BAA2B,ggBAA8f,4BAA6B,sDAAuD,qEAAsE,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,KAC3xC,CAAC,kCAAmC,0EAA2E,sCAAuC,oCAAqC,+HAAgI,SAAU,aAAc,WAAY,MAAO,WAAY,iBAAkB,YAAa,MAAO,YAAa,SAAU,WAAY,YAAa,MAAO,YAAa,kCAAmC,kEAAmE,GAAI,2vBAA4vB,uIAAwI,sDAAuD,wGAAyG,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,sGAAuG,GAAI,KAC10D,CAAC,iBAAkB,yDAA0D,6DAA8D,oCAAqC,8GAA+G,SAAU,aAAc,WAAY,MAAO,WAAY,iBAAkB,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,sDAAuD,wBAAyB,kvBAAmvB,4FAA6F,6BAA8B,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,mBAAoB,GAAI,KACrjD,CAAC,oBAAqB,4DAA6D,0DAA2D,qCAAsC,6IAA8I,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,qBAAsB,2DAA4D,mBAAoB,8LAA+L,2GAA4G,sDAAuD,yDAA0D,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,gBAAiB,GAAI,KACrlC,CAAC,aAAc,qDAAsD,yCAA0C,sCAAuC,oHAAqH,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,GAAI,sBAAuB,+hCAAwgC,qGAAsG,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,IAAK,kCAAmC,sBAAuB,GAAI,KACh0D,CAAC,oBAAqB,4DAA6D,gBAAiB,oCAAqC,oHAAgH,SAAU,aAAc,WAAY,MAAO,WAAY,QAAS,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,uBAAwB,oDAAqD,GAAI,gbAA4a,uJAAwJ,yCAA0C,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,IAAK,oBAAqB,mBAAoB,GAAI,KACvuC,CAAC,cAAe,sDAAuD,6CAA8C,2CAA4C,mIAAoI,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,6BAA8B,0CAA2C,uBAAwB,sgBAAugB,oGAAqG,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,yCAA0C,GAAI,MACp3C,CAAC,sBAAuB,8DAA+D,sCAAuC,qCAAsC,sIAAuI,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,GAAI,wBAAyB,kdAA8c,6GAA8G,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,oBAAqB,GAAI,KAC/wC,CAAC,uBAAwB,+DAAgE,gDAAiD,2CAA4C,oIAAqI,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,2CAA4C,uBAAwB,05BAA25B,sFAAuF,iDAAkD,oBAAqB,GAAI,eAAgB,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,iCAAkC,GAAI,KAC3uD,CAAC,cAAe,sDAAuD,sCAAuC,kCAAmC,4FAA6F,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,yBAA0B,+DAAgE,kCAAmC,qpBAAspB,gDAAiD,sBAAuB,qEAAsE,GAAI,eAAgB,aAAc,MAAO,IAAK,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,2BAA4B,GAAI,KACj6C,CAAC,mBAAoB,2DAA4D,6CAA8C,kCAAmC,yGAA0G,SAAU,aAAc,UAAW,MAAO,UAAW,gBAAiB,WAAY,MAAO,WAAY,SAAU,WAAY,GAAI,GAAI,GAAI,8BAA+B,mDAAoD,yBAA0B,iyBAAkyB,GAAI,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,cAAe,GAAI,KACphD,CAAC,UAAW,kDAAmD,sCAAuC,0CAA2C,kGAAmG,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,8CAA+C,mBAAoB,inBAAymB,2FAA4F,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,MAAO,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,IAAK,oBAAqB,gBAAiB,GAAI,MAC94C,CAAC,cAAe,sDAAuD,8CAA+C,oCAAqC,sIAAuI,SAAU,aAAc,GAAI,GAAI,GAAI,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,GAAI,sBAAuB,0uBAAsuB,iBAAkB,sDAAuD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,YAAa,GAAI,KACx3C,CAAC,wBAAyB,gEAAiE,8CAA+C,4CAA6C,sHAAuH,SAAU,aAAc,YAAa,MAAO,YAAa,iBAAkB,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,mBAAoB,GAAI,iBAAkB,wtBAAqsB,eAAgB,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,qBAAsB,GAAI,KACh5C,CAAC,uBAAwB,+DAAgE,yDAA0D,8CAA+C,wHAAyH,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,GAAI,mBAAoB,0aAA2a,oFAAqF,6FAA8F,gCAAiC,GAAI,gBAAiB,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,eAAgB,GAAI,KACnvC,CAAC,6BAA8B,qEAAsE,wCAAyC,uCAAwC,sIAAuI,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,WAAY,GAAI,GAAI,GAAI,kCAAmC,6DAA8D,+BAAgC,yiBAA0iB,8GAA+G,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,MAAO,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,gCAAiC,GAAI,KACp9C,CAAC,gBAAiB,uDAAwD,8BAA+B,uCAAwC,mHAAoH,SAAU,aAAc,WAAY,MAAO,WAAY,OAAQ,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,qDAAsD,wBAAyB,kOAAmO,WAAY,yCAA0C,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,OAAQ,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,eAAgB,GAAI,KAC93B,CAAC,eAAgB,uDAAwD,2CAA4C,yCAA0C,8IAA+I,SAAU,aAAc,WAAY,MAAO,WAAY,iBAAkB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,+CAAgD,uBAAwB,iRAAkR,yBAA0B,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,YAAa,GAAI,KACpiC,CAAC,qBAAsB,6DAA8D,mEAAoE,uCAAwC,yHAA0H,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,GAAI,GAAI,6VAA8V,8FAA+F,sDAAuD,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,wCAAyC,GAAI,KACxnC,CAAC,YAAa,oDAAqD,4DAA6D,2CAA4C,sFAAuF,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,8CAA+C,qBAAsB,qbAAsb,yEAA0E,qEAAsE,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,kBAAmB,GAAI,MACjuC,CAAC,mBAAoB,2DAA4D,0CAA2C,kCAAmC,2IAA4I,SAAU,aAAc,WAAY,MAAO,WAAY,iBAAkB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,kCAAmC,wDAAyD,4BAA6B,kfAAmf,qEAAsE,qEAAsE,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,iBAAkB,GAAI,KACt1C,CAAC,uBAAwB,+DAAgE,iEAAkE,yCAA0C,qIAAsI,SAAU,aAAc,WAAY,MAAO,WAAY,mBAAoB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,6DAA8D,sBAAuB,k3BAAw2B,kFAAmF,qEAAsE,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,kBAAmB,GAAI,KACvvD,CAAC,kBAAmB,0DAA2D,wEAAyE,mCAAoC,wHAAyH,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,kCAAmC,oDAAqD,6BAA8B,kgBAAmgB,GAAI,8DAA+D,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,iDAAkD,GAAI,KACzxC,CAAC,UAAW,qEAAsE,6EAA8E,mCAAoC,4GAA6G,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,0EAA2E,iCAAkC,urBAAwrB,yCAA0C,sDAAuD,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,8CAA+C,GAAI,KACr/C,CAAC,YAAa,oDAAqD,sDAAuD,0CAA2C,kIAAmI,SAAU,aAAc,GAAI,GAAI,GAAI,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,GAAI,qBAAsB,+4BAAg5B,0GAA2G,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,gBAAiB,GAAI,KACrrD,CAAC,0BAA2B,kEAAmE,6CAA8C,0CAA2C,gHAAiH,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,yBAA0B,0DAA2D,iBAAkB,icAA6a,mHAAoH,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,MAAO,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,+BAAgC,GAAI,KAC9zC,CAAC,UAAW,sDAAuD,wDAAyD,wCAAyC,0GAA2G,SAAU,aAAc,UAAW,MAAO,UAAW,WAAY,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,gDAAiD,oBAAqB,0LAA2L,GAAI,sDAAuD,UAAW,GAAI,gBAAiB,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,8BAA+B,GAAI,KACl4B,CAAC,kBAAmB,0DAA2D,qEAAsE,yCAA0C,wHAAyH,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,gCAAiC,sDAAuD,0BAA2B,kfAAmf,mHAAoH,6EAA8E,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,iBAAkB,GAAI,MACh5C,CAAC,uBAAwB,+DAAgE,yCAA0C,uCAAwC,qIAAsI,SAAU,aAAc,UAAW,MAAO,UAAW,iBAAkB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,yDAA0D,GAAI,giBAAiiB,2FAA4F,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,2CAA4C,GAAI,KACz4C,CAAC,2BAA4B,mEAAoE,kDAAmD,uCAAwC,oGAAqG,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,GAAI,0BAA2B,uqBAAmqB,eAAgB,yDAA0D,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,KACn0C,CAAC,2BAA4B,mEAAoE,wCAAyC,mCAAoC,yGAA0G,SAAU,aAAc,UAAW,MAAO,UAAW,kBAAmB,UAAW,MAAO,UAAW,SAAU,SAAU,GAAI,GAAI,GAAI,oBAAqB,2DAA4D,wBAAyB,iLAAkL,GAAI,sDAAuD,yCAA0C,GAAI,iBAAkB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,MAAO,IAAK,oBAAqB,mBAAoB,GAAI,KACp7B,CAAC,qBAAsB,iEAAkE,0DAA2D,sCAAuC,2FAA4F,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,0CAA2C,kBAAmB,uJAAwJ,wDAAyD,sDAAuD,wGAAyG,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,WAAY,GAAI,KAC99B,CAAC,cAAe,qDAAsD,8CAA+C,oCAAqC,gHAAiH,SAAU,aAAc,UAAW,MAAO,UAAW,iBAAkB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,qDAAsD,kBAAmB,+ZAAga,GAAI,sDAAuD,0BAA2B,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,cAAe,GAAI,KACxmC,CAAC,iBAAkB,yDAA0D,yCAA0C,0CAA2C,0IAA2I,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,GAAI,GAAI,oWAAqW,2GAA4G,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,uDAAwD,GAAI,KAC9qC,CAAC,yBAA0B,iEAAkE,uCAAwC,oCAAqC,mFAAoF,SAAU,aAAc,GAAI,GAAI,GAAI,cAAe,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,wCAAyC,qBAAsB,scAAuc,6HAAyH,cAAe,yBAA0B,GAAI,gBAAiB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,YAAa,GAAI,KACpqC,CAAC,2BAA4B,mEAAoE,2CAA4C,sCAAuC,sIAAuI,SAAU,aAAc,WAAY,MAAO,WAAY,gBAAiB,WAAY,MAAO,WAAY,SAAU,WAAY,YAAa,MAAO,YAAa,sBAAuB,GAAI,mBAAoB,kiCAAmiC,yBAA0B,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,IAAK,kCAAmC,GAAI,GAAI,KACtzD,CAAC,sBAAuB,8DAA+D,6CAA8C,uCAAwC,+HAAgI,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,WAAY,GAAI,GAAI,GAAI,oCAAqC,sDAAuD,8BAA+B,2jBAA+iB,gBAAiB,sDAAuD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,kCAAmC,GAAI,GAAI,KAC/zC,CAAC,UAAW,kDAAmD,wDAAyD,uCAAwC,2EAA4E,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,4DAA6D,GAAI,6SAA8S,+GAAgH,cAAe,yBAA0B,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,iBAAkB,GAAI,KACjhC,CAAC,6BAA8B,qEAAsE,wCAAyC,0CAA2C,+HAAgI,SAAU,aAAc,UAAW,MAAO,UAAW,QAAS,WAAY,MAAO,WAAY,SAAU,SAAU,YAAa,MAAO,YAAa,oBAAqB,6DAA8D,GAAI,uKAAwK,6FAA8F,sDAAuD,oBAAqB,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,GAAI,GAAI,KACh/B,CAAC,UAAW,kDAAmD,sCAAuC,uCAAwC,2FAA4F,SAAU,aAAc,WAAY,MAAO,WAAY,gBAAiB,YAAa,MAAO,YAAa,SAAU,SAAU,WAAY,MAAO,WAAY,yBAA0B,wCAAyC,GAAI,oyBAAqyB,4FAA6F,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,GAAI,gBAAiB,GAAI,KAC7iD,CAAC,qBAAsB,6DAA8D,gDAAiD,2CAA4C,iDAAkD,SAAU,aAAc,WAAY,MAAO,WAAY,iBAAkB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,qDAAsD,qBAAsB,2pBAA4pB,GAAI,sDAAuD,UAAW,GAAI,eAAgB,aAAc,MAAO,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,aAAc,GAAI,KAC9yC,CAAC,qBAAsB,6DAA8D,6CAA8C,oCAAqC,mIAAoI,SAAU,aAAc,SAAU,MAAO,SAAU,QAAS,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,2DAA4D,oBAAqB,oNAAqN,+GAAgH,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,kBAAmB,GAAI,KAC5gC,CAAC,SAAU,iDAAkD,8DAA+D,6CAA8C,6FAA8F,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,YAAa,MAAO,YAAa,SAAU,WAAY,GAAI,GAAI,GAAI,wBAAyB,yDAA0D,kBAAmB,iXAAkX,mHAAoH,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,IAAK,oBAAqB,GAAI,GAAI,KACpsC,CAAC,YAAa,oDAAqD,iDAAkD,sCAAuC,6HAA8H,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,wDAAyD,6BAA8B,kSAAmS,8GAA+G,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,kBAAmB,GAAI,KACznC,CAAC,YAAa,oDAAqD,sCAAuC,kCAAmC,6IAAyI,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,4DAA6D,oBAAqB,mgCAA0/B,GAAI,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,MAAO,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,mCAAoC,GAAI,KAClvD,CAAC,oBAAqB,4DAA6D,wCAAyC,uCAAwC,4IAA6I,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,YAAa,MAAO,YAAa,SAAU,WAAY,YAAa,MAAO,YAAa,0BAA2B,oDAAqD,qBAAsB,q3BAAs3B,iFAAkF,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,IAAK,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,eAAgB,iBAAkB,GAAI,MACtvD,CAAC,mCAA+B,+CAAgD,6CAA8C,wCAAyC,yHAA0H,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,sEAAuE,oBAAqB,+eAAgf,0FAA2F,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,MAAO,IAAK,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,GAAI,GAAI,KAC1zC,CAAC,uBAAwB,+DAAgE,2CAA4C,uCAAwC,uHAAwH,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,uCAAwC,GAAI,GAAI,+cAAgd,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,wCAAyC,GAAI,KAC9mC,CAAC,oBAAqB,4DAA6D,+EAAgF,0CAA2C,kJAAmJ,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,WAAY,MAAO,WAAY,SAAU,WAAY,GAAI,GAAI,GAAI,8BAA+B,oDAAqD,4BAA6B,84BAA04B,gGAAiG,8EAA+E,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,+BAAgC,GAAI,KACj2D,CAAC,2BAA4B,mEAAoE,4CAA6C,wCAAyC,uHAAwH,SAAU,aAAc,UAAW,MAAO,UAAW,kBAAmB,WAAY,MAAO,WAAY,SAAU,WAAY,GAAI,GAAI,GAAI,sCAAuC,GAAI,uBAAwB,k/BAAm/B,mBAAoB,sDAAuD,wGAAyG,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,GAAI,GAAI,KAC9xD,CAAC,uBAAwB,+DAAgE,yCAA0C,wCAAyC,2FAA4F,SAAU,aAAc,SAAU,MAAO,SAAU,kBAAmB,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,yBAA0B,uDAAwD,mBAAoB,s8BAAo8B,4EAA6E,sDAAuD,yCAA0C,GAAI,iBAAkB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,eAAgB,GAAI,KACpuD,CAAC,WAAY,mDAAoD,kEAAmE,iDAAkD,wIAAyI,SAAU,aAAc,WAAY,MAAO,WAAY,gBAAiB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,0BAA2B,wCAAyC,sBAAuB,gpBAAipB,qGAAsG,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,KACv/C,CAAC,UAAW,kDAAmD,2CAA4C,0CAA2C,qFAAsF,SAAU,aAAc,UAAW,MAAO,UAAW,QAAS,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,GAAI,mBAAoB,unBAAwnB,gCAAiC,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,iEAAkE,GAAI,KACtzC,CAAC,sBAAuB,8DAA+D,wDAAyD,qCAAsC,yIAA0I,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,WAAY,GAAI,GAAI,GAAI,0BAA2B,yCAA0C,oBAAqB,4eAAwe,GAAI,sDAAuD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,GAAI,GAAI,eAAgB,GAAI,GAAI,KACvsC,CAAC,kCAAmC,0EAA2E,+CAAgD,mCAAoC,8HAA+H,SAAU,aAAc,UAAW,MAAO,UAAW,gBAAiB,WAAY,MAAO,WAAY,SAAU,WAAY,GAAI,GAAI,GAAI,sBAAuB,8DAA+D,oBAAqB,y4BAA+3B,gCAAiC,qEAAsE,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,IAAK,oBAAqB,WAAY,GAAI,KAClsD,CAAC,yBAA0B,iEAAkE,2CAA4C,qCAAsC,4IAA6I,SAAU,aAAc,GAAI,GAAI,GAAI,kBAAmB,WAAY,MAAO,WAAY,SAAU,WAAY,GAAI,GAAI,GAAI,8BAA+B,qFAAsF,qBAAsB,uqCAAwqC,iHAAkH,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,kCAAmC,GAAI,GAAI,KAC1kE,CAAC,WAAY,mDAAoD,kDAAmD,2CAA4C,2CAA4C,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,GAAI,wBAAyB,+LAAgM,yEAA0E,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,mBAAoB,GAAI,KAC13B,CAAC,uBAAwB,+DAAgE,0CAA2C,kCAAmC,qGAAsG,SAAU,aAAc,UAAW,MAAO,UAAW,mBAAoB,UAAW,MAAO,UAAW,SAAU,SAAU,GAAI,GAAI,GAAI,oBAAqB,6DAA8D,yBAA0B,0hCAA2hC,GAAI,qEAAsE,wGAAyG,GAAI,gBAAiB,aAAc,OAAQ,IAAK,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,mBAAoB,GAAI,KACj1D,CAAC,6BAA8B,qEAAsE,gDAAiD,oCAAqC,+FAAgG,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,GAAI,gBAAiB,uVAAmV,wBAAyB,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,wBAAyB,GAAI,KAC/hC,CAAC,2BAA4B,mEAAoE,mEAAoE,oDAAqD,2GAA4G,SAAU,aAAc,UAAW,MAAO,UAAW,kBAAmB,WAAY,MAAO,WAAY,SAAU,SAAU,YAAa,MAAO,YAAa,yBAA0B,2DAA4D,GAAI,8UAA4U,GAAI,2EAA4E,gCAAiC,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,kBAAmB,GAAI,KAC1nC,CAAC,sBAAuB,8DAA+D,6CAA8C,uCAAwC,4HAA0H,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,SAAU,GAAI,GAAI,GAAI,wBAAyB,sDAAuD,GAAI,wfAAse,GAAI,sDAAuD,GAAI,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,GAAI,GAAI,KAC7qC,CAAC,6BAA8B,0DAA2D,2DAA4D,uCAAwC,sFAAuF,SAAU,aAAc,YAAa,MAAO,YAAa,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,YAAa,MAAO,YAAa,gCAAiC,2CAA4C,8BAA+B,yaAA0a,qFAAsF,sDAAuD,oBAAqB,GAAI,gBAAiB,aAAc,MAAO,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,2BAA4B,GAAI,KACxvC,CAAC,qBAAsB,6DAA8D,2CAA4C,2CAA4C,+HAAgI,SAAU,aAAc,UAAW,MAAO,UAAW,QAAS,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,sDAAuD,0BAA2B,+aAAgb,iFAAkF,sDAAuD,wGAAyG,GAAI,eAAgB,aAAc,OAAQ,IAAK,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,kBAAmB,GAAI,KAC/yC,CAAC,kBAAmB,0DAA2D,qCAAsC,qCAAsC,8IAA+I,SAAU,aAAc,WAAY,MAAO,WAAY,iBAAkB,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,qDAAsD,0BAA2B,4xBAAmxB,6DAA8D,yDAA0D,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,6DAA8D,GAAI,KAC9lD,CAAC,wBAAyB,gEAAiE,sCAAuC,kDAAmD,2IAA4I,SAAU,aAAc,UAAW,MAAO,UAAW,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,sCAAuC,yDAA0D,mCAAoC,q5DAA44D,+CAAgD,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,8CAA+C,GAAI,KACnwF,CAAC,oCAAqC,+CAAgD,yFAA0F,wCAAyC,yGAA0G,SAAU,aAAc,UAAW,MAAO,UAAW,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,kCAAmC,mEAAoE,gCAAiC,qcAA4b,GAAI,qEAAsE,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,eAAgB,GAAI,KACptC,CAAC,WAAY,mDAAoD,6CAA8C,4CAA6C,2IAA4I,SAAU,aAAc,WAAY,MAAO,WAAY,iBAAkB,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,sBAAuB,GAAI,oBAAqB,iuBAAkuB,GAAI,sDAAuD,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,iBAAkB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,mBAAoB,GAAI,KACp4C,CAAC,UAAW,8DAA+D,oDAAqD,uCAAwC,gGAAiG,SAAU,aAAc,WAAY,MAAO,WAAY,iBAAkB,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,+CAAgD,mBAAoB,uTAAwT,0FAA2F,oFAAqF,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,MAAO,IAAK,kCAAmC,2BAA4B,GAAI,KAC9nC,CAAC,cAAe,sDAAuD,6CAA8C,sCAAuC,+GAAgH,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,GAAI,sBAAuB,qSAAsS,GAAI,sDAAuD,GAAI,GAAI,cAAe,aAAc,MAAO,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,0BAA2B,GAAI,KAC76B,CAAC,WAAY,mDAAoD,6CAA8C,2CAA4C,2IAA4I,SAAU,aAAc,GAAI,GAAI,GAAI,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,iDAAkD,uBAAwB,0xBAA2xB,uFAAwF,sDAAuD,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,0BAA2B,GAAI,KACpkD,CAAC,kBAAmB,0DAA2D,iEAAkE,wCAAyC,uGAAwG,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,gCAAiC,GAAI,0BAA2B,wRAAyR,oEAAqE,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,oBAAqB,GAAI,KAC1iC,CAAC,qBAAsB,6DAA8D,2DAA4D,iCAAkC,iIAAkI,SAAU,aAAc,GAAI,GAAI,GAAI,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,mCAAoC,0DAA2D,wCAAyC,uLAAwL,iIAAkI,sDAAuD,UAAW,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,yCAA0C,GAAI,KAChlC,CAAC,UAAW,kDAAmD,qCAAsC,wCAAyC,kHAAmH,SAAU,aAAc,SAAU,MAAO,SAAU,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,kCAAmC,8CAA+C,mBAAoB,s7BAAu7B,wHAAyH,yDAA0D,oBAAqB,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,aAAc,GAAI,KACjvD,CAAC,iBAAkB,yDAA0D,iFAAkF,qCAAsC,oHAAqH,SAAU,aAAc,UAAW,MAAO,UAAW,WAAY,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,qBAAsB,iDAAkD,kBAAmB,oUAAgU,qFAAsF,0EAA2E,GAAI,GAAI,gBAAiB,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,eAAgB,GAAI,KAC5nC,CAAC,YAAa,oDAAqD,2CAA4C,oCAAqC,sIAAuI,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,WAAY,GAAI,GAAI,GAAI,0BAA2B,iDAAkD,GAAI,0tCAA2tC,GAAI,sDAAuD,wGAAyG,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,GAAI,GAAI,KAC1/D,CAAC,yBAA0B,iEAAkE,oDAAqD,0CAA2C,2HAA4H,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,kCAAmC,GAAI,4BAA6B,2xBAA4xB,iHAAkH,sDAAuD,UAAW,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,IAAK,oBAAqB,iDAAkD,GAAI,KACrnD,CAAC,QAAS,gDAAiD,2DAA4D,sCAAuC,8IAA+I,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,6CAA8C,iBAAkB,uPAAwP,yEAA0E,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,aAAc,GAAI,KAC1iC,CAAC,aAAc,qDAAsD,kDAAmD,uCAAwC,uFAAwF,SAAU,aAAc,GAAI,GAAI,GAAI,OAAQ,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,+CAAgD,GAAI,+WAAgX,aAAc,sDAAuD,UAAW,GAAI,GAAI,aAAc,OAAQ,GAAI,OAAQ,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,KAC/7B,CAAC,SAAU,iFAAkF,2BAA4B,wCAAyC,uIAAwI,SAAU,aAAc,UAAW,MAAO,UAAW,kBAAmB,UAAW,MAAO,UAAW,SAAU,SAAU,GAAI,GAAI,GAAI,sBAAuB,GAAI,GAAI,qjBAAsjB,GAAI,yDAA0D,2BAA4B,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,IAAK,oBAAqB,GAAI,GAAI,KACptC,CAAC,4BAA6B,oEAAqE,uDAAwD,qCAAsC,sFAAuF,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,iBAAkB,GAAI,0BAA2B,26BAA46B,GAAI,wFAAyF,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,gBAAiB,GAAI,KACplD,CAAC,UAAW,kDAAmD,sCAAuC,qCAAsC,4EAA6E,SAAU,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,GAAI,6BAA8B,0hBAA2hB,mDAAoD,sDAAuD,oBAAqB,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,kCAAmC,GAAI,KAC5rC,CAAC,oBAAqB,4DAA6D,qFAAsF,0CAA2C,yIAA0I,SAAU,aAAc,UAAW,MAAO,UAAW,iBAAkB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,kCAAmC,GAAI,4BAA6B,ogCAAy9B,UAAW,sDAAuD,UAAW,GAAI,cAAe,aAAc,OAAQ,GAAI,iBAAkB,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,4DAA6D,GAAI,KACzvD,CAAC,sBAAuB,8DAA+D,oCAAqC,2CAA4C,oFAAqF,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,GAAI,0BAA2B,0TAA2T,iJAAkJ,oFAAqF,wGAAyG,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,gBAAiB,GAAI,KACrsC,CAAC,SAAU,qDAAsD,oDAAqD,mCAAoC,wGAAyG,SAAU,aAAc,UAAW,MAAO,UAAW,QAAS,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,GAAI,kBAAmB,8lBAAqlB,sDAAuD,sDAAuD,UAAW,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,eAAgB,GAAI,KAC7uC,CAAC,cAAe,sDAAuD,yBAA0B,iCAAkC,qHAAsH,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,2CAA4C,sBAAuB,4NAA6N,kBAAmB,yDAA0D,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,wBAAyB,GAAI,KAC94B,CAAC,SAAU,iDAAkD,6CAA8C,uCAAwC,sIAAuI,SAAU,aAAc,WAAY,MAAO,WAAY,mBAAoB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,qBAAsB,0CAA2C,oBAAqB,gmBAAimB,mFAAoF,sDAAuD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,OAAQ,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,KACl1C,CAAC,2BAA4B,mEAAoE,wDAAyD,uCAAwC,wFAAyF,SAAU,aAAc,UAAW,MAAO,UAAW,QAAS,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,GAAI,GAAI,qlBAAslB,yEAA0E,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,cAAe,GAAI,KACxvC,CAAC,qBAAsB,6DAA8D,yEAA0E,uCAAwC,qIAAsI,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,mCAAoC,qDAAsD,6BAA8B,q6BAAs6B,8HAA+H,qEAAsE,0BAA2B,GAAI,eAAgB,aAAc,MAAO,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,cAAe,GAAI,KAC30D,CAAC,oBAAqB,4DAA6D,wDAAyD,oCAAqC,mJAAoJ,SAAU,aAAc,UAAW,MAAO,UAAW,QAAS,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,GAAI,+BAAgC,4fAA6f,iGAAkG,8EAA+E,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,IAAK,kCAAmC,GAAI,GAAI,KACh2C,CAAC,UAAW,kDAAmD,4EAA6E,uCAAwC,2GAA4G,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,2CAA4C,mBAAoB,qUAAsU,uHAAwH,oFAAqF,wGAAyG,GAAI,eAAgB,aAAc,MAAO,GAAI,GAAI,GAAI,SAAU,aAAc,MAAO,GAAI,GAAI,cAAe,GAAI,MACxvC,CAAC,iBAAkB,yDAA0D,sCAAuC,yCAA0C,gIAAiI,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,sEAAuE,yBAA0B,0UAA8T,mGAAoG,sDAAuD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,MAChoC,CAAC,aAAc,qDAAsD,0EAA2E,sCAAuC,gGAAiG,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,8CAA+C,sBAAuB,uRAAwR,yFAA0F,sDAAuD,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,mBAAoB,GAAI,MAC1iC,CAAC,YAAa,oDAAqD,+BAAgC,oCAAqC,2GAA4G,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,6CAA8C,qBAAsB,4YAAwY,GAAI,wDAAyD,UAAW,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KACjhC,CAAC,uBAAwB,+DAAgE,6CAA8C,0CAA2C,6IAA8I,SAAU,aAAc,UAAW,MAAO,UAAW,iBAAkB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,GAAI,wBAAyB,yTAA0T,mBAAoB,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,gBAAiB,GAAI,KAC3hC,CAAC,OAAQ,+CAAgD,iEAAkE,+CAAgD,mIAAoI,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,sBAAuB,GAAI,GAAI,ynBAA0nB,uFAAwF,qEAAsE,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,YAAa,GAAI,KACh5C,CAAC,OAAQ,+CAAgD,wDAAyD,wCAAyC,sIAAuI,SAAU,aAAc,QAAS,MAAO,QAAS,kBAAmB,QAAS,MAAO,QAAS,SAAU,SAAU,GAAI,GAAI,GAAI,uBAAwB,6CAA8C,gBAAiB,uWAAwW,GAAI,qEAAsE,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,IAAK,oBAAqB,gBAAiB,GAAI,KAC3jC,CAAC,iBAAkB,yDAA0D,4DAA6D,0CAA2C,kIAAmI,SAAU,aAAc,YAAa,MAAO,YAAa,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,GAAI,GAAI,yfAA0f,+FAAgG,qEAAsE,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,aAAc,GAAI,KAC7yC,CAAC,aAAc,qDAAsD,yCAA0C,wCAAyC,+FAAgG,SAAU,aAAc,WAAY,MAAO,WAAY,iBAAkB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,oDAAqD,yBAA0B,gJAAiJ,mGAAoG,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,qCAAsC,GAAI,KACr9B,CAAC,uBAAwB,+DAAgE,uDAAwD,qCAAsC,kGAAmG,SAAU,aAAc,UAAW,MAAO,UAAW,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,wDAAyD,+BAAgC,+mBAAgnB,mGAAoG,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,0BAA2B,GAAI,KACp9C,CAAC,sBAAuB,8DAA+D,oDAAqD,oCAAqC,6HAA8H,SAAU,aAAc,YAAa,MAAO,YAAa,kBAAmB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,yBAA0B,6DAA8D,iBAAkB,03BAAs3B,uEAAwE,sDAAuD,oBAAqB,GAAI,cAAe,aAAc,MAAO,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,GAAI,aAAc,GAAI,KACxqD,CAAC,WAAY,mDAAoD,yDAA0D,wCAAyC,yHAA0H,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,6CAA8C,uBAAwB,uZAAwZ,qCAAsC,sDAAuD,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,kCAAmC,GAAI,KAC/oC,CAAC,wBAAyB,gEAAiE,2DAA4D,wCAAyC,wIAAyI,SAAU,aAAc,SAAU,MAAO,SAAU,kBAAmB,UAAW,MAAO,UAAW,SAAU,SAAU,GAAI,GAAI,GAAI,yBAA0B,GAAI,mBAAoB,6/CAA8/C,GAAI,sDAAuD,GAAI,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,GAAI,GAAI,KAC/rE,CAAC,cAAe,sDAAuD,sCAAuC,sCAAuC,8GAA+G,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,oDAAqD,GAAI,+VAAgW,+FAAgG,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,cAAe,GAAI,KAC/nC,CAAC,sBAAuB,8DAA+D,+CAAgD,6CAA8C,0HAA2H,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,gCAAiC,GAAI,mCAAoC,yfAA0f,GAAI,qEAAsE,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,IAAK,oBAAqB,GAAI,GAAI,KACvsC,CAAC,aAAc,qDAAsD,uCAAwC,wCAAyC,4IAA6I,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,+CAAgD,GAAI,2cAA4c,gGAAiG,cAAe,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,qBAAsB,GAAI,KAChrC,CAAC,kBAAmB,0DAA2D,oDAAqD,mCAAoC,kIAAmI,SAAU,aAAc,WAAY,MAAO,WAAY,iBAAkB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,mDAAoD,GAAI,mIAAoI,GAAI,uCAAwC,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,iBAAkB,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,aAAc,GAAI,KAClzB,CAAC,sBAAuB,8DAA+D,oDAAqD,0CAA2C,kHAAmH,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,GAAI,kBAAmB,4lBAAwlB,uEAAwE,sDAAuD,oBAAqB,GAAI,eAAgB,aAAc,QAAS,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,aAAc,GAAI,KACv0C,CAAC,WAAY,mDAAoD,8BAA+B,2CAA4C,2GAA4G,SAAU,aAAc,QAAS,MAAO,QAAS,OAAQ,QAAS,MAAO,QAAS,SAAU,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,0JAA2J,gCAAiC,yCAA0C,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,OAAQ,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KAC7qB,CAAC,SAAU,iDAAkD,6CAA8C,sCAAuC,mGAAoG,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,iDAAkD,GAAI,6pBAA8pB,4HAA6H,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,KACt8C,CAAC,aAAc,qDAAsD,kDAAmD,uCAAwC,+IAAgJ,SAAU,aAAc,SAAU,MAAO,SAAU,iBAAkB,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,GAAI,GAAI,0oCAA2oC,oEAAqE,sDAAuD,wGAAyG,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,GAAI,GAAI,KAC/6D,CAAC,wBAAyB,gEAAiE,2BAA4B,qCAAsC,uIAAwI,SAAU,aAAc,SAAU,MAAO,SAAU,OAAQ,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,4RAAwR,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,OAAQ,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KACz1B,CAAC,WAAY,mDAAoD,gDAAiD,4CAA6C,8IAA+I,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,sBAAuB,GAAI,oBAAqB,2+BAA4+B,kBAAmB,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KAC/nD,CAAC,iBAAkB,yDAA0D,gDAAiD,qCAAsC,qIAAsI,SAAU,aAAc,UAAW,MAAO,UAAW,kBAAmB,UAAW,MAAO,UAAW,SAAU,WAAY,GAAI,GAAI,GAAI,gCAAiC,iDAAkD,GAAI,iyBAAkyB,iBAAkB,sDAAuD,yBAA0B,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,yCAAoC,GAAI,KAC1iD,CAAC,yBAA0B,2DAA4D,iDAAkD,uCAAwC,0GAA2G,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,GAAI,2BAA4B,8cAA+c,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,QAAS,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,cAAe,GAAI,KAC3mC,CAAC,sBAAuB,8DAA+D,uCAAwC,mCAAoC,4IAA6I,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,yCAA0C,iCAAkC,wcAAyc,4FAA6F,oFAAqF,wGAAyG,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,gBAAiB,GAAI,KAC33C,CAAC,uBAAwB,+DAAgE,6BAA8B,iCAAkC,2GAA4G,SAAU,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,SAAU,GAAI,GAAI,GAAI,8BAA+B,sEAAuE,4BAA6B,qhCAA8gC,GAAI,sDAAuD,oBAAqB,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,GAAI,GAAI,IAChqD,CAAC,WAAY,mDAAoD,gFAAiF,mCAAoC,wFAAyF,SAAU,aAAc,UAAW,MAAO,UAAW,kBAAmB,UAAW,MAAO,UAAW,SAAU,SAAU,GAAI,GAAI,GAAI,sBAAuB,4CAA6C,mBAAoB,63BAAy3B,GAAI,+EAAgF,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,GAAI,kCAAmC,GAAI,KACjnD,CAAC,UAAW,kDAAmD,+CAAgD,uCAAwC,0HAA2H,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,GAAI,GAAI,0ZAA2Z,8CAA+C,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,MAC7kC,CAAC,WAAY,mDAAoD,qDAAsD,iDAAkD,gHAAiH,SAAU,aAAc,UAAW,MAAO,UAAW,iBAAkB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,GAAI,oBAAqB,0aAA2a,kFAAmF,sDAAuD,UAAW,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,6BAA8B,GAAI,KACrpC,CAAC,oBAAqB,4DAA6D,8CAA+C,0CAA2C,4EAA6E,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,UAAW,MAAO,UAAW,SAAU,SAAU,GAAI,GAAI,GAAI,+CAAgD,GAAI,yBAA0B,2UAA4U,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,GAAI,GAAI,KACx9B,CAAC,2BAA4B,kEAAmE,8CAA+C,gCAAiC,kFAAmF,SAAU,aAAc,GAAI,GAAI,GAAI,QAAS,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,qCAAsC,GAAI,gCAAiC,wYAAyY,kCAAmC,sDAAuD,GAAI,GAAI,GAAI,aAAc,MAAO,GAAI,OAAQ,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KACv/B,CAAC,SAAU,iDAAkD,yCAA0C,iCAAkC,+IAAgJ,SAAU,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,GAAI,GAAI,uVAA2U,gDAAiD,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,eAAgB,GAAI,KACz/B,CAAC,sBAAuB,8DAA+D,4BAA6B,qCAAsC,kHAAmH,SAAU,aAAc,SAAU,MAAO,SAAU,iBAAkB,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,GAAI,6BAA8B,2XAA4X,GAAI,kEAAmE,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,GAAI,IAAK,GAAI,GAAI,GAAI,GAAI,KACphC,CAAC,gDAAiD,wFAAyF,wFAAyF,kCAAmC,kIAAmI,SAAU,aAAc,UAAW,MAAO,UAAW,QAAS,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,oCAAqC,iFAAkF,gBAAiB,2ZAAuZ,6CAA8C,uFAAwF,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,GAAI,KAAM,GAAI,GAAI,GAAI,GAAI,KACxwC,CAAC,oBAAqB,4DAA6D,sCAAuC,sCAAuC,0FAA2F,SAAU,aAAc,GAAI,GAAI,GAAI,2BAA4B,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,gCAAiC,sDAAuD,4BAA6B,+jBAA2jB,qCAAsC,sDAAuD,oBAAqB,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,GAAI,GAAI,GAAI,GAAI,aAAc,GAAI,KACjuC,CAAC,WAAY,mDAAoD,iDAAkD,wCAAyC,+GAAgH,SAAU,aAAc,UAAW,MAAO,UAAW,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,GAAI,yBAA0B,0UAA2U,qGAAsG,sDAAuD,UAAW,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,qBAAsB,GAAI,KAC7jC,CAAC,wBAAyB,gEAAiE,sCAAuC,0CAA2C,2GAA4G,SAAU,aAAc,WAAY,MAAO,WAAY,iBAAkB,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,uFAAwF,yBAA0B,qUAAsU,gIAAiI,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,IAAK,kCAAmC,iBAAkB,GAAI,KACnvC,CAAC,UAAW,kDAAmD,6CAA8C,oCAAqC,8HAA+H,SAAU,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,0CAA2C,8BAA+B,0bAA2b,+FAAgG,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,KACruC,CAAC,WAAY,mDAAoD,8DAA+D,uCAAwC,2IAA4I,SAAU,aAAc,SAAU,MAAO,SAAU,2BAA4B,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,GAAI,0BAA2B,8aAA+a,iBAAkB,8EAA+E,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,8CAA+C,GAAI,KAClsC,CAAC,wBAAyB,gEAAiE,2DAA4D,4CAA6C,0IAA2I,SAAU,aAAc,UAAW,MAAO,UAAW,iBAAkB,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,0DAA2D,4DAA6D,wBAAyB,6cAA8c,kBAAmB,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,iBAAkB,GAAI,KACtuC,CAAC,YAAa,oDAAqD,wCAAyC,sCAAuC,0DAA2D,SAAU,aAAc,UAAW,MAAO,UAAW,iBAAkB,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,GAAI,qBAAsB,mZAAoZ,qBAAsB,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,eAAgB,GAAI,KAC//B,CAAC,eAAgB,uDAAwD,2DAA4D,mCAAoC,sHAAuH,SAAU,aAAc,SAAU,MAAO,SAAU,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,+CAAgD,wBAAyB,+gBAAghB,GAAI,sDAAuD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,mDAAoD,GAAI,KAC1vC,CAAC,YAAa,oDAAqD,uCAAwC,+BAAgC,wFAAyF,SAAU,aAAc,UAAW,MAAO,UAAW,OAAQ,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,4CAA6C,qBAAsB,iQAAkQ,GAAI,0EAA2E,GAAI,GAAI,gBAAiB,aAAc,OAAQ,GAAI,OAAQ,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,gBAAiB,GAAI,KACx4B,CAAC,sBAAuB,8DAA+D,wDAAyD,wCAAyC,6HAA8H,SAAU,aAAc,UAAW,MAAO,UAAW,WAAY,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,GAAI,oBAAqB,oQAAqQ,oDAAqD,iEAAkE,wGAAyG,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,4BAA6B,GAAI,KAC/kC,CAAC,mBAAoB,2DAA4D,6BAA8B,wCAAyC,6EAA8E,SAAU,aAAc,GAAI,GAAI,GAAI,QAAS,GAAI,GAAI,GAAI,SAAU,SAAU,YAAa,MAAO,YAAa,6BAA8B,yDAA0D,GAAI,oWAAqW,wCAAyC,sDAAuD,yDAA0D,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,KAC9hC,CAAC,UAAW,kDAAmD,kDAAmD,uCAAwC,+HAAgI,SAAU,aAAc,SAAU,MAAO,SAAU,OAAQ,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,4YAA6Y,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,OAAQ,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,sCAAuC,GAAI,KACt+B,CAAC,OAAQ,+CAAgD,+DAAgE,sCAAuC,wIAAyI,SAAU,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,SAAU,GAAI,GAAI,GAAI,sBAAuB,uCAAwC,sBAAuB,sZAAuZ,GAAI,gEAAiE,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,MAAO,GAAI,GAAI,qBAAsB,GAAI,IACvkC,CAAC,iBAAkB,yDAA0D,0EAA2E,wCAAyC,uHAAwH,SAAU,aAAc,UAAW,MAAO,UAAW,iBAAkB,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,iCAAkC,gDAAiD,GAAI,iaAAka,GAAI,sDAAuD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,0BAA2B,GAAI,KAC/mC,CAAC,uBAAwB,+DAAgE,+CAAgD,qCAAsC,oIAAqI,SAAU,aAAc,SAAU,MAAO,SAAU,iBAAkB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,GAAI,sBAAuB,+eAAgf,GAAI,qEAAsE,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,KACzqC,CAAC,aAAc,qDAAsD,gDAAiD,sCAAuC,qGAAsG,SAAU,aAAc,UAAW,MAAO,UAAW,gBAAiB,YAAa,MAAO,YAAa,SAAU,WAAY,YAAa,MAAO,YAAa,2BAA4B,6CAA8C,GAAI,imBAAkmB,6FAA8F,sDAAuD,wGAAyG,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,GAAI,GAAI,KACh8C,CAAC,SAAU,iDAAkD,qDAAsD,oCAAqC,6EAA8E,SAAU,aAAc,GAAI,GAAI,GAAI,iBAAkB,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,0CAA2C,kBAAmB,2TAA4T,2BAA4B,qEAAsE,yDAA0D,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,gBAAiB,GAAI,KACz/B,CAAC,qBAAsB,6DAA8D,oDAAqD,2CAA4C,yHAA0H,SAAU,aAAc,SAAU,MAAO,SAAU,2BAA4B,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,mBAAoB,GAAI,iBAAkB,2UAAuU,GAAI,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,iBAAkB,GAAI,KACngC,CAAC,SAAU,8DAA+D,yCAA0C,yCAA0C,uIAAwI,SAAU,aAAc,GAAI,GAAI,GAAI,kBAAmB,GAAI,GAAI,GAAI,SAAU,SAAU,GAAI,GAAI,GAAI,wBAAyB,yCAA0C,iCAAkC,88BAA48B,2BAA4B,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,GAAI,GAAI,KAC3rD,CAAC,YAAa,oDAAqD,kDAAmD,gCAAiC,wFAAyF,UAAW,aAAc,UAAW,MAAO,UAAW,WAAY,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,GAAI,GAAI,udAA0c,GAAI,sDAAuD,UAAW,GAAI,gBAAiB,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KAC1hC,CAAC,eAAgB,sDAAuD,sCAAuC,qCAAsC,4GAA6G,UAAW,aAAc,SAAU,MAAO,SAAU,2BAA4B,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,iCAAkC,GAAI,GAAI,u9BAAy8B,GAAI,8DAA+D,GAAI,GAAI,gBAAiB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KAC3iD,CAAC,SAAU,iDAAkD,uCAAwC,yCAA0C,iGAAkG,UAAW,aAAc,UAAW,MAAO,UAAW,2BAA4B,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,GAAI,oBAAqB,uQAAwQ,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,MAAO,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KACn1B,CAAC,WAAY,mDAAoD,4DAA6D,kCAAmC,8FAA+F,UAAW,aAAc,UAAW,MAAO,UAAW,kBAAmB,UAAW,MAAO,UAAW,SAAU,SAAU,GAAI,GAAI,GAAI,0BAA2B,GAAI,qBAAsB,wwBAA0vB,GAAI,qEAAsE,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KACj3C,CAAC,eAAgB,uDAAwD,uCAAwC,2CAA4C,iIAAkI,UAAW,aAAc,UAAW,MAAO,UAAW,QAAS,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,oBAAqB,GAAI,kBAAmB,omBAAqmB,gCAAiC,+EAAgF,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,aAAc,GAAI,KAC9wC,CAAC,wCAAyC,gFAAiF,gBAAiB,4CAA6C,kHAAmH,UAAW,aAAc,SAAU,MAAO,SAAU,QAAS,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,yEAA0E,wBAAyB,kHAAmH,gCAAiC,yCAA0C,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KAC7zB,CAAC,wBAAyB,gEAAiE,gBAAiB,uCAAwC,8HAA+H,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,SAAU,aAAc,MAAO,aAAc,0BAA2B,uDAAwD,mBAAoB,4gBAAwgB,GAAI,yCAA0C,wGAAyG,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,IAAK,oBAAqB,yBAA0B,GAAI,IACnxC,CAAC,qBAAsB,6DAA8D,sCAAuC,mCAAoC,sHAAuH,UAAW,aAAc,SAAU,MAAO,SAAU,kBAAmB,SAAU,MAAO,SAAU,SAAU,WAAY,GAAI,GAAI,GAAI,+BAAgC,uDAAwD,6BAA8B,msBAAosB,GAAI,sDAAuD,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,eAAgB,oBAAqB,GAAI,KACh6C,CAAC,UAAW,kDAAmD,yCAA0C,wCAAyC,4IAA6I,UAAW,aAAc,QAAS,MAAO,QAAS,OAAQ,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,qBAAsB,GAAI,mBAAoB,qRAAiR,GAAI,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,iCAAkC,GAAI,KAC57B,CAAC,SAAU,iDAAkD,iEAAkE,sCAAuC,sFAAuF,UAAW,aAAc,SAAU,MAAO,SAAU,wBAAyB,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,kCAAmC,GAAI,GAAI,qQAAsQ,mBAAoB,sDAAuD,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KAC90B,CAAC,qBAAsB,2DAA4D,wCAAyC,iDAAkD,8FAA+F,UAAW,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,SAAU,YAAa,MAAO,YAAa,0BAA2B,+CAAgD,kCAAmC,46BAA66B,8DAA+D,sDAAuD,oBAAqB,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,8DAA+D,GAAI,KAC7vD,CAAC,iBAAkB,yDAA0D,8CAA+C,uCAAwC,wGAAyG,UAAW,aAAc,UAAW,MAAO,UAAW,WAAY,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,GAAI,GAAI,wXAAyX,QAAS,cAAe,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,IAAK,sBAAuB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,KACn+B,CAAC,oBAAqB,4DAA6D,+DAAgE,+BAAgC,mGAAoG,UAAW,aAAc,GAAI,GAAI,GAAI,cAAe,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,mCAAoC,qDAAsD,4BAA6B,wkBAAokB,iCAAkC,qFAAsF,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,cAAe,GAAI,KAC5xC,CAAC,gBAAiB,wDAAyD,2CAA4C,wCAAyC,8HAA+H,UAAW,aAAc,WAAY,MAAO,WAAY,mBAAoB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,+BAAgC,gDAAiD,8BAA+B,ufAAwf,uHAAwH,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,4BAA6B,GAAI,KACt3C,CAAC,mBAAoB,2DAA4D,kGAAmG,uCAAwC,2GAA4G,UAAW,aAAc,GAAI,GAAI,GAAI,QAAS,GAAI,GAAI,GAAI,SAAU,SAAU,GAAI,GAAI,GAAI,kCAAmC,uDAAwD,4BAA6B,kgCAAmgC,+BAAgC,+HAAgI,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,iBAAkB,GAAI,KACt0D,CAAC,wBAAyB,gEAAiE,8BAA+B,wCAAyC,wEAAyE,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,+DAAgE,GAAI,wYAAyY,GAAI,cAAe,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,IACt8B,CAAC,4BAA6B,oEAAqE,2DAA4D,yCAA0C,2IAA4I,UAAW,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,SAAU,YAAa,MAAO,YAAa,2BAA4B,4DAA6D,qBAAsB,klBAAmlB,8FAA+F,sDAAuD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,eAAgB,GAAI,KACz9C,CAAC,kCAAmC,yEAA0E,4EAA6E,mCAAoC,uGAAwG,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,sBAAuB,kEAAmE,GAAI,mlCAA2kC,GAAI,8FAA+F,UAAW,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,IAAK,oBAAqB,GAAI,GAAI,IAC/xD,CAAC,4BAA6B,oEAAqE,0CAA2C,4CAA6C,mHAAoH,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,yCAA0C,uBAAwB,2aAA4a,uHAAwH,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,uBAAwB,GAAI,KACzxC,CAAC,oBAAqB,4DAA6D,6BAA8B,qCAAsC,uIAAwI,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,sBAAuB,GAAI,sBAAuB,owBAAqwB,GAAI,sDAAuD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,gBAAiB,GAAI,IACh2C,CAAC,wBAAyB,gEAAiE,oDAAqD,qCAAsC,iJAAkJ,UAAW,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,GAAI,sBAAuB,u0BAAk0B,sCAAuC,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,MAAO,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,cAAe,GAAI,KAC7kD,CAAC,qBAAsB,6DAA8D,gBAAiB,0CAA2C,yCAA0C,UAAW,aAAc,SAAU,MAAO,SAAU,WAAY,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,GAAI,GAAI,yCAA0C,GAAI,yCAA0C,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,OAAQ,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KAChhB,CAAC,qBAAsB,6DAA8D,0DAA2D,wCAAyC,2IAA4I,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,SAAU,GAAI,GAAI,GAAI,mCAAoC,qDAAsD,uBAAwB,+mBAA2mB,GAAI,qEAAsE,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,GAAI,GAAI,IACp2C,CAAC,WAAY,mDAAoD,6CAA8C,yCAA0C,kIAAmI,UAAW,aAAc,UAAW,MAAO,UAAW,iBAAkB,YAAa,MAAO,YAAa,SAAU,SAAU,GAAI,GAAI,GAAI,0BAA2B,6CAA8C,oBAAqB,40BAA60B,mHAAoH,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,wBAAyB,GAAI,KACxrD,CAAC,YAAa,oDAAqD,sCAAuC,sCAAuC,qHAAsH,UAAW,aAAc,UAAW,MAAO,UAAW,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,kDAAmD,qBAAsB,y5BAA64B,uFAAwF,sDAAuD,oBAAqB,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,iDAAkD,GAAI,KACprD,CAAC,cAAe,sDAAuD,yEAA0E,oCAAqC,qIAAsI,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,gDAAiD,wBAAyB,24CAA44C,GAAI,kFAAmF,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,YAAa,GAAI,IACpkE,CAAC,sBAAuB,8DAA+D,6DAA8D,yCAA0C,8IAA+I,UAAW,aAAc,SAAU,MAAO,SAAU,2BAA4B,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,oCAAqC,GAAI,iBAAkB,uLAAwL,GAAI,qEAAsE,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,GAAI,GAAI,KACl4B,CAAC,kBAAmB,0DAA2D,6BAA8B,oCAAqC,uEAAwE,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,GAAI,yBAA0B,sYAAuY,GAAI,sDAAuD,GAAI,GAAI,gBAAiB,GAAI,GAAI,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,IAC74B,CAAC,yBAA0B,iEAAkE,4CAA6C,kCAAmC,kJAA8I,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,oFAAqF,GAAI,2xBAAwwB,GAAI,mCAAoC,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,IAAK,oBAAqB,GAAI,GAAI,IACx6C,CAAC,YAAa,oEAAqE,6BAA8B,qCAAsC,iGAAkG,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,SAAU,GAAI,GAAI,GAAI,4BAA6B,4CAA6C,GAAI,2wBAAuwB,GAAI,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,oBAAqB,GAAI,GAAI,IACr3C,CAAC,+BAAgC,sEAAuE,gBAAiB,uCAAwC,6FAA8F,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,kCAAmC,gEAAiE,0BAA2B,wXAAyX,GAAI,yCAA0C,UAAW,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,GAAI,IAAK,GAAI,GAAI,iBAAkB,GAAI,IACv9B,CAAC,SAAU,iDAAkD,gBAAiB,wCAAyC,0DAA2D,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,+CAAgD,oBAAqB,0NAA2N,GAAI,yCAA0C,oBAAqB,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,IAAK,kCAAmC,iBAAkB,GAAI,IAClxB,CAAC,kBAAmB,0DAA2D,sCAAuC,sCAAuC,6IAA8I,UAAW,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,WAAY,GAAI,GAAI,GAAI,iCAAkC,kDAAmD,GAAI,o8BAAq8B,4BAA6B,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,GAAI,GAAI,eAAgB,aAAc,GAAI,KACtqD,CAAC,4BAA6B,wEAAyE,gBAAiB,qCAAsC,8HAA+H,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,SAAU,GAAI,GAAI,GAAI,2BAA4B,4DAA6D,qBAAsB,u5BAAq5B,GAAI,yCAA0C,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,kCAAmC,iBAAkB,GAAI,IAClmD,CAAC,kBAAmB,0DAA2D,uCAAwC,+BAAgC,yIAA0I,UAAW,aAAc,SAAU,MAAO,SAAU,OAAQ,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,GAAI,0BAA2B,oIAAqI,GAAI,sDAAuD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,OAAQ,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,mBAAoB,GAAI,KAC/wB,CAAC,YAAa,oDAAqD,gCAAiC,iCAAkC,6IAA8I,UAAW,aAAc,QAAS,MAAO,QAAS,OAAQ,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,kDAAmD,GAAI,iWAAkW,GAAI,sDAAuD,GAAI,GAAI,gBAAiB,aAAc,OAAQ,GAAI,OAAQ,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,aAAc,GAAI,KAC3+B,CAAC,uBAAwB,+DAAgE,iBAAkB,uCAAwC,yHAA0H,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,0CAA2C,GAAI,yMAA0M,GAAI,cAAe,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,IAC7wB,CAAC,WAAY,mDAAoD,sCAAuC,+BAAgC,yEAA0E,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,SAAU,GAAI,GAAI,GAAI,sBAAuB,oDAAqD,oBAAqB,4aAAma,GAAI,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,GAAI,GAAI,IAC3+B,CAAC,WAAY,mDAAoD,8CAA+C,0CAA2C,+GAAgH,UAAW,aAAc,UAAW,MAAO,UAAW,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,6CAA8C,oBAAqB,41BAA61B,wGAAyG,sDAAuD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,IAAK,kCAAmC,yCAA0C,GAAI,KACxpD,CAAC,QAAS,gDAAiD,wCAAyC,2CAA4C,uIAAwI,UAAW,aAAc,GAAI,GAAI,GAAI,OAAQ,GAAI,GAAI,GAAI,SAAU,SAAU,GAAI,GAAI,GAAI,uBAAwB,4CAA6C,wBAAyB,oMAAqM,oBAAqB,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,GAAI,GAAI,KAC/2B,CAAC,yBAA0B,iEAAkE,yCAA0C,wCAAyC,qFAAsF,UAAW,aAAc,UAAW,MAAO,UAAW,2BAA4B,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,oCAAqC,iEAAkE,GAAI,qFAAsF,GAAI,sDAAuD,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,YAAa,GAAI,KACjwB,CAAC,UAAW,kDAAmD,uCAAwC,mCAAoC,+FAAgG,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,6DAA8D,0BAA2B,0jBAAyiB,GAAI,cAAe,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,gCAAiC,GAAI,IAC1mC,CAAC,MAAO,8CAA+C,gCAAiC,iDAAkD,uIAAmI,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,qBAAsB,GAAI,eAAgB,qPAAsP,4GAA6G,iDAAkD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,8DAA+D,GAAI,KAClgC,CAAC,6BAA8B,qEAAsE,gCAAiC,uCAAwC,qGAAsG,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,+CAAgD,sBAAuB,uOAAwO,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,MAAO,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,IAAK,kCAAmC,aAAc,GAAI,IACh3B,CAAC,UAAW,kDAAmD,mDAAoD,yCAA0C,uHAAwH,UAAW,aAAc,UAAW,MAAO,UAAW,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,4CAA6C,GAAI,0lDAA2lD,yDAA0D,mDAAoD,yBAA0B,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,oCAAqC,GAAI,KAC70E,CAAC,2BAA4B,mEAAoE,sCAAuC,uCAAwC,gIAAiI,UAAW,aAAc,SAAU,MAAO,SAAU,mBAAoB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,GAAI,oBAAqB,opBAAqpB,qEAAsE,sDAAuD,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,yCAA0C,GAAI,KAC75C,CAAC,yBAA0B,iEAAkE,oCAAqC,iCAAkC,wIAAyI,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,GAAI,wBAAyB,yJAA0J,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,IAAK,kCAAmC,GAAI,GAAI,IACrwB,CAAC,cAAe,sDAAuD,sEAAuE,oCAAqC,oEAAqE,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,GAAI,GAAI,2PAA4P,GAAI,qEAAsE,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,GAAI,GAAI,IACryB,CAAC,gBAAiB,wDAAyD,0EAA2E,oCAAqC,qIAAsI,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,iCAAkC,GAAI,GAAI,22BAAo0B,GAAI,6GAA8G,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,IACn9C,CAAC,yBAA0B,iEAAkE,6CAA8C,sCAAuC,kHAAmH,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,WAAY,GAAI,GAAI,GAAI,8BAA+B,yDAA0D,GAAI,ijBAAkjB,kDAAmD,6BAA8B,uDAAwD,GAAI,iBAAkB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,kCAAmC,GAAI,GAAI,KACv1C,CAAC,YAAa,oDAAqD,6BAA8B,wCAAyC,oCAAqC,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,8CAA+C,qBAAsB,shBAA+gB,GAAI,sDAAuD,oBAAqB,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,2BAA4B,GAAI,IACjkC,CAAC,oBAAqB,4DAA6D,gBAAiB,0CAA2C,sEAAuE,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,kCAAmC,GAAI,4BAA6B,0LAA2L,GAAI,yCAA0C,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,kBAAmB,GAAI,IAC1rB,CAAC,SAAU,iDAAkD,wCAAyC,wCAAyC,wFAAyF,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,2CAA4C,iBAAkB,69BAAo9B,GAAI,sDAAuD,wGAAyG,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,IAAK,oBAAqB,GAAI,GAAI,IACxnD,CAAC,oBAAqB,4DAA6D,uCAAwC,0CAA2C,mGAAoG,UAAW,aAAc,UAAW,MAAO,UAAW,2BAA4B,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,kCAAmC,GAAI,GAAI,gJAAiJ,GAAI,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,gBAAiB,GAAI,KAC/yB,CAAC,YAAa,oDAAqD,wFAAyF,uCAAwC,mJAA+I,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,iDAAkD,GAAI,mhBAA0gB,GAAI,8EAA+E,yBAA0B,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,iBAAkB,GAAI,IACxtC,CAAC,WAAY,mDAAoD,gBAAiB,qCAAsC,oHAAqH,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,gDAAiD,oBAAqB,2bAA4b,GAAI,yCAA0C,GAAI,GAAI,gBAAiB,aAAc,MAAO,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IAC3+B,CAAC,sBAAuB,8DAA+D,iDAAkD,wCAAyC,2EAA4E,UAAW,aAAc,GAAI,GAAI,GAAI,iBAAkB,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,4DAA6D,wBAAyB,w9CAAy7C,OAAQ,sDAAuD,UAAW,GAAI,GAAI,aAAc,OAAQ,IAAK,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,KAChkE,CAAC,cAAe,sDAAuD,sCAAuC,qCAAsC,6IAA8I,UAAW,aAAc,WAAY,MAAO,WAAY,qBAAsB,WAAY,MAAO,WAAY,SAAU,WAAY,GAAI,GAAI,GAAI,6BAA8B,wCAAyC,mCAAoC,ikBAAkkB,qGAAsG,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,GAAI,GAAI,KACt5C,CAAC,QAAS,gDAAiD,sCAAuC,4CAA6C,8GAA+G,UAAW,aAAc,UAAW,MAAO,UAAW,2BAA4B,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,mBAAoB,+CAAgD,sBAAuB,kfAAmf,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,KACjoC,CAAC,uBAAwB,+DAAgE,yCAA0C,uCAAwC,sIAAuI,UAAW,aAAc,WAAY,MAAO,WAAY,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,sDAAuD,0BAA2B,gKAAiK,8DAA+D,wDAAyD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,kCAAmC,GAAI,KACn9B,CAAC,uCAAwC,+EAAgF,gBAAiB,kCAAmC,2IAA4I,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,SAAU,GAAI,GAAI,GAAI,2CAA4C,GAAI,gCAAiC,ogCAA2/B,GAAI,yCAA0C,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,GAAI,qDAAsD,GAAI,IAC1oD,CAAC,WAAY,mDAAoD,6CAA8C,2CAA4C,sIAAuI,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,GAAI,8BAA+B,6fAA8f,8GAA+G,sDAAuD,oBAAqB,GAAI,GAAI,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,wBAAyB,GAAI,KAC/xC,CAAC,aAAc,qDAAsD,yCAA0C,sCAAuC,wIAAyI,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,mDAAoD,GAAI,ibAAkb,GAAI,+EAAgF,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,IAC5iC,CAAC,aAAc,qDAAsD,iDAAkD,uCAAwC,sIAAuI,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,GAAI,sBAAuB,s+BAAu+B,+GAAgH,sDAAuD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,KACtuD,CAAC,sBAAuB,8DAA+D,sDAAuD,2CAA4C,oHAAqH,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,WAAY,GAAI,GAAI,GAAI,2BAA4B,sDAAuD,GAAI,yrBAA0rB,wGAAyG,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,GAAI,GAAI,KAClgD,CAAC,QAAS,gDAAiD,oDAAqD,4CAA6C,mGAAoG,UAAW,aAAc,UAAW,MAAO,UAAW,iBAAkB,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,GAAI,iBAAkB,ygCAA0gC,GAAI,sDAAuD,yDAA0D,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,KAC1pD,CAAC,gBAAiB,wDAAyD,gBAAiB,0CAA2C,iFAAkF,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,GAAI,GAAI,itDAAktD,GAAI,yCAA0C,oBAAqB,GAAI,GAAI,aAAc,MAAO,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,GAAI,GAAI,IACxsE,CAAC,0BAA2B,kEAAmE,2DAA4D,oCAAqC,gHAAiH,UAAW,aAAc,GAAI,GAAI,GAAI,2BAA4B,WAAY,MAAO,WAAY,SAAU,WAAY,GAAI,GAAI,GAAI,qBAAsB,yCAA0C,GAAI,k3CAAm3C,oDAAqD,sDAAuD,wGAAyG,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,GAAI,GAAI,KAChrE,CAAC,WAAY,mDAAoD,+CAAgD,oCAAqC,6IAA8I,UAAW,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,sBAAuB,6DAA8D,oBAAqB,sgBAA6f,2CAA4C,qEAAsE,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,gBAAiB,GAAI,KAC3yC,CAAC,iBAAkB,yDAA0D,iBAAkB,sCAAuC,uEAAwE,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,yCAA0C,sBAAuB,iIAAkI,GAAI,cAAe,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,IAAK,GAAI,GAAI,SAAU,aAAc,IAAK,IAAK,oBAAqB,YAAa,GAAI,IACvrB,CAAC,OAAQ,+CAAgD,2CAA4C,0CAA2C,4IAA6I,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,WAAY,YAAa,MAAO,YAAa,sBAAuB,+CAAgD,cAAe,89BAA+9B,GAAI,sDAAuD,oBAAqB,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,GAAI,GAAI,IACrnD,CAAC,WAAY,mDAAoD,oDAAqD,2CAA4C,yGAA0G,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,wCAAyC,GAAI,2vBAA6uB,GAAI,4GAA6G,yBAA0B,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,oBAAqB,GAAI,KACx8C,CAAC,qBAAsB,6DAA8D,6CAA8C,kCAAmC,gGAAiG,UAAW,aAAc,SAAU,MAAO,SAAU,iBAAkB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,GAAI,GAAI,64BAA84B,+CAAgD,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,oBAAqB,GAAI,KAC3kD,CAAC,mBAAoB,2DAA4D,qDAAsD,4BAA6B,8IAA+I,UAAW,aAAc,UAAW,MAAO,UAAW,WAAY,WAAY,MAAO,WAAY,SAAU,SAAU,YAAa,MAAO,YAAa,iCAAkC,mDAAoD,2BAA4B,gkBAAikB,oGAAqG,sDAAuD,oBAAqB,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,kCAAmC,GAAI,KACj7C,CAAC,uBAAwB,+DAAgE,sDAAuD,2CAA4C,kGAAmG,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,uDAAwD,wBAAyB,+6BAAg7B,GAAI,wFAAyF,UAAW,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,IAAK,kCAAmC,GAAI,GAAI,IAC7mD,CAAC,qBAAsB,6DAA8D,yCAA0C,2CAA4C,sDAAuD,UAAW,aAAc,GAAI,GAAI,GAAI,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,oCAAqC,GAAI,GAAI,qNAAsN,yEAA0E,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,+BAAgC,GAAI,KACp4B,CAAC,0BAA2B,kEAAmE,2DAA4D,oCAAqC,0FAA2F,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,GAAI,wBAAyB,8gBAA+gB,GAAI,sDAAuD,oBAAqB,GAAI,cAAe,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,IACtlC,CAAC,cAAe,sDAAuD,sCAAuC,uCAAwC,mIAAoI,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,GAAI,uBAAwB,0uBAA2rB,mBAAoB,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,uBAAwB,GAAI,KAC51C,CAAC,aAAc,qDAAsD,2EAA4E,2CAA4C,yIAA0I,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,mEAAoE,2BAA4B,ydAA0d,GAAI,8GAA+G,yBAA0B,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,aAAc,GAAI,IACvuC,CAAC,uBAAwB,8DAA+D,6CAA8C,0CAA2C,6HAAyH,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,iCAAkC,mDAAoD,0BAA2B,qlEAA6jE,GAAI,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IAC3uF,CAAC,mCAAoC,wEAAyE,iBAAkB,yCAA0C,wIAAyI,UAAW,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,GAAI,qBAAsB,8rBAAyrB,sFAAuF,cAAe,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KACn4C,CAAC,SAAU,iDAAkD,sEAAuE,uCAAwC,oIAAqI,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,WAAY,YAAa,MAAO,YAAa,yBAA0B,GAAI,GAAI,6jBAA8jB,oHAAqH,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,eAAgB,wCAAyC,GAAI,KACx5C,CAAC,sBAAuB,8DAA+D,8BAA+B,uCAAwC,yIAA0I,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,wDAAyD,GAAI,4KAA6K,GAAI,cAAe,GAAI,GAAI,eAAgB,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,IAAK,oBAAqB,GAAI,GAAI,IACtvB,CAAC,oBAAqB,4DAA6D,iDAAkD,wCAAyC,mHAAoH,UAAW,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,yDAA0D,qBAAsB,mcAAoc,kGAAmG,sDAAuD,UAAW,GAAI,GAAI,aAAc,OAAQ,IAAK,GAAI,GAAI,SAAU,aAAc,GAAI,IAAK,oBAAqB,4CAA6C,GAAI,KAC7xC,CAAC,WAAY,mDAAoD,+BAAgC,qCAAsC,4HAA6H,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,4CAA6C,gCAAiC,yWAA0W,GAAI,wDAAyD,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,6BAA8B,GAAI,IAC59B,CAAC,aAAc,qDAAsD,sCAAuC,qCAAsC,wGAAyG,UAAW,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,GAAI,uBAAwB,uVAAwV,4GAA6G,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,mCAAoC,GAAI,KACjoC,CAAC,UAAW,kDAAmD,6CAA8C,mCAAoC,iHAAkH,UAAW,aAAc,UAAW,MAAO,UAAW,2BAA4B,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,qBAAsB,2CAA4C,mBAAoB,6bAAob,GAAI,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,IAAK,kCAAmC,GAAI,GAAI,KACxoC,CAAC,kBAAmB,0DAA2D,0BAA2B,2CAA4C,sHAAuH,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,iCAAkC,mDAAoD,0BAA2B,gdAAid,GAAI,sDAAuD,wGAAyG,GAAI,iBAAkB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,IACnrC,CAAC,2CAA4C,iFAAkF,qDAAsD,yCAA0C,kIAAmI,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,GAAI,qBAAsB,mOAAoO,GAAI,8EAA+E,GAAI,GAAI,gBAAiB,aAAc,MAAO,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IAC73B,CAAC,UAAW,kDAAmD,2DAA4D,qCAAsC,4IAA6I,UAAW,aAAc,SAAU,MAAO,SAAU,2BAA4B,SAAU,MAAO,SAAU,SAAU,WAAY,GAAI,GAAI,GAAI,qBAAsB,+CAAgD,iBAAkB,8OAA+O,GAAI,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,GAAI,GAAI,KAC58B,CAAC,eAAgB,uDAAwD,8BAA+B,sCAAuC,wIAAyI,UAAW,aAAc,GAAI,GAAI,GAAI,2BAA4B,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,GAAI,0BAA2B,qzBAAszB,0DAA2D,cAAe,yCAA0C,GAAI,iBAAkB,aAAc,MAAO,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,IAAK,oBAAqB,aAAc,GAAI,KAC7+C,CAAC,YAAa,oDAAqD,2CAA4C,qCAAsC,wGAAyG,UAAW,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,WAAY,GAAI,GAAI,GAAI,uBAAwB,GAAI,GAAI,gQAA4P,0EAA2E,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,kCAAmC,GAAI,GAAI,KACj7B,CAAC,yCAA0C,iFAAkF,sDAAuD,mCAAoC,uFAAwF,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,GAAI,oCAAqC,uyEAA8sE,GAAI,wFAAyF,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IACx3F,CAAC,0BAA2B,kEAAmE,gBAAiB,4CAA6C,sIAAuI,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,GAAI,GAAI,y9BAAy8B,GAAI,yCAA0C,wGAAyG,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,IAC9lD,CAAC,0BAA2B,kEAAmE,6BAA8B,oCAAqC,0CAA2C,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,WAAY,YAAa,MAAO,YAAa,qBAAsB,+DAAgE,mBAAoB,26BAAk6B,GAAI,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,IAAK,kCAAmC,GAAI,GAAI,IACriD,CAAC,kDAAmD,wFAAyF,oCAAqC,0CAA2C,wIAAyI,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,iFAAkF,oBAAqB,sZAAkZ,GAAI,iEAAkE,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,IACpnC,CAAC,uBAAwB,+DAAgE,sDAAuD,uCAAwC,+IAAgJ,UAAW,aAAc,UAAW,MAAO,UAAW,iBAAkB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,6DAA8D,mBAAoB,+UAAgV,+GAAgH,sDAAuD,sEAAuE,GAAI,cAAe,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,0CAA2C,GAAI,KACrxC,CAAC,yBAA0B,iEAAkE,0CAA2C,iDAAkD,oIAAqI,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,GAAI,4BAA6B,ycAA8b,uJAAwJ,6EAA8E,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,GAAI,GAAI,KACjxC,CAAC,uBAAwB,+DAAgE,8CAA+C,sCAAuC,6HAA8H,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,wDAAyD,iBAAkB,soEAA8mE,GAAI,gEAAiE,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,IAAK,kCAAmC,GAAI,GAAI,IACpzF,CAAC,sBAAuB,8DAA+D,yEAA0E,qCAAsC,oIAAqI,UAAW,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,WAAY,GAAI,GAAI,GAAI,yBAA0B,GAAI,GAAI,s8BAAu8B,wFAAyF,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,GAAI,GAAI,eAAgB,GAAI,GAAI,KACnvD,CAAC,4BAA6B,oEAAqE,wDAAyD,mCAAoC,kIAAmI,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,iCAAkC,GAAI,2BAA4B,0bAAsZ,GAAI,qEAAsE,UAAW,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,GAAI,GAAI,IACjiC,CAAC,iCAAkC,oDAAqD,+CAAgD,0CAA2C,wHAAyH,UAAW,aAAc,GAAI,GAAI,GAAI,QAAS,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,GAAI,qBAAsB,6nBAA8nB,gFAAiF,sDAAuD,wGAAyG,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,mBAAoB,GAAI,KACh8C,CAAC,UAAW,kDAAmD,8DAA+D,iDAAkD,wIAAyI,UAAW,aAAc,UAAW,MAAO,UAAW,gBAAiB,YAAa,MAAO,YAAa,SAAU,WAAY,GAAI,GAAI,GAAI,qBAAsB,0CAA2C,GAAI,wtBAAytB,4GAA6G,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,IAAK,oBAAqB,kBAAmB,GAAI,KACpjD,CAAC,mBAAoB,2DAA4D,2DAA4D,wCAAyC,8HAA+H,UAAW,aAAc,WAAY,MAAO,WAAY,iBAAkB,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,GAAI,iBAAkB,2dAA4d,qEAAsE,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,QAAS,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,oBAAqB,GAAI,KAC1uC,CAAC,wBAAyB,gEAAiE,mEAAoE,+CAAgD,6IAA8I,UAAW,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,WAAY,YAAa,MAAO,YAAa,6BAA8B,GAAI,sBAAuB,mSAAoS,mFAAoF,0EAA2E,oBAAqB,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,kBAAmB,GAAI,KACrqC,CAAC,QAAS,gDAAiD,gEAAiE,uCAAwC,oGAAqG,UAAW,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,GAAI,GAAI,q1BAAs1B,8EAA+E,8GAA+G,oBAAqB,GAAI,cAAe,aAAc,QAAS,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,sCAAuC,GAAI,KAC1nD,CAAC,6BAA8B,qEAAsE,sCAAuC,0CAA2C,mIAAoI,UAAW,aAAc,GAAI,GAAI,GAAI,kBAAmB,WAAY,MAAO,WAAY,SAAU,WAAY,GAAI,GAAI,GAAI,6BAA8B,GAAI,GAAI,wjBAAyjB,wFAAyF,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,KAC7zC,CAAC,sBAAuB,8DAA+D,6CAA8C,0CAA2C,iIAAkI,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,uDAAwD,GAAI,kbAAya,GAAI,sDAAuD,oBAAqB,GAAI,eAAgB,aAAc,MAAO,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,oBAAqB,GAAI,IAClkC,CAAC,mBAAoB,2DAA4D,sDAAuD,kCAAmC,kIAAmI,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,kCAAmC,wDAAyD,2BAA4B,wtBAAytB,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,6BAA8B,GAAI,IAC14C,CAAC,WAAY,iDAAkD,2DAA4D,wCAAyC,0IAA2I,UAAW,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,GAAI,GAAI,wSAAyS,qBAAsB,qGAAsG,UAAW,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,GAAI,GAAI,KAC1/B,CAAC,mBAAoB,2DAA4D,oDAAqD,sCAAuC,iIAAkI,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,iCAAkC,mEAAoE,GAAI,kUAAmU,GAAI,sDAAuD,wGAAyG,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,gBAAiB,GAAI,IAC3kC,CAAC,uBAAwB,+DAAgE,yCAA0C,4CAA6C,kIAAmI,UAAW,aAAc,UAAW,MAAO,UAAW,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,GAAI,uBAAwB,0zBAAszB,0GAA2G,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,mCAAoC,GAAI,KAC/nD,CAAC,mBAAoB,0DAA2D,yCAA0C,qCAAsC,qGAAsG,UAAW,aAAc,GAAI,GAAI,GAAI,2BAA4B,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,kCAAmC,mDAAoD,GAAI,4dAAmd,uBAAwB,gDAAiD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,8BAA+B,GAAI,KAChnC,CAAC,WAAY,mDAAoD,sDAAuD,uCAAwC,4IAA6I,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,GAAI,GAAI,2UAA4U,mHAAoH,sDAAuD,yBAA0B,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,KAC3kC,CAAC,WAAY,mDAAoD,sCAAuC,wCAAyC,iGAAkG,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,GAAI,uBAAwB,8UAA+U,GAAI,sDAAuD,wGAAyG,GAAI,eAAgB,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,kDAAmD,GAAI,KACpkC,CAAC,qBAAsB,6DAA8D,4CAA6C,uCAAwC,8HAA+H,UAAW,aAAc,GAAI,GAAI,GAAI,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,GAAI,sBAAuB,8dAA+d,gHAAiH,sDAAuD,oBAAqB,GAAI,GAAI,aAAc,QAAS,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,kBAAmB,GAAI,KACrvC,CAAC,6BAA8B,qEAAsE,6BAA8B,sCAAuC,8GAA+G,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,SAAU,WAAY,MAAO,WAAY,kCAAmC,6DAA8D,4BAA6B,gVAAiV,GAAI,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,GAAI,GAAI,IAChhC,CAAC,QAAS,gDAAiD,gDAAiD,mCAAoC,mIAAoI,UAAW,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,oDAAqD,iBAAkB,8aAA+a,0BAA2B,6EAA8E,6EAA8E,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,oBAAqB,GAAI,KAChuC,CAAC,8BAA+B,sEAAuE,6BAA8B,sCAAuC,kIAAmI,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,qCAAsC,+DAAgE,GAAI,qYAAsY,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,IAChhC,CAAC,iBAAkB,yDAA0D,oDAAqD,uCAAwC,2IAA4I,UAAW,aAAc,UAAW,MAAO,UAAW,2BAA4B,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,GAAI,GAAI,6aAA8a,GAAI,gEAAiE,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,gBAAiB,GAAI,KACrlC,CAAC,0BAA2B,kEAAmE,gBAAiB,0CAA2C,6IAA8I,UAAW,aAAc,GAAI,GAAI,GAAI,OAAQ,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,uCAAwC,GAAI,+BAAgC,iaAAka,aAAc,yCAA0C,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,OAAQ,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KACxjC,CAAC,eAAgB,uDAAwD,2CAA4C,oCAAqC,sIAAuI,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,GAAI,2BAA4B,obAAqb,GAAI,iCAAkC,GAAI,GAAI,gBAAiB,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IAC59B,CAAC,gBAAiB,wDAAyD,6CAA8C,wCAAyC,kHAAmH,UAAW,aAAc,SAAU,MAAO,SAAU,iBAAkB,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,iDAAkD,4BAA6B,ogBAAqgB,GAAI,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,KACptC,CAAC,aAAc,qDAAsD,sCAAuC,oCAAqC,8DAA+D,UAAW,aAAc,SAAU,MAAO,SAAU,OAAQ,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,+CAAgD,GAAI,siCAAuiC,GAAI,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,OAAQ,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,YAAa,GAAI,KACnpD,CAAC,mBAAoB,2DAA4D,4DAA6D,2CAA4C,iEAAkE,UAAW,aAAc,UAAW,MAAO,UAAW,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,GAAI,GAAI,uqBAAwqB,mEAAoE,sDAAuD,GAAI,GAAI,iBAAkB,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,KAC9zC,CAAC,WAAY,mDAAoD,iBAAkB,qCAAsC,6HAA8H,UAAW,aAAc,GAAI,GAAI,GAAI,OAAQ,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,GAAI,GAAI,6rBAA8rB,0BAA2B,cAAe,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,OAAQ,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KAC3rC,CAAC,kBAAmB,0DAA2D,6CAA8C,uCAAwC,wHAAyH,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,gCAAiC,GAAI,mBAAoB,4dAA6d,gGAAiG,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,YAAa,GAAI,KAC5uC,CAAC,8BAA+B,sEAAuE,sCAAuC,kCAAmC,uFAAmF,UAAW,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,GAAI,kBAAmB,ipBAAkpB,kDAAmD,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KACh1C,CAAC,uBAAwB,+DAAgE,6CAA8C,2CAA4C,wHAAyH,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,GAAI,GAAI,onBAA0mB,kEAAmE,gEAAiE,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,oCAAqC,GAAI,KACt3C,CAAC,mBAAoB,2DAA4D,uDAAwD,uCAAwC,yHAA0H,UAAW,aAAc,GAAI,GAAI,GAAI,2BAA4B,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,iCAAkC,oEAAqE,GAAI,yVAA0V,wCAAyC,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,GAAI,GAAI,KAC/kC,CAAC,uBAAwB,+DAAgE,oDAAqD,mCAAoC,0HAA2H,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,GAAI,sBAAuB,wZAAyZ,GAAI,sDAAuD,UAAW,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,IAAK,oBAAqB,GAAI,GAAI,IACngC,CAAC,wBAAyB,gEAAiE,sDAAuD,0CAA2C,oIAAqI,UAAW,aAAc,UAAW,MAAO,UAAW,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,GAAI,GAAI,ggCAAigC,gIAAiI,sDAAuD,oBAAqB,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,oBAAqB,GAAI,KAC5zD,CAAC,0BAA2B,kEAAmE,6BAA8B,wCAAyC,oIAAqI,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,WAAY,GAAI,GAAI,GAAI,8BAA+B,GAAI,wBAAyB,saAAua,GAAI,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,uCAAwC,GAAI,IACrlC,CAAC,YAAa,oDAAqD,4CAA6C,uCAAwC,sHAAuH,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,SAAU,GAAI,GAAI,GAAI,4BAA6B,kDAAmD,sBAAuB,+7BAAm7B,GAAI,qEAAsE,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,IACtiD,CAAC,oBAAqB,4DAA6D,+CAAgD,qCAAsC,uGAAwG,UAAW,aAAc,UAAW,MAAO,UAAW,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,kCAAmC,GAAI,mBAAoB,mdAAod,sGAAuG,qEAAsE,UAAW,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,8BAA+B,GAAI,KAC3tC,CAAC,qBAAsB,6DAA8D,iDAAkD,2CAA4C,gHAAiH,UAAW,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,WAAY,GAAI,GAAI,GAAI,uBAAwB,GAAI,GAAI,uUAAwU,gGAAiG,8EAA+E,wGAAyG,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,GAAI,GAAI,KAC3qC,CAAC,WAAY,mDAAoD,6BAA8B,uCAAwC,mGAAoG,UAAW,aAAc,UAAW,MAAO,UAAW,2BAA4B,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,sBAAuB,GAAI,wBAAyB,8SAA+S,GAAI,sDAAuD,UAAW,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,KAC14B,CAAC,WAAY,mDAAoD,6CAA8C,mCAAoC,qIAAiI,UAAW,aAAc,WAAY,MAAO,WAAY,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,GAAI,GAAI,obAAgb,0GAA2G,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,IAAK,oBAAqB,eAAgB,GAAI,KAC1sC,CAAC,yBAA0B,iEAAkE,iBAAkB,+CAAgD,sDAAuD,UAAW,aAAc,GAAI,GAAI,GAAI,2BAA4B,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,GAAI,GAAI,qeAAse,4CAA6C,cAAe,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KAC5+B,CAAC,gCAAiC,wEAAyE,gCAAiC,4CAA6C,+IAAgJ,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,+EAAgF,GAAI,4PAAoP,GAAI,sDAAuD,GAAI,GAAI,iBAAkB,GAAI,GAAI,GAAI,MAAO,GAAI,SAAU,GAAI,IAAK,GAAI,eAAgB,GAAI,GAAI,IACp5B,CAAC,oBAAqB,4DAA6D,8BAA+B,wCAAyC,yEAA0E,UAAW,aAAc,GAAI,GAAI,GAAI,iBAAkB,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,oCAAqC,GAAI,4BAA6B,krBAAmrB,0BAA2B,yCAA0C,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,iBAAkB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,oCAAqC,GAAI,KAC7xC,CAAC,6BAA8B,qEAAsE,sDAAuD,0CAA2C,2HAA4H,UAAW,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,GAAI,GAAI,ggCAAigC,UAAW,sDAAuD,oBAAqB,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,GAAI,GAAI,KAC3rD,CAAC,kBAAmB,0DAA2D,yCAA0C,qCAAsC,0IAA2I,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,kCAAmC,wDAAyD,0BAA2B,iZAAkZ,GAAI,6BAA8B,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,IAC3gC,CAAC,sBAAuB,8DAA+D,4BAA6B,uCAAwC,qGAAsG,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,sBAAuB,GAAI,GAAI,kuBAAmuB,GAAI,wDAAyD,wGAAyG,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,IAC/zC,CAAC,0BAA2B,kEAAmE,6CAA8C,sCAAuC,+FAAgG,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,GAAI,0BAA2B,2NAA4N,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,MAAO,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,IAAK,kCAAmC,GAAI,GAAI,IAC/yB,CAAC,4BAA6B,oEAAqE,6BAA8B,0CAA2C,8IAA+I,UAAW,aAAc,GAAI,GAAI,GAAI,2BAA4B,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,kCAAmC,GAAI,GAAI,0UAAsU,mBAAoB,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,KAChgC,CAAC,UAAW,kDAAmD,oCAAqC,iCAAkC,4IAA6I,UAAW,aAAc,SAAU,MAAO,SAAU,OAAQ,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,GAAI,GAAI,6QAA8Q,YAAa,sDAAuD,UAAW,GAAI,gBAAiB,aAAc,OAAQ,GAAI,OAAQ,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KACl3B,CAAC,YAAa,oDAAqD,iBAAkB,uCAAwC,iHAAkH,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,SAAU,GAAI,GAAI,GAAI,4BAA6B,GAAI,oBAAqB,mEAAoE,GAAI,cAAe,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,GAAI,GAAI,GAAI,IAChjB,CAAC,SAAU,iDAAkD,wDAAyD,qCAAsC,wHAAyH,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,WAAY,GAAI,GAAI,GAAI,wBAAyB,GAAI,GAAI,24BAA44B,GAAI,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,IACp+C,CAAC,UAAW,kDAAmD,0DAA2D,qCAAsC,4IAA6I,UAAW,aAAc,GAAI,GAAI,GAAI,2BAA4B,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,4CAA6C,2BAA4B,4rBAA6rB,2CAA4C,6GAA8G,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,eAAgB,GAAI,KAC/8C,CAAC,oBAAqB,4DAA6D,sCAAuC,uCAAwC,2IAA4I,UAAW,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,kCAAmC,GAAI,iCAAkC,uNAAwN,+DAAgE,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,oBAAqB,GAAI,KACx/B,CAAC,oCAAqC,gFAAiF,6BAA8B,0CAA2C,6HAA8H,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,WAAY,GAAI,GAAI,GAAI,+BAAgC,GAAI,GAAI,wfAAyf,GAAI,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,IACjoC,CAAC,QAAS,gDAAiD,2CAA4C,+CAAgD,8GAA+G,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,4CAA6C,wBAAyB,2fAA4f,wEAAyE,sDAAuD,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,kBAAmB,GAAI,KAC3uC,CAAC,cAAe,sDAAuD,iBAAkB,qCAAsC,uDAAwD,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,yEAA0E,GAAI,m+BAA89B,GAAI,cAAe,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,IAC99C,CAAC,aAAc,qDAAsD,+BAAgC,wCAAyC,sIAAuI,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,6CAA8C,uBAAwB,q8BAAs8B,GAAI,wDAAyD,wGAAyG,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IAC7oD,CAAC,YAAa,qFAAsF,0DAA2D,iDAAkD,+CAAgD,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,WAAY,YAAa,MAAO,YAAa,4BAA6B,GAAI,GAAI,g2CAAi2C,gHAAiH,sDAAuD,0BAA2B,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,GAAI,GAAI,eAAgB,qBAAsB,GAAI,KACrmE,CAAC,0BAA2B,kEAAmE,2CAA4C,wCAAyC,uHAAwH,UAAW,aAAc,SAAU,MAAO,SAAU,iBAAkB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,GAAI,mBAAoB,2eAA4e,uCAAwC,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,6CAA8C,GAAI,KACxvC,CAAC,YAAa,oDAAqD,wDAAyD,qCAAsC,iEAAkE,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,SAAU,GAAI,GAAI,GAAI,4BAA6B,yDAA0D,qBAAsB,yoBAAooB,GAAI,yEAA0E,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,GAAI,kBAAmB,GAAI,IACruC,CAAC,oBAAqB,4DAA6D,uDAAwD,2CAA4C,oJAAqJ,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,+uBAAgvB,+FAAgG,sDAAuD,wGAAyG,GAAI,GAAI,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,KACvjD,CAAC,uBAAwB,mEAAoE,gDAAiD,uCAAwC,mHAAoH,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,WAAY,GAAI,GAAI,GAAI,sCAAuC,GAAI,GAAI,8bAA+b,GAAI,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,eAAgB,eAAgB,GAAI,IACtkC,CAAC,WAAY,mDAAoD,qDAAsD,uCAAwC,gBAAiB,UAAW,aAAc,GAAI,GAAI,GAAI,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,GAAI,GAAI,6lBAA8lB,qHAAsH,sDAAuD,UAAW,GAAI,gBAAiB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,8BAA+B,GAAI,KACxuC,CAAC,gBAAiB,0DAA2D,4CAA6C,wCAAyC,+IAAgJ,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,kDAAmD,uBAAwB,wiBAAyiB,GAAI,wFAAyF,UAAW,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,IAC1tC,CAAC,aAAc,qDAAsD,gBAAiB,0CAA2C,4IAA6I,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,GAAI,GAAI,+WAAgX,GAAI,yCAA0C,GAAI,GAAI,iBAAkB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,IAAK,oBAAqB,GAAI,GAAI,IACv5B,CAAC,iBAAkB,6DAA8D,2CAA4C,kCAAmC,mHAAoH,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,mDAAoD,yBAA0B,ukBAAwkB,GAAI,sDAAuD,GAAI,GAAI,gBAAiB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,IACzrC,CAAC,SAAU,qDAAsD,4CAA6C,oCAAqC,iDAAkD,UAAW,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,WAAY,GAAI,GAAI,GAAI,6BAA8B,yCAA0C,8BAA+B,uiBAAwiB,oEAAqE,qEAAsE,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,GAAI,GAAI,eAAgB,cAAe,GAAI,KACxxC,CAAC,YAAa,oDAAqD,iDAAkD,sCAAuC,0IAA2I,UAAW,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,8CAA+C,GAAI,iNAAkN,GAAI,gEAAiE,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,0CAA2C,GAAI,KACt9B,CAAC,SAAU,iDAAkD,iDAAkD,iCAAkC,oFAAqF,UAAW,aAAc,UAAW,MAAO,UAAW,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,iQAAkQ,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,IAAK,oBAAqB,GAAI,GAAI,KAC7yB,CAAC,uBAAwB,+DAAgE,gBAAiB,2CAA4C,8IAA4I,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,GAAI,iCAAkC,67BAA66B,GAAI,yCAA0C,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,cAAe,GAAI,IACpjD,CAAC,yBAA0B,iEAAkE,8DAA+D,wCAAyC,0FAA2F,UAAW,aAAc,GAAI,GAAI,GAAI,2BAA4B,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,GAAI,GAAI,qSAAsS,gIAAiI,8EAA+E,qEAAsE,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,GAAI,GAAI,KAClmC,CAAC,uBAAwB,+DAAgE,iCAAkC,qCAAsC,8IAA+I,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,sCAAuC,wDAAyD,0CAA2C,qxBAAsxB,GAAI,uFAAwF,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,GAAI,GAAI,IACp+C,CAAC,8BAA+B,sEAAuE,8BAA+B,+BAAgC,+IAAgJ,UAAW,aAAc,GAAI,GAAI,GAAI,iBAAkB,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,iCAAkC,0DAA2D,mCAAoC,wMAAyM,4BAA6B,cAAe,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,iBAAkB,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,gBAAiB,GAAI,KACr4B,CAAC,oBAAqB,gDAAiD,sCAAuC,wCAAyC,uIAAwI,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,GAAI,GAAI,+2BAAg3B,oJAAqJ,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,GAAI,GAAI,KAC9oD,CAAC,YAAa,oDAAqD,sCAAuC,0CAA2C,gFAAiF,UAAW,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,GAAI,GAAI,6aAA8a,sBAAuB,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,KAC5/B,CAAC,qBAAsB,6DAA8D,qDAAsD,oCAAqC,oIAAqI,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,GAAI,kBAAmB,4/BAA6/B,6EAA8E,kFAAmF,wGAAyG,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,KACt1D,CAAC,WAAY,mDAAoD,6CAA8C,sCAAuC,6FAA8F,UAAW,aAAc,GAAI,GAAI,GAAI,2BAA4B,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,4CAA6C,oBAAqB,6ZAA8Z,aAAc,sDAAuD,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,IAAK,oBAAqB,qBAAmB,GAAI,KACxiC,CAAC,aAAc,qDAAsD,iCAAkC,2CAA4C,2EAA4E,UAAW,aAAc,GAAI,GAAI,GAAI,2BAA4B,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,GAAI,GAAI,+UAAgV,gBAAiB,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,4BAA6B,GAAI,KACz4B,CAAC,YAAa,oDAAqD,gDAAiD,4CAA6C,iHAAkH,UAAW,aAAc,UAAW,MAAO,UAAW,2BAA4B,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,GAAI,GAAI,kSAA8R,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,GAAI,GAAI,KACr4B,CAAC,WAAY,mDAAoD,6CAA8C,oCAAqC,kHAAmH,UAAW,aAAc,UAAW,MAAO,UAAW,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,GAAI,GAAI,qlBAAykB,2CAA4C,sDAAuD,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,IAAK,oBAAqB,qCAAsC,GAAI,KAC1yC,CAAC,WAAY,mDAAoD,oDAAqD,uCAAwC,sIAAuI,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,GAAI,oBAAqB,koBAAmoB,uGAAwG,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,kBAAmB,GAAI,KAC95C,CAAC,uBAAwB,+DAAgE,kDAAmD,qCAAsC,gGAAiG,UAAW,aAAc,UAAW,MAAO,UAAW,2BAA4B,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,GAAI,GAAI,gWAAiW,GAAI,gEAAiE,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,KACp9B,CAAC,WAAY,mDAAoD,gBAAiB,wCAAyC,oHAAqH,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,sBAAuB,iDAAkD,2BAA4B,saAAua,GAAI,yCAA0C,0BAA2B,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,IACv/B,CAAC,yBAA0B,iEAAkE,sCAAuC,2CAA4C,qEAAsE,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,weAAye,GAAI,sDAAuD,UAAW,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,IACp9B,CAAC,wBAAyB,gEAAiE,iDAAkD,wCAAyC,oHAAqH,UAAW,aAAc,UAAW,MAAO,UAAW,iBAAkB,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,GAAI,uBAAwB,oVAAqV,GAAI,gEAAiE,GAAI,GAAI,iBAAkB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,sBAAuB,GAAI,KAC7/B,CAAC,oBAAqB,4DAA6D,8BAA+B,qCAAsC,mIAAoI,UAAW,aAAc,UAAW,MAAO,UAAW,2BAA4B,UAAW,MAAO,UAAW,SAAU,SAAU,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,69BAA89B,sBAAuB,sDAAuD,oBAAqB,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,eAAgB,oBAAqB,GAAI,KACznD,CAAC,cAAe,sDAAuD,6CAA8C,uCAAwC,4IAA6I,UAAW,aAAc,UAAW,MAAO,UAAW,2BAA4B,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,GAAI,sBAAuB,09CAA29C,GAAI,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,KACzoE,CAAC,mBAAoB,2DAA4D,wDAAyD,yCAA0C,8GAA+G,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,GAAI,sCAAuC,wkBAAykB,GAAI,wDAAyD,wGAAyG,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,WAAY,GAAI,IACtwC,CAAC,gBAAiB,wDAAyD,yCAA0C,uCAAwC,wHAAyH,UAAW,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,iDAAkD,wBAAyB,0mCAAilC,mFAAoF,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,IAAK,kCAAmC,GAAI,GAAI,KACh3D,CAAC,QAAS,gDAAiD,iDAAkD,oCAAqC,sGAAuG,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,GAAI,qBAAsB,glBAAilB,GAAI,sDAAuD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,kCAAmC,GAAI,IAC1oC,CAAC,iBAAkB,yDAA0D,2DAA4D,qCAAsC,2GAA4G,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,iCAAkC,GAAI,0BAA2B,w7CAAy7C,uFAAwF,sDAAuD,GAAI,GAAI,GAAI,aAAc,QAAS,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,KACnpE,CAAC,gBAAiB,wDAAyD,4DAA6D,0CAA2C,sHAAuH,UAAW,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,GAAI,GAAI,gSAAiS,gGAAiG,qEAAsE,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,eAAgB,GAAI,KAChiC,CAAC,UAAW,kDAAmD,gBAAiB,iDAAkD,uFAAwF,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,GAAI,sBAAuB,wdAAyd,yBAA0B,yCAA0C,UAAW,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,KACpiC,CAAC,SAAU,iDAAkD,sCAAuC,0CAA2C,mIAAoI,UAAW,aAAc,UAAW,MAAO,UAAW,2BAA4B,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,GAAI,kBAAmB,mjBAAojB,kFAAmF,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,qBAAsB,GAAI,KACxyC,CAAC,cAAe,sDAAuD,6CAA8C,mCAAoC,mFAAoF,UAAW,aAAc,GAAI,GAAI,GAAI,OAAQ,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,4DAA6D,4BAA6B,kMAAmM,eAAgB,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,OAAQ,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,6BAA8B,GAAI,KACh0B,CAAC,YAAa,oDAAqD,kCAAmC,0CAA2C,qFAAsF,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,6CAA8C,gBAAiB,w2BAAy2B,GAAI,0FAA2F,GAAI,GAAI,gBAAiB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,iBAAkB,GAAI,IACz8C,CAAC,uBAAwB,+DAAgE,gBAAiB,4CAA6C,uIAAwI,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,GAAI,wBAAyB,0oCAA2oC,GAAI,yCAA0C,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,IACnsD,CAAC,cAAe,sDAAuD,+BAAgC,0CAA2C,4IAA6I,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,GAAI,4BAA6B,kcAA6b,GAAI,wDAAyD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,iBAAkB,GAAI,IACxjC,CAAC,8BAA+B,sEAAuE,iBAAkB,qCAAsC,oFAAqF,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,sEAAuE,GAAI,+mCAAgnC,GAAI,cAAe,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IACtoD,CAAC,8BAA+B,sEAAuE,yDAA0D,4CAA6C,sIAAuI,UAAW,aAAc,SAAU,MAAO,SAAU,QAAS,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,+DAAgE,uBAAwB,iWAAkW,UAAW,qGAAsG,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KACjqC,CAAC,SAAU,iDAAkD,2DAA4D,qCAAsC,oGAAqG,UAAW,aAAc,GAAI,GAAI,GAAI,iBAAkB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,GAAI,yBAA0B,q4BAAs4B,oGAAqG,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,2BAA4B,GAAI,KAC3nD,CAAC,YAAa,oDAAqD,sCAAuC,wCAAyC,kHAAmH,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,8CAA+C,+BAAgC,qMAAsM,GAAI,sDAAuD,GAAI,GAAI,gBAAiB,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,IAC3xB,CAAC,wBAAyB,gEAAiE,yCAA0C,0CAA2C,+CAAgD,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,WAAY,GAAI,GAAI,GAAI,0BAA2B,wDAAyD,6BAA8B,yNAA0N,gEAAiE,sDAAuD,GAAI,GAAI,GAAI,aAAc,QAAS,GAAI,MAAO,aAAc,SAAU,aAAc,KAAM,GAAI,eAAgB,GAAI,GAAI,KAC/5B,CAAC,yCAA0C,+EAAgF,4DAA6D,oCAAqC,0CAA2C,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,kCAAmC,0CAA2C,uBAAwB,8YAA+Y,GAAI,uFAAwF,GAAI,GAAI,eAAgB,aAAc,MAAO,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IAC1gC,CAAC,sBAAuB,8DAA+D,gCAAiC,sCAAuC,8DAA+D,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,oBAAqB,GAAI,gBAAiB,0XAAsX,GAAI,sDAAuD,UAAW,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IACt2B,CAAC,qBAAsB,6DAA8D,gCAAiC,mCAAoC,4EAA6E,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,kEAAmE,GAAI,sUAAuU,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,GAAI,GAAI,IACl4B,CAAC,sBAAuB,8DAA+D,6BAA8B,uCAAwC,6GAA8G,UAAW,aAAc,GAAI,GAAI,GAAI,WAAY,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,0CAA2C,sBAAuB,4JAA6J,eAAgB,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,YAAa,GAAI,KAChyB,CAAC,qBAAsB,6DAA8D,oCAAqC,uCAAwC,qHAAsH,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,qDAAsD,gCAAiC,2mDAAilD,GAAI,sDAAuD,UAAW,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,IACxtE,CAAC,yBAA0B,iEAAkE,6CAA8C,qCAAsC,4IAA6I,UAAW,aAAc,WAAY,MAAO,WAAY,mBAAoB,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,oBAAqB,8CAA+C,GAAI,0SAA2S,kFAAmF,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,uEAAwE,GAAI,KAC7pC,CAAC,SAAU,iDAAkD,6CAA8C,wCAAyC,6IAA8I,UAAW,aAAc,UAAW,MAAO,UAAW,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,yCAA0C,mBAAoB,yoBAA0oB,qBAAsB,sDAAuD,SAAU,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,cAAe,GAAI,KAC70C,CAAC,UAAW,kDAAmD,2DAA4D,0CAA2C,oDAAqD,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,GAAI,GAAI,yfAAqf,uFAAwF,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,GAAI,GAAI,KACrpC,CAAC,cAAe,0DAA2D,+BAAgC,qCAAsC,gGAAiG,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,+CAAgD,wBAAyB,gGAAiG,GAAI,wDAAyD,GAAI,GAAI,GAAI,aAAc,MAAO,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,GAAI,GAAI,IAC5qB,CAAC,iCAAkC,yEAA0E,mEAAoE,wCAAyC,uHAAqH,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,kCAAmC,GAAI,gCAAiC,ugBAAqgB,GAAI,qEAAsE,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,GAAI,GAAI,IACjsC,CAAC,oBAAqB,4DAA6D,sCAAuC,yCAA0C,0IAA2I,UAAW,aAAc,UAAW,MAAO,UAAW,iBAAkB,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,GAAI,6BAA8B,+QAAgR,GAAI,sDAAuD,mCAAoC,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KAC37B,CAAC,UAAW,kDAAmD,sCAAuC,wCAAyC,+HAA2H,UAAW,aAAc,SAAU,MAAO,SAAU,2BAA4B,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,GAAI,GAAI,m8BAA07B,GAAI,+EAAgF,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,gCAAiC,GAAI,KACnmD,CAAC,cAAe,sDAAuD,gCAAiC,uCAAwC,qGAAsG,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,wEAAyE,GAAI,61BAA+0B,GAAI,6BAA8B,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IACp3C,CAAC,kBAAmB,0DAA2D,6CAA8C,uCAAwC,2GAA4G,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,mCAAoC,GAAI,GAAI,yMAA0M,iCAAkC,sDAAuD,GAAI,GAAI,gBAAiB,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KAC91B,CAAC,qBAAsB,6DAA8D,gBAAiB,qCAAsC,kDAAmD,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,SAAU,GAAI,GAAI,GAAI,qCAAsC,iEAAkE,6BAA8B,4eAAme,GAAI,yCAA0C,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,IACzgC,CAAC,2BAA4B,kEAAmE,uCAAwC,2CAA4C,4DAA6D,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,wMAAyM,sCAAuC,cAAe,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,gBAAiB,GAAI,KACtvB,CAAC,sBAAuB,8DAA+D,gBAAiB,0CAA2C,0IAA2I,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,GAAI,GAAI,0IAA2I,GAAI,yCAA0C,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,GAAI,GAAI,IAC3rB,CAAC,cAAe,qDAAsD,yFAA0F,2CAA4C,0FAA2F,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,GAAI,GAAI,giBAAiiB,GAAI,qGAAsG,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IACvoC,CAAC,YAAa,oDAAqD,iDAAkD,uCAAwC,8HAA+H,UAAW,aAAc,WAAY,MAAO,WAAY,kBAAmB,WAAY,MAAO,WAAY,SAAU,WAAY,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,2rBAA4rB,2DAA4D,qEAAsE,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,GAAI,GAAI,eAAgB,GAAI,GAAI,KAC34C,CAAC,uBAAwB,+DAAgE,sDAAuD,uCAAwC,mIAAoI,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,YAAa,MAAO,YAAa,SAAU,UAAW,GAAI,GAAI,GAAI,qCAAsC,GAAI,+BAAgC,66BAA86B,GAAI,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KACvoD,CAAC,gBAAiB,wDAAyD,sCAAuC,2CAA4C,mFAAoF,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,GAAI,wBAAyB,k2BAA81B,GAAI,6DAA8D,GAAI,GAAI,GAAI,aAAc,MAAO,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,GAAI,GAAI,IACj3C,CAAC,8BAA+B,sEAAuE,8CAA+C,uCAAwC,0FAA2F,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,2CAA4C,iDAAkD,mBAAoB,iZAAkZ,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,cAAe,GAAI,IACxhC,CAAC,0BAA2B,gEAAiE,0DAA2D,sCAAuC,4IAA6I,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,qBAAsB,GAAI,GAAI,utBAAwtB,GAAI,qEAAsE,SAAU,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,8CAA+C,GAAI,IAC/2C,CAAC,6DAA8D,mGAAoG,6BAA8B,wCAAyC,0HAA2H,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,GAAI,GAAI,0lBAA2lB,GAAI,sDAAuD,GAAI,GAAI,cAAe,aAAc,MAAO,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IAC5sC,CAAC,oBAAqB,4DAA6D,+BAAgC,kDAAmD,6HAA8H,UAAW,aAAc,UAAW,MAAO,UAAW,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,GAAI,yBAA0B,+/BAAs/B,4FAA6F,wDAAyD,oBAAqB,GAAI,GAAI,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KACvuD,CAAC,UAAW,kDAAmD,2BAA4B,oCAAqC,yHAA0H,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,gDAAiD,GAAI,uYAAwY,GAAI,yEAA0E,wGAAyG,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,IAAK,oBAAqB,GAAI,GAAI,IACzkC,CAAC,oBAAqB,4DAA6D,kCAAmC,qCAAsC,kIAAmI,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,mCAAoC,qDAAsD,kCAAmC,ihBAAkhB,GAAI,uCAAwC,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,IAChpC,CAAC,UAAW,kDAAmD,uEAAwE,uCAAwC,6FAA8F,UAAW,aAAc,SAAU,MAAO,SAAU,iBAAkB,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,sBAAuB,GAAI,GAAI,maAAoa,GAAI,sDAAuD,yCAA0C,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,mBAAoB,GAAI,KACziC,CAAC,UAAW,kDAAmD,mDAAoD,uCAAwC,wFAAoF,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,SAAU,GAAI,GAAI,GAAI,yBAA0B,GAAI,sBAAuB,gvEAAivE,GAAI,sFAAuF,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,IACnyF,CAAC,8BAA+B,sEAAuE,sDAAuD,2CAA4C,+GAAgH,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,GAAI,yBAA0B,yNAA0N,GAAI,sDAAuD,GAAI,GAAI,gBAAiB,aAAc,MAAO,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IAC/zB,CAAC,oBAAqB,4DAA6D,iDAAkD,kCAAmC,2IAA4I,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,oDAAqD,oBAAqB,gRAAiR,GAAI,sDAAuD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,IACx5B,CAAC,mBAAoB,2DAA4D,gBAAiB,oCAAqC,yDAA0D,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,SAAU,GAAI,GAAI,GAAI,GAAI,GAAI,2BAA4B,+pBAAgqB,GAAI,yCAA0C,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,GAAI,IAAK,oBAAqB,GAAI,GAAI,IACvnC,CAAC,WAAY,mDAAoD,6CAA8C,mCAAoC,gHAA4G,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,wDAAyD,GAAI,6gBAA+f,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,KAAM,GAAI,eAAgB,GAAI,GAAI,IACxkC,CAAC,qBAAsB,6DAA8D,yCAA0C,wCAAyC,yIAA0I,UAAW,aAAc,UAAW,MAAO,UAAW,2BAA4B,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,mCAAoC,GAAI,6BAA8B,smBAAumB,GAAI,sDAAuD,GAAI,GAAI,iBAAkB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,KACnxC,CAAC,oBAAqB,4DAA6D,+CAAgD,oCAAqC,+HAAgI,UAAW,aAAc,UAAW,MAAO,UAAW,iBAAkB,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,qDAAsD,GAAI,8sBAA+sB,qHAAsH,qEAAsE,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,qBAAsB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,gBAAiB,GAAI,KAC5gD,CAAC,qBAAsB,6DAA8D,gDAAiD,2CAA4C,yHAA0H,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,g4BAAi4B,GAAI,sFAAuF,UAAW,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IACj8C,CAAC,sBAAuB,8DAA+D,8CAA+C,+BAAgC,8FAA+F,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,iFAAkF,oBAAqB,6JAA8J,GAAI,cAAe,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,GAAI,GAAI,IAChvB,CAAC,wCAAyC,gFAAiF,0DAA2D,6CAA8C,iJAA6I,UAAW,aAAc,UAAW,MAAO,UAAW,QAAS,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,GAAI,wBAAyB,8hBAA+hB,GAAI,2DAA4D,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,GAAI,IAAK,GAAI,GAAI,mCAAoC,GAAI,KAChwC,CAAC,QAAS,gDAAiD,4GAA6G,mCAAoC,2EAA4E,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,oBAAqB,GAAI,GAAI,yXAA0X,GAAI,0HAA2H,yCAA0C,GAAI,gBAAiB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,sBAAuB,GAAI,IAC1hC,CAAC,oBAAqB,4DAA6D,+CAAgD,oCAAqC,2IAA4I,UAAW,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,GAAI,GAAI,0QAA2Q,GAAI,cAAe,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,KACv2B,CAAC,gBAAiB,wDAAyD,8BAA+B,oCAAqC,uCAAwC,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,iDAAkD,iBAAkB,wXAAyX,GAAI,cAAe,GAAI,GAAI,gBAAiB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,IACp1B,CAAC,SAAU,iDAAkD,sCAAuC,gCAAiC,8CAA+C,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,GAAI,qBAAsB,siCAAuiC,GAAI,sDAAuD,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IAC1/C,CAAC,cAAe,sDAAuD,sCAAuC,iCAAkC,8FAA+F,UAAW,aAAc,UAAW,MAAO,UAAW,WAAY,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,GAAI,sBAAuB,6pCAAwpC,4CAA6C,sDAAuD,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,KAC5xD,CAAC,mBAAoB,2DAA4D,iDAAkD,sCAAuC,iHAAkH,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,0CAA2C,GAAI,4oBAA6oB,GAAI,kFAAmF,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IAChwC,CAAC,uBAAwB,+DAAgE,0EAA2E,uCAAwC,0IAAwI,UAAW,aAAc,GAAI,GAAI,GAAI,WAAY,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,6BAA8B,uDAAwD,uBAAwB,kVAAgV,GAAI,6GAA8G,yBAA0B,GAAI,cAAe,aAAc,OAAQ,GAAI,sBAAuB,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,cAAe,GAAI,KAC5nC,CAAC,UAAW,kDAAmD,sCAAuC,uCAAwC,+CAAgD,UAAW,aAAc,WAAY,MAAO,WAAY,2BAA4B,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,GAAI,GAAI,mUAAoU,+EAAgF,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KAC/5B,CAAC,+BAAgC,uEAAwE,sDAAuD,uCAAwC,gIAAiI,UAAW,aAAc,UAAW,MAAO,UAAW,2BAA4B,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,sBAAuB,uEAAwE,uBAAwB,wbAAyb,GAAI,sDAAuD,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,eAAgB,GAAI,KACtrC,CAAC,wBAAyB,gEAAiE,uCAAwC,iDAAkD,uHAAwH,UAAW,aAAc,WAAY,MAAO,WAAY,WAAY,WAAY,MAAO,WAAY,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,GAAI,GAAI,6eAA8e,mFAAoF,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,mBAAoB,GAAI,KACjvC,CAAC,8DAA+D,8FAA+F,iDAAkD,mCAAoC,iIAAkI,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,GAAI,GAAI,sxBAAuxB,GAAI,iEAAkE,GAAI,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,IACx6C,CAAC,mCAAoC,0EAA2E,iBAAkB,oCAAqC,0IAA2I,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,GAAI,GAAI,0IAA2I,GAAI,cAAe,oBAAqB,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IAC3rB,CAAC,aAAc,qDAAsD,8CAA+C,uCAAwC,0IAA2I,UAAW,aAAc,SAAU,MAAO,SAAU,OAAQ,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,GAAI,sBAAuB,gpBAAipB,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,GAAI,GAAI,KACvwC,CAAC,sBAAuB,8DAA+D,+CAAgD,yCAA0C,mFAA+E,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,4DAA6D,GAAI,+TAA2T,GAAI,+EAAgF,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,GAAI,GAAI,IACj6B,CAAC,oBAAqB,4DAA6D,4BAA6B,4CAA6C,sDAAuD,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,sCAAuC,yCAA0C,4BAA6B,ifAA8d,GAAI,gDAAiD,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IACtgC,CAAC,+BAAgC,uEAAwE,gBAAiB,uCAAwC,0FAA2F,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,SAAU,GAAI,GAAI,GAAI,8BAA+B,GAAI,8BAA+B,+MAAgN,GAAI,yCAA0C,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,GAAI,IAAK,oBAAqB,GAAI,GAAI,IACjwB,CAAC,4BAA6B,oEAAqE,6BAA8B,+BAAgC,8IAA+I,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,gCAAiC,GAAI,6BAA8B,slCAAqkC,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,wBAAyB,GAAI,IAC7rD,CAAC,iBAAkB,yDAA0D,wDAAyD,uCAAwC,8HAA+H,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,WAAY,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,ohBAAqhB,GAAI,yEAA0E,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,GAAI,GAAI,eAAgB,GAAI,GAAI,IAC5lC,CAAC,yBAA0B,iEAAkE,2CAA4C,wCAAyC,6IAA8I,UAAW,aAAc,SAAU,MAAO,SAAU,2BAA4B,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,GAAI,6BAA8B,ggBAAigB,0BAA2B,sDAAuD,yCAA0C,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,kBAAmB,GAAI,KAC3vC,CAAC,6BAA8B,yEAA0E,sFAAuF,0CAA2C,yFAA0F,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,2BAA4B,GAAI,GAAI,oWAAqW,GAAI,yDAA0D,GAAI,GAAI,cAAe,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IAC77B,CAAC,0BAA2B,sEAAuE,2FAA4F,yCAA0C,oHAAqH,UAAW,aAAc,SAAU,MAAO,SAAU,QAAS,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,uBAAwB,GAAI,iBAAkB,qfAAsf,UAAW,wIAAyI,UAAW,GAAI,eAAgB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,KAC5vC,CAAC,iBAAkB,yDAA0D,wCAAyC,kCAAmC,+FAAgG,UAAW,aAAc,GAAI,GAAI,GAAI,OAAQ,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,iCAAkC,GAAI,GAAI,iSAAkS,iEAAkE,qEAAsE,GAAI,GAAI,gBAAiB,aAAc,QAAS,GAAI,OAAQ,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,0BAA2B,GAAI,KAC36B,CAAC,aAAc,qDAAsD,sCAAuC,gCAAiC,6GAA8G,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,GAAI,sBAAuB,oZAAqZ,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,GAAI,GAAI,GAAI,eAAgB,GAAI,GAAI,IAC96B,CAAC,2CAA4C,mFAAoF,0CAA2C,6CAA8C,4HAA6H,UAAW,aAAc,UAAW,MAAO,UAAW,2BAA4B,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,wFAAyF,GAAI,uYAAwY,GAAI,sDAAuD,GAAI,GAAI,gBAAiB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,0BAA2B,GAAI,KAChqC,CAAC,WAAY,mDAAoD,6BAA8B,sCAAuC,0GAA2G,UAAW,aAAc,UAAW,MAAO,UAAW,iBAAkB,UAAW,MAAO,UAAW,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,GAAI,oBAAqB,gDAAiD,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,KAClnB,CAAC,eAAgB,uDAAwD,gBAAiB,oCAAqC,+FAAgG,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,GAAI,wBAAyB,6LAAyL,GAAI,yCAA0C,GAAI,GAAI,gBAAiB,aAAc,MAAO,GAAI,GAAI,GAAI,SAAU,aAAc,KAAM,GAAI,GAAI,GAAI,GAAI,IACprB,CAAC,aAAc,qDAAsD,yCAA0C,wCAAyC,wBAAyB,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,wBAAyB,8CAA+C,wBAAyB,6BAA8B,GAAI,sCAAuC,GAAI,GAAI,GAAI,aAAc,MAAO,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,mBAAoB,GAAI,IAChhB,CAAC,mBAAoB,2DAA4D,0DAA2D,iCAAkC,2IAA4I,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,qDAAsD,8BAA+B,w9BAAy9B,GAAI,wIAAyI,GAAI,GAAI,gBAAiB,aAAc,MAAO,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IACvsD,CAAC,qBAAsB,6DAA8D,8DAA+D,yCAA0C,0FAA2F,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,qDAAsD,4BAA6B,yRAA0R,GAAI,gDAAiD,GAAI,GAAI,gBAAiB,aAAc,MAAO,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,iBAAkB,GAAI,IAC35B,CAAC,OAAQ,+CAAgD,8CAA+C,uCAAwC,+IAAgJ,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,WAAY,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,ieAAke,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,aAAc,SAAU,aAAc,IAAK,IAAK,oBAAqB,GAAI,GAAI,IAChhC,CAAC,gBAAiB,wDAAyD,2BAA4B,gCAAiC,kIAAmI,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,iCAAkC,kDAAmD,yBAA0B,yvBAAqvB,GAAI,oDAAqD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,IAAK,GAAI,GAAI,GAAI,GAAI,IAC/0C,CAAC,qBAAsB,6DAA8D,sCAAuC,yCAA0C,mHAAoH,UAAW,aAAc,SAAU,MAAO,SAAU,iBAAkB,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,GAAI,mBAAoB,gpBAA4oB,GAAI,2EAA4E,yDAA0D,GAAI,gBAAiB,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,eAAgB,GAAI,KACn1C,CAAC,2BAA4B,mEAAoE,6BAA8B,2CAA4C,6DAA8D,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,4BAA6B,4DAA6D,sBAAuB,ofAAqf,GAAI,sDAAuD,oBAAqB,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,GAAI,GAAI,eAAgB,GAAI,GAAI,IAChlC,CAAC,oBAAqB,4DAA6D,yBAA0B,uCAAwC,4DAA6D,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,0BAA2B,4CAA6C,GAAI,2fAA4f,GAAI,iDAAkD,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IACx+B,CAAC,UAAW,kDAAmD,sCAAuC,qCAAsC,2IAA4I,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,qBAAsB,GAAI,GAAI,qRAAsR,GAAI,sDAAuD,yCAA0C,GAAI,GAAI,aAAc,OAAQ,GAAI,MAAO,GAAI,SAAU,aAAc,IAAK,GAAI,eAAgB,GAAI,GAAI,IACn2B,CAAC,eAAgB,4DAA6D,iBAAkB,uCAAwC,8IAA+I,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,gCAAiC,+DAAgE,+BAAgC,+tBAAguB,GAAI,cAAe,GAAI,GAAI,GAAI,aAAc,MAAO,GAAI,GAAI,GAAI,SAAU,GAAI,GAAI,GAAI,GAAI,6BAA8B,GAAI,IACh0C,CAAC,UAAW,kDAAmD,iBAAkB,4CAA6C,wCAAyC,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,sBAAuB,GAAI,GAAI,y/BAAq/B,GAAI,cAAe,oBAAqB,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IACr4C,CAAC,2CAA4C,mFAAoF,gBAAiB,mCAAoC,oHAAqH,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,+BAAgC,GAAI,yBAA0B,8RAA+R,GAAI,yCAA0C,GAAI,GAAI,gBAAiB,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IAC31B,CAAC,mBAAoB,2DAA4D,gCAAiC,wCAAyC,kBAAmB,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,8fAA+f,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IAC15B,CAAC,8BAA+B,sEAAuE,oDAAqD,gCAAiC,yIAA0I,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,8BAA+B,GAAI,GAAI,iTAAkT,GAAI,sDAAuD,GAAI,GAAI,gBAAiB,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IACh4B,CAAC,SAAU,iDAAkD,qDAAsD,4CAA6C,8EAA+E,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,SAAU,UAAW,GAAI,GAAI,GAAI,yBAA0B,GAAI,GAAI,0iCAA4hC,GAAI,8EAA+E,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,GAAI,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,IACtiD,CAAC,sBAAuB,8DAA+D,8CAA+C,2CAA4C,wGAAyG,YAAa,aAAc,SAAU,MAAO,SAAU,OAAQ,SAAU,MAAO,SAAU,SAAU,UAAW,GAAI,GAAI,GAAI,GAAI,GAAI,GAAI,8LAA+L,GAAI,sDAAuD,GAAI,GAAI,GAAI,aAAc,OAAQ,GAAI,OAAQ,GAAI,SAAU,aAAc,GAAI,GAAI,GAAI,GAAI,GAAI,MA+CnvBpB,QAASA,EACTE,QAntBU,CACdmB,QAAQ,EACRC,WAAY,WACZC,kBAAkB,EAClB1C,WAAY,WACZ2C,aAAa,EACbC,iBAAkB,CAChBC,SAAS,UCjHAC,EAZS,SAAAC,GAClBA,GAAeA,aAAuBC,UACxC,8BAAqBC,MAAK,YAAkD,IAA/CC,EAA8C,EAA9CA,OAAQC,EAAsC,EAAtCA,OAAQC,EAA8B,EAA9BA,OAAQC,EAAsB,EAAtBA,OAAQC,EAAc,EAAdA,QAC3DJ,EAAOH,GACPI,EAAOJ,GACPK,EAAOL,GACPM,EAAON,GACPO,EAAQP,OCDdQ,IAASC,OACP,cAAC,IAAMC,WAAP,UACE,cAAC,EAAD,MAEFC,SAASC,eAAe,SAM1Bb,M","file":"static/js/main.e4b6ec9a.chunk.js","sourcesContent":["export default __webpack_public_path__ + \"static/media/logo.6ce24c58.svg\";","import logo from './logo.svg';\nimport './App.css';\n\nimport MUIDataTable from \"mui-datatables\";\nimport InputLabel from \"@material-ui/core/InputLabel\";\nimport MenuItem from \"@material-ui/core/MenuItem\";\nimport FormHelperText from \"@material-ui/core/FormHelperText\";\nimport FormControl from \"@material-ui/core/FormControl\";\nimport Select from \"@material-ui/core/Select\";\nimport React, { useState } from \"react\";\nimport ReactDOM from \"react-dom\";\n\nfunction App() {\n  const [responsive, setResponsive] = useState(\"vertical\");\n  const [tableBodyHeight, setTableBodyHeight] = useState(\"100%\");\n  const [tableBodyMaxHeight, setTableBodyMaxHeight] = useState(\"\");\n\n  //const columns = ['Organization Name', 'Organization Name URL', 'Industries', 'Headquarters Location', 'Description', 'CB Rank (Company)', 'Last Funding Date', 'Last Funding Amount', 'Last Funding Amount Currency', 'Last Funding Amount Currency (in USD)', 'Last Funding Type', 'Total Funding Amount', 'Total Funding Amount Currency', 'Total Funding Amount Currency (in USD)', 'Number of Employees', 'IPO Status', 'Valuation at IPO', 'Valuation at IPO Currency', 'Valuation at IPO Currency (in USD)', 'Website', 'LinkedIn', 'Contact Email', 'Full Description', 'Top 5 Investors', 'Industry Groups', 'IPqwery - Most Popular Patent Class', 'Investment Stage', 'Estimated Revenue Range', 'Founded Date', 'Founded Date Precision', 'Number of Investments', 'Funding Status', 'IPO Date', 'Operating Status', 'Company Type', 'Number of Articles', 'Number of Acquisitions', 'Acquisition Status', 'Founders', 'Accelerator Program Type', 'Number of Funding Rounds'];\n\n  function get_cell_style(val) {\n    let parentStyle = {\n      position: \"absolute\",\n      top: 0,\n      right: 0,\n      bottom: 0,\n      left: 0,\n      boxSizing: \"border-box\",\n      display: \"block\",\n      width: \"100%\"\n    };\n    let cellStyle = {\n      boxSizing: \"border-box\",\n      overflow: \"hidden\",\n      textOverflow: \"ellipsis\",\n      whiteSpace: \"nowrap\"\n    };\n    return (\n      <div style={{ position: \"relative\", height: \"20px\" }}>\n        <div style={parentStyle}>\n          <div style={cellStyle}>{val}</div>\n        </div>\n      </div>\n    ); \n  }\n\n  function get_cell_style_url(val) {\n    let parentStyle = {\n      position: \"absolute\",\n      top: 0,\n      right: 0,\n      bottom: 0,\n      left: 0,\n      boxSizing: \"border-box\",\n      display: \"block\",\n      width: \"100%\"\n    };\n    let cellStyle = {\n      boxSizing: \"border-box\",\n      overflow: \"hidden\",\n      textOverflow: \"ellipsis\",\n      whiteSpace: \"nowrap\"\n    };\n    return (\n      <div style={{ position: \"relative\", height: \"20px\" }}>\n        <div style={parentStyle}>\n          <div style={cellStyle}><a href={val}>{val}</a></div>\n        </div>\n      </div>\n    ); \n  }\n\n\n  const columns = [\n    { name: \"Organization Name\", options: { customBodyRender: get_cell_style } },\n    { name: \"Organization Name URL\", options: { customBodyRender: get_cell_style_url } }, \n    { name: \"Industries\", options: { customBodyRender: get_cell_style } },\n    { name: \"Headquarters Location\", options: { customBodyRender: get_cell_style } },\n    { name: \"Description\", options: { customBodyRender: get_cell_style } },\n    { name: \"CB Rank (Company)\", options: { customBodyRender: get_cell_style } },\n    { name: \"Last Funding Date\", options: { customBodyRender: get_cell_style } },\n    { name: \"Last Funding Amount\", options: { customBodyRender: get_cell_style } },\n    { name: \"Last Funding Amount Currency\", options: { customBodyRender: get_cell_style } },\n    { name: \"Last Funding Amount Currency (in USD)\", options: { customBodyRender: get_cell_style } },\n    { name: \"Last Funding Type\", options: { customBodyRender: get_cell_style } },\n    { name: \"Total Funding Amount\", options: { customBodyRender: get_cell_style } },\n    { name: \"Total Funding Amount Currency\", options: { customBodyRender: get_cell_style } },\n    { name: \"Total Funding Amount Currency (in USD)\", options: { customBodyRender: get_cell_style } },\n    { name: \"Number of Employees\", options: { customBodyRender: get_cell_style } },\n    { name: \"IPO Status\", options: { customBodyRender: get_cell_style } },\n    { name: \"Valuation at IPO\", options: { customBodyRender: get_cell_style } },\n    { name: \"Valuation at IPO Currency\", options: { customBodyRender: get_cell_style } },\n    { name: \"Valuation at IPO Currency (in USD)\", options: { customBodyRender: get_cell_style } },\n    { name: \"Website\", options: { customBodyRender: get_cell_style } },\n    { name: \"LinkedIn\", options: { customBodyRender: get_cell_style } },\n    { name: \"Contact Email\", options: { customBodyRender: get_cell_style } },\n    { name: \"Full Description\", options: { customBodyRender: get_cell_style } },\n    { name: \"Top 5 Investors\", options: { customBodyRender: get_cell_style } },\n    { name: \"Industry Groups\", options: { customBodyRender: get_cell_style } },\n    { name: \"IPqwery - Most Popular Patent Class\", options: { customBodyRender: get_cell_style } },\n    { name: \"Investment Stage\", options: { customBodyRender: get_cell_style } },\n    { name: \"Estimated Revenue Range\", options: { customBodyRender: get_cell_style } },\n    { name: \"Founded Date\", options: { customBodyRender: get_cell_style } },\n    { name: \"Founded Date Precision\", options: { customBodyRender: get_cell_style } },\n    { name: \"Number of Investments\", options: { customBodyRender: get_cell_style } },\n    { name: \"Funding Status\", options: { customBodyRender: get_cell_style } },\n    { name: \"IPO Date\", options: { customBodyRender: get_cell_style } },\n    { name: \"Operating Status\", options: { customBodyRender: get_cell_style } },\n    { name: \"Company Type\", options: { customBodyRender: get_cell_style } },\n    { name: \"Number of Articles\", options: { customBodyRender: get_cell_style } },\n    { name: \"Number of Acquisitions\", options: { customBodyRender: get_cell_style } },\n    { name: \"Acquisition Status\", options: { customBodyRender: get_cell_style } },\n    { name: \"Founders\", options: { customBodyRender: get_cell_style } },\n    { name: \"Accelerator Program Type\", options: { customBodyRender: get_cell_style } },\n    { name: \"IndusNumber of Funding Roundstries\", options: { customBodyRender: get_cell_style } },\n  ];\n\n\n\n  const options = {\n    filter: true,\n    filterType: \"dropdown\",\n    resizableColumns: true,\n    responsive: \"standard\",\n    fixedHeader: true,\n    draggableColumns: {\n      enabled: true\n    }\n  };\n/*\n  setRowProps: (row, index) => { \n    return { \n      style: {\n        backgroundColor: index % 2 ==0? '#efefef': \"#ffffff\",cursor:'pointer' }, }; \n      }\n*/\n  const data = [\n  ['Dyno Therapeutics', 'https://www.crunchbase.com/organization/dyno-therapeutics', 'Artificial Intelligence, Biotechnology, Health Care', 'Cambridge, Massachusetts, United States', 'Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.', '487', '2021-05-06', '100000000', 'USD', '100000000', 'Series A', '109000000', 'USD', '109000000', '51-100', 'Private', '', '', '', 'https://www.dynotx.com', 'https://www.linkedin.com/company/dynotx/', 'info@dynotx.com', 'Dyno Therapeutics is pioneering an artificial intelligence (AI) powered approach to gene therapy. Using machine learning and quantitative high-throughput in vivo experimentation, we are inventing new ways to design gene vectors with a focus on cell-targeting capsid proteins from adeno-associated virus (AAV), the most widely-used vector for gene therapies.', 'Lux Capital, Andreessen Horowitz, CRV, Obvious Ventures, GV', 'Artificial Intelligence, Biotechnology, Data and Analytics, Health Care, Science and Engineering, Software', '', '', '', '2018-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '9', '', '', 'Adrian Veres, Alan Crane, Eric Kelsic, George Church, Sam Sinai, Tomas Bjorklund', '', '3'],\n  ['TwinStrand Biosciences', 'https://www.crunchbase.com/organization/twinstrand-biosciences', 'Biotechnology, Genetics, Health Care', 'Seattle, Washington, United States', 'TwinStrand Biosciences develops and commercializes the duplex sequencing technology for DNA sequencing.', '1,160', '2021-05-06', '50000000', 'USD', '50000000', 'Series B', '73219302', 'USD', '73219302', '51-100', 'Private', '', '', '', 'http://www.twinstrandbio.com', 'https://www.linkedin.com/company/twinstrand-biosciences', 'info@twinstrandbio.com', 'TwinStrand Biosciences improves the accuracy of DNA sequencing by >10,000 fold and allows detection of mutations that are invisible by other approaches, through its technology. Its technology, Duplex Sequencing, is based on research and has potential applications in a wide range of fields, including oncology, infectious disease, organ transplantation, reproductive and genetic health, and forensics. TwinStrand Biosciences holds an exclusive worldwide license to develop and commercialize Duplex Sequencing. It was founded in 2015 and is headquartered in Bellevue, Washington.', 'Madrona Venture Group, Alexandria Venture Investments, Janus Henderson Investors, Section 32, Soleus Capital', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$1M to $10M', '2015-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '7', '', '', 'Jesse Salk', '', '4'],\n  ['Bolt Threads', 'https://www.crunchbase.com/organization/bolt-threads', 'Biotechnology, Fashion, Manufacturing', 'Emeryville, California, United States', 'Bolt is a materials company that invents and scales materials that put the planet on a path towards a better future.', '1,248', '2017-11-09', '123000000', 'USD', '123000000', 'Series D', '218118794', 'USD', '218118794', '51-100', 'Private', '', '', '', 'http://www.boltthreads.com', 'https://www.linkedin.com/company/bolt-threads', 'hello@boltthreads.com', 'Bolt is a materials company that invents and scales materials that put the planet on a path towards a better future. Biofabricated silk fibers MicrosilkTM - based on proteins found in nature, produced using Bolt Threads proprietary technology and revolutionary bioengineering concepts. Next-generation of performance fibers, fabrics and luxury products that represent cutting-edge technology in science, while raising the bar for quality, performance, and design.', 'Founders Fund, Temasek Holdings, Foundation Capital, Fidelity Management and Research Company, Innovation Endeavors', 'Biotechnology, Clothing and Apparel, Design, Manufacturing, Science and Engineering', 'Organic Chemistry', '', '$10M to $50M', '2009-08-01', 'day', '', 'Late Stage Venture', '', 'Active', 'For Profit', '38', '1', 'Made Acquisitions', 'Dan Widmaier, David Breslauer, Ethan Mirsky', '', '5'],\n  ['Inivata', 'https://www.crunchbase.com/organization/inivata', 'Biotechnology, Genetics, Health Care, Medical Device', 'Cambridge, Massachusetts, United States', 'Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis', '1,454', '2021-02-04', '35000000', 'USD', '35000000', 'Series C', '164354305', 'USD', '164354305', '51-100', 'Private', '', '', '', 'http://www.inivata.com/', 'https://www.linkedin.com/company/inivata-limited', 'press@inivata.com', 'Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and their patients. Unlike conventional invasive biopsies, Inivata detects and analyses genomic material from a cancer patient’s cell-free, circulating tumour DNA (ctDNA) which can be collected through a simple blood sample. This non-invasive approach – a liquid biopsy – offers a revolution in how cancer is detected, monitored and treated.', 'IP Group Plc, Cambridge Innovation Capital, NeoGenomics, Janus Henderson Investors, Farallon Capital Management', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10M to $50M', '2014-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '22', '', 'Was Acquired', 'Davina Gale, James Brenton, Nitzan Rosenfeld, Tim Forshew', '', '5'],\n  ['Pendulum Therapeutics', 'https://www.crunchbase.com/organization/pendulum-therapeutics', 'Biotechnology, Health Diagnostics, Medical, Therapeutics', 'San Francisco, California, United States', 'Pendulum Therapeutics is a biotechnology company improving health through products targeting the microbiome.', '1,721', '2021-04-07', '54000000', 'USD', '54000000', 'Series C', '111200000', 'USD', '111200000', '51-100', 'Private', '', '', '', 'https://pendulumlife.com', 'https://www.linkedin.com/company/pendulumco/', '', 'Pendulum Therapeutics believes therapies developed using evidence-based microbiome science and DNA sequencing can help heal the body from within. Armed with 13 patents and 42 pending, the company introduced its flagship product Pendulum Glucose Control, a medical probiotic, in 2020 and demonstrated its efficacy in lowering blood sugar spikes and reducing A1C in a published clinical trial. Founded in 2013 by a diverse team of scientists with deep microbiology, biochemistry, computational, and clinical expertise, Pendulum has raised $111 million to date from Meritech Capital, Sequoia Capital, True Ventures, Khosla Ventures, AME Cloud Ventures and Mayo Clinic among others. Pendulum Therapeutics is headquartered in San Francisco.', 'True Ventures, Sequoia Capital, Mayo Clinic, Felicis Ventures, Khosla Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', 'Less than $1M', '2013-01-01', 'day', '', 'Late Stage Venture', '', 'Active', 'For Profit', '3', '', '', 'Colleen Cutcliffe, James H. Bullard, John S. Eid', '', '6'],\n  ['Florence Healthcare', 'https://www.crunchbase.com/organization/florence-heathcare', 'Biotechnology, EdTech, Health Care, Pharmaceutical', 'Atlanta, Georgia, United States', 'Florence is a clinical trials platform that connects pharmaceutical companies and study sites to decentralize trials for drug development.', '1,840', '2021-05-06', '80000000', 'USD', '80000000', 'Series C', '88800000', 'USD', '88800000', '51-100', 'Private', '', '', '', 'http://florencehc.com/', 'http://www.linkedin.com/company/florence-healthcare', 'info@florencehc.com', 'Florence advances clinical research through software. The Florence eBinder Suite replaces paper investigator site files, trial master files and source binders with a shared platform.  This shared platform approach makes remote monitoring of eRegulatory and eSource documents possible while giving sponsors real-time insights into study progress. Hundreds of sponsors and sites worldwide trust Florence eBinders to move past paper study roadblocks and enable new approaches to trial management. Florence is based in Atlanta, Georgia.', 'Alumni Ventures Group, Fitbit, Insight Partners, Bessemer Venture Partners, Bee Partners', 'Biotechnology, Education, Health Care, Science and Engineering, Software', '', '', '', '2014-08-14', 'day', '', 'Late Stage Venture', '', 'Active', 'For Profit', '2', '', '', 'Andres Garcia, Michael Kassin, Ryan Jones', '', '4'],\n  ['Biosplice Therapeutics', 'https://www.crunchbase.com/organization/samumed', 'Biotechnology, Health Care, Life Science', 'San Diego, California, United States', 'Biosplice Therapeutics is in the medical research and development for tissue-level regeneration.', '1,904', '2021-04-15', '120000000', 'USD', '120000000', 'Venture - Series Unknown', '778000000', 'USD', '778000000', '51-100', 'Private', '', '', '', 'https://www.biosplice.com/', 'https://www.linkedin.com/company/6318665', 'info@samumed.com', \"Biosplice Therapeutics is in the medical research and development for tissue-level regeneration. With their platform's origins in small molecule-based Wnt pathway modulation, they develop therapeutics to address a range of degenerative diseases, regenerative medicine, and oncology. Samumed adopted a fresh operating philosophy from the beginning — one based on a goal of building a broad technology platform aimed at modulating regenerative pathways to improve patient health.\", 'aMoon Fund, Sands Capital Ventures, Vickers Venture Partners, Verition Fund Management, Cem Ortabaş', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2008-01-01', 'year', '', '', '', 'Active', 'For Profit', '8', '', '', 'Osman Kibar', '', '5'],\n  ['Atomwise', 'https://www.crunchbase.com/organization/atomwise', 'Artificial Intelligence, Health Care, Machine Learning, Medical, Pharmaceutical', 'San Francisco, California, United States', 'Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.', '2,092', '2020-10-06', '2300000', 'USD', '2300000', 'Grant', '176645000', 'USD', '176645000', '51-100', 'Private', '', '', '', 'http://www.atomwise.com/', 'https://www.linkedin.com/company/atomwise/', 'hello@atomwise.com', 'Atomwise Inc. is a deep learning AI technology for structure-based small molecule drug discovery. Atomwise performs hundreds of projects per year in partnership with some of the world’s largest pharmaceutical and agrochemical companies, as well as more than 200 universities and hospitals in 40 countries. Its speed and accuracy make it the most advanced technology for small molecule binding affinity prediction. AtomNet, its AI platform built for drug discovery contains more than 16 billion molecules for virtual screening.', 'Tencent, B Capital Group, Y Combinator, Creative Destruction Lab, Khosla Ventures', 'Artificial Intelligence, Data and Analytics, Health Care, Science and Engineering, Software', 'Computing; Calculating', '', '$10M to $50M', '2012-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '50', '', '', 'Abraham Heifets, Alexander Levy, Dr. Izhar Wallach', '', '9'],\n  ['Immunai', 'https://www.crunchbase.com/organization/immunai', 'Artificial Intelligence, Biotechnology, Machine Learning, Therapeutics', 'New York, New York, United States', 'Immunai is a biotech company that combines single cell genomics with ML algorithms to enable high resolution profiling of the immune system.', '2,175', '2021-02-11', '60000000', 'USD', '60000000', 'Series A', '80000000', 'USD', '80000000', '51-100', 'Private', '', '', '', 'https://www.immunai.com/', 'https://www.linkedin.com/company/immunai/', 'press@immunai.com', \"Immunai is a biotech company that combines single-cell genomics with ML algorithms to enable high-resolution profiling of the immune system. Immunai's mission is to map the entire immune system and its functions using single-cell genomics and machine learning. Immunai leverages single-cell technologies to profile cells from a blood sample, and uses machine-learning algorithms (powered by its proprietary database) to map the hundreds of cell types and their states to create an immune profile. They work on biomarker discovery and insights that identify how a cell responds to its changing environment. The company is located in New York City, San Francisco, and Tel Aviv, Israel.\", 'TLV Partners, Catalio Capital Management, Viola Group, Duquesne Family Office, Schusterman Foundation', 'Artificial Intelligence, Biotechnology, Data and Analytics, Health Care, Science and Engineering, Software', '', '', '', '2018-12-01', 'month', '', 'Early Stage Venture', '', 'Active', 'For Profit', '19', '1', 'Made Acquisitions', 'Ansuman Satpathy, Dan Littman, Daniel Wells, Luis F Voloch, Noam Solomon', '', '2'],\n  ['Senti Biosciences', 'https://www.crunchbase.com/organization/senti-biosciences', 'Biotechnology, Health Care, Medical, Therapeutics', 'South San Francisco, California, United States', 'Senti Biosciences is a developer of a programmable biology platform for cancer therapies.', '2,379', '2021-01-06', '105000000', 'USD', '105000000', 'Series B', '158000000', 'USD', '158000000', '51-100', 'Private', '', '', '', 'https://www.sentibio.com/', 'https://www.linkedin.com/company/senti-biosciences/', 'contact@sentibio.com', 'Senti Biosciences is a developer of a programmable biology platform for cancer therapies. Its therapeutics specialize in cell engineering and biological programming to build the future of gene and cell-based therapies that enable physicians to give patients life-saving treatments at an affordable cost.', 'Lux Capital, Menlo Ventures, Gaingels, 8VC, Matrix Partners China', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', 'Less than $1M', '2016-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '13', '', '', 'Jim Collins, Philip Lee, Tim Lu, Tim Lu,, Timothy Lu, Wilson Wong', '', '2'],\n  ['Evelo Biosciences', 'https://www.crunchbase.com/organization/evelo-therapeutics', 'Biotechnology, Health Care, Medical, Therapeutics', 'Cambridge, Massachusetts, United States', 'Evelo Biosciences is dedicated to improving the lives of patients globally through the development of monoclonal microbials.', '2,456', '2021-01-29', '67500000', 'USD', '67500000', 'Post-IPO Equity', '281500003', 'USD', '281500003', '51-100', 'Public', '509000000', 'USD', '509000000', 'http://evelobio.com', 'https://www.linkedin.com/company/evelo-biosciences/', 'info@evelobio.com', 'Evelo Biosciences is dedicated to improving the lives of patients globally through the development of a new modality of medicines – monoclonal microbials. Monoclonal microbials are orally delivered medicines that modulate systemic immunology and biology through direct interactions with human cells in the gut. These new medicines are broadly applicable across many diseases – including autoimmune, immunoinflammatory, metabolic, neurological, neuroinflammatory diseases and cancer. Monoclonal microbials have the potential to fundamentally change traditional models of drug discovery and development. By finding and selecting naturally occurring monoclonal microbials with defined therapeutic effects, Evelo can improve the speed, cost and success of drug discovery and development. Evelo’s platform enables pharmacological intervention at all stages of disease with naturally occurring, safe and effective monoclonal microbials. Evelo Biosciences was conceived and created within VentureLabs®, Flagship Pioneering’s institutional innovation foundry, and launched by Flagship in 2015.', 'GV, Flagship Pioneering, Alexandria Venture Investments, Celgene, Dementia Discovery Fund', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2015-01-01', 'year', '', 'IPO', '2018-05-09', 'Active', 'For Profit', '32', '1', 'Made Acquisitions', 'David Berry, Noubar Afeyan', '', '5'],\n  ['Synlogic', 'https://www.crunchbase.com/organization/synlogic', 'Biotechnology, Health Care, Therapeutics', 'Cambridge, Massachusetts, United States', 'Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.', '2,596', '2021-04-16', '30000000', 'USD', '30000000', 'Post-IPO Equity', '226400000', 'USD', '226400000', '51-100', 'Public', '', '', '', 'http://synlogictx.com/', 'https://www.linkedin.com/company/synlogic-therapeutics/', 'info@synlogictx.com', \"Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases. The company's lead programs target patients with rare genetic metabolic diseases, including phenylketonuria and secondary hyperoxaluria. Synlogic is also hard at work on synthetic biotics to address more prevalent conditions, including inflammatory bowel disease, cancer, and other metabolic conditions.\", 'Ginkgo Bioworks, OrbiMed, New Enterprise Associates, Bill & Melinda Gates Foundation, Perceptive Advisors', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', 'Less than $1M', '2014-01-01', 'year', '', 'M&A', '2017-08-28', 'Active', 'For Profit', '44', '', 'Was Acquired', 'Alison Silva, Ankit Mahadevia, Dean Falb, Jim Collins, Tim Lu, Timothy Lu', '', '6'],\n  ['Thirty Madison', 'https://www.crunchbase.com/organization/thirty-madison', 'Health Care, Personal Health, Pharmaceutical, Wellness', 'New York, New York, United States', 'Thirty Madison offers direct-to-consumer healthcare and wellness products.', '2,885', '2020-08-14', '47000000', 'USD', '47000000', 'Series B', '69750000', 'USD', '69750000', '51-100', 'Private', '', '', '', 'https://www.thirtymadison.com', 'https://www.linkedin.com/company/thirty-madison-inc./', 'press@thirtymadison.com', 'Thirty Madison believes affordable specialized care and treatment should be available to everyone. Millions of people still lack the access and support they need to successfully manage their chronic conditions. We’re changing that with condition-specific brands —Keeps, Cove, Evens —\\xa0 that provide end-to-end treatment for patients.', 'Alumni Ventures Group, First Round Capital, Gaingels, Polaris Partners, Entrepreneurs Roundtable Accelerator', 'Health Care', '', '', '$1M to $10M', '2017-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '10', '', '', 'Demetri Karagas, Steven Gutentag', '', '4'],\n  ['Omega Therapeutics', 'https://www.crunchbase.com/organization/omega-20fc', 'Biotechnology, Health Care', 'Cambridge, Massachusetts, United States', 'Omega Therapeutics offers a proprietary epigenomic programming platform.', '2,904', '2021-03-30', '126000000', 'USD', '126000000', 'Series C', '211000000', 'USD', '211000000', '51-100', 'Private', '', '', '', 'https://www.omegatherapeutics.com/', 'https://www.linkedin.com/company/omega-therapeutics/', '', 'Omega Therapeutics, Inc. is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines.', 'BlackRock, Fidelity Management and Research Company, Flagship Pioneering, Point72, Invus', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2016-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '6', '', '', 'Omega Enterprises', '', '2'],\n  ['Mirati Therapeutics', 'https://www.crunchbase.com/organization/mirati-therapeutics-inc', 'Biopharma, Biotechnology, Medical', 'San Diego, California, United States', 'Mirati Therapeutics is a Biotechnology company located in 9363 Towne Centre Dr, San Diego, CA, United States.', '2,957', '2019-06-28', '234300000', 'USD', '234300000', 'Post-IPO Equity', '234300000', 'USD', '234300000', '51-100', 'Public', '', '', '', 'http://mirati.com', 'https://www.linkedin.com/company/10681135', 'info@mirati.com', 'Mirati Therapeutics Inc is a Biotechnology company located in 9363 Towne Centre Dr, San Diego, CA, United States.', '', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', 'Less than $1M', '1995-12-13', 'day', '1', 'IPO', '2013-07-16', 'Active', 'For Profit', '17', '1', 'Made Acquisitions', '', '', '1'],\n  ['Guardant Health', 'https://www.crunchbase.com/organization/guardant-health', 'Biotechnology, Health Care, Health Diagnostics', 'Redwood City, California, United States', 'Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs in oncology.', '3,074', '2018-08-06', '', '', '', 'Venture - Series Unknown', '550000000', 'USD', '550000000', '51-100', 'Public', '1587000000', 'USD', '1587000000', 'http://guardanthealth.com', 'http://www.linkedin.com/company/guardant-health', 'press@guardanthealth.com', 'Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing and rare-cell diagnostics and is closely advised by an oncologist-led medical steering committee from leading cancer centers across North America and abroad.', 'SoftBank Vision Fund, Temasek Holdings, Sequoia Capital, T. Rowe Price, Felicis Ventures', 'Biotechnology, Health Care, Science and Engineering', '', '', '$50M to $100M', '2012-01-01', 'year', '', 'IPO', '2018-10-04', 'Active', 'For Profit', '181', '1', 'Made Acquisitions', 'AmirAli Talasaz, Helmy Eltoukhy', '', '8'],\n  ['Inflammatix', 'https://www.crunchbase.com/organization/inflammatix', 'Big Data, Bioinformatics, Biotechnology, Health Care, Health Diagnostics', 'Burlingame, California, United States', 'Inflammatix develops a novel molecular diagnostics for acute infections and sepsis that work by reading the immune system.', '3,117', '2021-03-16', '102000000', 'USD', '102000000', 'Series D', '136099923', 'USD', '136099923', '51-100', 'Private', '', '', '', 'https://www.inflammatix.com', 'https://www.linkedin.com/company/inflammatix/', 'info@inflammatix.com', \"Inflammatix develops a novel molecular diagnostics for acute infections and sepsis that work by 'reading' the immune system.  It is a molecular diagnostics company developing rapid tests that read the immune system to resolve major clinical and public health challenges. They are initially focused on developing tests for acute bacterial and viral infections, and sepsis based on patent-pending biomarkers exclusively licensed from Stanford University. The company was founded by Timothy Sweeney and Jonathan Romanowsky in California.\", 'D1 Capital Partners, StartX (Stanford-StartX Fund), Khosla Ventures, Northpond Ventures, DARPA', 'Biotechnology, Data and Analytics, Health Care, Science and Engineering', '', '', '', '2016-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '12', '', '', 'Jonathan Romanowsky, Purvesh Khatri, Tim Sweeney', '', '6'],\n  ['QuVa Pharma', 'https://www.crunchbase.com/organization/quva-pharma', 'Health Care, Medical, Medical Device, Pharmaceutical', 'Sugar Land, Texas, United States', 'QuVa Pharma is a pharmaceutical company engaged in the innovation and production of pharmaceutical products.', '3,173', '2021-05-06', '275000000', 'USD', '275000000', 'Debt Financing', '356000000', 'USD', '356000000', '51-100', 'Private', '', '', '', 'http://www.quvapharma.com/', 'https://www.linkedin.com/company/quvapharma-inc-/', 'Customer.Service@QuVaPharma.com', 'QuVa Pharma will be the industry’s leading 503B platform and the partner of choice for compliance-oriented healthcare facilities looking to ensure quality, safe and consistent supply of medications. QuVa Pharma will achieve this through its commitment to innovation, by operating from superior facilities under stringent cGMP adherence, and by attracting individuals absolutely committed to quality and who bring deep sterile injectable manufacturing expertise.', 'Goldman Sachs, Bain Capital Ventures, Owl Rock Capital Partners, Silicon Valley Bank, Oxford Finance LLC', 'Health Care', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2015-01-01', 'year', '', 'Private Equity', '', 'Active', 'For Profit', '15', '1', 'Made Acquisitions', 'Peter Jenkins, Stuart Hinchen', '', '5'],\n  ['Beam Therapeutics', 'https://www.crunchbase.com/organization/beam-therapeutics', 'Biotechnology, Genetics, Medical, Therapeutics', 'Cambridge, Massachusetts, United States', 'Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.', '3,275', '2021-01-19', '260000000', 'USD', '260000000', 'Post-IPO Equity', '689000000', 'USD', '689000000', '51-100', 'Public', '843000000', 'USD', '843000000', 'https://beamtx.com/', 'https://www.linkedin.com/company/beamtx/', 'info@beamtx.com', \"Beam Therapeutics is a biotechnology company engaged in creating genetic medicines based on its base editing technology.  Beam is pioneering the use of base editing, a potential new class of precision genetic medicines, with a vision of providing life-long cures to patients suffering from serious diseases. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.\", 'GV, F-Prime Capital, ARCH Venture Partners, Casdin Capital, Perceptive Advisors', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', 'Less than $1M', '2017-01-01', 'year', '', 'IPO', '2020-02-05', 'Active', 'For Profit', '26', '1', 'Made Acquisitions', 'David R. Liu, Feng Zhang, J. Keith Joung', '', '4'],\n  ['MycoWorks', 'https://www.crunchbase.com/organization/mycoworks', 'Biotechnology, Building Material, Product Research, Renewable Energy, Sustainability', 'Emeryville, California, United States', 'MycoWorks is a biotech company that delivers commercially viable non-plastic and non-animal materials to the market.', '3,352', '2020-10-13', '45000000', 'USD', '45000000', 'Series B', '62000000', 'USD', '62000000', '51-100', 'Private', '', '', '', 'http://www.mycoworks.com', 'https://www.linkedin.com/company/mycoworks', 'info@mycoworks.com', 'MycoWorks is engaged in the creation of sustainable design solutions with advanced biomaterials. The company’s proprietary custom-engineered material is sustainable, versatile, and animal-free, and feels and performs like leather.  Their first product, Reishi, and the proprietary platform to make it, Fine Mycelium, are a groundbreaking approach to biomaterials that delivers unparalleled versatility and unmatched performance in strength, durability, and hand feel. The perfect intersection of art and science, Reishi is the only natural material that performs like cowhide leather and is engineered to meet the highest quality standards. MycoWorks was founded by Sophia Wang and Philip Ross in 2013 and is based in San Francisco, California.', 'IndieBio, SOSV, Gaingels, 8VC, Susa Ventures', 'Biotechnology, Data and Analytics, Design, Energy, Real Estate, Science and Engineering, Sustainability', 'Organic Macromolecular Compounds; Their Preparation Or Chemical Working-Up', '', '$1M to $10M', '2013-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '7', '', '', 'Philip Ross, Sophia Wang', '', '5'],\n  ['Mission Bio', 'https://www.crunchbase.com/organization/mission-bio', 'Bioinformatics, Biotechnology, Genetics, Health Care', 'San Francisco, California, United States', 'Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.', '3,518', '2020-08-13', '70000000', 'USD', '70000000', 'Series C', '110000000', 'USD', '110000000', '51-100', 'Private', '', '', '', 'http://www.missionbio.com', 'https://www.linkedin.com/company/mission-bio/', 'info@missionbio.com', 'Mission Bio delivers targeted solutions for high-impact applications with the Tapestri Platform. The Tapestri Platform is the industry’s first and only single-cell multi-omics platform, enabling genotype and phenotype from the same cell and precise detection of heterogeneity in disease progression and treatment response. Application areas include oncology blood cancers, solid tumors, and genome editing validation.', 'National Institutes of Health, Alumni Ventures Group, Tech Coast Angels, Agilent Technologies, LabCorp', 'Biotechnology, Data and Analytics, Health Care, Science and Engineering', '', '', '$10M to $50M', '2012-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '14', '', '', 'Adam Abate, Adam Sciambi, Charlie Silver, Dennis Eastburn', '', '6'],\n  ['Chiasma', 'https://www.crunchbase.com/organization/chiasma', 'Biopharma, Biotechnology, Therapeutics', 'Waltham, Massachusetts, United States', 'Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.', '3,599', '2019-04-08', '34500000', 'USD', '34500000', 'Post-IPO Equity', '246000000', 'USD', '246000000', '51-100', 'Public', '450000000', 'USD', '450000000', 'http://chiasmapharma.com', 'http://www.linkedin.com/company/chiasma', 'info@chiasmapharma.com', \"Chiasma applies its proprietary technology to approved drugs, which not only enables their being switched from injectable to oral, but importantly can result in new indications and/or enhanced absorption. The Company's Transient Permeability Enhancer technology promotes the delivery of drugs to the GI wall and from there to the liver. It is applicable to macromolecules that to-date can be administered only by injection. TPE can be utilized also with small molecules that are already orally available but are poorly absorbed.\", 'MPM Capital, ARCH Venture Partners, Rock Springs Capital, Abingworth, Sofinnova Investments', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2001-01-01', 'year', '', 'M&A', '2015-07-15', 'Active', 'For Profit', '19', '', 'Was Acquired', '', '', '11'],\n  ['Volastra Therapeutics', 'https://www.crunchbase.com/organization/volastra-therapeutics', 'Biotechnology, Medical', 'New York, New York, United States', 'Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.', '3,622', '2021-04-06', '32000000', 'USD', '32000000', 'Seed', '44000000', 'USD', '44000000', '51-100', 'Private', '', '', '', 'https://volastratx.com/', '', '', 'Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers by exploiting unique insights into chromosomal instability', 'Polaris Partners, ARCH Venture Partners, Vida Ventures, Catalio Capital Management, Quark Venture', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2019-01-01', 'year', '', 'Seed', '', 'Active', 'For Profit', '5', '', '', 'Lewis Cantley, Olivier Elemento, Samuel Bakhoum', '', '2'],\n  ['Selecta Biosciences', 'https://www.crunchbase.com/organization/selecta-biosciences', 'Biopharma, Biotechnology, Pharmaceutical', 'Watertown, Massachusetts, United States', 'Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.', '3,791', '2020-09-01', '35000000', 'USD', '35000000', 'Post-IPO Debt', '281587487', 'USD', '281587487', '51-100', 'Public', '249200000', 'USD', '249200000', 'http://www.selectabio.com', 'https://www.linkedin.com/company/selecta-bio', 'info@selectabio.com', 'Selecta Biosciences is a biopharmaceutical company developing the first generation of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Their proprietary product platform technology combines recent advances in immunobiology with cutting-edge nanotechnology to develop targeted immunomodulatory nanoparticles. It was founded in 2008 and is headquartered in Watertown, Massachusetts.', 'National Institutes of Health, Polaris Partners, Flagship Pioneering, OrbiMed, Silicon Valley Bank', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', 'Less than $1M', '2008-01-01', 'year', '', 'IPO', '2016-06-22', 'Active', 'For Profit', '72', '', '', 'Omid Farokhzad', '', '18'],\n  ['Emulate', 'https://www.crunchbase.com/organization/emulate', 'Biotechnology, Health Care, Life Science, Medical', 'Boston, Massachusetts, United States', 'Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.', '3,813', '2020-03-06', '19275000', 'USD', '19275000', 'Debt Financing', '142269991', 'USD', '142269991', '51-100', 'Private', '', '', '', 'http://emulatebio.com', 'https://www.linkedin.com/company/emulate-inc-/', 'jenn.perkins@emulatebio.com', 'Emulate Inc. is a privately held company that creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health. Our lab-ready Human Emulation System® includes three components: Zoë® Culture Module, Organ-Chips, and analytical software applications. The platform provides a window into the inner workings of human biology and disease—offering researchers a new technology designed to predict human response with greater precision and detail than conventional cell culture or animal-based experimental testing. Each of the Emulate proprietary Organ-Chip models—including the liver, intestine, and kidney—contains tiny hollow channels lined with tens of thousands of living human cells and tissues and is approximately the size of an AA battery. An Organ-Chip is a living, microengineered environment that recreates the natural physiology and mechanical forces that cells experience within the human body. Our founding team pioneered the Organs-on-Chips technology at the Wyss Institute for Biologically Inspired Engineering at Harvard University. Emulate holds the worldwide exclusive license from Harvard University to a robust and broad intellectual property portfolio for the Organs-on-Chips technology and related systems. For more information, please visit emulatebio.com.', 'National Institutes of Health, Founders Fund, Alumni Ventures Group, LabCorp, Northpond Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$1M to $10M', '2013-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '13', '', '', 'Daniel Levner, Donald Ingber, Geraldine A. Hamilton', '', '8'],\n  ['Geltor', 'https://www.crunchbase.com/organization/geltor', 'Advanced Materials, Biotechnology, Health Care', 'San Leandro, California, United States', 'Geltor is a bio-design company that makes proteins used in beauty, food, & beverage products like collagen and elastin, but without animals.', '3,871', '2020-07-27', '91300000', 'USD', '91300000', 'Series B', '114250000', 'USD', '114250000', '51-100', 'Private', '', '', '', 'https://www.geltor.com/', 'https://www.linkedin.com/company/geltor-inc.', 'info@geltor.com', 'Geltor is the bio-design company creating high-value designer proteins, including collagen. Its proteins are 100% animal- and GMO-free, and are cultivated using a sustainable fermentation process. Geltor’s products provide unprecedented functionality and benefits for consumers, while producing less waste and consuming fewer natural resources than archaic protein production platforms such as animals.', 'IndieBio, SOSV, BoxGroup, Pegasus Tech Ventures, Fifty Years', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', 'Organic Chemistry', '', '$1M to $10M', '2015-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '49', '', '', 'Alexander Lorestani, Nick Ouzounov', '', '5'],\n  ['Spark Therapeutics', 'https://www.crunchbase.com/organization/spark-therapeutics', 'Biotechnology, Genetics, Medical, Therapeutics', 'Philadelphia, Pennsylvania, United States', 'Spark Therapeutics is focused on the development of gene therapy.', '3,878', '2014-05-27', '72800000', 'USD', '72800000', 'Series B', '122800000', 'USD', '122800000', '51-100', 'Public', '352000000', 'USD', '352000000', 'http://sparktx.com', 'https://www.linkedin.com/company/spark-therapeutics-inc/', 'info@sparktx.com', 'Spark Therapeutics is developing potentially curative, one-time gene therapy products to transform the lives of patients and re-imagine the treatment of debilitating diseases.  The founding team includes scientists who have led the advancement of gene therapy over the past two decades, establishing human proof of concept of the expression of gene therapy in the eye and liver.  Spark’s robust pipeline includes SPK-RPE65, a fully enrolled, pivotal Phase 3 program in blindness due to mutations in the RPE65 gene, SPK-CHM for the treatment of choroideremia, and SPK-FIX, a program for the potential treatment of hemophilia B through a global collaboration with Pfizer Inc., as well as preclinical programs to address neurodegenerative diseases and other retinal degenerative diseases and hematologic disorders.  Spark has rights to a proprietary manufacturing platform that has a track record supporting clinical studies across diverse therapeutic areas and routes of administration.  Spark’s expertise across research, clinical, regulatory and manufacturing builds on a legacy of innovation and excellence in gene therapy established by Spark’s team while at The Children’s Hospital of Philadelphia Center for Cellular and Molecular Therapeutics.', 'T. Rowe Price, Wellington Management, Rock Springs Capital, Deerfield, Sofinnova Investments', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$1B to $10B', '2013-01-01', 'year', '', 'M&A', '2015-01-30', 'Active', 'For Profit', '105', '1', 'Made Acquisitions, Was Acquired', 'Beverly L. Davidson, J. Fraser Wright, Jeffrey Marrazzo, Katherine A. High', '', '2'],\n  ['ViaCyte', 'https://www.crunchbase.com/organization/viacyte', 'Biotechnology, Diabetes, Health Care, Medical, Therapeutics', 'San Diego, California, United States', 'ViaCyte is a preclinical therapeutic company specializing in regenerative medicine therapies for diabetes.', '3,936', '2021-04-22', '53931166', 'USD', '53931166', 'Venture - Series Unknown', '289476946', 'USD', '289476946', '51-100', 'Private', '', '', '', 'http://www.viacyte.com', 'https://www.linkedin.com/company/viacyte-formerly-novocell-', 'info@ViaCyte.com', 'ViaCyte is a preclinical therapeutic company specializing in regenerative medicine therapies for diabetes. Their therapy is based on the differentiation of stem cells into pancreatic beta-cell precursors, with subcutaneous implantation in an encapsulation device.  Data in their publications demonstrate that these cells can produce therapeutically relevant levels of insulin in response to blood glucose, and sustain diabetic animals. Their goal is a product which can free both Type 1 and Type 2 patients with diabetes from insulin dependence on a long-term basis, while reducing or eliminating hypoglycemic, microvasculature, and weight-related cardiovascular complications.', 'RA Capital Management, TPG, Bain Capital Life Sciences, Asset Management Ventures (AMV), JDRF (The Juvenile Diabetes Research Foundation)', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$10M to $50M', '1999-01-01', 'year', '', '', '', 'Active', 'For Profit', '50', '', '', 'Paul Laikind', '', '15'],\n  ['XtalPi', 'https://www.crunchbase.com/organization/xtalpi', 'Artificial Intelligence, Biotechnology, Pharmaceutical', 'Cambridge, Massachusetts, United States', 'XtalPi is a biotech firm that uses artificial intelligence and computing to accelerate the development of new pharmaceutical drugs.', '4,060', '2020-09-28', '318800000', 'USD', '318800000', 'Series C', '386401703', 'USD', '386401703', '51-100', 'Private', '', '', '', 'http://www.xtalpi.com/', 'https://www.linkedin.com/company/xtalpi/', 'contact@xtalpi.com', 'XtalPi is a biotech firm that uses artificial intelligence and computing to accelerate the development of new drugs. The firm uses algorithms to predict the crystalized form a drug will take. The data enables XtalPi to work with other pharmaceutical companies to develop new drugs and create new patents. It was founded in 2014 and headquartered in Cambridge, Massachusetts.', 'Tencent, SoftBank Vision Fund, ZhenFund, Alphabet, Sequoia Capital China', 'Artificial Intelligence, Biotechnology, Data and Analytics, Health Care, Science and Engineering, Software', '', '', '$1M to $10M', '2014-05-01', 'month', '2', 'Late Stage Venture', '', 'Active', 'For Profit', '7', '', '', 'Jian Ma, Lipeng Lai, Shuhao Wen', '', '9'],\n  ['ChemoCentryx', 'https://www.crunchbase.com/organization/chemocentryx', 'Biotechnology, Health Care, Medical Device', 'Mountain View, California, United States', 'ChemoCentryx develops orally administered small molecule therapeutics that target chemokine receptors and related chemo-attractants.', '4,188', '2020-06-10', '325400000', 'USD', '325400000', 'Post-IPO Equity', '569940000', 'USD', '569940000', '51-100', 'Public', '', '', '', 'http://www.chemocentryx.com', 'http://www.linkedin.com/company/chemocentryx', 'info@chemocentryx.com', 'ChemoCentryx focuses on discovery, development and commercialization of orally-administered small molecule therapeutics that target chemokine receptors and related chemo-attractant receptors.  Their small molecule product candidates is designed to target a specific chemokine or chemo-attractant receptor, thereby blocking the inappropriate immune system cascade underlying a given disease.', 'Hercules Capital, Inc., OrbiMed, Gimv, HBM Healthcare Investments AG, Alta Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '1997-01-01', 'year', '', 'IPO', '2012-02-08', 'Active', 'For Profit', '57', '', '', '', '', '7'],\n  ['Karius', 'https://www.crunchbase.com/organization/karius', 'Biotechnology, Genetics, Information Technology, Life Science', 'Redwood City, California, United States', 'Karius provides genomic insights for infectious diseases to enable clinicians to make life-saving treatment decisions.', '4,217', '2020-02-24', '165000000', 'USD', '165000000', 'Series B', '254000000', 'USD', '254000000', '51-100', 'Private', '', '', '', 'http://www.kariusdx.com', 'https://www.linkedin.com/company/7972561', 'info@kariusdx.com', 'Karius is a life sciences company focused on generating genomic insights for infectious diseases with a non-invasive Karius Test that helps clinicians make rapid, treatment decisions.  By mapping each patient’s microbial landscape from a single blood draw, Karius moves closer to a vision of a world where infectious disease is no longer  a major threat to human health.  The Karius laboratory is CLIA-certified and CAP-accredited to perform high-complexity clinical laboratory testing.', 'General Catalyst, Tencent, SoftBank Vision Fund, Innovation Endeavors, Lightspeed Venture Partners', 'Biotechnology, Health Care, Information Technology, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$10M to $50M', '2014-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '10', '', '', 'Mickey Kertesz, Steve Quake, Tim Blauwkamp', '', '4'],\n  ['UNITY Biotechnology', 'https://www.crunchbase.com/organization/unity-biotechnology', 'Biotechnology, Health Care, Medical', 'Brisbane, California, United States', 'Unity Biotechnology designs therapeutics that prevent, halt, and reverse various diseases of aging.', '4,347', '2019-03-01', '', '', '', 'Post-IPO Equity', '210591000', 'USD', '210591000', '51-100', 'Public', '712000000', 'USD', '712000000', 'http://unitybiotechnology.com/', 'https://www.linkedin.com/company/unity-biotechnology/', 'info@unitybiotechnology.com', 'Unity Biotechnology designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells; and designs senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected.', 'Founders Fund, Alumni Ventures Group, Mayo Clinic, Fidelity Management and Research Company, Venrock', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2009-01-01', 'year', '', 'IPO', '2018-05-02', 'Active', 'For Profit', '17', '', '', 'Keith Leonard, Nathaniel David, Nathaniel E. David', '', '7'],\n  ['Genocea Biosciences', 'https://www.crunchbase.com/organization/genocea-biosciences', 'Biotechnology, Medical', 'Cambridge, Massachusetts, United States', 'Genocea Biosciences is a biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies.', '4,362', '2020-07-22', '80000000', 'USD', '80000000', 'Post-IPO Equity', '470569774', 'USD', '470569774', '51-100', 'Public', '207000000', 'USD', '207000000', 'http://www.genocea.com', 'http://www.linkedin.com/company/genocea-biosciences', 'website.inquiry@genocea.com', 'Genocea Biosciences is a biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies to address diseases with significant unmet needs.Its product candidate includes GEN-003 which is an immunotherapy for the treatment of genital herpes as well as it owns pre-clinical immuno-oncology program focused on personalized cancer vaccines. The company focuses on developing vaccines and immunotherapies for unmet needs through its AnTigen Lead Acquisition System, which is used to design vaccines and immunotherapies. Genocea operates its business through the single segment being Developing and Commercializing vaccines.', 'Lux Capital, Polaris Partners, Alexandria Real Estate Equities, Bill & Melinda Gates Foundation, SR One', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2006-01-01', 'year', '', 'IPO', '2014-02-06', 'Active', 'For Profit', '58', '', '', 'Darren Higgins, David Sinclair, Jessica Baker Flechtner, Josh Wolfe, Kevin Bitterman', '', '14'],\n  ['Seer', 'https://www.crunchbase.com/organization/seer-b1f0', 'Biotechnology, Health Care, Life Science, Medical', 'Redwood City, California, United States', 'Seer is a biotechnology company that offers tools and solutions related to the field of proteomics.', '4,364', '2020-09-01', '', '', '', 'Venture - Series Unknown', '169500000', 'USD', '169500000', '51-100', 'Public', '1101600000', 'USD', '1101600000', 'https://seer.bio/', 'https://www.linkedin.com/company/seerbio/', 'info@seer.bio', \"Seer is a developer of a life sciences and health data platform intended to facilitate early, pre-symptomatic detection of chronic life-threatening diseases. The company's platform captures and translates molecular insights from the proteome with improved accuracy and speed, enabling healthcare professionals to detect cancer and neurological diseases, drive earlier treatment and improve patient outcomes.\", 'T. Rowe Price, Fidelity Management and Research Company, Maverick Ventures, Emerson Collective, Wing Venture Capital', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', 'Less than $1M', '2017-01-01', 'year', '', 'IPO', '2020-12-03', 'Active', 'For Profit', '', '', '', 'Omid Farokhzad, Philip Ma', '', '6'],\n  ['TScan Therapeutics', 'https://www.crunchbase.com/organization/tscan-therapeutics', 'Biotechnology, Health Care, Pharmaceutical, Therapeutics', 'Waltham, Massachusetts, United States', 'TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.', '4,401', '2021-01-25', '100000000', 'USD', '100000000', 'Series C', '137500000', 'USD', '137500000', '51-100', 'Private', '', '', '', 'https://www.tscan.com/', 'https://www.linkedin.com/company/tscan-therapeutics/', 'info@tscan.com', 'TScan Therapeutics is an experienced group of scientists, development specialists, and other leaders driving a cutting edge platform. TScan Therapeutics is an owner and operator of a biotechnology company intended to develop immunotherapy treatments for cancer. The company identifies T-cell targets in a genome-wide high-throughput manner, expanding the treatment of immuno-oncology to patients who have few therapeutic options. TScan Therapeutics is harnessing novel T cell systems to extend the promise of immunotherapy. The company is dedicated to changing lives by discovering new cancer targets and developing safe and effective T-cell therapies for patients.', 'BlackRock, Bessemer Venture Partners, RA Capital Management, GV, Longwood Fund', 'Biotechnology, Health Care, Science and Engineering', '', '', 'Less than $1M', '2018-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '11', '', '', 'Lea Hachigian, Tomasz Kula', '', '4'],\n  ['NovaSignal', 'https://www.crunchbase.com/organization/neural-analytics', 'Biotechnology, Health Care, Medical Device', 'Los Angeles, California, United States', 'NovaSignal is a medical technology company commercializing a robotic cerebral ultrasound system.', '4,505', '2020-05-07', '14905150', 'USD', '14905150', 'Venture - Series Unknown', '89958141', 'USD', '89958141', '51-100', 'Private', '', '', '', 'http://novasignal.com', 'http://www.linkedin.com/company/neural-analytics', 'info@novasignal.com', 'NovaSignal is a medical technology company commercializing a robotic cerebral ultrasound system. Its Robotic System combines non-invasive ultrasound, robotics, and artificial intelligence to assess real-time cerebral blood flow. Through the use of cloud computing and data analytics, NovaSignal supports physicians in their clinical decision making to help improve patient outcomes. It was founded in 2013 and is headquartered in Los Angeles, California.', 'National Institutes of Health, Tech Coast Angels, MassChallenge, Alpha Edison, Tigermed', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2013-02-06', 'day', '', '', '', 'Active', 'For Profit', '23', '', '', 'Dan J. Hanchey, Leo Petrossian, Robert B. Hamilton', '', '12'],\n  ['Truvian Sciences', 'https://www.crunchbase.com/organization/truvian-sciences', 'Biotechnology, Health Care, Health Diagnostics, Life Science, Medical Device', 'San Diego, California, United States', 'Truvian disrupts the blood-testing industry by developing an automated diagnostic system that provides lab-accurate results.', '4,807', '2021-02-24', '105000000', 'USD', '105000000', 'Series C', '134100000', 'USD', '134100000', '51-100', 'Private', '', '', '', 'https://www.truvianhealth.com', 'https://www.linkedin.com/company/truvian-sciences', 'info@truvianhealth.com', 'Truvian disrupts the blood-testing industry by developing an automated, benchtop diagnostic system to provide lab-accurate results. The blood-testing system combines chemistry, immunoassays, and hematology assays in one device. With its 20-minute, single-run wellness panel that requires only several drops of blood, the company aims to cover about 40 commonly ordered diagnostic tests, including a lipid panel, metabolic panel, and complete blood cell count. Its dry reagent and optical sensing technologies, which require no refrigeration, can perform a complete blood count, basic metabolic and lipid panel, hemoglobin and glucose tests, thyroid screenings, and liver and kidney function exams. The company also offers Easy Check, a blood-based serologic test Truvian claims can detect the presence of the antibodies effective against SARS-CoV-2, the virus that causes COVID-19. Dena Marrinucci, Kim Kamdar, Mark Bowles, and Pieter van Rooyen established the San Diego, California-based company in 2015.', 'General Catalyst, Tao Capital Partners, Domain Associates, DNS Capital, GreatPoint Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', '$10M to $50M', '2015-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '4', '', '', 'Dena Marrinucci, Kim Kamdar, Mark Bowles, Pieter van Rooyen', '', '3'],\n  ['Amunix', 'https://www.crunchbase.com/organization/amunix-2', 'Biotechnology, Developer Platform, Medical, Therapeutics', 'Mountain View, California, United States', 'Amunix is a biopharmaceutical company intended to discover, design, and develop novel biologics, protein, and peptide therapeutics.', '5,162', '2021-03-04', '117000000', 'USD', '117000000', 'Series B', '190000000', 'USD', '190000000', '51-100', 'Private', '', '', '', 'http://www.amunix.com', 'https://www.linkedin.com/company/amunix/', 'hr@amunix.com', 'Amunix is a biopharmaceutical company intended to discover, design, and develop novel biologics, protein, and peptide therapeutics. The company is focused on developing prodrugs to bring the promise of potent immune-activating biotherapeutics to patients with solid tumor cancers. By delivering breakthrough therapies that can safely harness the immune system, it aims to conquer cancer and save lives. Its pipeline products are based on its proprietary XTEN half-life extension, XDC drug-conjugate delivery, and ProTIA pro-drug, bispecific T cell engager platform and have ongoing collaborations with biopharma corporations harnessing these delivery technologies over a wide range of therapeutic areas, delivering improved pharmaceutical technologies. Amunix was founded in 2006 and is headquartered in Mountain View, California.', 'BlackRock, Viking Global Investors, Polaris Partners, Venrock, Casdin Capital', 'Biotechnology, Health Care, Science and Engineering, Software', '', '', '$50M to $100M', '2006-01-01', 'year', '1', 'Early Stage Venture', '', 'Active', 'For Profit', '5', '', '', 'Volker Schellenberger', '', '2'],\n  ['Kite Pharma', 'https://www.crunchbase.com/organization/kite-pharma', 'Biotechnology, Health Care, Medical', 'Los Angeles, California, United States', 'Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications..', '5,249', '2014-05-02', '50000000', 'USD', '50000000', 'Debt Financing', '85250000', 'USD', '85250000', '51-100', 'Delisted', '625000000', 'USD', '625000000', 'http://www.kitepharma.com', 'https://www.linkedin.com/company/kite-pharma-inc-', 'info@kitepharma.com', \"Kite Pharma is a privately held development stage biotechnology company engaged in the design and development of pioneering immune-based targeted therapies to treat different cancer indications. Kite has a portfolio of proprietary product candidates designed to stimulate the patient's own immune system to fight tumor cells. These potential therapies could provide novel strategies for the treatment and management of a wide range of tumor types.\", 'Alta Partners, Two River, Arie Belldegrun, Riverbank Capital Securities', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10B+', '2009-01-01', 'year', '7', 'M&A', '2014-06-27', 'Active', 'For Profit', '202', '', 'Was Acquired', 'Arie Belldegrun, Joshua Kazam', '', '4'],\n  ['Cognoa', 'https://www.crunchbase.com/organization/cognoa', 'Biotechnology, Health Care, Health Diagnostics, Therapeutics', 'Palo Alto, California, United States', 'Cognoa is a behavioral health company focused on improving the lives and outcomes of children and families living with behavioral conditions', '5,319', '2019-10-31', '', '', '', 'Series A', '53900000', 'USD', '53900000', '51-100', 'Private', '', '', '', 'https://www.cognoa.com/', 'https://www.linkedin.com/company/3680755/', 'contact@cognoa.com', 'Cognoa is the leading pediatric behavioral health company developing diagnostic and therapeutic solutions that will improve the lives and outcomes of children and families living with behavioral conditions. Cognoa’s products are designed to be routinely prescribed by pediatricians and covered by insurers to improve the standard of care for how children are diagnosed and treated for behavioral health conditions starting with autism.', 'Morningside Group, Stanford Technology Ventures Program', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '2013-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '17', '', '', 'Brent Vaughan, Dennis Wall', '', '4'],\n  ['Life Biosciences', 'https://www.crunchbase.com/organization/life-biosciences', 'Biotechnology, Life Science', 'Boston, Massachusetts, United States', 'Life Biosciences is a developer of drugs designed to promote longevity and find treatments for age-related diseases.', '5,360', '2020-05-29', '18185552', 'USD', '18185552', 'Venture - Series Unknown', '68185552', 'USD', '68185552', '51-100', 'Private', '', '', '', 'https://lifebiosciences.com', 'https://www.linkedin.com/company/lifebiosciences/', 'info@lifebiosciences.com', \"Life Biosciences is a developer of drugs designed to promote longevity and find treatments for age-related diseases. Developer of drugs designed to promote longevity and find treatments for age-related diseases. The company's drugs help to combat the eight pathways of age-related decline and it's work addresses health decline due to aging as a systemic breakdown of the body, rather than a series of isolated events and conditions, enabling senior citizens to tackle age-related diseases with a view to ultimately extending healthy life spans.\", 'LeFrak', 'Biotechnology, Science and Engineering', 'Organic Chemistry', '', '$1M to $10M', '2017-01-01', 'year', '', '', '', 'Active', 'For Profit', '5', '1', 'Made Acquisitions', 'David Sinclair, Tristan Edwards', '', '2'],\n  ['Intra-Cellular Therapies', 'https://www.crunchbase.com/organization/intra-cellular-therapies', 'Biopharma, Biotechnology, Health Care, Medical, Neuroscience, Pharmaceutical', 'New York, New York, United States', 'Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS.', '5,409', '2017-10-03', '150000000', 'USD', '150000000', 'Post-IPO Equity', '225289893', 'USD', '225289893', '51-100', 'Public', '', '', '', 'http://www.intracellulartherapies.com', 'https://www.linkedin.com/company/intra-cellular-therapies/', 'hr@intracellulartherapies.com', \"Intra-Cellular Therapies (ITI) is developing novel drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the Central Nervous System (CNS). We combine the efforts of medicinal chemists, pharmacologists, biologists and clinical development scientists into a vibrant team that translates world-class research expertise into novel drugs. The company's lead product, ITI-007 is a novel first-in-class 5-HT2A antagonist, Dopamine receptor phosphoprotein modulator (DPPM) designed to treat multiple deficits in patients with schizophrenia while lacking the side-effects of existing antipsychotic drugs. ITI has also developed a state of the art technology platform, called CNSProfile™ that is capable of generating a unique molecular signature for drug compounds. This profile provides us with a proprietary window into the intracellular action of CNS drugs or drug candidates. We use this tool to fingerprint the intracellular molecular actions of existing drugs and to drive our internal drug discovery and development. Our technology has also enabled the company to examine the toxic effects of brain damaging nerve agents, and as a result, we are involved in collaborative efforts with several military and contract organizations to develop antidotes to chemical warfare agents. Based upon our understanding of the Central Nervous System we have discovered novel drug candidates with promise for treating the panoply of symptoms associated with the transition from peri-menopausal to post-menopausal states. Intra-Cellular Therapies was founded in 2002 by Drs. Paul Greengard, Sharon Mates and Allen Fienberg. The company is headquartered in New York City.\", 'Deerfield, Broadfin Capital', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2002-01-01', 'year', '', 'IPO', '2014-02-14', 'Active', 'For Profit', '64', '', '', 'Allen A. Fienberg, Nobel Laureate, Paul Greengard, Sharon Mates', '', '3'],\n  ['Genapsys', 'https://www.crunchbase.com/organization/genapsys', 'Biotechnology, Genetics, Health Diagnostics, Information Technology, Medical', 'Redwood City, California, United States', 'GenapSys is developing a novel DNA sequencing technology and detection system for applied genomic testing and medical sequencing.', '5,457', '2020-02-06', '75000000', 'USD', '75000000', 'Debt Financing', '249000000', 'USD', '249000000', '51-100', 'Private', '', '', '', 'http://genapsys.com', 'https://www.linkedin.com/company/genapsys/', 'info@genapsys.com', 'GenapSys is actively looking to partner with local health agencies and researchers to arm researchers with access to the insight afforded by sequencing. With its sequencing technology, the company aims to help support the control and limit the spread of current and future outbreaks. The device can run off of a standard power source and is small enough to fit in the back of a truck or be deployed at hospitals, airports, and public transportation hubs for quick results on virus samples. It was founded in 2010 and headquartered in Redwood City, California.', 'Foresite Capital, Plug and Play, Oxford Finance LLC, Decheng Capital, IPV Capital', 'Biotechnology, Health Care, Information Technology, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$1M to $10M', '2010-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '7', '', '', 'Hesaam Esfandyarpour', '', '8'],\n  ['Foghorn Therapeutics', 'https://www.crunchbase.com/organization/foghorn-therapeutics', 'Biopharma, Biotechnology, Health Care, Life Science, Therapeutics', 'Cambridge, Massachusetts, United States', 'Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,', '5,840', '2019-05-12', '61000000', 'USD', '61000000', 'Venture - Series Unknown', '111000000', 'USD', '111000000', '51-100', 'Public', '571000000', 'USD', '571000000', 'http://foghorntx.com/', 'https://www.linkedin.com/company/foghorn-therapeutics/', 'info@foghorntx.com', 'Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order.By manipulating this system with our unique Gene Traffic ControlTM platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease.With Gene Traffic ControlTM Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.', 'Flagship Pioneering, Casdin Capital, Invus, Irving Investors', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2015-01-01', 'year', '', 'IPO', '2020-10-22', 'Active', 'For Profit', '10', '', '', 'Cigall Kadoch', '', '2'],\n  ['Alimera Sciences', 'https://www.crunchbase.com/organization/alimera-sciences', 'Biotechnology, Health Care, Medical', 'Alpharetta, Georgia, United States', 'Alimera Sciences is a biopharmaceutical company that\\xa0researches, develops, and commercializes\\xa0prescription ophthalmic pharmaceuticals.', '5,894', '2021-04-14', '20000000', 'USD', '20000000', 'Post-IPO Equity', '252550000', 'USD', '252550000', '51-100', 'Public', '518000000', 'USD', '518000000', 'http://www.alimerasciences.com', 'https://www.linkedin.com/company/alimera-sciences', 'customerservice@alimerasciences.com', 'Alimera Sciences is a pharmaceutical company that specializes in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. They are presently focused on diseases affecting the back of the eye, or retina because these diseases are not well treated with current therapies and will affect millions of people in their aging populations. It was founded in 2003 and is headquartered in Alpharetta, Georgia.', 'Hercules Capital, Inc., Polaris Partners, Scale Venture Partners, Venrock, New Enterprise Associates', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2003-01-01', 'year', '', 'IPO', '2010-04-22', 'Active', 'For Profit', '76', '', '', 'Dan Myers, Dave Holland', '', '9'],\n  ['Kaleido BioSciences', 'https://www.crunchbase.com/organization/kaleido-biosciences-2', 'Biotechnology', 'Bedford, Massachusetts, United States', 'Kaleido BioSciences is a company working to design and analyze the microbiome system and provide adaptive solutions.', '6,224', '2021-02-04', '60400000', 'USD', '60400000', 'Post-IPO Equity', '230900000', 'USD', '230900000', '51-100', 'Public', '444000000', 'USD', '444000000', 'http://www.kaleido.com', 'https://www.linkedin.com/company/kaleido-biosciences-inc.', 'info@kaleido.com', 'Kaleido Biosciences is a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health. The Company has built a human-centric proprietary product platform to enable the rapid and cost-efficient discovery and development of novel Microbiome Metabolic Therapies (MMT™).  MMTs are designed to modulate the metabolic output and profile of the microbiome by driving the function and distribution of the organ’s existing microbes. Kaleido is advancing a broad pipeline of MMT candidates with the potential to address a variety of diseases and conditions with significant unmet patient needs.', 'Fidelity Management and Research Company, Flagship Pioneering, Invus, Rock Springs Capital, Abu Dhabi Investment Authority', 'Biotechnology, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2015-01-01', 'year', '', 'IPO', '2019-02-27', 'Active', 'For Profit', '16', '', '', 'Geoffrey von Maltzahn, Noubar Afeyan', '', '4'],\n  ['StrideBio', 'https://www.crunchbase.com/organization/stridebio', 'Biotechnology, Health Care, Information Technology, Therapeutics', 'Durham, North Carolina, United States', 'StrideBio is a gene therapy company that develops genetic medicines with curative potential for patients with devastating conditions.', '6,799', '2021-03-16', '81500000', 'USD', '81500000', 'Series B', '97200000', 'USD', '97200000', '51-100', 'Private', '', '', '', 'http://www.stridebio.com/', 'https://www.linkedin.com/company/stridebio/', 'info@stridebio.com', 'StrideBio is a gene therapy company focused on developing genetic medicines with curative potential for patients with devastating conditions. It leverages its proprietary structure-inspired adeno-associated virus (AAV) vector engineering platform to create unique and differentiated vectors that improve upon naturally occurring AAV serotypes to overcome current limitations of first-generation gene therapies.  The company was founded in 2015 and is headquartered in Durham, North Carolina.', 'Novo Holdings, Sarepta Therapeutics, Northpond Ventures, Alexandria Venture Investments, UCB Pharma', 'Biotechnology, Health Care, Information Technology, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$1M to $10M', '2015-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '5', '', '', 'Aravind Asokan, Mavis Agbandje, Patrick Ritschel', '', '3'],\n  ['Translate Bio', 'https://www.crunchbase.com/organization/rana-therapeutics', 'Biotechnology, Genetics, Medical, Therapeutics', 'Cambridge, Massachusetts, United States', 'Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.', '6,979', '2019-05-03', '47454990', 'USD', '47454990', 'Post-IPO Equity', '227627221', 'USD', '227627221', '51-100', 'Public', '582000000', 'USD', '582000000', 'http://translate.bio/', 'https://www.linkedin.com/company/translate-bio/', 'bd@ranarx.com', 'Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases. therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. The company was founded in 2011 and headquartered in Lexington, Massachusetts.', 'Fidelity Management and Research Company, MRL Ventures Fund, Omega Funds, Rock Springs Capital, SR One', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2011-01-01', 'year', '', 'IPO', '2018-06-27', 'Active', 'For Profit', '16', '', '', 'Ankit Mahadevia, Jean-Francois Formela', '', '6'],\n  ['Kinnate Biopharma', 'https://www.crunchbase.com/organization/kinnate-biopharma', 'Biopharma, Biotechnology, Health Care, Medical, Therapeutics', 'San Diego, California, United States', 'Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers.', '7,125', '2020-08-26', '98000000', 'USD', '98000000', 'Series C', '194500000', 'USD', '194500000', '51-100', 'Public', '830540000', 'USD', '830540000', 'https://www.kinnate.com/', 'https://ir.linkedin.com/company/kinnate-biopharma-inc', '', 'Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers. Its mission is to expand the reach of targeted therapeutics by developing products for underserved populations.  The company utilizes its deep expertise in structure-based drug discovery, translational research, and patient-driven precision medicine. Its programs include candidates in preclinical development for cancers that are driven by specific oncogenic alterations in either the BRAF kinase gene or in the FGFR2 and FGFR3 kinase genes.', 'RA Capital Management, Fidelity Management and Research Company, Viking Global Investors, OrbiMed, Foresite Capital', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', 'Less than $1M', '2018-01-01', 'year', '', 'IPO', '2020-12-02', 'Active', 'For Profit', '7', '', '', 'Eric A Murphy, Stephen Kaldor', '', '3'],\n  ['Senseonics', 'https://www.crunchbase.com/organization/senseonics', 'Biotechnology, Health Care, Medical, Medical Device, Sensor, Wearables', 'Germantown, Maryland, United States', 'Senseonics is a medical device startup company that focuses on the design, development, and commercialization of glucose monitoring systems.', '7,135', '2021-01-18', '50000000', 'USD', '50000000', 'Post-IPO Equity', '455499998', 'USD', '455499998', '51-100', 'Public', '', '', '', 'http://senseonics.com', 'http://www.linkedin.com/company/senseonics-inc', 'admin@senseonics.com', 'Senseonics is a medical device startup company in Germantown, Maryland, USA (near Washington, DC) developing transformative glucose monitoring products that is intended to enable people with diabetes to confidently live their lives with ease. Utilizing breakthrough fluorescence sensing technology, the Senseonics continuous glucose monitoring (\"CGM\") system is being designed to be the first fully implantable CGM that is highly accurate and stable throughout its long sensor life.', 'PHC Holdings, New Enterprise Associates, Silicon Valley Bank, Greenspring Associates, Abingworth', 'Biotechnology, Consumer Electronics, Hardware, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '1996-01-01', 'year', '', 'IPO', '2016-04-27', 'Active', 'For Profit', '60', '', '', 'M. James Barrett', '', '13'],\n  ['BioAtla', 'https://www.crunchbase.com/organization/bioatla', 'Biotechnology, Health Care, Medical', 'San Diego, California, United States', 'BioAtla develops safer, more effective drugs for cancer using a proprietary next-generation antibody discovery and evolution platform.', '7,152', '2020-07-15', '72500000', 'USD', '72500000', 'Series D', '186500001', 'USD', '186500001', '51-100', 'Public', '577580000', 'USD', '577580000', 'http://bioatla.com', 'https://www.linkedin.com/company/bioatla', 'info@bioatla.com', 'BioAtla develops safer, more effective drugs for cancer using a proprietary next-generation antibody discovery and evolution platform. BioAtla is a San Diego biotech company that develops novel monoclonal antibody and cell-based therapeutics using our proprietary Conditionally Active Biologics (CAB) and Comprehensive Integrated Antibody Optimization (CIAO!) platforms. These and other proprietary technologies (protected by more than 150 issued patents and patent applications) allow them to develop novel biologics (CABs) that are better drugs in multiple ways including more selective targeting of cancer tissue and improved manufacturability. Improved selectivity for the tumor microenvironment, even when the target is also found in normal tissue, not only improves safety but also expands the universe of potential drug targets, enabling the treatment of previously untreatable cancers.', 'Cormorant Asset Management, Boxer Capital, Janus Henderson Investors, Farallon Capital Management, HBM Healthcare Investments AG', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$10M to $50M', '2007-01-01', 'year', '1', 'IPO', '2020-12-15', 'Active', 'For Profit', '16', '', '', 'Carolyn Short, Jay M. Short, Jay Short', '', '4'],\n  ['Asklepios BioPharmaceutical', 'https://www.crunchbase.com/organization/asklepios-biopharmaceutical', 'Biopharma, Biotechnology, Health Care, Manufacturing, Medical, Medical Device', 'Chapel Hill, North Carolina, United States', 'Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.', '7,389', '2020-09-02', '1990000', 'GBP', '2656252', 'Grant', '241756252', 'USD', '241756252', '51-100', 'Private', '', '', '', 'http://www.askbio.com/', 'https://www.linkedin.com/company/askbio/', '', 'Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders and other rare diseases. It offers proprietary AAV technology, manufacturing capabilities, and a robust pipeline of in-house clinical programs for clients in the medical biopharmaceutical industry. Its pipeline includes clinical-stage programs in Pompe disease and congestive heart failure and a diverse preclinical portfolio of therapeutics targeting neuromuscular, CNS, and other diseases, as well as out-licensed clinical indications for hemophilia and Duchenne muscular dystrophy. The company’s gene therapy platform includes Pro10, an industry-leading proprietary cell line manufacturing process, and an extensive AAV capsid, and promoter library. Asklepios BioPharmaceutical was founded in 2001 and is headquartered in Research Triangle Park, North Carolina.', 'Scottish Enterprise, Vida Ventures, TPG Capital Asia, Muscular Dystrophy Association', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$10M to $50M', '2001-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '8', '3', 'Made Acquisitions, Was Acquired', 'Jude Samuski, R. Jude Samulski, Sheila Mikhail', '', '4'],\n  ['Arrowhead Pharmaceuticals', 'https://www.crunchbase.com/organization/arrowhead-research', 'Biotechnology, Nanotechnology, Pharmaceutical', 'Pasadena, California, United States', 'Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.', '7,486', '2019-12-06', '266800000', 'USD', '266800000', 'Post-IPO Equity', '449882896', 'USD', '449882896', '51-100', 'Public', '', '', '', 'http://arrowheadpharma.com/', 'https://www.linkedin.com/company-beta/140164/', 'info@arrowres.com', 'Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.', 'RA Capital Management, OrbiMed, Silence Therapeutics, York Capital Management', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '1989-01-01', 'year', '2', 'IPO', '1995-02-08', 'Active', 'For Profit', '114', '', '', 'R. Bruce Stewart', '', '9'],\n  ['X4 Pharmaceuticals', 'https://www.crunchbase.com/organization/x4-pharmaceuticals', 'Biotechnology, Clinical Trials, Health Care, Pharmaceutical, Therapeutics', 'Cambridge, Massachusetts, United States', 'X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.', '7,499', '2021-03-19', '55000000', 'USD', '55000000', 'Post-IPO Equity', '119499999', 'USD', '119499999', '51-100', 'Public', '', '', '', 'https://www.x4pharma.com', 'https://www.linkedin.com/company/x4-pharmaceuticals/', 'info@x4pharma.com', 'X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment. The company is developing two unique programs such as drug candidate, X4P-001, has clinical experience in over 70 subjects, and is advancing into Phase 1/2 trials in refractory clear cell renal cell carcinoma (ccRCC) and refractory epithelial ovarian cancer (EOC), the second program, X4P-002, is a unique series of late lead molecules that penetrate the blood-brain barrier. They will pursue early clinical development in glioblastoma multiforme (GBM), a rare form of lethal brain cancer, for the X4P-002 program.', 'SV Health Investors, OrbiMed, Cormorant Asset Management, Bain Capital Life Sciences, Abingworth', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', 'Less than $1M', '2014-01-01', 'year', '', 'IPO', '2017-11-17', 'Active', 'For Profit', '26', '', '', 'Henri Termeer, Keith Flaherty, Renato Skerlj, Richard Peters', '', '5'],\n  ['Precigen', 'https://www.crunchbase.com/organization/intrexon-corporation', 'Biotechnology, Life Science, Medical, Therapeutics', 'Germantown, Maryland, United States', 'Precigen is a life sciences company researching and developing bio-therapeutic control systems to minimize toxicity.', '7,631', '2021-01-26', '129400000', 'USD', '129400000', 'Post-IPO Equity', '525803901', 'USD', '525803901', '51-100', 'Public', '', '', '', 'https://precigen.com/', 'https://www.linkedin.com/company/precigen/', 'swright@intrexon.com', \"Precigen is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.\", 'Third Security, NewVa Capital Partners, Randal J. Kirk', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$10M to $50M', '1998-01-01', 'year', '1', 'IPO', '2013-08-13', 'Active', 'For Profit', '92', '7', 'Made Acquisitions', 'Thomas D. Reed', '', '10'],\n  ['Prothena', 'https://www.crunchbase.com/organization/prothena', 'Biotechnology, Health Care, Health Diagnostics', 'South San Francisco, California, United States', 'Prothena is a clinical-stage neuroscience company focused on the discovery and development of novel therapies.', '8,471', '2021-03-24', '67800000', 'USD', '67800000', 'Post-IPO Equity', '273099997', 'USD', '273099997', '51-100', 'Public', '', '', '', 'http://prothena.com', '', 'info@Prothena.com', 'Prothena Corporation plc is a late-stage clinical company with expertise in protein dysregulation and a pipeline of novel investigational therapeutics with the potential to change the course of devastating rare peripheral amyloid and neurodegenerative diseases. Fueled by its deep scientific expertise built over decades of research, Prothena is advancing a pipeline of therapeutic candidates for a number of indications and novel targets for which its ability to integrate scientific insights around neurological dysfunction and the biology of misfolded proteins can be leveraged. Prothena’s pipeline includes both wholly-owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer’s disease, Parkinson’s disease and a number of other neurodegenerative diseases.', 'Sofinnova Investments', 'Biotechnology, Health Care, Science and Engineering', '', '', 'Less than $1M', '2012-01-01', 'year', '', 'IPO', '2012-12-28', 'Active', 'For Profit', '10', '', '', 'Dennis Selkoe', '', '4'],\n  ['Rani Therapeutics', 'https://www.crunchbase.com/organization/rani-therapeutics', 'Biotechnology, Pharmaceutical, Therapeutics', 'San Jose, California, United States', 'Rani Therapeutics develops bio-therapeutics technology for the oral delivery of large drug molecules.', '8,479', '2020-12-10', '69000000', 'USD', '69000000', 'Series E', '211500000', 'USD', '211500000', '51-100', 'Private', '', '', '', 'http://www.ranitherapeutics.com', 'https://www.linkedin.com/company/rani-therapeutics-llc/', 'info@ranitherapeutics.com', 'Rani Therapeutics develops an oral biotherapeutics technology for the oral delivery of large drug molecules, including peptides, proteins, and antibodies.  The company was founded in 2012 and is based in San Jose, California.', 'Novartis, GV, AstraZeneca, Ping An Ventures, InCube Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2012-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '36', '', '', 'Mir Imran', '', '6'],\n  ['Decibel Therapeutics', 'https://www.crunchbase.com/organization/decibel-therapeutics', 'Biotechnology, Medical Device, Therapeutics', 'Cambridge, Massachusetts, United States', 'Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair and restore hearing.', '8,506', '2020-11-09', '82200000', 'USD', '82200000', 'Series D', '189200000', 'USD', '189200000', '51-100', 'Public', '437418000', 'USD', '437418000', 'http://decibeltx.com/', 'https://www.linkedin.com/company/decibel-therapeutics', 'info@decibeltx.com', \"Decibel Therapeutics is a developer of hearing disorder therapeutics intended to protect, repair and restore hearing. The company's therapeutics have provided insights into the link between hearing dysfunction and inner ear pathology and it has capabilities to encompass animal models, drug delivery to the inner ear, imaging, inner ear PK/PD modeling and measurement, bioinformatics, genetics and target identification, enabling patients to experience hearing loss therapies with different forms of hearing disorders for their recovery.\", 'BlackRock, Bessemer Venture Partners, GV, OrbiMed, Regeneron', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2015-01-01', 'year', '', 'IPO', '2021-02-11', 'Active', 'For Profit', '24', '', '', 'Gabriel Corfas, M. Charles Liberman', '', '4'],\n  ['Affinivax', 'https://www.crunchbase.com/organization/affinivax', 'Biotechnology, Health Care, Medical, Pharmaceutical', 'Cambridge, Massachusetts, United States', 'Affinivax is a biopharmaceutical company developing vaccines used to enhance the depth of protection against infectious diseases.', '8,587', '2021-03-09', '22000000', 'USD', '22000000', 'Grant', '370500000', 'USD', '370500000', '51-100', 'Private', '', '', '', 'http://www.affinivax.com/', 'https://www.linkedin.com/company/affinivax-inc./', 'contact@affinivax.com', 'Affinivax is a biopharmaceutical company developing vaccines used to enhance the depth of protection against infectious diseases. This novel and highly efficient vaccine conjugation technology – named MAPS for Multiple Antigen Presenting System – has the potential to deliver novel vaccines that offer broader disease coverage than existing vaccines, as well as protect against infectious diseases for which there are no effective immunization strategies today. The company is rapidly advancing a lead program targeting Streptococcus pneumoniae (pneumococcus), a pathogen that is responsible for significant morbidity and mortality in children and adults worldwide. Affinivax was established based on the knowledge and insights of world-leading experts in the fields of infectious diseases and vaccines. The company is backed by an investment from the Bill & Melinda Gates Foundation and has an exclusive license from Boston Children’s Hospital for intellectual property related to the MAPS technology platform.', 'BlackRock, T. Rowe Price, Wellington Management, Viking Global Investors, Bill & Melinda Gates Foundation', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2014-06-01', 'month', '', 'Late Stage Venture', '', 'Active', 'For Profit', '8', '', '', 'Fan Zhang, George Siber, Richard Malley, Yingjie Lu', '', '4'],\n  ['Fog Pharmaceuticals', 'https://www.crunchbase.com/organization/fog-pharmaceuticals', 'Biotechnology, Health Care, Pharmaceutical', 'Cambridge, Massachusetts, United States', 'FogPharma creates a new class of medicines that target human disease drivers currently considered undruggable.', '8,652', '2021-01-11', '107000000', 'USD', '107000000', 'Series C', '184000000', 'USD', '184000000', '51-100', 'Private', '', '', '', 'http://www.fogpharma.com', 'https://www.linkedin.com/company/fog-pharmaceuticals/', 'info@fogpharma.com', 'FogPharma was born from the scientific and entrepreneurial vision of founder Greg Verdine, a pioneer in the discovery and development of new drug classes that “drug the undruggable.” FogPharma’s cell-penetrating miniproteins (CPMPs) are a broad new class of medicines that can drug targets beyond the reach of conventional therapeutics. Together with world-leading experts and collaborators in cancer biology and therapy, our team is building a drug discovery powerhouse having passion, knowledge, and creativity to develop fundamentally new cancer treatments. FogPharma derives financial support from a unique syndicate of extraordinary private and institutional investors. FogPharma’s network of friends includes our founders, employees, investors, advisors, collaborators, and cancer patients; all working together to pioneer a unique approach toward conquering cancer. We are laser-focused and unstoppable in our mission to deliver the new class of medicines to patients and their families to bring them years to life and life to years.', 'T. Rowe Price, GV, Horizons Ventures, WuXi AppTec, Casdin Capital', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$1M to $10M', '2015-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '1', '', '', 'Greg Verdine, Weiqing Zhou', '', '3'],\n  ['Vor Biopharma', 'https://www.crunchbase.com/organization/vor-biopharma', 'Biotechnology, Health Care, Pharmaceutical', 'Cambridge, Massachusetts, United States', 'Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.', '8,652', '2020-07-07', '110000000', 'USD', '110000000', 'Series B', '152000000', 'USD', '152000000', '51-100', 'Public', '641610000', 'USD', '641610000', 'http://www.vorbiopharma.com/', 'https://www.linkedin.com/company/vor-biopharma/', 'info@vorbiopharma.com', 'Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer. It is focused on developing technologies that can enable selective targeting of cancer cells without impacting normal cells. Cell surface-targeted immunotherapies, such as bispecific antibodies, antibody-drug conjugates, and chimeric antigen receptor (CAR) T cells, generally target both cancer and normal cells, causing substantial toxicities and limiting their potential.  The company is taking a fundamentally novel approach to targeting cancer selectively by developing hematopoietic stem cells (HSCs) that have been engineered to be protected from specifically targeted immunotherapies. These HSCs are designed to generate healthy, functional cells that are also protected from depletion by cancer-targeted therapies.', 'RA Capital Management, Fidelity Management and Research Company, Alexandria Venture Investments, OUP (Osage University Partners), Johnson & Johnson Innovation – JJDC', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', 'Less than $1M', '2016-01-01', 'year', '', 'IPO', '2021-02-05', 'Active', 'For Profit', '11', '', '', 'Aleks Radovic-Moreno', '', '2'],\n  ['Chimerix', 'https://www.crunchbase.com/organization/chimerix', 'Biotechnology, Health Care, Pharmaceutical', 'Durham, North Carolina, United States', 'Chimerix is a biotechnology company developing therapeutics for antiviral diseases.', '8,655', '2021-01-21', '100000000', 'USD', '100000000', 'Post-IPO Equity', '391249178', 'USD', '391249178', '51-100', 'Public', '341600000', 'USD', '341600000', 'http://www.chimerix.com', 'http://www.linkedin.com/company/chimerix-inc.', 'info@chimerix-inc.com', \"Chimerix is developing novel antiviral therapeutics with the potential to transform patient care in multiple settings, including transplant, oncology, acute care and global health. The company's lead candidate, CMX001, is being developed as a potential broad spectrum antiviral agent for the treatment of life-threatening double-stranded DNA (dsDNA) viral diseases. Over 350 people have received CMX001 to date, with a growing body of evidence supporting the drug's antiviral activity in humans. Clinical studies of CMX001 include an ongoing Phase 2 study of the prevention/control of cytomegalovirus (CMV) in hematopoietic stem cell transplant patients (CMX001-201), a Phase 2 study being initiated for the treatment of adenovirus (AdV) infection in pediatric and adult hematopoietic stem cell transplant patients (CMX001-202), and an Open-Label Study (CMX001-350) for the treatment of any of 12 different dsDNA viral infections, including AdV, herpes viruses such as CMV, herpes simplex virus and Epstein Barr virus, polyoma viruses such as BK virus and JC virus, and pox viruses. The Open-Label Study builds on Chimerixâ€™s extensive experience working with clinicians at over 55 leading institutions in the United States, Canada, Europe and Israel who have sought CMX001 for the treatment of more than 150 immunocompromised patients under Emergency INDs. CMX001 has been well tolerated in all studies. CMX001 is also being developed as a medical countermeasure in the event of a smallpox release. Chimerix has received significant federal funding for the development of CMX001 as a medical countermeasure against smallpox from the National Institute of Allergy and Infectious Diseases. Chimerix's second clinical-stage antiviral compound, CMX157, a potent nucleoside analogue with in vitro activity against HIV and hepatitis B, has the potential to directly address several limitations of current HIV therapies. Chimerix is developing CMX157 for the treatment of HIV infection including those caused by multi-drug resistant viruses. A Phase 1 clinical study has been completed demonstrating that the compound is well tolerated and that the active antiviral, TFV-PP, was measurable in peripheral blood mononuclear cells (PBMCs) after a single dose and remained detectable for six days, indicating that it may be suitable for once-weekly dosing. Led by a world-class antiviral drug development team, Chimerix is also leveraging the company's extensive chemical library to pursue new treatments for hepatitis C virus, flu, malaria and other global public health needs.\", 'National Institutes of Health, Canaan Partners, Frazier Healthcare Partners, Morningside Group, Asset Management Ventures (AMV)', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2002-01-01', 'year', '', 'IPO', '2013-04-19', 'Active', 'For Profit', '90', '1', 'Made Acquisitions', 'George Painter', '', '11'],\n  ['Sutro Biopharma', 'https://www.crunchbase.com/organization/sutro-biopharma', 'Biotechnology, Information Technology, Medical', 'South San Francisco, California, United States', 'Sutro Biopharma develops protein therapeutics by using OCFS protein synthesis technology.', '8,662', '2020-12-14', '144900000', 'USD', '144900000', 'Post-IPO Equity', '346605000', 'USD', '346605000', '51-100', 'Public', '342000000', 'USD', '342000000', 'http://www.sutrobio.com', 'http://www.linkedin.com/company/1329898', 'general@sutrobio.com', 'Sutro Biopharma is a clinical stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.', 'Merck, SV Health Investors, Surveyor Capital, Eli Lilly, Citadel', 'Biotechnology, Health Care, Information Technology, Science and Engineering', 'Organic Chemistry', '', '$10M to $50M', '2003-01-01', 'year', '', 'IPO', '2018-09-26', 'Active', 'For Profit', '55', '', '', 'James R. Swartz', '', '9'],\n  ['Tmunity Therapeutics', 'https://www.crunchbase.com/organization/tmunity-therapeutics', 'Biotechnology, Genetics, Health Care, Manufacturing, Therapeutics', 'Philadelphia, Pennsylvania, United States', 'Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells', '8,799', '2019-10-31', '75000000', 'USD', '75000000', 'Series B', '230000000', 'USD', '230000000', '51-100', 'Private', '', '', '', 'https://www.tmunity.com/', 'https://www.linkedin.com/company/tmunity-therapeutics-incorporated/', '', 'Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells to treat a wide range of disease indications. Tmunity is developing novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms that exhibit best-in-class control over T cell activation and direction in vivo, as well as proprietary technologies to activate, expand, and genetically engineer T cells from peripheral blood, cord blood and tumors. The company is rapidly advancing toward the clinic personalized next-generation immunotherapies for oncology, infectious diseases and autoimmune disease. The founding team includes experts in T-cell biology, manufacturing, regulatory affairs, and clinical development, who collectively have an unparalleled track record of executing safe and effective cell and gene therapy clinical trials. In addition, Tmunity’s manufacturing platform has a proven track record of success in supporting multi-center clinical studies across diverse therapeutic indications.', 'Andreessen Horowitz, Lilly Asia Ventures, University of Pennsylvania, Kleiner Perkins, Gilead Sciences', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2015-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '8', '', '', 'Anne Chew, Bruce Blazar, Bruce Levine, Carl June, James Riley, Yangbing Zhao', '', '5'],\n  ['Compass Therapeutics', 'https://www.crunchbase.com/organization/compass-therapeutics', 'Biopharma, Biotechnology, Therapeutics', 'Boston, Massachusetts, United States', 'Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.', '8,947', '2020-07-01', '60482210', 'USD', '60482210', 'Venture - Series Unknown', '176512210', 'USD', '176512210', '51-100', 'Private', '', '', '', 'http://www.compasstherapeutics.com/', 'https://www.linkedin.com/company/compass-therapeutics-llc/', 'media@compasstherapeutics.com', 'Compass Therapeutics is a clinical-stage biotechnology company targeting the human immune synapse with a new generation of antibody therapeutics. Compass has broadly drugged the immune system by generating epitopically diverse antibody panels to more than 40 targets across all immune cell types and is leveraging its proprietary StitchMabs and common light-chain based multispecific platforms to empirically identify combinations and multispecific with optimized activity. The company’s lead product candidate, CTX-471, is a fully human agonistic antibody of CD137, which is in a Phase 1 study in patients with inadequate responses to PD-1/PD-L1 checkpoint inhibitors. Compass is also progressing several preclinical assets including a novel class of NK cell engagers targeting NKp30 and multiple bispecific checkpoint programs. The company’s office and lab are based at 80 Guest Street, Boston, MA.', 'Founders Fund, Alumni Ventures Group, GV, F-Prime Capital, Polaris Partners', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$10M to $50M', '2014-01-01', 'year', '', '', '', 'Active', 'For Profit', '9', '', '', 'Errik Anderson, Thomas Schuetz', '', '7'],\n  ['Adicet Bio', 'https://www.crunchbase.com/organization/adicet-bio', 'Biopharma, Biotechnology, Health Care, Medical', 'Menlo Park, California, United States', 'Adicet Bio is a biotechnology company that designs and develops of off-the-shelf allogeneic gamma delta T cell therapies.', '8,948', '2019-09-02', '80000000', 'USD', '80000000', 'Series B', '145625000', 'USD', '145625000', '51-100', 'Private', '', '', '', 'http://www.adicetbio.com', 'https://www.linkedin.com/company/adicet-bio-inc/', '', 'Adicet Bio is a biotechnology company engaged in the design and development of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.', 'OrbiMed, Regeneron, Pontifax, Samsung Ventures, Johnson & Johnson Innovation', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$1M to $10M', '2014-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '3', '1', 'Made Acquisitions', 'Aya Jakobovits', '', '3'],\n  ['Syndax Pharmaceuticals', 'https://www.crunchbase.com/organization/sndax-pharmaceuticals', 'Biotechnology, Clinical Trials, Pharmaceutical', 'Waltham, Massachusetts, United States', 'Syndax Pharmaceuticals focuses on developing an HDAC inhibitor for solid tumors and hematological tumors.', '9,050', '2020-01-31', '30000000', 'USD', '30000000', 'Post-IPO Debt', '198281951', 'USD', '198281951', '51-100', 'Public', '', '', '', 'http://www.syndax.com', 'https://www.linkedin.com/company/syndax-pharmaceuticals', 'info@syndax.com', 'Syndax Pharmaceuticals is a clinical-stage pharmaceutical company that focuses on an HDAC inhibitor for solid tumors and hematological tumors. It offers therapies to treat solid tumors and lung, breast, and hematological cancer. The company is developing axatilimab, a monoclonal antibody that blocks the colony-stimulating factor 1 (CSF-1) receptor, in development for chronic Graft versus Host Disease, and entinostat, a class I HDAC inhibitor. Syndax Pharmaceuticals pipeline includes and SNDX-5613, a highly selective inhibitor of the Menin–MLL binding interaction, in development for the treatment of patients with MLLr and NPM1 acute leukemias.', 'Hercules Capital, Inc., Fidelity Management and Research Company, OrbiMed, MPM Capital, Cormorant Asset Management', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', 'Less than $1M', '2005-01-01', 'year', '', 'IPO', '2016-03-03', 'Active', 'For Profit', '42', '', '', 'Peter Ordentlich', '', '8'],\n  ['Frequency Therapeutics', 'https://www.crunchbase.com/organization/frequency-therapeutics', 'Biotechnology, Genetics, Medical', 'Woburn, Massachusetts, United States', 'Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.', '9,056', '2020-07-17', '42300000', 'USD', '42300000', 'Post-IPO Equity', '180300000', 'USD', '180300000', '51-100', 'Public', '425000000', 'USD', '425000000', 'http://www.frequencytx.com/index.php', 'https://www.linkedin.com/company/frequency-therapeutics', 'frequencytx@macbiocom.com', 'Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the transitory activation of these progenitor cells, Frequency enables disease modification without the complexity of genetic engineering.  It was founded in 2015 and headquartered in Woburn, Massachusetts.', 'Alexandria Real Estate Equities, Perceptive Advisors, Alexandria Venture Investments, Morningside Group, U.S. Department of Defense', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$1M to $10M', '2015-01-01', 'year', '', 'IPO', '2019-10-02', 'Active', 'For Profit', '21', '', '', 'Chris Loose, Dan O’Neill, David L. Lucchino, Jeff Karp, Will McLean', '', '6'],\n  ['SpringWorks Therapeutics', 'https://www.crunchbase.com/organization/springworks-therapeutics', 'Biopharma, Biotechnology, Therapeutics', 'Stamford, Connecticut, United States', 'SpringWorks Therapeutics is a biopharmaceutical company focused on developing medicines for patients with severe rare diseases and cancer.', '9,160', '2019-04-01', '125000000', 'USD', '125000000', 'Series B', '228000000', 'USD', '228000000', '51-100', 'Public', '752000000', 'USD', '752000000', 'https://www.springworkstx.com/', 'https://www.linkedin.com/company/springworks-therapeutics/', 'info@springworkstx.com', \"SpringWorks Therapeutics is a biotechnology company that specializes in identifying, developing, and commercializing therapies for underserved patient populations suffering from severe rare diseases and cancer. The firm's pipeline product includes Mirdametinib, Nirogacestat, and others. The company was founded in 2017 and headquartered in Connecticut, United States.\", 'GlaxoSmithKline, Bain Capital, OrbiMed, Perceptive Advisors, Samsara BioCapital', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10M to $50M', '2017-01-01', 'year', '', 'IPO', '2019-09-12', 'Active', 'For Profit', '7', '', '', 'Lara S. Sullivan', '', '2'],\n  ['Kallyope', 'https://www.crunchbase.com/organization/kallyope', 'Biotechnology, Health Care, Medical, Pharmaceutical', 'New York, New York, United States', 'Kallyope is a healthcare company focusing on biotechnology business.', '9,440', '2020-03-05', '112000000', 'USD', '112000000', 'Series C', '243000000', 'USD', '243000000', '51-100', 'Private', '', '', '', 'http://www.kallyope.com/', 'https://www.linkedin.com/company/kallyope', 'info@kallyope.com', 'Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the gut informs our brains about our well-being, metabolism, and nutritional state. The gut-brain axis—the communication highway between our gut and our brain—offers an unprecedented opportunity to access and influence brain centers involved in fundamental human processes. An understanding of the biology mediated by the gut and gut-brain circuits will change the way we think about food, nutrition, and human physiology', 'Lux Capital, Polaris Partners, Bill Gates, Casdin Capital, Two Sigma Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2015-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '4', '', '', 'Charles Zuker, Richard Axel, Tom Maniatis', '', '4'],\n  ['Fulcrum Therapeutics', 'https://www.crunchbase.com/organization/fulcrum-therapeutics', 'Biotechnology, Genetics, Health Care, Therapeutics', 'Cambridge, Massachusetts, United States', 'Fulcrum Therapeutics is a biotechnology company developing new medicines to deliver a new future to patients.', '9,463', '2020-06-09', '68499987', 'USD', '68499987', 'Post-IPO Equity', '208499987', 'USD', '208499987', '51-100', 'Public', '372000000', 'USD', '372000000', 'http://www.fulcrumtx.com/', 'https://www.linkedin.com/company/fulcrum-therapeutics/', 'info@fulcrumtx.com', 'Fulcrum Therapeutics is a biotechnology company developing new medicines to deliver a new future to patients. The company develops a proprietary product engine that employs to identify and validate cellular drug targets that can modulate gene expression. Its product candidate, losmapimod, is a small molecule that was developed for the treatment of FSHD, a muscle-wasting disorder that leads to physical impairments and disability. It is focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases.', 'Sanofi, Fidelity Management and Research Company, GV, Casdin Capital, Foresite Capital', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1B to $10B', '2016-01-01', 'year', '', 'IPO', '2019-07-17', 'Active', 'For Profit', '11', '', '', 'Jeannie T. Lee', '', '4'],\n  ['G1 Therapeutics', 'https://www.crunchbase.com/organization/g1-therapeutics', 'Biotechnology, Developer Platform, Medical, Therapeutics', 'Durham, North Carolina, United States', 'G1 Therapeutics is a clinical-stage company developing small-molecule therapies to address significant unmet needs in oncology.', '9,462', '2020-06-01', '100000000', 'USD', '100000000', 'Post-IPO Debt', '388918007', 'USD', '388918007', '51-100', 'Public', '399900000', 'USD', '399900000', 'http://www.g1therapeutics.com', 'https://www.linkedin.com/company/g1-therapeutics-inc-', 'info@g1therapeutics.com', 'G1 Therapeutics is a clinical-stage company developing novel cancer therapies. It was founded in 2008 by Drs. Norman Sharpless and Kwok-Kin Wong to capitalize on discoveries made and patented by Dr. Sharpless’ lab at the University of North Carolina at Chapel Hill, and subsequently licensed to G1 Therapeutics.  Trilaciclib is an investigational therapy designed to improve outcomes for people with cancer who are treated with chemotherapy. G1 is also advancing rintodestrant, a potential best-in-class oral selective estrogen receptor degrader, or SERD, for the treatment of ER+ breast cancer.', 'RA Capital Management, Hercules Capital, Inc., Franklin Templeton Investments, Cowen Group, Boxer Capital', 'Biotechnology, Health Care, Science and Engineering, Software', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2008-01-01', 'year', '', 'IPO', '2017-05-16', 'Active', 'For Profit', '16', '', '', 'Kwok-Kin Wong, Norman Sharpless', '', '7'],\n  ['Surface Oncology', 'https://www.crunchbase.com/organization/surface-oncology', 'Biotechnology, Health Care, Life Science', 'Cambridge, Massachusetts, United States', 'Surface Oncology was created to advance next-generation approaches to cancer immunotherapy based on proprietary insights.', '9,479', '2020-05-20', '28900000', 'USD', '28900000', 'Post-IPO Equity', '63900000', 'USD', '63900000', '51-100', 'Public', '', '', '', 'http://www.surfaceoncology.com/', 'https://www.linkedin.com/company/surface-oncology-inc-', 'info@labcentral.org', 'Surface Oncology was created to advance next-generation approaches to cancer immunotherapy based on proprietary insights about novel immunotherapy targets and emerging areas of cancer immuno-biology. Together with world-leading scientific founders, the Company is advancing multiple preclinical programs that target novel mechanisms shown to play vital roles in tumor immune-evasion. Surface is based in Cambridge, Mass.', 'F-Prime Capital, New Enterprise Associates, EcoR1 Capital, Eight Roads Ventures, Atlas Venture', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', 'Less than $1M', '2014-01-01', 'year', '', 'IPO', '2018-04-19', 'Active', 'For Profit', '28', '', '', 'Michael Gladstone', '', '3'],\n  ['Zentalis Pharmaceuticals', 'https://www.crunchbase.com/organization/zentalis-pharmaceuticals', 'Biopharma, Biotechnology, Pharmaceutical', 'New York, New York, United States', 'Zentalis is a clinical-stage biopharmaceutical company focused on developing clinically differentiated, novel small molecule therapeutics.', '9,902', '2020-05-20', '20000000', 'USD', '20000000', 'Post-IPO Equity', '139000000', 'USD', '139000000', '51-100', 'Public', '621000000', 'USD', '621000000', 'https://www.zentalis.com/', 'https://www.linkedin.com/company/zentalis-pharmaceuticals/', 'info@zentalis.com', 'Zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing clinically differentiated, novel small molecule therapeutics that target fundamental biological pathways in cancer.', 'Viking Global Investors, OrbiMed, Redmile Group, Perceptive Advisors, Surveyor Capital', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10M to $50M', '2014-12-01', 'month', '', 'IPO', '2020-04-07', 'Active', 'For Profit', '5', '', '', 'Kevin Bunker', '', '3'],\n  ['TMRW Life Sciences, Inc.', 'https://www.crunchbase.com/organization/tmrw-life-sciences', 'Biotechnology, Health Care, Life Science', 'New York, New York, United States', 'TMRW Life Sciences is a developer of a cryo-storage platform intended to improve the success rates of assisted reproductive technology.', '9,981', '2019-12-17', '36500000', 'USD', '36500000', 'Series B', '48500000', 'USD', '48500000', '51-100', 'Private', '', '', '', 'https://www.tmrw.org/', 'https://www.linkedin.com/company/tmrw-life-sciences-inc/', 'info@tmrw.org', \"TMRW is a life sciences technology company setting new standards for transparency, safety and accountability in IVF and cell management. TMRW's platform, the world's first automated cryo-management for eggs and embryos, provides a complete digital chain of custody fully integrated with a state of the art robotic storage and monitoring solution.  This is in contrast to the manual and analog methods that have gone unchanged throughout the history of IVF. With TMRW's platform, clinics significantly reduce the chances of potentially devastating errors. The TMRW team includes celebrated innovators in fertility, embryology, cryo-management, automation, software development and robotics. TMRW Co-Founders Joshua Abram, Alan Murray and Dr. Jeffrey Port are serial technology and life sciences entrepreneurs. Their immediate prior ventures sold for a combined sum of more than $1 billion. To date, TMRW has raised $50 million. For more information, please visit TMRW.org.\", '5AM Ventures, Special Situations Life Sciences Innovation Fund', 'Biotechnology, Health Care, Science and Engineering', 'Agriculture; Forestry; Animal Husbandry; Hunting; Trapping; Fishing', '', '$10M to $50M', '2018-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '', '', '', 'Alan Murray, Jeffrey Port, Joshua Abram', '', '2'],\n  ['Veracyte', 'https://www.crunchbase.com/organization/veracyte', 'Biotechnology, Health Care, Health Diagnostics', 'South San Francisco, California, United States', 'Veracyte develops molecular diagnostic tests to improve patient outcomes and lower healthcare costs.', '10,098', '2021-02-05', '550000000', 'USD', '550000000', 'Post-IPO Equity', '666250000', 'USD', '666250000', '51-100', 'Public', '', '', '', 'http://www.veracyte.com', 'http://www.linkedin.com/company/veracyte-inc.', 'info@veracyte.com', 'Veracyte is a global genomic diagnostics company that improves patient care by providing answers to clinical questions, informing diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. The company’s growing menu of genomic tests leverage advances in genomic science and technology, enabling patients to avoid risky, costly diagnostic procedures and quicken time to appropriate treatment. The company’s tests in thyroid cancer, lung cancer, breast cancer, and idiopathic pulmonary fibrosis are available to patients, and its lymphoma subtyping test is in development. With Veracyte’s exclusive global license to a best-in-class diagnostics instrument platform, the company is positioned to deliver its tests to patients worldwide.', 'Versant Ventures, Kleiner Perkins, Domain Associates, GE Ventures, TPG Biotech', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10M to $50M', '2006-01-01', 'year', '', 'IPO', '2013-10-30', 'Active', 'For Profit', '73', '2', 'Made Acquisitions', 'Bonnie Anderson', '', '6'],\n  ['Arcturus Therapeutics', 'https://www.crunchbase.com/organization/arcturus-therapeutics', 'Biotechnology, Genetics, Health Care, Medical, Therapeutics', 'San Diego, California, United States', 'Arcturus Therapeutics focuses on developing novel RNA therapeutics for the treatment of various diseases aiming at Rare Diseases.', '10,179', '2013-10-21', '5000000', 'USD', '5000000', 'Series A', '6880001', 'USD', '6880001', '51-100', 'Public', '', '', '', 'http://arcturusrx.com', 'https://www.linkedin.com/company/arcturus-therapeutics', 'info@ArcturusRx.com', 'Arcturus Therapeutics focuses on developing novel RNA therapeutics for the treatment of various diseases aiming at Rare Diseases. The company owns Unlocked Nucleic Acid (UNA) chemistry technology and patent portfolio (32 patents, USPTO granted) enabling the targeting of any gene in the human genome. It was founded in 2013 and headquartered in San Diego, California.', '', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$1M to $10M', '2013-01-01', 'year', '', 'IPO', '2017-11-16', 'Active', 'For Profit', '37', '1', 'Made Acquisitions', 'Joseph Payne, Pad (Padmanabh) Chivukula', '', '3'],\n  ['Profusa', 'https://www.crunchbase.com/organization/profusa', 'Biotechnology, Health Care, Medical, Medical Device, Personal Health, Wellness', 'San Francisco, California, United States', 'PROFUSA is a medical devices company creating tissue-integrated sensors for chronic disease management and healthy living.', '10,191', '2018-08-14', '45000000', 'USD', '45000000', 'Series C', '80918821', 'USD', '80918821', '51-100', 'Private', '', '', '', 'https://profusa.com/', 'https://www.linkedin.com/company/profusa', 'info@profusacorp.com', 'Profusa, Inc. operates in the health care sector. It is dedicated to the development of a new generation of biointegrated sensors that empowers the individual with the ability to monitor their unique body chemistry in unprecedented ways to transform the management of personal health and disease.  The company was incorporated in 2009 and is based in Cupertino, California.', 'Qihoo 360 Technology, Asset Management Ventures (AMV), Maxim Integrated, Atinum Investment, VMS Asset Management', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2009-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '5', '', '', 'Bill McMillan, Kristen Helton, Natalie Wisniewski', '', '6'],\n  ['CytomX Therapeutics', 'https://www.crunchbase.com/organization/cytomx-therapeutics', 'Biotechnology, Health Care, Pharmaceutical, Therapeutics', 'South San Francisco, California, United States', 'CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies.', '10,466', '2021-01-21', '93600000', 'USD', '93600000', 'Post-IPO Equity', '228523000', 'USD', '228523000', '51-100', 'Public', '', '', '', 'http://www.cytomx.com', 'https://www.linkedin.com/company/cytomx-therapeutics/', '', 'CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies. Their mission, alone and with the help of partners, is to provide patients with more effective and less toxic therapies for severe illnesses such as cancer and inflammatory diseases.', 'Canaan Partners, Wellington Management, Venrock, Casdin Capital, Perceptive Advisors', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$10M to $50M', '2008-01-01', 'year', '', 'IPO', '2015-10-08', 'Active', 'For Profit', '51', '1', 'Made Acquisitions', 'Fred Gluck, Patrick Daugherty', '', '7'],\n  ['Arranta Bio', 'https://www.crunchbase.com/organization/arranta-bio', 'Biotechnology', 'Watertown, Massachusetts, United States', 'Arranta Bio is a superior Contract Development Manufacturing Organization.', '10,477', '2021-03-08', '', '', '', 'Series B', '82000000', 'USD', '82000000', '51-100', 'Private', '', '', '', 'http://arrantabio.com/', 'https://www.linkedin.com/company/arranta-bio', 'info@arrantabio.com', 'Arranta Bio was formed in May 2019 with the vision to be the best-in-class microbiome CDMO, developing and manufacturing live biotherapeutic products (LBPs) for pioneers targeting diseases linked to the microbiome, using bacterial fermentation, isolation, drying and encapsulation. In October 2019, we completed an $82,000,000 funding round with sole institutional investor, Ampersand Capital, company founders and colleagues, and a strategic investment from Thermo Fisher Scientific.', 'Ampersand Capital Partners', 'Biotechnology, Science and Engineering', '', '', '$10M to $50M', '2019-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '5', '1', 'Made Acquisitions', 'Mark Bamforth', '', '2'],\n  ['Akouos', 'https://www.crunchbase.com/organization/akouos', 'Biotechnology, Health Diagnostics, Pharmaceutical', 'Boston, Massachusetts, United States', 'Akouos is a biotechnology company focusing on restoring and preserving hearing.', '10,496', '2020-03-03', '105000000', 'USD', '105000000', 'Series B', '137550000', 'USD', '137550000', '51-100', 'Public', '550800000', 'USD', '550800000', 'https://www.akouos.com/', 'https://www.linkedin.com/company/akouos/', 'info@akouos.com', 'Akouos is a biotechnology company focusing on restoring and preserving hearing. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and preserve hearing in genetically-defined patient populations in a range of forms, from a single genetic mutation to ototoxic drug exposure and to the aging process, enabling the healthcare industry to treat sensorineural hearing loss in an efficient manner.', 'RA Capital Management, Fidelity Management and Research Company, New Enterprise Associates, Cormorant Asset Management, Surveyor Capital', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2017-01-01', 'year', '', 'IPO', '2020-06-25', 'Active', 'For Profit', '14', '', '', 'Manny Simons, Michael McKenna', '', '3'],\n  ['NantWorks', 'https://www.crunchbase.com/organization/nantworks', 'Biotechnology, Health Care, Semiconductor', 'Culver City, California, United States', 'NantWorks combines semiconductor technology, supercomputing and advanced networks to improve healthcare, commerce and digital entertainment.', '10,607', '2014-05-18', '15000000', 'USD', '15000000', 'Venture - Series Unknown', '140000000', 'USD', '140000000', '51-100', 'Private', '', '', '', 'http://www.nantworks.com/', 'https://www.linkedin.com/company/nantworks', 'info@nantworks.com', 'NantWorks is a convergence of next generation machine vision, object and voice recognition technologies, ultra-low power semiconductors, supercomputing, and advanced networks for the purpose of bringing the digital revolution to healthcare, commerce and digital entertainment to an entirely new level.', 'Blackstone Group', 'Biotechnology, Hardware, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$100M to $500M', '2010-01-01', 'year', '8', '', '', 'Active', 'For Profit', '126', '2', 'Made Acquisitions', 'Patrick Soon-Shiong', '', '2'],\n  ['GTx', 'https://www.crunchbase.com/organization/gtx', 'Biopharma, Biotechnology, Health Care', 'Memphis, Tennessee, United States', 'At GTx, They focus on the development of small molecules that selectively modulate the effects of certain hormones produced by the body.', '10,624', '2017-09-26', '48500000', 'USD', '48500000', 'Post-IPO Equity', '163181455', 'USD', '163181455', '51-100', 'Delisted', '', '', '', 'http://www.gtxinc.com', 'https://www.linkedin.com/company/gtx-inc-', 'investor.relations@gtxinc.com', 'GTx, Inc. is a company of pioneering and driven individuals who are delivering better medicines with new science through established pathways.', 'CAM Capital, Oracle, Boxer Capital, Abingworth, Biotechnology Value Fund', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', 'Less than $1M', '1997-01-01', 'year', '', 'M&A', '2004-02-03', 'Active', 'For Profit', '60', '', 'Was Acquired', 'Andrew Romans', '', '5'],\n  ['Advaxis', 'https://www.crunchbase.com/organization/advaxis-inc', 'Biotechnology, Health Diagnostics, Pharmaceutical', 'Princeton, New Jersey, United States', 'Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.', '10,704', '2021-04-12', '20000000', 'USD', '20000000', 'Post-IPO Equity', '148537423', 'USD', '148537423', '51-100', 'Public', '', '', '', 'http://www.advaxis.com', 'https://www.linkedin.com/company/advaxis-inc-', 'mayes@advaxis.com', 'Advaxis is a clinical-stage biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases. Advaxis immunotherapies are based on a novel platform technology using live, attenuated bacteria that are bio-engineered to secrete antigen/adjuvant fusion protein(s) designed to redirect the powerful immune response all human beings have to the bacterium to the cancer itself. ADXS-HPV is being evaluated in four clinical trials for HPV-associated diseases: recurrent/refractory cervical cancer (India), locally advanced cervical cancer (GOG/NCI US study), head and neck cancer (CRUK study), and anal cancer (BrUOG). Over fifteen (15) distinct constructs are in various stages of development, developed directly by the Company and through strategic collaborations with recognized centers of excellence.', 'T. Rowe Price, Cormorant Asset Management, Adage Capital Management, Knight Therapeutics, Jefferies', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', 'Less than $1M', '2002-01-01', 'year', '', 'IPO', '2005-07-29', 'Active', 'For Profit', '104', '', '', 'Yvonne Paterson', '', '11'],\n  ['Otonomy', 'https://www.crunchbase.com/organization/otonomy', 'Biopharma, Biotechnology, Health Care', 'San Diego, California, United States', 'Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.', '10,746', '2021-04-07', '34700000', 'USD', '34700000', 'Post-IPO Equity', '188137000', 'USD', '188137000', '51-100', 'Public', '', '', '', 'http://www.otonomy.com', '', 'fran@otonomy.com', \"Otonomy was founded in 2008 by Avalon Ventures and experts in the otology field in order to build the premier company dedicated to the treatment of otic disorders via localized drug delivery. This approach has already been widely adopted for the delivery of short-acting antibiotics to treat otitis media through a tympanostomy tube. In addition, otolaryngologists have demonstrated that the injection of steroids into the middle ear cavity can provide a therapeutic effect for patients with acute inner ear disorders such as Ménière’s disease and sudden sensorineural hearing loss. Expansion of this effort holds great promise for the treatment of chronic hearing loss, severe vertigo, and even tinnitus. The key to Otonomy's leading position in this nascent field is the development of a proprietary formulation platform that provides sustained drug exposure from a single administration. Broad application of this technology has already been established across a number of therapeutic classes and from these, three product candidates have been advanced into development.\", 'OrbiMed, Perceptive Advisors, Avalon Ventures, Domain Associates, Ally Bridge Group', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', 'Less than $1M', '2008-01-01', 'year', '', 'IPO', '2014-08-14', 'Active', 'For Profit', '30', '', '', 'Jay Lichter, Jeffrey Harris', '', '6'],\n  ['Sigilon Therapeutics', 'https://www.crunchbase.com/organization/sigilon', 'Biotechnology', 'Cambridge, Massachusetts, United States', 'Sigilon is a biotech company which specializes in creating immune privileged products for unmet clinical needs.', '10,753', '2020-12-03', '144900000', 'USD', '144900000', 'Post-IPO Equity', '263200000', 'USD', '263200000', '51-100', 'Public', '543420000', 'USD', '543420000', 'http://sigilon.com/', 'https://www.linkedin.com/company-beta/10789207/', 'info@sigilon.com', 'Sigilon Therapeutics is to create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases.', 'BlackRock, Flagship Pioneering, Canada Pension Plan Investment Board, Eli Lilly, Longevity Vision Fund', 'Biotechnology, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2015-01-01', 'day', '', 'IPO', '2020-12-03', 'Active', 'For Profit', '2', '', '', 'Omid Veiseh', '', '4'],\n  ['Conagen', 'https://www.crunchbase.com/organization/conagen', 'Biotechnology, Chemical Engineering, Life Science, Manufacturing', 'Bedford, Massachusetts, United States', 'Conagen, a biotechnology company that focuses on bio-production of ingredients for food, pharmaceutical, and renewable materials industries.', '10,778', '2020-04-01', '30000000', 'USD', '30000000', 'Corporate Round', '30000000', 'USD', '30000000', '51-100', 'Private', '', '', '', 'http://conagen-inc.com/', 'https://www.linkedin.com/company/conagen-inc./', 'info@conagen-inc.com', 'Conagen is a biotechnology company that focuses on bio-production of ingredients for food, pharmaceutical, and renewable materials industries.  Conagen is a discovery-based company. It is passionate about understanding and engineering metabolic pathways. Its scientists are equipped with unprecedented systemic information on cellular metabolism. Its engineers have developed new automation systems and novel fermentation technologies to advance its bio-manufacturing capabilities. The company was founded in 2010 and is headquartered in Bedford, Massachusetts.', 'Sumitomo Chemical', 'Biotechnology, Manufacturing, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$1M to $10M', '2010-01-01', 'year', '', '', '', 'Active', 'For Profit', '8', '', '', 'Oliver Yu', '', '1'],\n  ['Global Blood Therapeutics', 'https://www.crunchbase.com/organization/global-blood-therapeutics', 'Biotechnology, Genetics, Medical, Therapeutics', 'San Francisco, California, United States', 'GBT is a clinical-stage biopharmaceutical company developing its lead product candidate, voxelotor, as a therapy for sickle cell disease.', '10,784', '2015-01-06', '48000000', 'USD', '48000000', 'Series B', '88700000', 'USD', '88700000', '51-100', 'Public', '540000000', 'USD', '540000000', 'http://www.gbt.com/', 'https://www.linkedin.com/company/global-blood-therapeutics', 'info@gbt.com', 'GBT is a clinical-stage biopharmaceutical company that focuses on discovering, developing, and delivering innovative treatments that provide hope to underserved patient communities. GBT is developing its product candidate, voxelotor, as an oral, once-daily therapy for sickle cell disease. It was founded in 2012 and headquartered in San Francisco, California.', 'RA Capital Management, Wellington Management, Deerfield, Third Rock Ventures, Sabby Capital', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$1M to $10M', '2012-01-01', 'year', '', 'IPO', '2015-08-21', 'Active', 'For Profit', '47', '', '', 'Andrej Sali, Charles Homcy, Craig Muir, David Phillips, Jack Taunton, Matthew Jacobson', '', '2'],\n  ['North Carolina Biotechnology Center', 'https://www.crunchbase.com/organization/north-carolina-biotechnology-center', 'Biotechnology, Life Science, Non Profit', 'Alexander, North Carolina, United States', 'North Carolina Biotechnology Center is a private company that works with university researchers in the field of biotechnology.', '10,785', '2019-01-29', '1400000', 'USD', '1400000', 'Grant', '7433000', 'USD', '7433000', '51-100', 'Private', '', '', '', 'http://www.ncbiotech.org/', 'https://www.linkedin.com/company/north-carolina-biotechnology-center', 'info@ncbiotech.org', 'The North Carolina Biotechnology Center is a private, non-profit corporation funded by the N.C. General Assembly to strengthen biotechnology research, business and education statewide. The Center is not a site for laboratory research; it works to support job creation in the biotechnology industry.', 'Pfizer', 'Biotechnology, Other, Science and Engineering', '', '', '$10M to $50M', '1984-01-01', 'year', '41', '', '', 'Active', 'For Profit', '57', '', '', 'James Hunt', '', '4'],\n  ['Ocular Therapeutix', 'https://www.crunchbase.com/organization/ocular-therapeutix', 'Biotechnology, Health Care, Medical Device', 'Bedford, Massachusetts, United States', 'Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.', '10,835', '2019-03-01', '37500000', 'USD', '37500000', 'Post-IPO Debt', '138395836', 'USD', '138395836', '51-100', 'Public', '', '', '', 'http://www.ocutx.com', 'https://www.linkedin.com/company/ocular-therapeutix-inc/', 'info@ocutx.com', 'Ocular Therapeutix, Inc. engages in the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. Its products include ReSure Adherent Ocular Bandage, a synthetic ocular bandage for ophthalmic surgery; ReSure Sealant, a synthetic and biocompatible hydrogel that creates a temporary, soft, and lubricious surface barrier to protect clear corneal incisions in the immediate post-operative period; and prostaglandin analog punctum plugs that are hydrogel-based punctum plug depots to deliver prostaglandin analogs to treat glaucoma.', 'Baxter International, SV Health Investors, Polaris Partners, Versant Ventures, Sparta Group', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2006-01-01', 'year', '', 'IPO', '2014-07-28', 'Active', 'For Profit', '95', '', '', 'Amarpreet Sawhney, Fred Khosravi', '', '8'],\n  ['PierianDx', 'https://www.crunchbase.com/organization/pieriandx', 'Biotechnology, Health Care, Health Diagnostics, Medical', 'St Louis, Missouri, United States', 'PierianDx is catalyzing global adoption of genomic sequencing in healthcare', '10,885', '2019-10-28', '27000000', 'USD', '27000000', 'Series B', '43950000', 'USD', '43950000', '51-100', 'Private', '', '', '', 'https://www.pieriandx.com', 'https://www.linkedin.com/company/pieriandx', 'info@pieriandx.com', 'PierianDx is catalyzing global adoption of genomic sequencing in healthcare by empowering physicians in the laboratory and clinic to more effectively diagnose and treat patients with cancer and other complex diseases. PierianDx’s industry-leading genomic SaaS solutions, CAP and CLIA accredited laboratory, and shared knowledgebase are used by health systems, cancer centers and commercial laboratories worldwide driving the most integrated approach across the clinical care spectrum. From genomic sequencing and biomedical informatics in the laboratory to reporting and decision support at the patient’s bedside, PierianDx has rapidly become the trusted source of ‘wisdom’ in every advanced genomic report.', 'Health Catalyst, SJF Ventures, Album VC, Inova Translational Medicine Institute, Health Catalyst Capital', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10M to $50M', '2014-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '15', '1', 'Made Acquisitions', 'Rakesh Nagarajan', '', '5'],\n  ['Kalderos', 'https://www.crunchbase.com/organization/kalderos', 'Health Care, Pharmaceutical, SaaS', 'Chicago, Illinois, United States', 'Kalderos provides a SaaS based drug discount management solution, which identifies, checks, and resolves non-compliance.', '11,016', '2020-06-15', '28000000', 'USD', '28000000', 'Series B', '35000000', 'USD', '35000000', '51-100', 'Private', '', '', '', 'https://kalderos.com/', 'https://www.linkedin.com/company/kalderos/', 'support@kalderos.com', 'Kalderos is the creator of a drug discount management solution. It provides a SaaS-based drug discount management solution, which identifies, checks, and resolves non-compliance.  Using models and machine learning processes, Kalderos detects inconsistencies overlooked by current methods, providing material benefits by eliminating waste. It was founded in 2016 and is headquartered in Chicago, Illinois.', 'Bain Capital Ventures, Mercato Partners', 'Health Care, Software', 'Computing; Calculating', '', '$1M to $10M', '2016-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '6', '', '', 'David DeVogel, Jeremy Docken, Jim Bonkowski', '', '2'],\n  ['Concert Pharmaceuticals', 'https://www.crunchbase.com/organization/concert-pharmaceuticals', 'Biotechnology, Health Care, Medical', 'Lexington, Massachusetts, United States', 'Concert Pharmaceuticals is a biotechnology company utilizing deuterium to develop novel medical candidates.', '11,051', '2020-01-30', '74700000', 'USD', '74700000', 'Post-IPO Equity', '204688000', 'USD', '204688000', '51-100', 'Public', '', '', '', 'http://www.concertpharma.com', 'http://www.linkedin.com/company/concert-pharmaceuticals', 'info@concertpharma.com', 'Founded in April 2006, Concert Pharmaceuticals is a clinical stage biotechnology company dedicated to creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. Concert applies its innovative precision deuterium chemistry platform to modify specific properties of validated drug molecules, yielding a rich pipeline of new chemical entities (NCEs). Concert leverages decades of pharmaceutical experience to create novel drug candidates with potential for best-in-class efficacy and safety, while greatly reducing R&D risk, time and expense.', 'GlaxoSmithKline, Hercules Capital, Inc., Flagship Pioneering, Greylock, Adage Capital Management', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '2006-01-01', 'year', '', 'IPO', '2014-02-13', 'Active', 'For Profit', '91', '', '', 'Richard Aldrich, Roger Tung', '', '7'],\n  ['Magenta Therapeutics', 'https://www.crunchbase.com/organization/magenta-therapeutics', 'Biotechnology, Medical, Therapeutics', 'Cambridge, Massachusetts, United States', 'Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology.', '11,214', '2018-04-09', '52000000', 'USD', '52000000', 'Series C', '150500000', 'USD', '150500000', '51-100', 'Public', '515000000', 'USD', '515000000', 'https://www.magentatx.com', 'https://www.linkedin.com/company/17874487', 'investor@magentatx.com', 'Magenta is focused on improving the patient experience in transplant medicine, with the goal of bringing this lifesaving procedure to more patients. Over the past 50 years, stem cell transplantation has been used in more than 1M patients worldwide. It is currently the only treatment with the potential to cure some of the most devastating hematologic cancers and autoimmune diseases. Despite the increased use and clinical advancements over the past several decades, stem cell transplant remains a high-risk last-resort therapeutic option due to the toxicity and potential long-term side effects.', 'GV, Casdin Capital, EcoR1 Capital, Atlas Venture, Third Rock Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2015-01-01', 'year', '', 'IPO', '2018-06-20', 'Active', 'For Profit', '30', '', '', 'David Scadden, Jason Gardner', '', '3'],\n  ['LifeMine Therapeutics', 'https://www.crunchbase.com/organization/lifemine-therapeutics', 'Biotechnology, Life Science, Therapeutics', 'Cambridge, Massachusetts, United States', 'Discovering powerful new drugs from eukaryotic microbes by combining Genomics with AI and Synthetic Biology.', '11,538', '2021-01-07', '50000000', 'USD', '50000000', 'Series B', '120000000', 'USD', '120000000', '51-100', 'Private', '', '', '', 'http://www.lifeminetx.com/', 'https://www.linkedin.com/company/10940444/', '', 'Discovering powerful new drugs from eukaryotic microbes by combining Genomics with AI and Synthetic Biology. Founded by Gregory Verdine, PhD, Rick Klausner, MD and WeiQing Zhou, MBA, LifeMine Therapeutics is headquartered in Cambridge, Massachusetts.', 'Merck, GV, MRL Ventures Fund, ARCH Venture Partners, Foresite Capital', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', 'Less than $1M', '2017-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '', '', '', 'Greg Verdine, Rick Klausner, WeiQing Zhou', '', '2'],\n  ['Everest Medicines', 'https://www.crunchbase.com/organization/everest-medicines', 'Biotechnology, Health Care, Pharmaceutical', 'New York, New York, United States', 'Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.', '11,544', '2020-06-03', '310000000', 'USD', '310000000', 'Series C', '310000000', 'USD', '310000000', '51-100', 'Public', '', '', '', 'http://www.everestmedicines.com/', 'https://in.linkedin.com/company/everest-medicines', '', 'Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients in the Emerging Market including Asia Pacific territories. We strive to be the partner of choice for innovative companies around the world with products that address critical unmet medical needs for patients in the Emerging Market and have a high probability of market approval.      The Everest Medicines team has deep expertise and extensive track record of high quality clinical development, regulatory affairs, CMC, business development and operations both in Asia Pacific territories and with leading global pharmaceutical companies.', 'RA Capital Management, Hillhouse Capital Group, Rock Springs Capital, Janus Henderson Investors, HBM Healthcare Investments AG', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '2017-01-01', 'year', '', 'IPO', '2020-10-09', 'Active', 'For Profit', '15', '', '', '', '', '1'],\n  ['AnaptysBio', 'https://www.crunchbase.com/organization/anaptysbio', 'Biotechnology, Health Care, Therapeutics', 'San Diego, California, United States', 'AnaptysBio is a biotechnology company that develops antibody therapeutics based on somatic hypermutation.', '11,554', '2015-07-15', '40000000', 'USD', '40000000', 'Series D', '85946511', 'USD', '85946511', '51-100', 'Public', '287000000', 'USD', '287000000', 'http://www.anaptysbio.com', 'https://www.linkedin.com/company/anaptysbio', 'corpdev@anaptysbio.com', \"AnaptysBio is a privately-held therapeutic antibody product company that uses of somatic hypermutation, or SHM, for antibody discovery and optimization. SHM is the body's natural process for generating potent antibodies to fight disease. The Company's SHM-Platform utilizes the key components of SHM and other techniques to generate antibodies for therapeutic applications through an iterative process of natural evolution and high-throughput selection a process that has been referred to as naturalizing antibodies.  This versatile platform can be used both to discover and optimize antibodies directed at specific disease targets and also affinity mature existing antibodies to improve their binding properties. In addition to providing a more powerful approach to antibody discovery and protein optimization, it addresses a growing void in the therapeutic antibody field due to a string of acquisitions and licensing deals that have reduced the availability of many technologies.\", 'Novo Holdings, Cormorant Asset Management, Avalon Ventures, Frazier Healthcare Partners, HBM Healthcare Investments AG', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$1M to $10M', '2005-01-01', 'year', '', 'IPO', '2017-01-26', 'Active', 'For Profit', '62', '', '', 'Andrew B. Cubitt', '', '5'],\n  ['IVERIC bio', 'https://www.crunchbase.com/organization/ophthotech', 'Biotechnology, Health Care, Pharmaceutical', 'Princeton, New Jersey, United States', 'IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.', '11,727', '2014-01-24', '41700000', 'USD', '41700000', 'Post-IPO Equity', '282700000', 'USD', '282700000', '51-100', 'Public', '', '', '', 'https://ivericbio.com/', 'https://www.linkedin.com/company/ivericbio/', '', 'Ophthotech Corporation, a biopharmaceutical company, develops various therapeutics to treat diseases of the eye. It is developing Fovista, which has completed Phase IIb clinical trials for use in combination with anti-VEGF drugs for the treatment of wet age-related macular degeneration (wet AMD); and ARC1905, a potent and selective inhibitor of complement factor C5 that has completed Phase I/IIa clinical trials to treat wet AMD. The company was founded in 2007 and is headquartered in New York, New York.', 'SV Health Investors, Novo Holdings, HBM Healthcare Investments AG, Sofinnova Investments, Clarus Ventures', 'Biotechnology, Health Care, Science and Engineering', '', '', '$100M to $500M', '2007-01-01', 'year', '', 'IPO', '2013-09-27', 'Active', 'For Profit', '71', '', '', 'Samir Patel', '', '6'],\n  ['Aptinyx', 'https://www.crunchbase.com/organization/aptinyx', 'Biopharma, Biotechnology, Health Care, Medical', 'Evanston, Illinois, United States', 'Aptinyx Inc. is a biopharmaceutical company.', '11,814', '2020-01-14', '35000000', 'USD', '35000000', 'Post-IPO Secondary', '170000000', 'USD', '170000000', '51-100', 'Public', '520000000', 'USD', '520000000', 'http://www.aptinyx.com/', 'https://www.linkedin.com/company/aptinyx-inc-', 'corporate@aptinyx.com', 'Aptinyx Inc. is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system. Aptinyx has a proven platform for discovering proprietary compounds that work through a novel mechanism: modulation of the NMDA receptor to enhance pathways involved with nerve cell communication. This mechanism has applicability across a number of CNS disorders. Our goal is to rapidly advance our most promising drug candidates into clinical development for indications with high unmet medical need.', 'Northwestern University, Adams Street Partners, Rock Springs Capital, Adage Capital Management, Bain Capital Life Sciences', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', 'Less than $1M', '2015-01-01', 'year', '', 'IPO', '2018-06-20', 'Active', 'For Profit', '23', '', '', 'Joseph Moskal', '', '3'],\n  ['SAB Biotherapeutics', 'https://www.crunchbase.com/organization/sab-biotherapeutics', 'Biotechnology, Clinical Trials, Therapeutics', 'Sioux Falls, South Dakota, United States', 'SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.', '12,036', '2020-07-17', '14000000', 'USD', '14000000', 'Series B', '40420000', 'USD', '40420000', '51-100', 'Private', '', '', '', 'http://www.sabbiotherapeutics.com/', '', 'info@sabbiotherapeutics.com', 'A biopharmaceutical development company leading the science and manufacturing of antibody therapeutics. Utilizing some of the most advanced antibody science in the world, SAB is delivering the world’s first large-scale platform to create immunoglobulins. This natural production platform holds the potential for treatment of public health problems, rare conditions, long-term diseases and global pandemic threats.', 'National Institutes of Health, Merck, South Dakota Equity Partners, Sioux Falls Development Foundation', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '2014-06-01', 'month', '', 'Early Stage Venture', '', 'Active', 'For Profit', '10', '', '', 'Eddie Sullivan, Edward Hamilton', '', '4'],\n  ['Amicus Therapeutics', 'https://www.crunchbase.com/organization/amicus-therapeutics', 'Biotechnology, Health Care, Pharmaceutical, Therapeutics', 'Cranbury, New Jersey, United States', 'Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.', '12,039', '2013-12-31', '10000000', 'USD', '10000000', 'Post-IPO Debt', '162866943', 'USD', '162866943', '51-100', 'Public', '330000000', 'USD', '330000000', 'http://www.amicusrx.com', 'http://www.linkedin.com/company/amicus-therapeutics', 'info@amicusrx.com', 'Amicus Therapeutics (Nasdaq:FOLD) is a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases. The Company has a robust pipeline of novel, first-in-class, small molecules called pharmacological chaperones for the treatment of lysosomal storage diseases (LSDs). These chaperones may offer a dual-treatment approach for Fabry, Pompe, Gaucher and other LSDs. As orally administered monotherapy agents, pharmacological chaperones are designed to bind to, stabilize and increase the activity of a patient’s own misfolded enzyme. In combination with enzyme replacement therapy (ERT), pharmacological chaperones may improve the uptake of the infused enzyme and potentially improve ERT outcomes.', 'Canaan Partners, GlaxoSmithKline, New Enterprise Associates, Silicon Valley Bank, Frazier Healthcare Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$50M to $100M', '2002-01-01', 'year', '', 'IPO', '2007-05-31', 'Active', 'For Profit', '175', '3', 'Made Acquisitions', 'John Crowley', '', '7'],\n  ['Reata Pharmaceuticals', 'https://www.crunchbase.com/organization/reata-pharmaceuticals', 'Biopharma, Biotechnology, Pharmaceutical', 'Irving, Texas, United States', 'Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.', '12,064', '2020-06-11', '350000000', 'USD', '350000000', 'Post-IPO Equity', '1330999840', 'USD', '1330999840', '51-100', 'Public', '', '', '', 'http://www.reatapharma.com', 'https://www.linkedin.com/company/reatapharma/', 'info@reatapharma.com', 'Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases. It offers antioxidant inflammation-modulating drugs, as well as drugs that correct protein misfolding. The company also develops drugs for the treatment of renal/cardiovascular and autoimmune diseases. The company was formerly known as Reata Discovery, Inc. and changed its name to Reata Pharmaceuticals, Inc. in May 2005. The company was founded in 2002 and is based in Irving, Texas.', 'Novo Holdings, Silicon Valley Bank, Oxford Finance LLC, The University of Texas at Austin, Blackstone Life Sciences', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2002-01-01', 'year', '', 'IPO', '2016-05-26', 'Active', 'For Profit', '43', '', '', 'Warren Huff', '', '10'],\n  ['Valeritas', 'https://www.crunchbase.com/organization/valeritas', 'Biotechnology, Diabetes, Health Care, Medical Device', 'Bridgewater, New Jersey, United States', 'Valeritas is the developer of V-GO, a disposable insulin pump, and a micro needle patch for the treatment of Type 2 diabetes.', '12,067', '2014-07-11', '45000000', 'USD', '45000000', 'Series D', '355000000', 'USD', '355000000', '51-100', 'Public', '68890000', 'USD', '68890000', 'http://www.valeritas.com', 'https://www.linkedin.com/company/valeritas', 'gen-info@Valeritas.com', \"Valeritas is a medical technology company committed to developing and commercializing innovative drug delivery solutions that contribute to clinical and humanistic outcomes for patients, with an initial focus on the treatment of diabetes.  Valeritas' medical technologies portfolio is headlined by the h-Patch technology. The first use of the h-Patch technology will be the V-Go disposable insulin delivery device for continuous delivery both at a preset basal rate and for on-demand bolus dosing at mealtimes. The V-Go is a simple-to-use, once-daily, disposable insulin delivery device that provides a preset basal rate and on-demand bolus dosing for mealtime coverage via a mealtime insulin. The V-Go will enable the millions suffering from Type 2 diabetes to conveniently and discreetly deliver insulin throughout the day bolus dose on-demand around mealtimes. The h-Patch technology is also being developed to serve as a launching platform for applications across a wide spectrum of medical needs.\", 'MPM Capital, U.S. Venture Partners, Pitango Venture Capital, HLM Venture Partners, Abingworth', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2006-01-01', 'year', '', 'M&A', '2017-03-23', 'Active', 'For Profit', '47', '', 'Was Acquired', 'Robert R. Gonnelli', '', '5'],\n  ['OncoSec', 'https://www.crunchbase.com/organization/oncosec-medical', 'Biotechnology, Health Care, Life Science', 'San Diego, California, United States', 'OncoSec is a biotechnology company pioneering new technologies to stimulate the body’s immune system to target and attack cancer.', '12,239', '2021-01-21', '42000000', 'USD', '42000000', 'Post-IPO Equity', '135763000', 'USD', '135763000', '51-100', 'Public', '', '', '', 'http://oncosec.com', 'http://www.linkedin.com/company/oncosec-medical-inc', 'investors@oncosec.com', \"OncoSec Medical is an advanced-stage biomedical company focused on the development of novel therapeutic oncology products. Its mission, above all, is to improve the quality and performance of treatments for patients suffering from solid tumor cancers. This is driven by its unwavering commitment to improving the quality of lives of cancer patients through the use of innovative research and the advancement of new “ElectroOncolog” therapies based on its proprietary OncoSe Medical System (OMS). OncSec's core technology is an untapped delivery system, which applies short electric impulses to a tumor causing transient pores to open in the cellular membrane allowing therapeutic agents to more readily enter cancer cells. This process is known as OMS Electroporation. Using OMS Electroporation in tandem with chemotherapeutic or biologic agents can selectively and effectively treat cancerous tumors and cells embedded amongst predominantly healthy tissue. Its treatment approach also reduces and even eliminates much of the detrimental outcomes associated with other “standard of care” therapies readily available in the clinic today.\", 'National Institutes of Health, Alpha Holdings', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2011-01-01', 'year', '', 'IPO', '2010-04-07', 'Active', 'For Profit', '29', '', '', 'Punit Dhillon', '', '9'],\n  ['Infinity Pharmaceuticals', 'https://www.crunchbase.com/organization/infinity-pharmaceuticals', 'Biopharma, Biotechnology, Pharmaceutical', 'Cambridge, Massachusetts, United States', 'Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.', '12,250', '2021-02-12', '92000000', 'USD', '92000000', 'Post-IPO Equity', '438040191', 'USD', '438040191', '51-100', 'Public', '', '', '', 'http://www.infi.com', 'http://www.linkedin.com/company/ipi', 'info@infi.com', 'Infinity is a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer, in multiple clinical studies. MARIO-275 is a global, randomized, placebo-controlled study of eganelisib combined with Opdivo® in I/O naïve urothelial cancer. MARIO-3 is the first eganelisib combination study in front-line advanced cancer patients and is evaluating eganelisib in combination with Tecentriq® and Abraxane® in front-line TNBC and in combination with Tecentriq and Avastin® in front-line RCC. In collaboration with Arcus Biosciences, Infinity is evaluating a checkpoint inhibitor-free, novel combination regimen of eganelisib plus etrumadenant (dual adenosine receptor antagonist) plus Doxil® in advanced TNBC patients. With these studies Infinity is evaluating eganelisib in the anti-PD-1 refractory, I/O-naïve, and front-line and second line settings.', 'Wellcome Trust, Alexandria Real Estate Equities, Venrock, New Enterprise Associates, Purdue Pharma', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2001-01-01', 'year', '', 'IPO', '2009-08-04', 'Active', 'For Profit', '130', '', '', 'Eric Lander, Frank Moss, Michael Foely', '', '9'],\n  ['Skyhawk Therapeutics', 'https://www.crunchbase.com/organization/skyhawk-therapeutics', 'Biotechnology, Construction, Landscaping, Transportation', 'Waltham, Massachusetts, United States', 'Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.', '12,304', '2019-01-01', '', '', '', 'Series A', '48203000', 'USD', '48203000', '51-100', 'Private', '', '', '', 'https://www.skyhawktx.com/', 'https://www.linkedin.com/company/skyhawk-therapeutics/', 'info@skyhawktx.com', \"Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.The company's therapeutics use proprietary technology that helps the rational design of small molecules that target specific binding pocket regions on RNA, using both sequence and structural specificity, at particular moments in the RNA splicing process, enabling physicians to target diseases driven by a type of RNA mis-splicing called exon skipping.\", 'Good Growth Capital, Alexandria Venture Investments, Agent Capital, GreatPoint Ventures, Celgene', 'Biotechnology, Real Estate, Science and Engineering, Transportation', 'Organic Chemistry', '', 'Less than $1M', '2016-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '11', '', '', 'Bill Haney, Kathleen McCarthy', '', '7'],\n  ['Forty Seven', 'https://www.crunchbase.com/organization/forty-seven', 'Biotechnology, Clinical Trials, Health Care', 'Palo Alto, California, United States', 'Forty Seven is a clinical-stage immuno-oncology company that is developing therapies targeting cancer immune evasion pathways.', '12,310', '2019-08-07', '6000000', 'USD', '6000000', 'Post-IPO Equity', '156000000', 'USD', '156000000', '51-100', 'Public', '479000000', 'USD', '479000000', 'http://www.fortyseveninc.com', 'https://www.linkedin.com/company/forty-seven-inc-/', 'info@fortyseveninc.com', 'Forty Seven, Inc. is a clinical-stage immuno-oncology company that is developing therapies targeting cancer immune evasion pathways based on technology licensed from Stanford University. Forty Seven\\'s lead program, 5F9, is a monoclonal antibody against the CD47 receptor, a \"don\\'t eat me\" signal that cancer cells commandeer to avoid being ingested by macrophages. This antibody is currently being evaluated in six clinical studies in patients with solid tumors, acute myeloid leukemia, non-Hodgkin\\'s lymphoma and colorectal carcinoma.', 'Wellington Management, GV, Lightspeed Venture Partners, Sutter Hill Ventures, Leukemia & Lymphoma Society', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$10M to $50M', '2015-01-01', 'year', '', 'M&A', '2018-06-27', 'Active', 'For Profit', '18', '', 'Was Acquired', 'Irving L. Weissman, Jens-Peter Volkmer, Mark Chao, Ravi Majeti', '', '3'],\n  ['Morphic Therapeutic', 'https://www.crunchbase.com/organization/morphic-rock-therapeutic', 'Biotechnology, Health Care, Medical, Therapeutics', 'Waltham, Massachusetts, United States', 'Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies.', '12,337', '2018-09-25', '80000000', 'USD', '80000000', 'Series B', '134500000', 'USD', '134500000', '51-100', 'Public', '428945745', 'USD', '428945745', 'http://morphictx.com/', 'https://www.linkedin.com/company/morphic-therapeutic/', 'info@morphictx.com', 'Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies. Drawing on discoveries made in the lab of Scientific Founder Tim Springer, Morphic was created in 2015 with co-founders Polaris Partners, T.A. Springer and   Schrödinger, Inc., along with ShangPharma Investment Group.', 'Polaris Partners, Novo Holdings, Schrödinger, Invus, Omega Funds', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$1M to $10M', '2015-01-01', 'year', '', 'IPO', '2019-06-27', 'Active', 'For Profit', '8', '', '', 'Timothy A. Springer', '', '3'],\n  ['Harpoon Therapeutics', 'https://www.crunchbase.com/organization/harpoon-therapeutics', 'Biotechnology, Health Care, Therapeutics', 'South San Francisco, California, United States', 'Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.', '12,420', '2018-11-12', '70000000', 'USD', '70000000', 'Series C', '130000000', 'USD', '130000000', '51-100', 'Public', '334726000', 'USD', '334726000', 'http://www.harpoontx.com/', 'https://www.linkedin.com/company/harpoon-therapeutics/', 'bd@harpoontx.com', \"Harpoon Therapeutics is a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. T cell engagers are engineered proteins that direct a patient’s own T cells to kill target cells that express specific proteins, or antigens, carried by the target cells. Using its proprietary Tri-specific T cell Activating Construct\\uf0d4 (TriTAC), platform, Harpoon is developing a pipeline of novel T cell engagers, or TriTACs, initially focused on the treatment of solid tumors and hematologic malignancies.  Harpoon's first drug candidate, HPN424, is currently in Phase 1 clinical trial as a treatment for prostate cancer.\", 'OrbiMed, MPM Capital, Arix Bioscience, Lilly Asia Ventures, New Leaf Venture Partners', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$1M to $10M', '2015-01-01', 'year', '', 'IPO', '2019-02-07', 'Active', 'For Profit', '10', '', '', 'Luke Evnin, Patrick Baeuerle', '', '3'],\n  ['Aerin Medical', 'https://www.crunchbase.com/organization/aerin-medical', 'Biotechnology, Health Care, Medical Device', 'Sunnyvale, California, United States', 'Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing.', '12,591', '2020-08-17', '48000000', 'USD', '48000000', 'Venture - Series Unknown', '130474998', 'USD', '130474998', '51-100', 'Private', '', '', '', 'http://www.aerinmedical.com/', 'https://www.linkedin.com/company/aerin-medical', 'info@aerinmedical.com', 'Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing. Its device utilizes low-power radiofrequency energy to remodel nasal soft tissues and address the underlying cause of nasal congestion, enabling patients suffering from nasal breathing disorders to open their nasal airway quickly, safely, and effectively.', 'OrbiMed, Horizon Technology Finance, LaunchCapital, Questa Capital Management, KCK', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2011-01-01', 'year', '', '', '', 'Active', 'For Profit', '7', '', '', 'Scott J. Wolf', '', '7'],\n  ['On Target Laboratories', 'https://www.crunchbase.com/organization/on-target-laboratories', 'Biotechnology, Life Science, Medical', 'Northbrook, Illinois, United States', 'On Target Laboratories engages in discovering, developing, and commercializing small molecules that target specific pathological', '12,674', '2021-03-24', '21000000', 'USD', '21000000', 'Series B', '81700000', 'USD', '81700000', '51-100', 'Private', '', '', '', 'http://www.ontargetlaboratories.com/', 'https://www.linkedin.com/company/on-target-laboratories-llc', '', 'On Target Laboratories, LLC engages in discovering, developing, and commercializing small molecules that target specific pathological cells, when conjugated with fluorescent dyes. It offers folate and other targeting agents that target, lung, uterine, kidney, breast, colon, pancreatic, and prostate cancer cells. The company was incorporated in 2010 and is based in Northbrook, Illinois.', 'H.I.G. Capital, Elevate Ventures, Johnson & Johnson Innovation, 3B Future Health Fund, Johnson & Johnson Innovation – JJDC', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '2010-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '4', '', '', 'Philip Low', '', '5'],\n  ['Eureka Therapeutics', 'https://www.crunchbase.com/organization/eureka-therapeutics', 'Biotechnology, Life Science, Medical, Medical Device, Therapeutics', 'Emeryville, California, United States', 'Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.', '12,782', '2020-03-17', '45000000', 'USD', '45000000', 'Series E', '128901450', 'USD', '128901450', '51-100', 'Private', '', '', '', 'http://eurekainc.com', 'http://www.linkedin.com/company/eureka-therapeutics-inc', 'admin@eurekainc.com', \"Eureka Therapeutics is a biotechnology company that focuses on immunotherapies for the treatment of cancer. The company's platform is a novel T-cell therapy construct that mimics the natural biology of T-cells to fight cancer. It utilizes a paradigm-changing technology platform to develop fully-human antibodies against intracellular cancer antigens. Eureka Therapeutics was founded in 2006 and is headquartered in Emeryville, California.\", 'Lyell Immunopharma, GP Capital, Majuven, Acorn Pacific Ventures, Harbinger Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$10M to $50M', '2006-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '13', '', '', 'Cheng Liu', '', '6'],\n  ['Peloton Therapeutics', 'https://www.crunchbase.com/organization/peloton-therapeutics', 'Biotechnology, Health Care, Medical Device, Pharmaceutical, Therapeutics', 'Dallas, Texas, United States', 'Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.', '12,824', '2019-02-20', '150000000', 'USD', '150000000', 'Series E', '242600000', 'USD', '242600000', '51-100', 'Private', '', '', '', 'http://www.pelotontherapeutics.com', 'https://www.linkedin.com/company/peloton-therapeutics', 'jane@jmgcomm.com', \"A peloton is a team of bicyclists who achieve great efficiency of motion through cooperative action. It is also the root of platoon, a nimble military unit with capabilities that exceed the sum of its component parts. Founded by Chairman of Biochemistry Steven L. McKnight of UT Southwestern Medical Center, Peloton Therapeutics represents a unique combination of innovative science, strong financial support from the Cancer Prevention Research Institute of Texas (CPRIT), and seasoned investors and management. Working in close collaboration with scientists at UT Southwestern, Peloton is advancing a promising discovery and development pipeline, comprised of several small molecule-based programs, each with a distinct target and mechanism of action. Peloton's vision is to become a major biotech company in Dallas with a passion for discovering and developing novel cancer drugs.\", 'RA Capital Management, OrbiMed, Foresite Capital, EcoR1 Capital, Vida Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2010-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '27', '', 'Was Acquired', 'Michael S. Brown, Steven McKnight', '', '4'],\n  ['Abeona Therapeutics', 'https://www.crunchbase.com/organization/abeona-therapeutics', 'Biotechnology, Genetics, Health Care, Medical Device', 'New York, New York, United States', 'Abeona Therapeutics develops gene therapy-based potential cures for Sanfilippo syndrome types A and B.', '12,887', '2019-12-28', '103500000', 'USD', '103500000', 'Post-IPO Equity', '232200000', 'USD', '232200000', '51-100', 'Public', '', '', '', 'http://abeonatherapeutics.com', 'https://www.linkedin.com/company/140013', 'tmiller@abeonatherapeutics.com', 'Abeona Therapeutics is developing gene therapy-based potential cures for the deadly childhood diseases Sanfilippo (SF) Syndrome Type A and Type B. Its multi-platform expertise across the manufacture, delivery, development, and discovery of the novel gene and cell therapies has it uniquely positioned for success. Underpinning the Company’s robust pipeline is its fully-operational manufacturing facility producing therapies and vectors for preclinical and clinical studies. Abeona is also developing the AIM Vector Platform: 100+ next-generation AAV capsids for delivering gene therapies targeting a wide range of organs and multiple routes of delivery.', 'RBC Capital Markets, Jefferies, Cantor Fitzgerald, Maxim Group, George Soros', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '1989-01-01', 'year', '', 'IPO', '2014-12-19', 'Active', 'For Profit', '45', '1', 'Made Acquisitions', 'Douglas McCarty, Haiyan Fu', '', '7'],\n  ['Vero Biotech', 'https://www.crunchbase.com/organization/geno', 'Biotechnology, Commercial, Health Care, Health Diagnostics, Medical, Medical Device, Pharmaceutical', 'Atlanta, Georgia, United States', 'Vero Biotech is a biopharmaceutical company developing products to address the medical needs of patients with pulmonary, cardiac diseases.', '12,996', '2021-01-20', '50000000', 'USD', '50000000', 'Debt Financing', '104638455', 'USD', '104638455', '51-100', 'Private', '', '', '', 'https://www.vero-biotech.com/', 'https://www.linkedin.com/company/vero-biotech/', 'contactus@genollc.com', 'Vero Biotech is a biopharmaceutical company focused on the design, development, and commercialization of next-generation products to address the unmet medical needs of patients with a variety of pulmonary and cardiac diseases. We are currently developing inhaled nitric oxide (NO) products for use in both the hospital setting and for longer-term applications outside of the hospital setting. These products, which are based on our GeNOsyl™ drug delivery technology, are comprised of a single-use drug cassette and either a portable console or wearable controller. Our technology is designed to deliver NO safely for a variety of therapeutic indications and to provide clinicians with a solution that is more user-friendly than currently available NO delivery systems.', 'Runway Growth Capital', 'Biotechnology, Health Care, Other, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', 'Less than $1M', '2006-01-01', 'year', '', '', '', 'Active', 'For Profit', '8', '', '', 'David Fine', '', '5'],\n  ['NantKwest', 'https://www.crunchbase.com/organization/nantkwest', 'Biotechnology, Health Care, Pharmaceutical', 'San Diego, California, United States', 'NantKwest is a clinical-stage immunotherapy company focused on harnessing the immune system to treat disease.', '13,085', '2019-03-26', '39000000', 'USD', '39000000', 'Post-IPO Equity', '103495481', 'USD', '103495481', '51-100', 'Public', '2600000000', 'USD', '2600000000', 'http://nantkwest.com/', 'https://www.linkedin.com/company/nantkwest/', 'contact@conkwest.com', 'NantKwest is a clinical-stage immunotherapy company focused on harnessing the immune system to treat disease. It is a biotechnology company, engages in developing immunotherapeutic agents for various clinical conditions in the United States. The company’s product candidates include activated natural killer candidates for the treatment of virally-induced cancers, such as human papilloma virus-induced cervical, and head and neck cancers; ebola; and serious viral, fungal, and bacterial infections, as well as that is in Phase II clinical trials for the treatment of polyoma virus-induced merkel cell carcinoma.', 'Patrick Soon-Shiong', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', 'Less than $1M', '2002-01-01', 'year', '1', 'IPO', '2015-07-28', 'Active', 'For Profit', '28', '', '', 'Patrick Soon-Shiong', '', '3'],\n  ['aTyr Pharma', 'https://www.crunchbase.com/organization/atyr-pharma', 'Biotechnology, Pharmaceutical, Therapeutics', 'San Diego, California, United States', 'aTyr Pharma is a biotherapeutics company that discovers and develops protein biologics for human therapeutics.', '13,451', '2017-08-28', '45000000', 'USD', '45000000', 'Post-IPO Equity', '245500000', 'USD', '245500000', '51-100', 'Public', '', '', '', 'http://www.atyrpharma.com', 'https://www.linkedin.com/company/atyr-pharma', 'media@atyrpharma.com', \"aTyr Pharma is a biotherapeutics company that discovers and develops protein biologics for human therapeutics. The company has established a dominant intellectual property estate surrounding Physiocrine-based compositions and potential therapeutic applications. aTyr’s key programs are focused on immunomodulation disorders in the areas of inflammation and immunity and are in preclinical development.  The company's primary focus is ATYR1923, a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to down-regulate immune engagement in interstitial lung diseases. The privately held biotech was founded by The Scripps Research Institute Professor Paul Schimmel, a leading aminoacyl tRNA synthetase scientist, and is backed by top life sciences investors Alta Partners, Cardinal Partners, Domain Associates and Polaris Ventures.\", 'T. Rowe Price, Viking Global Investors, Polaris Partners, Redmile Group, Silicon Valley Bank', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2005-01-01', 'year', '', 'IPO', '2015-05-15', 'Active', 'For Profit', '66', '', '', 'Paul Schimmel', '', '8'],\n  ['VIDA', 'https://www.crunchbase.com/organization/vida-diagnostics', 'Artificial Intelligence, Biotechnology, Health Care, Health Diagnostics, Medical, Medical Device', 'Coralville, Iowa, United States', 'VIDA is modernizing lung and respiratory care through intelligence', '13,640', '2020-03-12', '11000000', 'USD', '11000000', 'Series C', '20400000', 'USD', '20400000', '51-100', 'Private', '', '', '', 'https://vidalung.ai', 'https://www.linkedin.com/company/vidalung', 'info@vidalung.ai', 'VIDA modernizes lung and respiratory care, empowering healthcare organizations and physicians to improve patient outcomes, streamline care coordination and drive efficiencies through a comprehensive approach, proven quality, and clinical leadership. Through quantitative data intelligence and impactful visualizations, VIDA helps physicians manage patients with or at risk of chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), lung cancer, and now, COVID-19. VIDA’s software is FDA cleared, CE-marked, Health Canada licensed and TGA registered for clinical use in the US, European Economic Area, Canada, and Australia. Learn more at vidalung.ai.', 'First Analysis, Next Level Ventures, UnityPoint Health Ventures, Blue Heron Capital, Rittenhouse Ventures', 'Artificial Intelligence, Biotechnology, Data and Analytics, Health Care, Science and Engineering, Software', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2004-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '5', '', '', 'Eric A. Hoffman, Joseph M. Reinhardt', '', '6'],\n  ['Geron', 'https://www.crunchbase.com/organization/geron-corp', 'Biopharma, Biotechnology, Health Diagnostics, Pharmaceutical', 'Menlo Park, California, United States', 'Geron Corp. operates as a biopharmaceutical company which discovers and develops therapeutic products for cancer. Imetelstat, a novel,', '13,807', '2020-01-01', '', '', '', 'Post-IPO Equity', '96700000', 'USD', '96700000', '51-100', 'Public', '', '', '', 'http://www.geron.com', 'https://www.linkedin.com/company/geron', 'info@geron.com', 'Geron Corp. operates as a biopharmaceutical company which discovers and develops therapeutic products for cancer. Imetelstat, a novel, first-in-class telomerase inhibitor, is a product candidate in clinical development.', 'Venrock, New Enterprise Associates', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', 'Less than $1M', '1990-08-28', 'day', '', 'IPO', '1996-08-09', 'Active', 'For Profit', '29', '', '', 'Michael D West', '', '3'],\n  ['Scholar Rock', 'https://www.crunchbase.com/organization/scholar-rock', 'Biotechnology, Medical, Therapeutics', 'Cambridge, Massachusetts, United States', 'Scholar Rock is discovering and developing a new class of biologic therapies.', '13,952', '2018-01-03', '47000000', 'USD', '47000000', 'Series C', '103000000', 'USD', '103000000', '51-100', 'Public', '', '', '', 'http://scholarrock.com', 'https://www.linkedin.com/company/scholar-rock', 'info@scholarrock.com', 'Scholar Rock, Inc. is a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Our newly elucidated understanding of the molecular mechanisms of growth factor activation enabled us to develop a proprietary platform for the discovery and development of monoclonal antibodies that locally and selectively target these signaling proteins at the cellular level. We believe this approach, acting in the disease microenvironment, avoids the historical challenges associated with inhibiting growth factors for therapeutic effect. We believe our focus on biologically validated growth factors may facilitate a more efficient development path. We are advancing our lead product candidate, SRK-015, a selective first-in-class inhibitor of the activation of the growth factor myostatin in skeletal muscle, into clinical development for the treatment of spinal muscular atrophy, or SMA. We expect to initiate a Phase 1 clinical trial in the second quarter of 2018. Utilizing our proprietary platform, we are also creating a pipeline of novel product candidates with the potential to transform the lives of patients suffering from a wide range of serious diseases, including other neuromuscular disorders, cancer, fibrosis and anemia.', 'Fidelity Management and Research Company, Polaris Partners, ARCH Venture Partners, Cormorant Asset Management, Invus', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2012-01-01', 'year', '', 'IPO', '2018-05-23', 'Active', 'For Profit', '16', '', '', 'Leonard Zon, Timothy A. Springer', '', '3'],\n  ['GrayBug', 'https://www.crunchbase.com/organization/graybug', 'Biotechnology, Health Care, Medical', 'Baltimore, Maryland, United States', 'GrayBug focuses on developing the next generation of products for the treatment of chronic vision-threatening diseases.', '14,015', '2019-08-20', '80000000', 'USD', '80000000', 'Series C', '129240000', 'USD', '129240000', '51-100', 'Public', '320000000', 'USD', '320000000', 'http://graybug.com', 'https://www.linkedin.com/company/graybug', 'info@GrayBug.com', 'GrayBug is a pharmaceutical company that focuses on developing the next generation of products for the treatment of chronic vision-threatening diseases of the retina and optic nerve. The company is currently developing a continuum of proprietary micro – and nanoparticle controlled release technologies and implants for strategic partnership and its own therapeutic products for major ocular disease indications including wet AMD and Glaucoma. The company was founded in 2011 and headquartered in Baltimore, Maryland.', 'OrbiMed, Deerfield, Hatteras Venture Partners, Clarus Ventures, C-Bridge Capital', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10M to $50M', '2011-01-01', 'year', '', 'IPO', '2020-09-24', 'Active', 'For Profit', '5', '', '', 'Christy Wyskiel, Justin Hanes, Lewis J.', '', '6'],\n  ['CardioDx', 'https://www.crunchbase.com/organization/cardiodx', 'Biotechnology, Genetics, Health Care, Health Diagnostics, Pharmaceutical', 'Redwood City, California, United States', 'CardioDx is a cardiovascular genomic diagnostics company providing clinicians with information to enhance patient care.', '14,119', '2017-01-05', '22500000', 'USD', '22500000', 'Venture - Series Unknown', '317261831', 'USD', '317261831', '51-100', 'Private', '', '', '', 'http://www.cardiodx.com', 'https://www.linkedin.com/company/cardiodx', 'info@cardiodx.com', 'CardioDx is a cardiovascular genomic diagnostics company located in Palo Alto, CA. CardioDx develops clinically validated genomic tests to aid in assessing and tailoring care of individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias, and heart failures.', 'Temasek Holdings, JP Morgan Chase, TPG, Kleiner Perkins, Intel Capital', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$1M to $10M', '2004-01-01', 'year', '', '', '', 'Active', 'For Profit', '42', '', '', 'David Levison', '', '11'],\n  ['Strata Oncology', 'https://www.crunchbase.com/organization/strata-oncology', 'Biotechnology, Genetics, Health Care, Health Diagnostics, Medical Device', 'Ann Arbor, Michigan, United States', 'Strata Oncology is a precision oncology company dedicated to transforming cancer care.', '14,166', '2018-05-23', '26000000', 'USD', '26000000', 'Series B', '38000000', 'USD', '38000000', '51-100', 'Private', '', '', '', 'http://www.strataoncology.com/', 'https://www.linkedin.com/company/strata-oncology', 'partner@strataoncology.com', \"Strata Oncology is a precision oncology company dedicated to transforming cancer care by expanding patient access to precision medicine clinical trials and accelerating drug approval.  Strata's national precision oncology platform serves the needs of patients, providers and drug developers by providing a link from patient screening to streamlined enrollment in mutation-matched clinical trials. Follow us on Twitter @StrataOncology. \", 'Baird Capital, Merck Global Health Innovation Fund, Pfizer Venture Investments, Arboretum Ventures, eLab Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', '$1M to $10M', '2016-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '16', '', '', 'Dan Rhodes, Keith Flaherty, Scott Tomlins', '', '2'],\n  ['Mixlab', 'https://www.crunchbase.com/organization/mixlab', 'Health Care, Personal Health, Pet, Pharmaceutical, Wellness', 'New York, New York, United States', 'Mixlab is the best-in-class pet pharmacy that partners with veterinarians.', '14,248', '2020-08-18', '2000000', 'USD', '2000000', 'Undisclosed', '10500000', 'USD', '10500000', '51-100', 'Private', '', '', '', 'https://www.mixlabrx.com', 'https://www.linkedin.com/company/mixlabrx/', 'hello@mixlabrx.com', 'Mixlab is a modern pet pharmacy for veterinarians and pet parents. Our technology and customer experience greatly enhance veterinarian processes and ensure that pet parents receive personalized care that delights them.', 'Global Founders Capital, Brand Foundry Ventures, Social Starts, XFactor Ventures, R/GA Ventures', 'Community and Lifestyle, Health Care', '', '', 'Less than $1M', '2017-01-01', 'year', '', '', '', 'Active', 'For Profit', '3', '', '', 'Frederic Dijols, Stella Kim, Vinnie Dam, Webster Ross', '', '3'],\n  ['Silicon Therapeutics', 'https://www.crunchbase.com/organization/silicon-therapeutics', 'Biotechnology, Health Care, Pharmaceutical', 'Boston, Massachusetts, United States', 'Silicon Therapeutics is a fully integrated drug design, research, and development company.', '14,569', '2016-10-31', '6249498', 'USD', '6249498', 'Venture - Series Unknown', '6249498', 'USD', '6249498', '51-100', 'Private', '', '', '', 'http://www.silicontx.com/', 'https://www.linkedin.com/company/silicon-therapeutics/', '', 'Silicon Therapeutics is a fully integrated drug design, research, and development company. Their multi-disciplinary team is advancing a paradigm shift in biotechnology by pioneering a physics-driven approach to drug design that is tightly coupled to chemistry and biology R&D. Their unique platform is purpose-built to develop novel small molecule therapeutics to address biologically and genetically validated, but previously intractable, protein targets.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', 'Less than $1M', '2016-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '8', '', 'Was Acquired', 'Lanny Sun, Lijun Sun', '', '1'],\n  ['CardioFocus', 'https://www.crunchbase.com/organization/cardiofocus', 'Biotechnology, Health Care, Medical Device, Pharmaceutical', 'Marlborough, Massachusetts, United States', 'CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders.', '14,767', '2019-05-29', '55000000', 'USD', '55000000', 'Venture - Series Unknown', '224817942', 'USD', '224817942', '51-100', 'Private', '', '', '', 'http://www.cardiofocus.com', 'https://www.linkedin.com/company/cardiofocus', 'information@cardiofocus.com', 'CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders. The company specializes in providing electrophysiologists with innovative and effective tools that bring new levels of precision and control to the treatment of atrial fibrillation that focuses on developing, manufacturing, and investigating disposable fiber optic catheters for the visualization of the cardiac anatomy and the treatment of cardiac arrhythmias. CardioFocus was founded in 1990 and is headquartered in Marlborough, Massachusetts.', 'H.I.G. Capital, MassVentures, SV Health Investors, GPB Capital Holdings, Silicon Valley Bank', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '1990-01-01', 'year', '', '', '', 'Active', 'For Profit', '47', '', '', 'Edward Sinofsky', '', '16'],\n  ['BioVentrix', 'https://www.crunchbase.com/organization/bioventrix', 'Biotechnology, Health Care, Medical Device', 'San Ramon, California, United States', 'BioVentrix is a medical device company engaged in the improvement of treatments available for congestive heart failure.', '14,963', '2019-05-01', '21778700', 'USD', '21778700', 'Venture - Series Unknown', '100645079', 'USD', '100645079', '51-100', 'Private', '', '', '', 'http://www.bioventrix.com', 'https://www.linkedin.com/company/bioventrix', 'info@bioventrix.com', 'BioVentrix is a medical device company engaged in the improvement of treatments available for congestive heart failure. It is a biotechnology company that improves and expands the treatments available for congestive heart failure (CHF) caused by ischemic cardiomyopathy, through the development of less invasive and catheter-based approaches. The company was founded in 2003 and is headquartered in San Ramon, California, United States.', 'Telegraph Hill Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2003-01-01', 'year', '', '', '', 'Active', 'For Profit', '10', '', '', 'Arthur Bertolero', '', '8'],\n  ['Biological Dynamics', 'https://www.crunchbase.com/organization/biological-dynamics', 'Biotechnology, Electronics, Health Care', 'San Diego, California, United States', 'Next-gen liquid biopsy company using a true multiomics approach to detect cancer in blood in their earliest stages.', '15,171', '2020-07-29', '', '', '', 'Grant', '43800000', 'USD', '43800000', '51-100', 'Private', '', '', '', 'http://biologicaldynamics.com', 'http://www.linkedin.com/company/biological-dynamics-inc.', 'info@biologicaldynamics.com', \"Biological Dynamics, Inc. is a healthcare company committed to improving global health outcomes by detecting diseases in their earliest stages. The company's proprietary platform simplifies access to native-state biomarkers and nanoparticles, enabling multiomics applications. The company is focused on detecting cancers by applying its platform technology along with its machine learning capabilities. For more information, please visit www.biologicaldynamics.com and follow us at @BiodynSD on Twitter. It was founded in 2008 and is headquartered in San Diego, California.\", \"Bill & Melinda Gates Foundation, Alexandria Venture, Heritage Group, Alzheimer's Drug Discovery Foundation, Institutional Investor\", 'Biotechnology, Consumer Electronics, Hardware, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', 'Less than $1M', '2010-01-01', 'year', '', '', '', 'Active', 'For Profit', '16', '', '', 'Raj Krishnan', '', '6'],\n  ['HTG Molecular Diagnostics', 'https://www.crunchbase.com/organization/htg-molecular-diagnostics', 'Biotechnology, Genetics, Health Diagnostics, Life Science, Medical', 'Tucson, Arizona, United States', 'HTG Molecular Diagnostics develops assays and reagent systems for gene expression analysis.', '15,201', '2019-10-03', '22500000', 'USD', '22500000', 'Post-IPO Equity', '89005877', 'USD', '89005877', '51-100', 'Public', '', '', '', 'http://www.htgmolecular.com', 'http://www.linkedin.com/company/htg-molecular-diagnostics', 'info@htgmolecular.com', \"HTG Molecular Diagnostics is a leading provider of molecular-based technology solutions for gene expression profiling, miRNA, siRNA and mRNA measurement for translational medicine and diagnostic applications. The Company's qNPA molecular technology platform is well-suited for reliably detecting small, yet important, changes in gene expression levels in a variety of sample types. Privately-held HTG is based Tucson, Arizona.\", 'Novo Holdings, Silicon Valley Bank, SR One, Oxford Finance LLC, Solstice Capital', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$1M to $10M', '1997-01-01', 'year', '', 'IPO', '2015-04-28', 'Active', 'For Profit', '29', '', '', 'Bruce E. Seligmann', '', '12'],\n  ['Dare Bioscience', 'https://www.crunchbase.com/organization/dare-bioscience', 'Biopharma, Biotechnology, Health Care', 'La Jolla, California, United States', 'Daré Bioscience is a healthcare company committed to the development and commercialization of innovative products.', '15,254', '2020-09-21', '900000', 'USD', '900000', 'Grant', '3607516', 'USD', '3607516', '51-100', 'Public', '', '', '', 'https://www.darebioscience.com/contact', 'https://www.linkedin.com/company/dare-bioscience/', 'innovations@darebioscience.com', 'Daré Bioscience is a healthcare company committed to the development and commercialization of innovative products in women’s reproductive health. ', 'Bill & Melinda Gates Foundation, The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '2005-01-01', 'year', '', 'IPO', '2014-04-11', 'Active', 'For Profit', '23', '2', 'Made Acquisitions', '', '', '4'],\n  ['Entellus Medical', 'https://www.crunchbase.com/organization/entellus-medical', 'Biotechnology, Health Care, Medical, Medical Device', 'Plymouth, Minnesota, United States', 'Entellus Medical develops technology-based treatment solutions for ENT physicians, their patients and payers.', '15,502', '2017-07-27', '50000000', 'USD', '50000000', 'Post-IPO Equity', '182000000', 'USD', '182000000', '51-100', 'Delisted', '', '', '', 'http://www.entellusmedical.com', 'https://www.linkedin.com/company/entellus-medical', 'info@entellusmedical.com', 'Entellus Medical is focused on providing unique solutions to the unmet needs of the ENT (ear, nose and throat) physician, their patients, and payers through the development of innovative device technology and treatment solutions. Entellus is based in Maple Grove, MN and markets products throughout the United States. Entellus Medical works closely with leading researchers and clinicians to develop solutions that benefit patients, physicians, and payers. Entellus provides a simple, direct and effective treatment for Chronic Rhinosinusitis (CRS) that is less invasive, reduces pain and bleeding, shortens recovery time, and eliminates the need for general anesthesia. Entellus recently introduced FinESSâ„¢ Sinus Treatment, a simple and direct approach to effectively treat patients with CRS. FinESS can be performed under local anesthesia, with or without light sedation, and remodels the maxillary ostium and the ethmoid infundibulum using a micro endoscope and a small balloon catheter. Unlike sinus surgery techniques, FinESS does not require the removal of delicate bone or sinus tissue, resulting in shorter treatment time with very little pain or bleeding. Recovery time is usually one to two days with many patients resuming normal activity within a day.', 'SV Health Investors, Greenspring Associates, Essex Woodlands Healthcare Partners, Split Rock Partners, Covidien Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$50M to $100M', '2006-04-01', 'day', '', 'M&A', '2015-02-06', 'Active', 'For Profit', '23', '2', 'Made Acquisitions, Was Acquired', 'Peter Keith, Thomas Ressemann', '', '7'],\n  ['Lumen Bioscience', 'https://www.crunchbase.com/organization/lumen-bioscience-inc', 'Biopharma, Biotechnology, Life Science', 'Seattle, Washington, United States', 'Lumen Bio discovers, develops, & manufactures biologic drugs and vaccine candidates for several prevalent, worldwide diseases.', '15,962', '2021-01-27', '14500000', 'USD', '14500000', 'Grant', '43500000', 'USD', '43500000', '51-100', 'Private', '', '', '', 'http://lumen.bio', 'https://www.linkedin.com/company/18016410/', '', 'Lumen Bio is a clinical-stage biotechnology company developing topically and mucosally delivered biologic drugs to treat and prevent highly prevalent diseases.', 'US Department of Energy, CARB-X, Bioeconomy Capital, WestRiver Group, Columbia Pacific Advisors', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', 'Less than $1M', '2017-04-01', 'day', '', 'Early Stage Venture', '', 'Active', 'For Profit', '9', '', '', 'Brian Finrow, Jim Roberts', '', '5'],\n  ['Cognition Therapeutics', 'https://www.crunchbase.com/organization/cognition-therapeutics', 'Biotechnology, Life Science, Therapeutics', 'Pittsburgh, Pennsylvania, United States', 'Cognition Therapeutics develops new therapeutics to treat patients suffering from Alzheimer’s disease and other neurodegenerative disorders.', '16,121', '2020-07-31', '', '', '', 'Series B', '157485863', 'USD', '157485863', '51-100', 'Private', '', '', '', 'http://www.cogrx.com', 'https://www.linkedin.com/company/cognition-therapeutics', 'info@cogrx.com', \"Cognition Therapeutics, Inc. is focused on the discovery and development of small molecule therapeutics targeting the toxic proteins that cause the cognitive decline associated with Alzheimer's disease and other degenerative diseases of the human brain. Toxic proteins play a crucial role in a large class of disease targets, and there are currently no therapeutics available to prevent toxic protein accumulation or block their destructive effects. Cognition is founded on the unique combination of biological expertise around these targets, including proprietary assays that emphasize functional responses and proprietary medicinal chemistry that insures novel, high quality small-molecule drug candidates.\", 'Tech Coast Angels, Innovation Works, Golden Seeds, New York Angels, Dolby Family Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', 'Less than $1M', '2007-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '15', '', '', 'Gilbert M. Rishton, Susan Catalano', '', '19'],\n  ['Biocept', 'https://www.crunchbase.com/organization/biocept', 'Biotechnology, Health Care, Health Diagnostics', 'San Diego, California, United States', 'Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.', '16,269', '2018-01-30', '14800000', 'USD', '14800000', 'Post-IPO Equity', '43199999', 'USD', '43199999', '51-100', 'Public', '45223580', 'USD', '45223580', 'http://www.biocept.com', 'http://www.linkedin.com/company/biocept', 'info@biocept.com', 'Biocept, an emerging biotechnology leader in cell separation technology, is developing a new, powerful class of diagnostic assays for personalized medicine in early detection, diagnosis and monitoring of cancer. The CEEâ„¢ Cell Enrichment and Extraction platform combines sophisticated attachment chemistry with mathematically modeled fluid dynamics to enable earlier, accurate, less invasive diagnoses. Isolation, purification and analysis of rare cells are managed within their state-of-the-art CLIA-accredited laboratory. The clinical laboratory is accredited by the College of American Pathologists (CAP) and holds licenses in California and several other states.', 'ROTH Capital Partners, Needham Capital Partners, Chardan Capital', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', '$1M to $10M', '1993-01-01', 'year', '', 'IPO', '2013-02-05', 'Active', 'For Profit', '72', '', '', 'Soon Kap Hahn', '', '7'],\n  ['Corbus Pharmaceuticals', 'https://www.crunchbase.com/organization/corus-pharma', 'Biotechnology, Clinical Trials, Pharmaceutical', 'Norwood, Massachusetts, United States', 'Corbus Pharmaceuticals is a clinical-stage pharmaceutical company focused on treating inflammatory and fibrotic diseases.', '16,341', '2018-01-30', '25000000', 'USD', '25000000', 'Grant', '64049982', 'USD', '64049982', '51-100', 'Public', '', '', '', 'http://corbuspharma.com', 'http://www.linkedin.com/company/corbus-pharmaceuticals', 'info@corbuspharma.com', \"Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases by leveraging its pipeline of endocannabinoid system-targeting synthetic drug candidates. The Company's lead product candidate, lenabasum, is a novel, synthetic, oral, selective cannabinoid receptor type 2 (CB2) agonist designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. Corbus is also developing a pipeline of drug candidates from more than 600 novel compounds targeting the endocannabinoid system. The pipeline includes CRB-4001, a 2nd generation, peripherally-restricted, selective cannabinoid receptor type 1 (CB1) inverse agonist. Potential indications for CRB-4001 include NASH, among others. Corbus plans to start a Phase 1 study of CRB-4001 in 2019, intended to be followed by a National Institutes of Health (NIH)-funded proof-of-concept Phase 2 study.\", 'Boston Harbor Angels, SternAegis, Fort Point Angels, Oleg Uritsky', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2009-01-01', 'year', '', 'IPO', '2014-10-30', 'Active', 'For Profit', '42', '', '', 'Bruce Montgomery, Jonathan Mow', '', '5'],\n  ['Visterra', 'https://www.crunchbase.com/organization/visterra', 'Biotechnology, Clinical Trials, Health Diagnostics, Therapeutics', 'Cambridge, Massachusetts, United States', 'Visterra researches on and develops therapeutic and diagnostic products for the treatment of infectious diseases.', '16,360', '2017-10-05', '23600000', 'USD', '23600000', 'Series C', '125389699', 'USD', '125389699', '51-100', 'Private', '', '', '', 'http://www.visterrainc.com', 'https://www.linkedin.com/company/visterra-inc-/', 'info@visterrainc.com', 'Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. and changed its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.', 'Temasek Holdings, Lux Capital, Vertex Ventures, Polaris Partners, Flagship Pioneering', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$1M to $10M', '2007-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '33', '', 'Was Acquired', 'Kevin Bitterman, Ram Sasisekharan', '', '9'],\n  ['Prolacta Bioscience', 'https://www.crunchbase.com/organization/prolacta-bioscience', 'Biotechnology, Health Care, Life Science, Nutrition', 'City Of Industry, California, United States', 'Prolacta Bioscience provides human milk-based nutritional products for premature infants in the neonatal intensive care unit (NICU).', '16,378', '2018-05-15', '8908625', 'USD', '8908625', 'Venture - Series Unknown', '78043517', 'USD', '78043517', '51-100', 'Private', '', '', '', 'http://www.prolacta.com', 'http://www.linkedin.com/company/prolacta-bioscience', 'info@prolacta.com', 'Prolacta Bioscience, Inc. (www.prolacta.com) is a life science company founded by serial entrepreneur, Elena Medo who has dedicated her career to improving quality of life for sick infants by Advancing the Science of Human MilkTM. Prolacta creates specialty formulations made exclusively from human milk for the nutritional needs of critically ill, premature infants in neonatal intensive care units. It is the first and only company to provide a human milk fortifier made from 100% human milk, Prolact+ H2MF. They operate a pharmaceutical grade processing plant and have designed and patented processes that enable them to make their one-of-a-kind life saving products. Prolacta is committed to making a meaningful difference in the lives of the most vulnerable infants through world-class research and innovative products.', 'Mercury Fund, Draper Associates, Essex Woodlands Healthcare Partners, Aisling Capital, Alta Partners', 'Biotechnology, Food and Beverage, Health Care, Science and Engineering', 'Foods Or Foodstuffs; Their Treatment, Not Covered By Other Classes', '', '$10M to $50M', '1999-01-01', 'year', '', '', '', 'Active', 'For Profit', '27', '', '', 'Elena Medo', '', '7'],\n  ['ADMA Biologics', 'https://www.crunchbase.com/organization/adma-biologics', 'Biotechnology, Health Care, Medical', 'Ramsey, New Jersey, United States', 'ADMA Biologics develops plasma-based biologics for the treatment and prevention of certain infectious diseases.', '16,432', '2019-05-22', '51750000', 'USD', '51750000', 'Post-IPO Equity', '71750000', 'USD', '71750000', '51-100', 'Public', '', '', '', 'https://www.admabiologics.com/', '', 'info@admabio.com', 'ADMA is a specialty immune globulin company that develops, manufactures and intends to market plasma-based biologics targeted to niche patient populations for the treatment and prevention of certain infectious diseases. The Company’s target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-suppressed for medical reasons. ADMA also operates ADMA BioCenters, FDA-licensed source plasma collection facilities which provide a portion of blood plasma for the manufacturing of the Company’s lead product candidate RI-002.', 'Hercules Capital, Inc., Biomark Capital', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2004-01-01', 'year', '', 'IPO', '2013-10-18', 'Active', 'For Profit', '12', '1', 'Made Acquisitions', 'Adam Grossman, Jerrold B. Grossman', '', '4'],\n  ['Cidara Therapeutics', 'https://www.crunchbase.com/organization/cidara-therapeutics', 'Biotechnology, Health Care, Therapeutics', 'San Diego, California, United States', 'Cidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics.', '16,555', '2018-05-21', '', '', '', 'Grant', '121060000', 'USD', '121060000', '51-100', 'Public', '190000000', 'USD', '190000000', 'http://cidara.com', 'https://www.linkedin.com/company/cidara-therapeutics', 'info@cidara.com', 'Cidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics. The company focuses on developing innovative therapies to treat life-threatening illnesses exacerbated by deficiencies of the human immune system.  Cidara Therapeutics was founded in 2012 and headquartered in San Diego, California.', 'National Institutes of Health, RA Capital Management, CAM Capital, Fidelity, Perceptive Advisors', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2012-01-01', 'year', '', 'IPO', '2015-04-15', 'Active', 'For Profit', '42', '', '', 'Kevin Forrest, Kevin Judice', '', '6'],\n  ['Imago BioSciences', 'https://www.crunchbase.com/organization/imago-biosciences', 'Biotechnology, Life Science, Medical', 'San Carlos, California, United States', 'We are a company dedicated to translating state-of-the art science into novel medicines for the treatment of diseases', '16,565', '2020-11-19', '80000000', 'USD', '80000000', 'Series C', '146500000', 'USD', '146500000', '51-100', 'Private', '', '', '', 'http://imagobio.com/', '', 'info@imagobio.com', 'Imago BioSciences is a San Francisco-based clinical development company dedicated to translating state-of-the art science into novel medicines for treating diseases that currently pose great challenges to patients, their families and their physicians.  The company leverages the skills and extensive experience of its team and the financial commitment of its investors to focus on a small family of orphan diseases.  Imago BioSciences translates unique insights into high impact transformative therapies that alter the natural history of disease allowing patients to live longer, disease-free lives.', 'BlackRock, T. Rowe Price, MRL Ventures Fund, Omega Funds, Surveyor Capital', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$10M to $50M', '2012-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '7', '', '', 'Hugh Rienhoff', '', '3'],\n  ['LightDeck Diagnostics', 'https://www.crunchbase.com/organization/mbio-diagnostics', 'Biotechnology, Health Care, Health Diagnostics', 'Boulder, Colorado, United States', 'LightDeck is a developer of on-the-spot diagnostic products used to offer fast, accurate, simple, and low-cost diagnostic tests.', '16,623', '2020-10-29', '11000000', 'USD', '11000000', 'Series B', '28983456', 'USD', '28983456', '51-100', 'Private', '', '', '', 'http://lightdeckdx.com', 'https://www.linkedin.com/company/lightdeck-diagnostics', 'info@lightdeckdx.com', 'LightDeck is a developer of on-the-spot diagnostic products used to offer fast, accurate, simple, and low-cost diagnostic tests. Its proprietary platform combines an advanced laser waveguide with novel materials and patented manufacturing techniques to deliver lab-quality results anywhere, in minutes that provides emergency departments, nursing homes, and clinics to non-traditional settings such as pharmacies and the workplace with quicker point-of-care testing.', 'HESKA, Entrada Ventures, Boulder Ventures, John Ives, Incubic Venture Fund', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', '$1M to $10M', '2009-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '10', '1', 'Made Acquisitions', 'Christopher J. Myatt', '', '6'],\n  ['Viridian Therapeutics', 'https://www.crunchbase.com/organization/miragen-therapeutics', 'Biotechnology, Genetics, Health Care, Therapeutics', 'Boulder, Colorado, United States', 'Viridian Therapeutics discovers and develops innovative microRNA-targeting therapies to improve human health.', '16,689', '2020-11-06', '90997328', 'USD', '90997328', 'Post-IPO Equity', '186697328', 'USD', '186697328', '51-100', 'Public', '287000000', 'USD', '287000000', 'https://www.viridiantherapeutics.com/', 'https://www.linkedin.com/company/miragen-therapuetics/', 'info@miragentherapeutics.com', 'Viridian Therapeutics is a biotechnology company advancing new treatments for patients with diseases that are underserved by today’s therapies. Viridian is developing multiple product candidates to treat patients who suffer from thyroid eye disease (TED), a debilitating orphan disease, and has early-stage programs focused on other targets and indications.', 'Fidelity Management and Research Company, MRL Ventures Fund, JAFCO Japan, Broadview Ventures, Atlas Venture', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', 'Less than $1M', '2007-01-01', 'year', '', 'IPO', '2017-04-24', 'Active', 'For Profit', '10', '2', 'Made Acquisitions', 'Eric Newell Olson, William Marshall', '', '9'],\n  ['Vertos Medical', 'https://www.crunchbase.com/organization/vertos-medical', 'Biotechnology, Health Care, Medical, Medical Device', 'Aliso Viejo, California, United States', 'Vertos Medical is a healthcare company that develops and markets medical devices that are used for the treatment of common spinal diseases.', '16,884', '2020-09-22', '1000000', 'USD', '1000000', 'Venture - Series Unknown', '107241437', 'USD', '107241437', '51-100', 'Private', '', '', '', 'http://www.vertosmed.com', 'https://www.linkedin.com/company/vertos-medical-inc', 'customerservice@vertosmed.com', 'Vertos Medical is a healthcare company that offers medical devices used in the treatment of common spinal diseases. The company commercializes the percutaneous treatment for lumbar spinal stenosis (LSS). It also offers minimally invasive lumbar decompression devices for the treatment of various forms of LSS. The company offers its devices in the United States.  Vertos Medical, Inc. was founded by Dr. Dave Solsberg and Dr. Don Schomer in 2005 and is headquartered in Aliso Viejo, California, USA.', 'Foundation Capital, Mercury Fund, Pitango Venture Capital, Revelation Partners, MVM Life Science Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2005-01-01', 'year', '', '', '', 'Active', 'For Profit', '3', '', '', 'Dave Solsberg, Don Schomer', '', '12'],\n  ['Lucence Health', 'https://www.crunchbase.com/organization/lucence-diagnostics', 'Biotechnology, Genetics, Health Care, Health Diagnostics, Medical', 'Palo Alto, California, United States', 'Lucence Health is a liquid biopsy company detecting the hallmarks of cancer for earlier detection and targeted treatment.', '16,898', '2019-11-20', '20000000', 'USD', '20000000', 'Series A', '29200000', 'USD', '29200000', '51-100', 'Private', '', '', '', 'https://www.lucence.com/', 'https://www.linkedin.com/company/lucence/', 'media@lucence.com', 'Lucence Health is a liquid biopsy company detecting the hallmarks of cancer for earlier detection and targeted treatment.', 'SGInnovate, Boon Hwee Koh, IHH Healthcare Berhad, Heliconia Capital Management, Lim Kaling', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$10M to $50M', '2016-04-01', 'month', '', 'Early Stage Venture', '', 'Active', 'For Profit', '9', '', '', 'Min-Han Tan, Pan Zhao, Yukti Choudhury', '', '2'],\n  ['Corvus Pharmaceuticals', 'https://www.crunchbase.com/organization/corvus-pharmaceuticals', 'Biopharma, Biotechnology, Pharmaceutical', 'Burlingame, California, United States', 'Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.', '16,921', '2021-02-12', '31800000', 'USD', '31800000', 'Post-IPO Equity', '140300000', 'USD', '140300000', '51-100', 'Public', '', '', '', 'http://www.corvuspharma.com/', '', '', 'Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. With accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of immuno-oncology.', 'BlackRock, Fidelity Management and Research Company, OrbiMed, Adams Street Partners, Rock Springs Capital', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2014-01-01', 'year', '', 'IPO', '2016-03-23', 'Active', 'For Profit', '29', '', '', 'Joseph J Buggy, Richard A Miller', '', '3'],\n  ['Omeros', 'https://www.crunchbase.com/organization/omeros', 'Biotechnology, Health Care, Pharmaceutical', 'Seattle, Washington, United States', 'Omeros is a clinical-stage biopharmaceutical company developing products focused on inflammation and central nervous system disorders.', '16,945', '2017-08-22', '68000000', 'USD', '68000000', 'Post-IPO Equity', '354800000', 'USD', '354800000', '51-100', 'Public', '84000000', 'USD', '84000000', 'http://www.omeros.com', 'http://www.linkedin.com/company/omeros-corporation', '', 'Omeros is a Seattle-based commercial-stage biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, complement-mediated diseases and disorders of the central nervous system.', 'ARCH Venture Partners, Oxford Finance LLC, Novartis Venture Fund, East West Bank, MidCap Financial', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$50M to $100M', '1994-01-01', 'year', '', 'IPO', '2009-10-08', 'Active', 'For Profit', '37', '1', 'Made Acquisitions', 'Gregory A. Demopulos, Pamela Pierce Palmer', '', '7'],\n  ['Fortress Biotech', 'https://www.crunchbase.com/organization/fortress-biotech', 'Biotechnology, Health Care, Life Science, Pharmaceutical', 'New York, New York, United States', 'Fortress Biotech is biopharmaceutical company focused on acquiring, developing, and commercializing drugs and drug candidates.', '17,064', '2020-08-28', '60000000', 'USD', '60000000', 'Post-IPO Debt', '144275534', 'USD', '144275534', '51-100', 'Public', '', '', '', 'http://www.fortressbiotech.com/', 'https://www.linkedin.com/company/fortress-biotech/', 'bd@fortressbiotech.com', 'Fortress Biotech is a biopharmaceutical company focused on acquiring, developing and commercializing high-potential marketed and development-stage drugs and drug candidates. Fortress has 5 marketed products and over 25 programs in development through its majority-owned and majority-controlled partners and at partners it founded and holds significant minority ownership positions. Target therapeutic areas and technologies include oncology, rare diseases, gene and cell therapy, and other areas of high unmet need.', 'Hercules Capital, Inc., Oaktree Capital Management, National Securities Corporation', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '2006-01-01', 'year', '', 'IPO', '2011-12-30', 'Active', 'For Profit', '14', '', '', 'Lindsay Rosenwald', '', '8'],\n  ['Renmatix', 'https://www.crunchbase.com/organization/renmatix', 'Biotechnology, CleanTech, Energy, Renewable Energy', 'King Of Prussia, Pennsylvania, United States', 'Renmatix is a global technology licensor that enables the low-cost production of cellulosic sugars.', '17,190', '2020-03-24', '48641147', 'USD', '48641147', 'Venture - Series Unknown', '171041147', 'USD', '171041147', '51-100', 'Private', '', '', '', 'http://renmatix.com', 'https://www.linkedin.com/company/renmatix', 'marketing@renmatix.com', 'Renmatix, Inc. (formerly Sriya Innovations) enables the production of chemicals and fuels from cellulosic biomass. The company processes cellulosic sugars to provide intermediaries. It also involves in the conversion of cellulosic sugars into cellulosic ethanol or other advanced biofuels. The company was formerly known as Syria Innovations, Inc. and changed its name to Renmatix, Inc. in April 2011. The company was founded in 2003 and is based in Kennesaw, Georgia.', 'Bill Gates, Kleiner Perkins, Total Carbon Neutrality Ventures, Total, Waste Management', 'Biotechnology, Energy, Science and Engineering, Sustainability', 'Organic Macromolecular Compounds; Their Preparation Or Chemical Working-Up', '', '$10M to $50M', '2003-01-01', 'year', '', '', '', 'Active', 'For Profit', '18', '', '', 'Srinivas Kilambi', '', '8'],\n  ['Apollo Endosurgery', 'https://www.crunchbase.com/organization/apollo-endosurgery', 'Biotechnology, Health Care, Medical Device', 'Austin, Texas, United States', 'Apollo Endosurgery develops medical devices for the diagnosis and treatment of gastrointestinal diseases.', '17,364', '2019-08-13', '20000000', 'USD', '20000000', 'Post-IPO Debt', '333527392', 'USD', '333527392', '51-100', 'Public', '', '', '', 'http://www.apolloendo.com', 'http://www.linkedin.com/company/apollo-endosurgery', '', 'Apollo Endosurgery was founded upon the initial work of the Apollo Group, an international think tank of world-renowned gastroenterologists and surgeons from five leading universities (Mayo Clinic, Johns Hopkins, Medical University of South Carolina, University of Texas Medical Branch-Galveston and Chinese University-Hong Kong.)  Disappointed with the pace of innovation in therapeutic flexible endoscopy, the Group assembled in 1998 (Timeline) with the goal to advance the new discipline; their specific focus was the use of long, flexible instruments deployed through a natural orifice in order to diagnose and potentially treat gastrointestinal disorders.', 'H.I.G. Capital, Novo Holdings, Oxford Finance LLC, East West Bank, MidCap Financial', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2006-01-01', 'year', '', 'IPO', '2016-08-30', 'Active', 'For Profit', '19', '1', 'Made Acquisitions', 'Dennis L. McWilliams', '', '11'],\n  ['Tricida', 'https://www.crunchbase.com/organization/tricida', 'Health Care, Medical, Pharmaceutical', 'Menlo Park, California, United States', 'Tricida operates in the healthcare industry focusing on pharmaceutical business. ', '17,500', '2018-03-02', '100000000', 'USD', '100000000', 'Debt Financing', '257014244', 'USD', '257014244', '51-100', 'Public', '763000000', 'USD', '763000000', 'http://tricida.com', 'https://www.linkedin.com/company/tricida-inc-', 'info@tricida.com', 'Tricida, Inc. is a late-stage pharmaceutical company focused on the development and commercialization of its lead product candidate, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease (CKD). Metabolic acidosis is a condition commonly caused by CKD that is believed to accelerate the progression of kidney deterioration. Metabolic acidosis has been associated with increased muscle wasting, loss of bone density and death.', 'Hercules Capital, Inc., Wellington Management, OrbiMed, Venrock, Vivo Capital', 'Health Care', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2013-01-01', 'year', '', 'IPO', '2018-06-27', 'Active', 'For Profit', '10', '', '', 'Gerrit Klaerner', '', '6'],\n  ['BioAgilytix Labs', 'https://www.crunchbase.com/organization/bioagilytix-labs', 'Biotechnology', 'Durham, North Carolina, United States', 'BioAgilytix is a bioanalytical lab specializing in immunoassays and cell-based assays. Located in Research Triangle Park North Carolina,', '17,731', '2019-02-01', '23000000', 'GBP', '30094864', 'Venture - Series Unknown', '23000000', 'GBP', '30094864', '51-100', 'Private', '', '', '', 'http://www.bioagilytix.com', 'http://www.linkedin.com/company/bioagilytix-labs-inc.', 'info@bioagilytix.com', 'BioAgilytix is a bioanalytical lab specializing in immunoassays and cell-based assays.  Located in Research Triangle Park North Carolina, our growing team of highly dedicated individuals is driven by the desire to support the development of novel drugs and other scientific breakthroughs.  By employing highly experienced scientists with deep, focused expertise in an engaging work environment, we are able to consistently exceed our customers’ expectations.', 'GHO Capital, Caledonia Investments', 'Biotechnology, Science and Engineering', 'Testing', '', '$10M to $50M', '2008-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '8', '2', 'Made Acquisitions, Was Acquired', 'Afshin Safavi', '', '1'],\n  ['Raptor Pharmaceuticals', 'https://www.crunchbase.com/organization/raptor-pharmaceuticals', 'Biopharma, Biotechnology, Genetics, Therapeutics', 'Novato, California, United States', 'Raptor is a NASDAQ-listed biopharmaceutical company with the mission to develop and commercialize life-altering therapeutics.', '17,905', '2014-07-01', '60000000', 'USD', '60000000', 'Post-IPO Debt', '87386000', 'USD', '87386000', '51-100', 'Delisted', '', '', '', 'http://www.raptorpharma.com', '', 'info@raptorpharma.com', \"Raptor Pharmaceuticals Corp. operates as a development stage biotechnology company in the United States. The company engages in the discovery, research, and preclinical development of drug candidates and drug-targeting platforms for the treatment of various brain disorders and neurodegenerative diseases, genetic disorders, and cancer through the proprietary use of receptor-associated proteins and mesoderm development proteins. Its clinical-stage products include DR Cysteamine, which is in Phase IIb clinical trail for the treatment of nephropathic cystinosis or cystinosis; and in Phase IIa clinical trail for the treatment of non-alcoholic steatohepatitis. The company also develops Convivia, a Phase IIa clinical trail product for the treatment of aldehyde dehydrogenase or ALDH2 deficiency; DR Cysteamine, which is in Phase II clinical trail for the treatment of Huntington's Disease; and Tezampanel and NGX 426 that is in Phase II clinical trail for the treatment of migraine, acute pain, and chronic pain. In addition, its preclinical development products comprise HepTide for the treatment of Hepatocellular Carcinoma and Hepatitis C; WntTide for the treatment of breast cancer; and NeuroTrans for the treatment of neurodegenerative diseases. The company has collaboration agreements with the University of California, San Diego for a clinical study of DR Cysteamine in juvenile patients with Non-Alcoholic Steatohepatitis and to study DR Cysteamine in patients with cystinosis. Raptor Pharmaceuticals Corp was founded in 2005 and is based in Novato, California.\", 'Lincoln Park Capital Fund, Deerfield Capital Management, Heights Capital Management, Iroquois Capital, HealthCare Royalty Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2005-01-01', 'year', '', 'M&A', '2003-01-10', 'Active', 'For Profit', '10', '1', 'Made Acquisitions, Was Acquired', 'Christopher M. Starr', '', '4'],\n  ['Heliae', 'https://www.crunchbase.com/organization/heliae', 'Biotechnology, Nutrition, Therapeutics', 'Gilbert, Arizona, United States', 'Heliae is a platform technology company producing high-value products from algae by using sunlight and low-cost carbon feedstocks.', '17,976', '2013-09-03', '80000000', 'USD', '80000000', 'Venture - Series Unknown', '123400000', 'USD', '123400000', '51-100', 'Private', '', '', '', 'http://www.heliae.com', 'http://www.linkedin.com/company/heliae', 'info@Heliae.com', 'Heliae is a platform technology company that uses sunlight and low-cost carbon feedstocks to produce high-value products from algae. Based in Gilbert, Ariz., Heliae is leveraging its core production technology into four target markets: nutrition, therapeutics, health & beauty and agrosciences. With a seasoned management team and world-class science, Heliae is advancing the future of the algae industry by delivering novel algae-based products to dynamic markets around the world.', 'Mars, Thomas J. Edelman, Agri Investments Pte. Ltd', 'Biotechnology, Food and Beverage, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$10M to $50M', '2008-01-01', 'year', '1', '', '', 'Active', 'For Profit', '16', '', '', 'Frank Mars', '', '3'],\n  ['Harrow Health', 'https://www.crunchbase.com/organization/imprimis-pharmaceuticals', 'Biotechnology, Health Care, Medical', 'Nashville, Tennessee, United States', 'Harrow Health aims to commercialize compounded drug formulations and improve topical drug delivery.', '18,016', '2021-04-14', '50000000', 'USD', '50000000', 'Post-IPO Debt', '98746180', 'USD', '98746180', '51-100', 'Public', '', '', '', 'https://www.harrowinc.com/', 'http://www.linkedin.com/company/imprimis-pharmaceuticals-inc-', 'info@imprimispharma.com', 'Harrow Health, Inc. (NASDAQ: HROW) owns a portfolio of healthcare businesses, including the nation’s leading ophthalmology pharmaceutical compounding business, ImprimisRx. The company holds large equity positions in Eton Pharmaceuticals, Surface Pharmaceuticals, Melt Pharmaceuticals, Mayfield Pharmaceuticals and Radley Pharmaceuticals, companies founded as subsidiaries of Harrow Health. The Company also owns royalty rights in certain 505(b)(2) drug candidates being developed by Eton, Surface, Melt, Mayfield and Radley. Harrow intends to create, invest in and grow paradigm shifting health care businesses that put patients first.', 'Life Sciences Alternative Funding, SWK Funding', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '1998-01-01', 'year', '', 'IPO', '2007-04-30', 'Active', 'For Profit', '50', '', '', 'Mark Baum', '', '5'],\n  ['Aytu BioScience', 'https://www.crunchbase.com/organization/aytu-bioscience', 'Biotechnology, Health Care, Medical', 'Englewood, Colorado, United States', 'Aytu BioScience is a specialty healthcare company focused on developing treatments for urological and related conditions.', '18,017', '2017-08-22', '11800000', 'USD', '11800000', 'Post-IPO Equity', '16975000', 'USD', '16975000', '51-100', 'Public', '', '', '', 'http://aytubio.com/', 'https://www.linkedin.com/company/aytu-bioscience-inc-', 'info@aytubio.com', 'Aytu BioScience is a specialty healthcare company concentrating on developing products for redox-modulated conditions with a focus on urological indications and related conditions. Aytu BioScience is initially concentrating on male sexual dysfunction and male infertility and will seek expansion opportunities in other urological indications.', '', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', '$1M to $10M', '2002-01-01', 'year', '', 'IPO', '2008-10-03', 'Active', 'For Profit', '38', '3', 'Made Acquisitions', 'Josh Disbrow', '', '2'],\n  ['Xencor', 'https://www.crunchbase.com/organization/xencor', 'Biotechnology, Health Care, Therapeutics', 'Monrovia, California, United States', 'Xencor develops superior monoclonal antibody therapeutics to treat autoimmune disorders, asthma, allergic diseases and cancer.', '18,033', '2013-07-01', '7597653', 'USD', '7597653', 'Venture - Series Unknown', '108397653', 'USD', '108397653', '51-100', 'Public', '161824168', 'USD', '161824168', 'http://xencor.com', 'http://www.linkedin.com/company/xencor', 'info@xencor.com', 'Xencor, Inc. provides protein engineering technology platforms in the biotechnology industry.  Its products include antibody therapeutics, such as XmAb2513 for the treatment of relapsed Hodgkin’s lymphoma and anaplastic large cell lymphoma; XmAb5574, a humanized monoclonal antibody that targets the antigen CD19 for treatment of B cell malignancies; XmAb5592 for the treatment of myeloma; and XmAb5871 and XmAb7195, which are humanized monoclonal antibodies for the treatment of asthma and allergy. The company’s products also include XPro protein therapeutics, such as XPro1595, a dominant negative inhibitor for the treatment of multiple animal models of autoimmune and neuroinflammatory diseases.', 'Novo Nordisk, Oxford Bioscience Partners, Moore Capital, Sands Brothers Asset Management, Stafford Capital Partners', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$10M to $50M', '1997-01-01', 'year', '', 'IPO', '2013-12-03', 'Active', 'For Profit', '60', '', '', 'Bassil Dahiyat', '', '7'],\n  ['Fluxergy', 'https://www.crunchbase.com/organization/fluxergy', 'Biotechnology, Health Care, Health Diagnostics, Medical, Medical Device', 'Irvine, California, United States', 'Fluxergy applies modular diagnostic technologies to provide accurate answers at the point-of-use.', '18,440', '2020-05-13', '30000000', 'USD', '30000000', 'Series C', '49950000', 'USD', '49950000', '51-100', 'Private', '', '', '', 'http://www.fluxergy.com', 'https://www.linkedin.com/company/fluxergy', 'info@fluxergy.com', 'Better testing through disruptive technology: A portable platform that consolidates laboratory testing to one device. Fluxergy aims to make laboratory testing accessible everywhere.', '', 'Biotechnology, Health Care, Science and Engineering', 'Physical Or Chemical Processes Or Apparatus In General', '', 'Less than $1M', '2013-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '5', '', '', 'Ryan Revilla, Tej Patel', '', '4'],\n  ['OvaScience', 'https://www.crunchbase.com/organization/ovascience', 'Biotechnology, Health Care, Life Science', 'Boston, Massachusetts, United States', 'OvaScience is a life sciences company focused on the discovery, development and commercialization of treatments for infertility.', '18,450', '2016-06-01', '53800000', 'USD', '53800000', 'Post-IPO Equity', '135799920', 'USD', '135799920', '51-100', 'Public', '', '', '', 'http://ovascience.com', 'http://www.linkedin.com/company/ovascience', 'info@ovascience.com', \"The company is applying innovative science to improve the quality of eggs (oocytes) and increase the success of in vitro fertilization (IVF). OvaScience's proprietary technology, exclusively licensed from Harvard Medical School and Massachusetts General Hospital, enables the use of a women's own cellular energy to improve egg quality. OvaScience was co-founded by Richard Aldrich, Michelle Dipp, M.D., Ph.D., and Christoph Westphal M.D., Ph.D., of Longwood Founders Fund, along with fertility expert and Harvard Medical School Professor Jonathan Tilly, Ph.D. of Massachusetts General Hospital, and aging expert and Harvard Medical School Professor David Sinclair, Ph.D. The company is backed by leading life science investors Longwood Founders Fund and Bessemer Venture Partners. The company has assembled a world-class team of leading reproductive endocrinologists, embryologists, scientists and advisers to bring this technology to patients.\", 'General Catalyst, RA Capital Management, Cycad Group, BB&T, Hunt BioVentures', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', 'Less than $1M', '2011-01-01', 'year', '', 'M&A', '2013-05-10', 'Closed', 'For Profit', '103', '', 'Was Acquired', 'Christoph Westphal, David Sinclair, Johnathan Tilly, Michelle Dipp', '', '5'],\n  ['Collegium Pharmaceutical', 'https://www.crunchbase.com/organization/collegium-pharmaceutical', 'Biotechnology, Life Science, Medical, Therapeutics', 'Stoughton, Massachusetts, United States', 'Collegium Pharmaceutical is a specialty pharmaceutical company focused on the development of products for the treatment of chronic pain.', '18,496', '2015-03-10', '50000000', 'USD', '50000000', 'Private Equity', '106000002', 'USD', '106000002', '51-100', 'Public', '236495220', 'USD', '236495220', 'http://www.collegiumpharma.com', '', 'info@collegiumpharma.com', 'Collegium Pharmaceutical is a specialty pharmaceutical company focused on the development of proprietary, late-stage pharmaceutical products. These products address the growing problems associated with non-medical use and abuse of prescription drugs through formulation based improvements protected by intellectual property (IP). Collegium is focused on building a portfolio of products for the treatment of chronic pain that possess tamper-resistant features and provide extended-release delivery using its patent-protected DETERx formulation platform.', 'RA Capital Management, Rock Springs Capital, Adage Capital Management, EcoR1 Capital, Longitude Capital', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$50M to $100M', '2002-01-01', 'year', '', 'IPO', '2015-05-07', 'Active', 'For Profit', '31', '', '', 'Jane Hirsch, Mark Hirsch, Michael T. Heffernan', '', '8'],\n  ['Farcast', 'https://www.crunchbase.com/organization/mitra-biotech', 'Biotechnology, Health Care, Health Diagnostics, Medical, Pharmaceutical', 'Boston, Massachusetts, United States', 'Farcast develops a diagnostic platform that delivers powerful predictions for personalized cancer treatment selection and drug development.', '18,629', '2018-07-12', '40000000', 'USD', '40000000', 'Series C', '74511591', 'USD', '74511591', '51-100', 'Private', '', '', '', 'https://www.farcastbio.com/', 'https://www.linkedin.com/company/farcast-bio/', 'info@mitrabiotech.com', 'Farcast is a clinical diagnostic company whose mission it is to illuminate personal treatment truth of a cancer patient. The Farcast technology core is a human tumor micro-environment that enables oncologists and drug developers to test individual tumors to determine treatment response profiles. The company has its headquarters in Boston in Massachusetts, and operates a lab in Bangalore in India.', 'Alumni Ventures Group, Sequoia Capital India, RA Capital Management, Accel, Northpond Ventures', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '2010-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '11', '', '', 'Mallik Sundaram, Pradip Majumder', '', '5'],\n  ['Regulus Therapeutics', 'https://www.crunchbase.com/organization/regulus-therapeutics', 'Biotechnology, Genetics, Health Care, Therapeutics', 'Carlsbad, California, United States', 'Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs.', '18,706', '2019-05-07', '16700000', 'USD', '16700000', 'Post-IPO Equity', '111699992', 'USD', '111699992', '51-100', 'Public', '136521572', 'USD', '136521572', 'http://www.regulusrx.com', 'http://www.linkedin.com/company/regulus-therapeutics', 'info@regulusrx.com', 'Regulus Therapeutics Is a biopharmaceutical company leading the discovery of a new class of high-impact medicines based on microRNAs. The discovery of MicroRNA in humans is one of the most exciting scientific breakthroughs in the last decade. MicroRNAs are small RNA molecules, typically 20 to 25 nucleotides in length, that do not encode proteins but instead regulate gene expression.  It was founded in 2007 and is headquartered in Carlsbad, California.', 'New Enterprise Associates, Oxford Finance LLC, Sanofi Aventis', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', 'Less than $1M', '2007-09-01', 'day', '', 'IPO', '2012-10-05', 'Active', 'For Profit', '80', '', '', '', '', '7'],\n  ['Mustang Bio', 'https://www.crunchbase.com/organization/mustang-bio', 'Biotechnology, Pharmaceutical', 'New York, New York, United States', 'Mustang Bio is a clinical-stage biopharmaceutical company .', '18,828', '2019-04-01', '20000000', 'USD', '20000000', 'Post-IPO Debt', '20000000', 'USD', '20000000', '51-100', 'Public', '', '', '', 'http://www.mustangbio.com/', '', 'info@mustangbio.com', \"Mustang Bio is a clinical-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel cancer immunotherapy products designed to utilize the power of the patient's own immune system to eliminate cancer cells. The products under development are - CD123, CD20, and CS1.\", 'Horizon Technology Finance', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2015-01-01', 'year', '', 'IPO', '2017-08-01', 'Active', 'For Profit', '6', '', '', '', '', '1'],\n  ['Cellworks', 'https://www.crunchbase.com/organization/cellworks', 'Biotechnology, Life Science, Pharmaceutical, Therapeutics', 'San Jose, California, United States', 'Cellworks is a life sciences technology company involved in drug and bio-marker discovery and researches in therapeutic areas.', '19,054', '2020-06-29', '15479506', 'USD', '15479506', 'Venture - Series Unknown', '32997067', 'USD', '32997067', '51-100', 'Private', '', '', '', 'http://cellworksgroup.com', 'https://www.linkedin.com/company/cellworks-life', 'info@cellworksgroup.com', 'Cellworks Group operates as a life sciences technology company. The company provides iC-PHYS, a technology platform that enables drug and biomarker discovery and research in focused therapeutic areas. The company provides disease-focused drug discovery and research solutions in the areas of oncology, such as integrated tumor cell and endothelial cells with stromal inputs; inflammation diseases, such as macrophage, neutrophil, osteoclast, and T-cell; type-2 diabetes; infectious diseases; skin pigmentation and aging; and neurodegenerative. The company was founded in 2005 and is based in Saratoga, California. It has a research and development facility in Bangalore, India.', 'Sequoia Capital, Artiman Ventures', 'Biotechnology, Health Care, Science and Engineering', '', '', 'Less than $1M', '2005-01-01', 'year', '', '', '', 'Active', 'For Profit', '1', '', '', 'Pradeep Fernandes, Shireen Vali, Taher Abbasi', '', '4'],\n  ['Turing Pharmaceuticals', 'https://www.crunchbase.com/organization/turing-pharmaceuticals', 'Biopharma, Biotechnology, Medical', 'New York, New York, United States', 'Turing Pharmaceuticals is a biopharmaceutical company focusing on patients with unmet medical needs.', '19,249', '2015-08-10', '90000000', 'USD', '90000000', 'Series A', '90000000', 'USD', '90000000', '51-100', 'Private', '', '', '', 'http://turingpharma.com/', 'https://www.linkedin.com/company/turing-pharmaceuticals', 'info@turingpharma.com', 'Turing Pharmaceuticals is a biopharmaceutical company focusing on patients with unmet medical needs. The company is dedicated to helping patients, who often have no effective treatment options, by developing and commercializing innovative treatments. It was founded in 2014 and headquartered in New York, United States.', 'Martin Shkreli', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10M to $50M', '2014-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '734', '', '', 'Martin Shkreli', '', '1'],\n  ['Monocl', 'https://www.crunchbase.com/organization/monocl', 'Biotechnology, Life Science, Pharmaceutical, SaaS', 'Cambridge, Massachusetts, United States', 'Monocl empowers life science professionals with the complete global expert solution for impactful outreach and strategic engagement.', '19,312', '2019-07-09', '3300000', 'USD', '3300000', 'Venture - Series Unknown', '9000000', 'USD', '9000000', '51-100', 'Private', '', '', '', 'http://www.monocl.com/', 'http://www.linkedin.com/company/monocl', 'info@monocl.com', 'Monocl empowers life science professionals with the complete global expert solution designed to drive impactful outreach and strategic engagement. Our cloud-based expert platform - powered by machine learning - continuously analyzes an unrivaled amount of data across all therapeutic areas and regions, providing invaluable context and actionable insights.', 'GP Bullhound', 'Biotechnology, Health Care, Science and Engineering, Software', '', '', '$1M to $10M', '2014-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '1', '', 'Was Acquired', 'Björn Carlsson, Tobias Thornblad', '', '5'],\n  ['Inhibrx', 'https://www.crunchbase.com/organization/inhibrx', 'Biotechnology, Therapeutics', 'La Jolla, California, United States', 'Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates.', '19,419', '2019-05-21', '40000000', 'USD', '40000000', 'Convertible Note', '43550000', 'USD', '43550000', '51-100', 'Public', '623200000', 'USD', '623200000', 'http://inhibrx.com/', '', '', 'Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates. Inhibrx utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The Inhibrx pipeline is focused on oncology, orphan diseases and infectious diseases. Inhibrx has collaborations with Celgene and bluebird bio and has received awards from several granting agencies, including NIH, NIAID and CARB-X.', 'RA Capital Management, Viking Global Investors, Lilly Asia Ventures, ArrowMark Partners, WuXi Biologics', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$1M to $10M', '2017-01-01', 'year', '', 'IPO', '2020-08-18', 'Active', 'For Profit', '15', '', '', 'Brendan Eckelman, Mark Lappe, Quinn Deveraux', '', '2'],\n  ['Idera Pharmaceuticals', 'https://www.crunchbase.com/organization/idera-pharmaceuticals', 'Biotechnology, Health Care, Pharmaceutical', 'Cambridge, Massachusetts, United States', 'Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.', '19,485', '2020-04-07', '20700000', 'USD', '20700000', 'Post-IPO Equity', '74500000', 'USD', '74500000', '51-100', 'Public', '', '', '', 'http://www.iderapharma.com', 'http://www.linkedin.com/company/idera-pharmaceuticals', 'info@iderapharma.com', \"Idera Pharmaceuticals, Inc., a biotechnology company, discovers and develops DNA- and RNA-based drug candidates for the treatment of infectious diseases, autoimmune and inflammatory diseases, cancer, and asthma and allergies, and for use as vaccine adjuvants. The company designs and creates proprietary Toll-Like Receptors (TLR) to modulate immune responses, including TLR agonist, a compound that stimulates an immune response through the targeted TLR; and TLR antagonist, a compound that blocks activation of an immune response through the targeted TLR. Its drug candidates include IMO-2125, a TLR9 agonist, which is in Phase 1 clinical trial for hepatitis C virus infection; and TLR7, 8, and 9 agonists that are in research stage for viral diseases. The company also develops IMO-3100, a dual TLR7/TLR9 antagonist, which is in preclinical development stage for autoimmune and inflammatory diseases, such as lupus, rheumatoid arthritis, multiple sclerosis, psoriasis, and colitis. In addition, its drug candidates also comprise TLR7 and TLR8 agonists that are in research stage for solid tumor cancers. The company has a licensing and collaboration agreement with Merck KGaA to research, develop, and commercialize TLR9 agonists for the treatment of cancer, excluding cancer vaccines; a license and research collaboration agreement with Merck & Co., Inc. to research, develop, and commercialize therapeutic and prophylactic vaccine products containing its TLR7, 8, and 9 agonists in the fields of cancer, infectious diseases, and Alzheimer's disease; and a research collaboration and option agreement, and a license, development, and commercialization agreement with Novartis International Pharmaceutical, Ltd. to discover, develop, and commercialize TLR9 agonists for the treatment of asthma and allergies. The company was founded in 1989 and is based in Cambridge, Massachusetts.\", 'Merck', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', 'Less than $1M', '1989-01-01', 'year', '', 'IPO', '2007-12-19', 'Active', 'For Profit', '39', '', '', '', '', '4'],\n  ['Organovo Holdings', 'https://www.crunchbase.com/organization/organovo-holdings', 'Biotechnology, Medical, Therapeutics', 'San Diego, California, United States', 'Organovo develops a range of tissue and disease models for medical research and therapeutic applications.', '20,097', '2015-01-01', '', '', '', 'Post-IPO Equity', '43689760', 'USD', '43689760', '51-100', 'Public', '331591136', 'USD', '331591136', 'http://www.organovo.com/', 'https://www.linkedin.com/company/organovo-inc-', 'info@organovo.com', 'Organovo is focused on delivering breakthrough three-dimensional biology capabilities to create tissue on demand for research and surgical applications. As the first company with a three-dimensional tissue technology that works across tissue types, they are meeting the promise of regenerative medicine to fill unmet medical needs.', 'SternAegis, Spencer Trask & Co., Eric Del Balso, Michael Brams', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$1M to $10M', '2007-01-01', 'year', '', 'IPO', '2012-02-24', 'Active', 'For Profit', '40', '', '', 'Andras Forgacs, Gabor Forgacs', '', '4'],\n  ['Sapphire Energy', 'https://www.crunchbase.com/organization/sapphire-energy', 'Biotechnology, Clean Energy, Energy, Solar', 'San Diego, California, United States', 'Sapphire Energy develops products and processes based on photosynthetic microorganisms, and uses sunlight and CO2 as their feedstock.', '20,294', '2015-12-15', '92000000', 'USD', '92000000', 'Private Equity', '376524000', 'USD', '376524000', '51-100', 'Private', '', '', '', 'http://sapphireenergy.com', 'https://www.linkedin.com/company/sapphire-energy', 'info@sapphireenergy.com', 'San Diego-based Sapphire Energy is pioneering an entirely new industry – Green Crude – production with the potential to profoundly change America’s energy and petrochemical landscape for the better. Sapphire’s products and processes in this category differ significantly from other forms of biofuel because they are made solely from photosynthetic microorganisms (algae and cyanobacteria), using sunlight and CO2 as their feedstock; are not dependent on food crops or valuable farmland; do not use potable water; do not result in biodiesel or ethanol; enhance and replace petroleum-based products; are compatible with existing infrastructure; and are low carbon, renewable and scalable. Sapphire has an R&D facility in Las Cruces, New Mexico, and is currently building the first Integrated Algal BioRefinery in Columbus, New Mexico.', 'Wellcome Trust, Venrock, ARCH Venture Partners, ArrowMark Partners, U.S. Department of Agriculture', 'Biotechnology, Energy, Natural Resources, Science and Engineering, Sustainability', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$10M to $50M', '2007-01-01', 'year', '', 'Private Equity', '', 'Active', 'For Profit', '148', '', '', 'James Levine, Jason Pyle, Kristina Burow, Nathaniel David, Stephen Mayfield, Steven Briggs', '', '6'],\n  ['Accera', 'https://www.crunchbase.com/organization/accera', 'Biotechnology, Health Care, Pharmaceutical', 'Broomfield, Colorado, United States', 'Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases.', '20,444', '2018-10-04', '50000000', 'USD', '50000000', 'Venture - Series Unknown', '196221147', 'USD', '196221147', '51-100', 'Private', '', '', '', 'http://www.accerapharma.com', '', 'info@accerapharma.com', \"Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases. It offers Ketasyn, a molecule for Alzheimer's, Parkinson's, and age-associated memory impairment. It was founded in 2001 and is headquartered in Broomfield, Colorado.\", 'Wilmar International, Inventages Venture Capital Investment Inc., POSCO BioVentures, Bloodstone Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2001-01-01', 'year', '', '', '', 'Active', 'For Profit', '8', '', '', 'Mark Heiman, Samuel Henderson, Steve A. Orndorff, Steve Orndorff', '', '7'],\n  ['Braeburn', 'https://www.crunchbase.com/organization/braeburn-pharmaceuticals', 'Biotechnology, Health Care, Medical Device, Pharmaceutical', 'Plymouth Meeting, Pennsylvania, United States', 'Braeburn is dedicated to delivering solutions for people living with the serious, often fatal consequences of opioid use disorder.', '20,517', '2018-01-10', '110000000', 'USD', '110000000', 'Debt Financing', '133000000', 'USD', '133000000', '51-100', 'Private', '', '', '', 'https://braeburnrx.com/', 'https://www.linkedin.com/company/braeburn/', 'info@braeburnrx.com', 'Braeburn is dedicated to delivering solutions for people living with the serious, often fatal consequences of opioid use disorder. We are dedicated to advancing next-generation therapies, with individualized dosing regimens and delivery options, to address the escalating disease burden of opioid use disorder faced by patients, healthcare professionals, payers, and society.', 'RA Capital Management, Rock Springs Capital, Apple Tree Partners, New Leaf Venture Partners, Avista Capital Partners', 'Biotechnology, Health Care, Science and Engineering', 'Vehicles In General', '', '$1M to $10M', '2012-01-01', 'year', '', '', '', 'Active', 'For Profit', '22', '', '', '', '', '2'],\n  ['Aeglea BioTherapeutics', 'https://www.crunchbase.com/organization/aeglea-biotherapeutics', 'Biotechnology, Health Care, Therapeutics', 'Austin, Texas, United States', 'Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.', '20,645', '2015-03-23', '44000000', 'USD', '44000000', 'Series B', '56000000', 'USD', '56000000', '51-100', 'Public', '', '', '', 'http://aeglea.com', 'https://www.linkedin.com/company/aeglea-biotherapeutics', 'info@aeglea.com', \"Aeglea BioTherapeutics is a clinical-stage biotechnology company redefining the potential of human enzyme therapeutics to benefit people with rare and devastating metabolic diseases with limited treatment options. Aeglea's lead product candidate, pegzilarginase, is in a pivotal Phase 3 trial for the treatment of Arginase 1 Deficiency and has received both Rare Pediatric Disease and Breakthrough Therapy Designation. In the second quarter of 2020, the Company initiated a Phase 1/2 clinical trial of AGLE-177 for the treatment of Homocystinuria. AGLE-177 has also been granted Rare Pediatric Disease Designation. Aeglea has an active discovery platform focused on engineering small changes in human enzymes to have big impact on the lives of patients and their families. For more information, please visit http://aeglea.com.\", 'RA Capital Management, OrbiMed, Venrock, Rock Springs Capital, Ally Bridge Group', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2013-01-01', 'year', '', 'IPO', '2016-04-07', 'Active', 'For Profit', '16', '', '', 'David Lowe', '', '2'],\n  ['Receptos', 'https://www.crunchbase.com/organization/receptos', 'Biopharma, Biotechnology, Health Care', 'San Diego, California, United States', 'Receptos focuses on the discovery, development and commercialization of various therapeutics for immune disorders.', '20,667', '2013-03-27', '30000000', 'USD', '30000000', 'Series B', '103480066', 'USD', '103480066', '51-100', 'Delisted', '246465002', 'USD', '246465002', 'http://www.receptos.com', 'http://www.linkedin.com/company/receptos-inc.', 'info@receptos.com', 'Receptos is a privately-held drug discovery and development company which utilizes pioneering G protein-coupled receptor (GPCR) technology to facilitate information-driven drug design for developing best- and first-in-class drugs.', 'Polaris Partners, Flagship Pioneering, OrbiMed, Venrock, ARCH Venture Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2007-01-01', 'year', '', 'M&A', '2013-05-09', 'Active', 'For Profit', '23', '', 'Was Acquired', 'Fred Aslan, Hugh Rosen, Kristina Burow, Marcus F. Boehm, Raymond E. Stevens, Robert J. Peach, William Rastetter', '', '5'],\n  ['Simple Admit', 'https://www.crunchbase.com/organization/simple-admit', 'Health Care, Medical, Pharmaceutical', 'Baldwinsville, New York, United States', 'Simple Admit is a customized online preoperative health screening form for patients.', '20,743', '2018-09-25', '', '', '', 'Corporate Round', '610000', 'USD', '610000', '51-100', 'Private', '', '', '', 'http://www.simpleadmit.com', '', 'customerservice@simpleadmit.com', 'Simple Admit is a customized, online preoperative health screening form. Patients enter their medical information and health history. HIPAA compliant, secure, and convenient. Quick ROI and significant savings for facilities. It was founded in 2010 and headquartered in Baldwinsville, New York.', 'Bankers Healthcare Group', 'Health Care', '', '', '$1M to $10M', '2010-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', 'Dan Coholan, Mike Horning', '', '2'],\n  ['Trevena', 'https://www.crunchbase.com/organization/trevena', 'Biopharma, Biotechnology, Health Care, Pharmaceutical', 'King Of Prussia, Pennsylvania, United States', 'Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.', '20,788', '2014-11-05', '45000000', 'USD', '45000000', 'Post-IPO Equity', '174000000', 'USD', '174000000', '51-100', 'Public', '291000000', 'USD', '291000000', 'http://www.trevenainc.com', 'http://www.linkedin.com/company/trevena-inc', 'admin@trevenainc.com', \"Trevena is a privately held clinical stage biopharmaceutical company based in King of Prussia, PA, dedicated to the discovery and development of GPCR biased ligands. Established in late 2007, Trevena was created to translate groundbreaking research on GPCR signaling into a new generation of medicines. They have three programs in development: TRV027, currently in phase 2 clinical testing for the treatment of acute heart failure; TRV130, currently completing phase 1 testing for the intraveneous treatment of postoperative pain; and TRV734, currently in pre-clinical testing for oral treatment of acute and chronic pain. In addition, Trevena has built an early-stage portfolio of drug discovery programs currently in lead optimization. G protein coupled receptors are the targets for more than 30% of all currently marketed therapeutics. There is significant opportunity to improve upon currently marketed GPCR drugs because many have limited efficacy and undesirable adverse effects, which can prevent broader use. Furthermore, many GPCRs are linked to diseases but cannot be translated into medicines because of specific target-related adverse effects. Trevena's biased ligand approach has the potential to address these problems across a wide range of receptors and therapeutic areas.\", 'Polaris Partners, New Enterprise Associates, HealthCare Ventures, Alta Partners, Forest Laboratories', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2007-01-01', 'year', '', 'IPO', '2014-01-31', 'Active', 'For Profit', '81', '', '', 'Howard Rockman, Maxine Gowen, Robert Lefkowitz', '', '5'],\n  ['CymaBay Therapeutics', 'https://www.crunchbase.com/organization/cymabay-therapeutics', 'Biopharma, Biotechnology, Pharmaceutical', 'Hayward, California, United States', 'CymaBay Therapeutics is focused on the development and commercialization of proprietary new medicines for critical human diseases.', '20,832', '2015-08-14', '324999', 'USD', '324999', 'Post-IPO Debt', '191505694', 'USD', '191505694', '51-100', 'Public', '', '', '', 'http://www.cymabay.com', 'https://www.linkedin.com/company/cymabay-therapeutics', 'info@cymabay.com', 'CymaBay Therapeutics is a clinical-stage biopharmaceutical company located in the San Francisco Bay Area focused on the development and commercialization of proprietary new medicines for important human diseases. We are committed to developing breakthrough medicines that improve the lives of patients and their families. CymaBay was seeded with the assets from an earlier metabolic disease company in which more than $120M was invested to produce a robust pipeline. Arhalofenate is a novel oral small molecule being developed to treat the approximately 1 million gout patients that flare three or more times per year. Gout flares are painful inflammatory episodes caused by crystals of monosodium urate (MSU) that result from excess serum uric acid (sUA). In three Phase 2 studies in gout patients arhalofenate was shown to reduce the incidence and duration of flares while simultaneously lowering sUA. If confirmed in additional clinical studies, arhalofenate’s dual acting profile would be unique since all other urate lowering therapies paradoxically increase flares as they lower sUA over the first 6 to 12 months of treatment. Increased flares lead many patients to stop or avoid treatment leading to progression of disease with pain and suffering, erosion of joint structure and functionality, lost time from work, and increased healthcare costs.', 'T. Rowe Price, Versant Ventures, Novo Holdings, Venrock, Omega Funds', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '1991-01-01', 'year', '', 'IPO', '2014-07-18', 'Active', 'For Profit', '23', '', '', '', '', '11'],\n  ['Invuity', 'https://www.crunchbase.com/organization/invuity', 'Biotechnology, Health Care, Medical Device', 'San Francisco, California, United States', 'Invuity develops illumination and visualization products for minimally invasive surgical field applications.', '21,072', '2015-02-13', '22897572', 'USD', '22897572', 'Private Equity', '109897571', 'USD', '109897571', '51-100', 'Public', '207000000', 'USD', '207000000', 'http://www.invuity.com', '', 'info@invuity.com', 'Invuity, Inc. develops visualization products for the less invasive surgical field applications. It offers BriteField Port System that provides illumination and visualization during minimally invasive procedures; and BriteField McCulloch retractor, which allows physicians to achieve visualization during surgery while using traditional techniques. Invuity, Inc. was formerly known as Spotlight Surgical Inc. The company was founded in 2004 and is headquartered in San Francisco, California.', 'Wellington Management, Kleiner Perkins, InterWest Partners, Wexford Capital, HealthCare Royalty Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2004-01-01', 'year', '', 'M&A', '2015-06-15', 'Active', 'For Profit', '24', '', 'Was Acquired', 'Alex Vayser, Kenneth Trauner', '', '7'],\n  ['PowerVision', 'https://www.crunchbase.com/organization/powervision', 'Biotechnology, Health Care, Health Diagnostics, Medical', 'Belmont, California, United States', 'PowerVision is a device company developing implantable intraocular lenses.', '21,161', '2016-04-20', '10000000', 'USD', '10000000', 'Series D', '122927457', 'USD', '122927457', '51-100', 'Private', '', '', '', 'http://powervisionlens.com/', 'https://www.linkedin.com/company/powervision-inc./about/', 'info@powervisionlens.com', 'PowerVision is a private company focused on developing a novel accommodating intraocular lens, which is designed to restore True AccommodationTM. Their innovative FluidVisionTM accommodating intraocular lens (IOL) is poised to help individuals affected by presbyopia and/or cataracts regain the ability to dynamically adjust focus for clear vision at all distances. Fifty years ago, vision correction surgery was changed forever by the invention of the intraocular lens, which is used to treat a cataract – a clouding and hardening of the dime-sized, normally clear, crystalline lens inside your eye which can rob you of your vision in your 60’s, 70’s and 80’s. PowerVision set out to dramatically improve vision correction surgery again. They began the development of their FluidVision IOL, which mimics the way a healthy eye works and can restore clear vision at all distances, near, far, and everywhere in between.   It uses a tiny amount of fluid inside the lens and natural eye muscles to change shape and adjust focus just the way your healthy eye does. For the more than 20 million people with cataracts in the U.S. and, ultimately, the more than 90 million with Presbyopia – the loss of ability to focus up close that affects people in their 40’s and 50’s – the FluidVision lens can potentially give them freedom from ever needing glasses, contacts or any vision correction procedure again.', 'Medtronic, Venrock, Correlation Ventures, Frazier Healthcare Partners, Advanced Technology Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2002-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '16', '', 'Was Acquired', 'Barry Cheskin, Matthew Frinzi', '', '8'],\n  ['Sprout Pharmaceuticals, Inc.', 'https://www.crunchbase.com/organization/sprout-pharmaceuticals', 'Biotechnology, Health Care, Medical, Pharmaceutical', 'Raleigh, North Carolina, United States', 'Sprout Pharmaceuticals, Inc. is a medical company that develops products for the treatment of female sexual dysfunction.', '21,275', '2019-09-04', '20000000', 'USD', '20000000', 'Venture - Series Unknown', '104303861', 'USD', '104303861', '51-100', 'Private', '', '', '', 'https://sproutpharmaceuticals.com/', 'https://www.linkedin.com/company/sprout-pharmaceuticals-inc-/', '', \"Sprout Pharmaceuticals, Inc. develops products for the treatment of female sexual dysfunction. They're committed to breakthrough firsts in women’s sexual health.The company was incorporated in 2011 and is based in Raleigh, North Carolina.\", '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2011-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '86', '', 'Was Acquired', 'Cindy Eckert, Robert Whitehead', '', '5'],\n  ['Vanda Pharmaceuticals', 'https://www.crunchbase.com/organization/vanda-pharmaceuticals', 'Biopharma, Biotechnology, Health Care', 'Washington, District of Columbia, United States', 'Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies.', '21,289', '2014-10-29', '54000000', 'USD', '54000000', 'Post-IPO Equity', '72500000', 'USD', '72500000', '51-100', 'Public', '', '', '', 'http://www.vandapharma.com', 'http://www.linkedin.com/company/vanda-pharmaceuticals', 'kontakt-de@vandapharma.com', 'Vanda Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders to address unmet needs. The company has assembled an experienced team along with a portfolio of clinical and commercial stage programs with the goal of bringing important new treatment options to patients.', 'Domain Associates, Prospect Venture Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$50M to $100M', '2003-01-01', 'year', '', 'IPO', '2006-04-12', 'Active', 'For Profit', '31', '', '', 'Mihael Polymeropoulos', '', '2'],\n  ['Histogenics', 'https://www.crunchbase.com/organization/histogenics', 'Biotechnology, Health Care, Medical', 'Waltham, Massachusetts, United States', 'Histogenics is a tissue regeneration company developing breakthrough treatments for long-lasting joint repair.', '21,293', '2016-10-13', '30000000', 'USD', '30000000', 'Post-IPO Equity', '209500000', 'USD', '209500000', '51-100', 'Public', '500000000', 'USD', '500000000', 'http://www.histogenics.com', '', 'investorrelations@histogenics.com', 'Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Our regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. Our first investigational product candidate, NeoCart®, leverages our platform to provide an innovative treatment in the orthopedic space, specifically cartilage damage in the knee.', 'Precigen, Boston Millennia Partners, Sofinnova Investments, Stryker, Split Rock Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2000-01-01', 'day', '', 'M&A', '2014-12-04', 'Active', 'For Profit', '7', '1', 'Made Acquisitions, Was Acquired', 'Larry Berlowitz Tarrant, Shuichi Mizuno', '', '6'],\n  ['Zosano Pharma', 'https://www.crunchbase.com/organization/zosano-pharma', 'Biopharma, Biotechnology, Medical', 'Fremont, California, United States', 'Zosano Pharma is a biopharmaceutical company, develops products based on the transdermal delivery technology.', '21,554', '2016-08-29', '7536000', 'USD', '7536000', 'Post-IPO Equity', '166224887', 'USD', '166224887', '51-100', 'Public', '', '', '', 'http://zosanopharma.com', 'https://www.linkedin.com/company/zosano-pharma', 'bd@zosanopharma.com', \"Zosano Pharma focuses on creating better products with its innovative drug delivery technology. Zosano's objective is to discover and develop therapeutic drug candidates that address large unmet medical needs or have a significant potential for commercialization. It was founded in 2006 and headquartered in Fremont, California.\", 'Hercules Capital, Inc., New Enterprise Associates, HBM Healthcare Investments AG, BioMed Ventures, ProQuest Investments', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', 'Less than $1M', '2006-10-01', 'day', '', 'IPO', '2015-01-27', 'Active', 'For Profit', '37', '', '', 'Peter Daddona', '', '10'],\n  ['CellMax Life', 'https://www.crunchbase.com/organization/cellmax', 'Biotechnology, Health Care', 'Mountain View, California, United States', 'CellMax Life is a biotechnology company that is focused on developments in early cancer detection and prevention.', '21,672', '2016-07-26', '9000000', 'USD', '9000000', 'Series A', '14000000', 'USD', '14000000', '51-100', 'Private', '', '', '', 'http://cellmaxlife.com/', 'http://www.linkedin.com/company/cellmax-life', 'info@cellmaxlife.com', 'CellMax Life is a biotechnology company that is revolutionizing early cancer detection and prevention. The company’s product portfolio includes a blood test that can detect cancer before it is too late. CellMax Life was founded in 2013 and is based in California, United States. The company has offices in Silicon Valley (U.S.) and Taiwan, and is funded by a venture capital firm in the U.S. and technology industrialists in Taiwan.', 'Artiman Ventures, Stan Shih', 'Biotechnology, Health Care, Science and Engineering', '', '', 'Less than $1M', '2013-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '6', '', '', 'Atul Sharan, Ying-Chih Chang', '', '2'],\n  ['Undercover Colors', 'https://www.crunchbase.com/organization/undercover-colors', 'Biotechnology, Health Care, Social Impact', 'Raleigh, North Carolina, United States', 'Undercover Colors is a consumer company that introduces date rape drug detection in drinks.', '21,752', '2016-11-10', '5500000', 'USD', '5500000', 'Venture - Series Unknown', '8489998', 'USD', '8489998', '51-100', 'Private', '', '', '', 'http://undercovercolors.com', 'https://www.linkedin.com/company/undercover-colors', 'ContactUs@undercovercolors.com', \"Undercover Colors is a consumer company that introduces date rape drug detection in drinks. Miniaturized lateral flow technology detects the presence of common date rape drugs in drinks in one minute. The company's product SipChip accurately and discreetly identifies minute amounts of drugs in over 100 liquids. The First consumer products - a quarter-sized medallion housed in an iPhone holder and as a keychain, with refills - will be available in Fall 2018.\", '', 'Biotechnology, Health Care, Other, Science and Engineering', 'Testing', '', '$1M to $10M', '2014-01-01', 'year', '', '', '', 'Active', 'For Profit', '1', '', '', 'Ankesh Madan, Stephen Gray, Tasso von Windheim, Tyler Confrey Maloney', '', '4'],\n  ['Vital Therapies', 'https://www.crunchbase.com/organization/vital-therapies', 'Biotechnology, Health Care, Medical', 'San Diego, California, United States', 'Vital Therapies is a biotech company focused on developing a cell-based therapy targeting the treatment of acute liver failure.', '21,899', '2014-03-07', '13928129', 'USD', '13928129', 'Private Equity', '228408815', 'USD', '228408815', '51-100', 'Public', '', '', '', 'http://www.vitaltherapies.com', '', 'info@vitaltherapies.com', 'Vital Therapies is a biotherapeutic company focused on developing a cell-based therapy targeting the treatment of acute liver failure. Their product candidate, the ELAD System, or ELAD, is a bio-artificial liver therapy that operates outside the body, or extracorporeal, and is designed with the proposed intent to allow the patient’s own liver to regenerate to a healthy state, or to stabilize the patient until liver transplant. ELAD is an allogeneic cellular therapy system incorporating their human liver-derived C3A cells contained in four hollow fiber cartridges that are combined with a single-use customized disposable set and a reusable bedside unit. Data from ELAD clinical studies have shown trends that may indicate the potential to increase survival rates in patients with acute liver failure. ELAD has received orphan designation in the United States and Europe for the treatment of acute liver failure.  Prior to the initiation of their ongoing Phase III clinical trial program, more than 150 subjects have received ELAD therapy in seven clinical trials and through a compassionate use program, which they believe collectively suggests a promising therapeutic profile. They are currently initiating three Phase III clinical trials in various acute liver failure conditions. In March 2013, they initiated VTI-208, a Phase III randomized, controlled clinical trial in 200 subjects with alcohol-induced liver decompensation. In the fourth quarter of 2013, they intend to initiate two additional Phase III randomized controlled trials, VTI-210, in 120 subjects with acute alcoholic hepatitis, and VTI-212, in 126 subjects with fulminant hepatic failure.', 'Tech Coast Angels, Versant Ventures, Threshold, HBM Healthcare Investments AG, Delphi Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2003-01-01', 'year', '', 'M&A', '2014-04-17', 'Active', 'For Profit', '27', '', 'Was Acquired', '', '', '10'],\n  ['NorthStar Medical Radioisotopes', 'https://www.crunchbase.com/organization/northstar-medical-radioisotopes', 'Health Care, Health Diagnostics, Hospitality, Pharmaceutical, Therapeutics', 'Madison, Wisconsin, United States', 'NorthStar Medical Radioisotopes develops technologies and raw materials for the nuclear medicine market.', '21,989', '2019-04-23', '75000000', 'USD', '75000000', 'Venture - Series Unknown', '80465000', 'USD', '80465000', '51-100', 'Private', '', '', '', 'http://www.northstarnm.com/', 'https://www.linkedin.com/company/northstar-medical-radioisotopes-llc', '', 'NorthStar Medical Radioisotopes LLC (northstarnm.com) was founded in 2006 to address the needs of the nuclear medicine market in the United States. A wholly owned subsidiary of NorthStar Medical Technologies LLC, the company is committed to resolving industry-wide supply challenges that have caused shortages of vital medical isotopes, negatively impacting patient care and stalling clinical research. Its patented technologies include innovative non-uranium based molybdenum-99 production methods, a novel separation chemistry system and tools for the nuclear medicine market.', 'Illinois Ventures, Oberland Capital, Hendricks Investment Holdings, Stateline Angels', 'Health Care, Travel and Tourism', 'Nuclear Physics; Nuclear Engineering', '', '$1M to $10M', '2006-01-01', 'year', '', '', '', 'Active', 'For Profit', '17', '', '', 'George Messina, Glenn Isensee', '', '3'],\n  ['Living Proof', 'https://www.crunchbase.com/organization/living-proof', 'Beauty, Biotechnology, Cosmetics', 'Cambridge, Massachusetts, United States', 'Living Proof is a biotechnology company developing product formulae to solve beautycare problems.', '22,039', '2013-02-21', '30000000', 'USD', '30000000', 'Series C', '53000000', 'USD', '53000000', '51-100', 'Private', '', '', '', 'http://www.livingproof.com', '', 'questions@livingproof.com', 'Living Proof was created for the purpose of applying advanced technology to solve the toughest beauty challenges from a completely fresh perspective. They are a team of scientists from outside beauty, led by MIT Institute Professor Dr. Bob Langer, and beauty authorities with a shared vision: to invent efficient formulas based on entirely new molecules and breakthrough technologies for results you can see from across the room.', 'Polaris Partners, Leerink Partners, Piper Jaffray', 'Biotechnology, Consumer Goods, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2004-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '21', '', 'Was Acquired', 'Amir Nashat, Daniel Anderson, Jon Flint, Mitch De Rosa, Robert Langer, Ward Stegerhoek', '', '3'],\n  ['AcelRx Pharmaceuticals', 'https://www.crunchbase.com/organization/acelrx-pharmaceuticals', 'Biotechnology, Health Care, Pharmaceutical', 'Redwood City, California, United States', 'AcelRx Pharmaceuticals is engaged in the development and commercialization of therapies for the treatment of pain and other conditions.', '22,049', '2021-01-20', '27500000', 'USD', '27500000', 'Post-IPO Equity', '121154902', 'USD', '121154902', '51-100', 'Public', '95000000', 'USD', '95000000', 'http://www.acelrx.com', 'http://www.linkedin.com/company/acelrx-pharmaceuticals-inc.', 'info@acelrx.com', 'AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of pain and other conditions. It offers NanoTab, a tablet for oral transmucosal administration. The company also provides Sufentanil NanoTab PCA system, a sublingual patient-controlled analgesia system with a drug/device combination product candidate for the management of acute post-operative pain in the hospital settings; Sufentanil NanoTab BTP management systems for the treatment option for patients with cancer pain; and Sufentanil/Triazolam NanoTab, which provides analgesia and sedation for minor outpatient procedures. It serves patients, physicians, regulators, and payers. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is based in Redwood City, California.', 'Hercules Capital, Inc.', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', 'Less than $1M', '2005-01-01', 'year', '1', 'IPO', '2011-02-18', 'Active', 'For Profit', '29', '1', 'Made Acquisitions', 'Pamela Pierce Palmer', '', '6'],\n  ['Synta Pharmaceuticals', 'https://www.crunchbase.com/organization/synta-pharmaceuticals', 'Biotechnology, Health Care, Medical, Pharmaceutical', 'Lexington, Massachusetts, United States', 'Synta Pharmaceuticals is focused on developing and commercializing small molecule drugs to treat cancer and chronic inflammatory diseases.', '22,126', '2015-04-01', '38500000', 'USD', '38500000', 'Post-IPO Equity', '217350000', 'USD', '217350000', '51-100', 'Delisted', '338170000', 'USD', '338170000', 'http://www.syntapharma.com', 'http://www.linkedin.com/company/synta-pharmaceuticals', 'ir@syntapharma.com', 'Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. It has a global partnership with Roche for developing novel CRACM inhibitors, an oral calcium released activated calcium modulator ion channel inhibitor program that is in the lead optimization stage for the treatment of autoimmune diseases. The company also retains rights in various indications and markets to its other drug candidates and programs, which include STA-9090, an Hsp90 inhibitor that is in Phase 1 development; elesclomol, an oxidative stress inducer for the treatment of cancer; and apilimod, an oral IL-12/23 inhibitor, which is in Phase 2 for rheumatoid arthritis. In addition, Synta Pharmaceuticals Corp. is developing STA-9584, a vascular disrupting agent that is in preclinical development. The company was incorporated in 2000 and is based in Lexington, Massachusetts.', 'SunAmerica, Galleon Group, Caxton Associates, Duquesne Capital Management, Gollust Management', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2000-01-01', 'year', '', 'IPO', '2007-02-09', 'Active', 'For Profit', '29', '1', 'Made Acquisitions', 'Safi Bahcall', '', '8'],\n  ['Cheetah Medical', 'https://www.crunchbase.com/organization/cheetah-medical', 'Biotechnology, Developer Platform, Medical', 'Newton Center, Massachusetts, United States', 'Cheetah Medical is a device company developing non-invasive cardiac output and hemodynamic monitoring devices.', '22,258', '2018-04-24', '6999999', 'USD', '6999999', 'Venture - Series Unknown', '91109534', 'USD', '91109534', '51-100', 'Private', '', '', '', 'http://www.cheetah-medical.com', 'https://www.linkedin.com/company/cheetah-medical', 'cheetah@cheetah-medical.com', 'Cheetah’s proprietary CHEETAH NICOM system is CE marked and FDA cleared.  It is the only non-invasive cardiac output monitor with substantial equivalence to the Swan Ganz thermodilution system for U.S. regulatory purposes.  The CHEETAH NICOM is now used by leading medical centers around the globe providing clinicians with invaluable clinical information in complicated scenarios. Cheetah Medical is committed to ongoing research and development and close cooperation with clinicians.', 'Robert Bosch Venture Capital, MVM Life Science Partners, Ascension Health, HighCape Partners, Fletcher Spaght, Inc.', 'Biotechnology, Health Care, Science and Engineering, Software', '', '', '$1M to $10M', '2001-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '30', '', 'Was Acquired', 'Hanan Keren', '', '7'],\n  ['CSA Medical', 'https://www.crunchbase.com/organization/csa-medical', 'Biotechnology, Health Care, Medical Device', 'Lutherville Timonium, Maryland, United States', 'CSA Medical is a provider of innovative spray cryotherapy medical device solutions.', '22,280', '2019-02-07', '45218361', 'USD', '45218361', 'Venture - Series Unknown', '106045664', 'USD', '106045664', '51-100', 'Private', '', '', '', 'http://www.csamedical.com', 'https://www.linkedin.com/company/csa-medical-inc/', '', 'CSA Medical provides cryotherapy systems. It offers CryoSpray Ablation system, which enables the physicians to freeze, destroy, and remove unwanted tissues, as well as transports liquid nitrogen that is passed through a standard endoscope. CSA Medical was formerly known as Crymed Technologies and changed its name to CSA Medical in April 2006. The company was incorporated in 1993 and is based in Lutherville Timonium, Maryland.', 'SV Health Investors, Horizon Technology Finance, New Markets Venture Partners, Rose Park Advisors, First Analysis', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10M to $50M', '1993-01-01', 'year', '', '', '', 'Active', 'For Profit', '19', '', '', 'Steve Schaefer, Steven E. Schaefer', '', '8'],\n  ['Vericel Corp', 'https://www.crunchbase.com/organization/aastrom-biosciences', 'Biotechnology, Life Science, Therapeutics', 'Ann Arbor, Michigan, United States', 'Vericel Corp is engaged in the development of treatments for critical cardiovascular diseases.', '22,573', '2018-06-07', '74800000', 'USD', '74800000', 'Post-IPO Equity', '114800000', 'USD', '114800000', '51-100', 'Public', '', '', '', 'http://vcel.com/', 'https://www.linkedin.com/company/vericel-corporation/', 'mail@vcel.com', 'Vericel (formerly Aastrom Biosciences) is developing patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. Aastrom markets two autologous cell therapy products in the United States for the treatment of cartilage repair and skin replacement. Aastrom is also developing MACI™, a third-generation autologous chondrocyte implantation product for the treatment of focal chondral cartilage defects in the knee, and ixmyelocel-T, a patient-specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy.', 'Eastern Capital', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$10M to $50M', '1989-01-01', 'year', '', 'IPO', '1997-02-04', 'Active', 'For Profit', '4', '', '', 'Bernhard Palsson', '', '2'],\n  ['Proteostasis Therapeutics', 'https://www.crunchbase.com/organization/proteostasis-therapeutics', 'Biotechnology, Medical, Therapeutics', 'Cambridge, Massachusetts, United States', 'Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.', '22,774', '2015-09-08', '37000000', 'USD', '37000000', 'Series B', '105012271', 'USD', '105012271', '51-100', 'Public', '', '', '', 'http://www.proteostasis.com', 'https://www.linkedin.com/company/proteostasis-therapeutics-inc', 'info@proteostasis.com', \"Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body's protein homeostasis, or Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases. These novel therapies, or Proteostasis Regulators, are designed to treat multiple genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as emphysema, type II diabetes, Alzheimer's Disease and Huntington's Disease.\", 'F-Prime Capital, New Enterprise Associates, Cormorant Asset Management, Rock Springs Capital, Sanofi Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2007-01-01', 'year', '', 'IPO', '2016-02-01', 'Active', 'For Profit', '44', '', '', 'Dean Richard Morimoto, Jeffery W. Kelly, Randall King', '', '4'],\n  ['Stereotaxis', 'https://www.crunchbase.com/organization/stereotaxis', 'Biotechnology, Health Care, Medical Device, Navigation', 'St Louis, Missouri, United States', 'Stereotaxis develops robotic cardiology instrument navigation systems that enhances the treatment of arrhythmias and coronary diseases.', '23,187', '2018-03-06', '10000000', 'USD', '10000000', 'Post-IPO Equity', '80000000', 'USD', '80000000', '51-100', 'Public', '', '', '', 'http://www.stereotaxis.com', 'http://www.linkedin.com/company/stereotaxis', 'ROW@stereotaxis.com', \"Stereotaxis focuses on the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. With over 100 patents for use in a hospital's interventional surgical suite, Stereotaxis helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced collaboration of life-saving information.  Stereotaxis' core technologies are the Niobe® ES Remote Magnetic Navigation system, the Odyssey™ portfolio of lab optimization, networking and patient information management systems and the Vdrive™ Robotic Mechanical Navigation system and consumables.\", 'Advantage Capital, Stifel Financial Corp., A.G. Edwards & Sons, Alafi Capital, Ascension Ventures', 'Biotechnology, Health Care, Navigation and Mapping, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '1990-01-01', 'year', '', 'IPO', '2016-08-04', 'Active', 'For Profit', '27', '', '', 'Robert McNeil', '', '5'],\n  ['Cerus', 'https://www.crunchbase.com/organization/cerus-corporation', 'Biotechnology, Health Care, Industrial Automation, Manufacturing, Smart Building', 'Concord, California, United States', 'Cerus is a biomedical products company focused in the field of blood safety.', '23,223', '2018-05-17', '15000000', 'USD', '15000000', 'Grant', '45000000', 'USD', '45000000', '51-100', 'Public', '', '', '', 'http://www.cerus.com/', 'http://www.linkedin.com/company/cerus-industrial', '', 'Cerus Corporation is a biomedical products company focused in the field of blood safety. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. In the United States, Cerus is seeking regulatory approval of the INTERCEPT Blood System for plasma and platelets. The INTERCEPT red blood cell system is in clinical development.', 'Oxford Finance LLC', 'Biotechnology, Health Care, Manufacturing, Real Estate, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2003-01-01', 'year', '', 'IPO', '1997-01-31', 'Active', 'For Profit', '56', '', '', 'B.J. Cassin, Stephen T. Isaacs', '', '2'],\n  ['Aratana Therapeutics', 'https://www.crunchbase.com/organization/aratana-therapeutics', 'Biotechnology, Health Care, Pharmaceutical', 'Leawood, Kansas, United States', 'Aratana Therapeutics develops innovative therapies for the animal health industry.', '24,090', '2018-03-15', '11700000', 'USD', '11700000', 'Post-IPO Equity', '128505998', 'USD', '128505998', '51-100', 'Delisted', '223000000', 'USD', '223000000', 'https://www.aratana.com', 'http://www.linkedin.com/company/aratana-therapeutics-inc', '', 'Aratana is uniquely positioned to deliver new, high-quality medicines to address unmet needs in companion animal care. We are committed to bringing world class science to animal health for companion animals and the people who care for them. Our competitive advantage resides in our ability to identify, acquire and develop high-value commercial products for companion animals in a cost effective and efficient manner.', 'MPM Capital, Avalon Ventures, Oxford Finance LLC, Middleland Capital, Sandbox Industries', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2010-01-01', 'year', '', 'M&A', '2013-06-27', 'Active', 'For Profit', '27', '2', 'Made Acquisitions, Was Acquired', 'Steven Peter', '', '7'],\n  ['ZS Pharma', 'https://www.crunchbase.com/organization/zs-pharma', 'Biotechnology, Health Care, Medical, Pharmaceutical', 'Coppell, Texas, United States', 'ZS Pharma develops ion trap therapies for the treatment of life-threatening medical conditions such as hyperkalemia and liver diseases.', '24,228', '2014-07-18', '20000000', 'USD', '20000000', 'Post-IPO Debt', '122987972', 'USD', '122987972', '51-100', 'Delisted', '300000000', 'USD', '300000000', 'http://zspharma.com', 'https://www.linkedin.com/company/zs-pharma-inc-', 'info@zspharma.com', \"ZS Pharma is a privately held specialty pharmaceutical company based in Coppell, Texas, and Menlo Park, CA. Its core focus is the research and development of highly selective ion-trap therapies to treat serious medical conditions. The company'ss therapeutic candidate, ZS-9, is a novel treatment for hyperkalemia, a life-threatening condition that affects patients with chronic kidney disease, hypertension, diabetes, and/or chronic heart failure. Hyperkalemia is characterized by abnormally high concentrations of potassium in the blood. ZS-9 is currently being tested in late-stage clinical trials.\", 'RA Capital Management, Novo Holdings, Adage Capital Management, Sofinnova Investments, RiverVest', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2008-01-01', 'year', '', 'M&A', '2014-06-19', 'Active', 'For Profit', '39', '', 'Was Acquired', 'Alvaro Guillem, D. Jeffrey Keyser', '', '5'],\n  ['Sunesis Pharmaceuticals', 'https://www.crunchbase.com/organization/sunesis-pharmaceuticals', 'Biotechnology, Health Care, Pharmaceutical', 'South San Francisco, California, United States', 'Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.', '24,376', '2016-04-01', '15000000', 'USD', '15000000', 'Post-IPO Debt', '171700000', 'USD', '171700000', '51-100', 'Delisted', '', '', '', 'http://www.sunesis.com', 'http://www.linkedin.com/company/sunesis-pharmaceuticals', 'info@sunesis.com', 'Sunesis is an emerging biopharmaceutical company creating new medicines to improve the lives of people with cancer. They are building a pipeline of drugs that selectively block critical mechanisms required for tumor growth and survival. The fight against cancer is an enormous mission that requires an integrated approach fueled by a commitment to innovation.', 'Venrock, New Enterprise Associates, Mayfield Fund, Warburg Pincus, Abingworth', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', 'Less than $1M', '1998-01-01', 'year', '', 'M&A', '2005-10-27', 'Active', 'For Profit', '15', '', 'Was Acquired', 'Jim Wells', '', '7'],\n  ['MDxHealth', 'https://www.crunchbase.com/organization/mdxhealth', 'Biotechnology, Health Diagnostics, Medical Device', 'Irvine, California, United States', 'MDxHealth is a molecular diagnostics company that develops epigenetic tests for cancer assessment and personalized treatment of patients.', '24,423', '2020-04-27', '14000000', 'USD', '14000000', 'Post-IPO Equity', '37680865', 'USD', '37680865', '51-100', 'Public', '', '', '', 'http://mdxhealth.com', 'https://www.linkedin.com/company/mdxhealth', 'info@mdxhealth.com', 'MDxHealth is a molecular diagnostics company that develops and commercializes advanced epigenetic tests for cancer assessment and the personalized treatment of patients.', 'Idinvest Partners, EASME - EU Executive Agency for SMEs, MVM Life Science Partners, Valiance Asset Management, Biovest International', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '2003-01-01', 'year', '', 'IPO', '2006-07-07', 'Active', 'For Profit', '16', '1', 'Made Acquisitions', '', '', '4'],\n  ['Ceterix Orthopaedics', 'https://www.crunchbase.com/organization/ceterix-orthopaedics', 'Biotechnology, Health Care, Medical Device', 'Menlo Park, California, United States', 'Ceterix Orthopaedics develops novel surgical tools for arthroscopic procedures.', '24,437', '2016-12-19', '23000000', 'USD', '23000000', 'Venture - Series Unknown', '107338328', 'USD', '107338328', '51-100', 'Private', '', '', '', 'http://www.ceterix.com', 'http://www.linkedin.com/company/2458318', 'info@ceterix.com', 'Ceterix Orthopaedics, Inc. develops novel surgical tools for arthroscopic procedures. The Ceterix technology enables surgeons to place stitches in very tight joint compartments, while protecting sensitive surrounding structures such as nerves, arteries and cartilage. This technology has applications in numerous arthroscopic procedures in knees, hips and shoulders. Ceterix was established in October 2010. The company was founded based on the inventions of Dr. Justin Saliman, an orthopaedic surgeon specializing in sports medicine. Dr. Saliman envisioned improving the outcomes of arthroscopic procedures by enabling surgeons to place suture patterns that today can be done only in open procedures, if at all. Ceterix is based in Menlo Park, California.', 'Versant Ventures, Silicon Valley Bank, Oxford Finance LLC, 5AM Ventures, Novo Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2010-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '26', '', 'Was Acquired', 'Justin Saliman', '', '5'],\n  ['Portola Pharmaceuticals', 'https://www.crunchbase.com/organization/portola-pharmaceuticals', 'Biopharma, Biotechnology, Therapeutics', 'South San Francisco, California, United States', 'Portola Pharmaceuticals develops therapeutics for acute and chronic cardiovascular, and autoimmune and inflammatory diseases.', '24,458', '2011-11-21', '89000000', 'USD', '89000000', 'Series D', '331099999', 'USD', '331099999', '51-100', 'Public', '469000000', 'USD', '469000000', 'http://www.portola.com', 'https://www.linkedin.com/company/portola-pharmaceuticals/', 'info@portola.com', \"Portola Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops therapeutics for acute and chronic cardiovascular and autoimmune/inflammatory diseases. The company's products include PRT054021, an oral factor Xa inhibitor for the prevention and treatment of deep vein thrombosis and pulmonary embolism after orthopedic surgery; for stroke prevention in patients with atrial fibrillation; and for secondary prevention of myocardial infarction and stroke. Its products also include PRT060128, an oral and intravenous ADP receptor antagonist for the treatment of patients with acute coronary syndrome; for the prevention of cardiovascular events in patients undergoing percutaneous coronary intervention; and for secondary prevention of myocardial infarction and stroke. In addition, the company's products include PRT062607, an oral Syk-specific kinase inhibitor for treating chronic inflammatory diseases and Rheumatoid Arthritis (RA) which is used to treat certain cancers including non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Portola Pharmaceuticals, Inc. was founded in 2003 and is based in South San Francisco, California.\", \"Goldman Sachs, Temasek Holdings, T. Rowe Price, MPM Capital, Ontario Teachers' Pension Plan\", 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2003-01-01', 'year', '', 'M&A', '2013-05-23', 'Active', 'For Profit', '70', '', 'Was Acquired', 'Charles Homcy, David Phillips', '', '6'],\n  ['BioAmber', 'https://www.crunchbase.com/organization/bioamber', 'Biotechnology, Chemical, GreenTech', 'Plymouth, Minnesota, United States', 'BioAmber is a sustainable chemicals\\xa0firm\\xa0combining biotechnology and chemical catalysis to convert renewable feedstock into chemicals.', '24,481', '2016-04-26', '10000000', 'CAD', '7922982', 'Post-IPO Debt', '155551114', 'USD', '155551114', '51-100', 'Delisted', '', '', '', 'http://www.bio-amber.com', 'http://www.linkedin.com/company/1630096', 'info@bio-amber.com', 'BioAmber is a private US company registered in the state of Delaware. The company, formerly known as DNP Green Technology, changed its name to BioAmber following its acquisition of its joint venture with ARD. Following the transaction, they adopted the name BioAmber, which had been used to that point by the joint venture.', 'Toyota Motor, Hercules Capital, Inc., Mitsui & Co, Export Development Canada, Samsung Ventures', 'Biotechnology, Science and Engineering, Sustainability', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$500M to $1B', '2008-01-01', 'year', '', 'IPO', '2013-05-10', 'Active', 'For Profit', '64', '', '', 'Jean-Francois Huc, Nathan Johnson', '', '8'],\n  ['Alexza Pharmaceuticals', 'https://www.crunchbase.com/organization/alexza-pharmaceuticals', 'Biotechnology, Health Care, Pharmaceutical', 'Mountain View, California, United States', 'Alexza Pharmaceuticals is a pharmaceutical company developing novel products for the treatment of acute and intermittent conditions.', '24,691', '2016-02-24', '5000000', 'USD', '5000000', 'Post-IPO Equity', '185730309', 'USD', '185730309', '51-100', 'Delisted', '176000000', 'USD', '176000000', 'http://www.alexza.com', 'http://www.linkedin.com/company/alexza-pharmaceuticals', 'busdev@alexza.com', 'Alexza Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. It was founded in 2001 and headquartered in Mountain View, California.', 'T. Rowe Price, Hercules Capital, Inc., Versant Ventures, New Enterprise Associates, Frazier Healthcare Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2001-01-01', 'year', '', 'M&A', '2006-03-08', 'Active', 'For Profit', '20', '1', 'Made Acquisitions, Was Acquired', 'Alejandro Zaffaroni, Josh Rabinowitz', '', '8'],\n  ['Biothera', 'https://www.crunchbase.com/organization/biothera', 'Biotechnology, Medical, Medical Device', 'Eagan, Minnesota, United States', 'Biothera is a biotechnology company developing natural gluco polysaccharides that engage and direct natural innate immune systems.', '24,738', '2018-03-15', '13567590', 'USD', '13567590', 'Undisclosed', '19730720', 'USD', '19730720', '51-100', 'Private', '', '', '', 'http://biothera.com', 'https://www.linkedin.com/company/biothera', 'bgacki@biothera.com', 'Biothera, Inc., a biotechnology company, develops a natural gluco polysaccharide that engages and directs natural innate immune systems. Biothera was formerly known as Biopolymer Engineering, Inc. and changed its name to Biothera, Inc. in March 2005. The company was founded in 1997 and is based in Eagan, Minnesota.', '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '1997-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '1', '', 'Was Acquired', 'Daniel Conners', '', '4'],\n  ['Anacor Pharmaceutical', 'https://www.crunchbase.com/organization/anacor-pharmaceutical', 'Biotechnology, Health Care, Pharmaceutical', 'Palo Alto, California, United States', 'Anacor Pharmaceutical is a biopharmaceutical company developing small-molecule therapeutics from its boron chemistry platform.', '25,014', '2013-06-12', '45000000', 'USD', '45000000', 'Post-IPO Debt', '198350000', 'USD', '198350000', '51-100', 'Delisted', '', '', '', 'http://www.anacor.com', 'http://www.linkedin.com/company/anacor-pharmaceuticals', 'info@anacor.com', 'Anacor Pharmaceuticals is a biopharmaceutical company that engages in developing small-molecule therapeutics from its boron chemistry platform. It focuses on developing topical applications of its compounds to treat fungal, bacterial, and inflammatory diseases.  The companyâ€™s primary product candidate, AN2690, is a novel topical antifungal for the treatment of toenail onychomycosis, a fungal infection of the nail and nail bed. It is also developing AN2728, an anti-inflammatory product candidate for the treatment of psoriasis; AN0128, a product candidate that has antibiotic and anti-inflammatory properties; and AN2718, which is in preclinical development for the topical treatment of vaginal candidiasis and tineapedis.', 'Hercules Capital, Inc., Venrock, Aberdare Ventures, GSK, Care Capital', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$50M to $100M', '2000-01-01', 'year', '', 'M&A', '2010-11-24', 'Active', 'For Profit', '2', '', 'Was Acquired', 'Lucy Shapiro, Stephen Benkovic', '', '9'],\n  ['ReShape Lifesciences', 'https://www.crunchbase.com/organization/reshape-medical', 'Biotechnology, Health Care, Medical Device', 'San Clemente, California, United States', 'ReShape Lifesciencesis a developer of minimally invasive medical devices to treat obesity and metabolic diseases.', '25,050', '2019-06-14', '8000000', 'USD', '8000000', 'Post-IPO Equity', '128750000', 'USD', '128750000', '51-100', 'Public', '', '', '', 'https://www.reshapelifesciences.com/', 'https://www.linkedin.com/company/reshape-lifesciences-inc.', 'info@ReShapeLifesci.com', 'ReShape Lifesciences (formerly EnteroMedics Inc.) is a developer of minimally invasive medical devices to treat obesity and metabolic diseases.', 'SV Health Investors, U.S. Venture Partners, Silicon Valley Bank, Endeavour Vision, Oxford Finance LLC', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2005-01-01', 'year', '', 'M&A', '2007-11-16', 'Active', 'For Profit', '22', '1', 'Made Acquisitions, Was Acquired', 'Mark B. Knudson', '', '13'],\n  ['KBP Biosciences', 'https://www.crunchbase.com/organization/kbp-biosciences', 'Biotechnology, Health Care, Pharmaceutical', 'Princeton, New Jersey, United States', 'A multinational clinical stage biotechnology company.', '25,196', '2018-01-05', '76000000', 'USD', '76000000', 'Series A', '76000000', 'USD', '76000000', '51-100', 'Private', '', '', '', 'https://kbpbiosciences.com/', 'https://www.linkedin.com/company/kbp-biosciences/', 'fred.yang@kbpbiosciences.com', 'KBP is a world-class biotechnology research & development organization dedicated to providing innovative therapies for unmet medical needs.', 'Cowin Capital, CASH Capital, SDIC Venture Capital, Korea Investment Partners, Bay City Capital', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '2007-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '', '', '', 'Brian McVeigh, Fred Yang, Robert Segal, Zhenhua Huang', '', '1'],\n  ['SCYNEXIS', 'https://www.crunchbase.com/organization/scynexis', 'Biotechnology, Health Care, Manufacturing, Pharmaceutical', 'Durham, North Carolina, United States', 'Scynexis engages in drug discovery, development and manufacturing projects in various areas.', '25,305', '2019-12-12', '35000000', 'USD', '35000000', 'Post-IPO Equity', '46449343', 'USD', '46449343', '51-100', 'Public', '84000000', 'USD', '84000000', 'http://scynexis.com', 'http://www.linkedin.com/company/scynexis', 'Business.Development@scynexis.com', 'SCYNEXIS, Inc. operates as a drug discovery and development company in the United States and internationally. It engages in drug discovery, development, and manufacturing projects in various areas, such as antibacterials, antifungals, antiparasitics, antivirals, carbohydrates, central nervous system, controlled substances, kinases, natural products, neglected diseases, nuclear hormones, nucleosides, oncology, ophthalmology, pain, and prodrugs. The company offers SCY-635, a drug that is used for patients who are chronically infected with genotype 1 hepatitis C virus. It also provides contract research solutions, including medicinal chemistry, discovery biology, ADMET-PK, bioanalysis and analytical chemistry, process chemistry, and cGMP manufacturing. The company delivers drug pipeline solutions to pharmaceutical, health, and life science partners. SCYNEXIS, Inc. was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. The company was incorporated in 1999 and is based in Durham, North Carolina.', '', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', 'Less than $1M', '1999-01-01', 'year', '', 'IPO', '2014-05-09', 'Active', 'For Profit', '36', '', '', '', '', '2'],\n  ['GI Dynamics', 'https://www.crunchbase.com/organization/gi-dynamics', 'Biotechnology, Health Care, Medical Device, Therapeutics', 'Lexington, Massachusetts, United States', 'GI Dynamics is a medical device company developing therapies for the treatment of type 2 diabetes and related metabolic diseases.', '25,381', '2019-08-23', '10000000', 'USD', '10000000', 'Post-IPO Equity', '199946120', 'USD', '199946120', '51-100', 'Public', '', '', '', 'http://www.gidynamics.com', '', 'info@gidynamics.com', 'GI Dynamics, Inc., a medical device company, develops therapies for the treatment of type 2 diabetes and related metabolic diseases in the United States. Its products also include EndoBarrier, a non-surgical therapy to treat type 2 diabetes and obesity. The company was founded in 2003 and is based in Lexington, Massachusetts.', 'Medtronic, Polaris Partners, Domain Associates, Advanced Technology Ventures, Catalyst Health Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', 'Less than $1M', '2003-01-01', 'day', '', 'IPO', '2011-09-16', 'Active', 'For Profit', '60', '', '', 'Andy Levine', '', '13'],\n  ['Cleveland BioLabs', 'https://www.crunchbase.com/organization/cleveland-biolabs', 'Biotechnology, Health Care, Medical', 'Buffalo, New York, United States', 'Cleveland BioLabs is a clinical-stage biotech developing a robust pipeline of drugs for multiple medical and defense applications.', '25,406', '2021-02-19', '14000000', 'USD', '14000000', 'Post-IPO Equity', '100926557', 'USD', '100926557', '51-100', 'Public', '70800000', 'USD', '70800000', 'http://www.cbiolabs.com', 'http://www.linkedin.com/company/cleveland-biolabs', '', 'Cleveland BioLabs is a clinical-stage biotech developing a robust pipeline of drugs for multiple medical and defense applications, with a focus on oncology and tissue protection. The company pursues the research, development, and commercialization of proprietary products that have the potential to treat cancer, prevent, and treat acute radiation syndrome and counteract the toxic effects of radio and chemotherapies for oncology patients. Cleveland BioLabs was established in 2003 and is headquartered in Buffalo, New York.', 'Hercules Capital, Inc., Norma Investment, David Davidovich', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', 'Less than $1M', '2003-01-01', 'year', '2', 'IPO', '2006-07-28', 'Active', 'For Profit', '11', '1', 'Made Acquisitions', '', '', '10'],\n  ['MyoScience', 'https://www.crunchbase.com/organization/myoscience', 'Biotechnology, Pharmaceutical, Therapeutics', 'Redwood City, California, United States', 'MyoScience develops and commercializes technology-driven dermatological products.', '25,642', '2018-03-12', '10000000', 'USD', '10000000', 'Venture - Series Unknown', '134600043', 'USD', '134600043', '51-100', 'Private', '', '', '', 'http://www.myoscience.com', 'https://www.linkedin.com/company-beta/352608/?pathWildcard=352608', 'contact@myoscience.com', 'MyoScience Inc. engages in development and commercialization of technology driven dermatological products. MyoScience Inc. was founded in 2005 and is headquartered in Redwood City, California.', 'Western Technology Investment, DeNovo Ventures, Accuitive Medical Ventures, Saratoga Ventures, Valiance Asset Management', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$100M to $500M', '2005-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '7', '', 'Was Acquired', 'Lisa Elkins', '', '7'],\n  ['Socati', 'https://www.crunchbase.com/organization/socati', 'Biotechnology', 'Austin, Texas, United States', 'Socati is the leading producer of precision cannabinoid ingredients featuring THC-free broad spectrum hemp extract', '25,897', '2019-01-29', '33000000', 'USD', '33000000', 'Series A', '42000000', 'USD', '42000000', '51-100', 'Private', '', '', '', 'https://socati.com/', 'https://www.linkedin.com/company/socati-corp/', 'info@socati.com', \"Headquartered in Austin, Texas Socati is the leading producer of precision cannabinoid ingredients & THC-free broad-spectrum hemp extract. The company provides a top-quality and consistent product for a market projected to reach $22 billion by 2022. Leveraging investments in new technologies, Socati engages in large scale manufacturing and processes industrial quantities of hemp biomass to meet demand. Socati's dedication to safe quality ingredients through its GFSI designation gives reach into large, international CPG companies that are seeking high-quality ingredients to deliver to a consumer market hungry for the benefits of hemp-infused goods.\", 'Jim Mellon, JJR Capital Corp, Lorne Abony', 'Biotechnology, Science and Engineering', '', '', '$10M to $50M', '2011-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '1', '1', 'Made Acquisitions', '', '', '2'],\n  ['Durect Corp.', 'https://www.crunchbase.com/organization/durect-corp', 'Biotechnology, Health Diagnostics, Pharmaceutical', 'Cupertino, California, United States', 'DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases, with late-stage development', '26,122', '2021-02-04', '42500000', 'USD', '42500000', 'Post-IPO Equity', '62500000', 'USD', '62500000', '51-100', 'Public', '', '', '', 'http://www.durect.com', '', '', 'DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases, with late-stage development programs including REMOXY®, POSIDUR™, ELADUR®, and TRANSDUR®-Sufentanil. DURECT’s proprietary oral, transdermal and injectable depot delivery technologies enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs', 'Oxford Finance LLC', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '1998-01-01', 'year', '', 'IPO', '2000-10-06', 'Active', 'For Profit', '3', '2', 'Made Acquisitions', '', '', '2'],\n  ['Amalgam Rx', 'https://www.crunchbase.com/organization/amalgam-rx', 'Biotechnology, CRM, Health Care, Information Technology, Life Science, Medical Device', 'Wilmington, Delaware, United States', 'Amalgam Rx is a digital health company that combines clinical and behavioral interventions to support patients, providers, & life sciences.', '26,456', '2017-06-16', '1223886', 'USD', '1223886', 'Seed', '1223886', 'USD', '1223886', '51-100', 'Private', '', '', '', 'http://amalgamrx.com/', 'https://www.linkedin.com/company/amalgamrx/', 'contact@amalgamrx.com', 'Amalgam Rx is the leader in bringing providers, life sciences, and digital solutions together. For more than 15 years, our team has been reimagining care delivery and creating lasting change across the chronic care ecosystem. Working in partnership with many of the world’s leading life sciences companies, Amalgam Rx has built an innovative platform for rapidly developing and scaling digital solutions — delivered through a wide variety of business models. Our proven end-to-end methodology enables the entire life cycle from R&D to commercialization. Amalgam’s solutions have generated more than 5 billion RWE data points utilized by patients and providers on three continents. For more information on how Amalgam Rx’s regulated, clinically validated technologies bring patients and providers closer together, reduce costs for payers, and unlock sustained value for partners, visit amalgamrx.com.', '', 'Biotechnology, Health Care, Information Technology, Sales and Marketing, Science and Engineering, Software', '', '', 'Less than $1M', '2016-01-01', 'year', '', 'Seed', '', 'Active', 'For Profit', '4', '1', 'Made Acquisitions', 'Ryan Sysko, Suzanne Sysko Clough', '', '1'],\n  ['Femasys', 'https://www.crunchbase.com/organization/femasys', \"Biotechnology, Health Care, Manufacturing, Medical Device, Robotics, Women's\", 'Suwanee, Georgia, United States', \"Femasys engages in R&D and manufacture of medical devices for women's healthcare.\", '26,483', '2017-01-18', '4000000', 'USD', '4000000', 'Venture - Series Unknown', '63903202', 'USD', '63903202', '51-100', 'Private', '', '', '', 'http://femasys.com', 'https://www.linkedin.com/company/femasys', 'customerservice@femasys.com', 'Femasys engages in the research and development, and manufacture of medical device solutions for women’s healthcare primarily for use in the physician’s office. Its products include FemVue Saline-Air Device, which creates and delivers an alternating pattern of saline and air as a continuous stream, and enables physicians to assess their patients’ fallopian tubes; and FemChec Pressure Management Device, which limits the maximum applied pressure while performing hysterosalpingogram. It offers FemCerv, an endocervical curettage device to collect a non-contaminated tissue sample for cervical cancer screening.  The company primarily serves customers in the United States.', 'Salem Partners, Legacy Capital Partners, Mario Family Funds', 'Biotechnology, Community and Lifestyle, Hardware, Health Care, Manufacturing, Science and Engineering, Software', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2004-01-01', 'year', '', '', '', 'Active', 'For Profit', '5', '', '', 'Kathy Lee-Sepsick', '', '10'],\n  ['Small Bone Innovations', 'https://www.crunchbase.com/organization/small-bone-innovations', 'Health Care, Medical, Pharmaceutical', 'Morrisville, Pennsylvania, United States', 'Small Bones Innovations makes devices for small bones and joints, particularly focusing on trauma and arthroplasty.', '26,662', '2011-12-07', '43000000', 'USD', '43000000', 'Debt Financing', '286200000', 'USD', '286200000', '51-100', 'Private', '', '', '', 'http://www.totalsmallbone.com', '', '', 'Small Bones Innovations (SBi) makes devices for small bones and joints, particularly focusing on trauma and arthroplasty.', 'Goldman Sachs, 3i Group, Fortress Investment Group, Khazanah Nasional, Trevi Health Ventures', 'Health Care', '', '', '$10M to $50M', '2004-05-01', 'day', '', 'M&A', '', 'Active', 'For Profit', '4', '2', 'Made Acquisitions, Was Acquired', 'John Viscogliosi', '', '7'],\n  ['Crescendo Bioscience', 'https://www.crunchbase.com/organization/crescendo-bioscience', 'Biotechnology, Health Care, Medical', 'South San Francisco, California, United States', 'Crescendo Bioscience develops diagnostic tools to provide rheumatologists with clinical insights to autoimmune and inflammatory disease.', '26,760', '2013-01-03', '28000000', 'USD', '28000000', 'Series D', '166682003', 'USD', '166682003', '51-100', 'Private', '', '', '', 'http://www.crescendobio.com', 'https://www.linkedin.com/company/myriad-genetics/', 'rrogers@myriad.com', 'Crescendo Bioscience, Inc. develops quantitative and objective diagnostic tools to provide rheumatologists with clinical insights to manage patients with autoimmune and inflammatory diseases. It provides diagnostic, prognostic, staging, therapy selection, and monitoring facilities to physicians. Crescendo Bioscience, Inc. was formerly known as Riley Genomics, Inc. The company was founded in 2002 and is based in South San Francisco, California.', 'Kleiner Perkins, Safeguard Scientifics, Mohr Davidow Ventures, Skyline Ventures, Aeris Capital', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', '$10M to $50M', '2002-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '26', '', 'Was Acquired', 'Michael B Centola, Michael Centola', '', '6'],\n  ['Pearl Therapeutics', 'https://www.crunchbase.com/organization/pearl-therapeutics', 'Biotechnology, Health Care, Medical', 'Morristown, New Jersey, United States', 'Pearl develops a combination of products for the treatment of respiratory diseases, including chronic obstructive pulmonary disease.', '27,027', '2013-04-01', '41726900', 'USD', '41726900', 'Venture - Series Unknown', '255500100', 'USD', '255500100', '51-100', 'Private', '', '', '', 'http://www.pearltherapeutics.com', 'https://www.linkedin.com/company/pearl-therapeutics/', 'info@pearltherapeutics.com', \"Pearl Therapeutics is developing unique dual and triple combination products for the treatment of widely prevalent respiratory diseases, including chronic obstructive pulmonary disease.  Pearl's current focus is on making advanced inhaled therapies available to broad patient populations via familiar and accepted metered dose inhalers. Pearl is a privately held company led by a seasoned team of respiratory product development experts.  Pearl aims to offer patients and healthcare providers alternatives that better meet their needs and improve upon the safety and efficacy of existing respiratory therapeutics to achieve better clinical outcomes.\", 'Nektar Therapeutics, Silicon Valley Bank, Oxford Finance LLC, 5AM Ventures, New Leaf Venture Partners', 'Biotechnology, Health Care, Science and Engineering', '', '', '$100M to $500M', '2006-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '26', '', 'Was Acquired', 'Sarvajna Dwivedi', '', '8'],\n  ['Egalet', 'https://www.crunchbase.com/organization/egalet', 'Biopharma, Biotechnology, Health Care', 'Wayne, Pennsylvania, United States', 'Egalet is a specialty pharmaceutical company that develops pain management products.', '27,705', '2016-09-01', '40000000', 'USD', '40000000', 'Post-IPO Debt', '115200000', 'USD', '115200000', '51-100', 'Public', '', '', '', 'http://www.egalet.com', 'https://www.linkedin.com/company/8281787?trk=prof-exp-company-name', 'info@egalet.com', 'Egalet is a specialty pharmaceutical company that develops pain management products. The company is developing a pipeline of abuse-resistant opioids that are nearing pivotal testing. Egalet has pioneered one of the world’s first erosion-based delivery technologies to enable the controlled release of drugs through gradual erosion of a tablet and has optimized the abuse deterrent properties that can be applied to a broad range of opioids and non-opioids.', 'Index Ventures, Omega Funds, Atlas Venture, Sunstone Life Science Ventures, Danske Bank', 'Biotechnology, Health Care, Science and Engineering', '', '', '$50M to $100M', '1995-01-01', 'year', '', 'IPO', '2019-03-22', 'Active', 'For Profit', '55', '', '', 'Jan Quistgaard', '', '6'],\n  ['HUYA Bioscience', 'https://www.crunchbase.com/organization/huya-bioscience-international', 'Biotechnology, Health Care, Pharmaceutical', 'San Diego, California, United States', 'HUYA Bioscience enables and accelerates the global development of novel biopharmaceutical product opportunities.', '27,926', '2015-04-22', '48000000', 'USD', '48000000', 'Debt Financing', '60613293', 'USD', '60613293', '51-100', 'Private', '', '', '', 'http://huyabio.com', 'https://in.linkedin.com/company/huya-bioscience-international', 'info@huyabio.com', 'HUYA Bioscience enables and accelerates the global development of novel biopharmaceutical product opportunities. It identifies and licenses pre-clinical and clinical-stage compounds, then leverages and extends the research efforts of its partners and also provides a bridge into the international development process and global biopharma market while lowering risk, providing partner companies with an ensured and continuous source of compounds for the future. HUYA Bioscience was founded in 2004 and is headquartered in San Diego, California.', '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2004-01-01', 'year', '', '', '', 'Active', 'For Profit', '14', '', '', 'Mireille Gillings', '', '3'],\n  ['Verdezyne', 'https://www.crunchbase.com/organization/verdezyne', 'Biotechnology, Clean Energy, Life Science', 'Carlsbad, California, United States', 'Verdezyne is an industrial biotechnology company using biological algorithms to produce chemicals from renewable non-food sources.\\xa0', '28,090', '2014-03-28', '48000000', 'USD', '48000000', 'Venture - Series Unknown', '86466000', 'USD', '86466000', '51-100', 'Private', '', '', '', 'http://www.verdezyne.com', 'https://www.linkedin.com/company/verdezyne', 'info@verdezyne.com', 'Verdezyne was a privately-held company that employs its biological expertise and proprietary advanced computational algorithms to design and synthesize novel, high-diversity gene libraries for engineering proteins, metabolic pathways, and microorganisms. The company creates and harnesses this unique biological diversity to optimize commercial fermentation processes for the production of petrochemical replacements.', 'BP, Tech Coast Angels, Sime Darby, DSM Venturing, Seraphim Capital', 'Biotechnology, Energy, Science and Engineering, Sustainability', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '', '2005-01-01', 'year', '', '', '', 'Closed', 'For Profit', '26', '', '', 'G. Wesley Hatfield, Richard H. Lathrop, Robert J. Molinari', '', '11'],\n  ['Astute Medical', 'https://www.crunchbase.com/organization/astute-medical', 'Biotechnology, Health Care, Health Diagnostics, Medical', 'San Diego, California, United States', 'Astute Medical provides diagnosis of high-risk medical conditions through the identification and validation of protein biomarkers.', '28,452', '2016-12-16', '43000000', 'USD', '43000000', 'Venture - Series Unknown', '209134082', 'USD', '209134082', '51-100', 'Private', '', '', '', 'http://www.astutemedical.com', '', 'info@astutemedical.com', \"Astute Medical is dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers that can serve as the basis for novel diagnostic tests. The Company's focus is on community and hospital-acquired acute conditions that require rapid diagnosis and risk assessment. The company's current areas of interest include abdominal pain, acute coronary syndromes, cerebrovascular injury, kidney injury and sepsis. Founded in 2007, the company is led by Christopher Hibberd and Paul McPherson, former members of the management at Biosite Incorporated, a leading diagnostics company acquired by Inverness Medical Innovations in 2007 for $1.7 billion. Hibberd served at Biosite for 10 years, most recently as Senior Vice President Corporate Development. Dr. McPherson was at Biosite for 14 years, most recently as Vice President Research and Development.\", 'MPM Capital, Domain Associates, Kaiser Permanente Ventures, Delphi Ventures, Fosun Pharma', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', '$10M to $50M', '2007-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '23', '', 'Was Acquired', 'Chris Hibberd, Paul McPherson', '', '9'],\n  ['Rheonix', 'https://www.crunchbase.com/organization/rheonix', 'Biotechnology, Health Care, Health Diagnostics, Homeland Security, Medical Device', 'Ithaca, New York, United States', 'RHEONIX develops automated molecular testing solutions for interchangeable purification, amplification and detection.', '29,025', '2015-10-20', '28600000', 'USD', '28600000', 'Venture - Series Unknown', '86724758', 'USD', '86724758', '51-100', 'Private', '', '', '', 'http://www.rheonix.com', 'http://www.linkedin.com/company/352574', 'info@rheonix.com', 'Rheonix, Inc. operates as a biomedical device company. Its products include CARD (Chemistry And Reagent Device) system to miniaturize and automate new and existing assays in multiple fields. Its products and technology are used in human/veterinary in vitro diagnostics, food/water testing, SNP analysis for personalized medicine applications, homeland security/defense applications, process control and final product QC, and tissue culture analysis in a research or production setting. Rheonix, Inc. was founded in 2007 and is based in Ithaca, New York.', 'Advantage Capital, Rand Capital, Cayuga Venture Fund, Gefinor Capital, Limestone Capital Advisors', 'Biotechnology, Health Care, Privacy and Security, Science and Engineering', 'Physical Or Chemical Processes Or Apparatus In General', '', '$1M to $10M', '2007-01-01', 'year', '', '', '', 'Active', 'For Profit', '6', '', '', 'Gregory J. Galvin', '', '7'],\n  ['OrthoAccel Technologies', 'https://www.crunchbase.com/organization/orthoaccel-technologies', 'Biotechnology, Developer Platform, Manufacturing, Medical', 'Houston, Texas, United States', 'OrthoAccel Technologies develops and manufactures an acceleration device for orthodontics.', '29,120', '2019-05-03', '20500000', 'USD', '20500000', 'Debt Financing', '87898975', 'USD', '87898975', '51-100', 'Private', '', '', '', 'http://www.acceledent.com/home', 'http://www.linkedin.com/company/orthoaccel-technologies-inc.', 'info@orthoaccel.com', 'OrthoAccel Technologies (OATI) designs, develops, markets, and sells the most revolutionary device in orthodontics – the Celerect 1000 – that cuts treatment time for braces in half and works in combination with all existing orthodontic bracket technologies. This proprietary technology (three issued patents) is licensed from the University of Illinois at Chicago and the company has engaged the leading researchers in this field including the inventor, Dr. Jeremy Mao, at Columbia University, Baylor College of Dentistry, and the University of Texas Health Sciences Center, Dental Branch. Together with these world-class partners, management will commercialize this innovation by 2009.', 'S3 Ventures, Comerica Incorporated, Houston Angel Network, Piper Jaffray, HealthpointCapital', 'Biotechnology, Health Care, Manufacturing, Science and Engineering, Software', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2007-02-01', 'day', '', 'Late Stage Venture', '', 'Active', 'For Profit', '20', '', '', 'Mike Lowe', '', '16'],\n  ['GENETICA® US', 'https://www.crunchbase.com/organization/genetica-us', 'Biotechnology', 'San Francisco, California, United States', 'Genetica® - Leading Gene Decoding In Asia', '29,325', '2021-03-10', '2500000', 'USD', '2500000', 'Seed', '2500000', 'USD', '2500000', '51-100', 'Private', '', '', '', 'https://genetica.asia/', 'https://www.linkedin.com/company/genetica-us', 'cs@genetica.asia', 'Originated from San Francisco, Genetica® is a leading and the fastest growing gene testing company in Asia with leading-edge proprietary technology.', 'Craig Sherman, Dave Strohm, Guy Miasnik', 'Biotechnology, Science and Engineering', '', '', '', '2018-05-16', 'day', '', 'Seed', '', 'Active', 'For Profit', '13', '', '', 'Duyen Bui, Giang Pham, Tuan Cao', '', '1'],\n  ['Array BioPharma', 'https://www.crunchbase.com/organization/array-biopharma', 'Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics', 'Boulder, Colorado, United States', 'Array BioPharma is a biopharmaceutical company focused on the development and commercialization of targeted small molecule drugs.', '29,433', '2016-09-17', '1400000', 'USD', '1400000', 'Post-IPO Equity', '121400000', 'USD', '121400000', '51-100', 'Public', '', '', '', 'http://arraybiopharma.com', 'https://www.linkedin.com/company/array-biopharma/', 'info@arraybiopharma.com', 'Array BioPharma is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company partnered drugs are binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology), and tucatinib (partnered with Cascadian Therapeutics).  The company is committed to providing therapies to patients. Array BioPharma was founded on 1998 and is headquartered in Boulder, Colorado.', 'Redmile Group, Deerfield Management', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$100M to $500M', '1998-01-01', 'year', '', 'M&A', '2000-11-01', 'Active', 'For Profit', '42', '', 'Was Acquired', 'Kevin Koch, Tony Piscopio', '', '3'],\n  ['Emisphere Technologies', 'https://www.crunchbase.com/organization/emisphere-technologies', 'Biotechnology, Clinical Trials, Pharmaceutical', 'Roseland, New Jersey, United States', 'Emisphere is a pharmaceutical company utilizing its proprietary Eligen Technology to create new oral formulations of therapeutic agents.', '29,825', '2014-08-20', '20000000', 'USD', '20000000', 'Post-IPO Debt', '42499964', 'USD', '42499964', '51-100', 'Public', '', '', '', 'http://www.emisphere.com/', '', 'mgarone@emisphere.com', \"Emisphere is a pharmaceutical company utilizing its proprietary Eligen Technology to create new oral formulations of therapeutic agents. Emisphere currently has a number of product candidates in its pipeline at varying stages. There are multiple product candidates in clinical development as well as several pre-clinical development/research programs. The Company considers specific criteria when deciding whether to devote resources to a development program. The markets that Emisphere seeks to enter for a potential product should be substantial. The product candidate should meet a clear unmet medical or market need and the product profile should clearly differentiate Emisphere's products. The Company also considers the level of product development effort in relation to a reasonable return on investment within an acceptable timeframe.\", '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '', '', '', 'M&A', '2009-06-09', 'Active', 'For Profit', '9', '', 'Was Acquired', '', '', '3'],\n  ['Enanta Pharmaceuticals', 'https://www.crunchbase.com/organization/enanta-pharmaceuticals', 'Biotechnology, Health Care, Pharmaceutical', 'Watertown, Massachusetts, United States', 'Enanta Pharmaceuticals is an R&D company\\xa0discovers, develops and promotes\\xa0of small molecule drugs in the areas of anti-infective.', '29,834', '2013-09-03', '9200000', 'USD', '9200000', 'Post-IPO Equity', '84600000', 'USD', '84600000', '51-100', 'Public', '', '', '', 'http://www.enanta.com', 'http://www.linkedin.com/company/enanta-pharmaceuticals', 'info@enanta.com', \"Enanta Pharmaceuticals, Inc., a research and development company, engages in the discovery, development, and promotion of small molecule drugs in the areas of anti-infective. It develops protease, NS5A, polymerase, and cyclophilin-based inhibitors for the treatment of hepatitis C virus (HCV). The company also develops ABT-450/r, an oral protease inhibitor for the treatment of hepatitis C (HCV) infection. In addition, it develops Bicyclolides, a macrolide antibiotic, which overcomes bacterial resistance; and EDP-420, a bicyclolide antibiotic for the treatment of community-acquired pneumonia. The company's antibacterial focus areas include superbugs, respiratory tract infections, and intravenous and oral treatments for hospital and community MRSA. The company has strategic alliances with Abbott Laboratories; and Shionogi & Co., LTD. Enanta Pharmaceuticals, Inc. was formerly known as NovirX, Inc. and changed its name to Enanta Pharmaceuticals, Inc. in May 1999. The company was founded in 1998 and is based in Watertown, Massachusetts.\", 'Advent International, Omega Funds, Oxford Bioscience Partners, Bioventures Investors, Yasuda Enterprise Development', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$50M to $100M', '1998-01-01', 'year', '', 'IPO', '2013-03-21', 'Active', 'For Profit', '72', '', '', '', '', '8'],\n  ['Stratos Genomics', 'https://www.crunchbase.com/organization/stratos-genomics', 'Biotechnology, Genetics, Medical Device, Product Design', 'Seattle, Washington, United States', 'Stratos Genomics develops Sequencing by Expansion (SBX), a single-molecule detection process that enables whole-genome sequencing.', '29,858', '2018-01-08', '20000000', 'USD', '20000000', 'Series B', '55929000', 'USD', '55929000', '51-100', 'Private', '', '', '', 'http://www.stratosgenomics.com', 'https://www.linkedin.com/company/stratos-genomics/', 'mkokoris@stratosgenomics.com', 'Stratos Genomics develops sequencing by expanding the single-molecule detection process that allows whole-genome sequencing.  The company was founded in 2007 and is based in Seattle, Washington.', 'Roche Venture Fund, Fisk Ventures', 'Biotechnology, Design, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$1M to $10M', '2007-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '11', '', 'Was Acquired', 'Allan Stephan, Mark Kokoris', '', '8'],\n  ['Virus Geeks Inc.', 'https://www.crunchbase.com/organization/virus-geeks', 'Biotechnology, Health Diagnostics, Information Technology', 'San Francisco, California, United States', 'SaaS, Mobile App, BioHealth, Information Technology', '29,914', '2020-12-01', '2000000', 'USD', '2000000', 'Seed', '2100000', 'USD', '2100000', '51-100', 'Private', '', '', '', 'http://www.virusgeeks.com', 'http://www.linkedin.com/company/virusgeeks', 'sales@virusgeeks.com', 'Virus Geeks is a data-driven BioHealth technology company that develops health-centric initiatives to improve the quality of life through strategic partnerships across healthcare & biotechnology sectors. We help communities gain access to COVID-19 testing and related healthcare benefits.', 'Curzon Investment', 'Biotechnology, Health Care, Information Technology, Science and Engineering', '', '', '', '2020-06-22', 'day', '', 'Seed', '', 'Active', 'For Profit', '', '', '', 'Frank Lee, Neil Kwan', '', '2'],\n  ['Antares Pharma', 'https://www.crunchbase.com/organization/antares-pharma', 'Health Care, Medical, Pharmaceutical', 'Minneapolis, Minnesota, United States', 'Antares Pharma is a revenue-generating product focused specialty pharmaceutical company', '30,212', '2017-06-07', '35000000', 'USD', '35000000', 'Post-IPO Debt', '45000000', 'USD', '45000000', '51-100', 'Public', '', '', '', 'http://www.antarespharma.com/', 'http://www.linkedin.com/company/antares-pharma-inc.', 'jhowarth@antarespharma.com', 'Antares Pharma is a revenue-generating product focused specialty pharmaceutical company that has developed three proprietary platforms, two of which now include FDA approved products. Our products typically improve safety and efficacy profiles by minimizing dosing and reducing side effects while improving patient compliance. We focus on self-injection pharmaceutical products and technologies and topical gel -based products. Our subcutaneous injection technology platforms include Vibex™ disposable pressure-assisted auto injectors, Vision® reusable needle-free injectors, and disposable multi-use pen injectors.', 'Hercules Capital, Inc., MMV Capital Partners, HSBC Venture Capital Coverage Group', 'Health Care', '', '', '', '1979-01-01', 'year', '', 'IPO', '2017-08-27', 'Active', 'For Profit', '42', '', '', '', '', '2'],\n  ['Lycera', 'https://www.crunchbase.com/organization/lycera', 'Biopharma, Biotechnology, Pharmaceutical', 'Ann Arbor, Michigan, United States', 'Lycera engages in the development of small-molecule immunomodulators for the treatment of patients with autoimmune diseases.', '30,537', '2015-06-22', '29892748', 'USD', '29892748', 'Series B', '85892748', 'USD', '85892748', '51-100', 'Private', '', '', '', 'http://www.lycera.com', 'https://www.linkedin.com/company/lycera', 'info@lycera.com', \"Lycera is a preclinical-stage biopharma company focused on small molecule immunomodulators for the treatment of rheumatoid arthritis, lupus erythematosus, and inflammatory bowel disease Lycera's first-in-class drugs are designed to treat immune disorders. The company's technology platforms include proprietary small molecules that modulate a target, which is central to cellular bioenergetics along with molecules that target the Th17 pathway. Drugs that emerge from the Lycera pipeline will represent first-in-class agents that have the potential for first-in-class oral efficacy without the adverse effects of current standard-of-care antiproliferative and immunosuppressive agents.\", 'ARCH Venture Partners, InterWest Partners, Clarus Ventures, EDF Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$1M to $10M', '2006-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '21', '', 'Was Acquired', 'Anthony Opipari, Gary Glick', '', '6'],\n  ['Luna Innovations', 'https://www.crunchbase.com/organization/luna-innovations', 'Biotechnology, Hardware, Manufacturing', 'Roanoke, Virginia, United States', 'Luna Innovations develops sensing and instrumentation products for the healthcare, telecommunications, energy and defense sectors.', '30,589', '2014-04-24', '6000000', 'USD', '6000000', 'Post-IPO Equity', '13115002', 'USD', '13115002', '51-100', 'Public', '', '', '', 'http://www.lunainnovations.com', 'http://www.linkedin.com/company/luna-innovations', 'ir@lunainnovations.com', \"Luna Innovations is focused on sensing and instrumentation. Luna develops and manufactures new-generation products for the healthcare, telecommunications, energy and defense markets. The company's products are used to measure, monitor, protect and improve critical processes in the markets we serve. Luna, a recognized leader in transitioning science to solutions, is headquartered in Roanoke, Virginia.\", 'Intuitive Surgical', 'Biotechnology, Hardware, Manufacturing, Science and Engineering', 'Testing', '', '$10M to $50M', '1990-01-01', 'year', '', 'IPO', '2006-06-02', 'Active', 'For Profit', '21', '4', 'Made Acquisitions', '', '', '2'],\n  ['BAROnova', 'https://www.crunchbase.com/organization/baronova', 'Biotechnology, Developer Platform, Health Care, Medical Device', 'Goleta, California, United States', 'BAROnova is a clinical-stage medical-device company focused on developing non-surgical non-pharmacologic devices to induce weight loss.', '30,899', '2016-09-14', '7500000', 'USD', '7500000', 'Debt Financing', '85900000', 'USD', '85900000', '51-100', 'Private', '', '', '', 'http://www.baronova.com', '', 'inquiries@baronova.com', 'BAROnova, founded in 2006 and based in Goleta, CA, is a clinical-stage medical-device company focused on developing non-surgical non-pharmacologic devices to induce weight loss.', 'Boston Scientific, Highland Capital Partners, Longitude Capital, Lumira Ventures, Allergan', 'Biotechnology, Health Care, Science and Engineering, Software', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2006-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '7', '', '', 'HUGH NARCISO', '', '7'],\n  ['Plandai Biotechnology', 'https://www.crunchbase.com/organization/plandai-biotechnology', 'Biotechnology, Health Care, Nutraceutical, Pharmaceutical', 'Seattle, Washington, United States', 'Plandaí\\xad Biotechnology, Inc. intends to transform the world of nutraceuticals by making available extracts from live plant material that', '31,335', '2014-02-10', '15300000', 'USD', '15300000', 'Post-IPO Equity', '15300000', 'USD', '15300000', '51-100', 'Public', '', '', '', 'http://plandaibiotech.com', '', 'info@plandaibiotech.com', 'Plandaí\\xad Biotechnology, Inc. intends to transform the world of nutraceuticals by making available extracts from live plant material that deliver the highest levels of bioavailability currently in the market. Our headquarters are in Seattle, Washington, USA. Although we also have a global presence with offices in London, England and Nelspruit in the province of Mpumalanga, South Africa. This enables us to react more efficiently to any worldwide market changes as well as to any customer requirements.', 'Lincoln Park Capital Fund', 'Biotechnology, Health Care, Science and Engineering', 'Foods Or Foodstuffs; Their Treatment, Not Covered By Other Classes', '', 'Less than $1M', '2012-01-01', 'year', '', 'IPO', '2012-01-05', 'Active', 'For Profit', '1', '', '', '', '', '1'],\n  ['Cellular Dynamics International', 'https://www.crunchbase.com/organization/cellular-dynamics-international', 'Biotechnology, Health Care, Medical', 'Madison, Wisconsin, United States', 'Cellular Dynamics International develops stem cell technologies for drug development and personalized medicine applications.', '31,522', '2013-07-03', '20000000', 'USD', '20000000', 'Debt Financing', '129641664', 'USD', '129641664', '51-100', 'Delisted', '204000000', 'USD', '204000000', 'http://www.cellulardynamics.com', 'http://www.linkedin.com/company/cellular-dynamics-international', '', \"Cellular Dynamics International Inc., (CDI) is a developer and manufacturer of fully functioning cells in industrial quantities to precise specifications. CDI's proprietary products include true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell Products). CDI's products provide standardized, easy-to-use, cost-effective access to the human cell, the smallest fully functioning operating unit of human biology. Customers use our products, among other purposes, for drug discovery and screening, to test the safety and efficacy of their small molecule and biological drug candidates, for stem cell banking, and in the research and development of cellular therapeutics. \", 'Wisconsin Alumni Research Foundation, Equity Group Investments, Rose Ventures, Tactics II Stem Cell Ventures, Tactics II Investments', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$10M to $50M', '2004-01-01', 'year', '', 'M&A', '2013-07-25', 'Active', 'For Profit', '89', '', 'Was Acquired', 'Craig T. January, Igor Slukvin, James A. Thomson, Robert J. Palay, Thomas M. Palay, Timothy J. Kamp', '', '5'],\n  ['Paradigm Spine', 'https://www.crunchbase.com/organization/paradigm-spine', 'Health Care, Manufacturing, Medical Device, Pharmaceutical', 'New York, New York, United States', 'Paradigm Spine is a medical device company developing spinal implants for the spine and orthopedic markets.', '31,645', '2014-02-23', '75000000', 'USD', '75000000', 'Debt Financing', '167552310', 'USD', '167552310', '51-100', 'Private', '', '', '', 'http://www.paradigm-spine.de', 'https://www.linkedin.com/company/paradigm-spine-llc', 'info@paradigmspine.de', \"Paradigm Spine, LLC (Paradigm Spine) is a privately-held medical device company, engaged in the development of spinal implants for the spine and orthopedic markets. It develops non fusion spinal implants, motion preserving products and tissue sparing products. Paradigm Spine's product Coflex, an interspinous implant used in the treatment of facet arthosis and decompressive procedures. Its products are used for spinal stabilization, rebalances spinal segment and restores natural anatomical function. The company is headquartered in New York, the US. The company also focused on the development of DSS system, a minimally-invasive pedicle-screw based system, which received a European CE Mark in April 2007 and FDA market clearance in January 2008.\", 'PDL Biopharma, Tim Davis, Trevi Health Ventures, Fifth Third Capital, Praefinium Partners', 'Health Care, Manufacturing', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2005-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '13', '', 'Was Acquired', 'John Viscogliosi', '', '9'],\n  ['NeuMoDx Molecular', 'https://www.crunchbase.com/organization/neumodx-molecular', 'Biotechnology, Health Care, Health Diagnostics, Medical', 'Ann Arbor, Michigan, United States', 'NeuMoDx Molecular, Inc. operates as a molecular diagnostics company. The company develops solutions for molecular diagnostic (MDx) testing', '31,903', '2018-05-03', '20039942', 'USD', '20039942', 'Venture - Series Unknown', '66039937', 'USD', '66039937', '51-100', 'Private', '', '', '', 'http://neumodx.com', 'https://www.linkedin.com/company/neumodx-molecular-inc./', 'info@neumodx.com', 'NeuMoDx Molecular, Inc. operates as a molecular diagnostics company. The company develops solutions for molecular diagnostic (MDx) testing in hospital and clinical reference laboratories.', 'Baird Capital, Pfizer Venture Investments, Arboretum Ventures, Venture Investors, Wolverine Venture Fund', 'Biotechnology, Health Care, Science and Engineering', 'Physical Or Chemical Processes Or Apparatus In General', '', '$1M to $10M', '2012-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '4', '', 'Was Acquired', 'Jeff Williams', '', '4'],\n  ['SkinMedica', 'https://www.crunchbase.com/organization/skinmedica', 'Biotechnology, Medical, Medical Device', 'Carlsbad, California, United States', 'SkinMedica is focused on developing, acquiring, and commercializing products that improve the appearance of skin.', '32,139', '2012-01-06', '16750000', 'USD', '16750000', 'Venture - Series Unknown', '96188712', 'USD', '96188712', '51-100', 'Private', '', '', '', 'http://www.skinmedica.com', '', 'info@skinmedica.com', \"SkinMedica is focused on developing, acquiring, and commercializing products that improve the appearance of skin. SkinMedica markets and sells to physicians, with a focus on aesthetics, both prescription and non-prescription skin care products. The company's full line of aesthetic skin care products includes the revolutionary TNS Essential Serum® and hallmark TNS Recovery Complex®. The formulations in SkinMedica’s clinical skin care collection enhance skin appearance, reduce signs of aging, and provide other skin care benefits. SkinMedica's primary prescription product, VANIQA® (eflornithine hydrochloride) Cream 13.9%, is the only FDA-approved prescription product for the reduction of unwanted facial hair in women. Colorescience Pro’s dermatologist recommended, high-performance cosmetics are formulated to remedy and camouflage specific skin concerns and protect skin from damaging effects of the sun and environment. Colorescience Pro’s luxury aesthetic makeup line is sold in the physician and medical spa channels.\", 'Apax Partners, Greenspring Associates, Domain Associates, HealthCare Ventures, Split Rock Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$50M to $100M', '1999-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '30', '1', 'Made Acquisitions, Was Acquired', 'Richard Fitzpatrick', '', '7'],\n  ['SIGA Technologies', 'https://www.crunchbase.com/organization/siga-technologies', 'Biotechnology', 'New York, New York, United States', 'At SIGA, we specialize in developing therapeutic solutions for some of the most lethal pathogens – smallpox.', '32,376', '2020-06-17', '23000000', 'USD', '23000000', 'Grant', '84000000', 'USD', '84000000', '51-100', 'Public', '', '', '', 'http://www.siga.com/', 'http://www.linkedin.com/company/siga-technologies', '', 'SIGA is a pharmaceutical company specializing in the development of pharmaceutical solutions for some of the most lethal pathogens – variola (smallpox), Ebola, dengue, Lassa fever and other dangerous viruses. Our objective is to discover, develop, and commercialize drugs to prevent and treat these high-priority threats.  Our mission is to disarm dreaded viral diseases and create robust, modern biodefense countermeasures.', 'Biomedical Advanced Research and Development Authority (BARDA), National Institute of Allergy and Infectious Diseases, National Institutes of Health', 'Biotechnology, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1995-01-01', 'year', '', 'IPO', '1997-09-12', 'Active', 'For Profit', '6', '2', 'Made Acquisitions', 'Judson A. Cooper', '', '4'],\n  ['AirXpanders', 'https://www.crunchbase.com/organization/airxpanders', 'Biotechnology, Health Care, Medical Device', 'Mountain View, California, United States', 'AirXpanders develop technology enabling tissue expansion after reconstructive surgery with an emphasis on breast reconstruction.', '32,941', '2018-09-11', '15000000', 'USD', '15000000', 'Post-IPO Equity', '138918456', 'USD', '138918456', '51-100', 'Public', '', '', '', 'http://www.airxpanders.com', 'http://www.linkedin.com/company/1446970', 'info@airxpanders.com', 'AirXpanders develop technology enabling tissue expansion after reconstructive surgery with an emphasis on breast reconstruction. It addresses current unmet needs for patients who require tissue expansion after reconstructive surgery with the first emphasis on breast reconstruction. Present methods of tissue expansion utilize saline-filled implants that are typically injected on a weekly basis after surgery in order to reach the volume of skin and tissue required for the placement of a permanent breast implant.', 'Correlation Ventures, Vivo Capital, Western Technology Investment, Oxford Finance LLC, GE Capital', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2006-01-01', 'year', '', 'IPO', '2015-06-23', 'Active', 'For Profit', '29', '', '', 'Barry Cheskin, Sam Sawan, Teddy Shalon', '', '15'],\n  ['OptiScan Biomedical', 'https://www.crunchbase.com/organization/optiscan-biomedical', 'Biotechnology, Health Care, Medical', 'Hayward, California, United States', 'OptiScan Biomedical develops glucose monitoring systems to assist healthcare providers to manage the glucose level of the patients.', '33,622', '2019-03-20', '20000000', 'USD', '20000000', 'Series E', '165033282', 'USD', '165033282', '51-100', 'Private', '', '', '', 'http://www.optiscancorp.com', '', 'info@optiscancorp.com', 'OptiScan Biomedical Corporation develops glucose monitoring systems for the intensive care unit (ICU)/CCU. It offers OptiScanner, an automated, bedside glucose monitoring system to assist healthcare providers manage the glucose level of critically ill patients. The company’s OptiScanner provides serial blood glucose measurements for a range of glucose concentrations. OptiScan Biomedical Corporation was founded in 1994 and is based in Hayward, California.', 'Wellcome Trust, Morgenthaler Ventures, Wexford Capital, Mitsui Global Investment, JPMorgan Partners (JPMP)', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '1994-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '3', '', '', 'Daniel Goldberger', '', '7'],\n  ['Siluria Technologies', 'https://www.crunchbase.com/organization/siluria-technologies', 'Biotechnology, Chemical, Fuel, Nanotechnology', 'San Francisco, California, United States', 'Siluria Technologies is a material innovation company developing processes for transforming natural gas into chemicals and fuels.', '33,811', '2016-07-13', '45000000', 'USD', '45000000', 'Series E', '150662685', 'USD', '150662685', '51-100', 'Private', '', '', '', 'http://www.siluria.com', 'https://www.linkedin.com/company/1856109', 'info@siluriatech.com', \"Siluria Technologies is a materials innovation company solving global challenges for partners in the natural gas, chemicals and fuel industries. Integrating nanotechnology, biotechnology and chemical engineering, Siluria has developed a solution to the grand challenge of efficient manufacturing: the ability to produce chemicals and fuels from a cheaper, more abundant resource than oil. The company's economically superior, energy-efficient platform converts natural gas into the same materials manufactured today using current industry infrastructure. Siluria's world-class R&D and engineering teams are rapidly commercializing the company's technology to pilot-scale production in close dialogue with the world's largest chemical and fuel companies.Siluria's backers include Alloy Ventures, ARCH Venture Partners, Kleiner Perkins Caufield & Byers, Altitude Life Science Ventures, Lux Capital, and Presidio Ventures.\", 'Wellcome Trust, Lux Capital, Vulcan Capital, ARCH Venture Partners, Kleiner Perkins', 'Biotechnology, Energy, Science and Engineering', 'Organic Chemistry', '', '$10M to $50M', '2008-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '22', '', '', 'Alex Tkachenko, Angela Belcher', '', '7'],\n  ['MusclePharm', 'https://www.crunchbase.com/organization/musclepharm', 'Health Care, Pharmaceutical, Sports', 'Denver, Colorado, United States', 'MusclePharm provides sports nutrition products and supplements for athletes of all kinds.', '33,833', '2016-01-14', '10000000', 'USD', '10000000', 'Post-IPO Equity', '31647506', 'USD', '31647506', '51-100', 'Public', '', '', '', 'http://musclepharm.com', 'https://www.linkedin.com/in/musclepharm-corporation-b7bb4876', 'customerservice@musclepharm.com', \"Headquartered in Denver, Colorado, MusclePharm Corporation is the healthy lifestyle company that truly lives and breathes the healthy lifestyle. MusclePharm develops and manufactures a full line of nutritional supplements that are free of banned substances. Every product is tested by the world's most regarded independent testing organizations and represents years of exhaustive research by the sports medicine professionals at the MusclePharm Sports Science Center Research Institute. Top nutritional scientists and doctors utilize an advanced six-stage research protocol, then field-test each supplement with the help of hundreds of professional athletes.\", 'Prestige Capital Corporation, The Frost Group', 'Health Care, Sports', 'Foods Or Foodstuffs; Their Treatment, Not Covered By Other Classes', '', '$10M to $50M', '2008-04-01', 'day', '1', 'IPO', '2010-04-23', 'Active', 'For Profit', '17', '', '', 'Brad Pyatt, Cory Gregory', '', '6'],\n  ['Galena Biopharma', 'https://www.crunchbase.com/organization/galena-biopharma', 'Biotechnology, Health Diagnostics, Medical', 'Portland, Oregon, United States', 'Galena Biopharma, Inc. is focused on discovering, developing and commercializing innovative therapies.', '34,193', '2016-07-26', '9100000', 'USD', '9100000', 'Post-IPO Debt', '33100000', 'USD', '33100000', '51-100', 'Delisted', '', '', '', 'http://galenabiopharma.com/', 'http://www.linkedin.com/company/galena-biopharma', 'ir@galenabiopharma.com', 'Galena Biopharma, Inc. (Galena) is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using targeted biotherapeutics. The Company is pursuing the development of cancer therapeutics using peptide-based immunotherapy products, including its main product candidate, NeuVaxTM (E75), for the treatment of breast cancer and other tumors. NeuVax is a peptide-based immunotherapy intended to reduce the recurrence of breast cancer in low-to-intermediate HER2-positive breast cancer patients not eligible for trastuzumab (Herceptin; Genentech/Roche). In January 2014, Galena Biopharma Inc acquired Mills Pharmaceuticals, which has the worldwide rights to GALE-401 (Anagrelide CR), a patented, controlled release formulation of anagrelide.', '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2003-01-01', 'year', '', 'IPO', '2008-03-20', 'Active', 'For Profit', '65', '1', 'Made Acquisitions', 'Craig Mello', '', '2'],\n  ['Sonendo', 'https://www.crunchbase.com/organization/sonendo', 'Biotechnology, Health Care, Medical', 'Laguna Hills, California, United States', 'Sonendo is a developing innovative and disruptive technologies to transform endodontic therapy.', '34,419', '2020-01-06', '85000000', 'USD', '85000000', 'Venture - Series Unknown', '271749879', 'USD', '271749879', '51-100', 'Private', '', '', '', 'http://www.sonendo.com', 'http://www.linkedin.com/company/sonendo-inc', 'info@sonendo.com', 'Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely used endodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.', 'General Atlantic, OrbiMed, Redmile Group, Perceptive Advisors, Meritech Capital Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2006-06-01', 'day', '', '', '', 'Active', 'For Profit', '13', '1', 'Made Acquisitions', 'Olav Bergheim', '', '13'],\n  ['Incube Labs', 'https://www.crunchbase.com/organization/incube-labs', 'Biotechnology, Life Science, Medical Device', 'San Antonio, Texas, United States', 'InCube Labs is a life sciences research lab focused on developing medical breakthroughs that dramatically improve patient outcomes.', '34,616', '2018-11-01', '', '', '', 'Venture - Series Unknown', '30000000', 'USD', '30000000', '51-100', 'Private', '', '', '', 'http://www.incubelabs.com', '', 'jobs@incubelabs.com', 'InCube Labs is a life sciences research lab focused on developing medical breakthroughs that dramatically improve patient outcomes. Their multi-disciplinary approach integrates traditional device technologies such as electronics, software, mechanical engineering and material science, with innovations from the pharmaceutical industry, often involving protein chemistry, pharmacology and cell biology. InCube is led by Mir Imran, an accomplished medical innovator, entrepreneur and venture capitalist, who has founded more than 20 life sciences companies and holds more than 200 patents. Many of Imran’s innovations have resulted in new standards of care, including the first FDA-approved Automatic Implantable Cardioverter Defibrillator.', 'Sebastian Zhou', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10M to $50M', '2007-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', 'Mir Imran', '', '2'],\n  ['Iroko Pharmaceuticals', 'https://www.crunchbase.com/organization/iroko-pharmaceuticals', 'Biotechnology, Life Science, Pharmaceutical', 'Philadelphia, Pennsylvania, United States', 'Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.', '34,697', '2016-06-29', '140000000', 'USD', '140000000', 'Debt Financing', '215000000', 'USD', '215000000', '51-100', 'Private', '', '', '', 'http://iroko.com', '', 'info@iroko.com', 'In the short period since Iroko was founded in 2007, we have assembled a portfolio of proven pharmaceuticals, especially prescription pain medicines. Our goal has been to bring new life to these trusted products—new geographic markets, new indications, and new benefits through further development enabled by new technology. We have already extended a distribution and sales network across more than 40 countries. And we have developed an industry-leading pipeline of nano-formulated lower-dose NSAIDs to address the need for new options in pain management. Experience. Marketed products. A global presence. Innovation. That’s Iroko. We’re an established company. And we’re hurrying to improve healthcare.', 'OrbiMed, CRG', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2007-01-01', 'year', '', '', '', 'Active', 'For Profit', '8', '', '', 'Osagie O. Imasogie', '', '2'],\n  ['Amastan Technologies', 'https://www.crunchbase.com/organization/amastan-technologies', 'Biotechnology, Information Technology, Market Research', 'North Andover, Massachusetts, United States', 'Amastan Technologies LLC specializes in the development, commercialization and implementation of plasma technologies.', '34,735', '2019-05-20', '11000000', 'USD', '11000000', 'Series B', '28968545', 'USD', '28968545', '51-100', 'Private', '', '', '', 'http://www.amastan.com/', '', 'info@amastan.com', 'Amastan Technologies LLC specializes in the development, commercialization and implementation of plasma technologies for the production and processing of nanomaterials.  Amastan proudly relies on its highly educated scientists and engineers who combine industry and academic experience in a variety of fields such as plasma physics and plasma chemistry, industrial processes, material sciences, and engineering.\\ufeff\\ufeff', 'Anzu Partners, LaunchCapital, Material Impact Fund, MassDevelopment, RKS Ventures', 'Biotechnology, Data and Analytics, Design, Information Technology, Science and Engineering', 'Ferrous Or Non-Ferrous Alloys', '', 'Less than $1M', '2007-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '1', '', '', 'Kamal Hadidi', '', '4'],\n  ['Kythera Biopharmaceuticals', 'https://www.crunchbase.com/organization/kythera-biopharmaceuticals', 'Biopharma, Biotechnology, Health Care', 'Calabasas, California, United States', 'Kythera Biopharmaceuticals\\xa0discovers, develops and commercializes novel prescription products for the aesthetic medicine market.', '34,918', '2011-09-19', '37400000', 'USD', '37400000', 'Series D', '98400000', 'USD', '98400000', '51-100', 'Delisted', '', '', '', 'http://www.kytherabiopharma.com', 'http://www.linkedin.com/company/kythera-biopharmaceuticals', 'amunshi@kytherabiopharma.com', 'KYTHERA Biopharmaceuticals, Inc., formerly known as AESTHERx, Inc., was founded in August 2005 and is a privately held biopharmaceutical company located north of Los Angeles in southern California. KYTHERA is focused on science and innovation in aesthetic medicine. This market is expanding rapidly driven by an aging population, increasing discretionary income, and an evolution of patient preference toward restorative and preventative care. The company uses the tools of biotechnology to develop prescription therapeutics for this emerging market.', 'Versant Ventures, ARCH Venture Partners, Invus, Prospect Venture Partners, Wilson Sonsini Goodrich & Rosati', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2005-08-01', 'day', '', 'M&A', '2012-10-11', 'Active', 'For Profit', '18', '', 'Was Acquired', 'Jay Birnbaum, Nathaniel David', '', '4'],\n  ['NKGen Biotech', 'https://www.crunchbase.com/organization/nkgenbiotech', 'Biotechnology, Life Science', 'Santa Ana, California, United States', 'NKGen Biotech is restoring immune function through the development of unique natural killer (NK) cell therapies.', '35,034', '2019-12-17', '11000000', 'USD', '11000000', 'Seed', '11000000', 'USD', '11000000', '51-100', 'Private', '', '', '', 'https://nkgenbiotech.com/', 'https://www.linkedin.com/company/nkgen-biotech-inc', 'info@nkgenbiotech.com', \"NKGen Biotech is harnessing the power of the body's immune system through the development of unique Natural Killer (NK) cell therapies.  NK cell adoptive immunotherapy enhances a patient's ability to destroy abnormal cells.\", 'Gaingels', 'Biotechnology, Science and Engineering', '', '', '$1M to $10M', '2017-01-01', 'year', '', 'Seed', '', 'Active', 'For Profit', '', '', '', 'Sangwoo Park', '', '1'],\n  ['Tenex Health', 'https://www.crunchbase.com/organization/tenex-health', 'Biotechnology, Health Care, Therapeutics', 'Lake Forest, California, United States', 'Tenex Health develops minimally invasive therapies for the removal of diseased soft tissue and the restoration of musculoskeletal function.', '35,188', '2012-01-25', '11843224', 'USD', '11843224', 'Private Equity', '18518224', 'USD', '18518224', '51-100', 'Private', '', '', '', 'http://www.tenexhealth.com', 'http://www.linkedin.com/company/tenex-health', 'info@tenexhealth.com', 'Tenex Health is pioneering minimally invasive therapies for removal of diseased soft tissue and restoration of healthy musculoskeletal function. Their mission is to help people quickly and safely relieve pain, restore function, and return to doing the things they enjoy.', 'Emerge Financial Group', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2009-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '2', '', 'Was Acquired', 'Jagi Gill', '', '3'],\n  ['Scioto Biosciences', 'https://www.crunchbase.com/organization/scioto-biosciences', 'Biotechnology, Diabetes, Health Care, Life Science, Therapeutics', 'Indianapolis, Indiana, United States', 'Scioto is a developer of Activated Bacterial Therapeutics (ABT) platform intended to deliver live bacteria to the gut.', '35,219', '2020-08-10', '26500000', 'USD', '26500000', 'Series B', '30955000', 'USD', '30955000', '51-100', 'Private', '', '', '', 'http://sciotobiosciences.com', '', '', 'Scioto Biosciences is a developer of Activated Bacterial Therapeutics (ABT) platform intended to deliver live bacteria to the gut. The company is developing innovative therapies devoted to having a transformative impact on the delivery of microbiome therapeutics, enabling medical practitioners to advance healing through microbiome therapeutics.', 'National Institutes of Health, Rev1 Ventures, Genome & Co., Elevate Ventures, BioCrossroads', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '2017-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '3', '', '', 'James Schulz, Jim Schulz, Joe Trebley', '', '6'],\n  ['InfraReDx', 'https://www.crunchbase.com/organization/infraredx', 'Biotechnology, Health Care, Manufacturing, Medical Device', 'Burlington, Massachusetts, United States', 'InfraReDx designs and develops intelligent catheter-based coronary imaging devices.', '35,242', '2013-08-22', '25000000', 'USD', '25000000', 'Corporate Round', '117894000', 'USD', '117894000', '51-100', 'Private', '', '', '', 'http://www.infraredx.com', 'https://www.linkedin.com/company/infraredx/', 'info@infraredx.com', 'InfraReDx, Inc. designs, develops, manufactures, and distributes medical devices. The company specializes in near-infrared spectroscopic (NIRS) technology and its application to coronary imaging. It develops a fiber-optic, catheter-based, near-infrared (NIR) spectroscopy system to identify and characterize vulnerable plaque in the coronary arteries. The company was founded in 1998 and is headquartered in Burlington, Massachusetts.', 'GE Capital, Sanderling Ventures, Nipro Corporation, Difference Capital', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '1998-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '9', '', 'Was Acquired', 'James E. Muller', '', '12'],\n  ['Nanotherapeutics', 'https://www.crunchbase.com/organization/nanotherapeutics', 'Biopharma, Biotechnology, Manufacturing', 'Alachua, Florida, United States', 'Nanotherapeutics is a privately held specialty biopharmaceutical company with full product development, cGMP manufacturing capabilities,', '35,309', '2015-03-18', '28500000', 'USD', '28500000', 'Debt Financing', '66500000', 'USD', '66500000', '51-100', 'Private', '', '', '', 'http://www.nanotherapeutics.com', 'http://www.linkedin.com/company/nanotherapeutics-inc.', 'info@nanotherapeutics.com', \"Nanotherapeutics is a privately held specialty biopharmaceutical company with full product development, cGMP manufacturing capabilities, and a proprietary pipeline. The Company's technologies can be used with all drug types ranging from small molecules to proteins and peptides. These technologies can be employed with new chemical entities or with generic drugs and can be used with the spectrum of existing drug types ranging from small synthetic molecules to large recombinant macromolecules.\", 'Hercules Capital, Inc., Trinity Capital, White Oak Global Advisors', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '1999-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '4', '', 'Was Acquired', 'James D Talton', '', '3'],\n  ['Ellipse Technologies', 'https://www.crunchbase.com/organization/ellipse-technologies', 'Biopharma, Health Care, Manufacturing, Medical, Medical Device', 'Aliso Viejo, California, United States', 'Ellipse Technologies develops implantable technologies for the treatment of a broad spectrum of spine and orthopedic applications.', '35,918', '2015-06-29', '10000000', 'USD', '10000000', 'Convertible Note', '38869715', 'USD', '38869715', '51-100', 'Private', '', '', '', 'http://www.ellipse-tech.com', 'https://www.linkedin.com/company/ellipse-technologies-inc-', 'cs@ellipse-tech.com', 'Ellipse Technologies is focused on developing its implantable remote control technology platforms to include innovative treatments for a broad spectrum of spinal and orthopedic deformity applications, orthopedic trauma and fracture management. The initial products restore proper anatomic position and alignment of the spine and long-bones. MAGECâ„¢ MAGnetic Expansion Control System utilizes a novel motion-preserving, minimally-invasive technology that, through communication with an external magnetic field, can be non-invasively adjusted in an outpatient setting via remote control by the physician to correct spinal deformities. PRECICE System uses non-invasive adjustable intramedullary rods or bone plates to treat long-bone abnormalities, often the result of acute or chronic fractures. Ellipse is a privately-held medical device company located in California.', 'HBM Healthcare Investments AG, Wexford Capital, BioStar Ventures, MedFocus Fund', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2005-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '18', '', 'Was Acquired', 'Samuel Shaolian', '', '5'],\n  ['CDx Diagnostics', 'https://www.crunchbase.com/organization/cdx-diagnostics', 'Biopharma, Biotechnology, Health Care, Pharmaceutical, Product Design', 'Suffern, New York, United States', 'CDx Diagnostics develops and provides diagnostic systems intended to prevent cancer by detecting pre-cancerous cells.', '35,997', '2019-12-30', '11037631', 'USD', '11037631', 'Venture - Series Unknown', '11037631', 'USD', '11037631', '51-100', 'Private', '', '', '', 'https://www.cdxdiagnostics.com/', 'https://www.linkedin.com/company/cdx-diagnostics/', 'support@cannablisslabs.com', 'CDx develops and provides diagnostic systems intended to prevent cancer by detecting pre-cancerous cells. It offers OralCDx, an accurate and non-invasive biopsy to evaluate common oral lesions to rule out dysplasia or cancer, prevention of cancer of the oral cavity, pharynx, larynx, and esophagus through early detection of their easily treatable and pre-cancerous precursors. It provides these tests and systems nationally to gastroenterologists, otolaryngologists, oral surgeons, periodontists, and dentists.', '', 'Biotechnology, Design, Health Care, Science and Engineering', '', '', '$10M to $50M', '1997-01-01', 'year', '', '', '', 'Active', 'For Profit', '1', '', '', 'Drore Eisen, Mark Rutenberg, William Huffnagle', '', '1'],\n  ['OmniSeq', 'https://www.crunchbase.com/organization/omniseq-precision-medicine', 'Biopharma, Biotechnology, Clinical Trials, Health Care, Health Diagnostics', 'Buffalo, New York, United States', 'OmniSeq offers physicians and their patients of the most actionable tumor-profiling information possible.', '36,103', '2019-06-20', '1568650', 'USD', '1568650', 'Venture - Series Unknown', '11568650', 'USD', '11568650', '51-100', 'Private', '', '', '', 'https://www.omniseq.com/', 'https://www.linkedin.com/company/omniseq-precision-medicine-technology/', 'firstname.lastname@omniseq.com', 'OmniSeq offers physicians and their patients of the most actionable tumor-profiling information possible.  OmniSeq, an innovation of Roswell Park Cancer Institute, is a molecular diagnostic laboratory. It endeavors to find the right drug or the right trial for every patient. It also offers NY State CLEP approved assays, including OmniSeq Comprehensive, a 144 gene NGS assay that covers almost all known genetic alterations associated with an FDA-approved targeted therapy or genotype directed clinical trial. OmniSeq is also making significant investments to create better diagnostics for immuno-oncology therapy selection. The company was founded in 2015 and is based in Buffalo, New York.', 'LabCorp, Roswell Park Cancer Institute', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '2015-01-01', 'year', '', '', '', 'Active', 'For Profit', '6', '', '', 'Carl Morrison, Jeffrey Conroy, Mary Nesline', '', '3'],\n  ['Promedior', 'https://www.crunchbase.com/organization/promedior', 'Biopharma, Biotechnology, Health Care, Therapeutics', 'Lexington, Massachusetts, United States', 'Promedior is a biopharmaceutical company developing novel therapeutics for the treatment of inflammatory and fibrotic diseases.', '36,445', '2019-01-01', '', '', '', 'Venture - Series Unknown', '63000000', 'USD', '63000000', '51-100', 'Private', '', '', '', 'http://promedior.com', '', 'info@promedior.com', 'Promedior is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of inflammatory and fibrotic diseases Promedior has developed a novel drug discovery platform to regulate the monocyte-derived cell populations that play key roles in fibrotic, inflammatory and autoimmune diseases.  By specifically targeting these cells at the site of injury, Promedior is able to treat the source of aberrant immune system responses, promote tissue healing and resolution, and greatly reduce the risk of systemic side effects inherent in current therapeutic approaches.  Promedior is developing drugs to address the most severe and difficult-to-treat fibrotic and inflammatory conditions of the eye, lung and kidney such as glaucoma, age-related macular degeneration, diabetic retinopathy and dry eye disease; pulmonary fibrosis, scleroderma and COPD; and acute and chronic nephropathy.', 'Polaris Partners, HealthCare Ventures, Sofinnova Investments, Trellis Bioscience, Morgenthaler Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2006-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '22', '', 'Was Acquired', 'Jim Broderick', '', '7'],\n  ['OncoMed Pharmaceuticals', 'https://www.crunchbase.com/organization/oncomed-pharmaceuticals', 'Biotechnology, Health Care, Pharmaceutical', 'Redwood City, California, United States', 'OncoMed Pharmaceuticals is a biotechnology company developing novel therapeutics for the treatment of cancer.', '36,458', '2013-12-06', '22249996', 'USD', '22249996', 'Post-IPO Equity', '210149996', 'USD', '210149996', '51-100', 'Public', '770000000', 'USD', '770000000', 'http://www.oncomed.com', 'http://www.linkedin.com/company/oncomed-pharmaceuticals', 'bd@oncomed.com', 'OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment, by developing monoclonal antibodies that target the biologic pathways critical to tumor initiating cells, also known as â€œcancer stem cellsâ€\\x9d. They are leveraging their understanding of these tumor initiating cells to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer.', 'U.S. Venture Partners, Adams Street Partners, Morgenthaler Ventures, Delphi Ventures, Latterell Venture Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2004-08-01', 'day', '', 'IPO', '2013-07-26', 'Active', 'For Profit', '44', '', '', 'Max Wicha, Michael F. Clarke', '', '4'],\n  ['Apostle', 'https://www.crunchbase.com/organization/apostle-inc', 'Biopharma, Biotechnology, Health Care, Medical Device', 'Menlo Park, California, United States', 'Apostle is a biotechnology company that invents in cfDNA technologies that are used in a liquid biopsy.', '36,495', '2019-05-22', '3333333', 'USD', '3333333', 'Series A', '5683333', 'USD', '5683333', '51-100', 'Private', '', '', '', 'http://apostlebio.com', 'https://www.linkedin.com/company/apostle-inc/', 'pr@apostlebio.com', 'Apostle is a biotechnology company that invents in cfDNA technologies that are used in a liquid biopsy. The company was founded in 2017 and is headquartered in Menlo Park, California.', '', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', 'Less than $1M', '2017-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '20', '', '', 'Bo Zhang, David Ge, Xin Guo', '', '2'],\n  ['ReVision Optics', 'https://www.crunchbase.com/organization/revision-optics', 'Biotechnology, Health Care, Manufacturing, Medical, Product Design', 'Lake Forest, California, United States', 'ReVision Optics offers PRESBYLENS, a refractive surgery solution to correct vision loss by the natural aging process.', '37,360', '2016-11-10', '32000000', 'USD', '32000000', 'Venture - Series Unknown', '194889998', 'USD', '194889998', '51-100', 'Private', '', '', '', 'http://www.revisionoptics.com', 'https://www.in.linkedin.com/company/revision-optics', 'info@revisionoptics.com', 'ReVision Optics, Inc. designs, manufactures, and delivers implantable products for the treatment of presbyopia. It offers PRESBYLENS Corneal Inlay, a refractive surgery solution to correct vision lost by the natural aging process called presbyopia. The company serves the ophthalmology professionals. ReVision Optics, Inc. was formerly known as IntraLens Vision, Inc. and changed its name to ReVision Optics, Inc. in 2005. The company was founded in 1996 and is based in Lake Forest, California.', 'Canaan Partners, InterWest Partners, Domain Associates, Square 1 Bank, Johnson & Johnson Development Corporation', 'Biotechnology, Design, Health Care, Manufacturing, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '1996-01-01', 'year', '', '', '', 'Active', 'For Profit', '28', '', '', 'Hansen A. Yuan', '', '10'],\n  ['Idun Pharmaceuticals', 'https://www.crunchbase.com/organization/idun-pharmaceuticals', 'Biopharma, Biotechnology, Therapeutics', 'San Diego, California, United States', 'IDUN Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of human therapeutics to control', '37,398', '2015-07-13', '1125000', 'USD', '1125000', 'Debt Financing', '30125044', 'USD', '30125044', '51-100', 'Private', '', '', '', 'https://www.idun.com/sv/', 'https://www.linkedin.com/company/idun-pharmaceuticals/', '', 'IDUN Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of human therapeutics to control apoptosis. Its products under Phase 2 and preclinical trials include drugs for liver disease, CNS diseases, inflammation, and cancer, as well as IDN-6556 for the treatment of liver diseases in patients infected with Hepatitis C virus. The company was founded in 1993 and is based in San Diego, California. As of July 30, 2010, IDUN Pharmaceuticals, Inc. operates as a subsidiary of Conatus Pharmaceuticals Inc.', 'MPM Capital, Venrock, Sutter Hill Ventures, Prospect Venture Partners, Aberdare Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '1993-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', 'John C. Reed, Larry Bock, Robert Horvitz', '', '4'],\n  ['Amerigen Pharmaceuticals', 'https://www.crunchbase.com/organization/amerigen-pharmaceuticals', 'Manufacturing, Pharmaceutical, Product Research', 'Lyndhurst, New Jersey, United States', 'Amerigen Pharmaceuticals develops, manufactures, and distributes generic pharmaceutical products.', '38,478', '2015-01-09', '35000000', 'USD', '35000000', 'Venture - Series Unknown', '35000000', 'USD', '35000000', '51-100', 'Private', '', '', '', 'http://amerigenpharma.com', '', 'info@amerigenpharma.com', 'company that was founded in 2007 by a group of healthcare investors. The company has a focus on the development, manufacture and sale of high quality generic pharmaceutical products for two of the most important markets in the world…the United States and China. Our US office is located in central New Jersey. In addition to executive management, this location also houses staff in the following functions for the US market: product and business development, finance, regulatory affairs, and commercial operations. Product development is being undertaken at various locations around the world under the supervision of its experienced R&D, quality, and regulatory leaders.', 'Fosun Pharma', 'Data and Analytics, Design, Health Care, Manufacturing', '', '', '$1M to $10M', '2007-01-01', 'year', '', '', '', 'Active', 'For Profit', '7', '', '', '', '', '1'],\n  ['Spectrum Pharmaceuticals', 'https://www.crunchbase.com/organization/spectrum-pharmaceuticals', 'Biopharma, Biotechnology, Health Care', 'Henderson, Nevada, United States', 'Spectrum Pharmaceuticals is a biotechnology company developing drugs to treat oncology and hematology.', '38,537', '2016-04-29', '3000000', 'USD', '3000000', 'Post-IPO Equity', '3000000', 'USD', '3000000', '51-100', 'Public', '', '', '', 'http://sppirx.com', 'http://www.linkedin.com/company/spectrum-pharmaceuticals', 'compliance@sppirx.com', 'Spectrum Pharmaceuticals is a commercial-stage biotechnology company with fully integrated commercial and drug development operations, and a focus in oncology and hematology.', '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$100M to $500M', '1987-01-01', 'year', '', 'IPO', '1996-10-04', 'Active', 'For Profit', '134', '2', 'Made Acquisitions', 'Rajesh Shrotriya', '', '1'],\n  ['Ariosa Diagnostics', 'https://www.crunchbase.com/organization/ariosa-diagnostics-inc', 'Biotechnology, Health Care, Health Diagnostics, Medical', 'San Jose, California, United States', 'Ariosa Diagnostics is a molecular diagnostics company focused on improving patient care.', '38,719', '2012-01-09', '52700000', 'USD', '52700000', 'Series C', '67500000', 'USD', '67500000', '51-100', 'Private', '', '', '', 'http://www.ariosadx.com', 'http://www.linkedin.com/company/1138294', 'info@ariadx.com', 'Ariosa Diagnostics, Inc. (formerly Aria Diagnostics (formerly known as Tandem Diagnostics)), a San Jose, Calif.-based molecular diagnostics company.', 'Venrock, Meritech Capital Partners, Domain Associates', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$10M to $50M', '2009-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '6', '', 'Was Acquired', 'Ken Song', '', '3'],\n  ['Advion Inc.', 'https://www.crunchbase.com/organization/advion-inc', 'Biotechnology, Pharmaceutical, Therapeutics', 'New York, New York, United States', 'Advion is a company that offers the expression family of compact mass spectrometers designed for the chemist.', '39,043', '2014-06-30', '1500000', 'USD', '1500000', 'Debt Financing', '10678043', 'USD', '10678043', '51-100', 'Private', '', '', '', 'http://www.advion.com/', 'http://www.linkedin.com/company/advion-biosciences', 'info@advion.com', 'Advion is a global company that offers a variety of systems and consumables for life science research. Its clientele is comprised of pharmaceutical companies, government life science research agencies, and universities. Advion provides a diverse portfolio of microfluidic and mass spec-based products for the life science industry. It was founded in 1993. The company is headquartered in New York, United States.', '', 'Biotechnology, Health Care, Science and Engineering', 'Basic Electric Elements', '', '$10M to $50M', '1993-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '1', '', 'Was Acquired', 'Jack Henion', '', '2'],\n  ['480 Biomedical', 'https://www.crunchbase.com/organization/480-biomedical', 'Biotechnology, Medical, Medical Device', 'Watertown, Massachusetts, United States', '480 Biomedical focuses on the development of a bioresorbable scaffold for treating occlusive disease in the superficial femoral artery.', '39,552', '2016-01-01', '6000000', 'USD', '6000000', 'Venture - Series Unknown', '55656999', 'USD', '55656999', '51-100', 'Private', '', '', '', 'http://www.480biomedical.com', '', '', '480 Biomedical focuses on the development of a bioresorbable scaffold for treating occlusive disease in the superficial femoral artery (SFA). Its lead product, SFA scaffold, is a proprietary scaffold and delivery system for use in treating peripheral arterial disease in the SFA. The company was founded in 2011 and is based in Watertown, Massachusetts.', 'Polaris Partners, Broadview Ventures, North Bridge Venture Partners & Growth Equity, Intersouth Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2011-01-01', 'year', '', '', '', 'Active', 'For Profit', '1', '', '', 'Carmichael Roberts, George Whitesides, Robert Langer', '', '6'],\n  ['Healthcare Interactive', 'https://www.crunchbase.com/organization/healthcare-interactive', 'Health Care, Medical, Pharmaceutical', 'Glenwood, Maryland, United States', 'Healthcare Interactive is dedicated to the transformation of the administration.', '39,938', '2018-01-01', '', '', '', 'Undisclosed', '14463730', 'USD', '14463730', '51-100', 'Private', '', '', '', 'http://www.hciactive.com/', 'http://www.linkedin.com/company/hci_2', 'info@hciactive.com', 'Healthcare Interactive is dedicated to the transformation of the administration and delivery of healthcare to improve health in our communities. We enable our client-partners to effectively leverage their data to identify the health risk and cost drivers of the populations they serve, develop specific programs to engage members and improve outcomes, and provide the administrative tools to deliver, manage, and measure the success of those programs.', 'Revolution’s Rise of the Rest Seed Fund, Revolution, Grotech Ventures, Harbert Growth Partners, Maryland Venture Fund', 'Health Care', 'Computing; Calculating', '', 'Less than $1M', '2006-01-01', 'year', '', '', '', 'Active', 'For Profit', '12', '', '', 'Henry Cha', '', '4'],\n  ['Cornerstone Therapeutics', 'https://www.crunchbase.com/organization/cornerstone-therapeutics', 'Biotechnology, Health Care, Therapeutics', 'Cary, North Carolina, United States', 'Cornerstone Therapeutics is a pharmaceutical company focused on developing and commercializing products for the respiratory system.', '40,430', '2012-07-02', '30000000', 'USD', '30000000', 'Post-IPO Debt', '30000000', 'USD', '30000000', '51-100', 'Delisted', '167300000', 'USD', '167300000', 'http://www.crtx.com', '', 'medical@crtx.com', \"Cornerstone Therapeutics Inc. (NASDAQ: CRTX), headquartered in Cary, N.C., is a specialty pharmaceutical company focused on developing, acquiring, and commercializing products for the respiratory, hospital and related specialty markets. Key elements of the Company's strategy are to focus on identifying therapeutic niches within respiratory, hospital and related specialty markets to leverage existing business and create new opportunities; promote the Company's current products to high prescribing physicians through the Company's respiratory sales force and to hospital-based healthcare professionals through the Company's hospital sales force; license or acquire rights to existing patent- or trade secret-protected, branded products, which can be promoted through the same channels to generate on-going high-value earnings streams; advance the Company's development projects and further build a robust pipeline; and generate revenues by marketing approved generic products through the Company's wholly owned subsidiary, Aristos Pharmaceuticals, Inc.\", 'Chiesi Pharmaceuticals', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2000-01-01', 'year', '', 'M&A', '2004-05-27', 'Active', 'For Profit', '3', '3', 'Made Acquisitions, Was Acquired', '', '', '1'],\n  ['Durata Therapeutics', 'https://www.crunchbase.com/organization/durata-therapeutics', 'Biotechnology, Health Care, Pharmaceutical', 'Branford, Connecticut, United States', 'Durata Therapeutics is a clinical, development-stage pharmaceutical company focused on the treatment of infectious diseases.', '40,475', '2013-11-07', '70000000', 'USD', '70000000', 'Post-IPO Equity', '70000000', 'USD', '70000000', '51-100', 'Delisted', '', '', '', 'http://www.duratatherapeutics.com', 'http://www.linkedin.com/company/durata-therapeutics', 'info@duratatherapeutics.com', 'Durata was created by a five-member venture capital syndicate to pursue late-stage clinical development of novel antibiotic programs. The acquisition was funded through a stock purchase by New Leaf Venture Partners, LLC, Domain Associates, LLC, Aisling Capital, Sofinnova Ventures Inc. and Canaan Partners. Durata is focused on Vicuronâ€™s antibiotic drug candidate, dalbavancin. Its product portfolio also includes two preclinical antibiotic programs while Pfizer will retain the marketed anti-fungal agent, EraxisTM, which was formerly owned by Vicuron.', 'PDL Biopharma', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10M to $50M', '2009-01-01', 'year', '', 'M&A', '2012-07-19', 'Active', 'For Profit', '17', '1', 'Made Acquisitions, Was Acquired', '', '', '1'],\n  ['Acurian', 'https://www.crunchbase.com/organization/acurian', 'Clinical Trials, Health Care, Medical, Pharmaceutical', 'Horsham, Pennsylvania, United States', 'Recruits patients and doctors for participation in clinical drug trials.', '40,670', '2017-02-08', '3400000', 'USD', '3400000', 'Venture - Series Unknown', '43400000', 'USD', '43400000', '51-100', 'Private', '', '', '', 'https://www.acurian.com', 'https://www.linkedin.com/company/acurian?trk=mini-profile', '', 'Acurian provides solutions needed to recruit, enroll, and retain patients for clinical trials. The company offers recruitment feasibility, site identification and selection, patient recruitment and retention, and cancer solutions.  Acurian was founded in 1998 and is based in Horsham, Pennsylvania.', 'JPMorgan Partners (JPMP), ProQuest Investments, Flatiron Partners, Merck Capital Ventures, EuclidSR Partners', 'Health Care', 'Computing; Calculating', '', '$10M to $50M', '1998-01-01', 'year', '', '', '', 'Active', 'For Profit', '3', '', '', 'Lance Converse', '', '4'],\n  ['Tetraphase Pharmaceuticals', 'https://www.crunchbase.com/organization/tetraphase-pharmaceuticals', 'Biopharma, Biotechnology, Health Care', 'Watertown, Massachusetts, United States', 'Tetraphase Pharmaceuticals is a company leveraging a dynamic drug engine targeted at several significant disease categories.', '41,311', '2017-04-01', '4000000', 'USD', '4000000', 'Grant', '99040000', 'USD', '99040000', '51-100', 'Public', '138600000', 'USD', '138600000', 'http://tphase.com', 'http://www.linkedin.com/company/tetraphase-pharmaceuticals', '', 'Capitalizing on breakthrough synthetic chemistry, Tetraphase Pharmaceuticals is leveraging a dynamic drug engine targeted at several significant disease categories.', 'Flagship Pioneering, F-Prime Capital, Excel Venture Management, CARB-X, CB Health Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$1M to $10M', '2006-01-01', 'year', '', 'M&A', '2013-03-20', 'Active', 'For Profit', '20', '', 'Was Acquired', '', '', '7'],\n  ['Tengion', 'https://www.crunchbase.com/organization/tengion', 'Biotechnology, Health Care, Medical', 'Audubon, Pennsylvania, United States', 'Tengion is a clinical-stage biotechnology company developing neo-organs and neo-tissues.', '41,397', '2013-08-07', '74304002', 'USD', '74304002', 'Post-IPO Debt', '297263531', 'USD', '297263531', '51-100', 'Public', '61750000', 'USD', '61750000', 'http://www.tengion.com', 'http://www.linkedin.com/company/50276', '', \"Tengion, a clinical-stage biotechnology company, is a leader in developing neo-organs and neo-tissues, currently derived from a patient's own (autologous) cells.  The Company has completed two Phase 2 human clinical trial in the United States with its Tengion Neo-Bladder Augment for children with neurogenic bladder due to spina bifida and in adults with neurogenic bladder due to spinal cord injury. A successful academic human clinical experience with a urinary Neo-Bladder Augment was reported in The Lancet in April 2006 by investigators from the Children's Hospital Boston. Tengion has an effective investigational new drug application (IND) for its Neo-Urinary Conduit and expects to begin a Phase 1 clinical trial in the first half of 2010 in bladder cancer patients requiring bladder removal.\", 'Bain Capital, Safeguard Scientifics, Oxford Finance LLC, Oak Investment Partners, Celgene', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2003-01-01', 'year', '', 'IPO', '2010-04-09', 'Active', 'For Profit', '7', '', '', 'Anthony Atala', '', '8'],\n  ['Genia Technologies', 'https://www.crunchbase.com/organization/genia-technologies', 'Biotechnology, Genetics, Health Care, Medical', 'Mountain View, California, United States', 'Genia Technologies is a biotechnology company.', '41,566', '2013-05-29', '10438672', 'USD', '10438672', 'Debt Financing', '10438672', 'USD', '10438672', '51-100', 'Private', '', '', '', 'http://geniachip.com', 'http://www.linkedin.com/company/genia-technologies', 'jobs@geniachip.com', \"As the genomics community pushes toward the $1,000 genome, Genia is looking beyond, to the $100 genome, bringing the benefits of genome sequencing out of the lab and into the everyday world. Genia's technology is based on Biological Nanopores: Structure-Based Sequencing of Single DNA Molecules. We aim to reduce the price of sequencing and increase speed, accuracy, and sensitivity by moving away from amplification, complicated fluidics, and optical detection. Genia Technologies, Inc. is a private company located in Mountain View, CA. Genia was founded in March, 2009. The company recently closed its Series A round with a publicly held global biotech company.\", '', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', '$10M to $50M', '2009-03-01', 'day', '', 'M&A', '', 'Active', 'For Profit', '8', '', 'Was Acquired', 'Roger Chen', '', '1'],\n  ['Oraya Therapeutics', 'https://www.crunchbase.com/organization/oraya-therapeutics', 'Biotechnology, Health Care, Medical Device', 'Newark, California, United States', 'Oraya Therapeutics develops non-invasive robotically-controlled treatments for inflammatory and neovascular diseases of the eye.', '41,946', '2014-08-05', '215000', 'USD', '215000', 'Grant', '97347081', 'USD', '97347081', '51-100', 'Private', '', '', '', 'http://www.orayainc.com', 'https://www.linkedin.com/company/oraya-therapeutics-inc.', 'info@orayainc.com', 'Oraya Therapeutics is currently testing its first application of the IRay system. Oraya Therapeutics develops noninvasive robotically controlled treatments for inflammatory and neovascular diseases of the eye.', 'Scale Venture Partners, Domain Associates, Essex Woodlands Healthcare Partners, Synergy Life Science Partner', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2007-01-01', 'year', '', 'Late Stage Venture', '', 'Closed', 'For Profit', '8', '', '', 'Michael Gertner', '', '7'],\n  ['Cempra', 'https://www.crunchbase.com/organization/cempra', 'Biotechnology, Clinical Trials, Health Care, Pharmaceutical', 'Chapel Hill, North Carolina, United States', 'Cempra develops medicines for the treatment of bacterial infections and chronic illnesses.', '42,069', '2012-10-30', '25119996', 'USD', '25119996', 'Post-IPO Equity', '108119996', 'USD', '108119996', '51-100', 'Delisted', '', '', '', 'http://www.cempra.com', 'http://www.linkedin.com/company/cempra-pharmaceuticals', 'info@cempra.com', 'Cempra seeks to discover and develop well-differentiated medicines that cure bacterial infections and improve the quality of life for those with chronic illnesses.  The company balances near-term product development opportunities, including the macrolide CEM-101, while investing in future products from new technologies to derive the next generation of antibiotics.', \"Ontario Teachers' Pension Plan, Aisling Capital, Intersouth Partners, Quaker BioVentures, Devon Park BioVentures\", 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2006-01-01', 'year', '', 'IPO', '2012-02-10', 'Active', 'For Profit', '9', '1', 'Made Acquisitions', '', '', '5'],\n  ['VaxInnate', 'https://www.crunchbase.com/organization/vaxinnate', 'Biotechnology, Health Care, Health Diagnostics', 'Cranbury, New Jersey, United States', 'VaxInnate is a vaccine company developing cures for flu, malaria, dengue, papillomavirus, and respiratory syncytial virus.', '42,079', '2015-09-28', '3248047', 'USD', '3248047', 'Venture - Series Unknown', '132458455', 'USD', '132458455', '51-100', 'Private', '', '', '', 'http://www.vaxinnate.com', 'http://www.linkedin.com/company/vaxinnate-corporation', 'skidmorecomm@earthlink.net', 'VaxInnate is a vaccine company that focuses on developing cures for flu, malaria, dengue, papillomavirus, and respiratory syncytial virus. It specializes in the fields of healthcare, health diagnostics, and biotechnology. It was founded in 2002 and headquartered in Cranbury, New Jersey.', 'Wellcome Trust, Canaan Partners, HealthCare Ventures, New Leaf Venture Partners, Oxford Bioscience Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '2002-01-01', 'year', '', '', '', 'Closed', 'For Profit', '3', '', '', 'Michael Sherman', '', '9'],\n  ['CorMatrix', 'https://www.crunchbase.com/organization/cormatrix', 'Biotechnology, Health Care, Medical', 'Roswell, Georgia, United States', 'CorMatrix is a medical device company developing biomaterial devices that harness the body’s ability to repair damaged heart tissues.', '42,160', '2015-01-16', '1000000', 'USD', '1000000', 'Venture - Series Unknown', '25860032', 'USD', '25860032', '51-100', 'Private', '', '', '', 'http://cormatrix.com', 'https://www.linkedin.com/company/cormatrix-cardiovascular', 'ecm@cormatrix.com', 'CorMatrix Cardiovascular is a privately held medical device company that is dedicated to developing and delivering innovative biomaterial devices that harness the body’s own innate ability to repair damaged heart tissue. The company is currently researching, developing, and commercializing a platform technology, known as CorMatrix ECM, for a variety of cardiovascular indications. Incorporated in December of 2001, CorMatrix was co-founded by David Camp, an entrepreneurial executive in the cardiovascular medical device field, and Robert G. Matheny, MD, a cardiothoracic surgeon and co-inventor on several patents related to extracellular matrix (ECM) technology. Dr. Matheny’s interest and experience with these unique materials began at Purdue University in the 1990s while he was a private practice cardiac surgeon in Indianapolis. Realizing the potential of extracellular matrix materials for cardiovascular surgery, he further increased his study and preclinical work in matrix materials and tissue repair.', '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2001-12-01', 'day', '', '', '', 'Active', 'For Profit', '7', '', '', 'David B. Camp, Robert G. Matheny', '', '3'],\n  ['Ambit Biosciences', 'https://www.crunchbase.com/organization/ambit-biosciences', 'Biopharma, Biotechnology, Health Care', 'San Diego, California, United States', 'Ambit Biosciences, a biopharmaceutical company, develops small molecule kinase inhibitors for cancer and inflammatory disease treatments.', '42,441', '2012-11-06', '50000000', 'USD', '50000000', 'Venture - Series Unknown', '215727869', 'USD', '215727869', '51-100', 'Delisted', '142000000', 'USD', '142000000', 'http://www.ambitbio.com', 'http://www.linkedin.com/company/ambit-biosciences', 'sales@ambitbio.com', \"Ambit Biosciences is a privately-held biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease, and other indications. Ambit's lead compound, AC220, is a novel, potent, highly selective, orally bioavailable FMS-like tyrosine kinase-3 (FLT3) inhibitor, and is currently under clinical investigation in patients with relapsed or refractory AML.  Ambit is developing AC220 in collaboration with Astellas Pharma Inc. as part of a worldwide agreement to jointly develop and commercialize FLT3 kinase inhibitors in oncology and non-oncology indications.  In addition to AC220, Ambit's clinical pipeline includes AC480, a pan-HER inhibitor, and AC430, an oral JAK2 inhibitor.  Ambit also has a pipeline of preclinical candidates which includes CEP-32496, a BRAF inhibitor licensed to Cephalon.\", 'OrbiMed, Horizon Technology Finance, Gimv, Avalon Ventures, Roche Venture Fund', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2000-01-01', 'year', '1', 'M&A', '2013-05-16', 'Active', 'For Profit', '8', '', 'Was Acquired', 'Kevin Kinsella', '', '10'],\n  ['BionX™ Medical Technologies', 'https://www.crunchbase.com/organization/biom', 'Biotechnology, Health Care, Pharmaceutical', 'Bedford, Massachusetts, United States', 'BiOM is engaged in developing the PowerFoot One, an ankle-foot device providing active amputees with near-normal gait.', '42,766', '2015-12-23', '17057767', 'USD', '17057767', 'Series E', '77657767', 'USD', '77657767', '51-100', 'Private', '', '', '', 'http://www.bionxmed.com', 'https://www.linkedin.com/company-beta/1653455/?pathWildcard=1653455', 'info@iwalkpro.com', 'BiOM (fromerly iWalk) is a Massachusetts based company whose sole product is the PowerFoot One. The Powerfoot One has two powerful microprocessors and six environmental sensors evaluate and adjust ankle position, stiffness, damping and power thousands of times a second. Control algorithms generate human-like force while traversing level ground, slopes and stairs, providing active amputees with near-normal gait and lower energy expenditure compared to state-of-the-art passive prosthetics.', 'General Catalyst, Sigma Prime Ventures, MIT Media Lab, Gilde Healthcare, Sigma Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2007-01-01', 'day', '1', 'M&A', '', 'Active', 'For Profit', '12', '', 'Was Acquired', '', '', '7'],\n  ['Angarus Therapeutics', 'https://www.crunchbase.com/organization/angarus-therapeutics', 'Biotechnology, Health Care, Therapeutics', 'Sunnyvale, California, United States', 'Angarus Therapeutics enhances immuno-oncology therapies intended to respond to the urgent needs of cancer treatment.', '44,025', '2020-12-29', '7830438', 'USD', '7830438', 'Venture - Series Unknown', '7830438', 'USD', '7830438', '51-100', 'Private', '', '', '', 'https://www.angarustherapeutics.com/', '', '', 'Angarus Therapeutics develops immuno-oncology therapies intended to respond to the urgent needs of cancer treatment. The therapy serves as checkpoint blockers on the innate immunity STING pathway, with preclinical data demonstrating that a combination of checkpoint blockers, both innate and adaptive, leads to long term survival, enabling patients with a wide range of cancer treatments. Chih-Ping Liu established the company in Sunnyvale, California in 2018.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2018-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', 'Chih-Ping Liu, Lingyin Li, Mark Smith', '', '1'],\n  ['BIND Therapeutics', 'https://www.crunchbase.com/organization/bind-therapeutics', 'Biotechnology, Clinical Trials, Health Care, Information Technology, Medical', 'Cambridge, Massachusetts, United States', 'BIND Therapeutics is\\xa0a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.', '44,229', '2013-02-11', '8697684', 'USD', '8697684', 'Venture - Series Unknown', '69847684', 'USD', '69847684', '51-100', 'Delisted', '', '', '', 'http://bindtherapeutics.com', 'http://www.linkedin.com/company/bind-therapeutics', 'info@bindtherapeutics.com', 'They are a clinical-stage nanomedicine platform company developing Accurins™, our novel targeted and programmable therapeutics. Accurins are designed with specified physical and chemical characteristics to target specific cells or tissues and concentrate a therapeutic payload at the site of disease to enhance efficacy while minimizing adverse effects on healthy tissues. Our strategy is to leverage our medicinal nanoengineering platform to develop our own pipeline of Accurins, initially in oncology, as well as Accurins in collaboration with biopharmaceutical companies. Our lead drug candidate, BIND-014, is in Phase 2 clinical trials for non-small cell lung cancer (NSCLC) and metastatic castrate-resistant prostate cancer (mCRPC). To date in 2013, we have announced collaborations with Amgen, Pfizer and AstraZeneca to develop Accurins based on therapeutic payloads from their product pipelines.', 'Polaris Partners, Flagship Pioneering, ARCH Venture Partners, Endeavour Vision, NanoDimension', 'Biotechnology, Health Care, Information Technology, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2006-01-01', 'year', '', 'M&A', '2013-09-27', 'Active', 'For Profit', '48', '', 'Was Acquired', 'Noubar Afeyan, Robert Langer', '', '6'],\n  ['Asterias Biotherapeutics', 'https://www.crunchbase.com/organization/asterias-biotherapeutics', 'Biotechnology, Life Science, Therapeutics', 'Menlo Park, California, United States', 'Asterias Biotherapeutics is a development-stage biotechnology company pioneering the field of regenerative medicine.', '44,466', '2015-02-23', '4000000', 'USD', '4000000', 'Post-IPO Equity', '16500000', 'USD', '16500000', '51-100', 'Delisted', '', '', '', 'http://asteriasbiotherapeutics.com/', '', 'News@asteriasbio.com', 'Asterias Biotherapeutics is a development-stage biotechnology company pioneering the field of regenerative medicine. It focuses on the development of therapeutic products to treat neurology, oncology, cardiology, metabolic diseases, ophthalmology, orthopedics, and blood and vascular diseases. It is also developing human embryonic stem cell programs, including cell lines and a Phase I clinical trial in patients with acute spinal cord injury; intellectual property related to its autologous cellular immunotherapy program, including a Phase I/II clinical trial of autologous immunotherapy in patients with acute myelogenous leukemia; and non-therapeutic applications of pluripotent stem cells, such as cellular assay products for use in drug development and toxicity screening.  The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is based in Menlo Park, California.', 'Pedro Lichtinger', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$1M to $10M', '2012-01-01', 'year', '', 'M&A', '2014-08-01', 'Active', 'For Profit', '42', '', 'Was Acquired', '', '', '2'],\n  ['Corcept Therapeutics', 'https://www.crunchbase.com/organization/corcept-therapeutics', 'Biotechnology, Medical, Pharmaceutical', 'Menlo Park, California, United States', 'Corcept Therapeutics discovers and develops drugs that regulate the effects of cortisol.', '44,879', '2012-04-10', '525305', 'USD', '525305', 'Post-IPO Equity', '80089479', 'USD', '80089479', '51-100', 'Public', '', '', '', 'http://www.corcept.com', 'http://www.linkedin.com/company/corcept-therapeutics', 'info@corcept.com', \"Since our founding in May 1998 we have been focused on the impact of cortisol and the potential benefits of developing glucocorticoid receptor antagonists. About 80 percent of the tissues in the body have receptors for cortisol, and the effects of excess cortisol are severe and often life-threatening. Our initial research has been with mifepristone, which potently blocks the cortisol receptor. On February 17, 2012, the FDA approved Korlym® (mifepristone) in the United States as a once-daily oral medication for treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. Mifepristone is also being studied in a phase 3 trial, evaluating the impact of cortisol blockade on the psychotic features of psychotic depression. We plan to continue enrolling patients in this study throughout 2013.\", 'Sutter Hill Ventures, Longitude Capital, Alta Partners, Paperboy Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$100M to $500M', '1998-01-01', 'year', '', 'IPO', '2004-04-16', 'Active', 'For Profit', '36', '', '', 'David Singer', '', '7'],\n  ['diaDexus', 'https://www.crunchbase.com/organization/diadexus', 'Biotechnology, Clinical Trials, Health Care, Health Diagnostics', 'South San Francisco, California, United States', 'diaDexus is a biotechnology company focused on the development and commercialization of diagnostic products with high clinical value.', '45,863', '2014-08-18', '15000000', 'USD', '15000000', 'Post-IPO Debt', '171200000', 'USD', '171200000', '51-100', 'Public', '', '', '', 'http://www.diadexus.com', 'http://www.linkedin.com/company/35558', 'support@diazyme.com', \"diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. The company's lead product, the PLAC Test, measures Lp-PLA2 (lipoprotein-associated phospholipase A2) a vascular-specific inflammatory enzyme implicated in the formation of rupture-prone plaque. It is plaque rupture and thrombosis, not stenosis, that cause the majority of cardiovascular events.  The PLAC Test is the only blood test cleared by the FDA as an aid in assessing risk for coronary heart disease, and ischemic stroke associated with atherosclerosis.\", 'Scale Venture Partners, Oxford Finance LLC, GSK, Rho Capital Partners, Baker Brothers Advisors LLC', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '1997-01-01', 'year', '', 'M&A', '1999-06-01', 'Closed', 'For Profit', '3', '', 'Was Acquired', '', '', '5'],\n  ['Galenea', 'https://www.crunchbase.com/organization/galenea', 'Biotechnology, Health Care, Therapeutics', 'Cambridge, Massachusetts, United States', 'Galenea is engaged in developing therapeutics for central nervous system diseases.', '45,906', '2012-09-06', '3000000', 'USD', '3000000', 'Grant', '13500000', 'USD', '13500000', '51-100', 'Private', '', '', '', 'http://www.galenea.com', '', 'info@Galenea.com', 'Galenea Corp., a biopharmaceutical company, engages in developing therapeutics for central nervous system (CNS) diseases. The company focuses on psychiatric disorders, schizophrenia and calcineurin, and obesity and 5-HT2C agonists. Its products include in vitro and in vivo synaptic functional screening and brain slice electrophysiology assays, which include techniques for recording disease-relevant neuronal activity in the prefrontal cortex to measure the effects of drug candidates in animals performing critical memory or cognition-dependent tasks. The company was founded in 2003 and is based in Cambridge, Massachusetts.', 'National Institutes of Health', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2004-01-01', 'year', '', '', '', 'Active', 'For Profit', '4', '', '', 'David Gerber, Jianzhu Chen, Maria Karayiorgou, Susumu Tonegawa', '', '3'],\n  ['WaferGen Biosystems', 'https://www.crunchbase.com/organization/wafergen-biosystems', 'Biotechnology, Genetics, Life Science, Pharmaceutical', 'Fremont, California, United States', 'WaferGen Biosystems is\\xa0a life science company offering genomic tools for targeted resequencing, genotyping and expression analysis.', '46,199', '2013-08-27', '15000000', 'USD', '15000000', 'Post-IPO Equity', '56896750', 'USD', '56896750', '51-100', 'Delisted', '', '', '', 'http://www.wafergen.com', 'http://www.linkedin.com/company/127335', 'info@wafergen.com', 'WaferGen Bio-systems, Inc. is an emerging genomic analysis company in the early stage of commercialization. The company offers the transformative SmartChip Real-Time PCR System—a next-generation Real-Time PCR System for profiling and validation of gene expression patterns (biomarkers) on a single platform. The SmartChip System provides a range of high-throughput capabilities including microRNA and mRNA gene expression profiling and single nucleotide polymorphism (SNP) genotyping.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10M to $50M', '2002-01-01', 'year', '', 'M&A', '2007-06-15', 'Active', 'For Profit', '', '', 'Was Acquired', '', '', '4'],\n  ['Bacterin International Holdings', 'https://www.crunchbase.com/organization/bacterin-international-holdings', 'Biotechnology, Manufacturing, Medical Device', 'Belgrade, Montana, United States', 'Bacterin International Holdings is a medical device company and accredited tissue bank providing advanced medical products.', '46,311', '2014-03-10', '4000000', 'USD', '4000000', 'Post-IPO Debt', '37561000', 'USD', '37561000', '51-100', 'Delisted', '', '', '', 'http://bacterin.com', 'http://www.linkedin.com/company/bacterin-international-inc.', 'info@bacterin.com', 'Bacterin is a medical device company and accredited tissue bank that designs, processes, manufactures, and markets advanced medical products. Using designs focused on efficacy and safety for the patient, and functionality and ease of use for the surgeon, our innovative products fulfill niche needs in the industry. Our Biologics Division, has revolutionized the handling characteristics of allograft bone while maintaining many of the benefits that are native functions of autograft bone. Our OsteoSponge® product line has a highly osteoconductive matrix that is essential for neovascularization and bone formation, while exhibiting osteoinductive properties by exposing native BMP’s and growth factors. In addition to OsteoSponge®, Bacterin Biologics has an allograft portfolio designed specifically to meet the needs of the Spine, Cranio-maxillofacial, reconstructive, and trauma markets.', 'Western Technology Investment', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1998-01-01', 'year', '', 'IPO', '2011-03-07', 'Active', 'For Profit', '8', '1', 'Made Acquisitions', 'Guy Cook', '', '5'],\n  ['Cascadian Therapeutics', 'https://www.crunchbase.com/organization/cascadian-therapeutics', 'Biotechnology, Health Care, Therapeutics', 'Seattle, Washington, United States', 'Cascadian Therapeutics is a bio-pharmaceutical company that researches, develops, and sells therapeutic products for treatment of cancer.', '46,418', '2016-01-01', '', '', '', 'Post-IPO Equity', '64900000', 'USD', '64900000', '51-100', 'Delisted', '', '', '', 'http://www.cascadianrx.com/', 'https://www.linkedin.com/company/cascadian-therapeutics-inc./?originalSubdomain=in', 'bd@oncothyreon.com', 'Cascadian Therapeutics, a clinical-stage biopharmaceutical company, researches and develops, and sells therapeutic products for the treatment of cancer in the United States.  The company lead clinical-stage product candidate is tucatinib, an orally active and HER2-selective small molecule tyrosine kinase inhibitor, which is in two Phase Ib trials, one in combination with Kadcyla and another in combination with Xeloda and/or Herceptin. It is also developing Checkpoint kinase 1, a protein kinase that is in pre-clinical studies to regulate the cell division cycle, as well as to DNA damage and replication stress.  In addition, the company focuses on the development of novel antibodies and T-cell immunoreceptor with Ig and ITM domains, an inhibitory receptor expressed on T-cells and NK cells that negatively regulate immune response to cancers. It has a license agreement with Array BioPharma Inc. to develop, manufacture and commercialize tucatinib; research collaboration agreement with Sentinel Oncology Ltd. for the discovery of novel Chk1 inhibitors; and collaboration agreement with Adimab LLC for the discovery of novel antibodies against d immunotherapy targets in oncology.', 'New Enterprise Associates, Cowen Group, Biotechnology Value Fund, Heights Capital Management, Iroquois Capital', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '1985-01-01', 'year', '', 'M&A', '1991-11-29', 'Active', 'For Profit', '34', '2', 'Made Acquisitions, Was Acquired', '', '', '4'],\n  ['NeuroVia', 'https://www.crunchbase.com/organization/neurovia', 'Biopharma, Biotechnology, Medical, Therapeutics', 'San Francisco, California, United States', 'NeuroVia is a biopharmaceutical company.', '46,932', '2017-07-20', '14000000', 'USD', '14000000', 'Series A', '14000000', 'USD', '14000000', '51-100', 'Private', '', '', '', 'http://www.neurovia-inc.com', '', 'info@neurovia-inc.com', 'NeuroVia, Inc. is committed to addressing unmet medical needs in neurological diseases with the primary goal to arrest the onset of devastating neurological deficits associated with X-ALD.', 'Sanofi Ventures, Novartis Venture Fund, BioMed Ventures, Enso Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2013-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '', '', '', 'Giovanni Ferrara', '', '1'],\n  ['Dyadic International', 'https://www.crunchbase.com/organization/dyadic-international', 'Biopharma, Biotechnology, Manufacturing', 'Jupiter, Florida, United States', 'Dyadic International is a biotechnology company, developing and manufacturing bio-based chemicals.', '47,708', '2015-03-09', '2000000', 'USD', '2000000', 'Convertible Note', '2000000', 'USD', '2000000', '51-100', 'Public', '', '', '', 'http://dyadic.com', 'https://www.linkedin.com/company/dyadic-international-inc.', 'information@dyadic.com', 'Dyadic International, Inc., is a global biotechnology company headquartered in Jupiter, Florida with its research and development center in the Netherlands. Dyadic uses its patented and proprietary technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceuticals and industrial enzyme industries. Dyadic utilizes an integrated technology platform based on its patented and proprietary C1 fungus which enables the development and large scale manufacture of low cost enzymes and other proteins for diverse market opportunities. The C1 platform technology can also be used to screen for the discovery of novel genes and proteins. Dyadic actively pursues licensing arrangements and other commercial opportunities to leverage the value of these technologies by providing its partners and collaborators with the benefits of manufacturing and/or utilizing the enzymes which these technologies help produce', '', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', 'Less than $1M', '1979-01-01', 'year', '2', 'IPO', '2018-01-18', 'Active', 'For Profit', '19', '', '', 'Mark A. Emalfarb', '', '1'],\n  ['BioNumerik Pharmaceuticals', 'https://www.crunchbase.com/organization/bionumerik-pharmaceuticals', 'Biotechnology, Medical Device, Pharmaceutical', 'San Antonio, Texas, United States', 'BioNumerik Pharmaceuticals discovers, develops and commercializes drugs for treating cancer.', '47,763', '2012-11-08', '10190500', 'USD', '10190500', 'Venture - Series Unknown', '63320500', 'USD', '63320500', '51-100', 'Private', '', '', '', 'http://bionumerik.com', '', 'Info@bnpi.com', 'BioNumerik Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drugs that help in the treatment of cancer. The company’s two oncology drug candidates, Tavocept and BNP1350, are in late-stage clinical development. BioNumerik Pharmaceuticals, Inc. was founded in 1992 and is based in San Antonio, Texas.', 'Takeda Pharmaceutical', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '1992-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', 'Frederick H. Hausheer', '', '3'],\n  ['Liquidmetal Technologies', 'https://www.crunchbase.com/organization/liquidmetal-technologies', 'Biotechnology, Manufacturing, Mining Technology, Precious Metals', 'Rancho Santa Margarita, California, United States', 'Liquidmetal Technologies focuses on the research, development, and commercialization of amorphous metal.', '47,871', '2016-03-15', '8400000', 'USD', '8400000', 'Post-IPO Equity', '43525010', 'USD', '43525010', '51-100', 'Public', '610000000', 'USD', '610000000', 'http://liquidmetal.com', 'http://www.linkedin.com/company/liquidmetal-technologies', '', \"Liquidmetal® Technologies is a leading force in the research, development, and commercialization of amorphous metals. The company's revolutionary class of patented alloys and processes form the basis of high-performance materials utilized in a broad range of medical, military, consumer, industrial, and sporting goods products.\", '', 'Biotechnology, Manufacturing, Natural Resources, Science and Engineering', 'Ferrous Or Non-Ferrous Alloys', '', 'Less than $1M', '1984-01-01', 'year', '', 'IPO', '2002-05-22', 'Active', 'For Profit', '75', '', '', 'Peter Hermeling', '', '3'],\n  ['Apricus Biosciences', 'https://www.crunchbase.com/organization/apricus-biosciences', 'Biotechnology, Health Care, Pharmaceutical', 'San Diego, California, United States', 'Apricus Bio (Nasdaq:APRI) is a pharmaceutical company that has an approved product, Vitaros®, for the treatment of ED.', '48,257', '2016-03-04', '10000000', 'USD', '10000000', 'Post-IPO Equity', '12300000', 'USD', '12300000', '51-100', 'Public', '', '', '', 'http://apricusbio.com', 'http://www.linkedin.com/company/apricus-biosciences', '', 'Apricus Bio (Nasdaq:APRI) is a pharmaceutical company that has an approved product, Vitaros®, for the treatment of ED. Vitaros® is approved in Europe and Canada and will be commercialized by Apricus’ marketing partners, which include Abbott Laboratories Limited, Takeda Pharmaceuticals International GmbH, Hexal AG (Sandoz), and Bracco SpA. Femprox®, the Company’s product candidate for the treatment of FSAID, has successfully completed a nearly 400-subject proof-of-concept study.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '$50M to $100M', '1987-01-01', 'year', '', 'IPO', '2003-01-10', 'Active', 'For Profit', '14', '1', 'Made Acquisitions', '', '', '2'],\n  ['Turning Point Therapeutics', 'https://www.crunchbase.com/organization/tp-therapeutics', 'Biotechnology, Health Care, Pharmaceutical, Therapeutics', 'San Diego, California, United States', 'Turning Point Therapeutics is a structure-based drug design pharmaceutical company.', '48,436', '2020-05-18', '373800000', 'USD', '373800000', 'Post-IPO Equity', '720709731', 'USD', '720709731', '51-100', 'Public', '533772000', 'USD', '533772000', 'http://www.tptherapeutics.com', 'https://www.linkedin.com/company/6727624', 'peter.li@tptherapeutics.com', 'Turning Point Therapeutics, Inc. is a clinical-stage structure-based drug design company for the discovery and development of precision medicines for cancer and other diseases.  We are focusing on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating tumor microenvironment and tumor immunity.', 'OrbiMed, Lilly Asia Ventures, Foresite Capital, Cormorant Asset Management, SR One', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$50M to $100M', '2013-10-08', 'day', '', 'IPO', '2019-04-17', 'Active', 'For Profit', '13', '', '', 'J. Jean Cui, Y. Peter Li', '', '7'],\n  ['Trellis Bioscience', 'https://www.crunchbase.com/organization/trellis-bioscience', 'Biotechnology, Health Care, Therapeutics', 'San Francisco, California, United States', 'Trellis Bioscience is a therapeutic antibody company developing treatments for infectious diseases and oncology indications.', '49,092', '2019-10-01', '3200000', 'USD', '3200000', 'Grant', '28576708', 'USD', '28576708', '51-100', 'Private', '', '', '', 'http://www.trellisbio.com', 'https://www.linkedin.com/company/trellis-bioscience', 'mmoncada@trellisbio.com', \"Trellis Bioscience develops a technology platform for cellular informatics. The company's technology has applications in the discovery and production of therapeutic monoclonal antibodies. Its cell biology platform provides a direct readout at the single cell level for monitoring activity of diverse cell types and quantifying the impact of potential therapeutic interventions. The company is based in San Francisco, California.\", 'CARB-X, Morgenthaler Ventures, Novartis Venture Fund, Easton Capital, Pac-Link', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$10M to $50M', '1998-01-01', 'year', '1', '', '', 'Active', 'For Profit', '1', '', '', 'Lawrence Kauvar', '', '5'],\n  ['Aurora Biofuels', 'https://www.crunchbase.com/organization/aurora-biofuels', 'Biofuel, CleanTech, Pharmaceutical', 'Hayward, California, United States', 'Aurora Biofuels, now Aurora Algae, produces premium, algae-based products for the pharmaceutical, nutrition, aquaculture and fuels markets.', '49,331', '2013-04-01', '16000000', 'USD', '16000000', 'Private Equity', '101718192', 'USD', '101718192', '51-100', 'Private', '', '', '', 'http://www.aurorainc.com', 'https://www.linkedin.com/company/aurora-algae-inc/', 'info@aurorabiofuels.com', 'Aurora Biofuels is now Aurora Algae. Please update your settings to follow Aurora Algae.     Aurora Algae is a producer of high-performance, premium algae-based products for the pharmaceutical, nutrition, aquaculture and fuels markets. The company has developed the industry’s first commercial-scale photosynthetic platform for sustainable, algae-based product development. Aurora Algae’s proprietary algae strains and production process uses arid land, seawater and captured carbon pollution from industrial emitters resulting in more capitally efficient and more environmentally sustainable algae farming. Aurora Algae enables its customers and partners to improve the diversity and sustainability of their product portfolios, while addressing consumer demand for natural products.', 'Oak Investment Partners, Gabriel Venture Partners, Noventi', 'Energy, Health Care, Natural Resources, Sustainability', '', '', '$10M to $50M', '2007-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '25', '', 'Was Acquired', 'Bertrand Vick, Matt Caspari, Matthew Caspari, Tasios Melis', '', '7'],\n  ['Chase Pharmaceuticals', 'https://www.crunchbase.com/organization/chase-pharmaceuticals', 'Biotechnology, Health Care, Medical', 'Washington, District of Columbia, United States', 'Chase Pharmaceuticals is engaged in the clinical development of medically improved treatments for central nervous system (CNS) diseases.', '49,635', '2016-02-18', '3500000', 'USD', '3500000', 'Series B', '28700000', 'USD', '28700000', '51-100', 'Private', '', '', '', 'http://www.chasepharmaceuticals.com', 'https://www.linkedin.com/company/chase-pharmaceuticals', 'cpcinfo@chasepharmaceuticals.com', 'Chase Pharmaceuticals (CPC) is engaged in the identification and clinical development of medically improved, commercially promising, treatments for central nervous system (CNS) disease. The Company was incorporated in 2007 to link emerging technical opportunities in the basic neurosciences to the expanding medical needs of those with neuropsychiatric disease. Operations thus focus on selecting product candidates to license-in, adding value by advancing towards global registration, and licensing-out to commercial partners. There success reflects an exceptional ability to select promising drug candidates, intimate knowledge of the development process as well as our ability to devise the most efficient path to regulatory approval. Since inception, CPC has sought to develop novel compounds that could improve the treatment of AD and related neurodegenerative disorders. Alzheimer’s disease constitutes the largest unmet medical need in neuropsychiatry. No emerging therapies have clearly demonstrated the potential to fulfill this medical need. Symptoms include an increasing loss of memory and other cognitive functions later combined with a variety of neuropsychiatric and behavioral disturbances. Progression is relentless, typically leading to death within 10 to 15 years. AD is now recognized as the third leading killer in the U.S. It is estimated that the 37 million afflicted worldwide cost society over $600 billion annually. As the population ages, this burden will rapidly climb to unsustainable levels. Although US sales of Alzheimer’s disease medications last year topped $4.7 billion, none of the current treatments improve symptoms more than marginally. Moreover, tolerability is poor, dose titration prolonged, and dropout rates high. Chase founders have invented and patented a unique combination of proven, currently marketed pharmaceuticals that we believe will benefit the symptomatic treatment of AD.', 'Cipla, Andera Partners, New Rhein Healthcare', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', 'Less than $1M', '2007-01-01', 'year', '', 'M&A', '', 'Closed', 'For Profit', '12', '', 'Was Acquired', 'Kathleen E. Clarence-Smith, Thomas N. Chase', '', '4'],\n  ['Grand River Aseptic Manufacturing', 'https://www.crunchbase.com/organization/gram', 'Biopharma, Biotechnology, Clinical Trials, Life Science, Manufacturing, Pharmaceutical', 'Grand Rapids, Michigan, United States', 'Grand River Aseptic Manufacturing is a parenteral contract development and manufacturing organization.', '49,688', '2014-06-09', '7583554', 'USD', '7583554', 'Series C', '10839530', 'USD', '10839530', '51-100', 'Private', '', '', '', 'http://grandriverasepticmfg.com', 'http://www.linkedin.com/company/grand-river-aseptic-manufacturin', 'info@grandriverasepticmfg.com', 'Grand River Aseptic Manufacturing (GRAM), a parenteral contract development and manufacturing organization, delivers customized solutions to meet clients’ fill and finish needs from development through commercialization. With capabilities for biologics as well as controlled substances, GRAM’s expert project managers and modern facilities support pharmaceutical development and cGMP manufacturing, analytical testing and regulatory filing.', '', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', '', '', '$10M to $50M', '2006-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '8', '', 'Was Acquired', 'Jerry Arthur', '', '3'],\n  ['Theracos', 'https://www.crunchbase.com/organization/theracos', 'Biotechnology, Health Care, Pharmaceutical', 'Marlborough, Massachusetts, United States', 'Theracos Inc., a pharmaceutical research and development company, supports research programs in inflammation, metabolism and depression.', '49,742', '2016-01-15', '25000000', 'USD', '25000000', 'Private Equity', '118092700', 'USD', '118092700', '51-100', 'Private', '', '', '', 'http://theracos.com', '', 'info@theracos.com', 'Theracos, Inc. is a privately held pharmaceutical research and development company located in Marlborough, Massachusetts. The company was founded in 2000 with the mission to develop novel therapeutic agents for diseases with significant unmet medical need. It is currently conducting development of multiple programs in human clinical testing. Theracos is well positioned to accomplish its development and commercialization objectives due to its understanding of the marketplace and its network of partners. The company has a strong advisory team in toxicology, formulation development, QA/QC, regulatory, clinical, and trial design and execution. The team members have over 10-20 years of experience each in their areas of expertise.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '2000-01-01', 'year', '', 'Private Equity', '', 'Active', 'For Profit', '1', '', '', 'Edward P. Amento', '', '2'],\n  ['Mascoma', 'https://www.crunchbase.com/organization/mascoma-corporation', 'Biofuel, Biomass Energy, Biotechnology, CleanTech', 'Boston, Massachusetts, United States', 'Mascoma is a biofuel company that produces cellulosic ethanol made from wood and switchgrass.', '50,241', '2011-08-19', '50000000', 'USD', '50000000', 'Debt Financing', '179800000', 'USD', '179800000', '51-100', 'Private', '', '', '', 'http://www.mascoma.com', 'http://www.linkedin.com/company/mascoma-corp', 'info@mascoma.com', 'Mascoma Corporation was founded in late 2005 with initial funding from Khosla Ventures and Flagship Ventures in early 2006.  A Series B round of funding was closed in November of 2006 and a Series C round of funding was closed in May of 2008. They wish to replace the use of gasoline with cellulosic ethanol.', 'General Catalyst, Flagship Pioneering, Khosla Ventures, Kleiner Perkins, New York State', 'Biotechnology, Energy, Natural Resources, Science and Engineering, Sustainability', '', '', '$10M to $50M', '2005-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '101', '1', 'Made Acquisitions, Was Acquired', 'Colin South, Lee R. Lynd', '', '6'],\n  ['Trio Health', 'https://www.crunchbase.com/organization/trio-health', 'Biotechnology, Health Care, Pharmaceutical', 'La Jolla, California, United States', 'Trio Health offers a CareLogic, a proprietary system to collect and share information from all stakeholders.', '51,934', '2014-11-25', '3765000', 'USD', '3765000', 'Venture - Series Unknown', '3765000', 'USD', '3765000', '51-100', 'Private', '', '', '', 'http://triohealth.com/', '', 'info@triohealth.com', 'Trio Health offers a CareLogic, a proprietary system to collect and share information from all stakeholders. It gives pharmaceutical and biotechnology companies, specialty pharmacies, and physicians with access to information and opportunities. Trio Health is based in La Jolla, California.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '2013-01-11', 'day', '', '', '', 'Active', 'For Profit', '3', '', '', 'Brent Clough, Yoori Lee', '', '1'],\n  ['Sequenta', 'https://www.crunchbase.com/organization/sequenta', 'Biotechnology, Health Diagnostics, Medical', 'San Francisco, California, United States', 'Sequenta is engaged in the discovery and development of clinical diagnostics based on a platform for understanding immune system status.', '52,510', '2014-10-20', '', '', '', 'Venture - Series Unknown', '43460000', 'USD', '43460000', '51-100', 'Private', '', '', '', 'http://www.sequenta.com/', 'https://www.linkedin.com/company/sequenta-inc-', 'tom.willis@mlcdx.com', 'Sequenta is a venture funded biotech company dedicated to the discovery and development of clinical diagnostics based on a revolutionary new platform for understanding immune system status. A profound revolution in the cost of DNA sequencing has enabled the company to develop brand new approaches to measuring the most variable part of the human genome: the immune cell receptor genes. The incredible diversity created by these genes are at the heart of a large number of conditions critical to human health and disease allowing the company to be in a position to inform a large number of clinical decisions using a single powerful assay. The company was founded in 2008 by entrepreneurs who previously founded ParaAllele BioScience, a successful startup company sold to Affymetrix in 2005.', 'Index Ventures, Foresite Capital, Mohr Davidow Ventures, Celgene, Farzad (Zod) Nazem', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '2008-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '22', '', 'Was Acquired', 'Malek Faham, Tom Willis', '', '5'],\n  ['TriReme Medical', 'https://www.crunchbase.com/organization/trireme-medical', 'Biotechnology, Health Care, Health Diagnostics, Medical Device', 'Pleasanton, California, United States', 'TriReme Medical develops novel stent technologies for the treatment of coronary artery bifurcations.', '52,608', '2012-11-27', '18000000', 'USD', '18000000', 'Series E', '58920997', 'USD', '58920997', '51-100', 'Private', '', '', '', 'http://www.trirememedical.com', '', 'info@TriRemeMedical.com', 'TriReme Medical, Inc. (TMI) is a privately held medical device company based in Pleasanton, California. Founded in 2005, it is dedicated to the development and manufacturing of novel stent technologies for the treatment of coronary artery disease (CAD) at or near bifurcations.', 'Adams Street Partners, EDBI, Three Arch Partners, Luminor Capital', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2005-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '16', '', '', 'Eitan Konstantino', '', '5'],\n  ['Cleveland HeartLab', 'https://www.crunchbase.com/organization/cleveland-heartlab', 'Biotechnology, Health Care, Life Science, Medical Device', 'Cleveland, Ohio, United States', 'Cleveland HeartLab is a clinical laboratory and disease management firm, develops biomarker technologies and diagnostic tests.', '53,081', '2016-03-01', '', '', '', 'Venture - Series Unknown', '48051203', 'USD', '48051203', '51-100', 'Private', '', '', '', 'http://www.clevelandheartlab.com', 'http://www.linkedin.com/company/cleveland-heartlab-inc-', 'customerservice@clevelandheartlab.com', 'Cleveland HeartLab, Inc. is a specialty clinical laboratory and disease management company focused on novel biomarker technologies and the creation of proprietary diagnostic tests.', 'Advantage Capital, Excel Venture Management, HealthCare Ventures, Merck Global Health Innovation Fund, Mutual Capital Partners', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', '$1M to $10M', '2000-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '8', '', 'Was Acquired', 'Jake Orville, Marc Penn, Stanley Hazen', '', '6'],\n  ['Segetis', 'https://www.crunchbase.com/organization/segetis', 'Biotechnology, Chemical, CleanTech', 'Minneapolis, Minnesota, United States', 'Segetis is transforming the chemical industry by offering unique material properties, cost effective economics.', '53,534', '2015-06-30', '965000', 'USD', '965000', 'Venture - Series Unknown', '73901999', 'USD', '73901999', '51-100', 'Private', '', '', '', 'http://www.segetis.bio/company/', 'http://www.linkedin.com/company/segetis-inc', 'info@segetis.com', \"Segetis, Inc., a green chemistry company, engages in the development, production, and commercialization of renewable polymers. The company focuses on a platform of binary monomers based on renewable feed stocks. The company's technology enables the use of non-food agricultural and forestry feed stocks for the production of various materials, as well as enables the second wave of industrial bioproducts, such as bio-plastics, surfactants, plasticizers, adhesives, coalescent solvents, and other compounds for specialty chemical applications. Its chemistries offer various opportunities for product enablement and synergies for industries engaged in the processing of starch and sugar crops; processing of wood, cellulose, and paper pulp; chemical processing of vegetable oils; manufacturing of biodiesel; and the manufacturing of linear alpha-olefins and other compounds. The company was founded in 2006 and is based in Golden Valley, Minnesota.\", 'Khosla Ventures, DSM Venturing, SABIC Ventures, Malaysian Life Sciences Capital Fund, PNB Equity Resource Sdn. Berhad', 'Biotechnology, Science and Engineering, Sustainability', 'Organic Chemistry', '', '$1M to $10M', '2006-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '15', '', 'Was Acquired', 'Samir Kaul', '', '6'],\n  ['Vixiar Medical', 'https://www.crunchbase.com/organization/vixiar-medical', 'Biotechnology, Clinical Trials, Health Care, Medical, Medical Device, Robotics', 'Baltimore, Maryland, United States', 'Vixiar Medical develops non-invasive, cost-effective devices and systems for monitoring cardiopulmonary diseases.', '54,748', '2019-03-20', '1500000', 'USD', '1500000', 'Series A', '4723750', 'USD', '4723750', '51-100', 'Private', '', '', '', 'http://vixiar.com/', 'https://in.linkedin.com/company/vixiar-medical', 'info@vixiar.com', 'Vixiar Medical develops non-invasive, cost-effective devices, and systems for monitoring cardiopulmonary diseases, particularly those with a significant clinical and economic burden. The Company’s first product, Indicor, is a handheld point of care device and digital platform for monitoring worsening heart failure.', 'Gaingels, TEDCO, MedTech Innovator, Emerald Development Managers, Abell Foundation', 'Biotechnology, Hardware, Health Care, Science and Engineering, Software', '', '', 'Less than $1M', '2013-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '1', '', '', 'Harry Silber', '', '5'],\n  ['StemCells', 'https://www.crunchbase.com/organization/stemcells', 'Biotechnology, Health Care, Therapeutics', 'Newark, California, United States', 'StemCells, Inc. is engaged in the research, development, and commercialization of cell-based therapeutics and tools for use in stem', '54,764', '2014-07-21', '20000000', 'USD', '20000000', 'Post-IPO Equity', '20000000', 'USD', '20000000', '51-100', 'Delisted', '', '', '', 'http://stemcellsinc.com', 'http://www.linkedin.com/company/stemcells-inc.', '', \"StemCells, Inc. is engaged in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery. The Company's lead therapeutic product candidate, HuCNS-SC(R) cells (purified human neural stem cells), is currently in development as a potential treatment for a broad range of central nervous system disorders. In a Phase I clinical trial in Pelizaeus-Merzbacher disease (PMD), a fatal myelination disorder in children, the Company has shown preliminary evidence of progressive and durable donor-derived myelination in all four patients transplanted with HuCNS-SC cells. The Company is conducting a Phase I/II clinical trial in chronic spinal cord injury in Switzerland, Canada and the United States, and has reported positive interim data for the first three patients. The Company is also conducting a Phase I/II clinical trial in dry age-related macular degeneration (AMD) in the United States. In addition, the Company is pursuing preclinical studies in Alzheimer's disease, with support from the California Institute for Regenerative Medicine (CIRM). StemCells also markets stem cell research products, including media and reagents, under the SC Proven(R) brand.\", '', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', 'Less than $1M', '1992-01-01', 'year', '', 'IPO', '1992-03-25', 'Active', 'For Profit', '34', '1', 'Made Acquisitions', '', '', '1'],\n  ['Predictive Biosciences', 'https://www.crunchbase.com/organization/predictive-biosciences', 'Biotechnology, Health Diagnostics, Medical Device', 'Lexington, Massachusetts, United States', 'Predictive Biosciences is a molecular diagnostics company developing diagnostic products for informed cancer management.', '55,159', '2013-01-15', '1345000', 'USD', '1345000', 'Venture - Series Unknown', '68095000', 'USD', '68095000', '51-100', 'Private', '', '', '', 'http://www.predictivebiosci.com', '', 'info@predictivebiosci.com', \"Predictive Biosciences, Inc., a molecular diagnostics company, develops diagnostic products for informed cancer management. It specializes in proteomics, diagnostics, oncology, and tumor biomarkers. The company offers biomarkers and proteomics-based assay technologies. These assays detect urinary biomarkers associated with the physiological changes resulting from cancer development and progression. It also provides Triage Monitoring Assay, which allows physicians to delay and invasive diagnostic procedures; Interval Monitoring Assay that is for surveillance and detection of cancer between follow-ups; and Stratification Assay, which supports a physician's decision to manage a patient.  Predictive Biosciences, Inc. was founded in 2006 and is headquartered in Lexington, Massachusetts.\", 'Highland Capital Partners, New Enterprise Associates, Flybridge, Chiratae Ventures, Kaiser Permanente Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', '', '2006-01-01', 'year', '', '', '', 'Closed', 'For Profit', '3', '1', 'Made Acquisitions', 'Anthony P. Shuber, Eugene Chiu, Marsha A.Moses', '', '6'],\n  ['Cebix', 'https://www.crunchbase.com/organization/cebix', 'Biotechnology, Health Care, Pharmaceutical, Therapeutics', 'La Jolla, California, United States', 'Cebix is a biopharmaceutical company developing treatments for diabetic complications that affect the function of nerves, kidneys and eyes.', '55,427', '2014-11-13', '33188333', 'USD', '33188333', 'Venture - Series Unknown', '101425972', 'USD', '101425972', '51-100', 'Private', '', '', '', 'http://www.cebix.com', 'http://www.linkedin.com/company/cebix-inc.', 'info@cebix.com', 'Cebix is focused on the development of chronic replacement therapy based on human proinsulin C-peptide for the treatment of type 1 diabetic neuropathy.  The role of C-peptide will also be explored in type 1 diabetic nephropathy and retinopathy.', 'InterWest Partners, Sofinnova Investments, Thomas, McNerney & Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2008-01-01', 'year', '', '', '', 'Active', 'For Profit', '4', '', '', 'Lars Ekman', '', '6'],\n  ['Quantum SI', 'https://www.crunchbase.com/organization/quantum-si', 'Biotechnology, Health Diagnostics, Life Science', 'Guilford, Connecticut, United States', 'Quantum SI offers Next Generation Protein Sequencing that makes diagnostics digital.', '56,479', '2015-01-01', '', '', '', 'Seed', '', '', '', '51-100', 'Private', '', '', '', 'https://www.quantum-si.com/', 'https://www.linkedin.com/company/quantum-si/', '', 'Quantum-Si has created a very unique environment where bright, highly committed individuals are given the freedom, ownership, and resources to solve tough problems and be the first to do new science. Quantum-Si is fully-funded by successful founders so employees can focus on creating, building, learning, and getting to market products that will change the world.', '4Catalyzer', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', '', '2015-01-01', 'year', '', 'Seed', '', 'Active', 'For Profit', '4', '', '', '', '', '1'],\n  ['JanOne', 'https://www.crunchbase.com/organization/appliance-recycling-centers-of-america', 'Biotechnology, Recycling', 'Minneapolis, Minnesota, United States', 'JanOne is a pharmaceutical company focused on finding treatments for conditions that cause severe pain and bringing to market drugs.', '56,512', '2021-01-29', '6000000', 'USD', '6000000', 'Post-IPO Equity', '6000000', 'USD', '6000000', '51-100', 'Public', '', '', '', 'https://janone.com/', '', '', 'JanOne is focused on developing treatments for diseases that cause severe pain. By alleviating pain at the source, JanOne aims to reduce the need for opioid prescriptions to treat disease associated pain that can lead to opioid abuse. The company is also exploring solutions for non-addictive pain medications. Its lead candidate JAN101 is for treating peripheral artery disease (PAD), a condition that affects over 8.5 million Americans. JAN101 demonstrated positive results in a Phase 2a clinical trial, and Phase 2b trials are expected to begin in early 2021.', '', 'Biotechnology, Science and Engineering, Sustainability', 'Refrigeration Or Cooling', '', '', '2019-01-01', 'year', '', 'IPO', '1991-11-08', 'Active', 'For Profit', '1', '1', 'Made Acquisitions', '', '', '1'],\n  ['Vitamin Research Products', 'https://www.crunchbase.com/organization/vitamin-research-products', 'Biotechnology, Health Care, Manufacturing, Nutrition', 'Carson City, Nevada, United States', 'Vitamin Research Products develops, manufactures and sells nutritional supplements.', '56,539', '2012-02-23', '4500023', 'USD', '4500023', 'Venture - Series Unknown', '4500023', 'USD', '4500023', '51-100', 'Private', '', '', '', 'http://vrp.com', '', 'customerservice@vrp.com', \"Vitamin Research Products, LLC develops, manufactures, and sells nutritional supplements. It offers accessories, amino acids, antioxidants, botanicals and herbs, energizers, healthy fats and oils, minerals, mood enhancers, multi nutrients, pet products, protein supplements, single vitamins, sleep aids, test kits, and phytonutrients. The company also provides supplements for blood sugar, bone and joint, brain and digestive health, liver support, hair/skin and nails, urinary tract support, vision and sight, weight management, women's health, Xylitol, detoxification, heart health, hormone support, immune system, inflammation, heart and men's health, neuroendocrine support, physical performance, and stress problems. In addition, it sells vitamins, and books and software online. The company was founded in 1979 and is based in Carson City, Nevada. As of 2005, Vitamin Research Products, LLC operates as a subsidiary of Argan, Inc.\", '', 'Biotechnology, Food and Beverage, Health Care, Manufacturing, Science and Engineering', '', '', '$10M to $50M', '1979-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', 'Steven Fowkes', '', '1'],\n  ['Gliknik', 'https://www.crunchbase.com/organization/gliknik', 'Biotechnology, Health Care, Medical', 'Baltimore, Maryland, United States', 'Gliknik develops therapies for patients with cancer and immune disorders.', '56,639', '2019-02-19', '15000000', 'USD', '15000000', 'Corporate Round', '58561082', 'USD', '58561082', '51-100', 'Private', '', '', '', 'http://www.gliknik.com', '', 'jamielacey@presscommpr.com', 'Gliknik, Inc., a biopharmaceuticals company, develops therapies for patients with cancer and immune disorders. Its Immunomodulator Platform involves in off-the-shelf peptide drugs that increase CD4, CD8, and antibody immune responses against cancer; Stradomer Platform produces drugs designed to mimic the eficacy of pooled human intravenous immunoglobulin; and Stradobody Platform produces compounds that are similar to moncolonal antibodies for tumor cell killing. The company was founded in 2007 and is based in Baltimore, Maryland.', 'Pfizer, Baxter International, Joel B. Braunstein', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$10M to $50M', '2007-01-01', 'year', '', '', '', 'Active', 'For Profit', '2', '', '', 'David S. Block, Scott E. Strome', '', '8'],\n  ['Metamark Genetics', 'https://www.crunchbase.com/organization/metamark-genetics', 'Biotechnology, Genetics, Health Care, Health Diagnostics, Medical, Personal Health', 'Cambridge, Massachusetts, United States', 'Metamark Genetics develops prognostic and predictive diagnostic tests that enable personalized treatment planning for cancer patients.', '57,516', '2012-11-15', '9109287', 'USD', '9109287', 'Private Equity', '46759287', 'USD', '46759287', '51-100', 'Private', '', '', '', 'http://www.metamarkgenetics.com', '', 'info@metamarkgenetics.com', 'Metamark Genetics, Inc is a life science company dedicated to the development of prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients, improved outcomes, and reduced healthcare costs. Metamark was founded in November, 2007 to transform cancer diagnosis and treatment by developing pioneering diagnostic products based on its Prognosis Determinantsâ„¢ Platform. Prognosis Determinantsâ„¢ are functionally validated genetic elements at the core of cancer progression across many major cancer types. Based on pioneering research in melanoma by Dr. Lynda Chin at the Dana-Farber Cancer Institute and Harvard Medical School, the Prognosis Determinantsâ„¢ were first discovered as functionally active drivers of metastasis that confer poor outcome. Prognosis Determinantsâ„¢ have been shown to be relevant to a broad spectrum of different tumors and can stratify patients according to their overall and metastasis-free survival.', 'Perseus', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', '$1M to $10M', '2007-01-01', 'year', '', 'Private Equity', '', 'Active', 'For Profit', '11', '', '', 'David Rimm, Kenneth E. Weg, Lynda Chin, Ronald A. DePinho', '', '4'],\n  ['Cobalt Technologies', 'https://www.crunchbase.com/organization/cobalt-technologies', 'Biofuel, Biotechnology, CleanTech', 'Mountain View, California, United States', 'Cobalt Technologies develops technologies that focuses and designed for biofuels.', '57,799', '2014-05-28', '7000000', 'USD', '7000000', 'Venture - Series Unknown', '62893000', 'USD', '62893000', '51-100', 'Private', '', '', '', 'http://www.cobalttech.com', '', 'info@cobaltbiofuels.com', 'Cobalt Technologies develops technologies that focuses and designed for biofuels. Cobalt is pioneering science that makes possible a new generation of fuels that burn cleaner, are more cost-effective and have a smaller environmental impact. It was founded in 2005 and headquartered in Mountain View, California.', 'Life Sciences Partners, @Ventures, VantagePoint Capital Partners, Heartwood Partners (previously known as Capital Partners), Pinnacle Ventures', 'Biotechnology, Energy, Natural Resources, Science and Engineering, Sustainability', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$10M to $50M', '2005-01-01', 'year', '', '', '', 'Active', 'For Profit', '8', '', '', 'Pamela Contag', '', '6'],\n  ['ZYOMYX', 'https://www.crunchbase.com/organization/zyomyx-inc', 'Biotechnology, Health Diagnostics, Pharmaceutical', 'Fremont, Missouri, United States', 'Zyomyx develops and commercializes diagnostic platforms, including a point-of-care test for HIV/AIDS.', '57,942', '2014-03-26', '7500000', 'USD', '7500000', 'Grant', '34275015', 'USD', '34275015', '51-100', 'Private', '', '', '', 'http://www.zyomyx.com', '', 'info@zyomyx.com', 'Zyomyx has a unique expertise in and passion for tackling difficult “outside-the-box” problems. Highly user-friendly, instrument-free point-of-care tests need to be designed with an advanced level of cartridge engineering and reagent stability, and aligned with aggressive cost targets. Zyomyx specializes in exactly these demanding product requirements.  Our immediate focus is an advanced, but simple to use and inexpensive CD4 T-cell point-of-care test that will be launched globally and configured to especially meet the demanding specifications for use in low and middle income countries.', 'Bill & Melinda Gates Foundation, Mylan, Jenny Rooke', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', '$10M to $50M', '1998-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', 'Peter Wagner', '', '4'],\n  ['Nu-Tek Salt', 'https://www.crunchbase.com/organization/nu-tek-salt', 'Biotechnology, Organic', 'Omaha, Nebraska, United States', 'Nu-Tek Salt introduces reduced sodium and salt replacement products that incorporate a novel, patented technology.', '58,494', '2014-01-13', '12651217', 'USD', '12651217', 'Venture - Series Unknown', '12651217', 'USD', '12651217', '51-100', 'Private', '', '', '', 'https://nuteksalt.com/', 'https://www.linkedin.com/company/3256238', 'info@nu-teksalt.com', 'Nu-Tek Salt introduces reduced sodium and salt replacement products that incorporate a novel, patented technology and better tasting potassium chloride (NPC) to help lower the sodium content in your food applications.', 'Khosla Ventures', 'Biotechnology, Science and Engineering, Sustainability', '', '', '$1M to $10M', '2006-01-01', 'year', '', '', '', 'Active', 'For Profit', '1', '', '', 'Thomas (Tom) L Manuel', '', '2'],\n  ['Viriom', 'https://www.crunchbase.com/organization/viriom', 'Biotechnology, Health Care, Pharmaceutical', 'San Diego, California, United States', 'Viriom is  a clinical and commercial stage biotech developing drugs for treatment, prevention and cure of HIV and other infections.', '58,719', '2017-12-06', '12500000', 'USD', '12500000', 'Convertible Note', '35410000', 'USD', '35410000', '51-100', 'Private', '', '', '', 'http://viriom.com/', 'https://www.linkedin.com/company/viriom', 'viriom@viriom.com', 'Viriom Inc. is a development and commercial stage biotech company developing novel and affordable medicines against life threatening infections such as HIV and HBV. The company has an exclusive worldwide license to its phase 3 and commercial stage lead compounds (Elpida/elsulfavirine and VM1500A) from Hoffmann-La Roche and has developed proprietary drug candidates VM2500, VM3500  LAI formulations and combinations  with cell, vaccine and antibody drugs for treatment,  prophylaxis and cure of HIV. Viriom makes a breakthrough in treating, preventing and curing HIV and chronic HBV infections worldwide.', 'Pharmstandard, Skolkovo Foundation, Torrey Pines Investment, ChemRar Ltd, MIT RF', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10M to $50M', '2009-01-01', 'year', '', 'Seed', '', 'Active', 'For Profit', '5', '', '', '', '', '8'],\n  ['InterveXion Therapeutics', 'https://www.crunchbase.com/organization/intervexion-therapeutics', 'Biopharma, Biotechnology, Health Care, Pharmaceutical', 'Little Rock, Arkansas, United States', 'InterveXion Therapeutics is a privately-held clinical-stage biopharmaceutical company', '58,724', '2020-10-05', '8100000', 'USD', '8100000', 'Grant', '39000000', 'USD', '39000000', '51-100', 'Private', '', '', '', 'http://intervexion.com/', '', '', 'InterveXion is a privately-held clinical-stage biopharmaceutical company developing novel product candidates for the treatment of addiction disorders.  Their lead clinical asset is IXT-m200, a monoclonal antibody directed against methamphetamine, which acts by re-partitioning methamphetamine away from its sites of action in the CNS.  IXT-m200 has received US FDA Fast Track Designation, and is being studied in an ongoing Phase 2 proof-of-concept study (STAMPOUT; NCT03336866).  They are also developing a novel vaccine (IXT-v100) against methamphetamine, which is in Preclinical Development.', 'National Institutes of Health, National Institute on Drug Abuse (NIDA)', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2004-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', 'Ralph Henry', '', '4'],\n  ['Daylight Solutions', 'https://www.crunchbase.com/organization/daylight-solutions', 'Biotechnology, Health Care, Health Diagnostics, Manufacturing, Medical', 'San Diego, California, United States', 'Daylight Solutions manufactures molecular detection and imaging instruments for diagnostics, homeland security, military and more.', '59,034', '2011-07-11', '15000000', 'USD', '15000000', 'Series C', '36000000', 'USD', '36000000', '51-100', 'Private', '', '', '', 'http://www.daylightsolutions.com', 'http://www.linkedin.com/company/daylight-solutions', 'info@daylightsolutions.com', 'Daylight Solutions, Inc. manufactures molecular detection and imaging instruments for the medical diagnostics, homeland security, military, and industrial/environmental monitoring applications. The company also manufactures tunable lasers and tiny tunables for original equipment manufacture and scientific applications. It offers solutions for non-invasive medical diagnostics, medical imaging, and drug discovery applications in biomedical field; for detection and alert applications in military markets; for detection applications in homeland security market; and for process monitoring and leak detection applications in industrial market. Daylight Solutions, Inc., through distributors, offers its solutions in China, Japan, Germany, Switzerland, Austria, France, the United Kingdom, the Netherlands, Belgium, Luxembourg, Spain, Sweden, Norway, and Finland.  The company was founded in 2005 and is based in Poway, California.', 'Western Technology Investment, Northrop Grumman, Jade Invest, Masters Capital Nanotechnology, HamiltonTech Capital Partners', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', 'Basic Electric Elements', '', '$10M to $50M', '2004-12-01', 'day', '', 'M&A', '', 'Active', 'For Profit', '11', '', 'Was Acquired', 'Timothy Day', '', '5'],\n  ['Isto Technologies', 'https://www.crunchbase.com/organization/isto-technologies', 'Biotechnology, Information Technology, Medical Device', 'St Louis, Missouri, United States', 'ISTO Technologies is an orthobiologics\\xa0firm\\xa0developing biologic products to regenerate and restore function to damaged cartilage and bone.', '60,000', '2015-07-29', '1200000', 'USD', '1200000', 'Grant', '33897298', 'USD', '33897298', '51-100', 'Private', '', '', '', 'http://www.istotech.com', '', 'customerservice@istotech.com', 'ISTO Technologies, Inc., an orthobiologics company, develops biologic products to regenerate and restore function to damaged cartilage and bone. It offers InQu, a resorbable bone graft extender and substitute; NuQu, a cell-based injectable therapy for disc regeneration; and DeNovo ET, an engineered cartilage implant for the repair and regeneration of knee cartilage. The company provides its products through distributors. ISTO Technologies, Inc. was founded in 1997 and is based in St. Louis, Missouri.', 'National Institutes of Health, Life Sciences Partners, NIST, Alafi Capital, Ascension Ventures', 'Biotechnology, Health Care, Information Technology, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '1997-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '1', '1', 'Made Acquisitions, Was Acquired', '', '', '9'],\n  ['Coskata', 'https://www.crunchbase.com/organization/coskata', 'Biotechnology, Energy, Fuel, Mining, Oil and Gas, Renewable Energy, Solar', 'Warrenville, Illinois, United States', 'Coskata is a biology-based renewable energy company producing ethanol from a variety of input materials.', '60,008', '2015-02-20', '2399000', 'USD', '2399000', 'Venture - Series Unknown', '120686000', 'USD', '120686000', '51-100', 'Private', '', '', '', 'http://www.coskata.com', 'https://www.linkedin.com/company/coskata', 'info@coskata.com', 'Coskata, Inc. is a biology-based renewable energy company, with technology for the production of liquid fuels. Using proprietary microorganisms and transformative bioreactor designs, the company will produce ethanol from a wide variety of input materials to provide economic, environmental, and national security benefits.', 'Khosla Ventures, Blackstone Group, Riverside Company, Total Carbon Neutrality Ventures, Advanced Technology Ventures', 'Biotechnology, Energy, Natural Resources, Science and Engineering, Sustainability', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$10M to $50M', '2006-07-01', 'day', '', '', '', 'Active', 'For Profit', '151', '', '', 'Todd Kimmel', '', '11'],\n  ['WaveTec Vision', 'https://www.crunchbase.com/organization/wavetec-vision', 'Biotechnology, Health Care, Medical', 'Aliso Viejo, California, United States', 'WaveTec Vision\\xa0develops and provides\\xa0a wavefront measurement technology for cataract surgeons with\\xa0their ORA System.', '60,328', '2014-03-06', '2893286', 'USD', '2893286', 'Venture - Series Unknown', '91143286', 'USD', '91143286', '51-100', 'Private', '', '', '', 'http://www.wavetecvision.com', 'https://www.linkedin.com/company/wavetec-vision-systems-inc-/about/', 'info@wavetecvision.com', 'WaveTec Vision is a small company with a big idea â€“ and the ability and the team to achieve it. Their proprietary intraoperative aberrometer system ORange will transform and advance the emerging convergence of refractive and cataract surgery.  It was founded in 1997 and headquartered in Aliso Viejo, California.', 'Versant Ventures, Foresite Capital, DeNovo Ventures, Accuitive Medical Ventures, Biomark Capital', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10M to $50M', '1997-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '7', '', 'Was Acquired', '', '', '10'],\n  ['NuScriptRx', 'https://www.crunchbase.com/organization/nuscriptrx', 'Biotechnology, Health Care, Health Diagnostics, Medical, Pharmaceutical', 'Nashville, Tennessee, United States', 'NuScriptRX is an institutional pharmacy serving long-term care facilities and their patients.', '60,499', '2015-03-18', '3849424', 'USD', '3849424', 'Venture - Series Unknown', '64630077', 'USD', '64630077', '51-100', 'Private', '', '', '', 'http://www.nuscriptrx.com', 'https://www.linkedin.com/company/nuscriptrx', 'info@nuscriptrx.com', 'Based in Nashville, Tenn., NuScriptRX is an institutional pharmacy that serves the pharmaceutical needs of long-term care facilities and their patients. The company was developed by long-term care professionals who have more than 100 years of experience in SNFs, ALFs and RCs.', 'Innova Memphis, FCA Venture Partners, Launch Tennessee, Square 1 Bank, Council Capital', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '2007-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', 'Richard J. Wager', '', '14'],\n  ['Biomerica', 'https://www.crunchbase.com/organization/biomerica', 'Biotechnology, Manufacturing', 'Irvine, California, United States', 'Biomerica is a biomedical company that develops, manufactures, and markets advanced diagnostic products.', '61,415', '2020-02-26', '2000001', 'USD', '2000001', 'Venture - Series Unknown', '2000001', 'USD', '2000001', '51-100', 'Private', '', '', '', 'http://biomerica.com/', 'https://www.linkedin.com/company/biomerica', 'info@biomerica.com', 'Biomerica is a biomedical company that develops, manufactures, and markets advanced diagnostic products. The company’s products are designed to enhance the health and well being of people while reducing total healthcare costs. It primarily focuses on products for diabetes, gastrointestinal disease, and esoteric testing. Founded in 1971, Biomerica is headquartered in Irvine, California.', '', 'Biotechnology, Manufacturing, Science and Engineering', 'Testing', '', '$1M to $10M', '1971-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', '', '', '1'],\n  ['Thar Pharmaceuticals', 'https://www.crunchbase.com/organization/thar-pharmaceuticals', 'Biotechnology, Health Care, Medical Device', 'Pittsburgh, Pennsylvania, United States', 'Thar Pharmaceuticals identifies and develops prescription drugs that solve clinical opportunities such as efficacy, absorption and safety.', '62,411', '2016-04-05', '1371500', 'USD', '1371500', 'Debt Financing', '12366958', 'USD', '12366958', '51-100', 'Private', '', '', '', 'http://tharpharma.com', '', 'bmoyer@tharpharma.com', 'Thar Pharmaceuticals, Inc. engages in the identification and development of prescription drugs. It focuses on the drugs that solve clinical opportunities, such as improved bioavailability, efficacy, absorption, safety, or toxicity. The company was incorporated in 2008 and is based in Pittsburgh, Pennsylvania.', 'Innovation Works', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2008-01-01', 'year', '', '', '', 'Active', 'For Profit', '4', '', '', 'Lalit Chordia', '', '7'],\n  ['TyRx', 'https://www.crunchbase.com/organization/tyrx', 'Advanced Materials, Biotechnology, Health Care, Medical Device', 'Monmouth Junction, New Jersey, United States', 'TYRX delivers site-specific therapy by commercializing medical-pharmaceutical combination devices for multiple surgical markets.', '64,584', '2013-06-04', '1999999', 'USD', '1999999', 'Venture - Series Unknown', '21999999', 'USD', '21999999', '51-100', 'Private', '', '', '', 'http://www.tyrx.com', '', '', 'TyRx engages in the design, development, and commercialization of resorbable polymeric biomaterials. It offers PIVIT CRM, a mesh based pouch, which contains antibacterial agents to help provide protection from microbial colonization of the generator or defibrillator during and immediately after surgical implant. The company also provides AIGISRx Flat, an antibacterial product that provides protection against infections associated with implanted pacemakers and defibrillators. TyRx Pharma, Inc. was formerly known as Advanced Materials Design, LLC. The company was founded in 1997 and is based in Monmouth Junction, New Jersey.', 'HLM Venture Partners, Pappas Ventures, Clarus Ventures, MemorialCare Innovation Fund', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1998-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '2', '', 'Was Acquired', 'Jeff Wolf', '', '2'],\n  ['SOHM', 'https://www.crunchbase.com/organization/sohm', 'Biotechnology, Manufacturing, Medical, Pharmaceutical', 'Buena Park, California, United States', 'Sohm is a generic pharmaceutical manufacturer that produces and markets generic drugs\\xa0for all the\\xa0major treatment categories.', '64,814', '2012-06-13', '95000', 'USD', '95000', 'Post-IPO Equity', '95000', 'USD', '95000', '51-100', 'Public', '', '', '', 'http://www.sohm.com/', 'https://www.linkedin.com/company/sohm-inc.', 'info@sohm.com', 'Sohm, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters is located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia.', '', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', '', '', '$10M to $50M', '1998-01-01', 'year', '', 'IPO', '2007-12-28', 'Closed', 'For Profit', '1', '1', 'Made Acquisitions', 'Shailesh Shah', '', '1'],\n  ['Cameron Health', 'https://www.crunchbase.com/organization/cameron-health', 'Biotechnology, Health Care, Manufacturing, Medical Device', 'San Clemente, California, United States', 'Cameron Health, a development stage medical device company, develops, manufactures, and distributes implantable defibrillators.', '65,372', '2011-05-18', '107000000', 'USD', '107000000', 'Series F', '233500000', 'USD', '233500000', '51-100', 'Private', '', '', '', 'http://www.cameronhealth.com', '', '', 'Cameron Health, Inc., a development stage medical device company, is creating the next generation of implantable electronic device utilizing state-of-the-art technologies. They are a team of specialized, high technology, creative individuals with decades of experience in solving difficult medical problems. Their current target is the development of a family of devices that will afford patient treatment that has been, until now, unattainable with the current therapeutic modalities and technologies.', 'Boston Scientific, Versant Ventures, Greenspring Associates, Alloy Ventures, Delphi Ventures', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2001-01-01', 'year', '', 'M&A', '', 'Closed', 'For Profit', '9', '', 'Was Acquired', 'Gust Bardy', '', '6'],\n  ['InnoPharma', 'https://www.crunchbase.com/organization/innopharma', 'Biotechnology, Medical, Pharmaceutical', 'Piscataway, New Jersey, United States', 'InnoPharma develops niche-generic, specialty pharmaceutical and bio-pharmaceutical products.', '65,500', '2013-11-13', '20000000', 'USD', '20000000', 'Debt Financing', '43000000', 'USD', '43000000', '51-100', 'Private', '', '', '', 'http://innopharmainc.com', 'https://www.linkedin.com/company/innopharma-inc-/', 'info@innopharmainc.com', 'InnoPharma, LLC. Founded in 2005, is a privately held pharmaceutical research and development (R&D) company, based in Piscataway, New Jersey.', 'NXT Capital, Comerica Incorporated, Athyrium Capital Management, LP, Thomas, McNerney & Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2005-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '2', '', 'Was Acquired', 'Navneet Puri, Sriram J. Ramanathan', '', '3'],\n  ['Regenesis Biomedical', 'https://www.crunchbase.com/organization/regenesis-biomedical', 'Biotechnology, Health Care, Medical Device, Wellness', 'Scottsdale, Arizona, United States', 'Regenesis Biomedical focuses on the development of non-invasive regenerative medicine products.', '66,821', '2011-06-06', '5300000', 'USD', '5300000', 'Series C', '11735000', 'USD', '11735000', '51-100', 'Private', '', '', '', 'http://www.regenesisbio.com', 'https://www.linkedin.com/company/regenesis-biomedical', 'info@regenesisbiomedical.com', 'Regenesis Biomedical a medical technology company that focuses on developing and marketing noninvasive regenerative medicine products. The company offers Provant Therapy System, a medical device that aids in reduction of pain and swelling of skin and soft tissues following surgery. Its customers include health care facilities and providers that serve patients being treated by acute care hospitals, long-term acute care hospitals, skilled nursing facilities, rehabilitation centers, home healthcare agencies, and wound care clinics. Regenesis Biomedical was founded in 1996 and is headquartered in Scottsdale, Arizona.', 'Fulcrum Equity Partners, Solstice Capital, Valley Ventures, TGap Ventures, Aztec Venture Network', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '1997-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '5', '', '', 'Frank George, Mary Ritz', '', '4'],\n  ['Y-mAbs Therapeutics', 'https://www.crunchbase.com/organization/y-mabs-therapeutics', 'Biotechnology, Health Care, Medical, Therapeutics', 'New York, New York, United States', 'YmAbs is a clinical stage biopharmaceutical company that discovers and develops innovative treatments for cancer patients.', '67,310', '2021-02-17', '115000000', 'USD', '115000000', 'Post-IPO Equity', '195000000', 'USD', '195000000', '51-100', 'Public', '', '', '', 'https://www.ymabs.com/', 'https://www.linkedin.com/company/y-mabs-therapeutics-inc-/', 'info@ymabs.com', \"YmAbs is a clinical stage biopharmaceutical company that discovers and develops innovative treatments for cancer patients through immunotherapies. YmAbs utilizes its platform technologies to create next-generation humanized, affinity matured bispecific antibodies. To further improve its bispecific antibodies, the company collaborates on the development of a novel human protein tag that dimerizes T-cell engaging bispecific antibodies, which enables higher tumor binding and results in a longer serum half-life and a significantly greater T-cell mediated killing of tumor cells.  YmAbs' treatments claims to potentially reduce longer-term toxicities associated with current chemotherapeutics and provide the potential for curative therapy even for patients with widespread disease. YmAbs’ goal is to drive multiple product candidates in select solid tumor cancers to FDA approval.\", 'HBM Healthcare Investments AG, Sofinnova Investments, Scopia Capital', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$1M to $10M', '2015-04-01', 'day', '', 'IPO', '2018-09-20', 'Active', 'For Profit', '8', '', '', 'Thomas Gad', '', '3'],\n  ['Demetrix', 'https://www.crunchbase.com/organization/demetrix', 'Biopharma, Biotechnology, Life Science, Medical Device', 'Emeryville, California, United States', 'Demetrix is a biotechnology company that manufactures natural medicines using synthesis biology to make medical drugs.', '67,430', '2019-07-11', '50000000', 'USD', '50000000', 'Series A', '61000000', 'USD', '61000000', '51-100', 'Private', '', '', '', 'https://demetrixbio.com', 'https://www.linkedin.com/company/demetrix/', 'info@demetrixbio.com', 'Demetrix manufactures natural medicines using synthesis biology. The company uses genetics and computing enabled deciphering technology to produce drugs. It enables refactoring biotechnology microbial hosts for gene synthesis. The company engineers strain to produce co-evolved and bio-inspired medicines and nutraceuticals. The company was founded in 2015 and is headquartered in Emeryville, California.', 'Horizons Ventures, Tuatara Capital', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '2015-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '3', '', '', 'Jay Keasling, William Haseltine', '', '2'],\n  ['Generex Biotechnology', 'https://www.crunchbase.com/organization/generex-biotechnology', 'Biopharma, Biotechnology, Medical Device, Pharmaceutical', 'Miramar Beach, Florida, United States', 'Generex Biotechnology develops and commercializes\\xa0drug delivery systems and technologies for metabolic and immunological diseases.', '67,785', '2012-08-10', '750000', 'USD', '750000', 'Post-IPO Equity', '9350000', 'USD', '9350000', '51-100', 'Public', '', '', '', 'http://www.generex.com', '', 'info@generex.com', \"Generex Biotechnology Corporation, a development stage company, engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases. It develops a proprietary platform technology for the oral administration of large molecule drugs, including proteins, peptides, monoclonal antibodies, hormones, and vaccines. The company's products include Generex Oral-lyn, an insulin spray formulation used for the treatment of Type-1 and Type-2 diabetes; Glucose RapidSpray, which provides an alternative for people who require additional glucose in their diet, as well as delivers glucose formulation directly into the mouth; BaBOOM! Energy Spray, an instant energy spray designed to increase energy levels for sports, work, study, travel, and overall fatigue; and Crave-NX, a fat-free glucose spray that is used as an aid for dieters. Generex Biotechnology Corporation's under development products include medicinal chewing gum for the treatment of Type-2 diabetes mellitus and obesity; morphine and fentanyl products for breakthrough and postoperative pain; and AE37, an immunotherapeutic vaccine that is in Phase II clinical trials for patients with HER-2/neu positive breast cancer. The company markets its products through distributors and retail chains in Ecuador, Canada, and the United States. It has collaboration with Fertin Pharma A/S for the development of a metformin medicinal chewing gum. The company was founded in 1983 and is based in Toronto, Canada.\", '', 'Biotechnology, Health Care, Science and Engineering', '', '', 'Less than $1M', '1983-01-01', 'year', '', 'IPO', '2010-11-12', 'Active', 'For Profit', '20', '5', 'Made Acquisitions', '', '', '4'],\n  ['Intellikine', 'https://www.crunchbase.com/organization/intellikine', 'Biotechnology, Health Care, Medical', 'La Jolla, California, United States', 'Intellikine is focused on the R&D of orally available small molecule drugs targeting the PI3K/mTOR pathway.', '68,981', '2011-10-31', '4000000', 'USD', '4000000', 'Venture - Series Unknown', '85000000', 'USD', '85000000', '51-100', 'Private', '', '', '', 'http://www.intellikine.com', 'https://www.linkedin.com/company/intellikine-inc/', '', 'Intellikine works in the discovery and development of novel, small molecule therapies targeting the PI3K/Akt/mTOR pathway.  Intellikine is committed to building an exceptional team and a powerful discovery platform that rapidly generates small molecule kinase inhibitor drug candidates that will become the next generation of medical breakthroughs.', 'U.S. Venture Partners, Abingworth, Biogen Idec, Sofinnova Investments, Novartis Venture Fund', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '2007-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '18', '', 'Was Acquired', 'Troy Wilson', '', '3'],\n  ['Orthopaedic Synergy', 'https://www.crunchbase.com/organization/orthopaedic-synergy', 'Biotechnology, Manufacturing, Medical Device', 'East Taunton, Massachusetts, United States', 'Orthopaedic Synergy engages in the design, development, and manufacture of medical devices for the orthopedic industry.', '70,340', '2014-04-30', '42500000', 'USD', '42500000', 'Venture - Series Unknown', '61201392', 'USD', '61201392', '51-100', 'Private', '', '', '', 'http://orthopaedicsynergy.com', '', 'enquiries@orthopaedicsynergy.com', 'Orthopaedic Synergy, Inc., through its subsidiaries, engages in the design, development, and manufacture of medical devices for the orthopedic industry. It offers hip instruments, including hip calibration gauges, STAR drills, offset cup impactors, minimally invasive hip sets, light pipes, and retractors that are used in a range of procedures for the placement and impaction of implants, patient leg length assessment, soft tissue repair, and surgical exposure; and spine instruments and extremities.', '', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', '', '', '$1M to $10M', '2008-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '1', 'Made Acquisitions', '', '', '3'],\n  ['MedVentive', 'https://www.crunchbase.com/organization/medventive', 'Health Care, Medical, Pharmaceutical', 'Waltham, Massachusetts, United States', 'MedVentive, an accountable care organization, offers MedVentive Population Manager, a network platform for clinical integration programs.', '71,143', '2011-10-21', '12000000', 'USD', '12000000', 'Series D', '31900000', 'USD', '31900000', '51-100', 'Private', '', '', '', 'http://www.medventive.com', 'https://www.linkedin.com/company-beta/49696/', '', 'MedVentive provides leading-edge technology solutions that enable physician groups, integrated delivery systems, health plans and self-insured employers to effect meaningful and measurable change in the quality and cost of the care they deliver to patients. Founded in 1997 by physicians, MedVentive has been at the forefront of the development of innovative and clinically sophisticated solutions to reduce healthcare costs and improve healthcare quality.', 'Excel Venture Management, HLM Venture Partners, LRVHealth, Core Capital Partners, CHV Capital', 'Health Care', '', '', '', '1997-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '14', '', 'Was Acquired', 'Jonathan M. Niloff', '', '7'],\n  ['ReCept Pharmacy', 'https://www.crunchbase.com/organization/recept-pharmacy', 'Communities, Health Care, Medical, Pharmaceutical', 'Fort Worth, Texas, United States', 'ReCept Pharmacy has a rich tradition of delivering specialty patient care within the community it has served for over 40 years.', '71,848', '2011-12-27', '10154182', 'USD', '10154182', 'Private Equity', '10154182', 'USD', '10154182', '51-100', 'Private', '', '', '', 'http://receptrx.com/', 'https://www.linkedin.com/company/recept-pharmacy', '', 'ReCept Holdings Inc. owns and operates a chain of pharmacies. The company was founded in 1978 and is based in Fort Worth, Texas.', '', 'Community and Lifestyle, Health Care', '', '', '$10M to $50M', '1978-01-01', 'year', '', 'Private Equity', '', 'Active', 'For Profit', '', '', '', 'Nicky Otts', '', '1'],\n  ['Akarna Therapeutics', 'https://www.crunchbase.com/organization/akarna-therapeutics', 'Biotechnology, Health Care, Medical, Therapeutics', 'Cambridge, Massachusetts, United States', 'At Akarna, our mission is to develop best-\\xadin-\\xadclass treatments for NASH and other chronic liver diseases', '72,345', '2016-02-16', '15000000', 'USD', '15000000', 'Series B', '15000000', 'USD', '15000000', '51-100', 'Private', '', '', '', 'http://www.akarna.com/', '', 'info@akarna.com', 'Akarna Therapeutics is a biopharmaceutical company with offices in San Diego and Cambridge (UK) that is developing novel small molecule therapeutics that target inflammatory and fibrotic diseases. Our lead program is a non-bile acid FXR agonist that is potentially a best-in-class therapeutic for the treatment of nonalcoholic steatohepatitis (NASH), a progressive form of fatty-liver disease for which there are no approved therapies. Akarna’s lead candidate is currently in preclinical, IND-enabling toxicology and safety pharmacology studies with first-in-human studies planned for early 2017.', 'New Science Ventures, Third Point Ventures, Forbion Capital Partners', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$10M to $50M', '2014-10-01', 'month', '', 'M&A', '', 'Active', 'For Profit', '3', '', 'Was Acquired', 'Raju Mohan', '', '1'],\n  ['Vitalink', 'https://www.crunchbase.com/organization/vitalink', 'Biotechnology, Life Science', 'San Francisco, California, United States', 'Vitalink is a biotech smartwatch accessory company that will increase users quality of life by-altering.', '72,819', '2021-04-12', '15000', 'USD', '15000', 'Seed', '15000', 'USD', '15000', '51-100', 'Private', '', '', '', '', '', '', 'Vitalink is a biotech smartwatch accessory company that will increase users quality of life by-altering a person energy level and helping them-wake up.', 'Sunstone Innovation Challenge', 'Biotechnology, Science and Engineering', '', '', '', '', '', '', 'Seed', '', 'Active', 'For Profit', '', '', '', '', '', '1'],\n  ['Baxano', 'https://www.crunchbase.com/organization/baxano', 'Biotechnology, Health Care, Medical Device', 'San Jose, California, United States', 'Baxano develops minimally-invasive tools to restore spine function and preserve healthy tissues.', '73,211', '2014-04-24', '10000000', 'USD', '10000000', 'Venture - Series Unknown', '61200000', 'USD', '61200000', '51-100', 'Private', '', '', '', 'http://www.baxano.com', 'https://www.linkedin.com/company/baxano/about/', '', 'Baxano, Inc. develops minimally invasive tools to restore spine function and preserve healthy tissue. The company offers iO-Flex System, which targets and decompresses bone and soft tissue in the foramen, lateral recess, and central canal for patients with single and multi-level mild, moderate, and severe stenosis. Its products comprise Neuro Check device that allows the surgeon to confirm that the device is against the bone and the nerve is safely out of the way; MicroBlade ShaverTM instrument, which is used to remove the impinging bone and ligament; Guidewire; probes; and distal handles. The company was founded in 2005 and is based in San Jose, California.', 'Prospect Venture Partners, Kaiser Permanente Ventures, Kearny Venture Partners, CMEA Capital, Affinity Capital Management', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2005-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '6', '', 'Was Acquired', '', '', '4'],\n  ['Immunetics', 'https://www.crunchbase.com/organization/immunetics', 'Biotechnology, Health Diagnostics, Life Science', 'Boston, Massachusetts, United States', 'Immunetics, a biotechnology company, develops immunoassay and molecular probe kits and instruments for the diagnosis of infectious diseases.', '73,215', '2014-03-10', '835000', 'USD', '835000', 'Debt Financing', '8064000', 'USD', '8064000', '51-100', 'Private', '', '', '', 'http://www.immunetics.com', '', '', \"Immunetics, Inc., a biotechnology company, researches and develops immunoassay and molecular probe kits and instruments for the diagnosis of infectious diseases. Its products include Miniblotter instrument system for western blot, spoligotyping, and various multi-probe membrane assays; cell adhesion flow chamber for cell-cell interaction studies; and C6 peptide Lyme ELISA, a synthetic peptide ELISA test for Lyme disease anthrax. The company's products also include QuickELISA, a blood test for anthrax infection; and QualiCode western blot assays for diseases where diagnosis is challenging. In addition, it offers QuickELISA Anthrax-PA kit, an in vitro diagnostic test for the detection of antibodies to protective antigen of anthrax in human and animal samples; and BacTx Test for the bacterial contamination of platelets. The company sells its products through distributors in Belgium, Denmark, Norway, Finland, Sweden, France, Germany, Italy, the Netherlands, Switzerland, the United Kingdom, Canada, Honduras, Brazil, Ecuador, Venezuela, Australia, China, Korea, and Taiwan. Immunetics, Inc. was founded in 1987 and is based in Boston, Massachusetts.\", 'National Institutes of Health, Massachusetts Life Sciences Center', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '', '1987-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '10', '', 'Was Acquired', '', '', '5'],\n  ['Chamishi Therapeutics', 'https://www.crunchbase.com/organization/chamishi-therapeutics', 'Biopharma, Biotechnology', 'Deerfield, Illinois, United States', 'Chamishi Therapeutics is a drug discovery and development company focused on neurodegenerative diseases and other related disorders.', '74,581', '2019-10-07', '490386', 'USD', '490386', 'Seed', '490386', 'USD', '490386', '51-100', 'Private', '', '', '', '', '', '', 'Chamishi Therapeutics, a drug discovery and development company focused on neurodegenerative diseases and other related disorders. Chamishi will initially focus on developing antisense oligonucleotide (ASO) therapies for Glucosylceramidase Beta Acid (GBA)-Parkinson’s disease.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2019-01-01', 'year', '', 'Seed', '', 'Active', 'For Profit', '', '', '', '', '', '1'],\n  ['Inclinix', 'https://www.crunchbase.com/organization/inclinix', 'Biotechnology, Medical Device, Pharmaceutical', 'Wilmington, North Carolina, United States', 'Inclinix focuses on customized Phase I-IV clinical enrollment solutions for pharmaceutical, biotechnology and medical device organizations.', '74,998', '2014-06-19', '3396287', 'USD', '3396287', 'Venture - Series Unknown', '30596287', 'USD', '30596287', '51-100', 'Private', '', '', '', 'http://inclinix.com', '', 'info@inclinix.com', \"Inclinix, Inc. is a division of Inclinix-PMG Holdings, Inc., the industry's most innovative solution for clinical trial enrollment that combines the world-class sites of PMG Research Inc. with Inclinix's premier patient recruitment solutions. Inclinix specializes in customized Phase I-IV clinical enrollment solutions for global pharmaceutical, biotechnology, and medical device organizations. Clients benefit from twelve years of experience in multiple therapeutic areas, as well as leading edge technologies that meet the challenge of clinical development from feasibility through compliance. Inclinix delivers a customized, site-focused approach to patient recruitment ensuring every available study candidate is identified, qualified and presented with a study opportunity. By combining our powerful in-field approach with social media and highly targeted advertising, Inclinix creates effective outreach campaigns breitling replica watches that result in enrolled patients and productive sites.\", 'Frontier Growth', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '1999-01-01', 'year', '', '', '', 'Closed', 'For Profit', '', '', '', '', '', '4'],\n  ['VirtualScopics', 'https://www.crunchbase.com/organization/virtualscopics', 'Biotechnology, Medical Device, Pharmaceutical', 'Rochester, New York, United States', 'VirtualScopics provides imaging solutions for clinical trials in the pharmaceutical, biotechnology, and medical device industries.', '75,587', '2012-04-18', '6000000', 'USD', '6000000', 'Post-IPO Equity', '9800000', 'USD', '9800000', '51-100', 'Delisted', '', '', '', 'http://www.virtualscopics.com', 'http://www.linkedin.com/company/virtualscopics', '', 'VirtualScopics, Inc. provides imaging solutions for clinical trials serving the pharmaceutical, biotechnology, and medical device industries. The company offers a suite of image analysis software tools and applications, which are used in detecting and measuring specific anatomical structures and metabolic activity using medical images. Its image-based measurement and visualization tools enable automated, accurate, and reproducible measurement of changes that occur in anatomic structures in musculoskeletal, oncological, cardiological, and neurological diseases. VirtualScopics has strategic relationship with Pfizer Inc. for the discovery, validation, and application of image-based biomarkers for clinical research. The company was founded in 2000 and is headquartered in Rochester, New York.', 'Trillium Group', 'Biotechnology, Health Care, Science and Engineering', 'Computing; Calculating', '', '$10M to $50M', '1990-01-01', 'year', '', 'M&A', '2005-11-18', 'Active', 'For Profit', '12', '', 'Was Acquired', 'José Tamez-Peña, Saara Totterman', '', '2'],\n  ['CNS Therapeutics (Old)', 'https://www.crunchbase.com/organization/cns-therapeutics', 'Biotechnology, Health Care, Health Diagnostics', 'Saint Paul, Minnesota, United States', 'CNS Therapeutics develops pharmaceuticals for the treatment of neurological disorders and chronic pain.', '76,977', '2012-12-21', '3050000', 'USD', '3050000', 'Venture - Series Unknown', '10050000', 'USD', '10050000', '51-100', 'Private', '', '', '', 'http://cnstherapeutics.com', '', 'info@cnstherapeutics.com', \"CNS Therapeutics is a private company based in St. Paul, Minn. CNS Therapeutics develops and markets safe, high-quality pharmaceuticals for site-specific delivery to the central nervous system to treat neurological disorders and chronic pain. In addition to its first FDA-approved product, Gablofen, CNS Therapeutics is currently collaborating with U.S. and international scientific experts to develop and test new treatments for pain and Parkinson's disease.\", '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2007-07-01', 'month', '', 'M&A', '', 'Active', 'For Profit', '6', '', 'Was Acquired', 'Pratik Shah', '', '2'],\n  ['OPX Biotechnologies', 'https://www.crunchbase.com/organization/opx-biotechnologies', 'Biofuel, Biotechnology, Clean Energy', 'Boulder, Colorado, United States', 'OPX Biotechnologies is a bioproducts company using technology to convert renewable feedstocks into biofuels and green chemistry products.', '77,602', '2011-07-07', '36500000', 'USD', '36500000', 'Series C', '57600000', 'USD', '57600000', '51-100', 'Private', '', '', '', 'http://www.opxbio.com', 'http://www.linkedin.com/company/334217', 'aburley@opxbiotechnologies.com', 'OPX Biotechnologies, Inc. is a Colorado-based bioproducts company using proprietary bioengineering technology to convert renewable feedstocks into biofuels and green chemistry products. The OPX EDGE - Efficiency Directed Genome Engineering - technology platform rapid, rational, and robust optimization of microbes and bioprocesses to achieve equivalent product performance with improved sustainability at lower cost versus petroleum based alternatives.', 'Altira Group, Mohr Davidow Ventures, Braemar Energy Ventures, DBL Partners, XSeed Capital', 'Biotechnology, Energy, Natural Resources, Science and Engineering, Sustainability', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$1M to $10M', '2007-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '13', '', 'Was Acquired', 'Michael Lynch', '', '4'],\n  ['Assembly Biosciences', 'https://www.crunchbase.com/organization/assembly-biosciences', 'Biotechnology, Health Care', 'Carmel, Indiana, United States', 'Assembly Biosciences, Inc. is a public biotechnology company and provider of oral biologic therapeutics.', '78,385', '', '', '', '', '', '', '', '', '51-100', 'Public', '', '', '', 'http://www.assemblybio.com/', 'https://www.linkedin.com/company-beta/1744866/?pathWildcard=1744866', 'investors@assemblybio.com', \"Assembly Biosciences, Inc. is a public biotechnology company developing two innovative platform programs: an HBV program advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and a microbiome program developing novel oral biotherapeutics designed to address diseases associated with the microbiome. Assembly‘s HBV program is advancing multiple drug candidates with the aim of increasing cure rates in patients with chronic HBV. The company's microbiome program consists of a fully integrated platform that includes a robust strain identification and selection process, methods for strain isolation and growth under current Good Manufacturing Practices and a patent-pending delivery system, GEMICEL®, which allows for targeted oral delivery of live biologic and conventional therapies to the lower gastrointestinal tract. The lead program from this platform is in development for the treatment of C. difficile infections. Assembly is also developing additional microbiome product candidates.\", '', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$1M to $10M', '2005-01-01', 'year', '', 'IPO', '2010-12-23', 'Active', 'For Profit', '28', '', '', '', '', ''],\n  ['Encision', 'https://www.crunchbase.com/organization/encision', 'Biotechnology, Developer Platform, Health Care, Manufacturing, Medical Device', 'Boulder, Colorado, United States', 'Encision is a medical device company that develops laparoscopic surgical instruments.', '78,391', '2014-01-16', '1970500', 'USD', '1970500', 'Post-IPO Equity', '3725500', 'USD', '3725500', '51-100', 'Public', '', '', '', 'http://encision.com', 'https://www.linkedin.com/company/encision', 'info@encison.com', 'Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. It offers Active Electrode Monitoring (AEM) surgical instruments to enhance electrosurgery and reduce the chance for patient injury in minimally invasive surgery. The company’s product line includes a range of articulating instruments, such as scissors, graspers, and dissectors; fixed-tip electrodes; and suction-irrigation electrodes. It also provides handles that are used for advanced laparoscopic procedures, which incorporate stiffer shafts and ergonomic features; and markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products primarily to hospitals through a network of direct and independent sales representatives. Encision Inc. was founded in 1991 and is based in Boulder, Colorado.', '', 'Biotechnology, Health Care, Manufacturing, Science and Engineering, Software', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '1991-01-01', 'year', '', 'IPO', '1999-01-12', 'Active', 'For Profit', '4', '', '', 'David W. Newton, Roger C. Odell', '', '2'],\n  ['Sangart', 'https://www.crunchbase.com/organization/sangart', 'Biotechnology, Clinical Trials, Therapeutics', 'San Diego, California, United States', 'Sangart is a biopharmaceutical company developing global scientific, clinical and commercial oxygen-therapeutic agents.', '78,505', '2012-05-24', '50000000', 'USD', '50000000', 'Series G', '294450381', 'USD', '294450381', '51-100', 'Private', '', '', '', 'http://www.sangart.com', '', '', 'Sangart, Inc. is a privately held biopharmaceutical company focused on being the global scientific, clinical and commercial leader in oxygen-therapeutic agents, providing innovative products to patients in need.  Sangart was founded in 1998 based on discoveries arising from over two decades of research in red blood cell substitutes and the mechanisms of oxygen transport by cell-free hemoglobin solutions.', 'Jefferies Financial Group, ODIN Forvaltning', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1998-01-01', 'year', '', 'Late Stage Venture', '', 'Closed', 'For Profit', '4', '', '', '', '', '10'],\n  ['Nodality', 'https://www.crunchbase.com/organization/nodality', 'Biotechnology, Clinical Trials, Health Diagnostics', 'South San Francisco, California, United States', 'Nodality develops biologically-informed clinical treatments for patients with cancer and autoimmune diseases.', '78,627', '2011-08-08', '9999999', 'USD', '9999999', 'Debt Financing', '47039999', 'USD', '47039999', '51-100', 'Private', '', '', '', 'http://www.nodalityinc.com', '', 'info@nodality.com', 'Nodality, Inc., a biotechnology company, discovers and develops personal diagnostics characterizing cell signaling pathways in defined cellular sub-populations of malignant and normal cells from individual patients. The company focuses on hematological malignancies and autoimmune disorders. Nodality, Inc. was incorporated in 2003 and is based in San Francisco, California with an additional office in Franklin, Tennessee.', 'Maverick Ventures, TPG, Kleiner Perkins, Pfizer Venture Investments, TPG Growth', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', '$1M to $10M', '2003-01-01', 'year', '', '', '', 'Active', 'For Profit', '14', '', '', 'Garry Nolan, Omar D. Perez', '', '6'],\n  ['Forte Biosciences', 'https://www.crunchbase.com/organization/forte-biosciences', 'Biotechnology, Life Science, Pharmaceutical', 'Sherman Oaks, California, United States', 'Forte Biosciences is a biotechnology company that focuses on dermatology.', '79,488', '2018-11-27', '5756000', 'USD', '5756000', 'Venture - Series Unknown', '5756000', 'USD', '5756000', '51-100', 'Public', '', '', '', 'https://www.fortebiorx.com/home/default.aspx', '', 'inquiry@fortebiorx.com', \"Forte Biosciences is a biotechnology company that focuses on dermatology. The company's lead product, FB-401, is a topically applied live biotherapeutic developed in collaboration with the National Institutes of Health and the National Institute of Allergy and Infectious Diseases for the treatment of inflammatory skin disease.\", '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2017-01-01', 'year', '', 'IPO', '2020-02-21', 'Active', 'For Profit', '14', '1', 'Made Acquisitions', '', '', '1'],\n  ['Innovative Genetics Inc.', 'https://www.crunchbase.com/organization/innovative-genetics-llc', 'Biotechnology, Pharmaceutical, Therapeutics', 'Miami, Florida, United States', 'Innovative Genetics is a pioneer in its segment of the biotechnology industry. ', '80,984', '2017-05-01', '', '', '', 'Angel', '300000', 'USD', '300000', '51-100', 'Private', '', '', '', 'https://www.innovativegenetics.com', '', 'a.tani@innovativegenetics.com', 'Innovative Genetics is a pioneer in its segment of the biotechnology industry. The company has developed patents ensuring high quality, safe and dependable extractions and delivery methods. All our patent-pending systems are in line with FDA and ASTM standards and are awaiting certification. We pride ourselves on fueling every step of our complex processes with dedication and expertise.', 'Alejandro Tani, Antonio Briceno', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2017-02-17', 'day', '', 'Seed', '', 'Active', 'For Profit', '', '', '', '', '', '2'],\n  ['Putney', 'https://www.crunchbase.com/organization/putney', 'Biotechnology, Medical, Pharmaceutical', 'Portland, Maine, United States', 'Putney develops high quality veterinary medicine, helping vets and pet owners to evaluate the best treatment options for their pet patients.', '81,499', '2014-06-23', '16056308', 'USD', '16056308', 'Venture - Series Unknown', '52100064', 'USD', '52100064', '51-100', 'Private', '', '', '', 'http://www.putneyvet.com', '', '', 'Putney is a pharmaceutical company specializing in the development of high quality drugs for pets. They focus on developing generics for frequently used drugs where cost is a barrier to prescribing, compliance or use. They offer our prescription drugs for sale to companion animal veterinarians â€”veterinarians who treat pets.', 'NewSpring, Safeguard Scientifics, Peter Werth', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2006-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '2', '', 'Was Acquired', 'Jean Hoffman', '', '6'],\n  ['ReveraGen BioPharma', 'https://www.crunchbase.com/organization/reveragen-biopharma', 'Biotechnology, Government', 'Rockville, Maryland, United States', 'ReveraGen BioPharma is a small clinical-stage drug development company with a focus on developing therapeutics.', '81,577', '2018-02-23', '800000', 'USD', '800000', 'Debt Financing', '800000', 'USD', '800000', '51-100', 'Private', '', '', '', 'http://www.reveragen.com/', '', 'eric.hoffman@reveragen.com', 'ReveraGen BioPharma is a small clinical-stage drug development company with a focus on developing therapeutics for Duchenne muscular dystrophy. they run under a venture philanthropy model, through collaborations and partnerships with non-profit foundations and government agencies in both the US and the EU. As such, we keep the focus on stakeholders rather than stockholders.', '', 'Biotechnology, Government and Military, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', 'Less than $1M', '2008-01-01', 'year', '', '', '', 'Active', '', '2', '', '', '', '', '1'],\n  ['Max Planck Florida Institute for Neuroscience', 'https://www.crunchbase.com/organization/max-planck-florida-institute-for-neuroscience', 'Biotechnology, Education, Market Research, Non Profit, Product Research, Universities', 'Jupiter, Florida, United States', 'The Max Planck Society for the Advancement of Science is a 60-year-old independent, non-profit scientific research organization', '81,996', '2016-08-09', '2400000', 'USD', '2400000', 'Grant', '4800000', 'USD', '4800000', '51-100', 'Private', '', '', '', 'https://www.maxplanckflorida.org/', 'https://www.linkedin.com/company/max-planck-florida-institute-for-neuroscience', 'info@mpfi.org', 'The Max Planck Florida Institute for Neuroscience (MPFIN) is part of Germany’s prestigious Max Planck Society for the Advancement of Science, whose accomplished researchers investigate particularly challenging fields within the natural sciences, life sciences, social sciences and the humanities. The MPFIN is the first Institute the German-based Max Planck Society has established in the United States.', 'National Institutes of Health, NIH Surgery', 'Biotechnology, Data and Analytics, Design, Education, Other, Science and Engineering', '', '', '$1M to $10M', '2008-01-01', 'year', '', '', '', 'Active', '', '12', '', '', '', '', '2'],\n  ['Singular Genomics', 'https://www.crunchbase.com/organization/singular-genomics', 'Biotechnology, Health Care, Medical', 'La Jolla, California, United States', 'Singular Genomics is a biotech company that delivers solutions for the genomics market.', '83,252', '2019-01-01', '', '', '', 'Venture - Series Unknown', '', '', '', '51-100', 'Private', '', '', '', 'https://singulargenomics.com/', 'https://www.linkedin.com/company/singular-genomics/', 'info@singulargenomics.com', 'Singular Genomics is a venture capital-backed biotech company in La Jolla, California. It fosters a dynamic, fast-paced, results-oriented environment where they offer employees the opportunity to make a significant impact in a rapidly expanding company. Singular Genomics is inventing at the forefront of genomics, one of the world’s fastest-growing industries.  The company is located in the center of the Biotech hub on the Torrey Mesa close to the Pacific Ocean and next door to prestigious institutions like the Salk Institute, Scripps, Sanford Burnham, and UCSD.', 'F-Prime Capital, Domain Associates', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '', '2016-01-01', 'year', '', '', '', 'Active', '', '', '', '', 'Eli Glezer', '', '2'],\n  ['Ikonisys', 'https://www.crunchbase.com/organization/ikonisys', 'Biotechnology, Health Care, Health Diagnostics', 'New Haven, Connecticut, United States', 'Ikonisys is transforming diagnostic medicine by enabling early, accurate and non-invasive disease detection.', '84,020', '2012-08-03', '1400000', 'USD', '1400000', 'Venture - Series Unknown', '48705000', 'USD', '48705000', '51-100', 'Private', '', '', '', 'http://www.ikonisys.com', '', 'questions@ikonisys.com', 'Ikonisys is transforming diagnostic medicine by enabling early, accurate and non-invasive disease detection. Through a unique combination of technology and science, Ikonisys is dedicated to helping physicians and researchers realize the promise of rare cell detection to give patients the best chance of managing their disease.', 'Goldman Sachs, New Science Ventures, Lakeview Capital Management, WGI Group, Trevi Health Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', '$1M to $10M', '1999-01-01', 'year', '', '', '', 'Active', 'For Profit', '1', '', '', 'Michael Kilpatrick', '', '5'],\n  ['PreCision Dermatology', 'https://www.crunchbase.com/organization/precision-dermatology', 'Biotechnology, Health Care, Medical', 'Cumberland, Rhode Island, United States', 'PreCision Dermatology is a fully-integrated dermatology company developing diagnostics and therapeutics.', '84,054', '2013-09-23', '67000000', 'USD', '67000000', 'Debt Financing', '115400002', 'USD', '115400002', '51-100', 'Private', '', '', '', 'http://www.precisionderm.com', 'https://www.linkedin.com/company/rio-2016-organizing-committee-for-the-olympic-games', 'info@precisionderm.com', 'PreCision Dermatology is a fully-integrated dermatology company with a mission to deliver innovative therapies to doctors and patients that demonstrably improve the care of skin. PreCision Dermatology is expanding rapidly through internally generated innovation, acquisitions, in-licensing, and co-marketing opportunities.', 'Longitude Capital, Frazier Healthcare Partners, Boston Millennia Partners, Essex Woodlands Healthcare Partners, Golub Capital', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2010-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '10', '1', 'Made Acquisitions, Was Acquired', 'Jeffrey Nugent', '', '3'],\n  ['Neomend', 'https://www.crunchbase.com/organization/neomend', 'Biotechnology, Health Care, Medical Device', 'Irvine, California, United States', 'Neomend is a biomedical device company engaged in the development and commercialization of surgical wound healing products.', '84,464', '2011-08-03', '20000000', 'USD', '20000000', 'Series D', '61702727', 'USD', '61702727', '51-100', 'Private', '', '', '', 'http://www.neomend.com', 'https://in.linkedin.com/company/neomend', 'customerservice@neomend.com', 'Neomend, Inc., a biomedical device company, engages in the development and commercialization of surgical wound healing products. Its platform technology, Pro/PEG, is a bioadhesive polymer hydrogel. NeoMend engages in commercialization of the combination wound sealant and adhesion barrier product that can be delivered during minimally invasive/laparoscopic procedures. Neomend, Inc. was founded in 1999 and is based in Irvine, California.', 'Vivo Capital, Prospect Venture Partners, Novo Ventures, Clarus Ventures, Sanderling Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '1999-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '2', '', 'Was Acquired', '', '', '6'],\n  ['LifeWave', 'https://www.crunchbase.com/organization/lifewave', 'Biotechnology, Health Care, Information Technology, Medical', 'Los Altos, California, United States', 'LifeWave focuses on developing non-invasive and sensing technology for prenatal and neonatal monitoring in clinical and remote settings.', '85,245', '2013-12-31', '618178', 'USD', '618178', 'Venture - Series Unknown', '618178', 'USD', '618178', '51-100', 'Private', '', '', '', 'http://lifewavebiomed.com', '', 'info@lifewavebiomed.com', 'LifeWave a medical device company, focuses on developing a non-invasive and sensing technology for prenatal and neonatal monitoring in clinical and remote settings. Its FetalConnect system is designed to have clinical application in intrapartum fetal monitoring. The company also focuses on developing maternal monitoring solutions for postpartum hemorrhage.  LifeWave was founded in 2000 and is based in Los Altos, California.', 'Keiretsu Forum', 'Biotechnology, Health Care, Information Technology, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2000-01-01', 'year', '', '', '', 'Active', 'For Profit', '3', '', '', 'David Schmidt, Joe Paul Tupin, Peter Mottur', '', '2'],\n  ['Pinpoint Therapeutics', 'https://www.crunchbase.com/organization/pinpoint-therapeutics', 'Biotechnology, Health Care, Pharmaceutical, Therapeutics', 'Philadelphia, Pennsylvania, United States', 'Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.', '85,762', '2019-12-30', '1000000', 'USD', '1000000', 'Debt Financing', '1000000', 'USD', '1000000', '51-100', 'Private', '', '', '', 'http://www.ctt.upenn.edu/upstart/pinpoint-therapeutics/', 'https://www.linkedin.com/company/penncenterforinnovation/', 'pciinfo@pci.upenn.edu', 'Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy, a key cell survival and treatment resistance pathway in cancer. Pinpoint inhibitors target a recently discovered enzyme in the autophagy pathway called PPT1, which is highly expressed across most cancers. These inhibitors could be applied to a broad range of cancers alone or in combination to overcome therapy resistance.', 'Kairos Ventures', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2018-01-01', 'year', '', '', '', 'Active', 'For Profit', '1', '', '', 'Ravi Amaravadi', '', '1'],\n  ['Pulmokine', 'https://www.crunchbase.com/organization/pulmokine', 'Biopharma, Biotechnology, Health Care', 'Rensselaer, New York, United States', 'Pulmokine is a privately held biopharmaceutical company', '88,138', '2015-03-03', '1000000', 'USD', '1000000', 'Debt Financing', '1000000', 'USD', '1000000', '51-100', 'Private', '', '', '', 'http://pulmokine.net', '', 'info@pulmokine.net', 'Pulmokine is a privately held biopharmaceutical company. Our focus is on pulmonary disease and kinase inhibitor technology, hence our name Pulmokine. The mission of Pulmokine is to develop new therapies for hard-to-treat lung conditions like pulmonary arterial hypertension (PAH) and related disorders. These include pulmonary arterial fibrosis/interstitial lung disease, sarcoidosis and lung cancer.', 'Broadview Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', 'Less than $1M', '2007-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', 'Larry Zisman', '', '1'],\n  ['AutoGenomics', 'https://www.crunchbase.com/organization/autogenomics', 'Biotechnology, Genetics, Health Care, Health Diagnostics', 'Vista, California, United States', 'AutoGenomics is a pioneer in developing the automated microarray based multiplexing molecular diagnostic platforms.', '89,640', '2013-01-11', '165600', 'USD', '165600', 'Venture - Series Unknown', '67443254', 'USD', '67443254', '51-100', 'Private', '', '', '', 'http://www.autogenomics.com', 'http://www.linkedin.com/company/autogenomics', 'info@autogenomics.com', \"AutoGenomics, Inc., a privately held company based in Vista, CA has developed one of the first automated microarray based multiplexing molecular diagnostic platforms that can be used to assess disease signatures with novel genetic biomarkers in the areas of women's health, cancer and personalized medicine. With discovery of genes and their link to various disease states the platform has the versatility to revolutionize the way patients are diagnosed, monitored and managed, leading to a new era of personalized medicine.\", '', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10M to $50M', '1999-01-01', 'year', '', '', '', 'Active', 'For Profit', '26', '', '', 'Fareed Kureshy, Ramanath Vairavan, Shelley Singh', '', '6'],\n  ['Protequus', 'https://www.crunchbase.com/organization/protequus', 'Big Data, Biotechnology, Health Care', 'Austin, Texas, United States', 'Devoted to optimizing health-related outcomes and enhancing the well-being of horses.', '89,722', '2016-11-07', '2250000', 'USD', '2250000', 'Seed', '2250000', 'USD', '2250000', '51-100', 'Private', '', '', '', 'http://www.protequus.com/', 'https://www.linkedin.com/company/3637920/', 'info@protequus.com', 'Protequus is a biomedical engineering and data science firm in Austin, TX dedicated to equine health & safety. It is comprised of advanced-degree science & technology professionals who share a relentless commitment to excellence and a passion for horses.', '', 'Biotechnology, Data and Analytics, Health Care, Science and Engineering', '', '', 'Less than $1M', '2013-01-01', 'year', '', 'Seed', '', 'Active', 'For Profit', '', '', '', 'Jeffrey Schab', '', '1'],\n  ['Allegro Diagnostics', 'https://www.crunchbase.com/organization/allegro-diagnostics', 'Biotechnology, Education, Health Diagnostics, Medical', 'Maynard, Massachusetts, United States', 'Allegro Diagnostics is focused on the development of genomic tests to support the diagnosis and management of lung cancer.', '90,106', '2011-07-07', '5400000', 'USD', '5400000', 'Series A', '5400000', 'USD', '5400000', '51-100', 'Private', '', '', '', 'http://www.allegrodx.com', '', 'info@veracyte.com', 'Allegro Diagnostics was founded in 2006 by Jerome Brody, M.D., and Avrum Spira, M.D., MSc, faculty at the Boston University School of Medicine and thought leaders in the field of pulmonology. The company is currently headquartered in Maynard, Massachusetts.', 'Catalyst Health Ventures, Kodiak Venture Partners', 'Biotechnology, Education, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '', '2006-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '7', '', 'Was Acquired', 'Avrum Spira, Jerome Brody', '', '1'],\n  ['Talis Biomedical', 'https://www.crunchbase.com/organization/talis-biomedical', 'Biotechnology, Health Care', 'Menlo Park, California, United States', 'Talis Biomedical is developing a point-of-care, sample-to-answer platform.', '91,669', '2018-07-16', '', '', '', 'Grant', '', '', '', '51-100', 'Public', '375664000', 'USD', '375664000', 'https://talis.bio/company/', 'https://www.linkedin.com/company/slipchip-corporation/', '', 'Talis is dedicated to transforming diagnostic testing by developing and commercializing innovative products that are designed to enable accurate, low cost and rapid molecular testing for infectious diseases at the point-of-care. The company is developing the Talis One platform, a compact, sample-to-answer, cloud-enabled, molecular diagnostic platform.', 'National Institutes of Health, CARB-X', 'Biotechnology, Health Care, Science and Engineering', 'Physical Or Chemical Processes Or Apparatus In General', '', '$1M to $10M', '2010-01-01', 'year', '', 'IPO', '2021-02-11', 'Active', 'For Profit', '1', '', '', '', '', '1'],\n  ['DiaVacs', 'https://www.crunchbase.com/organization/diavacs', 'Biotechnology, Health Diagnostics, Therapeutics', 'Edgewater, New Jersey, United States', 'DiaVacs is a developer of biotechnological products and drugs designed to liberate patients from lifelong insulin dependence', '91,676', '2015-03-11', '849999', 'USD', '849999', 'Seed', '849999', 'USD', '849999', '51-100', 'Private', '', '', '', '', '', '', \"The company potentially addresses the disadvantages of prior approaches by offering local antigen-specific immunosuppression, halting the pathogenic autoimmune response without compromising the body's immune system, and complements emerging regenerative approaches by protecting newly created beta cells from autoimmune attack, enabling patients to get rid from lifelong dependency on insulin.\", '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2013-01-01', 'year', '', 'Seed', '', 'Active', 'For Profit', '', '', '', 'Dietrich Stephan, Nick Giannoukakis', '', '1'],\n  ['XOMA', 'https://www.crunchbase.com/organization/xoma', 'Biotechnology, Developer Platform, Health Care, Therapeutics', 'Berkeley, California, United States', 'XOMA is at the forefront of antibody discovery and development, one of the most powerful and transformative fields of drug innovation', '92,335', '', '', '', '', '', '', '', '', '51-100', 'Public', '', '', '', 'http://www.xoma.com', 'http://www.linkedin.com/company/xoma', 'BizDevInfo@xoma.com', \"XOMA is at the forefront of antibody discovery and development, one of the most powerful and transformative fields of drug innovation today.  Building on a pioneering proprietary pipeline, a world-class antibody discovery and development platform, plus multiple revenue streams, XOMA is creating innovative human antibody therapeutics with the potential to transform medicine and reshape people's lives.\", '', 'Biotechnology, Health Care, Science and Engineering, Software', 'Medical Or Veterinary Science; Hygiene', '', '', '1981-01-01', 'year', '', 'IPO', '1986-06-13', 'Active', 'For Profit', '122', '', '', 'Patrick J. Scannon', '', ''],\n  ['IntelligentMDx', 'https://www.crunchbase.com/organization/intelligentmdx', 'Biotechnology, Health Care, Health Diagnostics, Medical, Medical Device', 'Waltham, Massachusetts, United States', 'IntelligentMDx develops innovative molecular diagnostic tests to maximize both patient impact and stakeholder value.', '94,566', '2014-08-06', '1605000', 'USD', '1605000', 'Debt Financing', '1605000', 'USD', '1605000', '51-100', 'Private', '', '', '', 'http://www.intelligentmdx.com/', 'http://ie.linkedin.com/company/intelligentmdx', '', 'IMDx was founded out of an underserved need in the industry: rapid and effective diagnostics to shrink the turnaround time between a patient presenting with an illness and a prescribed targeted treatment. As the IVD diagnostics space shifts from widely accepted, traditional culture methods, to highly sensitive and specific molecular methods, IMDx is uniquely positioned to make a difference in global healthcare.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10M to $50M', '2004-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', 'Alice Jacobs Nesselrodt', '', '1'],\n  ['Unigene Laboratories', 'https://www.crunchbase.com/organization/unigene-laboratories', 'Biotechnology, Manufacturing, Pharmaceutical', 'Boonton, New Jersey, United States', 'Unigene Laboratories is a biopharmaceutical company, engaged in the research, development and commercialization of peptide drugs.', '94,629', '2013-04-22', '750000', 'USD', '750000', 'Debt Financing', '37750000', 'USD', '37750000', '51-100', 'Private', '', '', '', 'http://www.unigene.com', '', 'jthomas@unigene.com', 'Founded in 1980, Unigene is a publicly traded biopharmaceutical company with corporate offices, an R&D facility and a state-of-the-art recombinant manufacturing facility in New Jersey.  There broad experience in molecular biology, protein chemistry, immunology and formulation development combined with there entrepreneurial spirit and innovation have led to the development of proprietary technologies, protected by a strong patent portfolio, enabling the commercialization of peptide drugs.', '', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1980-01-01', 'year', '', '', '', 'Closed', 'For Profit', '2', '', '', '', '', '4'],\n  ['Nanosphere', 'https://www.crunchbase.com/organization/nanosphere', 'Biotechnology, Genetics, Health Care, Medical', 'Northbrook, Illinois, United States', 'Nanosphere develops a molecular diagnostics platform for genomic and protein testing and analysis.', '95,653', '2015-05-29', '4070000', 'USD', '4070000', 'Post-IPO Debt', '125070000', 'USD', '125070000', '51-100', 'Delisted', '315000000', 'USD', '315000000', 'http://www.nanosphere.us', 'http://www.linkedin.com/company/nanosphere', '', \"Nanosphere, Inc. is a nanotechnology-based healthcare company, making clinical diagnostic tests that are two to three times as sensitive as those commonly used in hospital labs today and much simpler, taking just hours rather than days or weeks to complete. The company's instruments, which use microfluidics to pull DNA and proteins from a sample, detect genetic variations in blood that make some drugs more effective in some patients than others. The key is an array of gold nanoparticles studded with chemicals that capture characteristic proteins and nucleic acids from clinical samples such as blood.\", 'Bain Capital, Allen & Company, Takata Corporation, Lurie Investment Fund, Nextgen Partners', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '', '1999-01-01', 'year', '', 'M&A', '2007-11-09', 'Active', 'For Profit', '19', '', 'Was Acquired', '', '', '6'],\n  ['BioDot', 'https://www.crunchbase.com/organization/biodot', 'Biotechnology, Health Care, Manufacturing, Medical', 'Irvine, California, United States', 'BioDot is a manufacturer of automated low volume fluid dispensing systems.', '95,966', '2020-04-09', '', '', '', 'Private Equity', '', '', '', '51-100', 'Private', '', '', '', 'https://www.biodot.com', 'https://www.linkedin.com/company/biodot', 'info@biodot.com', 'BioDot manufactures premium non-contact and quantitative fluid dispensing systems. Combined with our expertise in lamination, cutting, and assembly, our wide range of platforms serve our customers from R&D through high volume manufacturing in the industrial, diagnostic, life science and medical product markets.', 'Artemis Capital Partners', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', 'Physical Or Chemical Processes Or Apparatus In General', '', 'Less than $1M', '1994-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '2', '', 'Was Acquired', 'Thomas Tisone', '', '1'],\n  ['UVLrx Therapeutics', 'https://www.crunchbase.com/organization/uvlrx-therapeutics', 'Biotechnology, Health Care, Medical, Therapeutics', 'Santa Barbara, California, United States', 'UVLrx Therapeutics is a biotechnology company that specializes in the fields of medical, healthcare, and therapeutics.', '96,272', '2016-11-03', '206000', 'USD', '206000', 'Venture - Series Unknown', '1149200', 'USD', '1149200', '51-100', 'Private', '', '', '', 'http://uvlrx.com', '', 'info@uvlrx.com', \"UVLrx Therapeutics is a biotechnology company that specializes in the fields of medical, healthcare, and therapeutics. It's on a mission to provide safe and effective therapeutic solutions to help heal some of the medical community’s greatest ailments. It was founded in 2011 and headquartered in Santa Barbara, California.\", '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2011-01-01', 'year', '', '', '', 'Active', 'For Profit', '1', '', '', 'Michael Harter', '', '5'],\n  ['Insmed', 'https://www.crunchbase.com/organization/insmed-incorporated', 'Biotechnology, Medical, Pharmaceutical', 'Bridgewater, New Jersey, United States', 'We are a publicly traded (NASDAQ: INSM) biopharmaceutical company dedicated to improving the lives of patients battling serious lung', '99,103', '2015-03-02', '', '', '', 'Post-IPO Equity', '', '', '', '51-100', 'Public', '', '', '', 'http://www.insmed.com', 'http://www.linkedin.com/company/insmed', 'businessdevelopment@insmed.com', \"Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is ARIKAYCE® (amikacin liposome inhalation suspension), which is approved in the United States for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. MAC lung disease is a rare and often chronic infection that can cause irreversible lung damage and can be fatal. Insmed's earlier-stage clinical pipeline includes INS1007, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases, and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for rare pulmonary disorders, including pulmonary arterial hypertension.\", 'Forbion Capital Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$50M to $100M', '1988-01-01', 'year', '', 'IPO', '2000-06-09', 'Active', 'For Profit', '29', '2', 'Made Acquisitions', '', '', '1'],\n  ['Aggredyne', 'https://www.crunchbase.com/organization/aggredyne', 'Biotechnology, Health Diagnostics, Therapeutics', 'Houston, Texas, United States', 'Aggredyne is a biomedical company developing diagnostic devices for platelet therapy.', '100,009', '2012-04-23', '3000000', 'USD', '3000000', 'Series A', '3000000', 'USD', '3000000', '51-100', 'Private', '', '', '', 'http://www.aggredyne.com', '', '', 'Aggredyne, Inc. (www.aggredyne.com), is a biomedical company founded in 2011 by Edward R. Teitel, MD, JD, and Robert C. Hux, CPA, to commercialize the AggreGuideTM platelet function analyzer. The AggreGuide system is an in-vitro diagnostic test that measures how sticky a patient’s platelets are and how well the patient is responding to antiplatelet medications such as aspirin or Plavix® (clopidogrel), Effient® (prasugrel) and Brillinta® (ticagrelor).', '', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', 'Less than $1M', '2011-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '', '', '', '', '', '1'],\n  ['AirWare Labs', 'https://www.crunchbase.com/organization/airware-lab', 'Biotechnology, Fitness, Health Care', 'Scottsdale, Arizona, United States', 'AirWare offers nasal breathing products for congestion, allergies, snoring, and travel-related illnesses.', '100,014', '2015-09-25', '185000', 'USD', '185000', 'Venture - Series Unknown', '250000', 'USD', '250000', '51-100', 'Private', '', '', '', 'http://www.airwarelabscorp.com', '', '', 'AirWare Labs is an innovator in breathing devices that enhance life, health, and promote good breathing. The AIR™ nasal breathing products address a wide range of issues, including congestion, allergies, snoring, and travel-related illnesses. Utilizing a comfortable and discreet design that is soft, pliable, and latex-free.  AIR™ sits nearly invisibly inside the nose, gently lifting and supporting nasal passages, resulting in up to 38% increased airflow and better breathing.  Air Essentials incorporate the powerful therapeutic properties of essential oils, and Air Filters feature filtration media from 3M, engineered to trap unhealthful particles before they enter the system. AIR™ is strategically poised to enter the Health and Wellness sector during a period of tremendous growth and expansion. Although breathing is the most basic of human functions, the expansive health benefits associated with improved breathing have thus far been greatly overlooked.', '', 'Biotechnology, Health Care, Science and Engineering, Sports', '', '', 'Less than $1M', '2010-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', '', '', '2'],\n  ['Merion', 'https://www.crunchbase.com/organization/merion', 'Biotechnology, Health Care, Wellness', 'West Covina, California, United States', 'Merion is a biotechnology company that produces, retails, and wholesales nutritional products.', '100,055', '2020-09-07', '1150000', 'USD', '1150000', 'Venture - Series Unknown', '2550000', 'USD', '2550000', '51-100', 'Private', '', '', '', 'https://www.merionus.com/', '', 'info@merionus.com', 'Merion is a biotechnology company that produces, retails, and wholesales nutritional products. The Company offers health and nutritional supplements and personal care products.  Merion serves customers worldwide. It is headquartered in West Covina, California.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2007-01-01', 'day', '', '', '', 'Active', 'For Profit', '', '', '', '', '', '2'],\n  ['Positron', 'https://www.crunchbase.com/organization/positron', 'Biotechnology, Health Care, Manufacturing, Medical Device', 'Fishers, Indiana, United States', 'Positron is a research and development company providing full nuclear cardiology solutions.', '100,215', '2012-11-13', '1500000', 'USD', '1500000', 'Post-IPO Equity', '1500000', 'USD', '1500000', '51-100', 'Public', '', '', '', 'http://www.positron.com', '', 'sales@positron.com', 'Originally a research and development company focused on technology, Positron’s business strategy has evolved over the past 3 years from an imaging device manufacturer to a company that provides a comprehensive “full nuclear cardiology solution”.  Positron is actively pursuing key initiatives to ensure the growth and longevity of the company, as well as, the industry by securing the supply of key isotopes, providing necessary radiopharmaceuticals that apply to both PET and SPECT imaging modalities and offering attractive financing solutions.  We strive to maximize market share by offering cost-effective, value added solutions to end-users, with the objective of becoming a sustained long-term value creator for industry participants and shareholders.', '', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', '', '', '$1M to $10M', '1983-01-01', 'year', '', 'IPO', '1999-01-15', 'Active', 'For Profit', '', '', '', '', '', '1'],\n  ['VGTI Florida', 'https://www.crunchbase.com/organization/vgti-florida', 'Biotechnology, Elderly, Therapeutics', 'Port Saint Lucie, Florida, United States', 'VGTI Florida is a research institute focused on boosting immunity of the elderly, and treating infectious diseases and cancer.', '107,214', '2013-07-15', '3600000', 'USD', '3600000', 'Grant', '3600000', 'USD', '3600000', '51-100', 'Private', '', '', '', 'http://vgtifl.org', '', 'info@vgtifl.org', 'VGTI Florida researchers are studying the human immune system with the goal of understanding the mechanisms and pathways that are responsible for our response to pathogens and cancer. Our research is therefore ultimately directed toward preventing and treating infectious diseases, cancer and boosting immunity of the elderly. We are working in collaboration, locally and globally, with others on developing new vaccines and treatments to fight diseases such as HIV/AIDS, breast and ovarian cancer, and influenza as well as emerging infectious diseases such as Yellow Fever, West Nile Virus, and Dengue Fever.', 'National Institutes of Health', 'Biotechnology, Community and Lifestyle, Health Care, Science and Engineering', '', '', '$10M to $50M', '2008-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', 'Jay Nelson', '', '1'],\n  ['National Disease Research Interchange', 'https://www.crunchbase.com/organization/national-disease-research-interchange', 'Biotechnology', 'Philadelphia, Pennsylvania, United States', 'National Disease Research Interchange is the source of human tissues, cells and organs for scientific research.', '113,448', '2020-04-07', '275000', 'USD', '275000', 'Grant', '275000', 'USD', '275000', '51-100', 'Private', '', '', '', 'https://ndriresource.org/', 'https://www.linkedin.com/company/national-disease-research-interchange', 'info@ndriresource.org', 'National Disease Research Interchange is the source of human tissues, cells and organs for scientific research.', 'National Institutes of Health', 'Biotechnology, Science and Engineering', '', '', '', '1980-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', '', '', '1'],\n  ['Maravai Life Sciences', 'https://www.crunchbase.com/organization/maravai-life-sciences', 'Biotechnology', 'San Diego, California, United States', 'Maravai, a leader in providing specialty reagents to researchers, biotherapeutics manufacturers and OEM partners worldwide.', '115,846', '', '', '', '', '', '', '', '', '51-100', 'Public', '6955700000', 'USD', '6955700000', 'http://www.maravai.com/', 'https://in.linkedin.com/company/maravai-lifesciences', 'info@maravai.com', 'Maravai LifeSciences was formed in March 2014 as a partnership among Carl Hull and Eric Tardif -- proven leaders in the life sciences industry -- and GTCR, a leading private equity firm.  Maravai’s mission is to build a transformative life sciences products company by acquiring outstanding businesses and accelerating their growth. They do this through direct cash investments in their existing operations, by acquiring complementary businesses or product lines and by contributing our proven operating expertise.  ', '', 'Biotechnology, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$10M to $50M', '2014-01-01', 'year', '', 'IPO', '2020-11-24', 'Active', 'For Profit', '6', '3', 'Made Acquisitions', 'Carl Hull, Eric Tardif', '', ''],\n  ['Cord Blood America', 'https://www.crunchbase.com/organization/cord-blood-america', 'Biotechnology, Health Care, Medical', 'Las Vegas, Nevada, United States', 'Cord Blood America engages in the business of collecting, testing, processing, and preserving umbilical cord blood.', '117,702', '2015-04-28', '724000', 'USD', '724000', 'Post-IPO Equity', '724000', 'USD', '724000', '51-100', 'Delisted', '', '', '', 'http://cordblood-america.com', 'https://www.linkedin.com/company/cord-blood-america/', 'Info@cordblood-america.com', 'Cord Blood America, through its wholly-owned subsidiary CorCell Companies, is engaged in the business of collecting, testing, processing and preserving umbilical cord blood, thereby allowing families to preserve cord blood at the birth of a child for potential use in future stem cell therapy. The umbilical cord which, at birth, traditionally has been thrown away, contains a rich store of stem cells. Cryogenically preserved umbilical cord stem cells have already been used to treat 75 major diseases, including leukemia, severe anemia, metabolic blood disorders, and immune deficiencies. This list is guaranteed to grow as medical research learns more about the incredible healing power of stem cells.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '2003-01-01', 'year', '', 'M&A', '2005-01-21', 'Active', 'For Profit', '3', '', 'Was Acquired', 'Matthew Schissler', '', '1'],\n  ['Medafor', 'https://www.crunchbase.com/organization/medafor', 'Biotechnology, Medical, Medical Device', 'Minneapolis, Minnesota, United States', 'Medafor develops novel hemostatic technology and absorbable hemostats called MPH(R), which accelerates the normal blood clotting process.', '119,549', '2012-09-27', '15000', 'USD', '15000', 'Seed', '115000', 'USD', '115000', '51-100', 'Private', '', '', '', 'http://medafor.com', '', 'info@medafor.com', 'Medafor, Inc. is a medical device company that has developed and commercialized a patented hemostatic agent that has been shown to enhance and accelerate the normal blood clotting process. Medafor’s MPH technology is unparalleled in terms of safety, efficacy, and cost.', '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1999-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', 'Donald Sturtevant, James Drake', '', '2'],\n  ['Acunon', 'https://www.crunchbase.com/organization/acunon', 'Biotechnology, Health Care, Health Diagnostics, Medical Device', 'Berkeley, California, United States', 'Acunon develops medical diagnostic devices that offers vitro test for STD patients.', '121,638', '2020-03-01', '105000', 'USD', '105000', 'Non-equity Assistance', '105000', 'USD', '105000', '51-100', 'Private', '', '', '', 'https://acunon.wixsite.com/home', '', '', 'Acunon develops medical diagnostic devices that offer vitro tests for STD patients. The company makes it convenient and accessible for low-income consumers, women, the LGBTQ+ community, and the elderly. Acunon Health is headquartered in Berkeley, California.', 'Berkeley SkyDeck', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '', '', '', '', '', 'Active', 'For Profit', '', '', '', '', '', '1'],\n  ['Cytokinetics, Inc.', 'https://www.crunchbase.com/organization/cytokinetics-inc', 'Biopharma, Biotechnology, Health Care', 'South San Francisco, California, United States', 'Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.', '122,577', '2011-04-19', '20000000', 'USD', '20000000', 'Post-IPO Equity', '93000000', 'USD', '93000000', '51-100', 'Public', '338000000', 'USD', '338000000', 'http://cytokinetics.com', 'http://www.linkedin.com/company/cytokinetics', 'medicalaffairs@cytokinetics.com', 'Cytokinetics is a different kind of company. It is increasingly unusual that an emerging growth biotechnology company would be dedicated to the discovery, development and commercialization of therapeutics. Similarly, it is more and more uncommon for a biopharmaceutical company to leverage their expertise in one area, in our case the cytoskeleton and the biology of muscle function, to tackle the pursuit of new treatments for multiple disease areas. However, the most important distinguishing feature of Cytokinetics is instead found in our commitment to innovation that has translated our focus on the cytoskeleton into a Research and Development pipeline of multiple, first-in-class compounds. All of the programs we are pursuing offer entirely novel therapeutic approaches to severe unmet clinical needs. The reason is simple. Innovative therapeutics are much more likely to bring substantial benefits to patients. That is our goal.', 'Federated Kaufmann Fund, Vulcan, Red Abbey Venture Partners', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$1M to $10M', '1998-01-01', 'year', '', 'IPO', '2004-04-29', 'Active', 'For Profit', '31', '', '', 'James Sabry, James Spudich, Lawrence Goldstein, Ronald Vale', '', '3'],\n  ['Elixir Medical', 'https://www.crunchbase.com/organization/elixir-medical', 'Health Care, Medical Device, Pharmaceutical', 'Sunnyvale, California, United States', 'Elixir Medical provides drug-device treatment solutions for the treatment of cardiovascular patients.', '122,672', '2005-03-18', '5299700', 'USD', '5299700', 'Series A', '5299700', 'USD', '5299700', '51-100', 'Private', '', '', '', 'http://elixirmedical.com', '', '', \"Elixir Medical Corporation, a privately held company headquartered in Sunnyvale, CA, specializes in developing products that combine state-of-the-art medical devices with advanced pharmaceuticals. The company's next-generation drug-eluting stent systems are designed to optimize localized drug delivery to provide a safe and effective treatment for cardiovascular patients.\", 'Invus', 'Health Care', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2004-01-01', 'year', '1', 'Early Stage Venture', '', 'Active', 'For Profit', '4', '', '', '', '', '1'],\n  ['Revision Skincare', 'https://www.crunchbase.com/organization/revision-skincare', 'Beauty, Biotechnology, Cosmetics, Health Care, Manufacturing', 'Irving, Texas, United States', 'Revision Skincare provides physicians with clinically proven, high-performing skincare products.', '125,984', '2016-08-03', '', '', '', 'Undisclosed', '', '', '', '51-100', 'Private', '', '', '', 'http://www.revisionskincare.com/', 'https://www.linkedin.com/company/revision-skincare', 'info@revisionskincare.com', 'For over 25 years, Revision Skincare has provided physicians with clinically proven, high-performing skincare products. Using only the purest, most efficacious ingredients, the Revision Skincare collection was formulated to provide targeted solutions for enhancing skin’s appearance and reducing signs of aging. Revision Skincare products represent the furthest advancements in scientific skincare. Our formulations are rooted in rigorous research and testing, and manufactured by us using the highest ethical standards. Revision Skincare products are never tested on animals.', 'RoundTable Healthcare Partners', 'Biotechnology, Consumer Goods, Health Care, Manufacturing, Science and Engineering', '', '', '$1M to $10M', '1984-01-01', 'year', '', '', '', 'Active', 'For Profit', '2', '', '', 'John Muller', '', '1'],\n  ['GlycoMimetics', 'https://www.crunchbase.com/organization/glycomimetics', 'Biotechnology, Health Care, Therapeutics', 'Gaithersburg, Maryland, United States', 'GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.', '126,036', '2010-10-27', '38979412', 'USD', '38979412', 'Convertible Note', '101779412', 'USD', '101779412', '51-100', 'Public', '', '', '', 'http://www.glycomimetics.com', 'http://www.linkedin.com/company/glycomimetics', 'webmaster@glycomimetics.com', 'GlycoMimetics, Inc., a biopharmaceutical company, engages in the design and development of small molecule therapeutics to mimic the functions of bioactive carbohydrates. Its products include GMI-1070, a synthetic glycomimetic molecule designed to inhibit selectin types, such as E, P, and L-selectin; and GMI-1051, a small molecular weight compound for the treatment or prevention of infections caused by pseudomonas aeruginosa. The company was founded in 2003 and is based in Gaithersburg, Maryland.', 'New Enterprise Associates, Sanofi Ventures, Novartis Venture Fund, PTV Healthcare Capital, Anthem Capital Management', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2003-01-01', 'year', '', 'IPO', '2014-01-10', 'Active', 'For Profit', '77', '', '', 'John Magnani, Rachel King', '', '5'],\n  ['Simulations Plus', 'https://www.crunchbase.com/organization/simulations-plus', 'Biotechnology, Computer, Data Mining, Enterprise Software, Information Technology, Life Science', 'Lancaster, California, United States', 'Simulations Plus is a developer of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET).', '126,922', '2020-05-28', '', '', '', 'Grant', '', '', '', '51-100', 'Public', '', '', '', 'http://www.simulations-plus.com', 'http://www.linkedin.com/company/simulations-plus-inc', 'info@simulations-plus.com', 'Simulations Plus is a developer of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) and Physiologically-Based Pharmacokinetic (PBPK) modeling and simulation software for the pharmaceutical and biotechnology, generics, chemical, cosmetic, and food ingredient industries today. Our software allows pharmaceutical scientists to predict certain key potential endpoints and dynamics, in silico, thereby reducing research & development costs and helping clients make better projects decisions... sooner. Founded in 1996, Simulations Plus employs over 60 employees and is publicly-traded on the NASDAQ stock exchange (ticker symbol = SLP).Our headquarters are based in Lancaster, California, with our pharmacometrics consulting team located in Buffalo, New York. Trusted distributors handle sales and scientific support in Asian territories. 19 of the top 20 pharmaceutical companies, plus numerous mid- and small-sized companies and all major regulatory agencies, license our modeling & simulation technology.', 'Food and Drug Administration', 'Biotechnology, Consumer Electronics, Data and Analytics, Hardware, Information Technology, Science and Engineering, Software', '', '', '', '1996-01-01', 'year', '', 'IPO', '1997-06-20', 'Active', 'For Profit', '92', '4', 'Made Acquisitions', 'Walter Woltosz', '', '1'],\n  ['Nexus Pharmaceuticals', 'https://www.crunchbase.com/organization/nexus-pharmaceuticals', 'Health Care, Pharmaceutical', 'Lincolnshire, Illinois, United States', 'Nexus Pharmaceuticals, a US-based, privately-held healthcare company.', '129,120', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://www.nexuspharma.net/', 'https://www.linkedin.com/company/nexus-pharmaceuticals-inc-/', '', \"At Nexus Pharmaceuticals, they specialize in innovative processes to make difficult-to-manufacture specialty and generic drugs that are easier to use, less labor intensive, and more streamlined in practice. Nexus ensures that its high-quality FDA-approved drugs fulfill a critical unmet medical need and delivers dependable live-saving treatment options when and where they're needed most.\", '', 'Health Care', 'Medical Or Veterinary Science; Hygiene', '', '$50M to $100M', '2003-01-01', 'year', '', '', '', 'Active', 'For Profit', '4', '', '', '', '', ''],\n  ['Achillion Pharmaceuticals', 'https://www.crunchbase.com/organization/achillion-pharmaceuticals', 'Biotechnology, Health Care, Pharmaceutical, Therapeutics', 'Blue Bell, Pennsylvania, United States', 'A biopharmaceutical company dedicated to transforming the lives of patients and families affected by disorders of the complement system.', '129,442', '2010-08-18', '50100000', 'USD', '50100000', 'Post-IPO Equity', '91100000', 'USD', '91100000', '51-100', 'Public', '177600000', 'USD', '177600000', 'http://www.achillion.com', 'http://www.linkedin.com/company/achillion-pharmaceuticals', 'info@achillion.com', 'At Achillion, we are driven to transform the lives of patients and families affected by diseases of the complement system, an integral part of the innate immune system. Scientific and clinical evidence has implicated the complement system, and specifically the complement Alternative Pathway (AP), in numerous devastating diseases and conditions. Our principal focus at Achillion is to advance our clinical-stage portfolio of orally administered factor D inhibitors into late-stage development and potential commercialization for patients with devastating disorders of the complement system.', 'Advent International, Domain Associates, Connecticut Innovations, Atlas Venture, GE Capital', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10M to $50M', '1998-01-01', 'year', '', 'M&A', '2006-11-03', 'Active', 'For Profit', '41', '', 'Was Acquired', 'William Rice', '', '2'],\n  ['Chembio Diagnostic Systems Inc.', 'https://www.crunchbase.com/organization/chembio-diagnostic-systems-inc', 'Biotechnology, Government, Health Care, Health Diagnostics, Manufacturing', 'Medford, New York, United States', 'Chembio Diagnostics, Inc. develops, manufactures, licenses and markets proprietary rapid diagnostic.', '129,472', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://chembio.com/', 'http://www.linkedin.com/company/chembio-diagnostic-systems-inc.', '', \"Chembio Diagnostics, Inc. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $10 billion point-of-care testing market. Chembio's two FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S. by Alere, Inc. (formerly, Inverness Medical Innovations, Inc.). Chembio markets its HIV STAT-PAK® line of rapid HIV tests internationally to government and donor-funded programs directly and through distributors. Chembio has developed a patented point-of-care test platform technology, the Dual Path Platform (DPP®) technology, which has significant advantages over lateral-flow technologies. This technology is providing Chembio with a significant pipeline of business opportunities for the development and manufacture of new products based on DPP®. Headquartered in Medford, NY, with approximately 170 employees, Chembio is licensed by the U.S. Food and Drug Administration (FDA) as well as the U. S. Department of Agriculture (USDA), and is certified for the global market under the International Standards Organization (ISO) directive 13.485.\", '', 'Biotechnology, Government and Military, Health Care, Manufacturing, Science and Engineering', 'Testing', '', '$10M to $50M', '1986-01-01', 'year', '', '', '', 'Active', 'For Profit', '6', '1', 'Made Acquisitions', '', '', ''],\n  ['Avid Radiopharmaceuticals', 'https://www.crunchbase.com/organization/avid-radiopharmaceuticals', 'Biotechnology, Diabetes, Pharmaceutical', 'Philadelphia, Pennsylvania, United States', 'Avid Radiopharmaceuticals develops molecular imaging agents for detecting and monitoring chronic human diseases.', '130,312', '2009-05-21', '34500000', 'USD', '34500000', 'Series D', '69900000', 'USD', '69900000', '51-100', 'Private', '', '', '', 'http://www.avidrp.com', 'http://www.linkedin.com/company/498749', 'carpenter@avidrp.com', 'Avid develops molecular imaging agents to aid medical management of chronic human diseases. They are located in Philadelphia, PA. Their mission is to develop new molecular imaging agents capable of changing the medical management of significant, chronic human diseases by identifying the first stages of pathological change, potentially assisting in earlier diagnosis, and better management and development of new therapies.', 'Safeguard Scientifics, AllianceBernstein, OUP (Osage University Partners), Alta Partners, Pfizer Venture Investments', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2005-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '9', '', 'Was Acquired', 'Daniel M. Skovronsky', '', '5'],\n  ['Novus Biologicals', 'https://www.crunchbase.com/organization/novus-biologicals', 'Biotechnology, Health Care', 'Littleton, Colorado, United States', 'Novus Biologicals is focused on accelerating scientific discovery by developing and marketing unique products for the life sciences.', '131,657', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://novusbio.com', '', 'orders@novusbio.com', 'The mission of Novus Biologicals, LLC is to accelerate scientific discovery by developing and marketing unique products for the lifesciences. Novus Biologicals is also organized to provide the biological research community with a mechanism for commercializing unique biological materials. We also focus on continually monitoring scientific trends and supply materials to serve these trends. By making these products widely available to institutional and commercial researchers, Novus Biologicals plays an important role in furthering biological research. All of Novus Biologicals products are supplied with detailed technical information and ongoing support. By serving both niche and emerging markets, Novus Biologicals has built solid partnerships with our customers.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10M to $50M', '1996-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '8', '', 'Was Acquired', 'Karen Padgett', '', ''],\n  ['Quark Pharmaceuticals', 'https://www.crunchbase.com/organization/quark-pharmaceuticals', 'Biotechnology, Clinical Trials, Genetics, Medical', 'Fremont, California, United States', 'Quark Pharmaceuticals\\xa0is a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics.', '133,290', '2010-06-01', '10000000', 'USD', '10000000', 'Venture - Series Unknown', '61399000', 'USD', '61399000', '51-100', 'Private', '', '', '', 'http://www.quarkpharma.com', '', 'qbi@quarkpharma.com', \"Founded in 1994, Quark devoted its early years to developing its innovative technology platform for identification of novel functional target genes and proteins, the â\\x80\\x9cBiFARâ\\x80\\x9d technology. The basic concept, patented by Quark, of high throughput gene inactivation combined with microarray detection of the functional genes responsible for the occurrence of phenotypes of interest, was at that time revolutionary. With the advent of siRNA technology, Quark's approach is rapidly becoming the technology of choice for functional studies industry-wide. We have applied our BiFAR platform in gene discovery programs in serious diseases with significant unmet medical needs, often in collaboration with large pharmaceutical partners. Today we are harvesting the fruits of the innovative targets and concepts we identified.\", 'Tako Ventures, SBI Asset Management', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '1994-12-01', 'day', '', '', '', 'Active', 'For Profit', '17', '', '', 'Daniel Zurr', '', '5'],\n  ['Sycamore Biopharma', 'https://www.crunchbase.com/organization/sycamore-biopharma', 'Biotechnology', 'Columbia, South Carolina, United States', 'Sycamore Biopharma is a Biotechnology.', '137,096', '2019-12-19', '500000', 'USD', '500000', 'Pre-Seed', '500000', 'USD', '500000', '51-100', 'Private', '', '', '', 'https://sycamorebp.com/', '', '', 'Sycamore Biopharma is a Biotechnology.', '', 'Biotechnology, Science and Engineering', '', '', '', '2018-01-01', 'year', '', 'Seed', '', 'Closed', 'For Profit', '', '', '', '', '', '1'],\n  ['Anika Therapeutics', 'https://www.crunchbase.com/organization/anika-therapeutics', 'Biotechnology, Health Care, Manufacturing, Therapeutics', 'Bedford, Massachusetts, United States', 'Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its', '138,004', '', '', '', '', '', '', '', '', '51-100', 'Public', '', '', '', 'http://www.anikatherapeutics.com', 'http://www.linkedin.com/company/anika-therapeutics', 'stayactive@anika.com', 'Anika Therapeutics, Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care.  We partner with physicians to understand what they need most in order to treat their patients and we develop minimally invasive products that restore active living for people around the world.  We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies.  Anika. Restore Active Living.™', '', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '1992-01-01', 'year', '', 'IPO', '1993-05-14', 'Active', 'For Profit', '69', '3', 'Made Acquisitions', '', '', ''],\n  ['Endocyte', 'https://www.crunchbase.com/organization/endocyte', 'Biotechnology, Health Care, Pharmaceutical', 'West Lafayette, Indiana, United States', 'Endocyte is a biopharmaceutical company that develops receptor-targeted therapeutics to treat cancer and inflammatory diseases.', '140,550', '2010-12-27', '8100000', 'USD', '8100000', 'Debt Financing', '114349000', 'USD', '114349000', '51-100', 'Public', '', '', '', 'http://www.endocyte.com', 'https://www.linkedin.com/company/novartis/', 'info@endocyte.com', 'Endocyte, Inc., a biopharmaceutical company, develops receptor-targeted therapeutics to treat cancer and autoimmune/inflammatory diseases. The company provides EC17, a folate-targeted hapten therapy drug to treat metastatic renal and ovarian cancer; EC145, a folate-targeted chemotherapeutic conjugate to treat various tumors, including cancers of the breast, lung, and blood; EC0225, a targeted chemotherapy drug; BMS753493, a folate-targeted anti-cancer therapy drug; EC0434 to target folate receptor positive tumors; and EC0305, an anti-cancer therapy drug. It also offers EC0286, a folate-targeted small molecule for the treatment of inflammatory diseases; and EC20, a folate-targeted radiopharmaceutical imaging agent to identify folate-receptor positive cancers. The company was founded in 1996 and is based in West Lafayette, Indiana.', 'Silicon Valley Bank, MidCap Financial, Blue Chip Venture Company, Sanderling Ventures, Twilight Venture Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', 'Less than $1M', '1996-01-01', 'year', '', 'M&A', '2011-02-04', 'Active', 'For Profit', '42', '', 'Was Acquired', 'Philip Low, Ron Ellis', '', '7'],\n  ['Plexxikon', 'https://www.crunchbase.com/organization/plexxikon', 'Biotechnology, Health Care, Medical', 'Berkeley, California, United States', 'Plexxikon, Inc. engages in the discovery and development of small molecule pharmaceuticals to treat human disease.', '142,739', '2005-03-01', '7490000', 'USD', '7490000', 'Series B', '80347000', 'USD', '80347000', '51-100', 'Private', '', '', '', 'http://www.plexxikon.com', 'https://www.linkedin.com/company/plexxikon-inc.', 'info@plexxikon.com', \"Plexxikon, Inc. engages in the discovery and development of small molecule pharmaceuticals to treat human disease.  The company's products include PLX204 for the treatment of diabetes; PLX4032 for the treatment of melanoma and colorectal cancer; and PLX5568 kinase inhibitors for the treatment of pain, polycystic kidney disease, rheumatoid arthritis, metastatic breast cancer, and renal disease.  It develops a portfolio of clinical and preclinical stage programs in various therapeutic areas, including metabolic disease, such as obesity indications; oncology, such as osteolytic metastatic disease; and CNS, such as multiple sclerosis. The companyâ€™s portfolio of clinical and preclinical stage programs for other therapeutic areas include inflammation, such as systemic lupus erythematosus, inflammatory bowel disease, and osteoporosis; and cardiovascular, including hypertension and atherosclerosis.\", 'Gimv, Walden International, Advanced Technology Ventures, Alta Partners, CW Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '', '2000-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '61', '', 'Was Acquired', 'Joseph Schlessinger, Peter Hirth, Sung-Hou Kim', '', '3'],\n  ['StemExpress', 'https://www.crunchbase.com/organization/stemexpress', 'Biotechnology, Life Science, Medical, Pharmaceutical, Product Research', 'Folsom, California, United States', 'StemExpress provides researchers with human tissue (peripheral blood, bone marrow, Leukopaks, cord blood, etc.) and primary cells.', '144,202', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://www.stemexpress.com/', 'https://www.linkedin.com/company/stemexpress/', 'sales@stemexpress.com', 'Every day, researchers around the world are looking for new treatments and cures for significant diseases. To conduct this vital research, they need biospecimens from donors, both healthy and diseased. They use these biospecimens to test applications, discover new drugs, and create new diagnostic and surgical devices. StemExpress provides these researchers with quick access to high-quality biospecimens, such as human tissue (peripheral blood, mobilized peripheral blood, diseased peripheral blood, maternal blood, bone marrow, maternal blood, and cord blood), and primary cells, for their studies. The StemExpress team has extensive experience in tissue and human primary cell collection, processing, isolation, cryopreservation, and shipping. Our breadth of knowledge and scientific expertise, as well as our state-of-the-art facilities, enable us to support clients at major universities, research institutes, government agencies, biotechnology and pharmaceutical companies, and contract research organizations (CROs) in the research and development of their cellular products for basic research on into clinical studies. By shortening the time to collect samples or isolate primary cells, StemExpress can help reduce months, and even years off of a project. That means new cures and treatments can reach patient care faster, giving months and years back to the people afflicted with severe medical conditions.', '', 'Biotechnology, Data and Analytics, Design, Health Care, Science and Engineering', '', '', '$1M to $10M', '2010-01-01', 'year', '', '', '', 'Active', 'For Profit', '8', '', '', 'Cate Dyer', '', ''],\n  ['Choice Therapeutics', 'https://www.crunchbase.com/organization/choice-therapeutics', 'Biotechnology, Manufacturing, Pharmaceutical, Therapeutics', 'Wrentham, Massachusetts, United States', 'Choice Therapeutics develops, manufactures and commercializes medical devices for burns, advanced wound care, and surgical site infections.', '146,105', '2011-07-28', '582000', 'USD', '582000', 'Venture - Series Unknown', '1954250', 'USD', '1954250', '51-100', 'Private', '', '', '', 'http://www.choicetherapeutics.com', '', 'ir@alliqua.com', 'Choice Therapeutics develops, manufactures and commercializes innovative medical devices targeted at three major markets - burns, advanced wound care, and surgical site infections.', '', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', '', '', '', '2006-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', '', '', '2'],\n  ['Microbiome Labs', 'https://www.crunchbase.com/organization/microbiome-labs', 'Biotechnology, Health Care', 'Glenview, Illinois, United States', 'Microbiome Labs was focused on providing probiotic bacteriotherapy. ', '147,143', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://microbiomelabs.com', '', 'orders@gomegaspore.com', 'Microbiome Labs was originally established as Physicians Exclusive in 2013 as an organization focused on providing probiotic bacteriotherapy. In the past several years our business model has grown and so has public awareness for gut health issues. Microbiome Labs comes to you as an all inclusive resource center designed to address the needs of physicians and health care practitioners.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', 'Less than $1M', '', '', '', 'M&A', '', 'Active', 'For Profit', '1', '', 'Was Acquired', '', '', ''],\n  ['Sebela Pharmaceuticals', 'https://www.crunchbase.com/organization/sebela-pharmaceuticals', 'Marketing, Medical Device, Pharmaceutical', 'Roswell, Georgia, United States', 'Sebela is committed to improving patients’ lives by developing, marketing and selling differentiated branded prescription pharmaceuticals.', '148,358', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.sebelapharma.com/', 'https://www.linkedin.com/company/sebela-pharmaceuticals-llc/?originalSubdomain=in', '', 'Sebela Pharmaceuticals is committed to improving patients’ lives by developing, marketing and selling differentiated branded prescription pharmaceuticals for patients whose needs are not adequately satisfied. Sebela Pharmaceutical’s commercial activities are focused in the United States for niche therapeutic markets including gastroenterology, dermatology and women’s health. To fulfill our commitment to improving patient’s lives, we are continuing to grow our US commercial infrastructure, marketed product portfolio and late stage development pipeline in our core therapeutic areas. Our growth strategy includes in-licensing and acquiring late-stage drug candidates and marketed products that utilize and enhance our existing development and commercial capabilities. ', '', 'Health Care, Sales and Marketing', '', '', '$1M to $10M', '2013-01-01', 'year', '', '', '', 'Active', 'For Profit', '1', '1', 'Made Acquisitions', '', '', ''],\n  ['SurModics', 'https://www.crunchbase.com/organization/surmodics-pharmaceuticals', 'Biotechnology, Health Care', 'Birmingham, Alabama, United States', 'SurModics vision is to extend and improve the lives of patients through technology innovation.', '148,895', '', '', '', '', '', '', '', '', '51-100', 'Public', '', '', '', 'http://www.surmodics.com/', 'http://www.linkedin.com/company/surmodics', '', 'SurModics™ vision is to extend and improve the lives of patients through technology innovation. The Company partners with the world foremost medical device, pharmaceutical and life science companies to develop and commercialize innovative products that result in improved diagnosis and treatment for patients. Core offerings include: drug delivery technologies (coatings, microparticles, nanoparticles, and implants); surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and specialized surfaces for cell culture and microarrays. SurModics is headquartered in Eden Prairie, Minnesota and its SurModics Pharmaceuticals subsidiary is located in Birmingham, Alabama.', '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1979-01-01', 'year', '', 'IPO', '1998-03-04', 'Active', 'For Profit', '18', '5', 'Made Acquisitions', '', '', ''],\n  ['Prometheus Laboratories Inc.', 'https://www.crunchbase.com/organization/prometheus-laboratories-inc', 'Biotechnology', 'San Diego, California, United States', 'At Prometheus Laboratories Inc., we enable unique health solutions with novel diagnostics.', '149,616', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://www.prometheuslabs.com/', 'https://www.linkedin.com/company/prometheus-laboratories-inc/', 'info@prometheuslabs.com', 'At Prometheus Laboratories Inc., we enable unique health solutions with novel diagnostics. As a leader of precision healthcare in gastroenterology, we develop and bring to market diagnostic tests that help physicians provide the highest level of patient care. Our commitment to innovation positions us for future growth and lays the foundation for expansion into new areas.', '', 'Biotechnology, Science and Engineering', 'Testing', '', '', '1995-01-01', 'year', '', '', '', 'Active', '', '1', '', '', 'Jonathan Braun', '', ''],\n  ['X-Chem', 'https://www.crunchbase.com/organization/x-chem', 'Biotechnology', 'Waltham, Massachusetts, United States', 'X-Chem, Inc. is a privately held biotechnology company.', '149,976', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.x-chemrx.com/', 'https://www.linkedin.com/company/x-chem-inc.', 'info@x-chemrx.com', 'X-Chem, Inc. is a privately held biotechnology company based in Waltham, Massachusetts, established in 2009 to apply its innovative drug discovery capabilities to the generation of novel small molecule therapeutics.', '', 'Biotechnology, Science and Engineering', 'Organic Chemistry', '', '$10M to $50M', '2009-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '13', '1', 'Made Acquisitions, Was Acquired', 'Richard Wagner', '', ''],\n  ['Vision Sciences', 'https://www.crunchbase.com/organization/vision-sciences', 'Biotechnology, Health Care, Medical', 'Orangeburg, New York, United States', 'Vision Sciences, a medical device company, develops flexible endoscopes as a control solution to decrease the risk of cross-contamination.', '150,242', '2011-02-01', '10500000', 'USD', '10500000', 'Post-IPO Equity', '10500000', 'USD', '10500000', '51-100', 'Delisted', '', '', '', 'http://www.visionsciences.com/', 'http://www.linkedin.com/company/vision-sciences', '', 'Vision-Sciences, Inc., is a medical device company. The Company designs, develops, manufactures and markets products for endoscopy with its product lines featuring a visualization system and sterile disposable microbial barrier, EndoSheath technology. The Company produces and markets Endoscopes, such as cystoscopes, ureteroscopes, laryngoscopes, otoscopes, sinuscopes, trans-nasal esophagoscopy (TNE) and bronchoscopes for medical use and borescopes for industrial use, and digital processing units (DPU). The Company offers Urgent PC Neuromodulation System, a nerve stimulation device that delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder (OAB). It also offers Macroplastique, an injectable, urethral bulking agent for the treatment of adult female stress urinary incontinence. It markets additional bulking agents: PTQ for the treatment of fecal incontinence and the VOX for vocal cord augmentation.', 'Lewis Pell, Katsumi Oneda', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '1987-01-01', 'year', '', 'M&A', '1992-12-24', 'Active', 'For Profit', '', '', 'Was Acquired', 'Lewis Pell', '', '1'],\n  ['Progenics Pharmaceuticals', 'https://www.crunchbase.com/organization/progenics-pharmaceuticals-inc', 'Biotechnology', 'Tarrytown, New York, United States', 'Progenics Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutics for cancer patients.', '151,959', '', '', '', '', '', '', '', '', '51-100', 'Public', '', '', '', 'http://www.progenics.com', 'http://www.linkedin.com/company/progenics-pharmaceuticals', 'info@progenics.com', \"Progenics Pharmaceuticals, Inc., of Tarrytown, N.Y., is a biopharmaceutical company focused on innovative therapeutics for patients suffering from cancer and related conditions. Progenics' pipeline candidates include PSMA ADC, a human monoclonal antibody-drug conjugate in phase 2 testing for treatment of prostate cancer, and preclinical stage novel multiplex phosphoinositide 3-kinase (PI3K) inhibitors for the treatment of cancer. Progenics has exclusively licensed development and commercialization rights for its first commercial product, RELISTOR®, to Salix Pharmaceuticals, Ltd. for markets worldwide other than Japan, where Ono Pharmaceutical Co., Ltd. holds an exclusive license for the subcutaneous formulation. RELISTOR (methylnaltrexone bromide) Subcutaneous Injection is a first-in-class treatment for opioid-induced constipation approved in more than 50 countries for patients with advanced illness.\", '', 'Biotechnology, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '1988-01-01', 'year', '', 'M&A', '1997-11-19', 'Active', 'For Profit', '44', '2', 'Made Acquisitions, Was Acquired', 'Paul J. Maddon', '', ''],\n  ['Nimbus Concepts', 'https://www.crunchbase.com/organization/nimbus-concepts', 'Biotechnology, Health Care, Wellness', 'Austin, Texas, United States', 'Nimbus Concepts develops and markets intellectual property and novel device technology in the field of radiofrequency tissue ablation.', '152,835', '2011-12-07', '142500', 'USD', '142500', 'Seed', '142500', 'USD', '142500', '51-100', 'Private', '', '', '', 'http://nimbusconcepts.com', '', 'info@nimbusconcepts.com', 'Nimbus Concepts, LLC operates in the biotechnology sector. The company was incorporated in 2011 and is based in Denver, Colorado.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10M to $50M', '2011-01-01', 'year', '', 'Seed', '', 'Closed', 'For Profit', '', '', '', 'Robert E. Wright', '', '1'],\n  ['BioVidria', 'https://www.crunchbase.com/organization/biovidria', 'Biotechnology, Pharmaceutical', 'Tucson, Arizona, United States', 'BioVidria is a biotech company that focuses on new materials for protein analysis to advance pharmaceuticals, proteomics, and agriculture.', '154,872', '2014-02-12', '80000', 'USD', '80000', 'Seed', '430000', 'USD', '430000', '51-100', 'Private', '', '', '', 'http://biovidria.com', 'https://www.linkedin.com/company/biovidria-inc.', '', 'bioVidria, Inc. engages in developing and manufacturing products that can aid disease detection. The product use silica colloidal crystals as a platform technology for a suite of products for fast biological analysis, with our micro-array substrates as the first product line. bioVidria, Inc. was incorporated in 2007 and is based in Tucson, Arizona.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', 'Less than $1M', '2007-01-01', 'year', '', 'Seed', '', 'Active', 'For Profit', '', '', '', 'Mary Wirth', '', '3'],\n  ['TerSera Therapeutics', 'https://www.crunchbase.com/organization/tersera-therapeutics', 'Pharmaceutical', 'Lake Forest, Illinois, United States', 'TerSera Therapeutics acquires and develops specialty pharmaceutical products with a focus on select therapeutic areas.', '155,179', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://www.tersera.com', 'https://in.linkedin.com/company/tersera', '', 'TerSera Therapeutics acquires and develops specialty pharmaceutical products with a focus on select therapeutic areas. Their mission is to market products which truly make a difference for patients.', '', 'Health Care', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2016-01-01', 'year', '', '', '', 'Active', 'For Profit', '2', '', '', '', '', ''],\n  ['XBiotech', 'https://www.crunchbase.com/organization/xbiotech', 'Biotechnology, Health Care, Medical', 'Austin, Texas, United States', 'XBiotech is a biopharmaceutical company developing antibody therapies.', '155,837', '', '', '', '', '', '', '', '', '51-100', 'Public', '', '', '', 'http://xbiotech.com', 'https://www.linkedin.com/company/xbiotech-usa-inc', 'info@xbiotech.com', 'XBiotech is a biopharmaceutical company developing first-in-class antibody therapies. The Company’s lead product candidate inhibits chronic (sterile) inflammation – a condition involved in the progression of many serious and common diseases. The Company has several groundbreaking clinical trial programs in different areas of medicine including dermatology, oncology, diabetes, cachexia and cardiovascular disease.', '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '2005-01-01', 'year', '', 'IPO', '2015-04-14', 'Active', 'For Profit', '10', '', '', '', '', ''],\n  ['ImpactRx', 'https://www.crunchbase.com/organization/impactrx', 'Biotechnology, Pharmaceutical, Therapeutics', 'Mount Laurel, New Jersey, United States', 'ImpactRx operates as a promotion research organization for the pharmaceutical industry in the United States.', '155,963', '2010-01-11', '1200000', 'USD', '1200000', 'Series E', '18500003', 'USD', '18500003', '51-100', 'Private', '', '', '', 'http://www.impactrx.com', 'https://www.linkedin.com/company/impactrx/', 'info@impactrx.com', 'ImpactRx, Inc. operates as a promotion research organization for the pharmaceutical industry in the United States. The company tracks and evaluates the impact of pharmaceutical promotions on the prescribing behavior of the physicians. Its ImpactRx technology enables to collect and process the information on the perceptions and activities of physicians, as well as allows pharmaceutical companies to diagnose and predict the efficiency and effectiveness of sales and marketing initiatives. The company structures its data into a range of syndicated and semi-custom products in the areas of brand management and market research, sales management, managed care marketing, and oncology sales and marketing to assist pharmaceutical and biotech enterprises in decision making. ImpactRx, Inc. was founded in 2000 and is headquartered in Mount Laurel, New Jersey.', 'Omega Funds, 3i Group, Oxford Bioscience Partners, Merck Capital Ventures, Mediphase Venture Partners', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10M to $50M', '2000-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '4', '4', 'Made Acquisitions, Was Acquired', 'Gerald J. Gallivan, Lawrence G. Miller', '', '4'],\n  ['VIVUS', 'https://www.crunchbase.com/organization/vivus', 'Biopharma, Biotechnology, Health Care', 'Mountain View, California, United States', 'VIVUS, Inc. is a drug-development company dedicated to the development and commercialization of next-generation therapeutic products', '156,455', '1991-01-01', '', '', '', 'Seed', '', '', '', '51-100', 'Public', '', '', '', 'http://www.vivus.com', 'http://www.linkedin.com/company/vivus-inc', 'sunshineact@vivus.com', 'VIVUS, Inc. is a drug-development company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity, diabetes, sleep apnea and sexual health.', 'Domain Associates', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1991-01-01', 'year', '', 'IPO', '1994-04-15', 'Active', 'For Profit', '22', '', '', '', '', '1'],\n  ['Spring Pharmaceuticals', 'https://www.crunchbase.com/organization/spring-pharmaceuticals', 'Biopharma, Biotechnology, Therapeutics', 'Duncan, South Carolina, United States', 'Spring Pharmaceuticals is a biotechnology company based in Duncan, South Carolina.', '157,248', '2010-01-22', '3750000', 'USD', '3750000', 'Venture - Series Unknown', '3750000', 'USD', '3750000', '51-100', 'Private', '', '', '', 'http://www.beyondspringpharma.com', 'https://www.linkedin.com/company/beyondspring-pharmaceuticals/', '', 'Spring Pharmaceuticals is a biotechnology company based in Duncan, South Carolina.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '2009-01-01', 'year', '', '', '', 'Active', 'For Profit', '1', '', '', 'Lan Huang', '', '1'],\n  ['Therigy', 'https://www.crunchbase.com/organization/therigy', 'Health Care, Medical, Pharmaceutical', 'Maitland, Florida, United States', \"Therigy is the healthcare industry's leading source of specialty pharmaceutical consulting, \", '157,440', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.therigy.com/', 'https://www.linkedin.com/company/therigy/?trk=top_nav_home', 'supportcase@therigy.com', 'Therigy® is a patient-focused specialty therapy management company. As an industry pioneer, Therigy continues to lead the specialty pharmacy market as the top choice in technology and consulting solutions—with the best possible outcomes for patients in mind. Therigy equips pharmacy stakeholders with the tools to standardize and scale patient management programs—with a depth and consistency of clinical care never before possible—helping them to deliver value-based outcomes, gain insights into evolving patient needs, and predict therapy trends. ', '', 'Health Care', '', '', '$1M to $10M', '2006-01-01', 'year', '', '', '', 'Active', 'For Profit', '3', '', '', 'Joseph Morse, Russel Allinson', '', ''],\n  ['LS9', 'https://www.crunchbase.com/organization/ls9', 'Biotechnology, Chemical, Fuel', 'South San Francisco, California, United States', 'LS9 is a biotechnology company developing UltraClean™ fuels and sustainable chemicals made with the power of synthetic biology.', '157,991', '2010-12-20', '30000000', 'USD', '30000000', 'Series D', '75000000', 'USD', '75000000', '51-100', 'Private', '', '', '', 'http://www.ls9.com', '', 'info@ls9.com', 'LS9, the Renewable Petroleum Company, is a privately-held industrial biotechnology company based in South San Francisco, California developing patent-pending UltraClean fuels and sustainable chemicals made with the power of synthetic biology.', 'BlackRock, Flagship Pioneering, Lightspeed Venture Partners, Khosla Ventures, Chevron Technology Ventures', 'Biotechnology, Energy, Science and Engineering', '', '', '$10M to $50M', '2005-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '97', '', 'Was Acquired', 'Chris Somerville, David Berry, George Church, Noubar Afeyan', '', '4'],\n  ['Nalpropion Pharmaceuticals', 'https://www.crunchbase.com/organization/nalpropion-pharmaceuticals', 'Biotechnology, Pharmaceutical', 'San Diego, California, United States', 'Nalpropion Pharmaceuticals is a biopharmaceutical company focused on the treatment of weight loss.', '158,088', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://www.nalpropion.com/', 'https://www.linkedin.com/company/nalpropion/', 'info@nalpropion.com', 'Nalpropion Pharmaceuticals is a patient-focused company dedicated to help improve the health of patients struggling to lose weight.The company focuses on the treatment of weight loss with the use of a medication called Contrave.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2018-04-17', 'day', '', 'M&A', '', 'Active', 'For Profit', '4', '1', 'Made Acquisitions, Was Acquired', 'John Sedor', '', ''],\n  ['NextBio', 'https://www.crunchbase.com/organization/nextbio', 'Biotechnology, Enterprise Software, Life Science', 'Santa Clara, California, United States', 'NextBio is a software company that provides a platform for life science researchers to discover and share knowledge.', '158,837', '2009-09-18', '8000000', 'USD', '8000000', 'Series C', '16100000', 'USD', '16100000', '51-100', 'Private', '', '', '', 'http://www.nextbio.com', 'https://www.linkedin.com/company/nextbio/', '', 'NextBio is privately owned software company that provides a platform for life science researchers to search, discover, and share knowledge across public and proprietary data. Nextbio was co-founded by Saeid Akhtari, Ilya Kupershmidt and Mostafa Ronaghi in 2004 and based in Cupertino California, USA. The NextBio Platform is an ontology-based semantic framework that connects highly heterogeneous data and textual information. The semantic framework is based on gene, tissue, disease and compound ontologies. This framework contains information from diverse organisms, platforms, data types and research areas is integrated into and correlated within a single searchable environment using proprietary algorithms. It provides a unified interface for researchers to formulate and test new hypotheses across vast collections of experimental data.  The enterprise version of the NextBio platform is being used in life science R&D and drug development by researchers and clinicians at: Merck Pharmaceutical, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Celgene, Genzyme, Eli Lilly and Company, and [[Regeneron Pharmaceuticals. This enterprise version allows internal, proprietary data to be uploaded and integrated into the NextBio database of publicly-available data. Scientists are using NextBio to improve their ability to identify relevant prognostic and predictive molecular signatures which are significant in their research. NextBio was a receiver of the Frost & Sullivan North American Life Sciences Customer Value Enhancement Award in 2008. Since the release it has had more than 1,500,000 visitors.', 'Signatures Capital, Amidzad Partners, Newbury Ventures', 'Biotechnology, Science and Engineering, Software', 'Computing; Calculating', '', '', '2004-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '20', '', 'Was Acquired', 'Ilya Kupershmidt, Mostafa Ronaghi', '', '3'],\n  ['Quinnova Pharmaceuticals', 'https://www.crunchbase.com/organization/quinnova-pharmaceuticals', 'Biotechnology, Health Care, Medical', 'Newtown, Pennsylvania, United States', 'Quinnova Pharmaceuticals is a biotech company engaged in the development and commercialization of prescription drug products.', '158,899', '2010-09-28', '300000', 'USD', '300000', 'Convertible Note', '31300000', 'USD', '31300000', '51-100', 'Private', '', '', '', 'http://www.quinnova.com', '', 'info@quinnova.com', 'Quinnova Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercial sale of prescription drug products based on dermal drug delivery platforms. It offers HYDRO 40 foam, a dry skin treatment product; tersi foam, a leave-on foam indicated for the treatment of seborrheic dermatitis and tinea versicolor; rinnovi nail system, a prescription nail system that is designed to clean, treat, and protect diseased, damaged, brittle, and ingrown nails; and cleanse and treat, a pad delivery technology system for the treatment of acne. Quinnova Pharmaceuticals, Inc. was founded in 2003 and is based in Newtown, Pennsylvania.', 'H.I.G. Capital, Safeguard Scientifics, Thomas, McNerney & Partners', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '2003-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '', '', '', 'Christopher S. Brennan, Jeffrey S. Day', '', '3'],\n  ['DNA Diagnostics Center', 'https://www.crunchbase.com/organization/dna-diagnostics-center', 'Biotechnology, Health Diagnostics', 'Fairfield, Ohio, United States', 'DNA Diagnostics Center, Inc. provides paternity and other DNA tests. DNA Diagnostics Center, Inc. was founded in 1995 and is based in', '160,891', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.dnacenter.com', '', 'contact@dnacenter.com', 'DNA Diagnostics Center, Inc. provides paternity and other DNA tests. DNA Diagnostics Center, Inc. was founded in 1995 and is based in Fairfield, Ohio.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '1995-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '8', '3', 'Made Acquisitions, Was Acquired', '', '', ''],\n  ['Epic Pharma', 'https://www.crunchbase.com/organization/epic-pharma', 'Biotechnology, Life Science, Manufacturing, Medical, Pharmaceutical', 'New York, New York, United States', 'Epic Pharma develops and manufactures generic prescription drugs.', '163,022', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.epic-pharma.com', '', '', 'EPIC PHARMA began operations in mid-2008 by purchasing the Sandoz facility located in Laurelton, NY. EPIC develops, manufactures and markets a broad array of generic pharmaceuticals that are improving the quality of life of people around the world.', '', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', '', '', '$10M to $50M', '2008-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', '', '', ''],\n  ['BenevolentBio', 'https://www.crunchbase.com/organization/benevolentbio', 'Artificial Intelligence, Biotechnology, Machine Learning, Nutraceutical', 'Brooklyn, New York, United States', 'BenevolentBio, a subsidiary of BenevolentAI, is responsible for applying AI technology in the human health and bioscience sectors.', '163,231', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://benevolent.ai/about-us', '', '', 'BenevolentBio is responsible for applying the company’s technology in the human health and bioscience sectors.  It is a subsidiary of BenevolentAI. Currently the company is focused on the disease areas of inflammation, neurodegeneration (e.g. Parkinson’s, Alzheimer’s), orphan diseases (e.g. Amyotrophic Lateral Sclerosis - ‘ALS’) and rare cancers.  However, given the scope of BenevolentAI’s artificial intelligence and machine learning capabilities the company aims to remain as flexible as possible should sufficiently interesting opportunities present themselves in the future. Other potential applications of the company’s technology could see the team move into other areas of biomedical discovery particularly relating to women’s health, rare human diseases, veterinary medicine, nutraceuticals, cosmeceuticals and agri-tech.', '', 'Artificial Intelligence, Biotechnology, Data and Analytics, Health Care, Science and Engineering, Software', '', '', '$1M to $10M', '2013-01-01', 'year', '', '', '', 'Active', 'For Profit', '1', '', '', '', '', ''],\n  ['Sagent Pharmaceuticals', 'https://www.crunchbase.com/organization/sagent-pharmaceuticals', 'Health Care, Manufacturing, Pharmaceutical', 'Schaumburg, Illinois, United States', 'Sagent Pharmaceuticals is focused on developing, manufacturing, sourcing and marketing pharmaceutical products.', '164,372', '2010-04-08', '40000000', 'USD', '40000000', 'Series B', '153000000', 'USD', '153000000', '51-100', 'Delisted', '', '', '', 'http://www.sagentpharma.com', 'http://www.linkedin.com/company/sagent-pharmacueticals', '', 'Sagent Pharmaceuticals is a privately held specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products. Sagent has created a unique, global network of resources, comprised of rapid development capabilities, sophisticated manufacturing and innovative drug-delivery technologies, quickly yielding an extensive portfolio of pharmaceutical products that fulfills the evolving needs of patients.  Sagent currently has more than 200 products in development.', 'Vivo Capital, Zhejiang Hisun Pharmaceutical Co.', 'Health Care, Manufacturing', 'Education; Cryptography; Display; Advertising; Seals', '', '$100M to $500M', '2007-01-01', 'year', '', 'M&A', '2011-04-19', 'Active', 'For Profit', '28', '1', 'Made Acquisitions, Was Acquired', '', '', '4'],\n  ['Epitomics', 'https://www.crunchbase.com/organization/epitomics', 'Biotechnology, Health Care', 'Burlingame, California, United States', 'An Emerging Biotechnology Company', '164,583', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://epitomics.com', 'https://www.linkedin.com/company/epitomics/', 'info@epitomics.com', 'Epitomics, an emerging biotechnology company, is dedicated to developing breakthrough monoclonal antibody technology for research and diagnostic applications. The company utilizes a unique and proprietary RabMAb® (Rabbit Monoclonal Antibody) technology which produces antibodies with superior binding affinity, specificity and bioactivity both in vitro and in vivo. Epitomics, Inc. is headquartered in Burlingame, California, and operates wholly owned subsidiaries in Hong Kong and Hangzhou, the People’s Republic of China.', '', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$10M to $50M', '2001-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '2', '', 'Was Acquired', 'Guo Liang Yu, Weimin Zhu', '', ''],\n  ['Halcyon Molecular', 'https://www.crunchbase.com/organization/halcyon-molecular', 'Biotechnology', 'Redwood City, California, United States', 'Halcyon Molecular develops an advanced DNA manipulation technology.', '166,540', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.halcyonmolecular.com', '', 'info@halcyonmolecular.com', 'Halcyon Molecular has developed an advanced DNA manipulation technology that will allow them to leapfrog other sequencing approaches by orders of magnitude on speed, cost and quality.', '', 'Biotechnology, Science and Engineering', '', '', '', '2008-01-01', 'year', '', '', '', 'Closed', 'For Profit', '17', '', '', 'William Andregg', '', ''],\n  ['DNA2.0', 'https://www.crunchbase.com/organization/dna2-0', 'Biotechnology, Genetics, Life Science', 'Menlo Park, California, United States', 'DNA2.0 has been the industry leader in Synthetic Biology Solutions for over a decade.', '166,851', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://www.dna20.com', 'http://www.linkedin.com/companies/615144', 'info@DNA20.com', 'DNA2.0 is the bioengineering solutions provider. Founded in 2003, DNA2.0 offers an integrated pipeline of solutions for the research community, including gene design, optimization, synthesis and cloning, as well as platforms for protein and strain engineering. It is the fastest provider of synthetic genes—based in the US with a global customer base encompassing academia, government and the pharmaceutical, chemical, agricultural and biotechnology industries. DNA2.0 is by far the most published synthetic gene vendor, providing expert support to and collaboration with scientists. DNA2.0 explores novel applications for synthetic genes and is exploiting the synergy between highly efficient gene design and synthesis processes and new protein optimization technologies. DNA2.0’s tools and solutions are fueling the transformation of biology from a discovery science to an engineering discipline. The company is privately held and is headquartered in Menlo Park, California.', '', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$10M to $50M', '2003-01-01', 'year', '', '', '', 'Active', 'For Profit', '2', '1', 'Made Acquisitions', '', '', ''],\n  ['Boston Biomedical', 'https://www.crunchbase.com/organization/boston-biomedical', 'Biotechnology, Medical, Therapeutics', 'Cambridge, Massachusetts, United States', 'Boston Biomedical focuses on the research and development of novel therapeutics to treat cancer.', '167,144', '2010-06-16', '2000000', 'USD', '2000000', 'Venture - Series Unknown', '2000000', 'USD', '2000000', '51-100', 'Private', '', '', '', 'http://www.bostonbiomedical.com', '', '', 'Boston Biomedical, Inc. is a privately held biotechnology company focusing on research and development of novel therapeutics to treat cancer.', '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '2007-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '19', '', 'Was Acquired', 'Willam Rutter', '', '1'],\n  ['AG Mednet', 'https://www.crunchbase.com/organization/ag-mednet', 'Clinical Trials, Information Technology, Life Science, Medical Device, Pharmaceutical', 'Boston, Massachusetts, United States', 'AG Mednet’s technology solves critical clinical trial workflow challenges for the pharmaceutical, biotechnology and medical device markets.', '167,828', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.agmednet.com', 'https://www.linkedin.com/company/agmednet-inc.', '', 'AG Mednet’s technology solves critical problems for the pharmaceutical, biotechnology and medical device markets. As the leading partner for endpoint/adverse event adjudication and imaging data management, we work with the world’s top bio-pharmaceutical companies and CROs. AG Mednet has more than 60,000 registered users in 80 countries. The company has been awarded more than 1,500 clinical trials, has been chosen to manage more than 50,000 endpoints and events, and processes more than 17,000,000 images per month.', '', 'Biotechnology, Health Care, Information Technology, Science and Engineering', 'Computing; Calculating', '', '$1M to $10M', '2004-01-01', 'year', '', '', '', 'Active', 'For Profit', '15', '', '', 'Abraham Gutman', '', ''],\n  ['AllCells', 'https://www.crunchbase.com/organization/allcells', 'Biotechnology', 'Alameda, California, United States', 'AllCells is a biotechnology company dedicated to providing global researchers and biomanufacturing organizations.', '168,799', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://www.allcells.com', 'https://www.linkedin.com/company/allcells-llc', 'info@allcells.com', 'AllCells is the leading provider of high quality human primary cells from peripheral blood and bone marrow. AllCells collects from bi-coastal (Alameda, CA | Qunicy, MA) owned and operated LeukoLab - Donor Care Management Facilities; and process in our adjacent laboratory. We partner with global life science researchers and bio-manu facturing organizations to develop immunotherapies, vaccines, and cell and gene therapy starting material.', '', 'Biotechnology, Science and Engineering', '', '', 'Less than $1M', '1998-05-19', 'day', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['Vector Laboratories', 'https://www.crunchbase.com/organization/vector-laboratories', 'Biotechnology, Health Care, Health Diagnostics', 'Burlingame, California, United States', 'Innovative labeling and detection solutions to the scientific community.', '170,382', '2016-04-07', '', '', '', 'Private Equity', '', '', '', '51-100', 'Private', '', '', '', 'http://www.vectorlabs.com/', 'https://www.linkedin.com/company/vector-laboratories-inc.', 'vector@vectorlabs.com', 'Since 1976 Vector Laboratories has provided innovative labeling and detection solutions to the scientific community. Shortly after introducing a line of purified lectin reagents, we revolutionized the field of histological staining with development of the versatile and sensitive Biotin-Avidin detection method leading to the VECTASTAIN® ABC family of products. These reagents provide consistent, reliable, sensitive, and low background staining for immunohistochemistry and other applications. Over the ensuing years, we have continued to innovate with the development of key reagents including: our ImmPRESS™ polymer detection systems – peroxidase micropolymers directly conjugated to secondary antibodies, which streamline detection procedures; the Vector® M.O.M.™ reagents, enabling the use of mouse primary antibodies on mouse tissue; proprietary enzyme substrates that yield a palette of colors for multiple labeling needs; our acclaimed anti-fade VECTASHIELD® mounting mediums, and our fluorescent products labeled with classic fluors as well as the new DyLight® dyes that allow superior fluorescence capabilities. Other pioneering products include neuronal tracers, ultrapure immunological products, and novel reagents for labeling, detection and isolation of nucleic acids, fusion proteins and carbohydrates.  Vector Laboratories’ substantial presence in the scientific literature is a testament to the widespread use of our products and their quality.', 'GTCR', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', '', '1947-01-01', 'year', '1', 'M&A', '', 'Active', 'For Profit', '2', '', 'Was Acquired', '', '', '1'],\n  ['PharmAthene', 'https://www.crunchbase.com/organization/pharmathene', 'Biotechnology, Health Care, Medical', 'Annapolis, Maryland, United States', 'PharmAthene develops medical countermeasures to prevent and treat morbidity and mortality associated with biological and chemical weapons.', '171,134', '2009-07-27', '19300000', 'USD', '19300000', 'Post-IPO Secondary', '84300000', 'USD', '84300000', '51-100', 'Delisted', '', '', '', 'http://www.pharmathene.com', 'http://www.linkedin.com/company/93621', 'stacey.jurchison@pharmathene.com', 'PharmAthene, Inc., a biodefense company, develops medical countermeasures to prevent and treat morbidity and mortality associated with the use of biological and chemical weapons in the United States. Its products, which are under development, include Valortim, a prophylactic and therapeutic anti-anthrax monoclonal antibody; and Protexia, a recombinant form of human butyrylcholinesterase for clinical use in the treatment of organophosphate intoxication due to exposure to chemical nerve agents. The company was founded in 2001 and is headquartered in Annapolis, Maryland.', \"MPM Capital, Ontario Teachers' Pension Plan, HealthCare Ventures, MDS, Baker Brothers Advisors LLC\", 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '2001-01-01', 'year', '', 'M&A', '2005-10-14', 'Active', 'For Profit', '18', '', 'Was Acquired', '', '', '4'],\n  ['Eviti', 'https://www.crunchbase.com/organization/eviti', 'Biotechnology, Health Care, Medical', 'Philadelphia, Pennsylvania, United States', 'eviti offers an oncology platform that assists clinicians in treatment decision-making for cancer patients.', '172,198', '2010-02-17', '5090004', 'USD', '5090004', 'Venture - Series Unknown', '5090004', 'USD', '5090004', '51-100', 'Private', '', '', '', 'http://eviti.com', 'https://www.linkedin.com/company/eviti-inc-/', 'evitiinfo@eviti.com', 'eviti is transforming the cancer treatment decision process with its innovative oncology platform called eviti Suite. Developed through a unique collaboration of leading oncologists, actuaries, insurance professionals and software engineers, eviti is pioneering the way to bring positive solutions to the cancer crisis by empowering physicians with advanced oncology decision support and payers with real-time automated precertification, aligning quality care with the appropriate reimbursement.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2003-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '1', '', 'Was Acquired', '', '', '1'],\n  ['Myriant Technologies', 'https://www.crunchbase.com/organization/myriant-technologies', 'Biotechnology, Chemical, Manufacturing', 'Quincy, Massachusetts, United States', 'Myriant Technologies utilizes renewable feedstocks to manufacture specialty chemicals that carry a smaller environmental footprint.', '172,206', '2011-01-24', '60000000', 'USD', '60000000', 'Venture - Series Unknown', '110000000', 'USD', '110000000', '51-100', 'Private', '', '', '', 'http://www.myriant.com', 'http://www.linkedin.com/company/myriant-corporation', 'productinfo@myriant.com', 'Myriant Technologies is focused on manufacturing specialty chemicals from renewable feedstocks. They deliver products with a smaller environmental footprint.', 'US Department of Energy, PTT Global Chemical Public Company', 'Biotechnology, Manufacturing, Science and Engineering', '', '', '$10M to $50M', '2005-01-01', 'year', '', '', '', 'Active', 'For Profit', '6', '', '', 'Lonnie Ingram, Stephen J. Gatto', '', '2'],\n  ['Creative Medical Technology Holdings', 'https://www.crunchbase.com/organization/creative-medical-technology-holdings', 'Biotechnology', 'Phoenix, Arizona, United States', 'Creative Medical Technology Holdings is a biotechnology company committed to improving patient lives in the areas of Urology, Neurology.', '172,361', '', '', '', '', '', '', '', '', '51-100', 'Public', '', '', '', 'http://www.creativemedicaltechnology.com', '', 'coo@creativemedicalhealth.com', 'Creative Medical Technology Holdings is a clinical-stage biotechnology company focused on treating erectile dysfunction and stroke using stem cell treatments. Since 2011 Creative Medical Technology Holdings, Inc. (CMTH) and  their affiliate company Creative Medical Health, Inc. have focused on regenerative medical solutions for unmet Urological and Neurological needs. Through their own research and collaborations with leading academic institutions, CMT has acquired a groundbreaking stem cell (Amniostem), developed proprietary protocols, built an extensive intellectual property portfolio, developed complete treatment offerings for erectile dysfunction, launched a 40-patient trial for ED at UCLA and are breaking new ground for treating stroke using their newly acquired amniotic fluid-based stem cell.Their  team consists of leading international researchers in regenerative medicine.Their “science-first” approach to treatments ensures that all of their treatments are proven to be both safe and effective.', '', 'Biotechnology, Science and Engineering', '', '', '', '', '', '', 'IPO', '2017-11-27', 'Active', 'For Profit', '8', '', '', 'Donald Dickerson, Thomas Ichim, Timothy Warbington', '', ''],\n  ['Archemix', 'https://www.crunchbase.com/organization/archemix', 'Biotechnology, Health Care, Pharmaceutical', 'San Francisco, California, United States', 'Archemix, a biotechnology company, develops and commercializes aptamer therapeutics for the treatment of chronic and acute diseases', '173,225', '2004-04-07', '50000000', 'USD', '50000000', 'Series B', '101750000', 'USD', '101750000', '51-100', 'Private', '', '', '', 'http://www.archemix.com', '', 'archemix@shareholderrep.com', 'Archemix Corp., a biotechnology company, engages in discovering, developing, and commercializing aptamer therapeutics for the prevention and treatment of chronic and acute diseases in Massachusetts. Its aptamer product candidates include ARC1779 for thrombotic microangiopathyies and carotid endarterectomy surgical procedure. The company also offers product candidates for cardiovascular, hematology, and oncology diseases. Archemix Corp. was incorporated in 2000 and is based in Cambridge, Massachusetts.', 'SV Health Investors, Highland Capital Partners, Atlas Venture, Prospect Venture Partners, Schroder Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '', '2000-01-01', 'year', '', 'Early Stage Venture', '', 'Closed', 'For Profit', '27', '', '', 'Jean-Francois Formela', '', '2'],\n  ['HealthCore', 'https://www.crunchbase.com/organization/healthcore', 'Biotechnology, Government, Health Care', 'Wilmington, Delaware, United States', 'HealthCore has three divisions defined by the type of client in the health care sector. Multiple teams at HealthCore collaborate with', '174,454', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.healthcore.com', 'https://www.linkedin.com/company/healthcore-inc.', '', 'HealthCore has three divisions defined by the type of client in the health care sector. Multiple teams at HealthCore collaborate with pharmaceutical, biotechnology and device companies to conduct Industry Sponsored Research (ISR). Separate and firewalled teams at HealthCore collaborate with government, academic and health plan stakeholders to form the Government and Academic Research (GAR) and Health Plan Research (HPR) areas.', '', 'Biotechnology, Government and Military, Health Care, Science and Engineering', '', '', '$1M to $10M', '1995-01-01', 'year', '', '', '', 'Active', 'For Profit', '5', '', '', '', '', ''],\n  ['BioImagene', 'https://www.crunchbase.com/organization/bioimagene', 'Biotechnology, Health Care, Health Diagnostics', 'Sunnyvale, California, United States', 'BioImagene offers tissue-based integrated hardware and software solutions for clinical diagnostics and drug discovery applications.', '174,531', '2008-08-19', '26000000', 'USD', '26000000', 'Series D', '30200000', 'USD', '30200000', '51-100', 'Private', '', '', '', 'http://www.bioimagene.com', '', 'info@bioimagene.com', 'BioImagene, Inc. provides digital pathology solutions for clinical diagnostics and drug discovery applications. It develops and distributes integrated hardware and software systems to acquire, view, share, manage, archive, and analyze tissue images in pathology laboratories. The company offers IHC algorithms, such as HER2, ER/PR, and p53 for breast cancer; Ki67 for breast, brain, and prostate cancers; CD138 for multiple myeloma; CD3/CD20 for lymphoma; iSlide input device, a device that allows pathologists to use a microscope interface to manipulate digital images of slides; and iScan Coreo Au digital slide scanners that enable digital pathology applications, such as image analysis, telepathology, remote microscopy, and education. It serves cancer research laboratories, academic medical centers, community hospitals, reference laboratories, teaching hospitals, biotech companies, and pharmaceutical companies. BioImagene, Inc. was founded in 2003 and is based in Sunnyvale, California.', 'Artiman Ventures, Ascension Ventures, ICCP Venture Partners, Burrill & Company, National Healthcare Services', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10M to $50M', '2003-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '6', '', 'Was Acquired', '', '', '2'],\n  ['MAP Pharmaceuticals', 'https://www.crunchbase.com/organization/map-pharmaceuticals', 'Biotechnology, Health Care, Medical, Pharmaceutical', 'Mountain View, California, United States', 'MAP Pharmaceuticals is focused\\xa0on developing novel inhalation therapies for respiratory and systemic diseases.', '174,825', '2007-03-28', '50000000', 'USD', '50000000', 'Series D', '105249000', 'USD', '105249000', '51-100', 'Delisted', '', '', '', 'http://www.mappharma.com', 'http://www.linkedin.com/company/map-pharmaceuticals', '', \"MAP Pharmaceuticals, Inc., a development stage company, focuses on developing novel inhalation therapies for respiratory and systemic diseases. It has various proprietary product candidates in clinical development, including Unit Dose Budesonide for pediatric asthma in children from six months to eight years of age and MAP0004 for migraine. The company's product portfolio also includes MAP0005 for the treatment of adolescent and adult asthma, and chronic obstructive pulmonary disease; and MAP0001 for the treatment of Type 1 and Type 2 diabetes via pulmonary delivery using its Tempo inhaler. MAP Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Mountain View, California.\", 'Alexandria Real Estate Equities, D. E. Shaw & Co., Bay City Capital, Skyline Ventures, Pequot Capital', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '2003-01-01', 'year', '', 'M&A', '2007-10-05', 'Active', 'For Profit', '10', '', 'Was Acquired', '', '', '3'],\n  ['IQuum', 'https://www.crunchbase.com/organization/iquum', 'Biotechnology, Health Diagnostics, Medical Device', 'Marlborough, Massachusetts, United States', 'Iquum is a biotech company that develops molecular diagnostics and biological sample technology.', '175,328', '2011-01-03', '1000000', 'USD', '1000000', 'Debt Financing', '1000000', 'USD', '1000000', '51-100', 'Private', '', '', '', 'http://www.iquum.com', '', 'info@IQuum.com', 'Founded in 1998 in the Boston metropolitan area, IQuum is an early stage company dedicated to further developing there unique platform that will improve the extraction of information from biological samples. The platform will deliver the recent achievements in genomics and biotechnology to healthcare and daily life.  IQuum has developed the novel lab-in-a-tube platform. The platform incorporates a closed sample tube, modular sample processor architecture and the latest biotechnology to provide a uniform system for cellular, protein, and nucleic acid tests. Our system enables rapid and ease-to-use biological sample testing, and performs multiple biological assays in an \"insert-and-test\" format, integrating all stages of sample processing -- from sample collection to result interpretation. The Company believes that this platform will meet the market needs for extracting comprehensive information from biological samples, and is developing the next generation of biological sample testing systems based on this platform.', '', 'Biotechnology, Health Care, Science and Engineering', 'Physical Or Chemical Processes Or Apparatus In General', '', '', '1998-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '4', '', 'Was Acquired', '', '', '1'],\n  ['Facet Biotech', 'https://www.crunchbase.com/organization/facet-biotech', 'Biotechnology', 'Redwood City, California, United States', 'Facet Biotech engages in the identification and development of oncology drugs.', '175,626', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.facetbiotech.com/', '', '', \"Facet Biotech Corporation, a biotechnology company, engages in the identification and development of oncology drugs. Facet was formed through a spin-off of the biotechnology segment of PDL BioPharma, Inc., which was completed on December 18, 2008. It was subsequently acquired by [Abbott Labs](/organization/abbott-labs). The company is headquartered in Redwood City, California. Its products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company is also developing Elotuzumab, a monoclonal antibody in Phase I/II clinical studies, which binds to a cell surface glycoprotein that is expressed on myeloma cells and normal human cells; PDL192, a monoclonal antibody in Phase I clinical study, which binds to the tumor necrosis factor-like weak inducer of apoptosis receptor; PDL241, a monoclonal antibody in the preclinical stage for immunologic diseases; and TRU-016, a small modular immunopharmaceutical protein therapeutic in Phase I clinical studies for the treatment of B-cell malignancies, such as chronic lymphocytic leukemia and non-Hodgkin's lymphoma, as well as autoimmune and inflammatory disease indications. It has collaboration agreements with Biogen Idec Inc.; Bristol-Myers Squibb Company; and Trubion Pharmaceuticals, Inc. Facet Biotech Corporation also has license agreements with Abbott Laboratories, Inc.; Actinium Pharmaceuticals, Inc.; Genentech, Inc.; Ophthotech Corporation; Progenics Pharmaceuticals, Inc.; and Seattle Genetics, Inc.\", '', 'Biotechnology, Science and Engineering', 'Organic Chemistry', '', '', '2008-07-01', 'day', '', 'M&A', '', 'Active', 'For Profit', '13', '', 'Was Acquired', '', '', ''],\n  ['Third Wave Technologies', 'https://www.crunchbase.com/organization/third-wave-technologies', 'Biotechnology, Genetics, Health Care, Health Diagnostics', 'Madison, Wisconsin, United States', 'Third Wave Technologies develops molecular diagnostic products for various DNA and RNA analysis applications.', '177,158', '2011-03-23', '', '', '', 'Venture - Series Unknown', '25300000', 'USD', '25300000', '51-100', 'Delisted', '', '', '', 'http://www.twt.com', 'http://www.linkedin.com/company/166432', '', \"Third Wave Technologies, Inc. engages in the development and marketing of molecular diagnostic products for various DNA and RNA analysis applications. It provides physicians and researchers with molecular solutions for the analysis and treatment of disease. The company offers products based proprietary Invader chemistry, a technology used in women's health, infectious disease, genetics and pharmacogenetics, and oncology segments. Third Wave principally offers inVitro diagnostic devices and analyte specific reagents. The company's analyte specific reagents allow laboratories to create assays to perform hepatitis C virus genotyping, inherited disorders testing, and a host of other mutations associated with genetic predispositions and other diseases. Third Wave also develops various DNA and RNA analysis products for the research and agricultural biotechnology markets. Its customers include clinical laboratories, pharmaceutical and biotechnology companies, academic research centers, and health care providers. Third Wave sells its products through a combination of direct sales personnel who focuses primarily on the clinical market, as well as through collaborative relationships in the United States and Europe. The company was founded in 1993 and is headquartered in Madison, Wisconsin. As of July 23, 2008, Third Wave Technologies Inc. operates as a subsidiary of Hologic Inc.\", 'SV Health Investors, Deerfield, Venture Investors', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '', '1993-01-01', 'year', '', 'M&A', '2001-02-13', 'Active', 'For Profit', '16', '', 'Was Acquired', '', '', '3'],\n  ['CeloNova', 'https://www.crunchbase.com/organization/celonova', 'Biotechnology, Manufacturing, Medical Device', 'San Antonio, Texas, United States', 'CeloNova BioSciences is a medical device firm that develops, manufactures and markets interventional cardiology and endovascular products.', '177,380', '2011-02-15', '20841869', 'USD', '20841869', 'Venture - Series Unknown', '20841869', 'USD', '20841869', '51-100', 'Private', '', '', '', 'http://celonova.com', 'https://www.linkedin.com/company/celonova-biosciences-inc-', 'info@celonova.com', 'CeloNova BioSciences, Inc., headquartered in San Antonio, Texas, is a global medical device company that develops, manufactures and markets a family of Interventional Cardiology and Endovascular products. Our products are developed and manufactured in California, U.S.A. and Germany.  The Company’s regional offices are located in Germany, France, United Kingdom, Netherlands and Austria. CeloNova’s Interventional Cardiology and Endovascular products are currently available in more than fifty countries.', 'FCA Venture Partners, Clayton Associates', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2000-01-01', 'year', '', '', '', 'Active', 'For Profit', '1', '', '', 'Goetz Richter', '', '2'],\n  ['Teikoku Pharma', 'https://www.crunchbase.com/organization/teikoku-pharma', 'Pharmaceutical', 'San Jose, California, United States', 'Teikoku Pharma is an international specialty pharmaceutical company.', '177,414', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.teikokuusa.com/', 'https://www.linkedin.com/company/85590', 'info@teikokuusa.com', 'Teikoku Pharma USA develops innovative products in the CNS, Pain Management and Oncology based on its drug delivery platforms.', '', 'Health Care', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '1997-01-01', 'year', '1', '', '', 'Active', 'For Profit', '1', '1', 'Made Acquisitions', 'Paul Mori', '', ''],\n  ['Dyax', 'https://www.crunchbase.com/organization/dyax', 'Biopharma, Biotechnology, Pharmaceutical', 'Cambridge, Massachusetts, United States', 'Dyax Corp. (Dyax) is a biopharmaceutical company focused on the discovery, development and commercialization of biotherapeutics for unmet', '177,920', '', '', '', '', '', '', '', '', '51-100', 'Delisted', '271000000', 'USD', '271000000', 'http://www.dyax.com', 'https://www.linkedin.com/company/dyax/about/', 'bd@dyax.com', \"Dyax Corp. (Dyax) is a biopharmaceutical company focused on the discovery, development and commercialization of biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications. The Company's lead product, DX-88, has been approved under the brand name KALBITOR (ecallantide) by the United States Food and Drug Administration (FDA) for treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older. The Company commercializes KALBITOR on its own in the United States. In addition to its approved commercial use for HAE in the United States, the Company is also developing DX-88 through collaborations in other indications. These include use of DX-88 for the reduction of blood loss during surgery in collaboration with Cubist Pharmaceuticals (Cubist), and for treatment of retinal diseases in collaboration with Fovea Pharmaceuticals (Fovea), which was acquired by sanofi-aventis during the year ended December 31, 2009.\", '', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '', '1989-01-01', 'year', '', 'M&A', '2000-08-25', 'Active', 'For Profit', '81', '', 'Was Acquired', '', '', ''],\n  ['TheraDoc', 'https://www.crunchbase.com/organization/theradoc', 'Biotechnology, Electronics, Health Care, Security', 'Charlotte, North Carolina, United States', 'A leading provider of electronic clinical surveillance to healthcare organizations across the country.', '178,003', '2005-06-03', '10500000', 'USD', '10500000', 'Series B', '10500000', 'USD', '10500000', '51-100', 'Private', '', '', '', 'http://www.theradoc.com/', 'https://www.linkedin.com/company/6766', '', 'TheraDoc, Inc., a wholly owned subsidiary of Hospira, Inc., is a leading provider of electronic clinical surveillance to healthcare organizations across the country. TheraDoc’s suite of software applications brings together disparate data from a hospital’s source systems, helps alert clinicians to potential risks, and empowers them with knowledge to improve clinical outcomes, lower costs, and strengthen regulatory compliance. Founded in 1999 by a group of clinicians and medical informatics experts, TheraDoc was one of the pioneers of electronic clinical surveillance, and has remained at the forefront of advances in this technology. TheraDoc was acquired by Hospira in 2009 as part of Hospira’s growing portfolio of Clinical IT solutions.', '', 'Biotechnology, Consumer Electronics, Hardware, Health Care, Privacy and Security, Science and Engineering', 'Computing; Calculating', '', '', '1999-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '2', '', 'Was Acquired', 'Stanley Pestotnik', '', '1'],\n  ['Altea Therapeutics', 'https://www.crunchbase.com/organization/altea-therapeutics', 'Biotechnology, Health Care, Pharmaceutical', 'Atlanta, Georgia, United States', 'Altea Therapeutics Corporation develops and commercializes transdermal drug delivery systems.', '178,592', '2010-10-24', '685000', 'USD', '685000', 'Debt Financing', '83484999', 'USD', '83484999', '51-100', 'Private', '', '', '', 'http://alteatherapeutics.com', '', '', 'Altea Therapeutics Corporation develops and commercializes transdermal drug delivery systems. It offers PassPort patch, a skin patch that uses short bursts of focused thermal energy to create tiny channels in the surface of the skin and these channels permit the flow of proteins, peptides, carbohydrates, and small molecules into the body without the use of needles. The company also provides Transdermal vaccine patch, a delivery system for water-soluble drugs and proteins; disease prevention products; insulin skin patch, a non-injectable daily insulin product; and opioid patches that provide delivery of opioids and incorporates the layers of deterrents. Altea Therapeutics Corporation was formerly known as Altea Development Corporation. The company was founded in 1998 and is based in Atlanta, Georgia. As of May 9, 2012, Altea Therapeutics Corporation operates as a subsidiary of Nitto Denko Corp.', 'Domain Associates, Aperture Venture Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1998-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '2', '', 'Was Acquired', 'Jonathan Eppstein', '', '5'],\n  ['NewLink Genetics', 'https://www.crunchbase.com/organization/newlink-genetics', 'Biotechnology, Genetics, Health Care, Therapeutics', 'Ames, Iowa, United States', 'NewLink Genetics, a biopharmaceutical company, develops therapeutic and diagnostic agents for patients with cancer and infectious diseases.', '181,382', '2009-07-21', '7500000', 'USD', '7500000', 'Series D', '33594000', 'USD', '33594000', '51-100', 'Public', '140000000', 'USD', '140000000', 'http://www.newlinkgenetics.com', 'http://www.linkedin.com/company/newlink-genetics', 'info@newlinkgenetics.com', 'NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer. Founded more than 15 years ago, NewLink Genetics continues to be at the forefront in immuno-oncology treatments led by a diverse group of industry professionals and physician-scientists. Personal cancer stories inspire their relentless research and development in advancing treatments. Their mission is to change the cancer treatment paradigm and make a difference in patient lives every day.', 'Ames Seed Capital, Chicagoland Investors, Iowa Capital Management, Midwest Oilseeds, NLG Advisors', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '', '1999-01-01', 'year', '', 'IPO', '2011-11-14', 'Active', 'For Profit', '36', '', '', 'Charles Link, Nicholas Vahanian', '', '4'],\n  ['Temptime Corporation', 'https://www.crunchbase.com/organization/temptime-corporation', 'Biotechnology, Electronics, Hardware, Manufacturing', 'Morris Plains, New Jersey, United States', 'Temptime Corporation is the worldwide leader in chemical time-temperature indicator technology.', '181,947', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.temptimecorp.com', 'http://www.linkedin.com/company/temptime-corporation', 'info@temptimecorp.com', 'Temptime Corporation is the worldwide leader in chemical time-temperature indicator technology. Temptime designs and manufactures time-temperature indicators that visually signal freeze events, threshold heat events, and cumulative heat excursions. They have a product portfolio of miniaturized devices that allow their products to be adhered at the unit level for full life monitoring of drugs, vaccines, medical devices, biological reagents and fresh foods. In concert with the full life monitoring, they offer the market a wide array of shipping and transportation monitoring devices too. The company serves health and food industries worldwide, with key customers in the United States, Europe, Japan, India and China. The company was founded in 1987 as LifeLines Technology, Inc. and changed its name to Temptime Corporation in 2004 to better reflect its core expertise. Temptime Corporation is based in Morris Plains, New Jersey (USA).', '', 'Biotechnology, Consumer Electronics, Hardware, Manufacturing, Science and Engineering', 'Testing', '', '', '1987-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '3', '1', 'Made Acquisitions, Was Acquired', '', '', ''],\n  ['Concentric Medical', 'https://www.crunchbase.com/organization/concentric-medical', 'Biotechnology, Medical, Medical Device', 'Mountain View, California, United States', 'Concentric Medical is a medical technology company.', '182,807', '2012-10-12', '', '', '', 'Series A', '15000000', 'USD', '15000000', '51-100', 'Private', '', '', '', 'http://www.concentric-medical.com', '', '', 'Concentric Medical headquartered in Mountain View, CA, is a medical device company focused on the design, development and commercialization of minimally invasive medical devices for use in the neurovasculature.', 'SV Health Investors, New Enterprise Associates, Greenspring Associates', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1999-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '11', '', 'Was Acquired', 'Hanson Gifford, Martin Dieck', '', '2'],\n  ['Checkpoint Therapeutics', 'https://www.crunchbase.com/organization/checkpoint-therapeutics', 'Biotechnology, Health Care, Pharmaceutical, Therapeutics', 'New York, New York, United States', 'Checkpoint Therapeutics is a clinical-stage, immuno-oncology biopharmaceutical company.', '183,096', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.checkpointtx.com', '', 'info@checkpointtx.com', 'Checkpoint Therapeutics, a Fortress Biotech Company, is an immuno-oncology biopharmaceutical company focused on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. They aim to acquire rights to these technologies by licensing the rights or otherwise acquiring an ownership interest in the technologies, funding their research and development and eventually either out-licensing or bringing the technologies to market.', '', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$1M to $10M', '', '', '', '', '', 'Active', 'For Profit', '5', '', '', '', '', ''],\n  ['Ion Torrent', 'https://www.crunchbase.com/organization/ion-torrent', 'Biotechnology, Health Care, Medical', 'Guilford, Connecticut, United States', 'Ion Torrent offers an approach to sequencing data that facilitates a direct connection between chemical and digital information.', '183,402', '2010-03-05', '37064376', 'USD', '37064376', 'Series C', '59864364', 'USD', '59864364', '51-100', 'Private', '', '', '', 'http://www.iontorrent.com', '', 'sales@iontorrent.com', \"Ion Torrent, a wholly-owned subsidiary of [Life Technologies](/organization/life-technologies), has pioneered an entirely new approach to sequencing that enables a direct connection between chemical and digital information. Ion Torrentâ„¢ technology doesn't use lightâ€”it's the first commercial PostLightâ„¢ sequencing technology. Instead, Ion Torrent marries simple chemistry to incredibly powerful, proven semiconductor technologyâ€”it's Watson meets Moore. The result is a sequencing system that is simpler, faster, more cost effective and scalable than any other technology available. The company's goal is to democratize sequencing and make this critical technology available to every lab.\", 'Bay City Capital', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2007-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '54', '', 'Was Acquired', 'Jonathan M. Rothberg', '', '2'],\n  ['Archimedes', 'https://www.crunchbase.com/organization/archimedes', 'Biotechnology, Consumer Electronics, Health Care, Information Technology', 'San Francisco, California, United States', 'Archimedes is company focused on the healthcare industry who provides clinical trial simulations, comparative effectiveness, and more.', '184,257', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://archimedesmodel.com', 'https://www.linkedin.com/company/archimedes-healthcare-modeling/', 'info@archimedesmodel.com', 'Archimedes is a healthcare modeling organization that offers Archimedes Model, a mathematical model of human physiology, diseases, interventions, and healthcare systems. The Archimedes Model is designed to help people understand the implications of their decisions and find answers to complex, real-world questions for health plans, pharmaceutical companies, researchers, and other organizations. Archimedes was founded in 1980 and is based in San Francisco, California.', '', 'Biotechnology, Consumer Electronics, Hardware, Health Care, Information Technology, Science and Engineering', 'Computing; Calculating', '', '', '1980-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', 'David Eddy', '', ''],\n  ['Caldera Medical Inc.', 'https://www.crunchbase.com/organization/caldera-medical-inc', 'Biotechnology, Health Care, Medical Device', 'Agoura Hills, California, United States', 'Caldera Medical is a privately held women‘s health medical device company focused on minimally invasive applications.', '184,487', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://www.calderamedical.com', 'https://www.linkedin.com/company/caldera-medical', 'info@calderamedical.com', 'Caldera Medical is a privately held women‘s health medical device company focused on minimally invasive applications. Caldera Medical is a Clifornia based company Developing technology for a new ERA.  In 2002, Caldera Medical was founded to bring differentiated technology to an emerging market. While large multinational corporations dominate the medical device industry, Caldera Medical foresaw an opportunity in the female pelvic health arena to form close relationships with surgeons and to build a company around this principle. Surgeon relationships continue to be the company touchstone, inspiring us to make life better® for surgeons, the facilities that they operate at, and the patients they care for.  In 2003, Caldera Medical launched its first product, a sling for incontinence, at the annual meeting of the American Urological Association.  In 2005, Caldera Medical entered the prolapse market via a partnership with a well-known tissue bank.  In 2006, Caldera Medical signed a far-reaching license agreement with American Medical Systems, Inc. Click here to read the press release.  In 2007, Caldera Medical introduced the next generation in female sling technology, Desara®. In addition, 2007 saw the divestment of Caldera Medical‘s male sling to Coloplast A/S. Click here to read the press release. Caldera Medical also secured a patent license agreement from Coloplast. Click here to read the press release.  In 2009, Caldera Medical launched the patented Ascend® Pelvic Floor Repair System.  In 2010, Caldera Medical elected a new Board of Directors and approved a strong growth initiative. Click here to read the press release. In addition, Caldera Medical relocated to larger corporate headquarters to accommodate the significant growth. Click here to read the press release. In 2013, Caldera Medical launched Desara® SL to provide a short 12cm length transobturator sling for those surgeons who wish to minimize the amount of mesh implanted.  In 2013, Caldera Medical launched Vertessa® Lite, a lightweight yet strong polypropylene mesh designed for use in sacrocolpopexy procedures.', '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2002-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['OraPharma Inc. (acquired by JNJ)', 'https://www.crunchbase.com/organization/orapharma-inc-acquired-by-jnj', 'Pharmaceutical', 'Bridgewater, New Jersey, United States', 'OraPharma is a specialty pharmaceutical company that develops and commercializes products that help improve and maintain oral health.', '185,436', '1998-12-14', '16000000', 'USD', '16000000', 'Venture - Series Unknown', '16000000', 'USD', '16000000', '51-100', 'Private', '', '', '', 'http://www.orapharma.com/', '', 'info@OraPharma.com', 'OraPharma is a specialty pharmaceutical company that develops and commercializes products that help improve and maintain oral health. They are dedicated to delivering scientifically and technologically advanced products to dental professionals and their practices. ARESTIN® (minocycline HCl) Microspheres, 1 mg is a locally administered antibiotic (LAA) offering a patented microsphere technology. OraPharma is proud to have introduced this revolutionary approach to treating periodontitis as an adjunct to scaling and root planing and continues to take a leadership role in educating clinicians and consumers on the disease. Read more about ARESTIN® or click here for Prescribing Information.', 'Canaan Partners, Domain Associates, Oak Investment Partners, TL Ventures, HealthCap', 'Health Care', '', '', '$10M to $50M', '1996-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', '', '', '1'],\n  ['Myogen', 'https://www.crunchbase.com/organization/myogen', 'Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics', 'Westminster, Colorado, United States', 'Myogen is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics.', '186,131', '2003-08-29', '40000000', 'USD', '40000000', 'Series D', '187770000', 'USD', '187770000', '51-100', 'Delisted', '350000000', 'USD', '350000000', 'http://www.myogen.com/', '', '', 'Myogen is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular disorders. They believe that our advanced understanding of the biology of cardiovascular disease combined with their clinical development expertise in cardiovascular therapeutics provide us with the capability to discover novel therapies, as well as identify, license or  acquire products that address serious, debilitating cardiovascular disorders that are not adequately treated with existing therapies.', 'New Enterprise Associates, Silicon Valley Bank, Adams Street Partners, Greenspring Associates, InterWest Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1996-01-01', 'year', '', 'M&A', '2003-10-30', 'Active', 'For Profit', '1', '', 'Was Acquired', 'Eric Newell Olson, Michael R. Bristow', '', '5'],\n  ['Kramer Laboratories', 'https://www.crunchbase.com/organization/kramer-laboratories', 'Health Care, Pharmaceutical', 'Coral Gables, Florida, United States', 'Kramer Laboratories is a well-established marketer of branded over-the counter medicines within the foot care and cough-cold segments.', '187,458', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://kramerlabs.com/', 'https://www.linkedin.com/company/kramer-laboratories/', '', 'Kramer Laboratories is a well-established marketer of branded over-the counter medicines within the foot care and cough-cold segments of the consumer healthcare market. ', '', 'Health Care', '', '', '$10M to $50M', '', '', '', '', '', 'Active', 'For Profit', '2', '1', 'Made Acquisitions', '', '', ''],\n  ['Tethys BioScience', 'https://www.crunchbase.com/organization/tethys-bioscience', 'Biotechnology, Health Care, Health Diagnostics', 'Emeryville, California, United States', 'Tethys BioScience develops and commercializes biological markers for use in the diagnosis of metabolic diseases.', '187,725', '2010-07-21', '23000000', 'USD', '23000000', 'Venture - Series Unknown', '63400000', 'USD', '63400000', '51-100', 'Private', '', '', '', 'http://www.tethysbio.com', 'http://www.linkedin.com/company/tethys-bioscience-inc.', 'info@tethysbio.com', 'Tethys BioScience, Inc. engages in the discovery, development, and commercialization of biological markers. Its products are used to diagnosis the metabolic diseases, such as diabetes. The company offers PreDx Diabetes Risk Test, a diagnostic test that analyzes a set of multiple proteins and other blood borne biomarkers implicated in the development of diabetes. Tethys BioScience, Inc. was founded in 2002 and is based in Emeryville, California.', 'Kleiner Perkins, Silicon Valley Bank, Intel Capital, Greenspring Associates, Oxford Finance LLC', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', '', '2002-01-01', 'year', '1', '', '', 'Closed', 'For Profit', '', '1', 'Made Acquisitions', 'David Hodgson, Dr .Urdea, Mickey S. Urdea', '', '5'],\n  ['Biogenex', 'https://www.crunchbase.com/organization/biogenex', 'Biotechnology, Manufacturing', 'Fremont, California, United States', 'Biogenex is a genome research company providing molecular pathology solutions and automation of cell and tissue staining.', '188,041', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://biogenex.com', 'https://www.linkedin.com/company/biogenex', 'customer.service@biogenex.com', 'BioGenex Laboratories, Inc., designs, develops, manufactures, and commercializes automated molecular pathology systems for cancer diagnosis, prognosis, personalized medicine, and life science research. The company offers a range of slide-based tissue staining products to support assay development in translational research and clinical diagnosis of cancers.', '', 'Biotechnology, Manufacturing, Science and Engineering', '', '', '$1M to $10M', '1981-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', 'Krishan Kalra, Satya Kalra', '', ''],\n  ['AngioScore', 'https://www.crunchbase.com/organization/angioscore', 'Biotechnology, Health Care, Medical', 'Fremont, California, United States', 'AngioScore develops scoring balloon catheters to treat cardiovascular and peripheral artery diseases.', '188,761', '2011-04-20', '12000000', 'USD', '12000000', 'Venture - Series Unknown', '87000000', 'USD', '87000000', '51-100', 'Private', '', '', '', 'http://www.angioscore.com', '', 'order@angioscore.com', 'AngioScore Inc. develops, manufactures and markets the AngioSculpt Scoring Balloon Catheter for both the coronary and peripheral interventional markets.   Designed specifically to address the limitations of conventional angioplasty balloon catheters, AngioSculpt combines a semi-compliant balloon with an innovative nitinol scoring element.', 'Pelion Venture Partners, Saints Capital, QuestMark Partners, Psilos Group, California Technology Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2003-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '37', '', 'Was Acquired', 'Eitan Konstantino, Gary Gershony', '', '4'],\n  ['AMENDIA', 'https://www.crunchbase.com/organization/amendia', 'Biotechnology, Health Care, Medical Device', 'Marietta, Georgia, United States', 'Amendia is a provider of innovative Class II and Class III medical devices used in spinal surgical procedures.', '189,571', '2011-02-01', '3450000', 'USD', '3450000', 'Venture - Series Unknown', '3730000', 'USD', '3730000', '51-100', 'Private', '', '', '', 'http://amendia.com', 'https://www.linkedin.com/company/amendia', 'info@amendia.com', 'Amendia is a leading provider of innovative medical devices used during spinal surgical procedures. Founded in 2008, Amendia’s Mission is to exceed surgeon and patient expectations by creating balanced solutions with disruptive technologies for medical devices paired with biologics and instrumentation. Amendia’s vertically-integrated strategy focuses on improving surgical outcomes and the lives of patients with spinal disorders.', '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2007-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '1', '2', 'Made Acquisitions, Was Acquired', '', '', '2'],\n  ['Kapa Biosystems', 'https://www.crunchbase.com/organization/kapa-biosystems', 'Biotechnology, Genetics', 'Wilmington, Massachusetts, United States', 'Kapa Biosystems offers next generation sequencing platforms for whole genomes, RNA sequencing, targeted sequencing.', '189,717', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://www.kapabiosystems.com', 'https://www.linkedin.com/company/kapa-biosystems', 'info@kapabiosystems.com', 'They are constantly evolving better science by applying the latest advances in genomics and synthetic biology to help reduce costs, simplify workflows and improve results. Their core protein engineering technologies enable us to tailor enzymes to suit specific applications in next-generation DNA and RNA sequencing, DNA amplification and molecular diagnostics. Biomedical research is no longer limited by the constraints of native enzyme structure or function.', '', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$100M to $500M', '2006-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '8', '', 'Was Acquired', '', '', ''],\n  ['SkyQuest Technology Consulting Pvt. Ltd.', 'https://www.crunchbase.com/organization/skyquest-technology-consulting-pvt-ltd', 'Biotechnology, Health Care, Information Technology', 'Springfield, New Jersey, United States', 'SkyQuest provide access to Innovations across sectors viz. agritech, cleantech, life sciences, nanotech as well as information.', '190,248', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://skyquestt.com', '', 'info@skyquestt.com', 'SkyQuest Technology Group is a Global Market Intelligence, Innovation Management & Commercialization organization that connects Innovation to new markets, networks & collaborators for achieving Sustainable Development Goals.', '', 'Biotechnology, Health Care, Information Technology, Science and Engineering', '', '', 'Less than $1M', '2006-06-28', 'day', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['Acucela', 'https://www.crunchbase.com/organization/acucela', 'Biotechnology, Health Care, Pharmaceutical, Therapeutics', 'Seattle, Washington, United States', 'Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the', '191,134', '2009-09-04', '439603', 'USD', '439603', 'Venture - Series Unknown', '439603', 'USD', '439603', '51-100', 'Delisted', '', '', '', 'http://acucela.com', 'http://www.linkedin.com/company/acucela-inc.', 'pr@acucela.com', 'Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide.', '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '2002-01-01', 'year', '', 'IPO', '2014-02-13', 'Active', 'For Profit', '20', '', '', '', '', '1'],\n  ['US WorldMeds', 'https://www.crunchbase.com/organization/us-worldmeds', 'Health Care, Pharmaceutical', 'Louisville, Kentucky, United States', 'US WorldMeds is a closely-held, Kentucky-based specialty pharmaceutical company. Our mission is to develop, license and commercialize', '192,199', '2016-07-01', '', '', '', 'Venture - Series Unknown', '', '', '', '51-100', 'Private', '', '', '', 'http://www.usworldmeds.com', '', 'medinfo@usworldmeds.com', 'US WorldMeds is a closely-held, Kentucky-based specialty pharmaceutical company. Our mission is to develop, license and commercialize unique and significant specialty pharmaceuticals that address unmet medical needs or overcome limitations of existing products. Organized on March 23, 2001 by current CEO Paul Breckinridge \"Breck\" Jones, US WorldMeds holds true to our founder\\'s original vision to become a substantial global operating enterprise while remaining closely-held and able to capitalize on local and experienced talent. US WorldMeds remains committed to continue to expand into a major corporate citizen and a formidable source of innovative pharmaceutical products and high-quality jobs for generations to come - both in our Louisville headquarters and our satellite offices and manufacturing facilities.', 'Kentucky Science and Technology Corporation (KSTC), CRG', 'Health Care', 'Medical Or Veterinary Science; Hygiene', '', '$100M to $500M', '2001-03-23', 'day', '', '', '', 'Active', 'For Profit', '7', '1', 'Made Acquisitions', 'Paul Jones', '', '2'],\n  ['OncoGenex', 'https://www.crunchbase.com/organization/oncogenex', 'Biotechnology, Health Care, Therapeutics', 'Bothell, Washington, United States', 'OncoGenex develops and commercializes innovative therapies for the treatment of a variety of cancers.', '192,712', '2009-12-29', '10000000', 'USD', '10000000', 'Post-IPO Equity', '34300000', 'USD', '34300000', '51-100', 'Delisted', '', '', '', 'http://oncogenex.com', '', '', 'OncoGenex’ mission is to meet the challenge of treatment resistance through the development and commercialization of first-in-class, innovative therapies that have the potential to redefine treatment outcomes for patients with a variety of cancers.', 'H.I.G. Capital, Ventures West, Bank Of Canada, Working Opportunity Fund', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '1991-01-01', 'year', '', 'M&A', '1995-10-20', 'Active', 'For Profit', '13', '1', 'Made Acquisitions, Was Acquired', '', '', '3'],\n  ['Ad-Tech Medical Instrument Corporation', 'https://www.crunchbase.com/organization/ad-tech-medical-instrument-corporation', 'Biotechnology, Electronics, Hardware, Manufacturing', 'Racine, Wisconsin, United States', 'A worldwide recognized medical device company dedicated to innovative neuro-devices.', '195,768', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://adtechmedical.com/', '', 'customersupport@adtechmedical.com', 'Ad-Tech Medical Instrument Corporation is the leading and well respected manufacturer and distributor worldwide of intra-cranial monitoring devices (“electrodes”) for the treatment of intractable epilepsy as well as complimentary neurosurgical instrumentation. The Company’s electrode devices are used for long-term EEG monitoring, mapping, SEEG, and stimulation of the brain for persons with intractable epilepsy and other brain diseases/disorders. Ad-Tech proprietary designs include subdural strip and grid electrodes, dual sided subdural electrodes, depth electrodes, depth electrodes with micro contacts, foramen ovale electrodes, intra operative electrodes, cranial nerve electrodes and spinal electrodes as well as related products including electrode placement kits/accessory placement devices and brain biopsy needles. The Company’s devices feature design elements such as advanced materials and components as well as field leading ease of use and connectivity, utilizing Ad-Tech’s patented connection systems. Ad-Tech’s devices are recognized for their elegant design, attention to the neurosurgeons requirements and simplicity of construction, resulting in safe and effective devices. With over 30 years of designing and manufacturing high-quality medical devices, Ad-Tech has cultivated a reputation for innovative designs, quality driven manufacturing, and proven performance in the field of neuro-monitoring and neurosurgery. The Company’s reputation for innovative designs dates back to 1985 with Ad-Tech’s creation of strip electrodes for long-term monitoring in the treatment of intractable epilepsy, which has become a market-leading position in the treatment of intractable epilepsy. As an example, Ad-Tech’s electrode designs were the first to use a “tunneling” technique to minimize the risk for CSF leakage. And Ad-Tech’s depth electrode design is considered the “gold standard” in it’s field. Over the course of Ad-Tech’s history, the Company has continued to develop innovative devices for intracranial monitoring and that has lead to it’s expansive offering as well as a pipeline for additional offerings. The Company’s reputation for innovation and quality are reinforced by a history of consistent performance in the field.', '', 'Biotechnology, Consumer Electronics, Hardware, Manufacturing, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '1983-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['Savient Pharmaceuticals', 'https://www.crunchbase.com/organization/savient-pharmaceuticals', 'Biotechnology', 'East Brunswick, New Jersey, United States', 'Savient Pharmaceuticals is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA (pegloticase).', '196,122', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.savientpharma.com', '', '', 'Savient Pharmaceuticals is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXAâ„¢ (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA and its uses from Duke University (\"Duke\") and Mountain View Pharmaceuticals, Inc. (\"MVP\").  Duke developed the recombinant uricase enzyme and MVP developed the PEGylation technology used in the manufacture of KRYSTEXXA. MVP and Duke have been granted U.S. and foreign patents disclosing and claiming the licensed technology and, in addition, Savient owns or co-owns U.S. and foreign patents and patent applications, which collectively form a broad portfolio of patents covering the composition, manufacture and methods of use and administration of KRYSTEXXA.  Savient also manufactures and supplies OxandrinÂ® (oxandrolone tablets, USP) CIII in the U.S.', '', 'Biotechnology, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '', '1980-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '5', '', 'Was Acquired', '', '', ''],\n  ['Sucampo Pharmaceuticals', 'https://www.crunchbase.com/organization/sucampo-pharmaceuticals', 'Biotechnology, Health Care', 'Bethesda, Maryland, United States', 'Sucampo is a biopharmaceutical company.', '196,603', '', '', '', '', '', '', '', '', '51-100', 'Delisted', '172500000', 'USD', '172500000', 'http://sucampo.com', 'http://www.linkedin.com/company/sucampo-pharmaceuticals-inc.', 'info@sucampo.com', ' Sucampo Pharmaceuticals, Inc. is focused on the development and commercialization of specialized medicines that meet major unmet medical needs of patients worldwide. Sucampo has two marketed products – AMITIZA, its lead product, and RESCULA – and a late-stage pipeline of product candidates in clinical development for orphan disease areas. VTS-270 is a mixture of 2-hydroxypropyl-B-cyclodextrins with a specific compositional fingerprint that has been granted orphan designation in the U.S. and Europe and is in a pivotal Phase 2/3 clinical trial for the treatment of Niemann-Pick Disease Type C-1. Sucampo has an option for the North American rights to CPP1- x/sulindac, which is in Phase 3 development for the treatment of familial adenomatous polyposis and has been granted orphan drug designation in the U.S. A global company, Sucampo is headquartered in Rockville, Maryland, and has operations in Japan and Switzerland.', '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1996-01-01', 'year', '', 'M&A', '2007-08-03', 'Active', 'For Profit', '13', '2', 'Made Acquisitions, Was Acquired', '', '', ''],\n  ['Bill & Melinda Gates Medical Research Institute', 'https://www.crunchbase.com/organization/bill-melinda-gates-medical-research-institute', 'Biotechnology, Education, Medical', 'Cambridge, Massachusetts, United States', 'Bill & Melinda Gates Medical Research Institute is a biotech organization dedicated to accelerating the product development timeline.', '197,835', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://www.gatesmri.org/', 'https://www.linkedin.com/company/bill-melinda-gates-medical-research-institute', 'info@gatesmri.org', \"Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Their mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world's poorest people.\", '', 'Biotechnology, Education, Health Care, Science and Engineering', '', '', '$1M to $10M', '2017-01-01', 'year', '', '', '', 'Active', 'Non-profit', '3', '', '', '', '', ''],\n  ['Ascenta Therapeutics', 'https://www.crunchbase.com/organization/ascenta-therapeutics', 'Biopharma, Biotechnology, Health Care, Therapeutics', 'Malvern, Pennsylvania, United States', 'Ascenta Therapeutics, a clinical-stage biopharmaceutical company, focuses on the discovery and development of new medicines to treat cancer.', '198,126', '2010-02-06', '1800180', 'USD', '1800180', 'Debt Financing', '87800180', 'USD', '87800180', '51-100', 'Private', '', '', '', 'http://www.ascenta.com', 'https://www.linkedin.com/company/ascenta-therapeutics-inc-', 'info@ascenta.com', \"Ascenta Therapeutics is a privately-held, clinical stage biopharmaceutical company dedicated to the discovery and development of new medicines to treat cancer.  Ascenta's current focus is a portfolio of novel, orally-active, small molecule drugs that restore the natural potential for cancer cells to undergo cell death (apoptosis).\", 'Scale Venture Partners, U.S. Venture Partners, Domain Associates, Sofinnova Investments, Enterprise Partners', 'Biotechnology, Health Care, Science and Engineering', 'Agriculture; Forestry; Animal Husbandry; Hunting; Trapping; Fishing', '', '$1M to $10M', '2003-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '5', '', '', 'Dajun Yang, Marc Lippman, Shaomeng Wang', '', '4'],\n  ['Solstice Neurosciences', 'https://www.crunchbase.com/organization/solstice-neurosciences', 'Biotechnology, Manufacturing, Marketing', 'South San Francisco, California, United States', 'Solstice Neurosciences is focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products.', '199,120', '2006-11-08', '85000000', 'USD', '85000000', 'Series B', '93000000', 'USD', '93000000', '51-100', 'Private', '', '', '', 'http://www.solsticeneuro.com', '', 'contact@solsticeneuro.com', \"Solstice Neurosciences is a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products. Solstice's first product named MyoblocÂ® (rimabotulinumtoxinB) Injection in the U.S. and NeuroBlocÂ® (Botulinum Toxin Type B) Injectable Solution in select overseas markets, represents the only botulinum toxin type B currently available to physicians and patients worldwide.\", 'Highland Capital Partners, Oxford Bioscience Partners, Investor Growth Capital Limited, Morgan Stanley Venture Partners, Thomas, McNerney & Partners', 'Biotechnology, Manufacturing, Sales and Marketing, Science and Engineering', '', '', '', '2003-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', '', '', '2'],\n  ['NDS Surgical Imaging', 'https://www.crunchbase.com/organization/nds-surgical-imaging', 'Biotechnology, DSP, Medical, Medical Device', 'San Jose, California, United States', 'NDS Surgical Imaging is a manufacturer of medical imaging and informatics systems for operative and interventional suites.', '199,899', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.ndssi.com/', 'https://www.linkedin.com/company/nds-surgical-imaging', 'info@ndssi.com', 'NDS Surgical Imaging revolutionized the medical imaging industry with its development of the industry’s first Digital Signal Processing (DSP) technologies for Minimally Invasive Surgery (MIS) viewing applications in 1996. The company continues that tradition of innovation with technological and engineering advances serving the rapidly developing surgical markets. Those markets encompass a range of specific areas where NDSsi’s products are used, including endoscopy, image guided surgery, interventional medicine, and patient monitoring. NDSsi is the global leader in designing and manufacturing comprehensive medical imaging and video processing solutions for today’s operative and interventional suites. NDS Surgical Imaging’s success is a testimony to a proven track record of innovation and adoption by leading medical technology companies, hospitals and university medical centers worldwide.  Its reputation for professional commitment and responsiveness to customers is unparalleled. Driven by technological innovation and real-time knowledge of medical imaging needs, NDSsi consistently raises the bar by staying ahead of the latest advancements in medical imaging technologies. NDS Surgical Imaging’s market leadership is built upon its unique ability to supply the medical profession with technologies that enable practitioners to integrate information from many sources, visualize a defect or condition within the body and to perform an intervention that improves the quality of care. NDSsi is located in Silicon Valley, with US-based manufacturing, R&D facilities and a strong global presence in more than 35 countries. The company recognizes that employees are a key value to its success. NDSsi is led by a seasoned management team with solid, quality engineering expertise in imaging technologies, and extensive industry backgrounds in healthcare technologies. NDSsi brings an in-depth understanding of the regulatory, compliance, and medical industry environment. The company is an FDA-registered and ISO-certified company with all products certified under the most stringent US, Asian, and European safety and environmental regulations.', '', 'Biotechnology, Hardware, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1996-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '4', '3', 'Made Acquisitions, Was Acquired', '', '', ''],\n  ['Xenogen Corporation', 'https://www.crunchbase.com/organization/xenogen-corporation', 'Biotechnology, Genetics, Health Care, Health Diagnostics, Therapeutics', 'Alameda, California, United States', 'Xenogen Corporation is an integrated system of instruments and equipment, software and reagents to academic and biopharmaceutical', '200,628', '2003-07-10', '22000000', 'USD', '22000000', 'Venture - Series Unknown', '96594985', 'USD', '96594985', '51-100', 'Delisted', '', '', '', 'http://www.xenogen.com', '', '', \"Xenogen Corporation is a biotechnology company offering an integrated suite of biophotonic real-time in vivo imaging and genetic modification technologies that can help expedite drug discovery and development, and significantly reduce the cost and time to market for new therapies. Xenogen's VivoVision(TM) Systems non-invasively illuminate and monitor biological processes within living mammals, at the molecular level, in real time. The technology is designed to provide higher quality in vivo data earlier in the drug discovery and development process. VivoVision(TM) Solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. VivoVision(TM) Biosciences represents more than 15 years of experience in the creation and characterization of animal models, including genetic modifications, comprehensive phenotyping, compound profiling and custom design and production of light producing cells, microorganisms and animals.\", 'SR One, Abingworth, Charlesbank Capital Partners, Delphi Ventures, Invemed Associates', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1994-01-01', 'year', '', 'M&A', '2004-07-16', 'Active', 'For Profit', '', '', 'Was Acquired', '', '', '5'],\n  ['WellSpring Pharmaceutical', 'https://www.crunchbase.com/organization/wellspring-pharmaceutical', 'Biotechnology, Manufacturing, Medical, Pharmaceutical', 'Sarasota, Florida, United States', 'WellSpring is a privately held company focused on the development, manufacturing and marketing of consumer healthcare products.', '201,409', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.wellspringpharm.com', '', 'info@wellspringpharm.com', 'WellSpring Pharmaceutical Corporation is a privately held company founded by Dr. Robert Vukovich in 1999 and headquartered in Sarasota, Florida. WellSpring markets and distributes four trusted over the counter brands, EmetrolÂ®, MicatinÂ®, GelusilÂ® and Glaxal BaseÂ® Skin Cream and Lotion. WellSpring Pharmaceutical Corporationâ€™s headquarters are located at 5911 North Honore Avenue in Sarasota, FL.', '', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', 'Testing', '', '', '1999-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', '', '', ''],\n  ['PrimeraDx (Primera Biosystems)', 'https://www.crunchbase.com/organization/primeradx', 'Biopharma, Biotechnology, Chemical, Genetics', 'Providence, Rhode Island, United States', 'PrimeraDx offers multiplexed infectious disease assays that include scalable target amplification routine technology.', '203,062', '2012-09-26', '', '', '', 'Grant', '53151129', 'USD', '53151129', '51-100', 'Private', '', '', '', 'http://www.primeradx.com', '', 'Info@PrimeraDx.com', 'PrimeraDx, Inc. offers multiplexed infectious disease assays. It provides Scalable Target Amplification Routine technology, which is a method for simultaneous quantitative measurement of multiple target nucleic acids. The company also offers ViraQuant, a multiplexed assay providing quantitative and simultaneous measurement of viruses; and FungiQuant Yeast and FungiQuant Mold, which are fungal panels for mycology testing. Its products are used in miRNA, DNA methylation, quantitative genotyping, gene expression, and viral load measurement applications. PrimeraDx, Inc. was founded in 2004 and is based in Mansfield, Massachusetts.', 'MPM Capital, Invus, InterWest Partners, Abingworth, National Cancer Institute', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$1M to $10M', '2004-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '1', '', 'Was Acquired', 'Vladimir Slepnev', '', '5'],\n  ['Anesiva', 'https://www.crunchbase.com/organization/anesiva', 'Biotechnology, Genetics, Health Care, Medical, Therapeutics', 'South San Francisco, California, United States', 'Anesiva, Inc., a biopharmaceutical company, engages in the development and commercialization of novel therapeutic treatments for pain', '204,771', '2009-06-04', '2000000', 'USD', '2000000', 'Post-IPO Debt', '113374000', 'USD', '113374000', '51-100', 'Delisted', '', '', '', 'http://anesiva.com', 'http://www.linkedin.com/company/anesiva', '', 'Anesiva, Inc., a biopharmaceutical company, engages in the development and commercialization of novel therapeutic treatments for pain management worldwide. Its lead product candidate includes Adlea, which completed multiple Phase II and Phase III trials for post-surgical, musculoskeletal, and neuropathic pain. The company was formerly known as AlgoRx Pharmaceuticals, Inc., it changed its name to Anesiva, Inc. in 2006. Anesiva, Inc. was founded in 1999 and is headquartered in South San Francisco, California. On January 15, 2010, Anesiva, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Northern District of California. On June 10, 2014 filed for Chapter 7 bankruptcy.', 'Temasek Holdings, InterWest Partners, HBM Healthcare Investments AG, Sofinnova Investments, Alta Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1999-01-01', 'year', '', 'IPO', '2004-02-12', 'Closed', 'For Profit', '4', '1', 'Made Acquisitions', 'John McLaughlin', '', '7'],\n  ['EKR Therapeutics', 'https://www.crunchbase.com/organization/ekr-therapeutics', 'Biotechnology, Health Care, Pharmaceutical, Therapeutics', 'Bedminster, New Jersey, United States', 'EKR Therapeutics provides a segment of the healthcare market with products to improve patient outcomes and quality of life.', '205,736', '2008-03-10', '95000000', 'USD', '95000000', 'Debt Financing', '163000000', 'USD', '163000000', '51-100', 'Private', '', '', '', 'http://www.ekrtx.com', '', 'info@EKRtx.com', 'EKR Therapeutics, Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing prescription products and oncology supportive care. It focuses on various areas, including oral mucositis, stomatitis, dry mouth/xerostomia, nutritional issues, cachexia, skin reactions, bone marrow depression, bone complications, acute and chronic pain, nausea, vomiting, and diarrhea. The company was founded in 2005 and is based in Bedminster, New Jersey.', 'NewSpring, MPM Capital, GE Healthcare, LLR Partners, Merrill Lynch', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '2006-02-01', 'month', '', 'M&A', '', 'Active', 'For Profit', '5', '', 'Was Acquired', 'Howard J. Weisman', '', '4'],\n  ['Vitae Pharmaceuticals', 'https://www.crunchbase.com/organization/vitae-pharmaceuticals', 'Biotechnology, Health Care, Pharmaceutical, Test and Measurement', 'Fort Washington, Pennsylvania, United States', 'Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds', '206,945', '2009-06-09', '15000000', 'USD', '15000000', 'Venture - Series Unknown', '94000000', 'USD', '94000000', '51-100', 'Delisted', '198000000', 'USD', '198000000', 'http://www.vitaepharma.com', '', 'contact@vitaerx.com', \"Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class compounds that address large markets with significant unmet medical needs, including chronic kidney disease, diabetes, atherosclerosis and Alzheimer's disease.\", 'Wellcome Trust, Venrock, New Enterprise Associates, Intel Capital, Atlas Venture', 'Biotechnology, Data and Analytics, Health Care, Science and Engineering', 'Organic Chemistry', '', 'Less than $1M', '2001-01-01', 'year', '', 'M&A', '2014-09-24', 'Active', 'For Profit', '31', '', 'Was Acquired', 'John J. Baldwin', '', '5'],\n  ['Syrrx', 'https://www.crunchbase.com/organization/syrrx', 'Biotechnology, Clinical Trials, Commercial, Content Discovery', 'San Diego, California, United States', 'Syrrx, Inc. is a drug discovery company committed to redefining the way medicines are discovered.', '207,007', '2001-12-26', '18500000', 'USD', '18500000', 'Venture - Series Unknown', '23600000', 'USD', '23600000', '51-100', 'Private', '', '', '', 'http://www.syrrx.com', '', '', 'Syrrx Inc focuses on drug targets that have been validated in human clinical trials and directs its efforts toward therapeutics to treat metabolic diseases, cancer, and inflammation. Syrrx exploits its competitive advantage in high-throughput structural biology to be the first organization to determine the three dimensional structure of known drug targets. Syrrx then uses these structures to drive iterative, structure-based drug design programs to efficiently generate potential drug candidates. Syrrx has an ongoing partnership for the development and commercialization of Syrrx-designed human dipeptidyl peptidase IV (DPP IV) inhibitors as drug products for the treatment of type 2 diabetes and other major human diseases. Syrrx also has a strategic alliance for the discovery and early development of inhibitors targeting human HDACs and HSD1.', 'Versant Ventures, MPM Capital, Bay City Capital, CMEA Capital, HBM Partners', 'Biotechnology, Content and Publishing, Health Care, Media and Entertainment, Other, Science and Engineering', 'Organic Chemistry', '', '$1M to $10M', '1999-02-01', 'month', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', 'Nathaniel David, Raymond E. Stevens', '', '2'],\n  ['Coley Pharmaceutical Group', 'https://www.crunchbase.com/organization/coley-pharmaceutical-group', 'Biotechnology, Health Care, Medical', 'Wellesley, Massachusetts, United States', 'Coley Pharmaceutical Group develops therapeutics and drug candidates to fight cancers, asthma, allergy and autoimmune disorders.', '207,195', '2007-02-01', '', '', '', 'Post-IPO Equity', '85100000', 'USD', '85100000', '51-100', 'Delisted', '', '', '', 'http://www.coleypharma.com', '', '', 'Coley Pharmaceutical Group operates as a biopharmaceutical company developing therapeutics and drug candidates that direct the human immune system to fight cancers, asthma and allergy, autoimmune disorders, and to enhance the effectiveness of vaccines. The company was formerly known as CpG ImmunoPharmaceuticals, Inc. and in August 2000 it changed its name to Coley Pharmaceutical Group, Inc. The company was founded in 1997 and is based in Wellesley, Massachusetts. As of December 28, 2007, Coley Pharmaceutical Group, Inc. operates as a subsidiary of Pfizer Inc.', 'Venrock, Qiagen, Pfizer Venture Investments, Techno Venture Management, Thuja Capital', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1997-01-01', 'year', '', 'M&A', '2005-08-10', 'Active', 'For Profit', '4', '', 'Was Acquired', '', '', '6'],\n  ['Kintai Therapeutics', 'https://www.crunchbase.com/organization/kintai-therapeutics', 'Biotechnology, Health Care, Medical Device', 'Cambridge, Massachusetts, United States', 'Kintai is a biotechnology company that advancing precision therapeutics based on enteric signaling networks in the human body.', '207,940', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://www.kintaitx.com/', 'https://www.linkedin.com/company/kintai-therapeutics', '', \"Kintai Therapeutics is a developer of healthcare technology platform designed to leverage the body's robust signaling networks based on orally available small molecule therapeutics to restore health and fight disease. The company's products are created using AI-based algorithms, enabling the researchers to use Enteric Biology and Analytics and Precision Enteric Medicines™ (PEM™) Discovery Platform to discover disease.\", '', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '$10M to $50M', '2016-01-01', 'day', '', '', '', 'Active', 'For Profit', '', '', '', 'Brett R. Blackman', '', ''],\n  ['Compass Research', 'https://www.crunchbase.com/organization/compass-research', 'Biotechnology, Health Care, Medical, Pharmaceutical', 'Orlando, Florida, United States', 'A clinical research company dedicated to testing investigational medications that cover a broad range of diseases and disorders', '209,510', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.compassresearch.com/', 'https://www.linkedin.com/company/compass-research-llc', 'info@compassresearch.com', 'Compass Research is a clinical research company dedicated to testing investigational medications that cover a broad range of diseases and disorders. By participating in a clinical research study with Compass Research, participants are given the opportunity to provide valuable information for the future of medicine. Their core value is to exceed the expectations of both our patients and sponsors. We do this through comprehensive quality control and attention to detail. Their staff has over 400 years of combined clinical research experience in all fields of medicine. This gives us extensive knowledge of the clinical research study process from beginning to end and the ability to provide quality data to their sponsors.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2006-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '2', '', 'Was Acquired', 'Craig Curtis, Sean Stanton', '', ''],\n  ['Optics 1', 'https://www.crunchbase.com/organization/optics', 'Biotechnology, Consumer Electronics, Industrial, Medical', 'Bedford, New Hampshire, United States', 'Optics1 is engaged in optics design and optical developments, including visible, infrared and ultraviolet light, X-rays and microwaves.', '210,105', '2010-01-21', '38000000', 'USD', '38000000', 'Venture - Series Unknown', '38000000', 'USD', '38000000', '51-100', 'Private', '', '', '', 'http://www.optics1.com', '', '', 'Optics 1specialized in optics, opto-mechanics and electro-optics, designs, develops and produces integrated systems and subsystems for the defense market in the United States and abroad. It also produces a range of commercial products for the medical, biotechnology and electronics industries.', 'United States Navy', 'Biotechnology, Consumer Electronics, Hardware, Health Care, Manufacturing, Science and Engineering', 'Testing', '', '', '1987-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', '', '', '1'],\n  ['Protein Sciences', 'https://www.crunchbase.com/organization/protein-sciences', 'Biotechnology, Health Care, Life Science, Medical', 'Meriden, Connecticut, United States', 'Protein Sciences is a research company that provides the research and creation of new vaccines and other protective medicines.', '210,472', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.proteinsciences.com', 'https://www.linkedin.com/company/70809?trk=prof-exp-company-name', '', 'Protein Sciences was founded in 1983 and has over 30 years of experience in developing vaccines and biopharmaceuticals for the prevention and treatment of a variety of diseases. They use their proprietary BEVS protein expression technology to produce high quality recombinant proteins quickly, reliably and at low cost.', '', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$1M to $10M', '1983-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '25', '', 'Was Acquired', 'Steven Zimmer', '', ''],\n  ['Bayhill Therapeutics', 'https://www.crunchbase.com/organization/bayhill-therapeutics', 'Biopharma, Biotechnology, Therapeutics', 'Portola Valley, California, United States', 'Bayhill Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapeutics.', '211,152', '2009-07-17', '9999999', 'USD', '9999999', 'Venture - Series Unknown', '61199999', 'USD', '61199999', '51-100', 'Private', '', '', '', 'http://bayhilltx.com', '', 'info@tolerioninc.com', 'Bayhill Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapeutics for autoimmune diseases. The company uses its therapeutic BHT-DNA platform to develop a pipeline of treatment candidates for autoimmune diseases. Its products in clinical pipeline include BHT-3021, which is in Phase I/II clinical trial for reducing or eliminating the immune system’s attack on the pancreas; BHT-3009, which completed its Phase II trial for the treatment of multiple sclerosis; and BHT-3034, which is in preclinical studies for the treatment of myasthenia gravis. The company was formerly known as Tolerion, Inc. and changed its name to Bayhill Therapeutics, Inc. in November 2002. Bayhill Therapeutics, Inc. was founded in 2000 and is headquartered in Palo Alto, California.', 'U.S. Venture Partners, Quintiles, Morgenthaler Ventures, The Vertical Group, Latterell Venture Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', 'Less than $1M', '2000-01-01', 'year', '', '', '', 'Active', 'For Profit', '4', '', '', 'Hideki Garren, Lawrence Steinman', '', '4'],\n  ['Essen BioScience', 'https://www.crunchbase.com/organization/essenbioscience', 'Biotechnology, Life Science, Real Time', 'Ann Arbor, Michigan, United States', 'Essen BioScience is a world leader in the field of cell-based in vitro assays and instrumentation.', '211,768', '2014-05-15', '', '', '', 'Venture - Series Unknown', '', '', '', '51-100', 'Private', '', '', '', 'http://www.essenbioscience.com/', 'http://www.linkedin.com/company/essen-bioscience', '', 'Essen BioScience is a world leader in the field of cell-based in vitro assays and instrumentation. Our inventions have spanned nearly twenty years, and are recognized as “first in class” in several technology areas including optical cell-based screening (FLIPR, 1994), high through electrophysiology (IonWorks, 2002) and kinetic imaging (IncuCyte, 2006; IncuCyte ZOOM, 2012). To date, our inventions have accounted for nearly 1 billion dollars in worldwide sales.', 'SFW Capital Partners', 'Biotechnology, Other, Science and Engineering', '', '', '', '1999-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '1', '', 'Was Acquired', 'Brad Neagle, Kirk Schroeder', '', '1'],\n  ['TargetRx', 'https://www.crunchbase.com/organization/targetrx', 'Biotechnology, Health Care, Medical, Pharmaceutical', 'Horsham, Pennsylvania, United States', 'TargetRx provides pharmaceutical and biotech companies with unique insight into the true drivers of product choice and adoption for their', '212,380', '2005-04-28', '15050000', 'USD', '15050000', 'Series D', '52517000', 'USD', '52517000', '51-100', 'Private', '', '', '', 'http://www.targetrx.com', '', '', 'TargetRx provides pharmaceutical and biotech companies with unique insight into the true drivers of product choice and adoption for their brands, so that they can confidently take the actions that will grow their businesses and help patients. They offer a suite of solutions that extends from the pipeline through patent expiry.', 'New Enterprise Associates, Greenspring Associates, Domain Associates, Montagu Private Equity, Quaker BioVentures', 'Biotechnology, Health Care, Science and Engineering', 'Computing; Calculating', '', '', '1999-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '3', '', 'Was Acquired', '', '', '5'],\n  ['AlphaVax', 'https://www.crunchbase.com/organization/alphavax', 'Biotechnology, Health Care, Medical', 'Durham, North Carolina, United States', 'AlphaVax develops a range of vaccine products for infectious diseases, biodefense, and cancer.', '212,543', '2007-02-05', '12620000', 'USD', '12620000', 'Series E', '48419999', 'USD', '48419999', '51-100', 'Private', '', '', '', 'http://www.alphavax.com', '', 'finance@alphavax.com', 'AlphaVax develops a range of vaccine products for infectious diseases, biodefense, and cancer. It uses alphavaccine vector platform technology to generate a portfolio of vaccine candidates for infectious disease prevention and cancer immunotherapy.  AlphaVax was founded by Jonathan F. Smith and is based in Durham, North Carolina.', '', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$10M to $50M', '1997-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '', '', '', 'Jonathan F. Smith, Nancy Davis, Robert Johnston', '', '5'],\n  ['Rinat Neuroscience', 'https://www.crunchbase.com/organization/rinat-neuroscience', 'Biotechnology, Neuroscience, Therapeutics', 'Palo Alto, California, United States', 'A leader in the development of therapeutic antibodies, spun out its key neuroscience assets under a broad license to Rinat.', '212,844', '2004-01-01', '', '', '', 'Venture - Series Unknown', '57500000', 'USD', '57500000', '51-100', 'Private', '', '', '', 'http://www.rinatneuro.com/', '', 'info@rinatneuro.com', 'Rinat, which means \"happiness\" in Hebrew, was formed in 2001 when Genentech, a leader in the development of therapeutic antibodies, narrowed its focus and spun out its key neuroscience assets under a broad license to Rinat. Genentech invested significant R&D resources in support of these assets over 15 years, and Rinat is now building on them as the pioneer in developing and commercializing antibody drugs for the treatment of diseases and disorders of the nervous system.', 'MPM Capital, HBM Healthcare Investments AG, Technology Partners, Prospect Venture Partners, Schroder Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '', '2000-10-01', 'month', '', 'M&A', '', 'Active', 'For Profit', '4', '', 'Was Acquired', 'Arnon Rosenthal', '', '3'],\n  ['Cumberland Pharmaceuticals', 'https://www.crunchbase.com/organization/cumberland-pharmaceuticals', 'Biotechnology, Health Care', 'Nashville, Tennessee, United States', 'A specialty pharmaceutical company that acquires, develops and commercializes branded prescription products', '213,727', '', '', '', '', '', '', '', '', '51-100', 'Public', '85000000', 'USD', '85000000', 'http://www.cumberlandpharma.com', 'http://www.linkedin.com/company/cumberland-pharmaceuticals', 'info@cumberlandpharma.com', 'Cumberland Pharmaceuticals is a specialty pharmaceutical company whose mission is to acquire currently marketed and late-stage development pharmaceutical products and grow them through marketing to targeted, underserved physician segments. Cumberland is dedicated to providing high quality products which address unmet medical needs.', '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1999-01-01', 'year', '', 'IPO', '2009-08-11', 'Active', 'For Profit', '22', '', '', '', '', ''],\n  ['Yulex', 'https://www.crunchbase.com/organization/yulex', 'Biotechnology, Energy, Manufacturing, Medical', 'Maricopa, Arizona, United States', 'Yulex Corporation produces agricultural-based biomaterials for the manufacturing of medical, industrial and bio-energy products.', '214,950', '2011-03-16', '15000000', 'USD', '15000000', 'Venture - Series Unknown', '15000000', 'USD', '15000000', '51-100', 'Private', '', '', '', 'http://www.yulex.com', 'http://www.linkedin.com/company/yulex-corporation', 'info@yulex.com', \"Yulex Corporation is the world leader in guayule crop science and renewable products made from guayule. Through Yulex's advancements in plant breeding, biotechnology, cultivation, product development, and proprietary processing technologies, the company has established a vital international medical industry and sustainable clean tech industry in the U.S. Southwest with international expansion to other arid regions underway.\", 'Argonaut Private Equity', 'Biotechnology, Energy, Health Care, Manufacturing, Science and Engineering', 'Organic Macromolecular Compounds; Their Preparation Or Chemical Working-Up', '', '$1M to $10M', '1997-01-01', 'year', '', '', '', 'Active', 'For Profit', '1', '', '', 'Jeffrey A. Martin', '', '1'],\n  ['Therapeutic Research Center', 'https://www.crunchbase.com/organization/therapeutic-research-center', 'Biotechnology, Health Care', 'Stockton, California, United States', 'Therapeutic Research Center offers analysis and evidence-based recommendations on pharmaceuticals and other therapeutic agents.', '214,960', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.therapeuticresearch.com', 'https://www.linkedin.com/company/therapeutic-research-center', '', \"Therapeutic Research Center and Therapeutic Research Faculty are internationally recognized for their world-class analysis and evidence-based recommendations on pharmaceuticals and other therapeutic agents.The mission has remained the same for over 25 years. The Center's goal since its formation in 1985 has been to enhance patient care in person and even through technology like apps.\", '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '1985-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '6', '', 'Was Acquired', '', '', ''],\n  ['Victory Pharma', 'https://www.crunchbase.com/organization/victory-pharma', 'Biotechnology, Developer Platform, Pharmaceutical', 'San Diego, California, United States', 'Victory Pharma, Inc. is a specialty pharmaceutical company that acquires, markets and develops prescription pharmaceutical products that', '215,464', '2009-03-20', '9999997', 'USD', '9999997', 'Venture - Series Unknown', '9999997', 'USD', '9999997', '51-100', 'Private', '', '', '', 'http://www.victorypharma.com', '', '', 'Victory Pharma, Inc. is a specialty pharmaceutical company that acquires, markets and develops prescription pharmaceutical products that treat pain and related conditions.  Victory markets these products to health care professionals through an experienced US commercial organization. They also develop novel products that effectively treat pain and minimize side effects commonly associated with widely-used pain therapeutics.', '', 'Biotechnology, Health Care, Science and Engineering, Software', '', '', '$10M to $50M', '2004-01-01', 'year', '', '', '', 'Active', 'For Profit', '3', '', '', 'David Preston', '', '1'],\n  ['Dynamis Pharmaceuticals', 'https://www.crunchbase.com/organization/dynamis-pharmaceuticals', 'Biotechnology', 'Jenkintown, Pennsylvania, United States', 'Dynamis Pharmaceuticals is a biopharma company that is developing proprietary small molecule drugs to treat chronic inflammatory diseases.', '217,004', '2004-01-15', '', '', '', 'Seed', '', '', '', '51-100', 'Private', '', '', '', 'http://www.dynamis-therapeutics.com/', '', 'egeimonen@dynamisscience.com', 'Dynamis Pharmaceuticals, Inc. is a biopharma company that is developing proprietary small molecule drugs to treat chronic inflammatory diseases. Its proprietary drug candidates inhibit a novel enzymatic pathway that causes the formation of a highly reactive sugar, 3-deoxyglucosone, that stimulates the production of Advanced Glycation End Products (AGEs), oxidative stress and a cascade of inflammatory cytokines.', 'BioAdvance', 'Biotechnology, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '1997-01-01', 'year', '', 'Seed', '', 'Active', 'For Profit', '', '', '', '', '', '1'],\n  ['White Bottle', 'https://www.crunchbase.com/organization/white-bottle', 'Nutraceutical, Nutrition, Pharmaceutical', 'Irvine, California, United States', 'White Bottle is a private label manufacturer of high quality nutraceutical supplements for physicians, retailers, and distributors.', '217,351', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://whitebottle.com/', '', 'concepts@whitebottle.com', 'White Bottle is a private label manufacturer of high quality nutraceutical supplements for physicians, retailers, and distributors. It specializes in creating customized innovative solutions with the best ingredients and the higher standards for testing. The company operates on the premise of developing transparent and cooperative relationships with their clients and offer premium products that help them differentiate themselves.', '', 'Food and Beverage, Health Care', '', '', 'Less than $1M', '', '', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['SpineFrontier', 'https://www.crunchbase.com/organization/spinefrontier', 'Biotechnology, Health Care, Medical Device', 'Beverly, Massachusetts, United States', 'SpineFrontier designs, develops, and markets implants and instruments used in the treatment of spinal diseases.', '218,280', '2010-05-25', '500000', 'USD', '500000', 'Debt Financing', '500000', 'USD', '500000', '51-100', 'Private', '', '', '', 'http://www.spinefrontier.com', 'https://www.linkedin.com/company/spinefrontier', 'contact@spinefrontier.com', 'SpineFrontier Inc., a medical device company that designs, develops, and markets implants and instruments used in the treatment of spinal diseases. It offers anterior cervical plates; FacetFuse MIS screw systems; interspinous fixation system; pedicle screw systems; MIS pedicle screw systems; spinal intervertebral body fusion (IBF) devices; lumbar IBF systems; anterior lumbar IBF systems; biologics materials; and retractor systems. SpineFrontier Inc. was founded in 2006 and is based in Beverly, Massachusetts.', '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$50M to $100M', '2006-01-01', 'year', '', '', '', 'Active', 'For Profit', '7', '', '', '', '', '1'],\n  ['NeoMed Inc', 'https://www.crunchbase.com/organization/neomed-inc', 'Biotechnology, Health Care, Medical', 'Woodstock, Georgia, United States', 'NeoMed designs and develops products for neonatal patients.', '219,798', '2010-07-20', '244822', 'USD', '244822', 'Seed', '244822', 'USD', '244822', '51-100', 'Private', '', '', '', 'http://www.neomedinc.com', 'https://www.linkedin.com/company/neomed-inc-', '', 'NeoMed, Inc. designs and produces neonatal products for neonatal patients. It offers enteral safety systems, such as oral dispensers, enteral only extension sets, and feeding tubes; polyurethane feeding tubes; solutions for the collection, storage, and feeding of expressed breast milk; and polyethylene drape/wrap products to reduce the risk of cold stress post-delivery and during sterile procedures in the NICU. The company also provides neonatal catheters and kits, including a line of specialty procedure kits, which include catheterization trays, urinary collection kits, and drainage catheters and lumbar puncture kits and needles; products to manage the identification, storage, and verification of breast milk before feeding; and a line of single and dual lumen silicone umbilical catheters. In addition, NeoMed manufactures products under a private label agreement. It offers its products through a network of distributors in the United States, Alaska, Hawaii, and internationally. The company was founded in 2007 and is based in Woodstock, Georgia.', '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2007-01-01', 'year', '', 'Seed', '', 'Active', 'For Profit', '', '', '', 'Tony Lair', '', '1'],\n  ['AGY Therapeutics', 'https://www.crunchbase.com/organization/agy-therapeutics', 'Biopharma, Biotechnology, Genetics, Medical, Therapeutics', 'San Francisco, California, United States', 'A South San Francisco, Calif .-based biopharmaceutical company', '222,433', '2004-08-07', '9000000', 'USD', '9000000', 'Series C', '22000000', 'USD', '22000000', '51-100', 'Private', '', '', '', 'http://www.agyinc.com/', '', '', 'AGY Therapeutics has one focus: the discovery, development and commercialization of breakthrough treatments for diseases of the central nervous system AGY has a pipeline of novel CNS therapeutic programs in the clinic and in preclinical development to meet major unmet medical needs. AGY built its pipeline using its unique, proprietary platform for functional gene discovery and mapping out specific pathways underlying central nervous system diseases. By harnessing these capabilities, AGY identified potential target proteins that can be modulated to block the progression of the disease process. This is paving the way for novel CNS therapeutics and future growth for AGY.', 'JAFCO Japan, Gimv, JAFCO Asia, GE Capital, Novartis Venture Fund', 'Biotechnology, Health Care, Science and Engineering', '', '', '$100M to $500M', '1998-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '1', '', '', '', '', '2'],\n  ['Avineuro', 'https://www.crunchbase.com/organization/avineuro', 'Pharmaceutical', 'Hallandale, Florida, United States', 'Avineuro Pharmaceuticals discovers and develops novel small molecules for unmet medical needs in neurology and psychiatry.', '223,814', '2011-05-11', '', '', '', 'Seed', '', '', '', '51-100', 'Private', '', '', '', 'http://www.avineuro.com/', '', '', 'Avineuro Pharmaceuticals, Inc. discovers and develops novel small molecules for unmet medical needs in neurology and psychiatry. Founded in August 2008 and headquartered in San Diego, California Avineuro is managed by professionals experienced in drug discovery and development. By acquiring lead compounds through collaborations and partnerships, Avineuro develops novel products and extends the reach of marketed compounds for indications with a significant commercial potential. Avineuro emphasizes a rational approach that combines modern medicinal chemistry with streamlined pre-clinical and clinical development studies, thus allowing a fast transition to proof-of-concept product candidates.', 'Torrey Pines Investment', 'Health Care', '', '', '', '2008-01-01', 'year', '', 'Seed', '', 'Active', 'For Profit', '', '', '', '', '', '1'],\n  ['Paracor Medical', 'https://www.crunchbase.com/organization/paracor-medical', 'Biotechnology, Health Care, Medical Device', 'Sunnyvale, California, United States', 'Paracor Medical is a medical device company providing technology-driven solutions for the treatment of heart failure.', '224,922', '2007-06-29', '44000000', 'USD', '44000000', 'Series D', '74500000', 'USD', '74500000', '51-100', 'Private', '', '', '', 'http://www.paracormedical.com', '', 'info@paracor.com', 'Paracor Medical is an innovative medical device company focused on providing unique, technology-driven solutions for the treatment of heart failure. Founded in 1999, Paracor was established to pursue new and innovative ways to treat heart failure (HF) that would not require the patient to undergo open chest surgery. Paracor engineers recognized that a mechanical approach to reducing the workload of a failing, diseased heart muscle could be a new and effective solution.', 'Greenspring Associates, InterWest Partners, Aberdare Ventures, Delphi Ventures, Alta Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1999-01-01', 'year', '', 'Late Stage Venture', '', 'Closed', 'For Profit', '2', '', '', 'Lilip Lau', '', '3'],\n  ['HemCon Medical Technologies', 'https://www.crunchbase.com/organization/hemcon-medical-technologies', 'Biotechnology, Health Care, Medical', 'Portland, Oregon, United States', 'HemCon Medical Technologies, Inc. was built on a simple premise – to save lives', '226,045', '2007-03-20', '12000000', 'USD', '12000000', 'Venture - Series Unknown', '12000000', 'USD', '12000000', '51-100', 'Private', '', '', '', 'http://www.hemcon.com/', '', 'info@hemcon.com', 'HemCon Medical Technologies, Inc. was founded on one simple premise. Save lives. With an initial foundation in chitosan based hemostatic solutions, they have evolved into a global medical products company encompassing a variety of innovative technologies, platforms and products serving the military, civilian and consumer medical markets. As a whole, the company works together to offer new and improved solutions to save and improve lives. In 2001, with funding from the U.S. Army and access to research by Dr. Kenton Gregory, Dr. Bill Wiesmann, the Oregon Medical Laser Center and Providence Health System, HemCon Medical Technologies was established.', 'Camden Partners, Torch Hill Investment Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2001-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', '', '', '1'],\n  ['Reliant Technologies', 'https://www.crunchbase.com/organization/reliant-technologies', 'Biotechnology, Health Care, Laser, Medical', 'Mountain View, California, United States', 'Reliant Technologies, LLC develops aesthetic clinical solutions to rejuvenate aging and environmentally damaged skin.', '228,099', '2007-04-19', '15000000', 'USD', '15000000', 'Series E', '58500000', 'USD', '58500000', '51-100', 'Private', '', '', '', 'http://www.reliant-tech.com', '', '', 'The Reliant team has created a breakthrough in laser delivery by focusing on Fraxelâ„¢ Laser Treatment. In the hands of clinicians worldwide, Reliant\\'s proprietary technology platform is poised to change the treatment paradigm to a new standard of care. In 2001, a group of prominent laser scientists, leading clinicians, and business executives came together with a shared vision. They would create a new science and breakthrough products to fulfill the promise of laser medicine. No more big dumb \"boxes.\" No more hype. They vowed to bring a new intelligence to solve the problems of aging and sun damaged skin.', 'Meritech Capital Partners, Delphi Ventures, Three Arch Partners', 'Biotechnology, Hardware, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '2001-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '6', '', 'Was Acquired', 'Len DeBenedictis, Maynard A. Howe', '', '5'],\n  ['Asante Solutions', 'https://www.crunchbase.com/organization/asante-solutions', 'Biotechnology, Diabetes, Health Care, Medical Device', 'Sunnyvale, California, United States', 'Asante Solutions operates as a medical device company that focuses on the management of diabetes in the United States.', '228,493', '2015-02-02', '', '', '', 'Venture - Series Unknown', '', '', '', '51-100', 'Private', '', '', '', 'http://www.asantesolutions.com', 'https://www.linkedin.com/company-beta/959919/?pathWildcard=959919', '', 'Asante Solutions was founded more than a decade ago in Denmark. While there, they developed close relationships with a select group of European-based venture capitalists. Backed with venture seed money, they began early stage development of an insulin delivery device that would ultimately become their first product - the Pearl Insulin Pump.', 'Seed Capital, Lundbeckfonden Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '2006-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '11', '', 'Was Acquired', '', '', '2'],\n  ['Diazyme Laboratories', 'https://www.crunchbase.com/organization/diazyme-laboratories', 'Biotechnology, Health Care, Life Science, Medical', 'Poway, California, United States', 'Diazyme uses its enzyme and antibody platform technologies to develop innovative assays for clinical and research uses.', '229,276', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.diazyme.com/', '', 'support@diazyme.com', 'Diazyme Laboratories is a division of General Atomics headquartered in La Jolla, California. Diazyme uses its enzyme and antibody platform technologies to develop innovative assays for clinical and research uses with reduced costs and improved performance. Products include diagnostic blood tests for cardiovascular disease, diabetes, nutritional assessment, liver disease, renal disease and electrolytes.', '', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', '$10M to $50M', '2000-01-01', 'year', '', '', '', 'Active', 'For Profit', '2', '1', 'Made Acquisitions', '', '', ''],\n  ['Genelabs Technologies', 'https://www.crunchbase.com/organization/genelabs-technologies', 'Biopharma, Biotechnology, Health Care, Therapeutics', 'Redwood City, California, United States', 'Genelabs Technologies is a biopharmaceutical company engaged in the R&D of therapeutics for the treatment of infectious diseases.', '229,953', '2007-06-30', '9000000', 'USD', '9000000', 'Venture - Series Unknown', '17300000', 'USD', '17300000', '51-100', 'Private', '', '', '', 'http://www.genelabs.com', '', '', \"As of January 6, 2009, Genelabs Technologies Inc. was acquired by SmithKline Beecham Corporation. Genelabs Technologies, Inc., a biopharmaceutical company, engages in the discovery and development of infectious disease therapies to improve human health. The company's product pipeline consists of infectious disease projects focusing on Hepatitis C virus infection; and late-stage clinical assets, including an investigational vaccine for hepatitis E virus that is being developed by GlaxoSmithKline; and Prestara, an investigational drug for systemic lupus erythematosus. It has license and collaboration agreement with the Novartis Institutes for BioMedical Research for HCV polymerase non-nucleoside discovery research. Genelabs Technologies also has a collaborative research agreement with the National Health Research Institutes and Genovate Biotechnology Co., Ltd. to discover and develop compounds that target the hepatitis C virus. The company was founded in 1983 and is headquartered in Redwood City, California.\", 'RA Capital Management, Paramount BioCapital Asset Management, Merlin Biomed, Fort Mason Capital, Centrecourt Asset Management', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '', '1983-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '5', '', 'Was Acquired', 'Edgar G. Engleman', '', '2'],\n  ['Inspire Pharmaceuticals', 'https://www.crunchbase.com/organization/inspire-pharmaceuticals', 'Biotechnology, Health Care', 'Durham, North Carolina, United States', 'Inspire Pharmaceuticals, Inc. is a biopharmaceutical company focused on researching, developing and commercializing prescription.', '231,159', '', '', '', '', '', '', '', '', '51-100', 'Delisted', '', '', '', 'http://www.inspirepharm.com', '', 'info@inspirepharm.com', 'Inspire Pharmaceuticals, Inc. is a biopharmaceutical company focused on researching, developing and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. The advanced compounds in the clinical pipeline are denufosol tetrasodium for cystic fibrosis and Prolacria for dry eye, both of which are in Phase III development, and AzaSite for blepharitis, which is in Phase II development.', '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1995-01-01', 'year', '', 'M&A', '2000-08-03', 'Active', 'For Profit', '14', '', 'Was Acquired', 'Richard C. Boucher, Terrance McGuire', '', ''],\n  ['SmartVest', 'https://www.crunchbase.com/organization/smartvest', 'Biotechnology, Health Care, Manufacturing', 'New Prague, Minnesota, United States', 'Electromed, Inc., is dedicated to designing, manufacturing and marketing innovative airway clearance technologies .', '232,190', '', '', '', '', '', '', '', '', '51-100', 'Public', '', '', '', 'http://www.smartvest.com/', 'http://www.linkedin.com/company/electromed-inc.', 'info@electromed.com', 'Electromed, Inc., (branded as Smartvest) is dedicated to designing, manufacturing and marketing innovative airway clearance technologies that help people around the world breathe better, stay healthier, and lead active and fulfilling lives. They are the first to develop a truly portable system for high frequency chest wall oscillation (HFCWO), making it possible for patients and their families to travel and take HFCWO therapy along. Electromed also pioneered the first programmable and first multi-positional HFCWO generator. Known as the “Innovation Leader in Airway Clearance,” Electromed holds 23 U.S. patents, 12 foreign patents, and has more than 25 U.S. and foreign patent applications pending. These innovations mean their SmartVest® Airway Clearance System is uniquely designed for ergonomic comfort and lifestyle convenience to promote consistent therapy adherence, so patients are more likely to gain maximum therapeutic benefit.', '', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', '', '', '', '1992-01-01', 'year', '', 'IPO', '2010-08-13', 'Active', 'For Profit', '2', '', '', '', '', ''],\n  ['Accuri Cytometers', 'https://www.crunchbase.com/organization/accuri-cytometers', 'Biotechnology, Manufacturing, Medical Device', 'Ann Arbor, Michigan, United States', 'Accuri Cytometers is a medical device company developing cost effective cytometers for laboratories.', '232,244', '2010-10-19', '6000000', 'USD', '6000000', 'Series E', '32655000', 'USD', '32655000', '51-100', 'Private', '', '', '', 'http://www.accuricytometers.com', '', 'info@uni-chem.rs', 'Accuri Cytometers was founded to address a compelling need: life scientists love the rapid cell-by-cell analysis capability of flow cytometers, but too few have a flow cytometer in their lab. The barriers for most researchers include cost of the instrument, complexity of the software, effort required for maintenance, and the large amount of bench space required for the instrument. As a result, the company is looking to develop affordable and robust cytometers.', 'Flagship Pioneering, F-Prime Capital, Fidelity, Western Technology Investment, Eight Roads Ventures', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', 'Testing', '', '', '2004-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '7', '', 'Was Acquired', 'Collin Rich, Jennifer Baird', '', '8'],\n  ['Sirna Therapeutics', 'https://www.crunchbase.com/organization/sirna-therapeutics', 'Biotechnology, Information Technology, Medical', 'San Francisco, California, United States', 'Sirna Therapeutics is a biotechnology company exploring the use of RNA interference in human disease therapy.', '232,739', '2005-07-05', '28000000', 'USD', '28000000', 'Venture - Series Unknown', '76000000', 'USD', '76000000', '51-100', 'Delisted', '', '', '', 'http://www.sirna.com', '', '', 'The scientific community considers RNA interference the breakthrough biological discovery of the decade with the potential to change how diseases are treated. Sirna Therapeutics is at the forefront of the effort to create RNAi- based therapies and leverage the vast potential of this technology to ultimately treat patients.', 'GGV Capital, Venrock, Oxford Bioscience Partners, Granite Ventures, Techno Venture Management', 'Biotechnology, Health Care, Information Technology, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '', '1992-01-01', 'year', '', 'M&A', '2006-03-08', 'Closed', 'For Profit', '30', '', 'Was Acquired', '', '', '2'],\n  ['Nexus Dx', 'https://www.crunchbase.com/organization/nexus-dx', 'Biotechnology, Health Care', 'San Diego, California, United States', 'Nexus Dx is a global provider of Near Patient Testing systems and advanced diagnostic solutions.', '233,216', '2009-09-28', '9000000', 'USD', '9000000', 'Venture - Series Unknown', '9000000', 'USD', '9000000', '51-100', 'Private', '', '', '', 'http://nexus-dx.com', '', 'cservice@nexus-dx.com', 'Nexus Dx is a global provider of Near Patient Testing systems and advanced diagnostic solutions.  The company is improving patient care by providing the medical community with rapid and reliable information at the point of care (POC), delivering patient information when and where it is needed most.', '', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', '', '2009-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '3', '', 'Was Acquired', '', '', '1'],\n  ['Xanodyne', 'https://www.crunchbase.com/organization/xanodyne', 'Biotechnology, Health Care, Pharmaceutical', 'Newport, Kentucky, United States', 'Xanodyne Pharmaceuticals is an integrated specialty pharmaceutical company focused on women’s healthcare and pain management.', '234,215', '2009-10-30', '87783861', 'USD', '87783861', 'Venture - Series Unknown', '307883861', 'USD', '307883861', '51-100', 'Private', '', '', '', 'http://www.xanodyne.com', '', '', 'Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company that offers developing and commercializing products in women’s healthcare and pain management in the United States.The company was formerly known as Xanodyne Pharmacal, Inc. and changed the name to Xanodyne Pharmaceuticals, Inc. in February, 2004. Xanodyne Pharmaceuticals, Inc. was incorporated in 2000 and is based in Newport, Kentucky.', 'MPM Capital, Apax Partners, Longitude Capital, HealthCare Ventures, Essex Woodlands Healthcare Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2000-01-01', 'year', '', '', '', 'Active', 'For Profit', '3', '1', 'Made Acquisitions', 'Roger Griggs', '', '5'],\n  ['Provid Pharmaceuticals', 'https://www.crunchbase.com/organization/provid-pharmaceuticals', 'Pharmaceutical', 'Monmouth Junction, New Jersey, United States', 'Provid Pharmaceuticals is a drug discovery company.', '236,064', '2006-11-20', '', '', '', 'Venture - Series Unknown', '', '', '', '51-100', 'Private', '', '', '', 'http://www.provid.com', '', '', 'Provid was co-founded in 2001 by Drs. Gary Olson, Christopher Self, and Charles Cook, together with Profs. Amos B. Smith, III and Ralph Hirschmann of the University of Pennsylvania. The team has exceptional talent in synthetic and medicinal chemistry and includes world leaders in peptide and peptide mimetics technology and in structure-based drug design. Their experience makes Provid the premier drug discovery company for early stage research and translational drug development.', 'New Jersey Economic Development Authority', 'Health Care', '', '', '$1M to $10M', '2001-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', '', '', '1'],\n  ['BTG Specialty Pharmaceuticals', 'https://www.crunchbase.com/organization/btg-specialty-pharmaceuticals', 'Biotechnology, Pharmaceutical', 'Conshohocken, Pennsylvania, United States', 'BTG Specialty Pharmaceuticals develops, manufactures and commercializes life-saving antidotes used in hospitals and emergency care settings.', '237,656', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://btgsp.com/en-us/', 'https://www.linkedin.com/showcase/boston-scientific-peripheral-interventions', '', 'The BTG Specialty Pharmaceuticals business develops, manufactures and commercializes life-saving antidotes used in hospitals and emergency care settings, including the clinically proven and leading products CroFab®, DigiFab®, and Voraxaze®.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '$100M to $500M', '', '', '', 'M&A', '', 'Active', '', '1', '', 'Was Acquired', '', '', ''],\n  ['Peloton Advantage', 'https://www.crunchbase.com/organization/peloton-advantage', 'Biotechnology, Life Science', 'Parsippany, New Jersey, United States', 'Peloton Advantage is a privately owned medical communications company.', '240,967', '2018-02-22', '', '', '', 'Private Equity', '', '', '', '51-100', 'Private', '', '', '', 'https://www.pelotonadvantage.com/', '', 'info@pelotonadvantage.com', 'Peloton Advantage, LLC is a privately owned medical communications company specializing in strategic publication planning and associated content development for medical education programs.  While establishing their industry leadership position over the last twelve years, we have received several awards for our successful growth from Inc., New Jersey Business, NJBIZ, and SmartCEO magazines and now employ more than 80 of the top professionals in medical communications. Their teams support US and global accounts for large and small pharmaceutical, biotechnology, and medical device companies, contributing to the success of more than 90 products spanning all major therapeutic areas. ', 'Amulet Capital Partners', 'Biotechnology, Science and Engineering', '', '', '$10M to $50M', '2005-01-01', 'year', '', 'Private Equity', '', 'Active', 'For Profit', '2', '', '', 'Carolyn Clark, Michael McLaughlin', '', '1'],\n  ['NeoGenesis Pharmaceuticals', 'https://www.crunchbase.com/organization/neogenesis-pharmaceuticals', 'Biotechnology, Health Care, Medical, Pharmaceutical', 'Cambridge, Massachusetts, United States', 'A drug discovery company which uses it proprietary affinity-based screening technologies and integrated chemical library', '242,033', '2001-01-08', '23000000', 'USD', '23000000', 'Venture - Series Unknown', '23000000', 'USD', '23000000', '51-100', 'Private', '', '', '', 'https://www.neogenesis.com/', '', '', \"NeoGenesis Pharmaceuticals, Inc. is a drug discovery company which uses it  proprietary affinity-based screening technologies and integrated chemical  library and chemistry approaches to discover and develop a portfolio of small  molecule drugs, both for itself and for its collaboration partners.  The  company's widely applicable and unbiased affinity-based technologies, coupled  with its proprietary library of diverse drug-like compounds, provide  efficiency in lead discovery and optimization,  NeoGenesis' core technology,  the Automated Ligand Identification System (ALIS), is a rapid, affinity-based  system for identifying and optimizing novel drug leads that in many cases may  not have been identified with traditional screening approaches.  Coupled with  the company's NeoMorph compound library, ALIS enables the identification and  optimization of novel and selective drug leads against validated and emerging  new targets.  The company was founded in 1997 and is headquartered in  Cambridge, Massachusetts.\", 'OrbiMed', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '', '1997-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', '', '', '1'],\n  ['Novitium Pharma', 'https://www.crunchbase.com/organization/novitium-pharma', 'Manufacturing, Medical, Pharmaceutical', 'Windsor, New Jersey, United States', 'Novitium Pharma is a pharmaceutical company that specializes in development, manufacturing, and distribution of niche generic products.', '242,120', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://www.novitiumpharma.com/', 'https://www.linkedin.com/company/novitium-pharma-llc/', 'info@novitiumpharma.com', 'Novitium Pharma is a pharmaceutical company that specializes in development, manufacturing, and distribution of niche generic products. It developed a growing commercial product portfolio spanning a diverse range of dosage forms and therapeutic categories. Novitium continues to invest in producing affordable, high-quality medication to fulfill the needs of pharmacists, patients, and communities.', '', 'Health Care, Manufacturing', '', '', '', '2016-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '2', '', 'Was Acquired', '', '', ''],\n  ['Diversa Corporation', 'https://www.crunchbase.com/organization/diversa-corporation', 'Biotechnology, Industrial', 'San Diego, California, United States', 'Diversa Corporation is an industrial biotechnology company that develops high performance enzymes.', '242,135', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://diversa.com/', '', '', 'Diversa Corporation is an industrial biotechnology company that develops high performance enzymes. It extracts microbial DNA directly from collected samples to avoid the often impossible task of growing microbes in the laboratory. It mines its collection of microbial genes, numbering in the billions, using high-throughput screening technologies designed to identify unique enzymes as product candidates. Diversa Corporation develops enzymes that are environmentally friendly and more cost-effective for industries such as the global food and fuel markets. It has developed enzymes \\xa0to meet the specific needs of companies in various markets, including grain processing, bio fuels, animal health and nutrition and other industries.', '', 'Biotechnology, Manufacturing, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '', '', '', '', '', '', 'Active', 'For Profit', '1', '', '', '', '', ''],\n  ['Crealta Pharmaceuticals', 'https://www.crunchbase.com/organization/crealta-pharmaceuticals', 'Biotechnology, Health Care, Pharmaceutical', 'Greendale, Wisconsin, United States', 'Crealta was founded in August 2013, in partnership with GTCR, a leading private equity firm.', '242,677', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://crealtapharma.com', '', 'media@horizonpharma.com', 'Crealta was founded in August 2013, in partnership with GTCR, a leading private equity firm. Crealta is actively pursuing the acquisition of specialty pharmaceutical products with a focus on select therapeutic areas.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2013-08-01', 'day', '', 'M&A', '', 'Active', 'For Profit', '4', '1', 'Made Acquisitions, Was Acquired', '', '', ''],\n  ['Transform Pharmaceuticals', 'https://www.crunchbase.com/organization/transform-pharmaceuticals', 'Biotechnology, Health Care', 'Lexington, Massachusetts, United States', 'Transform Pharmaceuticals was a company specializing in the discovery of improved formulations and crystalline forms of drug molecules.\\xa0', '243,874', '2002-01-01', '', '', '', 'Venture - Series Unknown', '', '', '', '51-100', 'Private', '', '', '', 'http://www.transformpharma.com/', '', '', 'Transform Pharmaceuticals was a pharmaceuticals company specializing in the discovery of improved formulations and novel crystalline forms of drug molecules.  Transform’s product portfolio included Topiramate, an anti-epileptic drug. The company was acquired by Johnson & Johnson in 2005.  The company was founded in 1998.', 'Polaris Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '1998-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '2', '', 'Was Acquired', '', '', '1'],\n  ['Analiza', 'https://www.crunchbase.com/organization/analiza', 'Biotechnology, Health Diagnostics', 'Cleveland, Ohio, United States', 'Analiza is a privately held corporation dedicated to discovering, developing, and commercializing new technologies for the life sciences.', '244,844', '2008-09-04', '300000', 'USD', '300000', 'Seed', '600000', 'USD', '600000', '51-100', 'Private', '', '', '', 'http://www.analiza.com/', '', '', 'ANALIZA, Inc. is a privately held corporation dedicated to discovering, developing, and commercializing new technologies for the life sciences. ANALIZA provides integrated solutions to key applications in the pharmaceutical, biotechnology and diagnostics industries.', 'JumpStart', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', 'Less than $1M', '2000-01-01', 'year', '', 'Seed', '', 'Active', 'For Profit', '', '', '', '', '', '2'],\n  ['Photocure', 'https://www.crunchbase.com/organization/photocure', 'Pharmaceutical', 'Princeton, New Jersey, United States', 'Photocure, the world leader in photodynamic technology, is a Norwegian based specialty pharmaceutical company.', '244,984', '', '', '', '', '', '', '', '', '51-100', 'Public', '', '', '', 'https://www.photocure.com', '', 'info@photocure.no', 'Photocure is a Norwegian based specialty pharmaceutical company.', '', 'Health Care', '', '', '', '1997-01-01', 'year', '', 'IPO', '2000-05-01', 'Active', 'For Profit', '24', '', '', '', '', ''],\n  ['Adolor', 'https://www.crunchbase.com/organization/adolor', 'Biopharma, Biotechnology, Health Care, Pharmaceutical', 'Exton, Pennsylvania, United States', 'Adolor focuses on the discovery, development and commercialization of prescription pain and pain-management products.', '245,152', '', '', '', '', '', '', '', '', '51-100', 'Delisted', '', '', '', 'http://www.adolor.com', '', '', 'Adolor Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of prescription pain and pain-management products. ENTEREG (alvimopan) is the United States Food and Drug Administration (FDA) approved product. ENTEREG is indicated to accelerate upper and lower gastrointestinal (GI) recovery following partial large or small bowel resection surgery with primary anastomosis. The Company is conducting two Phase 2 clinical trials of ADL5945 to treat opioid-induced constipation (OIC), a condition that often results from long-term use of opioid analgesics in the management of chronic pain conditions. In addition, it is continuing development efforts on ADL7445, a second peripherally-acting mu opioid receptor antagonist, which is considered a back-up compound in its OIC program. The Company has completed Phase 1 clinical evaluation of ADL6906 (beloxepin).', '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1993-01-01', 'year', '', 'M&A', '2000-11-14', 'Active', 'For Profit', '4', '', 'Was Acquired', '', '', ''],\n  ['Proxsys', 'https://www.crunchbase.com/organization/proxsys', 'Biotechnology, CRM, Health Care, Information Technology', 'Birmingham, Alabama, United States', 'Proxsys, LLC provides Web-based solutions in preadmissions to healthcare facilities. It focuses on the collection of patient information,', '245,367', '2007-03-12', '', '', '', 'Venture - Series Unknown', '', '', '', '51-100', 'Private', '', '', '', 'http://www.proxsyscorp.com', 'https://www.linkedin.com/company/proxsys/', 'helpdesk@proxsyscorp.com', 'Proxsys, LLC provides Web-based solutions in preadmissions to healthcare facilities. It focuses on the collection of patient information, scheduling of procedures, admitting of both inpatients and outpatients, and transmitting patient data to appropriate areas within healthcare organizations, as well as points in the process that involve communications with physician offices, insurance payors for purpose of precertification and approval requirements, hospitals, outpatient facilities, and patients. The company also provides security and electronic storage capabilities to safely protect and warehouse patient data. Proxsys, LLC was founded in 2004 and is headquartered in Birmingham, Alabama.', 'FCA Venture Partners, Clayton Associates', 'Biotechnology, Health Care, Information Technology, Sales and Marketing, Science and Engineering, Software', '', '', '', '2004-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '2', '', 'Was Acquired', 'George Salem', '', '1'],\n  ['Nuon Therapeutics', 'https://www.crunchbase.com/organization/nuon-therapeutics', 'Biotechnology, Health Care, Medical', 'San Mateo, California, United States', 'Nuon Therapeutics develops therapies for inflammation and neurological diseases, including RA, multiple sclerosis, and neuropathic pain.', '246,246', '2010-08-12', '10000000', 'USD', '10000000', 'Venture - Series Unknown', '48050000', 'USD', '48050000', '51-100', 'Private', '', '', '', 'http://www.nuontherapeutics.com', '', 'rpearlman@nuontherapeutics.com', 'Nuon Therapeutics is focused on the development and commercialization of new therapies in inflammation and neurological diseases, including rheumatoid arthritis (RA), multiple sclerosis (MS) and neuropathic pain.', 'Domain Associates, Frazier Healthcare Partners, GBS Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '2002-01-01', 'year', '', '', '', 'Closed', 'For Profit', '2', '', '', 'Lawrence Steinman', '', '4'],\n  ['Molecular Insight Pharmaceuticals', 'https://www.crunchbase.com/organization/molecular-insight-pharmaceuticals-inc', 'Biotechnology, Health Care', 'Cambridge, Massachusetts, United States', 'Molecular Insight Pharmaceuticals is a biopharmaceutical company specializing in the emerging field of molecular medicine.', '246,907', '', '', '', '', '', '', '', '', '51-100', 'Delisted', '', '', '', 'http://molecularinsight.com/', '', '', 'Molecular Insight Pharmaceuticals is a biopharmaceutical company specializing in the emerging field of molecular medicine, applying innovations in the identification and targeting of disease at the molecular level to improve patient healthcare by addressing significant unmet medical needs. They are focused on discovering, developing and commercializing innovative and targeted radiotherapeutics and molecular imaging pharmaceuticals with initial applications in the areas of oncology and cardiology.', '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1997-01-01', 'year', '', 'M&A', '2007-02-02', 'Active', 'For Profit', '1', '', 'Was Acquired', '', '', ''],\n  ['Gyros', 'https://www.crunchbase.com/organization/gyros', 'Biotechnology, Health Care, Therapeutics', 'Monmouth Junction, New Jersey, United States', 'Gyros is specialized in the production of automated micro-immunoassays for therapeutic protein development.', '247,922', '2009-07-06', '10400000', 'USD', '10400000', 'Series C', '39900000', 'USD', '39900000', '51-100', 'Private', '', '', '', 'http://www.gyros.com', 'https://www.linkedin.com/company/gyros-ab', 'information@gyros.com', \"Gyros is the world leader in automated micro-immunoassays for therapeutic protein development. Gyrolab, the company's automated and open platform, is a versatile analytical tool that dramatically reduces the time required to optimize and execute immunoassays. Time for assay optimization is often cut from weeks, to a matter of days. This results in increased efficiency in process development and in clinical evaluation of therapeutic proteins. The ease of assay transfer is unsurpassed in the industry.\", '3i Group, Industrifonden, HealthCap, Investor AB, Innovations Kapital', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '2000-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '1', '', '', 'Maris Hartmanis', '', '3'],\n  ['QOL Medical', 'https://www.crunchbase.com/organization/qol-medical', 'Pharmaceutical', 'Vero Beach, Florida, United States', 'QOL Medical is a specialty biopharmaceutical company', '250,421', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://www.qolmed.com/', 'https://www.linkedin.com/company/qol-medical-llc/?originalSubdomain=in', '', 'OL Medical is a specialty biopharmaceutical company dedicated to improving the quality of life for patients with rare diseases, for their families, and for the physicians and caregivers who support them. QOL Medical is a patient-centric company founded in 2003 to focus on the acquisition and commercialization of orphan products in underserved markets. QOL Medical ensures an expanded clinical awareness and patient access for improved quality of life in the treatment of rare and orphan diseases. The Company currently markets two FDA-approved products: Sucraid® (sacrosidase) Oral Solution and Ethamolin® (Ethanolamine Oleate) Injection, 5%. QOL Medical, in its commitment to assuring safe and effective products for our customers, uses validated procedures through audited and approved vendors for manufacturing, testing, and distribution. Additionally, QOL Medical has procedures for product monitoring, customer complaints, investigations into nonconformities, and change control.', '', 'Health Care', 'Medical Or Veterinary Science; Hygiene', '', '', '2003-01-01', 'year', '', '', '', 'Active', 'For Profit', '1', '', '', '', '', ''],\n  ['enzymatics', 'https://www.crunchbase.com/organization/enzymatics', 'Biotechnology, Manufacturing', 'Beverly, Massachusetts, United States', 'Enzymatics is an independent, ISO 13485:2003 certified OEM manufacturer of enzymes that brings to the marketplace a unique, quality', '251,167', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://enzymatics.com', 'http://www.linkedin.com/company/enzymatics', 'sales@enzymatics.com', \"Enzymatics is an independent, ISO 13485:2003 certified OEM manufacturer of enzymes that brings to the marketplace a unique, quality oriented, and customer focused approach to protein production. The company was founded in 2006 to specifically address the needs of commercial entities engaged in the development, manufacture, and distribution of platforms dedicated to nucleic acid identification. Enzymes are critical to the performance of these applications and the industry's relentless pursuit of higher performance emphasizes the need for analytical reagent purity and absolute production consistency. Operating from the perspective that we are a manufacturing division of our customer, Enzymatics consistently delivers the highest quality and value enzymes, leveraging them to drive customer success via a partnership business model; and our tremendous success confirms the need in the marketplace for a dedicated partner in the realm of enzyme technologies\", '', 'Biotechnology, Manufacturing, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$1M to $10M', '2006-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['Immunicon', 'https://www.crunchbase.com/organization/immunicon-now-veridex-a-johnson-johnson-co', 'Biotechnology, Health Care, Health Diagnostics, Medical', 'Huntingdon Valley, Pennsylvania, United States', 'Cell-based research and diagnostic products.', '254,904', '2003-07-10', '24750000', 'USD', '24750000', 'Series F', '53750000', 'USD', '53750000', '51-100', 'Delisted', '175200000', 'USD', '175200000', 'http://www.immunicon.com/', '', '', 'They are developing and commercializing proprietary cell-based research and diagnostic products with an initial focus on cancer. They believe that their current and future products can provide significant clinical benefits by giving physicians better information to understand, diagnose, treat and monitor cancer. They design their products to provide physicians and scientists with clinically meaningful information earlier than current diagnostic methods. Their technologies, which they brand as CellTracks, can identify, count and characterize the presence and quantity of a small number of tumor cells present in a blood sample. Their collaborator, Veridex, LLC, or Veridex, a Johnson & Johnson company, submitted a pre-market notification, or 510(k), to the US Food and Drug Administration, or FDA, in May 2003 for use of the CellSearch Epithelial Cell Kit in the management of metastatic breast cancer. They expect that the CellSearch Epithelial Cell Kit will be the initial product launched by Veridex based on their technologies. They believe that their products and underlying technology platforms have other applications in cancer diagnostics, in the development of cancer drugs and in cancer research. In addition, they believe that their proprietary technologies may have applications in other fields of medicine, such as cardiovascular and infectious diseases.', 'Canaan Partners, TL Ventures, Johnson & Johnson Development Corporation, Wheatley Partners, Burrill & Company', 'Biotechnology, Health Care, Science and Engineering', 'Basic Electric Elements', '', '', '1983-01-01', 'year', '', 'M&A', '2004-04-16', 'Active', 'For Profit', '', '', 'Was Acquired', 'Edward L. Erickson', '', '2'],\n  ['Juvaris BioTherapeutics', 'https://www.crunchbase.com/organization/juvaris-biotherapeutics', 'Biotechnology, Health Care, Therapeutics', 'Burlingame, California, United States', 'Juvaris BioTherapeutics develops adjuvanted vaccines and immunotherapeutics to treat cancer and infectious diseases.', '255,921', '2010-10-26', '750000', 'USD', '750000', 'Debt Financing', '63130000', 'USD', '63130000', '51-100', 'Private', '', '', '', 'http://www.juvaris.com', '', 'info@juvaris.com', \"Juvaris BioTherapeutics, Inc. is developing adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer.  The Company's platform technology induces profound immunostimulation via cationic lipid-DNA (non-coding) complexes (CLDC). The Company's lead product candidate, JVRS-100, stimulates adaptive and innate immune responses at levels many fold higher than other drugs in its class. JVRS-100 is in clinical development as a vaccine adjuvant and an immunotherapeutic.\", 'SV Health Investors, Kleiner Perkins', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2001-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '3', '', '', 'Jeff Fairman, Martin D. Cleary, Steven Dow', '', '5'],\n  ['Cyanotech', 'https://www.crunchbase.com/organization/cyanotech', 'Biotechnology, Health Care, Nanotechnology, Nutrition', 'Kailua Kona, Hawaii, United States', 'To develop and commercialize natural products from microalgae.', '258,622', '', '', '', '', '', '', '', '', '51-100', 'Public', '', '', '', 'http://www.cyanotech.com/', 'https://www.linkedin.com/company/cyanotech-corporation', 'info@cyanotech.com', \"Cyanotech Corporation, a world leader in microalgae technology, produces BioAstin® Natural Astaxanthin and Hawaiian Spirulina Pacifica® all natural, functional nutrients that leverage our experience and reputation for quality, building nutritional brands which promote health and well-being. Cyanotech's spirulina, FDA reviewed and accepted as Generally Recognized as Safe (GRAS) for use as a food ingredient, augments energy and immune response. BioAstin's benefits derive from its superior antioxidant activity and from its ability to fight free radical damage and combat ongoing oxidative stress, enhancing skin, muscle and joint health.\", '', 'Biotechnology, Food and Beverage, Health Care, Science and Engineering', '', '', '', '1983-01-01', 'year', '', 'IPO', '1991-05-31', 'Active', 'For Profit', '5', '', '', 'Gerald Cysewski', '', ''],\n  ['Perlegen Sciences', 'https://www.crunchbase.com/organization/perlegen-sciences', 'Biotechnology, Genetics, Health Care, Pharmaceutical', 'Mountain View, California, United States', 'Perlegen Sciences\\xa0develops genetic variations\\xa0providing physicians with information to improve the clinical process and treatment outcomes.', '261,346', '2006-01-06', '50000000', 'USD', '50000000', 'Series D', '154000000', 'USD', '154000000', '51-100', 'Private', '', '', '', '', '', '', 'Perlegen Sciences engages in the discovery and commercialization of genetic variations that provide physicians with information to improve the clinical decision-making process and patient treatment outcomes. Its products include MammaPLUS, a breast cancer risk stratifier and a panel of common genetic variants that stratifies individual genetic and background/clinical risk for those at moderately elevated risk for non-familial breast cancer, as well as impacts the risk for developing invasive breast cancer; and Genotype Browser Website that provides a way to access and view the results of a study of genetic variation in various diverse human populations. Perlegen Sciences, Inc. was founded in 2000 and is based in Mountain View, California.', 'Maverick Ventures, Eli Lilly, Glynn Capital Management, Unilever Ventures, Mizuho Securities', 'Biotechnology, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '', '2000-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '1', '', '', '', '', '3'],\n  ['Barrier Therapeutics', 'https://www.crunchbase.com/organization/barrier-therapeutics-inc', 'Biopharma, Health Care, Medical, Therapeutics', 'Princeton, New Jersey, United States', 'Barrier Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization.', '265,776', '', '', '', '', '', '', '', '', '51-100', 'Delisted', '', '', '', 'http://www.barriertherapeutics.com/', '', '', 'Barrier Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of a portfolio of innovative pharmaceutical products to address major medical needs in the field of dermatology. They currently have multiple product candidates based on intellectual property that they have licensed from third parties in clinical development, with four of these candidates in or entering Phase III clinical trials.', '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '2002-01-01', 'year', '', 'M&A', '2004-04-29', 'Active', 'For Profit', '1', '', 'Was Acquired', 'James Mervis', '', ''],\n  ['BioTrove', 'https://www.crunchbase.com/organization/biotrove', 'Biotechnology, Genetics, Health Care, Life Science', 'Woburn, Massachusetts, United States', 'Gene Analysis', '266,160', '2009-04-22', '', '', '', 'Series C', '41513329', 'USD', '41513329', '51-100', 'Private', '', '', '', 'http://www.biotrove.com', '', '', 'BioTrove, Inc. provides micro and nano-scale technology platforms for life science and drug discovery research applications. The company offers OpenArray, a technology platform for relative gene expression analysis that advances genomic research in various life science fields, including agriculture, disease research, and public health; RapidFire, a technology platform that enables the screening of intractable drug targets via mass spectrometry based assay development; and RapidFire mass spectrometry hardware system, a native detection technology for drug screening and in vitro ADME applications.', 'Excel Venture Management, CB Health Ventures, Technology Partners, Catalyst Health Ventures, Fletcher Spaght, Inc.', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', 'Less than $1M', '1997-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '7', '', 'Was Acquired', 'Colin Brenan, Tanya Kanigan', '', '7'],\n  ['OI Analytical', 'https://www.crunchbase.com/organization/o-i-corporation', 'Biotechnology, Electronics, Manufacturing', 'College Station, Texas, United States', 'OI Analytical is a Xylem brand with expertise in designing & manufacturing analytical instrumentation for diverse applications & industries.', '268,069', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://www.oico.com/', 'https://www.linkedin.com/company/o-i-analytical', 'oi-info@xyleminc.com', 'O.I. Corporation provides innovative products for chemical analysis and monitoring. Their products perform detection, analysis, measurement, and monitoring applications in a wide variety of industries, including environmental testing, food and flavors, pharmaceutical, semiconductor, power generation, chemical, petrochemical, and security. Management continually emphasizes product innovation, quality improvement, performance enhancement, and on-time delivery while striving for product cost improvements to promote added value for their products.', '', 'Biotechnology, Consumer Electronics, Hardware, Manufacturing, Science and Engineering', 'Testing', '', '', '1963-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '2', '', 'Was Acquired', '', '', ''],\n  ['PharmaDerm', 'https://www.crunchbase.com/organization/pharmaderm', 'Biotechnology', 'Florham Park, New Jersey, United States', 'PharmaDerm LLC engages in licensing, developing and commercializing of pharmaceutical and biotechnologies of ICBS Ltd., McCoy Enterprises', '269,300', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.pharmaderm.com', '', '', 'PharmaDerm LLC engages in licensing, developing and commercializing of pharmaceutical and biotechnologies of ICBS Ltd., McCoy Enterprises LLC and Connell Associates LLC. The company focuses on the commercialization of new treatments for skin disorders, chronic wounds, severe burns and dermatology. PharmaDerm LLC was founded in 2008 and is based in United States.', '', 'Biotechnology, Science and Engineering', '', '', '$100M to $500M', '2008-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '1', 'Made Acquisitions', '', '', ''],\n  ['Amniox Medical', 'https://www.crunchbase.com/organization/amniox-medical-inc', 'Biotechnology, Health Care, Therapeutics', 'Atlanta, Georgia, United States', 'Amniox Medical is a provider of matrix which is made up of preserved human amniotic membrane and umbilical cord.', '269,574', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.amnioxmedical.com', 'https://www.linkedin.com/company/amniox-medical/', 'info@amnioxmedical.com', \"Amniox Medical is a provider of matrix which is made up of preserved human amniotic membrane and umbilical cord. AMNIOX Medical is supported by more than 25 years of research in characterizing and preserving the biology and functionality of human Amniotic Membrane (AM) and Umbilical Cord (UC). AM and UC are restorative tissues that carry unique regenerative properties in the fetal environment and AMNIOX Medical is the sole provider of a matrix comprised of both human AM and UC. The company's extensive research allows us to preserve and deliver the most functional allograft.\", '', 'Biotechnology, Health Care, Science and Engineering', '', '', 'Less than $1M', '2011-01-01', 'year', '', '', '', 'Active', 'For Profit', '2', '', '', '', '', ''],\n  ['SenoRx', 'https://www.crunchbase.com/organization/senorx-inc', 'Biotechnology, Health Care, Manufacturing', 'Irvine, California, United States', 'Medical device manufacturer for breast cancer.', '270,999', '2001-05-07', '19000000', 'USD', '19000000', 'Venture - Series Unknown', '19000000', 'USD', '19000000', '51-100', 'Delisted', '', '', '', 'http://www.bardbiopsy.com/', 'http://www.linkedin.com/company/senorx', 'medical.services@crbard.com', 'SenoRx, Inc. was formerly known as BiopSolation Medical, Inc. and changed its name to SenoRx, Inc. in April 1998. The company was incorporated in 1998 and is headquartered in Irvine, California. As of July 6, 2010, SenoRx, Inc. operates as a subsidiary of Bard Peripheral Vascular, Inc. They develop, manufacture and sell minimally-invasive medical devices for the diagnosis of breast cancer. Their initial product focus has been biopsy systems and breast tissue markers. They also are developing products for use in the treatment of breast cancer.', 'MPM Capital, Mayfield Fund, Domain Associates, CIT VentureCapital', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1998-01-01', 'year', '', 'M&A', '2007-03-29', 'Active', 'For Profit', '', '', 'Was Acquired', 'Paul Lubock', '', '1'],\n  ['Replenish', 'https://www.crunchbase.com/organization/replenish', 'Biotechnology, Developer Platform, Health Care', 'Pasadena, California, United States', 'Replenish, Inc. intends to develop a flexible drug delivery platform. It offers drug delivery devices to treat ophthalmic diseases. The', '271,681', '2009-07-15', '10249632', 'USD', '10249632', 'Venture - Series Unknown', '10249632', 'USD', '10249632', '51-100', 'Private', '', '', '', 'http://www.replenishinc.com', 'https://www.linkedin.com/company/replenish/', '', 'Replenish, Inc. intends to develop a flexible drug delivery platform. It offers drug delivery devices to treat ophthalmic diseases. The company was incorporated in 2007 and is based in Pasadena, California.', '', 'Biotechnology, Health Care, Science and Engineering, Software', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2007-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', 'Mark Humayun, Sean Caffey, Yu-Chong Tai', '', '1'],\n  ['Dormir', 'https://www.crunchbase.com/organization/dormir', 'Biotechnology, Health Care, Health Diagnostics', 'Carmel, Indiana, United States', 'Dormir is a biotechnology company that provides patient care for sleep disorders.', '272,569', '2011-05-17', '2000000', 'USD', '2000000', 'Venture - Series Unknown', '11500000', 'USD', '11500000', '51-100', 'Private', '', '', '', '', '', '', 'Dormir LLC, through its subsidiaries, provides patient care for sleep disorders. The company develops and manages facility based sleep diagnostic centers and provides respiratory equipment. The company was founded in 2005 and is based in Carmel, Indiana.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2005-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '1', 'Made Acquisitions', '', '', '3'],\n  ['DUSA Pharmaceuticals', 'https://www.crunchbase.com/organization/dusa-pharmaceuticals', 'Biotechnology', 'Wilmington, Massachusetts, United States', 'DUSA Pharmaceuticals, Inc.® (NASDAQGM: DUSA) is a fully integrated specialty pharmaceutical company focused primarily on the development', '273,963', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.dusapharma.com', '', 'customerservice@dusapharma.com', 'DUSA Pharmaceuticals, Inc.® (NASDAQGM: DUSA) is a fully integrated specialty pharmaceutical company focused primarily on the development and marketing of its Levulan® photodynamic therapy (PDT) technology platform used in conjunction with it’s proprietary light source, the BLU-U® Blue Light Photodynamic Therapy Illuminator. Levulan Kerastick® (aminolevulinic acid HCl) for Topical Solution, 20% in combination with the BLU-U is approved by the U.S. Food and Drug Administration for the treatment of minimally to moderately thick actinic keratoses (AKs) of the face or scalp. Actinic Keratosis is the most frequently diagnosed skin disease by U.S. dermatologists. PDT is a two part process in which the target cells are made extremely sensitive to light and then exposed to blue light, which destroys the cells. The BLU-U, as a stand alone device, uses light to treat mild to moderate inflammatory acne. DUSA is based in Wilmington, MA.', '', 'Biotechnology, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '1991-01-01', 'year', '', 'M&A', '', 'Closed', 'For Profit', '10', '', 'Was Acquired', 'Rick Lufkin', '', ''],\n  ['Forhealth Technologies', 'https://www.crunchbase.com/organization/forhealth-technologies', 'Biotechnology, Health Care, Information Technology, Medical', 'Daytona Beach, Florida, United States', 'Forhealth Technologies provides automation technology for intravenous drug preparation.', '276,661', '2008-01-01', '', '', '', 'Venture - Series Unknown', '9000000', 'USD', '9000000', '51-100', 'Private', '', '', '', 'http://www.fhtinc.com/', '', '', 'Forhealth Technologies is focused on the development of automation technology solutions for the process of intravenous drug preparation. Forhealth Technologies was acquired by Baxa Corporation in March 2009. Forhealth Technologies was founded in 1998 and is based in Daytona Beach, Florida.', 'New Enterprise Associates, Excel Venture Management, Greenspring Associates, National Healthcare Services, Red River Ventures', 'Biotechnology, Health Care, Information Technology, Science and Engineering', 'Conveying; Packing; Storing; Handling Thin Or Filamentary Material', '', '', '1998-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', '', '', '2'],\n  ['Kalorama Information', 'https://www.crunchbase.com/organization/kalorama-information', 'Biotechnology, Events, Medical', 'Rockville, Maryland, United States', 'A leading publisher of market research in medical markets, including the biotechnology, diagnostics, healthcare, medical device industries.', '277,656', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.kaloramainformation.com/', 'https://www.linkedin.com/company/kalorama-information', 'customerservice@kaloramainformation.com', 'Kalorama Information has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, healthcare, medical device, and pharmaceutical industries. Their comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers. Kalorama began as a syndicated publishing arm of Find/SVP and its focus was on medical markets in the U.S. The brand was acquired by MarketResearch.com in 1998, and following a restructuring of its editorial focus and analytical team, Kalorama went global in its coverage. Kalorama continues to be the leading global publisher of market studies on healthcare industries.', '', 'Biotechnology, Events, Health Care, Media and Entertainment, Science and Engineering', '', '', '', '1998-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '47', '', 'Was Acquired', '', '', ''],\n  ['Tarrytown Expocare Pharmacy', 'https://www.crunchbase.com/organization/tarrytown-expocare-pharmacy', 'Health Care, Pharmaceutical', 'Austin, Texas, United States', 'Tarrytown Expocare Pharmacy is a long-term care pharmacy specializing in serving individuals with intellectual & developmental disabilities.', '278,021', '2020-01-07', '', '', '', 'Private Equity', '', '', '', '51-100', 'Private', '', '', '', 'https://tarrytownexpocare.com/', 'https://www.linkedin.com/company/tarrytown-expocare-llc', 'medication@tarrytownexpocare.com', 'Tarrytown Expocare Pharmacy is a long-term care pharmacy licensed in more than 40 states across the country. They specialize in serving individuals with intellectual and developmental disabilities.', 'Sheridan Capital Partners', 'Health Care', '', '', '', '2007-01-01', 'year', '', 'Private Equity', '', 'Active', 'For Profit', '', '', '', 'Mark Newberry', '', '1'],\n  ['Iomai Corporation', 'https://www.crunchbase.com/organization/iomai', 'Biotechnology, Health Care, Medical', 'Gaithersburg, Maryland, United States', 'Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called', '280,254', '2003-01-03', '54000000', 'USD', '54000000', 'Series C', '54000000', 'USD', '54000000', '51-100', 'Private', '', '', '', 'http://www.iomai.com', '', '', \"Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization (TCI). TCI taps into the unique benefits of a major group of antigen-presenting cells found in the outer layers of the skin to generate an enhanced immune response. Iomai is leveraging TCI to enhance the efficacy of existing vaccines, enable new vaccines that are viable only through transcutaneous administration and expand the global vaccine market.  The company was incorporated in 1997 and is based in Gaithersburg, Maryland. Intercell USA, Inc. was formerly known as Iomai Corporation. As a result of the acquisition of Iomai Corporation by Intercell Ag, Iomai Corporation's name was changed. As of August 5, 2008, Intercell USA, Inc. operates as a subsidiary of Intercell Biomedical Research & Development AG.\", 'New Enterprise Associates, Domain Associates, Essex Woodlands Healthcare Partners, ProQuest Investments, China Development Industrial Bank (CDIB)', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1997-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', '', '', '1'],\n  ['LeukoSite', 'https://www.crunchbase.com/organization/leukosite', 'Biotechnology, Health Care, Medical', 'Cambridge, Massachusetts, United States', 'LeukoSite develops small molecule and monoclonal antibody treatment and care.', '281,168', '1998-07-13', '12000000', 'USD', '12000000', 'Post-IPO Equity', '12000000', 'USD', '12000000', '51-100', 'Private', '', '', '', 'http://www.leukosite.com/', '', '', 'LeukoSite develops small molecule and monoclonal antibody treatment and care for inflammatory, autoimmune, cancer applications, and viral diseases.   Its product portfolio includes CAMPATH, a treatment intended for the cure of chronic lymphocytic leukemia, LDP-977 for the treatment of bronchial asthma, LDP-02 for inflammatory bowel disease, and more.   LeukoSite also had nine partner-funded research and discovery programs.', 'SV Health Investors', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '1992-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '3', '', 'Was Acquired', '', '', '2'],\n  ['EraGen Biosciences', 'https://www.crunchbase.com/organization/eragen-biosciences', 'Biotechnology, Health Diagnostics, Market Research', 'Madison, Wisconsin, United States', 'EraGen Biosciences, a biotech company, develops and markets molecular reagent products and software for diagnostics and research.', '281,653', '2006-01-09', '12000000', 'USD', '12000000', 'Series A', '12000000', 'USD', '12000000', '51-100', 'Private', '', '', '', 'http://www.eragen.com', '', 'info@eragen.com', 'EraGen Biosciences, Inc., a biotechnology company, develops, manufactures, and markets molecular reagent products and software for research and clinical testing markets. The company offers molecular diagnostic assays for the early detection and monitoring of cancer, genetic, and infectious diseases, as well as for genetic-based conditions. Its products include molecular diagnostic tests, analyte specific reagents, in vitro diagnostic reagents, and research use only reagents; MultiCode-PLx Analysis Software that allows users to create customized templates for plate and assay layouts; and MultiCode-RTx Analysis Software, which enables users to create templates for quantitative and qualitative analyses. The company serves clinical laboratories and medical researchers. It sells its products through distributors in the United States and Canada. The company was founded as Sulfonics, Inc. in 1994 and changed its name to EraGen Biosciences, Inc. in 1999. EraGen Biosciences, Inc. is based in Madison, Wisconsin.', 'First Analysis, Novartis Venture Fund, Prolog Ventures, Stonehenge Capital', 'Biotechnology, Data and Analytics, Design, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '', '1994-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '6', '', 'Was Acquired', '', '', '1'],\n  ['BioServe', 'https://www.crunchbase.com/organization/bioserve', 'Biotechnology, Health Diagnostics, Medical', 'Beltsville, Maryland, United States', 'BioServes Global BioRepository is a provider of leading academic and industry researchers.', '281,748', '2007-01-01', '', '', '', 'Venture - Series Unknown', '', '', '', '51-100', 'Private', '', '', '', 'http://www.bioserve.com', 'https://www.linkedin.com/company/bioserve', 'info@bioserve.com', 'BioServe is a leading pharmacogenomics company with operations in the US, India and Europe. Prior to investment, the company was based in Washington, and was looking for venture funding to expand into India. Ventureast clinched the deal by offering a term sheet with a better value proposition than those of other venture capitalists who proposed to invest, and by the testimonials of other investee companies.', 'VenturEast', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '1989-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '1', 'Made Acquisitions', 'François Thomas', '', '1'],\n  ['PhosImmune', 'https://www.crunchbase.com/organization/phosimmune', 'Biotechnology, Clinical Trials', 'Charlottesville, Virginia, United States', 'PhosImmune, a Charlottesville-based clinical-stage biotechnology company', '282,013', '2014-08-12', '', '', '', 'Venture - Series Unknown', '', '', '', '51-100', 'Private', '', '', '', 'http://phosimmune.com', '', '', 'PhosImmune is a clinical-stage biotechnology company developing therapeutic cancer vaccines. PhosImmune controls a library of unique, aberrantly phosphorylated tumor antigens (PTAs) that are directly implicated in metastasis, meeting a pressing need for high quality tumor antigens for use in new and more effective cancer vaccines.', 'CIT GAP Funds', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2012-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '2', '', 'Was Acquired', 'Donald Hunt, Mark Cobbold', '', '1'],\n  ['innocutis', 'https://www.crunchbase.com/organization/innocutis', 'Biotechnology, Medical Device, Pharmaceutical', 'Charleston, South Carolina, United States', 'Innocutis is a pharmaceutical and medical device company developing therapeutic for dermatological conditions.', '283,915', '2011-04-29', '6500000', 'USD', '6500000', 'Venture - Series Unknown', '6500000', 'USD', '6500000', '51-100', 'Private', '', '', '', 'http://innocutis.com', '', '', 'INNOCUTIS is a pharmaceutical and medical device company specializing in the development and commercialization of therapies and devices focused on medical treatment of dermatological conditions.  INNOCUTIS’ current portfolio of products consist of established branded prescriptions.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2005-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', '', '', '1'],\n  ['SuperGen', 'https://www.crunchbase.com/organization/supergen', 'Biotechnology, Health Care, Pharmaceutical', 'Dublin, California, United States', 'SuperGen operates a pharmaceutical compnay dedicated to the research and discovery of oncological drug therapy.', '284,427', '2009-10-22', '3000000', 'USD', '3000000', 'Venture - Series Unknown', '10600000', 'USD', '10600000', '51-100', 'Private', '', '', '', 'http://www.supergen.com', '', '', 'SuperGen, Inc., a pharmaceutical company, engages in the discovery, development, and commercialization of therapies to treat patients with cancer. Products in Development MP-470â€”DNA Repair Suppressor: MP-470 is a multi-targeted Tyrosine Kinase Inhibitor that is specific for mutant forms of c-kit, PDGFRa, and FLT3. These protein kinase targets are involved in the growth and proliferation of cancer cells. MP-470 is also a suppressor of Rad51, a DNA repair protein which is involved in resistance to various chemotherapy agents and radiation. SuperGen, Inc. was founded in 1991.', 'New Enterprise Associates, Tako Ventures', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', 'Less than $1M', '1991-01-01', 'year', '', '', '', 'Active', 'For Profit', '1', '1', 'Made Acquisitions', 'Gregory Swendsen, Joseph Rubinfeld', '', '3'],\n  ['Ceregene', 'https://www.crunchbase.com/organization/ceregene', 'Biotechnology, Health Diagnostics, Pharmaceutical', 'San Diego, California, United States', 'Ceregene is a biotechnology company that\\xa0treats neurodegenerative disorders using the delivery of nervous system growth factors.', '284,518', '2010-11-11', '11500000', 'USD', '11500000', 'Series D', '71500000', 'USD', '71500000', '51-100', 'Private', '', '', '', 'http://www.ceregene.com', '', 'info@ceregene.com', \"Ceregene is a private, San Diego-based biotechnology company focused on the treatment of major neurodegenerative disorders using the delivery of nervous system growth factors. Their clinical programs include CERE-110, an AAV2 based vector expressing nerve growth factor, which is about to enter Phase 2 studies for the treatment of Alzheimer's disease, and CERE-120, which recently completed a Phase 2 trial in Parkinson's disease and is currently being evaluated for future development. CERE-135 and CERE-140 are in preclinical development for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and ocular diseases, respectively.\", 'MPM Capital, Investor Growth Capital Limited, Michael J. Fox Foundation, Alta Partners, Cell Genesys', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '2000-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '2', '', 'Was Acquired', 'Stephen Sherwin', '', '3'],\n  ['Therapeutic Proteins', 'https://www.crunchbase.com/organization/therapeutic-proteins', 'Biotechnology, Developer Platform, Therapeutics', 'Deerfield, Illinois, United States', 'Therapeutic Proteins develops and commercializes biosimilar recombinant therapeutic proteins.', '285,476', '2010-07-13', '2500000', 'USD', '2500000', 'Venture - Series Unknown', '2500000', 'USD', '2500000', '51-100', 'Private', '', '', '', 'http://theraproteins.com', '', '', 'Therapeutic Proteins International, LLC. manufactures and markets bio-similar recombinant therapeutic proteins. Its portfolio of products includes small-dose cytokines, large-dose monoclonal antibodies and fusion proteins, and in situ pegylation of difficult to conjugate molecules. The company was founded in 2003 and is based in Chicago, Illinois.', '', 'Biotechnology, Health Care, Science and Engineering, Software', '', '', '$10M to $50M', '2003-01-01', 'year', '', '', '', 'Active', 'For Profit', '3', '', '', '', '', '1'],\n  ['Lynntech', 'https://www.crunchbase.com/organization/lynntech', 'Biotechnology', 'College Station, Texas, United States', 'Lynntech is a technology company that provides pretotype, development, and manufacturing for the research sector.', '286,000', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://lynntech.com', 'https://www.linkedin.com/company/lynntech-inc.', 'careerpaths@lynntech.com', \"Lynntech is a rapidly growing technology development company specializing in transitioning innovative ideas and concepts into marketable technologies. Lynntech is seeking highly motivated, creative researchers for our team-driven work environment. Lynntech's facilities are located in College Station, Texas, just four miles from Texas A&M University and centrally located near Dallas, San Antonio, Austin, and Houston.\", '', 'Biotechnology, Science and Engineering', 'Basic Electric Elements', '', '', '1987-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '1', '', 'Was Acquired', '', '', ''],\n  ['Hybritech Incorporated', 'https://www.crunchbase.com/organization/hybritech-incorporated', 'Biotechnology, Health Care, Medical', 'Mountain View, California, United States', 'Hybritech Incorporated develops and markets monoclonal antibodies.', '288,682', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', '', '', '', 'Hybritech Incorporated develops and markets monoclonal antibodies. It is a biotechnology company that uses these antibodies to make diagnostic and medical monitoring tests to identify a variety of infectious, viral and cancer-related diseases such as colon and prostate cancer, infertility, allergies, and issues that arise during pregnancy. Hybritech Incorporated was established in 1978 and is based in San Diego, California. Hybritech, Inc. operates as a subsidiary of Danaher Corp.', '', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', '', '2003-01-01', 'year', '', '', '', 'Active', 'For Profit', '1', '', '', '', '', ''],\n  ['Slate Pharmaceuticals', 'https://www.crunchbase.com/organization/slate-pharmaceuticals', 'Biotechnology, Developer Platform, Health Care', 'Durham, North Carolina, United States', 'Slate Pharmaceuticals acquires, develops, and commercializes products for the diseases of maturing men and women.', '289,335', '2010-09-24', '1990000', 'USD', '1990000', 'Debt Financing', '9777000', 'USD', '9777000', '51-100', 'Private', '', '', '', 'http://slatepharma.com', '', 'info@slatepharma.com', 'Slate Pharmaceuticals, Inc. acquires, develops, and commercializes products for the diseases of maturing men and women. It focuses on specialized subcutaneous pellet delivery of hormones. The company offers its products in the United States. Slate Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Durham, North Carolina.', '', 'Biotechnology, Health Care, Science and Engineering, Software', '', '', '$100M to $500M', '2007-01-01', 'year', '', '', '', 'Closed', 'For Profit', '1', '', '', 'Robert S. Whitehead', '', '3'],\n  ['Kosan Biosciences', 'https://www.crunchbase.com/organization/kosan-biosciences', 'Biotechnology, Therapeutics', 'Hayward, California, United States', 'Kosan Biosciences is a cancer therapeutics company developing various classes of anticancer agents through clinical development.', '291,236', '2006-07-19', '3000000', 'USD', '3000000', 'Venture - Series Unknown', '3000000', 'USD', '3000000', '51-100', 'Public', '', '', '', '', '', '', \"Kosan Biosciences Incorporated, a cancer therapeutics company, focuses on developing various classes of anticancer agents through clinical development. Its product KOS-953, a Hsp90 inhibitor is in Phase III clinical trial in combination with Velcade for multiple myeloma, as well as in Phase II clinical trial in combination with Herceptin for HER2-positive metastatic breast cancer. The company's product portfolio also includes KOS-1584, an epothilone anticancer product candidate evaluated in dose-escalating Phase I clinical trial in patients with solid tumors; KOS-1803, a preclinical stage product for cancer; KOS-2187, a potent motilin receptor agonist that is in Phase I clinical testing for the treatment of GERD. In addition, Kosan Biosciences develops KOS-2464, a preclinical stage product for cancer. The company was founded in 1995 and is based in Hayward, California. As of June 25, 2008, Kosan Biosciences Incorporated operates as a subsidiary of Bristol-Myers Squibb Co.\", 'Kingsbridge Capital', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '', '1995-01-01', 'year', '', 'M&A', '2000-10-10', 'Active', 'For Profit', '2', '', 'Was Acquired', 'Chaitan S. Khosla', '', '1'],\n  ['NMT Medical', 'https://www.crunchbase.com/organization/nmt-medical', 'Biotechnology, Health Care, Medical Device', 'Boston, Massachusetts, United States', 'NMT Medical develops implant technologies for cardiologists to treat cardiac structural heart diseases through catheter-based procedures.', '292,038', '2010-03-01', '5759760', 'USD', '5759760', 'Venture - Series Unknown', '5759760', 'USD', '5759760', '51-100', 'Private', '', '', '', 'http://www.nmtmedical.com', '', 'info@nmtmedical.com', \"NMT Medical, Inc., a medical technology company, engages in the design, development, manufacture, and marketing of proprietary implant technologies that allow interventional cardiologists to treat certain kinds of cardiac structural heart disease through catheter-based procedures. Products The company sells CardioSEAL cardiac septal repair implants, which are used for the repair of structural heart disease and intracardiac shunts that result in abnormal blood flow through the chambers of the heart in the United States, Canada, and Europe. It sells CardioSEAL, STARFlex and BioSTAR in Europe and Canada. It also re-sells third party products for use with the CardioSEAL, STARFlex and BioSTAR implant devices, specifically vascular sizing balloons and sheaths. The company's, STARFlex, incorporates a self-centering system. This system allows the implant to self-adjust to variations in the anatomy of a septal defect without deforming the septum or interfering with heart valve function. BioSTAR is the company's bioabsorbable patent foramen ovale (PFO) implant and the biological closure technology. The collagen matrix biomaterial in BioSTAR enhances cell growth, promoting sealing of the PFO defect. Customers The company's customers include hospitals, clinics, and other healthcare centers. Competition The company's competitors include AGA Medical Corp., W. L. Gore & Associates, Inc., Cardia, Inc., St. Jude Medical, Inc., and Occlutech. History NMT Medical, Inc. was founded in 1986.\", '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1986-01-01', 'year', '', '', '', 'Closed', 'For Profit', '2', '', '', '', '', '1'],\n  ['Anaerobe Systems', 'https://www.crunchbase.com/organization/anaerobe-systems', 'Biotechnology, Machinery Manufacturing, Manufacturing', 'Morgan Hill, California, United States', 'Anaerobe Systems manufactures pre-reduced anaerobically sterilized plated and tubed culture media products.', '293,641', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://anaerobesystems.com', '', 'customerservice@anaerobesystems.com', 'Anaerobe Systems manufactures pre-reduced anaerobically sterilized plated and tubed culture media products. The company provides anaerobic chambers, tubes, plates, transport media products, custom formulations, disks, and reagents for microbiology labs. It invented a gloveless anaerobic chamber enabling scientists to easily manipulate and work up anaerobic organisms under completely anaerobic conditions. It makes a variety of general enrichment, selective, differential, and transport media. Anaerobe Systems was founded on 1978 and is headquartered in Morgan Hill, California.', '', 'Biotechnology, Manufacturing, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '', '1978-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', 'Mike Cox', '', ''],\n  ['Galil Medical', 'https://www.crunchbase.com/organization/galil-medical', 'Biopharma, Health Care, Medical Device', 'Saint Paul, Minnesota, United States', 'Galil Medical designs and develops novel minimally-invasive cryotherapy technology for various clinical applications.', '293,754', '2006-12-11', '52000000', 'USD', '52000000', 'Venture - Series Unknown', '52000000', 'USD', '52000000', '51-100', 'Private', '', '', '', 'http://www.galil-medical.com', 'https://www.linkedin.com/company/galil-medical', 'info@galilmedical.com', 'Galil Medical is a new era of minimally invasive cryotherapy solutions that enhance patient quality of life.  Galil Medicalâ€™s technology involves freezing and ablating diseased tissue in a technique referred to as cryotherapy, also referred to as cryoablation and cryosurgery. Galil Medical cryotherapy systems use compressed Argon gas to produce extremely low temperatures. As the gas passes through the cryoablation needle, the tip of the needle is cooled, forming an iceball, which engulfs the tumor and destroys the tissue. A variety of needle types is available to sculpt a freeze zone conformed to the tumor size and shape.  Galil Medical cryosurgical systems precisely deliver sub-zero temperatures to target tissue with the aid of patented 17-gauge cryoablation needles and high-resolution imaging for the cryosurgical ablation of benign and cancerous tumors. Cryotherapy ablation has been widely used for prostate cancer treatment and kidney cancer treatment. New ablation treatments for various other tumors are being developed in the Womenâ€™s Health and Interventional Radiology markets.', 'Investor Growth Capital Limited, The Vertical Group, Thomas, McNerney & Partners', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '1996-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '21', '1', 'Made Acquisitions, Was Acquired', '', '', '1'],\n  ['amfAR', 'https://www.crunchbase.com/organization/amfar', 'Biotechnology, Clinical Trials, Medical Device', 'New York, New York, United States', 'Founded in 1985, amfAR is dedicated to ending the global AIDS epidemic through innovative research.', '294,066', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.amfar.org', '', 'info@treatasia.org', 'Founded in 1985, amfAR is dedicated to ending the global AIDS epidemic through innovative research. With the freedom and flexibility to respond quickly to emerging areas of scientific promise, amfAR plays a catalytic role in accelerating the pace of HIV/AIDS research and achieving real breakthroughs. amfAR-funded research has increased our understanding of HIV and has helped lay the groundwork for major advances in the study and treatment of HIV/AIDS. Since 1985, amfAR has invested nearly $290 million in its mission and has awarded grants to more than 2,000 research teams worldwide.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10M to $50M', '1985-01-01', 'year', '', '', '', 'Active', 'For Profit', '17', '', '', 'Elizabeth Taylor, Mathilde Krim', '', ''],\n  ['TransMolecular', 'https://www.crunchbase.com/organization/transmolecular', 'Biotechnology, Health Care, Pharmaceutical, Therapeutics', 'Birmingham, Alabama, United States', 'TransMolecular Inc a Birmingham, Ala.-based biotech company focused on the treatment of cancer and pain.', '296,276', '2004-03-01', '33200000', 'USD', '33200000', 'Series C', '42200000', 'USD', '42200000', '51-100', 'Private', '', '', '', 'http://www.transmolecular.com/', '', 'info@transmolecular.com', \"TransMolecular, Inc. is a neuroscience biotechnology company committed to discovering, developing and commercializing novel and proprietary drugs to diagnose and treat diseases of the central nervous system having inadequate pharmaceutical alternatives. The Company focuses its drug development on cancer and pain, and has built strong technology platforms to enrich its product discovery and development pipeline. Founded in July 1996, TransMolecular is privately held and venture capital backed, having raised $9.6MM to date through two private placements from internationally recognized investment firms. The Company has built a strong management team that is dedicated to the discovery and development of safe and effective products for patients suffering from cancer and pain. Its management team has more than 75 years of combined relevant experience in healthcare, pharmaceutical development, R&D, operations, and finance. TransMolecular's corporate offices and R&D laboratories are in Birmingham, Alabama. TransMolecular has received three Small Business Incentive Research (SBIR) grants totaling $1 million from the National Institutes of Health for its cancer and pain programs. The Company holds more than 25 patents and/or patent applications to protect its products worldwide, and has exclusive license agreements with the University of Alabama at Birmingham Research Foundation and Yale University for its cancer and pain technology, respectively.\", 'Aperture Venture Partners, Easton Capital, TVM Capital, Cogene Ventures, MDS Capital', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '1996-07-01', 'month', '', 'M&A', '', 'Active', 'For Profit', '1', '', 'Was Acquired', '', '', '3'],\n  ['CHF Solutions', 'https://www.crunchbase.com/organization/chf-solutions', 'Biotechnology, Health Care, Manufacturing, Medical Device', 'Brooklyn Park, Minnesota, United States', 'CHF Solutions designs and manufactures a device to remove excess fluid from patients suffering from fluid overload.', '297,774', '2005-01-20', '22900000', 'USD', '22900000', 'Venture - Series Unknown', '22900000', 'USD', '22900000', '51-100', 'Private', '', '', '', 'http://chfsolutions.com/', '', '', 'CHF Solutions manufactures innovative medical devices for cardiac care. Its mission is to provide medical practitioners with practical solutions that enable the treatment of patients with unmet clinical needs. CHF Solutions was founded in 1998 and is based in Brooklyn Park, Minnesota.', 'SV Health Investors, MPM Capital, Kaiser Permanente Ventures, Investor Growth Capital Limited', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', '', '', '', '1998-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '9', '', 'Was Acquired', 'Mark Gelfand', '', '1'],\n  ['BioSeek', 'https://www.crunchbase.com/organization/bioseek', 'Biotechnology', 'South San Francisco, California, United States', 'BioSeek provides cell-based human disease models for drug discovery and development.', '299,632', '2007-05-23', '10000000', 'USD', '10000000', 'Series C', '10000000', 'USD', '10000000', '51-100', 'Private', '', '', '', 'http://www.bioseekinc.com', '', 'info@bioseekinc.com', 'BioSeek, Inc. provides cell-based human disease models for drug discovery and development. It offers BioMap Systems, which are human primary cell-based assay systems for indications in vascular inflammation, cardiovascular and respiratory diseases, and fibrosis. The company also provides programs for the discovery of lead compounds for inflammatory and autoimmune disease indications. BioSeek, Inc. was founded in 2000 and is based in South San Francisco, California.', 'Amylin Pharmaceuticals', 'Biotechnology, Science and Engineering', 'Testing', '', '', '2000-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '4', '', 'Was Acquired', '', '', '1'],\n  ['Tolerx', 'https://www.crunchbase.com/organization/tolerx', 'Biotechnology, Health Care, Medical', 'Cambridge, Massachusetts, United States', 'Tolerx develops novel therapies that modulate T-cell activities to treat patients with autoimmune diseases, diabetes and cancer.', '300,127', '2010-12-01', '1500000', 'USD', '1500000', 'Venture - Series Unknown', '145500000', 'USD', '145500000', '51-100', 'Private', '', '', '', 'http://www.tolerx.com', '', 'info@tolerx.com', \"Tolerx, Inc. develops novel therapies focusing on modulating T-cell activities for treating autoimmune diseases, diabetes, and cancer. The company's products include otelixizumab, a targeted T-cell immunomodulator for treating type 1 diabetes; MTRX1011A, an anti-CD4 antibody for treating autoimmune indications; and TRX518 and TRX385, pre-clinical candidates that focuses on optimizing immune responses for treating cancer and chronic viral diseases. Tolerx, Inc., formerly known as TolerRx, Inc., was founded in 2000 and is based in Cambridge, Massachusetts.\", 'Duke University, Mizuho Capital, Genentech, HealthCare Ventures, Tenaya Capital', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '2000-01-01', 'year', '', '', '', 'Closed', 'For Profit', '1', '', '', 'Douglas J. Ringler', '', '5'],\n  ['OncoGenesis', 'https://www.crunchbase.com/organization/oncogenesis', 'Biotechnology, Health Care, Medical Device', 'Surprise, Arizona, United States', 'OncoGenesis is a Protein-Based Disease and Cancer Screening at the Point of Care', '300,716', '2009-04-04', '', '', '', 'Seed', '', '', '', '51-100', 'Private', '', '', '', 'http://oncogenesisdx.com/', 'https://www.linkedin.com/company/oncogenesis-corporation/', 'schristensen@oncogenx.com', 'OncoGenesis is a Protein-Based Disease and Cancer Screening at the Point of Care. OncoGenesis was formed to provide women worldwide with access to point-of-care screening for Cervical Cancer.', 'Avant Global', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2008-01-01', 'year', '', 'Seed', '', 'Active', 'For Profit', '', '', '', 'Paul Vichi, Peter Gombrich', '', '1'],\n  ['CellPress', 'https://www.crunchbase.com/organization/cellpress', 'Biotechnology, News, Publishing', 'Cambridge, Massachusetts, United States', 'CellPress is a print media company that publishes biomedical research and reviews.', '303,927', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.cell.com/', 'http://www.linkedin.com/company/cell-press', 'subs@cell.com', 'CellPress is a print media company that publishes biomedical research and reviews. Its aim is to engage the scientific community by communicating important and exciting discoveries that will have an impact on the future of research. In 1986, CellPress became established as an independent publisher and subsequently launched Hallmark journals, including Neuron, Immunity, and Molecular Cell. Currently, its editorial and production teams collaborate with authors and reviews to publish 13 Hallmark primary research journals, 3 primary research journals on behalf of learned societies, and 14 trends review journals, including Cell Reports and Stem Cell Reports. The company is focused on delivering research that drives scientific discovery spanning a wide range of biomedical disciplines. CellPress was founded in 1986 and is headquartered in Cambridge, Massachusetts.', '', 'Biotechnology, Content and Publishing, Media and Entertainment, Science and Engineering', '', '', 'Less than $1M', '1986-01-01', 'year', '', '', '', 'Active', 'For Profit', '20', '', '', 'Benjamin Lewin', '', ''],\n  ['Aqua Pharmaceuticals', 'https://www.crunchbase.com/organization/aqua-pharmaceuticals', 'Biotechnology', 'West Chester, Pennsylvania, United States', 'Aqua Pharmaceuticals is simple. We strive to attract and retain the best. Aqua is committed to being a leading provider of specialty', '305,314', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://aquapharm.com', '', 'careers@aquapharm.com', \"Aqua Pharmaceuticals is simple. We strive to attract and retain the best. Aqua is committed to being a leading provider of specialty pharmaceuticals just as we seek to create the best work environment for our employees. At Aqua, we conduct our business with integrity and honesty and aspire to excellence in all we do. We are continually challenged to excel, expand and advance our skills to keep pace with the evolving industry. We know our people are vital to the success of the business and encourage everyone to achieve their maximum potential. We offer a competitive benefits package and recognize the need for a healthy balance between work and family life. Join a progressive leader making a profound difference in people's lives. At Aqua, we value working relationships, and we're passionate about our work. Aqua welcomes the talent of people from diverse backgrounds to provide the expertise, dedication and imagination to propel us toward a prosperous future. We're inviting visionary and resourceful individuals to be part of a forward-thinking team. Aqua Pharmaceuticals is a progressive organization that offers a variety of career opportunities.\", '', 'Biotechnology, Science and Engineering', '', '', '', '2004-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '4', '', 'Was Acquired', '', '', ''],\n  ['OPK Biotech', 'https://www.crunchbase.com/organization/opk-biotech', 'Biotechnology, Manufacturing', 'Cambridge, Massachusetts, United States', 'OPK Biotech develops, manufactures and markets oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to', '306,702', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://opkbiotech.com', '', 'OPKbiotech@opkbiotech.com', \"OPK Biotech develops, manufactures and markets oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. Using their patented and proprietary technology, they have developed and manufacture two products: Hemopure® (HBOC-201) [hemoglobin glutamer - 250 (bovine)] for human use, and Oxyglobin® (HBOC-301) [hemoglobin glutamer - 200 (bovine)] for veterinary use.\", '', 'Biotechnology, Manufacturing, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2009-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', 'Jerry Kowalski', '', ''],\n  ['Breckenridge Pharmaceutical', 'https://www.crunchbase.com/organization/breckenridge-pharmaceutical', 'Pharmaceutical', 'Berlin, Connecticut, United States', 'Breckenridge Pharmaceutical, Inc. is a privately-held member of the Esteve Group.', '307,861', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.bpirx.com/html/', 'https://www.linkedin.com/company/breckenridge-pharmaceutical/about/', '', \"Breckenridge Pharmaceutical, Inc. is a privately-held member of the Esteve Group.  They are an own label Distributor that performs pharmaceutical research and development as well as marketing and distribution in the U.S.  The company was founded in 1983, and markets a broad range of generic prescription products in many therapeutic categories and dosage forms. The Breckenridge label is recognized by Retail Pharmacy Chains, Mail Order Pharmacies, Pharmacy Benefit Managers, Managed Care Facilities, and Group Purchasing Organizations as well as Wholesalers and Distributors throughout the United States.    They market in excess of 70 products in a variety of dosage forms including:  tablets, capsules, liquids, suspensions, ophthalmics, nasal sprays, powders and injectable products.  Their  pipeline includes:Inhalers, Transdermal patches, and Topical products. Breckenridge, headquartered in Berlin, CT has 30 approved Abbreviated New Drug Applications (ANDA's) approved by the Food and Drug Administration (FDA).  They  also have over 80 products in their  pipeline; including 25 that contain Paragraph IV patent challenges.\", '', 'Health Care', '', '', '', '1983-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['Solid State Cooling Systems', 'https://www.crunchbase.com/organization/solid-state-cooling-systems', 'Biotechnology, Electronics, Health Care, Manufacturing', 'Wappingers Falls, New York, United States', 'Systems engineers thermal management solutions for laser, laboratory, medical and biopharmaceutical and the semiconductor industry.', '308,104', '2007-03-30', '100000', 'USD', '100000', 'Grant', '478785', 'USD', '478785', '51-100', 'Private', '', '', '', 'http://www.sscooling.com', 'https://www.linkedin.com/company/solid-state-cooling-systems', 'info@trendbio.com.au', 'Solid State Cooling Systems develops and manufactures innovative, thermoelectric-based, precision temperature control systems for a wide variety of market applications, including:  semiconductor processing, precision lasers, medical lasers, analytical instruments, laboratory, medical equipment, aerospace & defense and other industrial applications.', 'NYSERDA', 'Biotechnology, Consumer Electronics, Hardware, Health Care, Manufacturing, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '1994-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', '', '', '2'],\n  ['BioSET', 'https://www.crunchbase.com/organization/bioset', 'Biotechnology, Health Care, Medical Device, Therapeutics', 'Rockville, Maryland, United States', 'BioSET develops therapeutic peptide-based medical devices to improve bone and soft tissue repair.', '310,178', '2014-01-06', '', '', '', 'Debt Financing', '22771486', 'USD', '22771486', '51-100', 'Private', '', '', '', 'http://biosetinc.com', '', 'troueche@biosetinc.com', 'BioSurface Engineering Technologies, Inc., also known as BioSET, engages in developing proprietary therapeutic peptides as medical devices to improve bone and soft tissue repair. The company focuses on developing devices for orthobiologics applications. Its products include AMPLEX, an implantable combination device of the B2A peptide and a synthetic ceramic scaffold for use as a surgical bone graft implant for lumbar degenerative disc disease, as well as for use in spine, cervical spine, and foot and ankle fusion surgeries. The company also develops products for sports medicine applications based on its F2A peptide; and peptide signaling molecules and various scaffold biomaterials for use in musculoskeletal applications, including trauma, fracture repair, and other soft tissue treatments. BioSurface Engineering Technologies, Inc. was founded in 2001 and is based in Rockville, Maryland.', 'Boston Scientific, The Vertical Group, Saints Capital, Maryland Venture Fund, MB Venture Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '2001-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '2', '', 'Was Acquired', 'Paul Zamora, Tom Roueche', '', '5'],\n  ['Herbology', 'https://www.crunchbase.com/organization/herbology', 'Biotechnology, Health Care, Medical', 'Gaithersburg, Maryland, United States', 'At Herbology we are committed to improving the quality of your life and restoring well being by providing safe.', '310,469', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://www.myherbology.com', 'https://www.linkedin.com/company/herbology/', 'info@herbologydispensary.com', 'At Herbology we are committed to improving the quality of your life and restoring well being by providing safe and reliable access to all qualified patients with debilitating medical conditions.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', 'Less than $1M', '', '', '', '', '', 'Active', 'For Profit', '2', '', '', '', '', ''],\n  ['Targanta Therapeutics', 'https://www.crunchbase.com/organization/targanta-therapeutics', 'Biopharma, Health Care, Pharmaceutical', 'Cambridge, Massachusetts, United States', 'Targanta Therapeutics is a biopharma Company', '311,526', '2007-02-12', '70000000', 'USD', '70000000', 'Series C', '70000000', 'USD', '70000000', '51-100', 'Delisted', '', '', '', 'http://www.targanta.com', 'http://www.linkedin.com/company/targanta-therapeutics', 'krishna.gorti@themedco.com', 'Targanta Therapeutics a biopharmaceutical company focused on the development and commercialization of innovative antibiotics for serious infections treated or acquired in hospitals and other institutional settings.', 'OrbiMed, Skyline Ventures, Radius Ventures, Brookside Capital', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2005-12-01', 'month', '', 'M&A', '2007-10-10', 'Active', 'For Profit', '16', '', 'Was Acquired', '', '', '1'],\n  ['Pharma & MedTech Business Intelligence', 'https://www.crunchbase.com/organization/pharma-medtech-business-intelligence', 'Health Care, Information Technology, News, Pharmaceutical', 'New York, New York, United States', 'Pharma & Medtech Business Intelligence.', '312,246', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://www.pharmamedtechbi.com', 'http://www.linkedin.com/company/1837961', 'custcare@informa.com', 'Pharma & MedTech Business Intelligence from Informa places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Pharma & MedTech Business Intelligence is a leader in the field of healthcare industry information.', '', 'Content and Publishing, Health Care, Information Technology, Media and Entertainment', '', '', '$10M to $50M', '1987-01-01', 'day', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['American Bio Medica', 'https://www.crunchbase.com/organization/american-bio-medica', 'Biotechnology, Medical Device', 'Kinderhook, New York, United States', 'American Bio Medica Corporation is a biotechnology company.', '314,775', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://abmc.com/', '', 'tech@abmc.com', 'American Bio Medica Corporation is a biotechnology company that develops, manufactures, and markets accurate, cost-effective immunoassay test kits, including some of the world’s most effective point of collection tests for drugs of abuse. The Company and its worldwide distribution network target the workplace, government, corrections, clinical and educational markets.', '', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', '', '1992-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['NeoGraft Solutions', 'https://www.crunchbase.com/organization/neograft-solutions', 'Biotechnology, Medical Device', 'Lewisville, Texas, United States', 'NeoGraft, the global leader in hair restoration treatments and therapies.', '314,913', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://www.neograft.com/', 'https://www.linkedin.com/company/neograft/?originalSubdomain=in', '', 'NeoGraft Solutions develops an automated hair transplant system that facilitates the harvesting of follicles during a follicular unit extraction hair transplant. The company offers HairMedica, a hair re-growth system for hair renovation, restoration, and long term rejuvenation. It serves men and women in the United States', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2008-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', '', '', ''],\n  ['SOLVO Biotechnology', 'https://www.crunchbase.com/organization/solvo-biotechnology', 'Biotechnology, Health Care', 'Boston, Massachusetts, United States', 'SOLVO Biotechnology is the leading worldwide provider of drug transporter technology, assays and reagents.', '318,767', '2011-12-01', '', '', '', 'Series B', '', '', '', '51-100', 'Private', '', '', '', 'http://www.solvobiotech.com', 'https://www.linkedin.com/company/633600', 'solvo_usa@solvo.com', 'SOLVO Biotechnology has been the pioneer and leader in the commercialization of membrane transporter technologies, diagnostics and drug discovery assays.', 'FastVentures', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '1999-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', 'Erno Duda', '', '1'],\n  ['Douglas Scientific', 'https://www.crunchbase.com/organization/douglas-scientific', 'Biotechnology, Health Diagnostics', 'Alexandria, Minnesota, United States', 'Douglas Scientific is dedicated to making our world a better place by delivering innovative laboratory automation.', '318,846', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://douglasscientific.com', 'http://www.linkedin.com/company/douglas-scientific', 'Contact@DouglasScientific.com', 'Douglas Scientific® LLC, located in Alexandria, MN, began as a division of Douglas Machine Inc in 2009, and was incorporated as a wholly owned company in 2010. Douglas Scientific Facility - Alexandria, MN The Company provides patented Array Tape™ automation that enables laboratories around the world to rapidly process billions of genetic samples and chemical compounds. Array Tape™ is a continuous polymer strip embossed with micro wells used in laboratory testing. Douglas Scientific also designs and manufactures a full line of laboratory instrumentation -- Nexar®, Soellex® and Araya® -- to optimize dispensing and scanning in the Array Tape™ wells. Their technology allows scientists to complete screening at unprecedented speed and fractional costs, which enables new discovery in plant genomics, animal health, human diagnostics, and pharmaceutical applications. The Team at Douglas Scientific is dedicated to making the world a better place, and accomplishes this by delivering innovative laboratory automation that supports scientific advancement around the world. As an organization they think globally and act locally. They are positively impacting lives around the world through their innovative laboratory automation and they are creating a strong impact locally by supporting their community. Since its founding, Douglas Scientific has experienced rapid growth (both in terms of product demand and workforce) and currently employs over 100 professionals at its facility in the Alexandria Industrial Park - including experts in engineering, biosciences, automation, motion control, and other fields.', '', 'Biotechnology, Health Care, Science and Engineering', 'Testing', '', '', '2009-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '1', '', 'Was Acquired', '', '', ''],\n  ['QuatRx Pharmaceuticals', 'https://www.crunchbase.com/organization/quatrx-pharmaceuticals', 'Biotechnology, Health Care, Pharmaceutical', 'Ann Arbor, Michigan, United States', 'QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds', '322,976', '2009-04-24', '14025045', 'USD', '14025045', 'Convertible Note', '119005045', 'USD', '119005045', '51-100', 'Private', '', '', '', 'http://quatrx.com', 'https://www.linkedin.com/groups?gid=3164365', '', 'QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds in the areas of endocrine, metabolic, and cardiovascular therapeutics.QuatRx Pharmaceuticals Company was founded in 2000 and is based in Ann Arbor, Michigan.', 'T. Rowe Price, Hercules Capital, Inc., MPM Capital, Venrock, InterWest Partners', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '2000-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '1', '', 'Was Acquired', 'Christopher Nicholas, Randy Whitcomb, Robert L. Zerbe, Stuart Dombey', '', '8'],\n  ['Xradia', 'https://www.crunchbase.com/organization/xradia', 'Biotechnology, Health Care, Medical Device', 'Pleasanton, California, United States', 'Xradia develops high-performance 3D X-ray microscopes with high resolution and superior contrast for industrial and research applications.', '324,075', '2007-03-08', '7000000', 'USD', '7000000', 'Series D', '11000000', 'USD', '11000000', '51-100', 'Private', '', '', '', 'http://www.xradia.com', 'https://www.linkedin.com/company/zeiss', 'sales@xradia.com', \"Xradia develops technology to help advance innovation in science and industry by providing unique insight through superior X-ray imaging solutions. Our products utilize advanced X-ray computed tomography (CT) imaging methodology and optics to nondestructively produce 3D images of objects with exceptional spatial resolution and contrast.  Xradia's technology is based on proprietary X-ray optics and detectors. Xradia produces state-of-the-art far-field ambient environment imaging systems capable of 3D imaging with  resolution below 50 nm. Xradia's commercial products have 3D resolution from the nanometer level up to several hundred microns.\", '180 Degree Capital', 'Biotechnology, Health Care, Science and Engineering', 'Optics', '', '', '1999-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '1', '', 'Was Acquired', 'Wenbing Yun', '', '2'],\n  ['Hypnion', 'https://www.crunchbase.com/organization/hypnion', 'Biotechnology, Health Diagnostics, Medical, Therapeutics', 'Lexington, Massachusetts, United States', 'Hypnion is a neuroscience drug discovery company.', '327,126', '2005-12-19', '20100000', 'USD', '20100000', 'Series B', '78000000', 'USD', '78000000', '51-100', 'Private', '', '', '', 'http://www.hypnion.com/', '', '', 'Hypnion is a neuroscience drug discovery and development company that develops novel therapeutics for the treatment of central nervous system disorders. The company develops treatments for sleep- and wake-alertness disorders and circadian rhythm abnormalities. Hypnion offers SCORE-2004, a drug discovery platform that is able to measure drugs’ impact on sleep and wake parameters. Hypnion is acquired by Eli Lilly and Company. Hypnion was founded in 2000 and is based in Worcester, Massachusetts.', 'Flagship Pioneering, MPM Capital, Alexandria Real Estate Equities, JAFCO Japan, Gimv', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '2000-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', '', '', '3'],\n  ['Biomicrolab', 'https://www.crunchbase.com/organization/biomicrolab-inc', 'Biotechnology, Manufacturing', 'Concord, California, United States', 'BioMicroLab designs and manufactures lab automation equipment for biotechnology and research.', '328,450', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://www.biomicrolab.com', 'https://www.linkedin.com/company/biomicrolab', 'sales@biomicrolab.com', 'BioMicroLab designs and manufactures lab automation equipment for biotechnology and research.', '', 'Biotechnology, Manufacturing, Science and Engineering', '', '', '', '2003-01-01', 'day', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', '', '', ''],\n  ['Imaging Sciences International', 'https://www.crunchbase.com/organization/imaging-sciences-international', 'Biotechnology, Health Care, Life Science, Manufacturing, Medical', 'Hatfield, Pennsylvania, United States', 'Imaging Sciences, Hatfield, Penn, manufactures, sells, and markets the i-CAT® Cone Beam 3-D dental imaging system', '330,480', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.imagingsciences.com/', '', 'marketing@imagingsciences.com', 'Imaging Sciences, Hatfield, Penn,  manufactures, sells, and markets the i-CAT® Cone Beam 3-D dental imaging system, a dental imaging solution for general practitioners and dental specialists. The i-CAT  captures views of critical anatomy, including bone structure and tooth orientation. Its imaging technology allows dental professionals to improve patient care by more accurately planning procedures such as implants and oral surgery, creating more predictable outcomes and reducing treatment time and radiation.', '', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1992-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', '', '', ''],\n  ['American TeleCare', 'https://www.crunchbase.com/organization/american-telecare', 'Biotechnology, Health Care, Medical', 'Eden Prairie, Minnesota, United States', 'Founded in 1993, American TeleCare, Inc. (ATI) pioneered video based in-home patient monitoring. ATI has worked with leading healthcare', '334,290', '2009-02-25', '1350000', 'USD', '1350000', 'Debt Financing', '1350000', 'USD', '1350000', '51-100', 'Private', '', '', '', 'http://americantelecare.com', '', 'Sales@AmericanTeleCare.com', 'American TeleCare, Inc. (ATI) pioneered video based in-home patient monitoring. ATI has worked with leading healthcare institutions, insurance companies, health plans and employers to improve healthcare quality and reduce costs through innovative telehealth solutions.', '', 'Biotechnology, Health Care, Science and Engineering', 'Electric Communication Technique', '', '', '1993-01-01', 'year', '', '', '', 'Closed', 'For Profit', '', '', '', '', '', '1'],\n  ['Bionovo', 'https://www.crunchbase.com/organization/bionovo', \"Biotechnology, Health Care, Women's\", 'Emeryville, California, United States', 'Bionovo operates as a late-stage clinical drug discovery and development company focusing on women’s health and cancer.', '339,139', '2010-07-06', '600000', 'USD', '600000', 'Venture - Series Unknown', '600000', 'USD', '600000', '51-100', 'Private', '', '', '', 'http://www.bionovo.com', '', '', 'Bionovo, Inc. operates as a late stage clinical drug discovery and development company focusing on women’s health and cancer primarily in the United States. The company’s drug development process utilizes botanical sources used in traditional Chinese medicine to produce biologically active compounds. Its lead drug candidate is Menerba, a receptor sub-type selective estrogen receptor modulator, which is in Phase III clinical trial for the treatment of vasomotor symptoms of menopause. The company is also developing Bezielle, an oral anti-cancer agent that in Phase II clinical trail for the treatment of advanced breast cancer; and Seala for the treatment of post-menopausal vulvar and vaginal atrophy. Bionovo, Inc. was founded in 2002 and is headquartered in Emeryville, California. On October 26, 2012, Bionovo, Inc. filed a voluntary petition for liquidation under Chapter 7 in the US Bankruptcy Court for the Northern District of California.', '', 'Biotechnology, Community and Lifestyle, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '2002-01-01', 'year', '', '', '', 'Closed', 'For Profit', '', '', '', 'Isaac Cohen, Mary Tagliaferri', '', '1'],\n  ['Prima Pharm', 'https://www.crunchbase.com/organization/prima-pharm', 'Manufacturing, Pharmaceutical', 'San Diego, California, United States', 'PrimaPharma, Inc. is a contract manufacturer of drugs, devices, cosmetics and diagnostic products.', '341,341', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://primapharm.net/', 'https://www.linkedin.com/company/primapharm-inc-?originalSubdomain=in', '', 'PrimaPharma, Inc. is a contract manufacturer of drugs, devices, cosmetics and diagnostic products. PrimaPharma has been in business since 1992 and is an ISO 13485 certified (BSI) and FDA (Drug & Device) inspected facility. The company has full manufacturing capabilities in over 20,000 square feet including class 10,000 and class 100 clean room facilities. The management team has experience in the manufacture and development of products for regulated industries worldwide. This experience includes injectable drugs, isolation of natural and biological products including enzymes, proteins and peptides. PrimaPharma customers have included major pharmaceutical companies as well as many “start-ups” and small to medium size companies engaged in product and process development. The company is compliant with cGMP’s, QSR and ISO requirements.', '', 'Health Care, Manufacturing', '', '', '', '1992-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['Sierra Surgical', 'https://www.crunchbase.com/organization/sierra-surgical', 'Biotechnology, Health Care, Medical Device', 'Palo Alto, California, United States', 'Sieraa Surgical develops minimally-invasive surgical systems based on female sterilization technologies.', '342,749', '2008-07-27', '14500000', 'USD', '14500000', 'Series B', '21600000', 'USD', '21600000', '51-100', 'Private', '', '', '', 'http://www.sierrasurgicalusa.com', '', '', 'Sierra Surgical Technologies develops minimally invasive surgical systems. The company develops female sterilization technology. Sierra Surgical Technologies, Inc. is based in Palo Alto, California.', 'Alta Partners, DeNovo Ventures', 'Biotechnology, Health Care, Science and Engineering', '', '', 'Less than $1M', '2008-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '', '', '', '', '', '2'],\n  ['Pascal Biosciences', 'https://www.crunchbase.com/organization/pascal-biosciences', 'Biotechnology', 'Seattle, Washington, United States', 'Pascal Biosciences  is a biotechnology company.', '348,131', '', '', '', '', '', '', '', '', '51-100', 'Public', '', '', '', 'https://www.pascalbiosciences.com/', 'https://www.linkedin.com/company/pascal-biosciences-inc/about/', 'info@pascalbiosciences.com', 'Pascal Biosciences Inc. (PAS, formerly, bioMmune Technologies Inc.) is a biotechnology company engaged in developing breakthrough treatments in the field of immuno-oncology. Their strategy aims to leverage their  innovative technologies and experienced leadership and scientific team to develop new, effective therapeutics that will change the lives of patients. Pascal is headquartered in Vancouver, Canada. The company trades on the TSX Venture Exchange under the symbol “PAS”.', '', 'Biotechnology, Science and Engineering', '', '', '', '2011-01-01', 'year', '', 'IPO', '2012-05-18', 'Active', 'For Profit', '2', '', '', '', '', ''],\n  ['JDS Pharmaceuticals LLC.', 'https://www.crunchbase.com/organization/jds-pharmaceuticals-llc', 'Health Care, Medical, Pharmaceutical', 'Morrisville, Pennsylvania, United States', 'JDS Pharmaceuticals is a specialty pharmaceutical company', '351,812', '2004-11-17', '62000000', 'USD', '62000000', 'Series A', '62000000', 'USD', '62000000', '51-100', 'Private', '', '', '', '', '', '', 'JDS Pharmaceuticals is a specialty pharmaceutical company that develops prescription psychiatry products. The company was founded by Michael Satow in 2004 and is based in Morrisville, Pennsylvania.', 'Galen Partners, ACG Equity Partners', 'Health Care', '', '', '', '2004-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', 'Michael Satow', '', '1'],\n  ['Progenika Biopharma', 'https://www.crunchbase.com/organization/progenika-biopharma', 'Biotechnology', 'Cambridge, Massachusetts, United States', 'Development and production of molecular biology tests for blood group genotyping, diagnosis of genetic complex diseases and monitoring.', '353,074', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.progenika.com', '', '', 'Development and production of molecular biology tests for blood group genotyping, diagnosis of genetic complex diseases and monitoring.', '', 'Biotechnology, Science and Engineering', '', '', '$1M to $10M', '2007-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', '', '', ''],\n  ['Cygnus Inc.', 'https://www.crunchbase.com/organization/cygnus-inc', 'Biotechnology, Consumer Electronics, Diabetes, Electronics, Health Care, Manufacturing', 'San Francisco, California, United States', 'Cygnus develops and manufactures automatic and non-invasive glucose monitoring devices.', '356,651', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.cygnusinc.net', '', '', 'Cygnus Inc. develops and manufactures frequent, automatic, and noninvasive glucose monitoring devices. It offered devices that were used to provide data to individuals and physicians to enable them to manage diabetes. The company had operations in the United States and the United Kingdom. Cygnus Inc. was formerly known as Cygnus Therapeutic Systems Inc. and changed its name to Cygnus Inc. in September 1995. Cygnus, Inc. was founded in 1985 and is based in San Francisco, California. As of February 9, 2005, Cygnus Inc. is in Liquidation.', '', 'Biotechnology, Consumer Electronics, Hardware, Health Care, Manufacturing, Science and Engineering', '', '', '$1M to $10M', '1997-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['Orthovita', 'https://www.crunchbase.com/organization/orthovita', 'Biopharma, Health Care, Manufacturing, Medical', 'Malvern, Pennsylvania, United States', 'Orthovita is a spine and orthopedic biosurgery company that manufactures and markets orthobiologic and biosurgery products.', '357,140', '2007-07-30', '32500000', 'USD', '32500000', 'Post-IPO Equity', '32500000', 'USD', '32500000', '51-100', 'Delisted', '', '', '', '', '', '', 'Orthovita is a spine and orthopedic biosurgery company that manufactures and markets orthobiologic and biosurgery products. Its orthobiologics platform offers products for the fusion, regeneration, and fixation of human bones; and the biosurgery platform provides products for controlling intra-operative bleeding. Orthovita sells its products directly, as well as through non-stocking distributors and independent sales agents in the United States; and directly and through independent stocking distributors internationally. The company has strategic partnerships with Kensey Nash Corporation, Angiotech Pharmaceuticals, and Medafor. It was founded in 1992 and is based in Malvern, Pennsylvania.', 'SV Health Investors, Essex Woodlands Healthcare Partners', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1992-01-01', 'year', '', 'M&A', '2006-12-01', 'Active', 'For Profit', '', '', 'Was Acquired', '', '', '2'],\n  ['Helicon Therapeutics', 'https://www.crunchbase.com/organization/helicon-therapeutics', 'Biotechnology, Genetics, Neuroscience, Therapeutics', 'San Diego, California, United States', 'Helicon Therapeutics discovers therapeutics to treat disorders of cognition through genetic basis of long-term memory formation.', '361,147', '2009-09-29', '50000000', 'USD', '50000000', 'Series F', '108798000', 'USD', '108798000', '51-100', 'Private', '', '', '', 'http://www.helicontherapeutics.com', '', 'info@helicontherapeutics.com', 'Helicon Therapeutics is a privately held Company formed to discover therapeutics to treat disorders of cognition through an understanding of the genetic basis of long-term memory formation. The scientific origin and founding intellectual property came from the neuroscience program at the Cold Spring Harbor Laboratory.  Through seminal studies of learning and memory in fruit flies, a key function of the CREB (cAMP Response Element Binding Protein) gene was defined for the first time. The CREB gene encodes a protein which regulates the biochemical pathway that converts short-term memory to long-term memory - and it appears to function similarly in both fruit fly and in man.  Further functional genomic studies have identified a large number of additional genes that participate in this (and parallel) memory pathway(s). All of these genes are potential targets for the production of drugs that enhance or diminish memory formation.', '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1997-01-01', 'year', '', 'Late Stage Venture', '', 'Active', 'For Profit', '', '', '', '', '', '5'],\n  ['PLOS Genetics', 'https://www.crunchbase.com/organization/plos-genetics', 'Biotechnology, Genetics, Non Profit', 'San Francisco, California, United States', 'PLOS Genetics is an open-access, peer-reviewed journal published weekly by PLOS.', '364,616', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://plosgenetics.org', '', 'plosgenetics@plos.org', 'Genetics and genomics research has grown at a bewildering pace in the past 15 years. The techniques of these fields are being applied to a wealth of biological questions and experimental systems. PLOS Genetics reflects the full breadth and interdisciplinary nature of this research by publishing outstanding original contributions in all areas of biology. PLOS Genetics publishes human studies, as well as research on model organisms—from mice and flies, to plants and bacteria. Their emphasis is on studies of broad interest that provide significant insight into a biological process or processes. Topics include (but are not limited to) gene discovery and function, population genetics, genome projects, comparative and functional genomics, medical genetics, disease biology, evolution, gene expression, complex traits, chromosome biology, and epigenetics.', '', 'Biotechnology, Health Care, Other, Science and Engineering', '', '', '', '2000-10-01', 'day', '', '', '', 'Active', 'For Profit', '21', '', '', '', '', ''],\n  ['County Line Pharmaceuticals', 'https://www.crunchbase.com/organization/county-line-pharmaceuticals', 'Biotechnology, Neuroscience, Pharmaceutical', 'Brookfield, Wisconsin, United States', 'County Line focuses on under-appreciated generic assets and specialty generic products.', '375,899', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.countylinepharmaceuticals.com', 'https://www.linkedin.com/company-beta/1894895/', 'info@alvogen.com', 'County Line Pharmaceuticals was founded in 2007 by a group of pharmaceutical executives with extensive experience in the pharmaceutical industry.  This team was formerly employed at Schwarz Pharma Inc. (the US branded product subsidiary for Schwarz Pharma AG) and played key roles in forming and building Kremers Urban, the highly successful and well-respected generic subsidiary of Schwarz Pharma.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2007-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', 'Jeff Rumler', '', ''],\n  ['Applied Precision, Inc.', 'https://www.crunchbase.com/organization/applied-precision-inc', 'Biotechnology, Health Care, Life Science, Manufacturing', 'Issaquah, Washington, United States', 'Applied Precision, Inc. provides imaging, measurement, and analysis systems for the life sciences industries and OEM markets. The company', '376,505', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.api.com', '', '', 'Applied Precision, Inc. provides imaging, measurement, and analysis systems for the life sciences industries and OEM markets. The company offers microscopy imaging solutions to help scientists address disease-related questions for cellular and sub-cellular analyses. Its products include DeltaVision OMX Imaging System, a microscope system that offers super-resolution imaging using 3D structured illumination and localization microscopy techniques; DV Elite, a live cell microscopy imaging system that is designed to enhance the ability to look at more probes and samples over longer periods of time; and PersonalDV, an integrated hardware/software solution for live cell research needs. The company... Detailed Description', '', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', 'Optics', '', '$10M to $50M', '1986-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', 'Donald Snow, Ron Seubert, Ronald C. Seubert', '', ''],\n  ['The Institute for Reproductive Medicine and Science - IRMS', 'https://www.crunchbase.com/organization/the-institute-for-reproductive-medicine-and-science-irms', 'Biotechnology, Health Care', 'Livingston, New Jersey, United States', 'The Institute for Reproductive Medicine and Science is a fertility center that provides advanced infertility treatment.', '377,842', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.sbivf.com/', '', '', 'The Institute for Reproductive Medicine and Science is a fertility center that provides advanced infertility treatment. It is focused on helping users with any questions or concerns regarding IUI, IVF, ICSI, PGD (preimplantation genetic diagnosis), CGH, egg donation, sperm donation, gestational surrogacy, and anything associated with having a baby. Treatment is individually designed for each patient, and may include intrauterine insemination (IUI), in vitro fertilization (IVF), ICSI, blastocyst transfer, preimplantation genetic diagnosis (PGD), egg or embryo cryopreservation, or egg donation.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '1995-01-01', 'day', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['Vanson HaloSource', 'https://www.crunchbase.com/organization/vanson-halosource', 'Biotechnology, Manufacturing', 'Washington, District of Columbia, United States', 'Vanson HaloSource Inc., a Redmond, Wash.-based provider of anti-microbial solutions for patient care and consumer hygiene.', '382,770', '2005-03-17', '5000000', 'USD', '5000000', 'Series B', '10500000', 'USD', '10500000', '51-100', 'Private', '', '', '', 'http://www.vanson.com', '', 'information@vanson.com', \"In the spring of 2002, Vanson, Inc. and HaloSource Corp. merged to form Vanson HaloSource, Inc. in order to expand opportunities for product commercialization by capitalizing on manufacturing facilities, distribution channels and intellectual property. Vanson’s cGMP certified manufacturing facility, located in Western Washington accommodates the production of most of Vanson HaloSource's products. The management team and a talented pool of chemists, biochemists and microbiologists are working together to create and expand the Company’s broad spectrum of applications.  Today the Company holds dozens of patents and patents pending on a broad range of products that are distributed to the pool and spa, wastewater treatment, and biomedical industries. The Company has a substantial pipeline of proprietary new products in research and development, and a growing number of strategic alliances with prestigious companies to manufacture and market value-added chitin/chitosan-based and antimicrobial products.\", 'Mars, Washington Research Foundation, Montlake Capital, Alexander Hutton Venture Partners', 'Biotechnology, Manufacturing, Science and Engineering', 'Organic Chemistry', '', '', '2002-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '', '', '', '', '', '2'],\n  ['BioZyme', 'https://www.crunchbase.com/organization/biozyme', 'Biotechnology, Nutrition', 'St Louis, Missouri, United States', 'BioZyme develops and manufactures natural, proprietary products focused on animal nutrition, health, and microbiology.', '382,839', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://biozymeinc.com/', 'https://www.linkedin.com/company/biozyme-inc/', '', 'BioZyme develops and manufactures natural, proprietary products focused on animal nutrition, health, and microbiology. With a continued commitment to research, BioZyme offers a complete line of feed additives and high density, highly available vitamin, mineral, trace mineral and protein supplements for a variety of animals including cattle, pigs, poultry, sheep, goats, horses and dogs.', '', 'Biotechnology, Food and Beverage, Health Care, Science and Engineering', 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering', '', '$10M to $50M', '1951-01-01', 'year', '', '', '', 'Active', 'For Profit', '1', '1', 'Made Acquisitions', '', '', ''],\n  ['Diamondback Drugs', 'https://www.crunchbase.com/organization/diamondback-drugs', 'Pet, Pharmaceutical, Veterinary', 'Scottsdale, Arizona, United States', 'Diamondback serves veterinary clinics, veterinary hospitals, zoos, aquariums, research institutions, and individual pet owners.', '385,268', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.diamondbackdrugs.com/', 'https://www.linkedin.com/company/diamondback-drugs', 'pharmacist@diamondbackdrugs.com', 'Diamondback Drugs stock the widest range of medications, chemicals, bases and flavors. Their State of the Art equipment assures top quality and pharmaceutical elegance while helping to reduce overall product cost. All of their pharmacists and technicians have undergone specialized training in basic compounding, sterile compounding of injectables and ophthalmic products, and veterinary compounding. Unlike most pharmacies, compounding is our primary business, so your prescription will receive prompt and complete attention.', '', 'Community and Lifestyle, Health Care', '', '', '', '2001-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '5', '', 'Was Acquired', '', '', ''],\n  ['MedNews', 'https://www.crunchbase.com/organization/mednews', 'Biotechnology, Health Care, Medical Device, Pharmaceutical, Wellness', 'Saint Paul, Minnesota, United States', 'MedNews is a medical device company developing treatments for patients with heart failure.', '397,837', '2010-06-09', '478476', 'USD', '478476', 'Debt Financing', '478476', 'USD', '478476', '51-100', 'Private', '', '', '', 'http://acorncv.com/', '', '', 'Acorn Cardiovascular, Inc., a medical device company, develops treatments for patients with heart failure. Its product includes CorCap cardiac support device, a mesh warp that is implanted around the heart to provide ventricular support and reduce ventricular wall stress in patients with dilated cardiomyopathy and symptomatic heart failure. The company was incorporated in 1996 and is based in St. Paul, Minnesota.', '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$10M to $50M', '1996-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', 'Donald Rohrbaugh', '', '1'],\n  ['VitaCig', 'https://www.crunchbase.com/organization/vitacig', 'Biotechnology, Electronics, Health Care, Medical', 'Jacksonville, Florida, United States', 'VitaCig, Inc. – Leveraging Mobile Vaporization for Medical Delivery Applications', '408,253', '', '', '', '', '', '', '', '', '51-100', 'Public', '', '', '', 'http://www.vitacig.org', '', 'support@vitacig.org', 'VitaCig, Inc. an mCig, Inc. (Stock Symbol: MCIG) Company, is a technology company that is harnessing mobile vaporization technology for medical delivery applications. The company  launched its first consumer product: The VitaCig, a $3 nicotine-free device that looks and feels like an electronic cigarette (eCig). Unlike a traditional eCig, the VitaCig delivers a water-vapor of natural flavors, vitamins, and phytonutrients. Initially the VitaCig will be produced in three flavor categories: Relax, Refresh, Energize with plans for additional flavor categories and targeted medical applications in the future.   Thinking Outside The Box The traditional tobacco industry is estimated at nearly $900 Billion a year. Financial analysts from Wells Fargo, Goldman Sachs, and Citigroup predict that by 2022 Electronic Cigarettes will supplant the traditional tobacco industry and eventually grow into a $1 Trillion industry. A Unique Product at the Right Time The VitaCig is the right product unveiled at the right time. Society is well educated as to the negative effects of traditional smoking yet at the same time genuinely confused as to whether electronic cigarettes as currently marketed represent a true improvement in health or are simply gimmicks disguising the delivery of nicotine. By removing nicotine entirely from the equation and delivering vitamins and nutrients instead, VitaCig is well-positioned to gain both the trust and acceptance of consumers around the world. Strategic Investment VitaCig, Inc. is 49% owned by mCig, Inc. (Stock Symbol: MCIG) a technology company that has a history of disrupting the traditional eCig industry by bringing to market the mCig, a $10 loose-leaf eCig. Simultaneously Disrupting Big Tobacco and Big Pharma VitaCig, Inc. is disrupting both the traditional tobacco industry and the growing electronic cigarette industry by appealing to the existing 1.2 Billion adults globally that smoke cigarettes, providing them with a nicotine and tobacco-free alternative that may assist in harm reduction. Moreover, the company is expanding the target market beyond the 1.2 Billion adults by appealing to non-smokers or occasional smokers with a superior method for the consumption of Vitamins, Nutrients, and other compounds with medicinal efficacy.', '', 'Biotechnology, Consumer Electronics, Hardware, Health Care, Science and Engineering', '', '', '', '2012-01-01', 'year', '', 'IPO', '2014-04-21', 'Active', 'For Profit', '2', '', '', '', '', ''],\n  ['PetLife Pharmaceuticals Inc', 'https://www.crunchbase.com/organization/petlife-pharmaceuticals-inc', 'Biotechnology, Health Care, Medical, Pharmaceutical', 'Beverly Hills, California, United States', 'Investment opportunity in the Private Placement, Petlife Pharmaceuticals, Inc. is a publicly traded company.', '411,016', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.petlifepharma.com', '', 'info@petlifepharma.com', 'PetLife Pharmaceuticals, Inc. is a registered U.S Veterinary Pharmaceutical company whose mission is to bring its scientifically proven, potentiated bio active medication and nutraceuticals to treat cancer in pets.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', 'Less than $1M', '2014-08-11', 'day', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['Amber Diagnostics', 'https://www.crunchbase.com/organization/amber-diagnostics', 'Biotechnology, Health Care, Health Diagnostics', 'Orlando, Florida, United States', 'Amber Diagnostics provides quality used and refurbished medical imaging equipment. They specialize in advanced technologies including CT', '415,085', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.amberusa.com', 'http://www.linkedin.com/company/amber-diagnostics', 'Info@AmberUSA.com', 'Amber Diagnostics provides quality used and refurbished medical imaging equipment. They specialize in advanced technologies including CT Scanners, MRI, PET-CT Scanners, C-Arms, Mammography, Portable X-Ray, Bone Densitometers, Radiographic Rooms, and Ultrasound systems.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10M to $50M', '1994-01-01', 'year', '', '', '', 'Active', 'For Profit', '2', '', '', '', '', ''],\n  ['Corix Bioscience', 'https://www.crunchbase.com/organization/corix-bioscience', 'Biotechnology', 'Irvine, California, United States', 'Corix Bioscience is an organic biotechnology company. ', '419,647', '', '', '', '', '', '', '', '', '51-100', 'Public', '', '', '', '', '', 'info@corixbioscience.com', \"Corix Bioscience is a research and development firm of cannabidiol (CBD) products and treatments. Corix has invested millions into state of the art laboratories, grow farms and scientific research in order to find the best medical applications and treatments of cannabidiol. Corix has locations in the US, Africa and UK, manufacturing the best and safest CBD oils in the world. Corix is publically traded under ticker symbol CXBS. Corix has expanded its reach nationwide with ventures in various marketing entities, to bring awareness of cannabidiol benefits main stream. Corix's goal is to launch a new era of CBD medicine into the world in a safe and effective way. \", '', 'Biotechnology, Science and Engineering', '', '', '', '2007-01-01', 'year', '', 'IPO', '2013-03-18', 'Active', 'For Profit', '', '1', 'Made Acquisitions', '', '', ''],\n  ['Cognigen', 'https://www.crunchbase.com/organization/cognigen', 'Biotechnology, Health Care, Pharmaceutical', 'Buffalo, New York, United States', 'Since opening our doors in 1992, we’ve partnered with leading pharmaceutical and biotechnology companies', '421,441', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://cognigencorp.com', 'https://www.linkedin.com/company/cognigen-corporation', '', 'Since opening our doors in 1992, we’ve partnered with leading pharmaceutical and biotechnology companies, the World Health Organization, and the U.S. Food and Drug Administration, as well as provided pharmacology consulting and pharmacometric analyses for more than 100 drugs. But there’s a lot more to us than protocol design and gap analyses. On top of our vast expertise and relentless attention to detail, we also have very charming personalities. Just ask anyone – or better yet, find out for yourself.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '1992-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '13', '', 'Was Acquired', '', '', ''],\n  ['Advanced BioEnergy', 'https://www.crunchbase.com/organization/advanced-bioenergy', 'Biotechnology, Medical, Medical Device', 'Minneapolis, Minnesota, United States', 'Advanced BioEnergy is a liability company formed to develop, construct, own, and operate ethanol plants and other biofuels businesses.', '424,117', '2009-12-30', '7746327', 'USD', '7746327', 'Venture - Series Unknown', '7746327', 'USD', '7746327', '51-100', 'Private', '', '', '', 'http://www.advancedbioenergy.com', '', 'info@advancedbioenergy.com', 'Advanced BioEnergy, LLC (ABE) is a Delaware limited liability company formed to develop, construct, own, and operate ethanol plants and other biofuels businesses. The Company was founded in January 2005 with the goal of becoming the most efficient, scaled pure play ethanol producer in the United States. ABE intends to establish a multi-plant presence across the United States in order to ensure access to a variety of markets for ethanol and co-products, capitalize on transportation and logistics advantages and reduce the impact of regional drought or disease on the supply of corn and sale of its products.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '$100M to $500M', '2005-01-01', 'year', '', '', '', 'Active', 'For Profit', '1', '', '', '', '', '1'],\n  ['Pegasus Biologics', 'https://www.crunchbase.com/organization/pegasus-biologics', 'Biotechnology, Manufacturing, Medical Device', 'Irvine, California, United States', 'Pegasus Biologics manufactures, develops, and markets bioimplants for soft tissue repair and wound care for diabetic ulcers.', '430,732', '2009-06-06', '1047369', 'USD', '1047369', 'Debt Financing', '32697369', 'USD', '32697369', '51-100', 'Private', '', '', '', 'http://www.pegasusbio.com', 'https://www.linkedin.com/company/pegasus-biologics', '', 'Pegasus Biologics, Inc. engages in manufacturing, developing, and marketing bioimplants for soft tissue repair and wound care for diabetic ulcers. Its products include OrthADAPT Bioimplant, which is an organized tissue scaffold that used for the repair and reinforcement of soft tissues, such as tendons and ligaments; and Unite Biomatrix, which is an enzyme resistant collagen scaffold that allows for suture retention and intrinsic strength. The company serves orthopedics, sports medicine, neurosurgical, and spine applications. Pegasus Biologics, Inc. was founded in 2003 and is based in Irvine, California. As of July 17, 2009, Pegasus Biologics, Inc. operates as a subsidiary of Synovis Life Technologies Inc.', 'Frazier Healthcare Partners, Life Science Angels, ONSET Ventures, Affinity Capital Management, Three Arch Partners', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', '', '', '', '2003-01-01', 'year', '', 'Late Stage Venture', '', 'Closed', 'For Profit', '1', '', '', 'France Helfer', '', '4'],\n  ['ACLARA BioSciences', 'https://www.crunchbase.com/organization/aclara-biosciences', 'Biotechnology, Consumer Electronics, Genetics', 'Mountain View, California, United States', 'Aclara Biosciences develops lab-on-a-chip technologies for use in genomics research and pharmaceutical drug screening.', '433,940', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', '', '', '', 'Aclara Biosciences develops lab-on-a-chip technologies for use in genomics research and pharmaceutical drug screening. ACLARA Biosciences provides assay chemistry solutions for drug discovery and development, providing critical high-value information about the expression and interaction of genes and proteins within cells. ACLARA is dedicated to unlocking the power of pathway biology to identify highly specific protein-based biomarkers, accelerate the development of next-generation targeted therapeutics, and recognize the most appropriate patients for approved therapies, thereby enabling physicians to create personalized treatment regimens for patients suffering from cancer and other life-threatening diseases. Aclara Biosciences Inc. was founded in 1995 and is based in Mountain View, California. As of December 10, 2004, Aclara Biosciences Inc. was acquired by Monogram Incorporated.', '', 'Biotechnology, Consumer Electronics, Hardware, Health Care, Science and Engineering', 'Testing', '', '', '1995-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['Biomed Laboratories', 'https://www.crunchbase.com/organization/biomed-laboratories', 'Health Care, Medical Device, Pharmaceutical', 'Dallas, Texas, United States', 'BioMed is a business-to-business developer and manufacturer of topical skin care solutions.', '434,796', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.biomedlabs.com/', 'https://www.linkedin.com/company/biomed-laboratories-llc/?originalSubdomain=in', 'cs@biomedlabs.com', 'BioMed is a business-to-business developer and manufacturer of topical skin care solutions for advanced wound care, ostomy and consumer wellness markets. ', '', 'Health Care', '', '', '', '2011-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', '', '', ''],\n  ['Bigelow Laboratory for Ocean Sciences', 'https://www.crunchbase.com/organization/bigelow-laboratory-for-ocean-sciences', 'Biotechnology, Education, Marine Technology, Non Profit', 'West Boothbay Harbor, Maine, United States', 'Bigelow Laboratory for Ocean Sciences, a non-profit organization, focuses on microbials affecting the productivity of the world’s oceans.', '440,958', '2010-09-30', '9000000', 'USD', '9000000', 'Grant', '9000000', 'USD', '9000000', '51-100', 'Private', '', '', '', 'http://www.bigelow.org', '', 'webmaster@bigelow.org', \"Founded in 1974, Bigelow Laboratory is an independent, non-profit organization with a primary focus on basic research of microbial processes affecting the productivity of the world's oceans, coastal seas, and estuaries. From its beginning, the Laboratory has been distinguished by its spirit of scientific freedom and a tradition of open, interdisciplinary collaboration, mentorship, and entrepreneurship. We have developed multiple learning and research affiliations with institutions of higher learning locally, nationally and worldwide.\", '', 'Biotechnology, Education, Other, Science and Engineering', '', '', '$1M to $10M', '1974-01-01', 'year', '', '', '', 'Active', '', '8', '', '', 'Charles Yentsch, Clarice Yentsch', '', '1'],\n  ['Zyvex', 'https://www.crunchbase.com/organization/zyvex', 'Advanced Materials, Biotechnology, Developer Platform, Electronics, Information Technology, Manufacturing', 'Richardson, Texas, United States', 'Zyvex was founded in 1997, as the first molecular nanotechnology company', '444,163', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://zyvex.com/', '', '', 'Zyvex was founded in 1997, as the first molecular nanotechnology company, with the vision of developing atomically precise manufacturing. By 2007, Zyvex research had been commercialized in several products. As those product lines grew, Zyvex restructured into separate companies so that each company could independently focus on its industry leading technology and products.', '', 'Biotechnology, Consumer Electronics, Hardware, Information Technology, Manufacturing, Science and Engineering, Software', 'Medical Or Veterinary Science; Hygiene', '', '$50M to $100M', '1997-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', 'James R. Von Ehr II', '', ''],\n  ['Touchstone Health', 'https://www.crunchbase.com/organization/touchstone-health', 'Dental, Health Care, Medical, Pharmaceutical', 'New York, New York, United States', 'Touchstone Health, a Medicare Advantage insurer, offered plans that included medical, pharmaceutical, dental and mental health benefits.', '451,374', '2010-10-20', '27500000', 'USD', '27500000', 'Venture - Series Unknown', '27500000', 'USD', '27500000', '51-100', 'Private', '', '', '', 'http://www.touchstoneh.com', '', '', 'Touchstone Health, a New York-based Medicare Advantage insurer. Touchstone offers a diverse portfolio of Medicare Advantage product options, including a choice of zero and low dollar co-pay plans with benefits including medical, pharmacy dental and mental health.', '', 'Health Care', '', '', '', '1998-01-01', 'year', '', '', '', 'Closed', 'For Profit', '2', '', '', '', '', '1'],\n  ['Besse Medical', 'https://www.crunchbase.com/organization/besse-medical', 'Health Care, Pharmaceutical', 'West Chester, Ohio, United States', 'Besse is a pharmaceuticals industry.', '458,424', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://www.besse.com', 'https://www.linkedin.com/company-beta/6715098/', 'info@besse.com', 'Besse is one of the  trusted distributors of pharmaceuticals, vaccines, biological and basic ancillary supplies to community physicians. Besse accelerate access to the products, insights, technology and guidance practices need to improve product access, maximize practice effectiveness and efficiency and ultimately help healthcare providers elevate the patient experience.', '', 'Health Care', '', '', 'Less than $1M', '1948-01-01', 'year', '', '', '', 'Active', 'For Profit', '1', '', '', '', '', ''],\n  ['AmStem', 'https://www.crunchbase.com/organization/amstem', 'Biotechnology, Health Care, Medical', 'Tampa, Florida, United States', 'AmStem operates as a biotechnology company.', '461,657', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://amsteminc.com', '', 'Info@amsteminc.com', 'AmStem Inc. is a corporation registered in the State of Nevada with offices in San Francisco, California and Seoul, Korea. The company is a world leader in the area of stem cell research using stem cells derived from the umbilical cord immediately after birth. The company has 19 U.S. and international patents related to stem cell processing, application and clinical treatments. AmStem owns one of the largest cord blood stem cell banks in the world with more than 80,000 cord blood units stored in Korea. The facility in Korea is highly accredited including Korean FDA approval (KFDA). The units of cord blood are processed and stored by the company for use in unrelated transplant for personal storage and use in the family setting for transplant and regenerative medicine. The company is developing a line of cosmeceuticals based upon its proprietary stem cell technology and sourcing its own materials from its expansive operation in Korea. The company has treated more than 800 people in clinical trials for purposes of developing its patent portfolio.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '$10M to $50M', '2000-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['MDG Medical', 'https://www.crunchbase.com/organization/mdg-medical', 'Biotechnology, Health Care, Medical', 'Beachwood, Ohio, United States', 'MDG Medical provider of an automated pharmaceutical dispensing system for use in hospitals.', '462,028', '2004-02-13', '7500000', 'USD', '7500000', 'Series B', '7500000', 'USD', '7500000', '51-100', 'Private', '', '', '', 'http://www.mdgmedical.com', '', 'info@mdgmedical.com', \"MDG Medical developed the affordable and cost-effective ServeRx® system for hospitals and long-term-care settings to reduce medication errors, improve management of medications and enhance patient safety. ServeRx® produces rapid return on investment as health-care institutions may quickly recognize thousands or millions of dollars of cost savings. Thousands of people die and tens of thousands more are injured each year due to preventable medication errors. These errors, including patient mixups, illegible prescriptions, confusion between different pharmaceuticals with similar names, and incorrect dosages, cause deep human suffering. For health-care institutions, preventable medication errors lengthen patients' hospital stays and create millions of dollars of additional operating expenses and liability costs. Adverse drug events (ADEs) occur at a rate of 2.5% of hospital admissions in the U.S. and 10% in Europe. Each of these ADEs costs hospitals an average of nearly $5,000. Worldwide, legislators and the public at large are demanding that health-care institutions take affirmative steps to better manage their medication efforts and protect their patients.\", 'RSL Venture Partners, LSKW Investments LP', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '2000-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '1', '', '', '', '', '1'],\n  ['Calvert Holdings', 'https://www.crunchbase.com/organization/calvert-holdings', 'Biotechnology, Market Research, Pharmaceutical', 'Cary, North Carolina, United States', 'Calvert Holdings is a company invested in the research of pre-clinical drug testing innovations and solutions.', '462,460', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://calvertholdings.com/', 'https://www.linkedin.com/company/831139', '', 'They are a diverse team of entrepreneurs, business developers, researchers, marketers and scientists committed to optimizing the success of their partners. They drive this success by identifying unseen opportunities and ensuring they can be fully realized by helping their partners secure the resources needed to fill crucial infrastructure, scientific and financial gaps. While life sciences comprise their core focus, they are constantly seeking to partner and collaborate with like-minded organizations who embrace the philosophy that there is always a solution that can lead to new potential, greater growth, and a better future for all of them.', '', 'Biotechnology, Data and Analytics, Design, Health Care, Science and Engineering', '', '', '$10M to $50M', '1996-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['Flagship Biosciences', 'https://www.crunchbase.com/organization/flagship-biosciences', 'Artificial Intelligence, Biotechnology, Health Care, Health Diagnostics', 'Westminster, Colorado, United States', 'Flagship Biosciences delivers comprehensive tissue profiling using our Artificial Intelligence (AI) enabled cTA® pathology platform.', '462,540', '2018-07-11', '', '', '', 'Series A', '', '', '', '51-100', 'Private', '', '', '', 'http://www.flagshipbio.com', 'http://www.linkedin.com/company/flagship-biosciences', 'info@flagshipbio.com', 'Flagship Biosciences delivers comprehensive tissue profiling for predictive diagnostic applications using our Artificial Intelligence (AI) enabled cTA® pathology platform. Our intuitive data reporting gives researchers, clinicians, and drug developers the actionable information needed to drive better clinical results for patients.', '', 'Artificial Intelligence, Biotechnology, Data and Analytics, Health Care, Science and Engineering, Software', 'Computing; Calculating', '', '$1M to $10M', '2009-01-01', 'year', '', 'Early Stage Venture', '', 'Active', 'For Profit', '8', '', '', 'David Young', '', '1'],\n  ['NovaSys', 'https://www.crunchbase.com/organization/novasys', 'Biotechnology, Health Care, Medical', 'Little Rock, Arkansas, United States', 'NovaSys is a contracted healthcare provider.', '471,237', '2008-05-16', '49500000', 'USD', '49500000', 'Venture - Series Unknown', '49500000', 'USD', '49500000', '51-100', 'Private', '', '', '', 'http://www.novasyshealth.com', '', '', 'At NovaSys Health they value your participation as a contracted provider. Roughly 11,000 providers in this region and over 4,300 providers in Arkansas have contracted with NovaSys Health making it one of the largest health plans in Arkansas. They take pride in the relationships that they have cultivated with providers.', 'Invesco, Versant Ventures, Alloy Ventures, Delphi Ventures, Skyline Ventures', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '1996-01-01', 'year', '', '', '', 'Closed', 'For Profit', '', '', '', '', '', '1'],\n  ['Digestive Disease Associates', 'https://www.crunchbase.com/organization/digestive-disease-associates', 'Biotechnology, Health Care, Medical, Pharmaceutical', 'Reading, Pennsylvania, United States', 'Digestive Disease Associates page was specifically created to keep our patients up to date with Digestive Disease Associates.', '473,284', '2009-09-23', '1132416', 'USD', '1132416', 'Venture - Series Unknown', '1132416', 'USD', '1132416', '51-100', 'Private', '', '', '', 'http://ddaberks.com', 'https://www.linkedin.com/company/digestive-disease-associates/about/', 'ddainfo@dda-bcdh.com', 'Digestive Disease Associates page was specifically created to keep our patients up to date with Digestive Disease Associates. No specific medical information will be given out through this page. We kindly ask that no medical information pertaining to or about any specific patient not be shared on this page. If you are experiencing a medical concern, please call our office at 610-374-4401 to make an appointment or to speak to a nurse.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '$1M to $10M', '1972-01-01', 'year', '', '', '', 'Active', 'For Profit', '1', '', '', 'Barton Smith', '', '1'],\n  ['Raven Biotechnologies', 'https://www.crunchbase.com/organization/raven-biotechnologies', 'Biotechnology, Medical, Therapeutics', 'South San Francisco, California, United States', 'Raven biotechnologies is focused on the development of monoclonal antibody therapeutics for the treatment of cancer.', '481,733', '2005-10-24', '48300000', 'USD', '48300000', 'Series D', '88300000', 'USD', '88300000', '51-100', 'Private', '', '', '', 'https://www.macrogenics.com/', '', '', 'Raven biotechnologies, Inc., a biotechnology company, focuses on the development of monoclonal antibody therapeutics for treating cancer. Its lead product candidate, RAV12, targets adenocarcinomas and used for the treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is based in South San Francisco, California. As of July 17, 2008, Raven Biotechnologies, Inc. operates as a subsidiary of MacroGenics, Inc.', 'Vulcan Capital, Mitsubishi UFJ Capital, U.S. Venture Partners, EDBI, Biogen Idec', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '1999-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', 'Jennie P. Mather', '', '2'],\n  ['American Society of Cataract and Refractive Surgery (ASCRS)', 'https://www.crunchbase.com/organization/american-society-of-cataract-and-refractive-surgery', 'Biotechnology, Education, Health Care, Medical', 'Fairfax, Virginia, United States', 'The American Society of Cataract and Refractive Surgery is an international, educational society with more than 9,000 members.', '483,130', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.ascrs.org/', '', '', \"The American Society of Cataract and Refractive Surgery is an international, educational society with more than 9,000 members. Its mission is to advance the art and science of ophthalmic surgery and the knowledge and skills of ophthalmic surgeons by providing clinical and practice management education and by working with patients, government, and the medical community to promote the delivery and advancement of high-quality eye care. Since its founding in 1974, ASCRS has led the field through significant advances in technology and clinical science through its educational programs, publications and on-line resources. ASCRS has become the surgeons' primary source of up-to-date clinical information, published research, and regulatory information affecting the practice of medicine.\", '', 'Biotechnology, Education, Health Care, Science and Engineering', '', '', '$10M to $50M', '1983-01-01', 'year', '', '', '', 'Active', 'For Profit', '7', '', '', '', '', ''],\n  ['Reliable Biopharmaceutical Corp.', 'https://www.crunchbase.com/organization/reliable-biopharmaceutical-corp', 'Pharmaceutical', 'St Louis, Missouri, United States', 'Reliable Biopharmaceutical Corporation engages in the development and manufacture of active pharmaceutical and high purity ingredients.', '486,729', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://reliablebiopharm.com/', '', '', 'Reliable Biopharmaceutical Corporation engages in the development and manufacture of active pharmaceutical and high purity ingredients.', '', 'Health Care', 'Organic Chemistry', '', '$10M to $50M', '1968-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['CymoGen Dx', 'https://www.crunchbase.com/organization/cymogen-dx', 'Biotechnology, Genetics, Health Diagnostics', 'New Windsor, New York, United States', 'CymoGen Dx is a genomic diagnostic company engaged in the development and application of fluorescence-based DNA detection technologies.', '489,774', '2010-07-07', '350161', 'USD', '350161', 'Seed', '350161', 'USD', '350161', '51-100', 'Private', '', '', '', 'http://cymogendx.com', '', 'sales@cymogendx.com', 'CymoGen Dx, LLC, a genomic diagnostic technology company, provides genomic-based reagents and fluorescent in-situ hybridization probes research products and solutions for the diagnosis and monitoring of cancers and human genetic disorders for clinical, biopharmaceutical, and research customers. It engages in the development, manufacture, and application of fluorescence-based DNA detection technology. The company provides tools for identifying genomic aberrations in cancer cells found in tissue and bone marrow specimens. CymoGen Dx, LLC was formerly known as CymoGen, LLC. The company was incorporated in 2010 and is based in New Windsor, New York.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2010-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', '', '', '1'],\n  ['Rubino OB/GYN Group', 'https://www.crunchbase.com/organization/rubino-ob-gyn-group', \"Biotechnology, Health Care, Medical, Women's\", 'West Orange, New Jersey, United States', 'Rubino OB/GYN Group provides non-invasive solutions to women’s health care.', '497,366', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://rubinoobgyn.com/', 'https://www.linkedin.com/company/the-rubino-ob-gyn-group/', '', 'Rubino OB/GYN Group provides non-invasive solutions to women’s health care. Its goal is to offer the obstetric and gynecological care available, including the most advanced and safest procedures, in a patient-centered environment. The company was founded in 1995 and is headquartered in West Orange, New Jersey.', '', 'Biotechnology, Community and Lifestyle, Health Care, Science and Engineering', '', '', '', '1995-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', '', '', ''],\n  ['PHL Life Sciences', 'https://www.crunchbase.com/organization/phl-life-sciences', 'Biotechnology, Non Profit', 'Philadelphia, Pennsylvania, United States', 'PHLLife, a division of the Philadelphia Convention.', '508,429', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.discoverphl.com/phllife/', 'https://www.linkedin.com/company/56174', 'marketing@discoverphl.com', 'PHLLife, a division of the Philadelphia Convention & Visitors Bureau (PHLCVB), connects the tri-state’s (Pennsylvania, New Jersey and Delaware) life sciences leaders representing medical, biotechnology, pharmaceutical, higher education, research, venture capital and the health care industries to collaborate and brand the Philadelphia region as “America’s Life Sciences Meetings Destination.” - See more at: http://www.discoverphl.com/phllife/about-us/#sthash.cnQDObqN.dpuf', '', 'Biotechnology, Other, Science and Engineering', '', '', '$1M to $10M', '1941-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['Kiwa Bio-Tech Products Group', 'https://www.crunchbase.com/organization/kiwa-bio-tech-products-group', 'Biotechnology', 'Claremont, California, United States', 'Kiwa Bio-Tech Products Group develops and manufactures safe bio-technological products.', '509,384', '', '', '', '', '', '', '', '', '51-100', 'Public', '', '', '', 'http://www.kiwabiotech.com/', '', 'kiwabiotech@kiwabiotech.com', 'Kiwa Bio-Tech Products Group develops, manufactures, distributes and markets innovative, cost-effective and environmentally safe bio-technological products for agricultural and environmental conservation.', '', 'Biotechnology, Science and Engineering', '', '', '', '1999-01-01', 'year', '', 'IPO', '2004-04-08', 'Active', 'For Profit', '', '2', 'Made Acquisitions', '', '', ''],\n  ['Opus Healthcare Solutions', 'https://www.crunchbase.com/organization/opus-healthcare-solutions', 'Biotechnology, Health Care', 'Austin, Texas, United States', 'Opus Healthcare Solutions, Inc. provides Web-based applications to hospital systems, physician group practices, and reference laboratories.', '522,155', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.opushealthcare.com', '', 'support@opushealthcare.com', 'Opus Healthcare Solutions, Inc. delivers web-based clinical solutions to hospital systems and integrated health networks nationwide and is one of only three companies worldwide that has achieved the \\'08 CCHIT Certified® Inpatient EHR System Certification Level.  Based on a Web 2.0 architecture that leverages full \"cloud computing\" capabilities, the \\'08 CCHIT Certified® Inpatient EHR System OpusClinicalSuite® Version 2.3 (Pre-Market) pushes clinical capabilities beyond the four walls of the hospital. The OpusClinicalSuite® provides a single point-of-access for clinicians to enter and retrieve all inpatient clinical information (patient vitals, lab results, medications, and imaging results) from the bedside or remote locations, including Smartphone access from any device with a data plan and standard Web browser.  Implementing the OpusClinicalSuite® with its CPOE, Clinical Documentation, and Clinical Decision support capabilities will position hospitals to achieve the Stage 4 Adoption Level in the HIMSS® EMR Adoption Model and benefit from ARRA reimbursement opportunities.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '1987-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', 'Fred Beck, Tim Rhoads', '', ''],\n  ['LJL Biosystems', 'https://www.crunchbase.com/organization/ljl-biosystems', 'Biotechnology, Information Technology, Product Design', 'Sunnyvale, California, United States', 'LJL is developing and marketing proprietary technologies and products to accelerate and enhance the drug discovery process.', '525,611', '', '', '', '', '', '', '', '', '51-100', 'Delisted', '', '', '', '', '', '', \"LJL is developing and marketing proprietary technologies and products to accelerate and enhance the drug discovery process. LJL's proprietary integrated technology platform is comprised of instrumentation and fluorescence-based and other assay technologies designed to provide a flexible solution to the current and evolving HTS requirements of drug discovery laboratories. The drug discovery process involves several stages including target identification, compound synthesis, assay development, screening and lead optimization.\", '', 'Biotechnology, Design, Information Technology, Science and Engineering', '', '', '', '1988-01-01', 'year', '', 'M&A', '1998-03-13', 'Active', 'For Profit', '', '', 'Was Acquired', '', '', ''],\n  ['Ancora Pharmaceuticals', 'https://www.crunchbase.com/organization/ancora-pharmaceuticals', 'Biopharma, Biotechnology, Pharmaceutical', 'Medford, Massachusetts, United States', 'Ancora Pharmaceuticals, Inc., a biopharmaceutical company, develops immune system modulation therapeutics using synthetic carbohydrates in', '537,792', '2009-11-09', '800000', 'USD', '800000', 'Venture - Series Unknown', '800000', 'USD', '800000', '51-100', 'Private', '', '', '', 'http://www.ancorapharma.com', '', 'contactus@cordenpharma.com', 'Ancora Pharmaceuticals, Inc., a biopharmaceutical company, develops immune system modulation therapeutics using synthetic carbohydrates in the United States. Its products include vaccines against bacterial, parasitic, and viral infectious diseases, as well as therapeutics to treat cardiovascular and metabolic diseases. The company was incorporated in 2001 and is based in Medford, Massachusetts. As of October 31, 2013, Ancora Pharmaceuticals, Inc. operates as a subsidiary of Corden Pharma Switzerland LLC.', 'University Venture Fund', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '$1M to $10M', '2001-01-01', 'year', '', '', '', 'Active', 'For Profit', '1', '', '', 'Louis Schofield', '', '2'],\n  ['Impact Product Development', 'https://www.crunchbase.com/organization/impact-product-development-llc', 'Industrial, Manufacturing, Medical, Pharmaceutical, Product Design, Virtual Reality', 'Merrimack, New Hampshire, United States', 'Innovative design development for medical devices, drug delivery, and consumer health.', '554,373', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.insightpd.com', '', '', 'Impact Product Development, LLC is a unique and creative product development company located in Merrimack NH. Core competencies include Industrial Design, Mechanical Engineering, Electrical Engineering and software engineering. Impact PD has a created a brand called Measure it and introducing Measure it Tournament described in the attached slide deck!', '', 'Design, Hardware, Health Care, Manufacturing, Software', '', '', '$1M to $10M', '1988-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['Energy Research Company', 'https://www.crunchbase.com/organization/energy-research-company-inc', 'Biotechnology, Electronics, Energy, Industrial, Information Technology, Renewable Energy', 'Staten Island, New York, United States', 'Energy Research Company develops laser diagnostic technologies to measure in-situ and the chemistry of materials.', '562,348', '2010-12-15', '249974', 'USD', '249974', 'Grant', '613974', 'USD', '613974', '51-100', 'Private', '', '', '', 'http://www.er-co.com', '', 'info@er-co.com', 'Energy Research Company (ERCo), formed in 1991, is a small high-tech company that conducts research in industrial energy and emissions related areas. ERCo has a number of federal and state R&D technology contracts as well as funding from commercial sources.  The company develops technologies that it owns and typically licenses to others for commercial deployment. Also, ERCo consults with other companies on technology matters and assists them in obtaining R&D technology or demonstration grants.', 'NYSERDA', 'Biotechnology, Consumer Electronics, Energy, Hardware, Information Technology, Manufacturing, Science and Engineering, Sustainability', 'Testing', '', '$10M to $50M', '1991-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', '', '', '3'],\n  ['Amend Surgical', 'https://www.crunchbase.com/organization/amend-surgical', 'Biotechnology, Manufacturing, Medical', 'Alachua, Florida, United States', 'Amend Surgical is focused on enhancing the healing and regenerative capacity of bone grafts.', '577,345', '2017-05-12', '', '', '', 'Seed', '', '', '', '51-100', 'Private', '', '', '', 'https://www.amendsurgical.com/', '', '', 'Amend Surgical is focused on enhancing the healing and regenerative capacity of bone grafts. They are manufacturing and developing a product portfolio of natural and synthetic bone graft substitutes. Amend Surgical is committed to innovation and advancing the science of orthobiologics.', 'Florida Institute for the Commercialization of Public Research', 'Biotechnology, Health Care, Manufacturing, Science and Engineering', '', '', 'Less than $1M', '2015-06-01', 'month', '', 'Seed', '', 'Active', 'For Profit', '2', '', '', 'Robby Lane, Ronald Cobb', '', '1'],\n  ['SPSmedical', 'https://www.crunchbase.com/organization/spsmedical', 'Biotechnology, Health Care, Medical', 'Rush, New York, United States', 'SPSmedical is a sterilizer testing laboratory that offers a complete line of sterility assurance products.', '579,795', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.spsmedical.com', '', 'info@spsmedical.com', \"SPSmedical is the largest sterilizer testing laboratory in North America and is a corporate member of AAMI (medical), OSAP (dental), and the Canadian Standards Association (medical). Having private labeled in past years to other companies, they now also offer the industry's most complete line of sterility assurance products under their own SPSmedical brand through authorized distributors worldwide.\", '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '1987-01-01', 'year', '', 'M&A', '', 'Active', '', '', '', 'Was Acquired', '', '', ''],\n  ['Diagnostic and Interventional Cardiology', 'https://www.crunchbase.com/organization/diagnostic-and-interventional-cardiology', 'Biotechnology, Clinical Trials, Medical', 'Morrisville, North Carolina, United States', 'DAIC magazine offers information about products cleared by the FDA and ongoing clinical trials to cardiology departments.', '580,426', '2010-08-09', '1550000', 'USD', '1550000', 'Venture - Series Unknown', '1550000', 'USD', '1550000', '51-100', 'Private', '', '', '', 'http://dicardiology.com', 'https://www.linkedin.com/groups/Diagnostic-Interventional-Cardiology-magazine-2573591', '', 'DAIC magazine connects cardiology departments with the latest products cleared by the FDA, news from ongoing clinical trials and offers information to aid in purchasing decisions. DAIC provides product comparison charts, overviews of how newer technology works and stories about how end-users have solved problems, increase workflow and improved patient outcomes using various technology.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', 'Less than $1M', '1960-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', 'Halbert Powers Gillette', '', '1'],\n  ['Veratect', 'https://www.crunchbase.com/organization/veratect', 'Biotechnology, Health Care', 'Kirkland, Washington, United States', 'Veratectprovides an early alert system to corporations and government agencies about disease outbreaks.', '591,068', '2009-10-06', '4200000', 'USD', '4200000', 'Debt Financing', '4200000', 'USD', '4200000', '51-100', 'Private', '', '', '', 'http://www.veratect.com', '', 'info@veratect.com', 'Tracks emerging health threats like swine flu', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2008-01-01', 'year', '', '', '', 'Closed', 'For Profit', '1', '', '', '', '', '1'],\n  ['Bio Safe One', 'https://www.crunchbase.com/organization/bio-safe-one', 'Biotechnology', 'New York, New York, United States', 'As a leading specialists in septic solutions, Bio-Safe One has done reseach and development.', '591,391', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.biosafeone.com', '', 'biosafeone5@gmail.com', 'Bio-Safe One has done research and development. Bio-Safe One featured products are BIO-112, Heavy Sludge DigesterTM - 5 Gallon – Liquid and B.O.S.S. - Bio-Safe One  Septic Solution.', '', 'Biotechnology, Science and Engineering', '', '', 'Less than $1M', '2001-01-15', 'day', '', '', '', 'Active', 'For Profit', '58', '', '', '', '', ''],\n  ['Circulants', 'https://www.crunchbase.com/organization/circulants', 'Information Technology, Pharmaceutical', 'Pleasanton, California, United States', 'Data Driven Decisions', '604,158', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://circulants.com', 'https://www.linkedin.com/company/circulants', 'sanjay@circulants.com', 'Pharma Operations on Cloud', '', 'Health Care, Information Technology', '', '', '', '2018-02-21', 'day', '', '', '', 'Active', 'For Profit', '', '', '', 'sanjay koshatwar', '', ''],\n  ['Gavin Publishers', 'https://www.crunchbase.com/organization/gavin-publishers', 'Biotechnology, Communities, Events, Medical, Publishing', 'Lisle, Illinois, United States', 'Gavin Publishers is an online international open access, peer reviewed journals publishing org which publishes all kinds of manuscripts.', '639,479', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://gavinpublishers.com/', 'https://www.linkedin.com/company/gavin-publishers/', 'contact@gavinpublishers.org', 'Gavin Publishers is an online international open access, peer reviewed journals publishing organization which publishes all kinds of manuscripts (Research, Review, Case Reports, Editorials, Brief Reviews, Research Highlights, etc.,) from the fields related to Clinical, Pharmaceutical, Medical Sciences and Engineering. Our passion for serving the scientific community drove us to publish our journals through an open access mode (free to read and free to download). We strive hard to spread the knowledge and to broaden the scope of Gavin Publishers Journals worldwide. We welcome distinguished researchers, scholar, academicians and people involved in and around the fields of Clinical, Biological, Pharmaceutical, Medical, Life Sciences and Engineering with open arms to come forward to share and to gain the knowledge by an open access mode and generate a platform for emerging scholars and researchers where they can build a huge forum of scientific community at global level.', '', 'Biotechnology, Community and Lifestyle, Content and Publishing, Events, Health Care, Media and Entertainment, Science and Engineering', '', '', 'Less than $1M', '2017-06-06', 'day', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['Lehigh Valley Tech', 'https://www.crunchbase.com/organization/lehigh-valley-tech', 'Enterprise Software, Information Technology, Pharmaceutical', 'Bethlehem, Pennsylvania, United States', 'The Lehigh Valley Tech is a group for startups, entrepreneurs, hackers, and technology.', '647,981', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://lehighvalleytech.org/', 'http://www.linkedin.com/company/lehigh-valley-tech', 'info@lehighvalleytech.org', 'Lehigh Valley Tech provides a collaboration platform for startups, entrepreneurs, hackers, and technology enthusiasts in the Lehigh Valley to share and demo what they are working on. The company was founded by Mark Koberlein in 2011 and is headquartered in Bethlehem, Palestine.', '', 'Health Care, Information Technology, Software', '', '', 'Less than $1M', '2011-02-01', 'day', '', '', '', 'Active', 'For Profit', '', '', '', 'Mark Koberlein', '', ''],\n  ['Ngen', 'https://www.crunchbase.com/organization/ngen', 'Biotechnology, Genetics, Health Diagnostics', 'San Diego, California, United States', 'Ngen integrates microelectronics and molecular biology into a technology platform with commercial apps in the fields of medical diagnostics.', '675,650', '', '', '', '', '', '', '', '', '51-100', 'Delisted', '', '', '', '', '', '', 'Nanogen, Inc. (\"Nanogen\" or the \"Company\") integrates advanced microelectronics  and molecular biology into a platform technology with broad commercial applications in the fields of medical diagnostics, biomedical research, genomics, genetic testing and drug discovery. Nanogen\\'s fully automated system, which incorporates a proprietary semiconductor microchip, provides a flexible tool for the rapid identification and analysis of any test sample containing charged molecules.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '1993-01-01', 'year', '', 'IPO', '1998-04-14', 'Active', 'For Profit', '1', '1', 'Made Acquisitions', '', '', ''],\n  ['The Scientist', 'https://www.crunchbase.com/organization/the-scientist', 'Biotechnology, Education', 'Midland, Texas, United States', 'The Scientist is a reports on the most exciting discoveries and innovative trends across the spectrum of life science research.', '680,663', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://www.the-scientist.com/', 'https://www.linkedin.com/company/the-scientist/', 'info@the-scientist.com', 'The Scientist is the magazine for life science professionals—a publication dedicated to covering a wide range of topics central to the study of cell and molecular biology, genetics, and other life-science fields. Through innovative print articles, online stories, and multimedia features, the magazine explores the latest scientific discoveries, trends in research, innovative techniques, new technology, business, and careers. It is read by leading researchers in industry and academia who value penetrating analyses and broad perspectives on life-science topics both within and beyond their areas of expertise. Written by prominent scientists and professional journalists, articles in The Scientist are concise, accurate, accessible, and entertaining.', '', 'Biotechnology, Education, Science and Engineering', '', '', '', '1986-01-01', 'year', '', '', '', 'Active', 'For Profit', '9', '', '', '', '', ''],\n  ['EnSolve Biosystems', 'https://www.crunchbase.com/organization/ensolve-biosystems', 'Biotechnology, Manufacturing, Water', 'Raleigh, North Carolina, United States', 'EnSolve Biosystems develops and manufactures solutions for filtering and cleaning maritime and industrial waste.', '690,181', '2009-12-01', '300000', 'USD', '300000', 'Debt Financing', '300000', 'USD', '300000', '51-100', 'Private', '', '', '', 'http://www.ensolve.com', '', 'info@ensolve.com', 'EnSolve Biosystems, Inc. is a biotechnology company that develops and manufactures solutions for filtering and cleaning maritime and industrial waste. The company’s products include PetroLiminator, which separates oil from water and GF 2010, a liquid detergent that dissolves and biologically consumes grease and oils. In addition, its products inlcude EnCell, which eliminates organic wastes from water; EnFlow, a technology that utilizes catalytic and biotechnology processes for filtering air; and OxiBlast that removes organic stains from water washable surfaces and fabrics. EnSolve was founded in 1995 and is based in Raleigh, North Carolina.', '', 'Biotechnology, Manufacturing, Natural Resources, Science and Engineering', 'Physical Or Chemical Processes Or Apparatus In General', '', 'Less than $1M', '1995-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', 'Jason Caplan', '', '1'],\n  ['Sea Lane Biotechnologies', 'https://www.crunchbase.com/organization/sea-lane-biotechnologies', 'Biotechnology, Health Care', 'Mountain View, California, United States', 'Sea Lane is the human bio-therapeutic platform technology.', '701,089', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.sealanebio.com', 'https://www.linkedin.com/company/sea-lane-biotechnologies', 'info@sealanebio.com', 'Sea Lane is the human bio-therapeutic platform technologies provide unique solutions for pressing therapeutic needs. Sea Lane technologies and inventions include the therapeutic class of entities known as Surrobodies and world-class human antibody libraries.  Each represents a bio-therapeutic platform which may be leveraged externally, via partnerships, or through internal discovery and development efforts to meet the rigorous requirements of creating a competitive product candidate pipeline.', '', 'Biotechnology, Health Care, Science and Engineering', 'Organic Chemistry', '', '', '2005-01-01', 'year', '', 'M&A', '', 'Active', 'For Profit', '', '', 'Was Acquired', '', '', ''],\n  ['Molecular Fitness', 'https://www.crunchbase.com/organization/molecular-fitness', 'Biotechnology, Fitness', 'Vancouver, Washington, United States', 'Molecular Fitness is your road map to your fitness goals.', '709,671', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://mtlfitness.com/', 'https://www.linkedin.com/company/3245204/', '', 'Molecular Fitness is your road map to your fitness goals. We use state-of-the-art technology to decode your genetic code, and apply years of research to create a nutrition and fitness plan uniquely designed for you. Your genetics determine how your body processes certain nutrients and they determine how you respond to different types of activity. By making yourself aware of these details, you can optimize your daily routine to ensure that your fitness and health goals are not only met, but exceeded.', '', 'Biotechnology, Science and Engineering, Sports', '', '', '', '', '', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['OtisMed', 'https://www.crunchbase.com/organization/otismed', 'Biotechnology, Health Care, Medical', 'Alameda, California, United States', 'OtisMed is a business unit of Stryker Orthopaedics that is focused on developing customizable instrumentation which has the potential to', '710,522', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://otismed.com', '', '', 'OtisMed is a business unit of Stryker Orthopaedics that is focused on developing customizable instrumentation which has the potential to complement the many benefits that surgeons and patients realize from the Stryker Triathlon Knee System as well as other Stryker implants.', '', 'Biotechnology, Health Care, Science and Engineering', 'Medical Or Veterinary Science; Hygiene', '', '', '2005-01-01', 'year', '', 'M&A', '', 'Closed', 'For Profit', '6', '', 'Was Acquired', '', '', ''],\n  ['Cyano Pharma', 'https://www.crunchbase.com/organization/cyano-pharma-b099', 'Pharmaceutical', 'Indore, West Virginia, United States', 'Cyano Pharma was established in the year 1965 as a Partnership Firm by a Technocrat and later on converted it in to a Proprietorship firm .', '719,719', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://cyanopharmagroup.com/', 'https://www.linkedin.com/company/cyano-pharma-pvt-ltd/about/', 'support@cyanopharmagroup.com', \"CYANO PHARMA was established in the year 1965 as a Partnership Firm by a Technocrat and later on converted it in to a Proprietorship firm . In the year 2000 it became a Private Limited Company, Cyano Pharma (P) Ltd; is one of India's leading Manufacturers of Generic &Patent Allopathic as well as AyurvedicPharma formulations, having sections of Tablets, Capsules, Oral Liquid, External Liquids,Ointments, Powders ,(O.R.S.) etc., The company having expertise in all field of manufacturing & supply mainly Ferrous Sulphate & Folic Acid Tablets , ORS mainly & many others products .Cyano Pharma (P)Ltd; supplies their products to Health Departments of all states as well as Domestic market.We Export our products since last 27 years .\", '', 'Health Care', '', '', '', '1965-04-04', 'day', '', '', '', 'Active', '', '', '', '', 'Cyano Pharma, Sandeep Shah', '', ''],\n  ['Demegen', 'https://www.crunchbase.com/organization/demegen', 'Pharmaceutical', 'Philadelphia, Pennsylvania, United States', 'Demegen  is a Pharmaceutical Company.', '743,310', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://demegen.com/', '', '', 'Almost every crop faces some fungal or bacterial problem. The effectiveness of Demegen’s technology in preventing crop diseases has been published by a number of independent researchers around the world. Success has been demonstrated against many important diseases, including Rhizoctonia, Phytophthora, and Erwinia. Currently, farmers spend $6 billion annually to treat these diseases with chemical sprays. Since the core patents and technology are established, Demegen is licensing this technology and expects to receive future royalties as individual crops are commercialized. Developing a new variety of a crop requires technical expertise specific to that crop. Scientists from the United States Department of Agriculture, universities, and private companies are applying Demegen technologies to a variety of crops including: apples, banana, calla, cocoa, cotton, dogwood, eucalyptus, flowering cherry, grapes, papaya, peanuts, pears, potato, soybean, spruce, strawberry, sugarcane, turfgrass, and wheat.', '', 'Health Care', 'Organic Chemistry', '', '', '1992-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['International Serum Industry Association', 'https://www.crunchbase.com/organization/international-serum-industry-association', 'Biotechnology', 'Mchenry, Maryland, United States', 'The International Serum Industry Association was formed in June 2006 with a specific focus on the Serum Industry.', '777,557', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.serumindustry.org', '', 'info@serumindustry.org', 'The International Serum Industry Association was formed in June 2006 with a specific focus on the Serum Industry. Since that time the scope of the Association has broadened to include all animal derived products for use in the multibillion dollar life science and biomedical sectors.', '', 'Biotechnology, Science and Engineering', '', '', 'Less than $1M', '', '', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['Adello Biologics', 'https://www.crunchbase.com/organization/adello-biologics', 'Biotechnology, Pharmaceutical', 'Piscataway, New Jersey, United States', 'Pharmaceuticals', '810,416', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', '', '', '', \"Adello is a privately held, U.S.-based biotechnology company that leads with science to accelerate development and drive manufacturing efficiency. The company's aim is to provide high-quality, affordable biosimilars to patients worldwide. Headquartered in Piscataway, NJ and driven by a team of highly skilled industry veterans, Adello is advancing a strategic pipeline of proteins and complex monoclonal antibodies with lead candidates in oncology and immunology. For more information, visit Adellobio.com.\", '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2012-01-01', 'year', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['US Pain and Spine Institute', 'https://www.crunchbase.com/organization/us-pain-and-spine-institute', 'Biotechnology, Health Care, Life Science, Medical', 'Houston, Texas, United States', 'Our physicians specialize in comprehensive pain medicine, including conservative medical management and minimally invasive procedures.', '853,144', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'https://uspshealthcare.com/', '', '', 'Our board-certified physicians (members of USPS Medical Associates) specialize in comprehensive pain medicine, including conservative medical management and minimally invasive procedures. Our mission is to accurately diagnose and treat chronic pain to provide patients with effective, long-term relief.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', 'Less than $1M', '', '', '', '', '', 'Active', 'For Profit', '', '', '', '', '', ''],\n  ['Numoda', 'https://www.crunchbase.com/organization/numoda', 'Biotechnology, Health Care, Information Technology', 'Philadelphia, Pennsylvania, United States', 'Numoda is the pioneer of a new model for supporting life sciences companies', '953,749', '', '', '', '', '', '', '', '', '51-100', 'Private', '', '', '', 'http://www.numoda.com/', '', '', 'Numoda is the pioneer of a new model for supporting life sciences companies as they move from clinical development of innovative treatments to ultimate relationships with marketing partners.  Their model aligns with both sponsor and vendor needs, addressing the broader issues that active and complex clinical trials face, by providing a single integrated location for entire trial. The Numoda approach – which has been proven across scores of relationships – calls for Numoda to share the risk with promising life sciences companies by assisting in business functions such as budgeting and logistics, and to apply patented information technologies and management expertise to achieve the successful completion of vital clinical trials. We even invest in select programs each year. The result is a unique partnership between Numoda’s finance, technology, and trial management specialists and innovative companies that, in the process, become better able to develop life-enhancing and life-saving treatments for the health of consumers of the future', '', 'Biotechnology, Health Care, Information Technology, Science and Engineering', '', '', '', '1996-01-01', 'year', '', '', '', 'Closed', 'For Profit', '', '', '', '', '', ''],\n  ['Secant Therapeutics', 'https://www.crunchbase.com/organization/secant-therapeutics', 'Biotechnology, Pharmaceutical, Therapeutics', 'Basking Ridge, New Jersey, United States', 'Secant Therapeutics develops a percutaneous transcatheter direct plication annuloplasty (DPA) device.', '1,166,168', '2011-01-19', '150000', 'USD', '150000', 'Seed', '150000', 'USD', '150000', '51-100', 'Private', '', '', '', '', '', '', 'Secant Therapeutics, Inc. develops a percutaneous transcatheter direct plication annuloplasty (DPA) device. The company was incorporated in 2010 and is based in Basking Ridge, New Jersey.', '', 'Biotechnology, Health Care, Science and Engineering', '', '', '', '2010-01-01', 'year', '', 'Seed', '', 'Active', 'For Profit', '', '', '', '', '', '1']     \n];\n\n  return (\n    <React.Fragment>\n      <FormControl\n        style={{ marginLeft: 10 }}\n      >\n        <InputLabel id=\"demo-simple-select-label\">Responsive Option</InputLabel>\n        <Select\n          labelId=\"demo-simple-select-label\"\n          id=\"demo-simple-select\"\n          value={responsive}\n          style={{ width: \"200px\", marginBottom: \"10px\", marginRight: 10 }}\n          onChange={(e) => setResponsive(e.target.value)}\n        >\n          <MenuItem value={\"vertical\"}>vertical</MenuItem>\n          <MenuItem value={\"standard\"}>standard</MenuItem>\n          <MenuItem value={\"simple\"}>simple</MenuItem>\n\n          <MenuItem value={\"scroll\"}>scroll (deprecated)</MenuItem>\n          <MenuItem value={\"scrollMaxHeight\"}>\n            scrollMaxHeight (deprecated)\n          </MenuItem>\n          <MenuItem value={\"stacked\"}>stacked (deprecated)</MenuItem>\n        </Select>\n      </FormControl>\n      <FormControl\n        style={{ marginLeft: 10 }}\n      >\n        <InputLabel id=\"demo-simple-select-label\">Table Body Height</InputLabel>\n        <Select\n          labelId=\"demo-simple-select-label\"\n          id=\"demo-simple-select\"\n          value={tableBodyHeight}\n          style={{ width: \"200px\", marginBottom: \"10px\", marginRight: 10 }}\n          onChange={(e) => setTableBodyHeight(e.target.value)}\n        >\n          <MenuItem value={\"\"}>[blank]</MenuItem>\n          <MenuItem value={\"400px\"}>400px</MenuItem>\n          <MenuItem value={\"800px\"}>800px</MenuItem>\n          <MenuItem value={\"100%\"}>100%</MenuItem>\n        </Select>\n      </FormControl>\n      <MUIDataTable\n        title={\"CB\"}\n        data={data}\n        columns={columns}\n        options={options}\n      />\n    </React.Fragment>\n  );\n}\n\nexport default App;\n","const reportWebVitals = onPerfEntry => {\n  if (onPerfEntry && onPerfEntry instanceof Function) {\n    import('web-vitals').then(({ getCLS, getFID, getFCP, getLCP, getTTFB }) => {\n      getCLS(onPerfEntry);\n      getFID(onPerfEntry);\n      getFCP(onPerfEntry);\n      getLCP(onPerfEntry);\n      getTTFB(onPerfEntry);\n    });\n  }\n};\n\nexport default reportWebVitals;\n","import React from 'react';\nimport ReactDOM from 'react-dom';\nimport './index.css';\nimport App from './App';\nimport reportWebVitals from './reportWebVitals';\n\nReactDOM.render(\n  <React.StrictMode>\n    <App />\n  </React.StrictMode>,\n  document.getElementById('root')\n);\n\n// If you want to start measuring performance in your app, pass a function\n// to log results (for example: reportWebVitals(console.log))\n// or send to an analytics endpoint. Learn more: https://bit.ly/CRA-vitals\nreportWebVitals();\n"],"sourceRoot":""}